Citrus Sinensis ID: 009543
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 532 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAL3 | 649 | Cysteine-rich receptor-li | yes | no | 0.981 | 0.804 | 0.707 | 0.0 | |
| Q9CAL2 | 646 | Cysteine-rich receptor-li | no | no | 0.913 | 0.752 | 0.459 | 1e-124 | |
| Q9FNE1 | 651 | Cysteine-rich receptor-li | no | no | 0.919 | 0.751 | 0.453 | 1e-121 | |
| Q9M0G5 | 625 | Putative cysteine-rich re | no | no | 0.932 | 0.793 | 0.402 | 1e-106 | |
| Q9LMB9 | 615 | Cysteine-rich receptor-li | no | no | 0.915 | 0.791 | 0.416 | 1e-105 | |
| Q9T0J1 | 665 | Cysteine-rich receptor-li | no | no | 0.847 | 0.678 | 0.374 | 5e-79 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.936 | 0.737 | 0.353 | 5e-77 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.894 | 0.759 | 0.356 | 2e-76 | |
| Q8S9L6 | 679 | Cysteine-rich receptor-li | no | no | 0.855 | 0.670 | 0.361 | 2e-76 | |
| O49564 | 642 | Cysteine-rich receptor-li | no | no | 0.902 | 0.747 | 0.353 | 6e-76 |
| >sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 761 bits (1964), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/526 (70%), Positives = 441/526 (83%), Gaps = 4/526 (0%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
+FL+ SL ++ GD R V +TC LEHN + +VPNFV TME IS Q++TSGFG+
Sbjct: 17 LMFLLSSLR---QITGDARARAVKVTCSPLLEHNETAYVPNFVATMEKISTQVQTSGFGV 73
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
A+TG+G D NYGLAQCYGDL L DCVLCYAEART+LPQCYP NGGRI+LDGCFMR+ENYS
Sbjct: 74 ALTGTGPDANYGLAQCYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYS 133
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F+ EY+GPED VCGN TRKN +F ++ R+ + AV A GGYAR + + ++SA
Sbjct: 134 FYNEYKGPEDSIVCGNTTRKNKTFGDAVRQGLRNAVTEASGTGGYARASAKAGESESESA 193
Query: 185 YVLVNCWKTLNSSSCEACLANASASIL-GCLPWSEGRALNTGCFMRYSDKDFLNKEPGKG 243
+VL NCW+TL+ SC+ CL NASAS++ GCLPWSEGRAL+TGCF+RYSD+DFLNK P G
Sbjct: 194 FVLANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFLNKIPRNG 253
Query: 244 RSRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNF 303
RSRG + IVVSV+S++VV +G+ + + K+R+I+RKRRGS D EK+ KTL D SLNF
Sbjct: 254 RSRGSVVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNF 313
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNII 363
KYSTLEKATGSFD ANKLGQGGFGTVYKGVLPDGR+IAVKRLFFNNRHRA +FYNEVN+I
Sbjct: 314 KYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYNEVNMI 373
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
S+VEHKNLVRLLGCSCSGPESLLVYE+L N+SLDRFIFD + KTL W++RY II+GT E
Sbjct: 374 STVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAE 433
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GLVYLHEQS ++IIHRDIKASNILLDS+L+AKIADFGLARSFQ+DKSHISTAIAGTLGYM
Sbjct: 434 GLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTLGYM 493
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT 529
APEYLAHGQLTE DVYSFG+L+LEIVTG+QN +SK S+Y+DSL+T
Sbjct: 494 APEYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLIT 539
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1142), Expect = e-124, Method: Compositional matrix adjust.
Identities = 236/514 (45%), Positives = 323/514 (62%), Gaps = 28/514 (5%)
Query: 21 DPRVHTVNITCGHQL--EHNSSIFVPNFVTTMENISEQMRTSGFGLAVTGSGLDINYGLA 78
D R TV C ++ S+FV NF+ M+ +S + G+G V G+G Y
Sbjct: 21 DSRGDTVAQICNNRTTTPQQRSLFVTNFLAAMDAVSPLVEAKGYGQVVNGTGNLTVYAYG 80
Query: 79 QCYGDLSLLDCVLCYAEARTLLPQCYPYN----GGRIYLDGCFMRSENYSFFGEYEGPED 134
+C DL DC LC+A+ + +P+C P+ GG+++ DGC++R ++Y+F+ E +D
Sbjct: 81 ECIKDLDKKDCDLCFAQIKAKVPRCLPFQKGTRGGQVFSDGCYIRYDDYNFYNETLSLQD 140
Query: 135 RAVCG----NGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNC 190
R VC G + + F+++A + V A NGG+ V N + + L C
Sbjct: 141 RTVCAPKEITGVNR-TVFRDNAAELVKNMSVEAVRNGGFYAGFVD---RHNVTVHGLAQC 196
Query: 191 WKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKE-------PGKG 243
W+TLN S C CL+ AS I CL EGR L+ GC+MR+S + F N G
Sbjct: 197 WETLNRSGCVECLSKASVRIGSCLVNEEGRVLSAGCYMRFSTQKFYNNSGNSTSDGNGGH 256
Query: 244 RSRGMIAAIVVSVVS-ALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLN 302
G+I A+ SVV+ L+V A G ++ R K++ E+K+ GS L N +L
Sbjct: 257 NHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAKKQR-EKKQLGS-----LFMLANKSNLC 310
Query: 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI 362
F Y LE+AT F + NKLGQGG G+VYKGVL +G+ +AVKRLFFN + +F+NEVN+
Sbjct: 311 FSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEVNL 370
Query: 363 ISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV 422
IS V+HKNLV+LLGCS +GPESLLVYE++ NQSL ++F + L W KR++IILGT
Sbjct: 371 ISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWAKRFKIILGTA 430
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
EG+ YLHE+S +RIIHRDIK SNILL+ +IADFGLAR F EDK+HISTAIAGTLGY
Sbjct: 431 EGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHISTAIAGTLGY 490
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516
MAPEY+ G+LTEKADVYSFG+L++E++TG++NN
Sbjct: 491 MAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNN 524
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1123), Expect = e-121, Method: Compositional matrix adjust.
Identities = 237/523 (45%), Positives = 312/523 (59%), Gaps = 34/523 (6%)
Query: 4 AFLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSI-FVPNFVTTMENISEQMRTSGF 62
+F FL L + D R + CG + + ++ ++P FV M ++S ++ T F
Sbjct: 18 SFFFLP----FLSSSSDDQRTTVSGLFCGGRSKSSADPNYIPTFVEDMHSLSLKLTTRRF 73
Query: 63 GLAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSEN 122
S I Y L QC+ DLS DC LCYA ART +P+C P + RI+LDGCF+R E
Sbjct: 74 ATESLNSTTSI-YALIQCHDDLSPSDCQLCYAIARTRIPRCLPSSSARIFLDGCFLRYET 132
Query: 123 YSFFGE-YEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAAN 181
Y F+ E D C N T + F + R A GG+ A
Sbjct: 133 YEFYDESVSDASDSFSCSNDTVLDPRFGFQVSETAARV---AVRKGGFGV-------AGE 182
Query: 182 KSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPG 241
+ L CW++L C CL A + C+ EGRA+NTGC++RYSD F N G
Sbjct: 183 NGVHALAQCWESLGKEDCRVCLEKAVKEVKRCVSRREGRAMNTGCYLRYSDHKFYN---G 239
Query: 242 KGR-------SRGMIAAIVVSVVS-ALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLV 293
G ++G+I AIV++ + +++L VI T+V K + E++ G +
Sbjct: 240 DGHHKFHVLFNKGVIVAIVLTTSAFVMLILLATYVIMTKVSKTKQ-EKRNLG-----LVS 293
Query: 294 KTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA 353
+ N+ FKY TLEKAT F LGQGG GTV+ G+LP+G+ +AVKRL FN R
Sbjct: 294 RKFNNSKTKFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAVKRLVFNTRDWV 353
Query: 354 ANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK 413
F+NEVN+IS ++HKNLV+LLGCS GPESLLVYE++PN+SLD+F+FD +++K L W +
Sbjct: 354 EEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFDESQSKVLNWSQ 413
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473
R IILGT EGL YLH S +RIIHRDIK SN+LLD +L KIADFGLAR F DK+H+S
Sbjct: 414 RLNIILGTAEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLARCFGLDKTHLS 473
Query: 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516
T IAGTLGYMAPEY+ GQLTEKADVYSFG+L+LEI G + N
Sbjct: 474 TGIAGTLGYMAPEYVVRGQLTEKADVYSFGVLVLEIACGTRIN 516
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (987), Expect = e-106, Method: Compositional matrix adjust.
Identities = 216/537 (40%), Positives = 317/537 (59%), Gaps = 41/537 (7%)
Query: 23 RVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLAVTGSGLDINYGLAQCYG 82
R+ + C + N + ++ ++ I MR FG G + Y L+QC
Sbjct: 28 RIDVLGYICNNGTVSNEEAYRRSYQINLDAIRGDMRHVKFGTHEHGDPPERMYVLSQCVS 87
Query: 83 DLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYEGPEDRAVCGNGT 142
DLS +C LC++ A LL QC+P GG +LDGCF+R++NYSF+ E +D +C +
Sbjct: 88 DLSSDECSLCWSRATDLLSQCFPATGGWFHLDGCFVRADNYSFYQEPVSHQDTKICASDK 147
Query: 143 RKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSSSCEAC 202
K++ F+ ++ V +AP + G++ ++ G + + Y L CW+TLN C+ C
Sbjct: 148 EKSAEFKGLVKEVTKSIVEAAPYSRGFSVAKM---GIRDLTVYGLGVCWRTLNDELCKLC 204
Query: 203 LANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGRSRGMIAA----------I 252
LA+ + S+ CLP EG ALN GC++RYS+ F N+ RG++A
Sbjct: 205 LADGALSVTSCLPSKEGFALNAGCYLRYSNYTFYNE-------RGLLAMSFTKENLTYIF 257
Query: 253 VVSVVSALVVLAVGIVIGTRVWKQRSIERKRR----------GSNDAEKLVKTLNDDS-- 300
V+S+V L + A G G + + S ++K + G EK +++ +S
Sbjct: 258 VISMVGVLAI-AAGFWCGKCFYMRTSPKKKIKGTKTKKFHLFGHLRIEKESESICTESHL 316
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEV 360
++F+YSTL+KAT +F+E+ KLG GG+G V+KG L DGREIA+KRL + + +NE+
Sbjct: 317 MSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEI 376
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
++IS +HKNLVRLLGC + S +VYEFL N SLD +F+ K K L W+KR IILG
Sbjct: 377 DVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILG 436
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI------ST 474
T EGL YLHE K IIHRDIKASNILLD + + KI+DFGLA+ + E I +
Sbjct: 437 TAEGLEYLHETCK--IIHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPS 494
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
+IAGTLGYMAPEY++ G+L+ K D YSFG+L+LEI +G +NN+ ++ ++L+T V
Sbjct: 495 SIAGTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNSLETLVTQV 551
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 381 bits (978), Expect = e-105, Method: Compositional matrix adjust.
Identities = 218/524 (41%), Positives = 305/524 (58%), Gaps = 37/524 (7%)
Query: 11 SLLMLVRVAGDPRVHTVNITC---GHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLAVT 67
S L+L+ G + C H L + S + F+ M ++++ + L V
Sbjct: 15 SFLVLLATVGSSSSSESLLNCQPLDHHLVNPSRLL--GFLRAMSSVNDFITNDK--LWVV 70
Query: 68 GSGLDIN---YGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
S D++ Y QC DLS+ DC C+ E+R L + +GGRI+ D CF+R ++
Sbjct: 71 SSITDVSPPIYVFLQCREDLSVSDCRHCFNESRLELERKCSGSGGRIHSDRCFLRFDDRD 130
Query: 125 FFGEYEGPE-DRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKS 183
F E+ P D+A C F +A++ A NGG+ V ++
Sbjct: 131 FSEEFVDPTFDKANCEETGTGFGEFWRFLDEALVNVTLKAVKNGGFGAASV----IKTEA 186
Query: 184 AYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLN----KE 239
Y L CW+TL+ ++C CL NA +S+ C E RA TGC+++YS F + +
Sbjct: 187 VYALAQCWQTLDENTCRECLVNARSSLRAC-DGHEARAFFTGCYLKYSTHKFFDDAAEHK 245
Query: 240 PGKGRSRGMIAAIVVSV----VSALVVLAVGIVIGTRV---WKQRSIERKRRGSNDAEKL 292
P + + ++ + V+ L + A+ + I T + R + RKR+ +
Sbjct: 246 PDADQRNFIRSSFFPHLSDRDVTRLAIAAISLSILTSLGAFISYRRVSRKRKAQVPS--- 302
Query: 293 VKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR 352
+NFKY LEKAT SF ++ KLGQGG G+VYKG+LPDGR +AVK+LFFN R
Sbjct: 303 -------CVNFKYEMLEKATESFHDSMKLGQGGAGSVYKGILPDGRIVAVKKLFFNTREW 355
Query: 353 AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE 412
A F+NEVN+IS V+HKNLVRLLGCS GP+SLLVYE++ N+SLD+ +F L+W+
Sbjct: 356 ADQFFNEVNLISGVQHKNLVRLLGCSIEGPKSLLVYEYVHNRSLDQILFMKNTVHILSWK 415
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472
+R+ II+G EGL YLH S+++IIHRDIK SNILLD L KIADFGL RS DK+
Sbjct: 416 QRFNIIIGISEGLEYLHRGSEVKIIHRDIKTSNILLDRNLSPKIADFGLIRSMGTDKTQT 475
Query: 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516
+T IAGTLGY+APEYL GQLTEKADVY+FG+L++EIVTG++NN
Sbjct: 476 NTGIAGTLGYLAPEYLIKGQLTEKADVYAFGVLIIEIVTGKKNN 519
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (756), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 182/486 (37%), Positives = 265/486 (54%), Gaps = 35/486 (7%)
Query: 62 FGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEA-RTLLPQCYPYNGGRIYLDGCFMRS 120
+ ++V S +N ++QC GD+ L C+ C A A + L+ C I+ D C R
Sbjct: 66 YNISVGDSDEKVN-SISQCRGDVKLEVCINCIAMAGKRLVTLCPVQKEAIIWYDKCTFRY 124
Query: 121 ENYSFFGEYEGPEDRAVCG--NGTRKNSSFQESARKAV--MRAVASAPSNGGYARVQVQV 176
N + F E ++ G N T S+++S R + ++ AS V +
Sbjct: 125 SNRTIFNRLEISPHTSITGTRNFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGET 184
Query: 177 SGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGR-ALNTGCFMRYSDKDF 235
SG + ++ + LV C ++ C CL+ A I C G ++ C + Y+ F
Sbjct: 185 SGPSFQTLFGLVQCTPDISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRF 244
Query: 236 LNK--------------EPGKG---------RSRGMIAAIVVSVVSALVVLAVGIVIGTR 272
+ P K ++RG+ A++ + S + ++ + IV+
Sbjct: 245 YDPVDTDDPSSVPATPSRPPKNETRSVTQGDKNRGVPKALIFASAS-VAIVVLFIVLLVV 303
Query: 273 VWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKG 332
K R E R N E + ++ DS+ F +S L+ AT F NKLG+GGFG VYKG
Sbjct: 304 FLKLRRKENIRNSENKHEN--ENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKG 361
Query: 333 VLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392
VL DG++IAVKRL N + F NE +++ ++H+NLV+LLG S G E LLVYEFLP
Sbjct: 362 VLSDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLP 421
Query: 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452
+ SLD+FIFD + L WE RY+II G GL+YLH+ S++RIIHRD+KASNILLD +
Sbjct: 422 HTSLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEM 481
Query: 453 RAKIADFGLARSFQEDKS--HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510
KIADFG+AR F D + + I GT GYMAPEY+ HGQ + K DVYSFG+L+LEI+
Sbjct: 482 TPKIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEII 541
Query: 511 TGRQNN 516
+G++N+
Sbjct: 542 SGKKNS 547
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (738), Expect = 5e-77, Method: Compositional matrix adjust.
Identities = 195/552 (35%), Positives = 285/552 (51%), Gaps = 54/552 (9%)
Query: 6 LFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQ--MRTSGFG 63
LF V ++L V DP + +I +S ++ N T + ++S S F
Sbjct: 11 LFSVFLFMILKTVTSDP-TYLYHICPNTTTYSRNSSYLTNLRTVLSSLSSPNAAYASLFD 69
Query: 64 LAVTGSGLDIN--YGLAQCYGDLSLLDCVLCYA-EARTLLPQCYPYNGGRIYLDGCFMRS 120
A G D N YG+ C GD+S C C A A L +C I+ D C +R
Sbjct: 70 NAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRY 129
Query: 121 ENYSFFGEYE-GPEDRAVCGNGTRKN--SSFQESARKAVMR-AVASAPSNGGYARVQVQV 176
N S G+ P +N S F ES ++ AV +A S+ +A +
Sbjct: 130 SNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANF 189
Query: 177 SGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEG-RALNTGCFMRYSDKDF 235
+ ++ Y LV C L + CE+CL + C S G R + C RY F
Sbjct: 190 T--VFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPF 247
Query: 236 LNK------------------------EPGKGRSRGMIAAIVVSVVSALVVLAVGIVIGT 271
N+ E GKG++ +I + VS V+L +G
Sbjct: 248 YNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLL-----LGA 302
Query: 272 RVWKQRSIERKRRGSNDAEKLVKTLNDD------SLNFKYSTLEKATGSFDEANKLGQGG 325
W + R+R AE + L++D +L F++S +E AT F E+NKLG GG
Sbjct: 303 MCWL---LARRRNNKLSAE--TEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGG 357
Query: 326 FGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385
FG VYKG L G +A+KRL + A F NEV++++ ++H+NL +LLG G E +
Sbjct: 358 FGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKI 417
Query: 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445
LVYEF+PN+SLD F+FD+ K + L W++RY+II G G++YLH S++ IIHRD+KASN
Sbjct: 418 LVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASN 477
Query: 446 ILLDSRLRAKIADFGLARSFQEDKSHISTA-IAGTLGYMAPEYLAHGQLTEKADVYSFGM 504
ILLD+ + KI+DFG+AR F D++ +T I GT GYM+PEY HG+ + K+DVYSFG+
Sbjct: 478 ILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGV 537
Query: 505 LLLEIVTGRQNN 516
L+LE++TG++N+
Sbjct: 538 LVLELITGKKNS 549
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 286 bits (733), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 188/528 (35%), Positives = 271/528 (51%), Gaps = 52/528 (9%)
Query: 39 SSIFVPNFVTTMENIS--EQMRTSGFGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYA-E 95
+S ++ N T + ++S ++GF A G D GL C GD+S C C A
Sbjct: 40 NSPYLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDVSPAVCRNCVAFS 99
Query: 96 ARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGE--YEGPEDR-----AVCGNGTRKNSSF 148
L QC Y D C +R + + Y+G R ++ N + F
Sbjct: 100 INDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIRMNGNISIDQNQMNRFKDF 159
Query: 149 QESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSSSCEACLANASA 208
S AS+P V+ + A ++ Y LV C L C +CL S+
Sbjct: 160 VSSTMNQAAVKAASSPRK----FYTVKATWTALQTLYGLVQCTPDLTRQDCFSCLE--SS 213
Query: 209 SILGCLPWSEGRALNTGCFMRYSDKDFLNKE------------------------PGKG- 243
L L + GR L + C RY F N+ PGK
Sbjct: 214 IKLMPLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPLVTSPSLPGKSW 273
Query: 244 RSRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLV-KTLNDDSLN 302
S ++ AIV++++ A ++L G RV + S++A + +SL
Sbjct: 274 NSNVLVVAIVLTILVAALLLIAGYCFAKRV---------KNSSDNAPAFDGDDITTESLQ 324
Query: 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI 362
Y + AT F E NK+GQGGFG VYKG +G E+AVKRL ++ F NEV +
Sbjct: 325 LDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQGDTEFKNEVVV 384
Query: 363 ISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV 422
++ ++H+NLVRLLG S G E +LVYE++PN+SLD F+FD AK L W +RY++I G
Sbjct: 385 VAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDWTRRYKVIGGIA 444
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA-IAGTLG 481
G++YLH+ S++ IIHRD+KASNILLD+ + K+ADFGLAR F D++ +T+ I GT G
Sbjct: 445 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQENTSRIVGTFG 504
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT 529
YMAPEY HGQ + K+DVYSFG+L+LEI++G++NN ++ L+T
Sbjct: 505 YMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVT 552
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (733), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 180/498 (36%), Positives = 260/498 (52%), Gaps = 43/498 (8%)
Query: 75 YGLAQCYGDLSLLDCVLCY-AEARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYE-GP 132
Y + C ++ DCV C AR L QC ++ C R N + +G E P
Sbjct: 83 YAIGLCRREVKRDDCVSCIQTAARNLTKQCPLTKQAVVWYTHCMFRYSNRTIYGRKETNP 142
Query: 133 EDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAAN---KSAYVLVN 189
+ G N E ++ ++ + + GG R Q +G+A+ + Y V
Sbjct: 143 TKAFIAGEEISANRDDFERLQRGLLDRLKGIAAAGGPNRKYAQGNGSASAGYRRFYGTVQ 202
Query: 190 CWKTLNSSSCEACLANASASILGCLPWSEG-RALNTGCFMRYS-------DKDFLNKEP- 240
C L+ C CL +I C G R + C R+ D D P
Sbjct: 203 CTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRWFSPSCNFRFETWRFYEFDADLEPDPPA 262
Query: 241 ------------------GKGRSRGMIAAIVVSVVSALVVLAVGIVIGTRV----WKQRS 278
GKG S+ +IA ++ ++ AL+ + + +V+ R +K +
Sbjct: 263 IQPADSPQSAARTERTGKGKGGSKVIIAIVIPILLVALLAICLCLVLKWRKNKSGYKNKV 322
Query: 279 IERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGR 338
+ + + AE N +SL + TL+ AT +F N+LG+GGFG+VYKGV P G+
Sbjct: 323 LGKSPLSGSIAEDEFS--NTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQ 380
Query: 339 EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398
EIAVKRL N+ F NE+ +++ ++H+NLVRL+G G E LLVYEF+ N SLD+
Sbjct: 381 EIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQ 440
Query: 399 FIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458
FIFD+ K + L W RY++I G GL+YLHE S+ RIIHRD+KASNILLD + KIAD
Sbjct: 441 FIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIAD 500
Query: 459 FGLARSFQEDKS---HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515
FGLA+ F ++ ++ IAGT GYMAPEY HGQ + K DV+SFG+L++EI+TG++N
Sbjct: 501 FGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRN 560
Query: 516 NR--SKNSEYTDSLLTIV 531
N S E + LL+ V
Sbjct: 561 NNGGSNGDEDAEDLLSWV 578
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 6e-76, Method: Compositional matrix adjust.
Identities = 190/537 (35%), Positives = 283/537 (52%), Gaps = 57/537 (10%)
Query: 24 VHTVNITCGHQLEHNSS--IFVPNFVTTMENISEQMRTSGF-GLAVTGSGLDINYGLAQC 80
VHT+ G N+S + + ++++ +++ + +GF +++ G ++N +A C
Sbjct: 30 VHTICYYDGGNFTSNTSYSLNLNRLISSLPDLTPTI--NGFYNISING---EVN-AIALC 83
Query: 81 YGDLSL-LDCVLCYAEA-RTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYEGPEDRAVC 138
GD+ DC+ C A + L+ C I+L+ C R + G+ E V
Sbjct: 84 RGDVKPNQDCISCITTAAKQLVESCPNIIEANIWLEKCMFRYTSRIILGQME-----PVP 138
Query: 139 GNGTRKNSSF--QESARKAVMRAVAS--APSNGGYARVQVQVSGAANKSAYVLVNCWKTL 194
+ T N S +E K + + S A + +V+ + + Y L C L
Sbjct: 139 FSYTSSNVSVTDKEGFSKGLGDLLDSLGAKIDAANETKEVKFAAGVKGTIYALAQCTPDL 198
Query: 195 NSSSCEACLANASASILGCLPW-SEGRALNTGCFMRYSDKDFLN-------KEP------ 240
+ S C CLA A + C + G N C+ R+ F + K+P
Sbjct: 199 SESDCRICLAQIFAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQKQPLSSHNN 258
Query: 241 ---------GKGRSRGMIAAIV--VSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDA 289
K RS+ +I A+V V+++ LV L + + +++ K N+
Sbjct: 259 NTRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKR-----RRKKKTLKENAENEF 313
Query: 290 EKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN 349
E + DSL+F + T+ AT F NK+G+GGFG VYKG LPDG EIAVKRL ++
Sbjct: 314 E------STDSLHFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHS 367
Query: 350 RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTL 409
A F EV +++ ++HKNLV+L G S E LLVYEF+PN SLDRF+FD K K L
Sbjct: 368 GQGNAEFKTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQL 427
Query: 410 TWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469
WEKRY II+G GL+YLHE S+ IIHRD+K+SN+LLD ++ KI+DFG+AR F D
Sbjct: 428 DWEKRYNIIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDN 487
Query: 470 SH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTD 525
+ ++ + GT GYMAPEY HG+ + K DVYSFG+L+LEI+TG++N+ E TD
Sbjct: 488 TQAVTRRVVGTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNSGLGLGEGTD 544
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 532 | ||||||
| 297739087 | 696 | unnamed protein product [Vitis vinifera] | 0.986 | 0.754 | 0.783 | 0.0 | |
| 225425605 | 654 | PREDICTED: cysteine-rich receptor-like p | 0.986 | 0.802 | 0.783 | 0.0 | |
| 147767573 | 654 | hypothetical protein VITISV_005913 [Viti | 0.990 | 0.805 | 0.783 | 0.0 | |
| 225425609 | 654 | PREDICTED: cysteine-rich receptor-like p | 0.990 | 0.805 | 0.783 | 0.0 | |
| 224144143 | 651 | predicted protein [Populus trichocarpa] | 0.988 | 0.807 | 0.787 | 0.0 | |
| 224107811 | 634 | predicted protein [Populus trichocarpa] | 0.956 | 0.802 | 0.772 | 0.0 | |
| 147765333 | 665 | hypothetical protein VITISV_031461 [Viti | 0.988 | 0.790 | 0.759 | 0.0 | |
| 356497745 | 652 | PREDICTED: cysteine-rich receptor-like p | 0.966 | 0.788 | 0.776 | 0.0 | |
| 356565986 | 626 | PREDICTED: cysteine-rich receptor-like p | 0.962 | 0.817 | 0.768 | 0.0 | |
| 357485785 | 646 | Cysteine-rich receptor-like protein kina | 0.964 | 0.794 | 0.735 | 0.0 |
| >gi|297739087|emb|CBI28576.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2259), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/526 (78%), Positives = 461/526 (87%), Gaps = 1/526 (0%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
FLF++ +L ++ AGDPR + ITC +Q EHNS+IFVPNFV MENIS Q+RTSGFG+
Sbjct: 85 FLFII-TLSVIELSAGDPRSRMIQITCANQPEHNSTIFVPNFVAMMENISNQVRTSGFGV 143
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
A++GSG D NYGLAQCYGDLSLLDCVLCYAEART+LPQC+PYNGGRIYLDGCFMR++NYS
Sbjct: 144 AISGSGPDANYGLAQCYGDLSLLDCVLCYAEARTVLPQCFPYNGGRIYLDGCFMRAQNYS 203
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 204 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVIVPGTANESA 263
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL +CW+TLN+SSC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 264 YVLADCWRTLNASSCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 323
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG + IVV VSA++VL V IG +WKQR I++KRRGSNDA KLVKTL+D SLNFK
Sbjct: 324 SRGTVIIIVVPAVSAVIVLLVLGAIGVYIWKQRKIQKKRRGSNDAIKLVKTLHDSSLNFK 383
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
Y+TLEKATGSFD NKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIIS
Sbjct: 384 YATLEKATGSFDNENKLGQGGFGTVYKGVLTDGREIAVKRLFFNNRHRAADFYNEVNIIS 443
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
SVEHKNLVRLLGCSCSGPESLLVYE+LPN+SLDRFIFD+ + K L WEKR EII+GT EG
Sbjct: 444 SVEHKNLVRLLGCSCSGPESLLVYEYLPNKSLDRFIFDTNRGKALNWEKRCEIIIGTAEG 503
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L YLHE S RIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSHI+TAIAGTLGYMA
Sbjct: 504 LAYLHENSTNRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSHITTAIAGTLGYMA 563
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530
PEYLAHGQLTEK DVYSFG+LLLEIVTGRQNNRSK SEY+DS++TI
Sbjct: 564 PEYLAHGQLTEKVDVYSFGVLLLEIVTGRQNNRSKTSEYSDSIVTI 609
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425605|ref|XP_002265829.1| PREDICTED: cysteine-rich receptor-like protein kinase 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2258), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/526 (78%), Positives = 461/526 (87%), Gaps = 1/526 (0%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
FLF++ +L ++ AGDPR + ITC +Q EHNS+IFVPNFV MENIS Q+RTSGFG+
Sbjct: 17 FLFII-TLSVIELSAGDPRSRMIQITCANQPEHNSTIFVPNFVAMMENISNQVRTSGFGV 75
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
A++GSG D NYGLAQCYGDLSLLDCVLCYAEART+LPQC+PYNGGRIYLDGCFMR++NYS
Sbjct: 76 AISGSGPDANYGLAQCYGDLSLLDCVLCYAEARTVLPQCFPYNGGRIYLDGCFMRAQNYS 135
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 136 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVIVPGTANESA 195
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL +CW+TLN+SSC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 196 YVLADCWRTLNASSCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 255
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG + IVV VSA++VL V IG +WKQR I++KRRGSNDA KLVKTL+D SLNFK
Sbjct: 256 SRGTVIIIVVPAVSAVIVLLVLGAIGVYIWKQRKIQKKRRGSNDAIKLVKTLHDSSLNFK 315
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
Y+TLEKATGSFD NKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIIS
Sbjct: 316 YATLEKATGSFDNENKLGQGGFGTVYKGVLTDGREIAVKRLFFNNRHRAADFYNEVNIIS 375
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
SVEHKNLVRLLGCSCSGPESLLVYE+LPN+SLDRFIFD+ + K L WEKR EII+GT EG
Sbjct: 376 SVEHKNLVRLLGCSCSGPESLLVYEYLPNKSLDRFIFDTNRGKALNWEKRCEIIIGTAEG 435
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L YLHE S RIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSHI+TAIAGTLGYMA
Sbjct: 436 LAYLHENSTNRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSHITTAIAGTLGYMA 495
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530
PEYLAHGQLTEK DVYSFG+LLLEIVTGRQNNRSK SEY+DS++TI
Sbjct: 496 PEYLAHGQLTEKVDVYSFGVLLLEIVTGRQNNRSKTSEYSDSIVTI 541
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767573|emb|CAN64526.1| hypothetical protein VITISV_005913 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2196), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/527 (78%), Positives = 455/527 (86%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
F + +L ++ AGDPR T+ + CG+Q EHNS+IFV NFV MENIS QMRTSGFG+
Sbjct: 16 LFFFILTLSVIELSAGDPRSRTIQMMCGNQREHNSTIFVINFVAMMENISNQMRTSGFGV 75
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
AV GS D YGLAQCYGDLSLLDCVLCYAEART LPQC+P+ GRIYLDGCFMR++NYS
Sbjct: 76 AVLGSAPDATYGLAQCYGDLSLLDCVLCYAEARTFLPQCFPFTTGRIYLDGCFMRAQNYS 135
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 136 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVMVPGTANESA 195
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL NCW+TLN+ SC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 196 YVLANCWRTLNAISCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 255
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG I IVVS VSA++VL VG IG + KQR I++KRRGSNDA KLVKTL+D SLNFK
Sbjct: 256 SRGTIIIIVVSAVSAVIVLLVGGAIGVYILKQRKIQKKRRGSNDAIKLVKTLHDSSLNFK 315
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
Y+TLEKATGSFD ANKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIIS
Sbjct: 316 YATLEKATGSFDNANKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRAADFYNEVNIIS 375
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
SVEHKNLVRLLGCSCSGPESLL+YEFLPN+SLDRFIFD+ + K L WEKR EII GT EG
Sbjct: 376 SVEHKNLVRLLGCSCSGPESLLIYEFLPNKSLDRFIFDTNRGKALNWEKRCEIITGTAEG 435
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
LVYLHE SKIRIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSHISTAIAGTLGYMA
Sbjct: 436 LVYLHENSKIRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 495
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
PEYLAHGQLTEKADVYSFG+LLLEI TGRQNNRSK +EY+DSL+TI
Sbjct: 496 PEYLAHGQLTEKADVYSFGVLLLEIXTGRQNNRSKTAEYSDSLVTIA 542
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425609|ref|XP_002265910.1| PREDICTED: cysteine-rich receptor-like protein kinase 2 [Vitis vinifera] gi|297739089|emb|CBI28578.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2196), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/527 (78%), Positives = 455/527 (86%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
F + +L ++ AGDPR T+ + CG+Q EHNS+IFV NFV MENIS QMRTSGFG+
Sbjct: 16 LFFFILTLSVIELSAGDPRSRTIQMMCGNQREHNSTIFVINFVAMMENISNQMRTSGFGV 75
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
AV GS D YGLAQCYGDLSLLDCVLCYAEART LPQC+P+ GRIYLDGCFMR++NYS
Sbjct: 76 AVLGSAPDATYGLAQCYGDLSLLDCVLCYAEARTFLPQCFPFTTGRIYLDGCFMRAQNYS 135
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 136 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVMVPGTANESA 195
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL NCW+TLN+ SC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 196 YVLANCWRTLNAISCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 255
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG I IVVS VSA++VL VG IG + KQR I++KRRGSNDA KLVKTL+D SLNFK
Sbjct: 256 SRGTIIIIVVSAVSAVIVLLVGGAIGVYILKQRKIQKKRRGSNDAIKLVKTLHDSSLNFK 315
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
Y+TLEKATGSFD ANKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIIS
Sbjct: 316 YATLEKATGSFDNANKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRAADFYNEVNIIS 375
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
SVEHKNLVRLLGCSCSGPESLL+YEFLPN+SLDRFIFD+ + K L WEKR EII GT EG
Sbjct: 376 SVEHKNLVRLLGCSCSGPESLLIYEFLPNKSLDRFIFDTNRGKALNWEKRCEIITGTAEG 435
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
LVYLHE SKIRIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSHISTAIAGTLGYMA
Sbjct: 436 LVYLHENSKIRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 495
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
PEYLAHGQLTEKADVYSFG+LLLEI TGRQNNRSK +EY+DSL+TI
Sbjct: 496 PEYLAHGQLTEKADVYSFGVLLLEIATGRQNNRSKTAEYSDSLVTIA 542
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224144143|ref|XP_002336113.1| predicted protein [Populus trichocarpa] gi|222873004|gb|EEF10135.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 845 bits (2184), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/528 (78%), Positives = 459/528 (86%), Gaps = 2/528 (0%)
Query: 5 FLFLVGSLLMLVRVA-GDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFG 63
F G +L+ RV GDPR TV + CG QLEHN++IFVPNFV TM NIS+QMR SGFG
Sbjct: 14 FFCFFGYVLLRERVVVGDPRSQTVQVMCGRQLEHNATIFVPNFVATMGNISDQMRASGFG 73
Query: 64 LAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENY 123
+AV+GSG DINYGLAQCYGDLSLLDCVLCYAEART+LPQCYPYNGGRIYLDGCFMR+ENY
Sbjct: 74 VAVSGSGPDINYGLAQCYGDLSLLDCVLCYAEARTVLPQCYPYNGGRIYLDGCFMRAENY 133
Query: 124 SFFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKS 183
SF+ EY GP D+AVCGN TRK+S+F ES R+AV +AV SA +N GYARVQ+ V G N+S
Sbjct: 134 SFYEEYLGPGDKAVCGNTTRKSSTFAESTRQAVSQAVTSASNNQGYARVQLTVPGT-NES 192
Query: 184 AYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKG 243
AYVL NCWKTLN+SSC ACL NA+ASILGCLPWSEGRAL TGCFMRYSD DFLN E G G
Sbjct: 193 AYVLANCWKTLNASSCRACLENATASILGCLPWSEGRALYTGCFMRYSDIDFLNDELGNG 252
Query: 244 RSRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNF 303
SRG I IVVSV+S+LVVL +G+ IG +WK+R I +KRRGSN+A+K+ +TLND SLNF
Sbjct: 253 SSRGSIVIIVVSVISSLVVLGLGVSIGVYIWKRRYIMKKRRGSNEAQKVARTLNDSSLNF 312
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNII 363
KYSTLEKATGSFD+ NKLGQGGFG+VYKG LPDGREIAVKRLFFNNRHRA +FYNE+N+I
Sbjct: 313 KYSTLEKATGSFDDTNKLGQGGFGSVYKGALPDGREIAVKRLFFNNRHRAKDFYNELNMI 372
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
SSVEHKNLVRLLGCSCSGPESLLVYEFLPN+SLDRFIFD K K LTWEKRYEII GT E
Sbjct: 373 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNRSLDRFIFDQNKGKELTWEKRYEIITGTAE 432
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GL YLH S IRIIHRDIKASNILLDSRLRAKIADFGLARSFQ+DKSHISTAIAGTLGYM
Sbjct: 433 GLAYLHMNSSIRIIHRDIKASNILLDSRLRAKIADFGLARSFQDDKSHISTAIAGTLGYM 492
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
APEYLAHGQLTEK DVY FG+LLLEIVTGRQNNRSKNSEYT+SL+ +
Sbjct: 493 APEYLAHGQLTEKVDVYGFGVLLLEIVTGRQNNRSKNSEYTESLVILT 540
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224107811|ref|XP_002314609.1| predicted protein [Populus trichocarpa] gi|222863649|gb|EEF00780.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/528 (77%), Positives = 446/528 (84%), Gaps = 19/528 (3%)
Query: 5 FLFLVGSLLMLVRVA-GDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFG 63
F G +L+ RV GDPR TV + CG QLEHN++IFVPNFV TM NIS+QMR SGFG
Sbjct: 14 FFCFFGYVLLRERVVVGDPRSQTVQVMCGRQLEHNATIFVPNFVATMGNISDQMRASGFG 73
Query: 64 LAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENY 123
+AV+GSG DINYGLAQCYGDLSLLDCVLCYAEART+LPQCYPYNGGRIYLDGCFMR+ENY
Sbjct: 74 VAVSGSGPDINYGLAQCYGDLSLLDCVLCYAEARTVLPQCYPYNGGRIYLDGCFMRAENY 133
Query: 124 SFFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKS 183
SF+ EY GP D+AVCGN TRK+S+F ES R+AV +AV SA +N GYARVQ+ V G N+S
Sbjct: 134 SFYEEYLGPGDKAVCGNTTRKSSTFAESTRQAVSQAVTSASNNQGYARVQLTVPGT-NES 192
Query: 184 AYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKG 243
AYVL NCWKTLN+SSC ACL NA+ASILGCLPWSEGRAL TGCFMRYSD DFLN E G G
Sbjct: 193 AYVLANCWKTLNASSCRACLENATASILGCLPWSEGRALYTGCFMRYSDIDFLNDELGNG 252
Query: 244 RSRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNF 303
SRG+ G+ IG +WK+R I +KRRGSN+A+KL +TLND SLNF
Sbjct: 253 SSRGL-----------------GVSIGVYIWKRRYIMKKRRGSNEAQKLARTLNDSSLNF 295
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNII 363
KYSTLEK TGSFDE NKLGQGGFG+VYKG LPDGREIAVKRLFFNNRHRAA+FYNEVN+I
Sbjct: 296 KYSTLEKGTGSFDETNKLGQGGFGSVYKGALPDGREIAVKRLFFNNRHRAADFYNEVNMI 355
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
SSVEHKNLVRLLGCSCSGPESLLVYEFLPN+SLDRFIFD K K LTWEKRYEII GT E
Sbjct: 356 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNRSLDRFIFDQNKGKELTWEKRYEIITGTAE 415
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GL YLH S IRIIHRDIKASNILLDSRLRAKIADFGLARSFQ+DKSHISTAIAGTLGYM
Sbjct: 416 GLAYLHMNSSIRIIHRDIKASNILLDSRLRAKIADFGLARSFQDDKSHISTAIAGTLGYM 475
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
APEYLAHGQLTEK DVY FG+LLLEIVTGRQNNRSKNSEYT+SL+ +
Sbjct: 476 APEYLAHGQLTEKVDVYGFGVLLLEIVTGRQNNRSKNSEYTESLVILT 523
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765333|emb|CAN71641.1| hypothetical protein VITISV_031461 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/540 (75%), Positives = 459/540 (85%), Gaps = 14/540 (2%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
FLF++ +L ++ AGDPR + ITC +Q EHNS+IFVPNFV MENIS Q+RTSGFG+
Sbjct: 15 FLFII-TLSVIELSAGDPRSRMIQITCANQPEHNSTIFVPNFVAMMENISNQVRTSGFGV 73
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
A++GSG D NYGLAQCYGDLSLLDCVLCYAEART+LPQC+PYNGGRIYLDGCFMR++NYS
Sbjct: 74 AISGSGPDANYGLAQCYGDLSLLDCVLCYAEARTVLPQCFPYNGGRIYLDGCFMRAQNYS 133
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 134 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVIVPGTANESA 193
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL +CW+TLN+SSC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 194 YVLADCWRTLNASSCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 253
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRG-------------SNDAEK 291
SRG + IVV V A++VL V IG +WKQR I++KRRG SNDA K
Sbjct: 254 SRGTVIIIVVPAVXAVIVLLVLGAIGVYIWKQRKIQKKRRGKKILENKFLFENGSNDAIK 313
Query: 292 LVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH 351
LVKTL+D SLNFKY+TLEKATGSFD NKLGQGGFGTVYKGVL DGREIAVKRLFFNNRH
Sbjct: 314 LVKTLHDSSLNFKYATLEKATGSFDNENKLGQGGFGTVYKGVLTDGREIAVKRLFFNNRH 373
Query: 352 RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTW 411
RAA+FYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE+LPN+SLDRFIFD+ + K L W
Sbjct: 374 RAADFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEYLPNKSLDRFIFDTNRGKALNW 433
Query: 412 EKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471
EKR EII+GT EGL YLHE S RIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSH
Sbjct: 434 EKRCEIIIGTAEGLAYLHENSTNRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSH 493
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
I+TAIAGTLGYMAPEYLAHGQLTEK DVYSFG+LLLEIVTGRQNNRSK EY+DSJ+TI
Sbjct: 494 ITTAIAGTLGYMAPEYLAHGQLTEKXDVYSFGVLLLEIVTGRQNNRSKTXEYSDSJVTIA 553
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356497745|ref|XP_003517719.1| PREDICTED: cysteine-rich receptor-like protein kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/514 (77%), Positives = 450/514 (87%)
Query: 18 VAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLAVTGSGLDINYGL 77
+ +PR TV ITCGH+LEHN++IFVPNFV TME IS++MR +GFG A+ G+G D NYGL
Sbjct: 27 IIAEPRAKTVLITCGHELEHNTTIFVPNFVATMEKISDEMRKTGFGTAIVGTGPDTNYGL 86
Query: 78 AQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYEGPEDRAV 137
AQCYGDLSLLDCVLCYAEART+LPQC+PYN GRI+LDGCFMR+ENYSFF EY GP DRAV
Sbjct: 87 AQCYGDLSLLDCVLCYAEARTVLPQCFPYNSGRIFLDGCFMRAENYSFFNEYTGPGDRAV 146
Query: 138 CGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSS 197
CGN TRKNSSF +A +AV+RAV AP+N GYA+ V V+G N+SAYVL +CW+TL+ S
Sbjct: 147 CGNTTRKNSSFHAAAMQAVLRAVQDAPNNKGYAKGNVAVAGTTNQSAYVLADCWRTLDKS 206
Query: 198 SCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGRSRGMIAAIVVSVV 257
SC+ACL NAS+SILGCLPW EGRALNTGCFMRYSD DFLNKE G SRG + IV++VV
Sbjct: 207 SCKACLENASSSILGCLPWQEGRALNTGCFMRYSDTDFLNKEQENGSSRGNVVVIVIAVV 266
Query: 258 SALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDE 317
S++ VL VG+ IG +WKQR I++KRRGSNDA+KL KTL +++LNFKYSTL+KAT SF E
Sbjct: 267 SSVTVLVVGVTIGVYIWKQRYIQKKRRGSNDAKKLAKTLQNNNLNFKYSTLDKATESFHE 326
Query: 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
NKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIISSVEHKNLVRLLGC
Sbjct: 327 NNKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRAADFYNEVNIISSVEHKNLVRLLGC 386
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
SCSGPESLLVYEFLPN+SLDR+IFD K K L WE RYEII+GT EGLVYLHE SK RII
Sbjct: 387 SCSGPESLLVYEFLPNRSLDRYIFDKNKGKELNWENRYEIIIGTAEGLVYLHENSKTRII 446
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKA 497
HRDIKASNILLD++LRAKIADFGLARSFQED+SHISTAIAGTLGYMAPEYLAHGQLTEKA
Sbjct: 447 HRDIKASNILLDAKLRAKIADFGLARSFQEDQSHISTAIAGTLGYMAPEYLAHGQLTEKA 506
Query: 498 DVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
DVYSFG+LLLEIVT RQNNRSK SEY+DSL+T+
Sbjct: 507 DVYSFGVLLLEIVTARQNNRSKASEYSDSLVTVA 540
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565986|ref|XP_003551216.1| PREDICTED: cysteine-rich receptor-like protein kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2101), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/513 (76%), Positives = 450/513 (87%), Gaps = 1/513 (0%)
Query: 20 GDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLAVTGSG-LDINYGLA 78
+PR TVNITC ++LEHN++IFVPNFV TME ISEQMR +G+G AV G+G D NYGLA
Sbjct: 2 AEPRARTVNITCNNKLEHNTTIFVPNFVATMEKISEQMRNTGYGTAVVGTGGPDTNYGLA 61
Query: 79 QCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYEGPEDRAVC 138
QCYGDLSLLDCVLCYAEART+LPQC+PYNGGRIYLDGCFMR+ENYSF+ EY GP D+AVC
Sbjct: 62 QCYGDLSLLDCVLCYAEARTVLPQCFPYNGGRIYLDGCFMRAENYSFYDEYIGPGDKAVC 121
Query: 139 GNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSSS 198
GN TRK++SFQ +A+KAV+ AV +A +N GYAR +V V+G N +AYVL NCW++L++ S
Sbjct: 122 GNTTRKSTSFQAAAKKAVLSAVQAAANNKGYARKEVFVAGTTNDAAYVLANCWRSLDTRS 181
Query: 199 CEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGRSRGMIAAIVVSVVS 258
C ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKE G S G + IVV+VVS
Sbjct: 182 CRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEQENGSSGGNVLVIVVAVVS 241
Query: 259 ALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEA 318
+++VL VGI I + K R I+ KRRGSNDAEKL K+L+ +SLNFKYSTLEKAT SFDEA
Sbjct: 242 SVIVLVVGIAIVVYIRKHRYIQMKRRGSNDAEKLAKSLHHNSLNFKYSTLEKATNSFDEA 301
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
NKLGQGGFGTVYKGVL DGREIA+KRL+FNNRHRAA+F+NEVNIISSVEHKNLVRLLGCS
Sbjct: 302 NKLGQGGFGTVYKGVLADGREIAIKRLYFNNRHRAADFFNEVNIISSVEHKNLVRLLGCS 361
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
CSGPESLL+YE+LPN+SLDRFIFD K + L W+KRY+II+GT EGLVYLHE S IRIIH
Sbjct: 362 CSGPESLLIYEYLPNRSLDRFIFDKNKGRELNWDKRYDIIIGTAEGLVYLHENSNIRIIH 421
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RDIKASNILLD++LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD
Sbjct: 422 RDIKASNILLDAKLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 481
Query: 499 VYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
VYSFG+LLLEI+TGR NNRSK SEY+DSL+T+
Sbjct: 482 VYSFGVLLLEIITGRLNNRSKASEYSDSLVTMT 514
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357485785|ref|XP_003613180.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355514515|gb|AES96138.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/526 (73%), Positives = 444/526 (84%), Gaps = 13/526 (2%)
Query: 6 LFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLA 65
L L+ +L+ + +PR TV ITCGHQ+EHN+SIFVPNFV TME ISEQMR++GFG A
Sbjct: 15 LLLIKFVLLSETIIAEPRAKTVMITCGHQVEHNTSIFVPNFVATMEKISEQMRSTGFGTA 74
Query: 66 VTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYSF 125
VTG+G D NYGLAQCYG LSLLDCVLCYAEART+LPQC+PYN GRIYLDGCFMRS NYSF
Sbjct: 75 VTGTGPDDNYGLAQCYGYLSLLDCVLCYAEARTVLPQCFPYNSGRIYLDGCFMRSVNYSF 134
Query: 126 FGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAY 185
F EY G EDR VCGN T+K+S FQ +A++AV++ +V VSG +N+SAY
Sbjct: 135 FSEYTGKEDRTVCGNTTKKSSGFQAAAKEAVLKR-------------KVVVSGTSNESAY 181
Query: 186 VLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGRS 245
VL +CW++L+S SC+ACL +AS+SIL CLP SEGRALNTGCFMRYS+ DFLNKE G S
Sbjct: 182 VLADCWRSLDSKSCKACLEHASSSILRCLPSSEGRALNTGCFMRYSNTDFLNKEVENGSS 241
Query: 246 RGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKY 305
G + IVV+VVS+++V+ V + G +WKQR I++KRRGSNDAEKL K+L SLNFKY
Sbjct: 242 GGNVVVIVVAVVSSVIVVVVAVTFGAYIWKQRYIQKKRRGSNDAEKLAKSLEQKSLNFKY 301
Query: 306 STLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISS 365
+TLEKATGSF++ K+G GGFGTVYKGVLPDGREIA+KRLFFNNRHRAA+F NEV+IIS
Sbjct: 302 NTLEKATGSFNDNRKIGHGGFGTVYKGVLPDGREIAIKRLFFNNRHRAADFSNEVDIISG 361
Query: 366 VEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
VEHKNLVRLLGCSCSGPESLLVYEF+PN+SLDRFIFD K + L WEKRYEII+GT EGL
Sbjct: 362 VEHKNLVRLLGCSCSGPESLLVYEFMPNRSLDRFIFDKNKGRELNWEKRYEIIIGTAEGL 421
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
VYLHE SKIRIIHRDIKASNILLDS+LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP
Sbjct: 422 VYLHENSKIRIIHRDIKASNILLDSKLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 481
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
EYLAHGQLTEKADVYSFG+LLLEIVTGRQNNRSK SEY+DSL+ +
Sbjct: 482 EYLAHGQLTEKADVYSFGVLLLEIVTGRQNNRSKASEYSDSLVIVT 527
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 532 | ||||||
| TAIR|locus:2026821 | 649 | CRK2 "cysteine-rich RLK (RECEP | 0.979 | 0.802 | 0.691 | 1.5e-200 | |
| TAIR|locus:2026785 | 646 | CRK3 "cysteine-rich RLK (RECEP | 0.949 | 0.781 | 0.440 | 1.1e-110 | |
| TAIR|locus:2139845 | 625 | AT4G28670 [Arabidopsis thalian | 0.430 | 0.366 | 0.535 | 4.7e-99 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.475 | 0.380 | 0.515 | 1.2e-77 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.468 | 0.368 | 0.468 | 5.2e-75 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.441 | 0.346 | 0.529 | 3.2e-73 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.409 | 0.325 | 0.543 | 2.3e-72 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.434 | 0.341 | 0.530 | 4.7e-72 | |
| TAIR|locus:2125766 | 654 | CRK40 "cysteine-rich RLK (RECE | 0.406 | 0.330 | 0.557 | 9.7e-72 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.443 | 0.349 | 0.497 | 5.3e-71 |
| TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1941 (688.3 bits), Expect = 1.5e-200, P = 1.5e-200
Identities = 363/525 (69%), Positives = 425/525 (80%)
Query: 6 LFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLA 65
+FL+ SL ++ GD R V +TC LEHN + +VPNFV TME IS Q++TSGFG+A
Sbjct: 18 MFLLSSLR---QITGDARARAVKVTCSPLLEHNETAYVPNFVATMEKISTQVQTSGFGVA 74
Query: 66 VTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYSF 125
+TG+G D NYGLAQCYGDL L DCVLCYAEART+LPQCYP NGGRI+LDGCFMR+ENYSF
Sbjct: 75 LTGTGPDANYGLAQCYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYSF 134
Query: 126 FGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAY 185
+ EY+GPED VCGN TRKN +F ++ R+ + AV A GGYAR + + ++SA+
Sbjct: 135 YNEYKGPEDSIVCGNTTRKNKTFGDAVRQGLRNAVTEASGTGGYARASAKAGESESESAF 194
Query: 186 VLVNCWKTLNSSSCEACLANASASIL-GCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
VL NCW+TL+ SC+ CL NASAS++ GCLPWSEGRAL+TGCF+RYSD+DFLNK P GR
Sbjct: 195 VLANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFLNKIPRNGR 254
Query: 245 SRGMXXXXXXXXXXXXXXXXXXXXXXTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG + K+R+I+RKRRGS D EK+ KTL D SLNFK
Sbjct: 255 SRGSVVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNFK 314
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
YSTLEKATGSFD ANKLGQGGFGTVYKGVLPDGR+IAVKRLFFNNRHRA +FYNEVN+IS
Sbjct: 315 YSTLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYNEVNMIS 374
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
+VEHKNLVRLLGCSCSGPESLLVYE+L N+SLDRFIFD + KTL W++RY II+GT EG
Sbjct: 375 TVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEG 434
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
LVYLHEQS ++IIHRDIKASNILLDS+L+AKIADFGLARSFQ+DKSHISTAIAGTLGYMA
Sbjct: 435 LVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTLGYMA 494
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT 529
PEYLAHGQLTE DVYSFG+L+LEIVTG+QN +SK S+Y+DSL+T
Sbjct: 495 PEYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLIT 539
|
|
| TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
Identities = 231/524 (44%), Positives = 314/524 (59%)
Query: 6 LFLVGSLLMLVRVAGDPRVHTVNITCGHQLE--HNSSIFVPNFVTTMENISEQMRTSGFG 63
L L+ L + V+ D R TV C ++ S+FV NF+ M+ +S + G+G
Sbjct: 7 LLLILGLFISPSVS-DSRGDTVAQICNNRTTTPQQRSLFVTNFLAAMDAVSPLVEAKGYG 65
Query: 64 LAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYN----GGRIYLDGCFMR 119
V G+G Y +C DL DC LC+A+ + +P+C P+ GG+++ DGC++R
Sbjct: 66 QVVNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKGTRGGQVFSDGCYIR 125
Query: 120 SENYSFFGEYEGPEDRAVCGNG--TRKNSS-FQESARKAVMRAVASAPSNGGYARVQVQV 176
++Y+F+ E +DR VC T N + F+++A + V A NGG+ V
Sbjct: 126 YDDYNFYNETLSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVEAVRNGGFYAGFVD- 184
Query: 177 SGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFL 236
N + + L CW+TLN S C CL+ AS I CL EGR L+ GC+MR+S + F
Sbjct: 185 --RHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLSAGCYMRFSTQKFY 242
Query: 237 NKEPGKGRSRGMXXXXXXXXXXXXXXXXXXXXXXTR----VWKQRSIERKRRGSNDAEKL 292
N G S G + K+R +K+R L
Sbjct: 243 NNS-GNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHA-KKQREKKQLGSL 300
Query: 293 VKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR 352
N +L F Y LE+AT F + NKLGQGG G+VYKGVL +G+ +AVKRLFFN +
Sbjct: 301 FMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQW 360
Query: 353 AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE 412
+F+NEVN+IS V+HKNLV+LLGCS +GPESLLVYE++ NQSL ++F + L W
Sbjct: 361 VDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWA 420
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472
KR++IILGT EG+ YLHE+S +RIIHRDIK SNILL+ +IADFGLAR F EDK+HI
Sbjct: 421 KRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHI 480
Query: 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516
STAIAGTLGYMAPEY+ G+LTEKADVYSFG+L++E++TG++NN
Sbjct: 481 STAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNN 524
|
|
| TAIR|locus:2139845 AT4G28670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 4.7e-99, Sum P(2) = 4.7e-99
Identities = 127/237 (53%), Positives = 171/237 (72%)
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEV 360
++F+YSTL+KAT +F+E+ KLG GG+G V+KG L DGREIA+KRL + + +NE+
Sbjct: 317 MSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEI 376
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
++IS +HKNLVRLLGC + S +VYEFL N SLD +F+ K K L W+KR IILG
Sbjct: 377 DVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILG 436
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-----KSHIS-T 474
T EGL YLHE KI IHRDIKASNILLD + + KI+DFGLA+ + E S +S +
Sbjct: 437 TAEGLEYLHETCKI--IHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPS 494
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
+IAGTLGYMAPEY++ G+L+ K D YSFG+L+LEI +G +NN+ ++ ++L+T V
Sbjct: 495 SIAGTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNSLETLVTQV 551
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 650 (233.9 bits), Expect = 1.2e-77, Sum P(2) = 1.2e-77
Identities = 134/260 (51%), Positives = 177/260 (68%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVL 334
K R E R N E + ++ DS+ F +S L+ AT F NKLG+GGFG VYKGVL
Sbjct: 306 KLRRKENIRNSENKHEN--ENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVL 363
Query: 335 PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394
DG++IAVKRL N + F NE +++ ++H+NLV+LLG S G E LLVYEFLP+
Sbjct: 364 SDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHT 423
Query: 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454
SLD+FIFD + L WE RY+II G GL+YLH+ S++RIIHRD+KASNILLD +
Sbjct: 424 SLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTP 483
Query: 455 KIADFGLARSFQEDKS--HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
KIADFG+AR F D + + I GT GYMAPEY+ HGQ + K DVYSFG+L+LEI++G
Sbjct: 484 KIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISG 543
Query: 513 RQNNRSKNSEYTDSLLTIVS 532
++N+ +SE DS+ ++S
Sbjct: 544 KKNS-GFSSE--DSMGDLIS 560
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 623 (224.4 bits), Expect = 5.2e-75, Sum P(2) = 5.2e-75
Identities = 120/256 (46%), Positives = 174/256 (67%)
Query: 283 RRGSNDAEKLVKTLNDD------SLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD 336
RR +N + L++D +L F++S +E AT F E+NKLG GGFG VYKG L
Sbjct: 309 RRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLIT 368
Query: 337 GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396
G +A+KRL + A F NEV++++ ++H+NL +LLG G E +LVYEF+PN+SL
Sbjct: 369 GETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSL 428
Query: 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456
D F+FD+ K + L W++RY+II G G++YLH S++ IIHRD+KASNILLD+ + KI
Sbjct: 429 DYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKI 488
Query: 457 ADFGLARSFQEDKSHISTA-IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515
+DFG+AR F D++ +T I GT GYM+PEY HG+ + K+DVYSFG+L+LE++TG++N
Sbjct: 489 SDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKN 548
Query: 516 NRSKNSEYTDSLLTIV 531
+ + L+T V
Sbjct: 549 SSFYEEDGLGDLVTYV 564
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 3.2e-73, Sum P(2) = 3.2e-73
Identities = 127/240 (52%), Positives = 168/240 (70%)
Query: 297 NDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANF 356
N +SL + TL+ AT +F N+LG+GGFG+VYKGV P G+EIAVKRL N+ F
Sbjct: 339 NTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEF 398
Query: 357 YNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE 416
NE+ +++ ++H+NLVRL+G G E LLVYEF+ N SLD+FIFD+ K + L W RY+
Sbjct: 399 KNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYK 458
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS--HIST 474
+I G GL+YLHE S+ RIIHRD+KASNILLD + KIADFGLA+ F ++ H T
Sbjct: 459 MIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFT 518
Query: 475 A-IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR--SKNSEYTDSLLTIV 531
+ IAGT GYMAPEY HGQ + K DV+SFG+L++EI+TG++NN S E + LL+ V
Sbjct: 519 SRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWV 578
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 627 (225.8 bits), Expect = 2.3e-72, Sum P(2) = 2.3e-72
Identities = 119/219 (54%), Positives = 162/219 (73%)
Query: 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYN 358
DSL Y T++ AT F E+NK+GQGGFG VYKG L DG E+AVKRL ++ F N
Sbjct: 332 DSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKN 391
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
EV +++ ++H+NLVRLLG G E +LVYE++PN+SLD F+FD AK L W +RY+II
Sbjct: 392 EVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKII 451
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA-IA 477
G G++YLH+ S++ IIHRD+KASNILLD+ + KIADFG+AR F D++ +T+ I
Sbjct: 452 GGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIV 511
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516
GT GYM+PEY HGQ + K+DVYSFG+L+LEI++G++N+
Sbjct: 512 GTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNS 550
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 4.7e-72, Sum P(2) = 4.7e-72
Identities = 123/232 (53%), Positives = 166/232 (71%)
Query: 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYN 358
DSL Y T++ AT F E+NK+G+GGFG VYKG +G+E+AVKRL N+R A F
Sbjct: 337 DSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKT 396
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
EV +++ ++H+NLVRLLG S G E +LVYE++PN+SLD +FD K L W +RY II
Sbjct: 397 EVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNII 456
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA-IA 477
G G++YLH+ S++ IIHRD+KASNILLD+ + KIADFG+AR F D++ +T+ I
Sbjct: 457 GGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIV 516
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT 529
GT GYMAPEY HGQ + K+DVYSFG+L+LEI++GR+N+ S+ LLT
Sbjct: 517 GTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLT 568
|
|
| TAIR|locus:2125766 CRK40 "cysteine-rich RLK (RECEPTOR-like protein kinase) 40" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 9.7e-72, Sum P(2) = 9.7e-72
Identities = 121/217 (55%), Positives = 155/217 (71%)
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEV 360
L F + AT F N LGQGGFGTVYKG P+G+E+AVKRL + F NEV
Sbjct: 334 LRFDLGMIVMATDDFSSENTLGQGGFGTVYKGTFPNGQEVAVKRLTKGSGQGDMEFKNEV 393
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
++++ ++HKNLV+LLG G E +LVYEF+PN SLD FIFD K LTWE R+ II G
Sbjct: 394 SLLTRLQHKNLVKLLGFCNEGDEEILVYEFVPNSSLDHFIFDEDKRSLLTWEVRFRIIEG 453
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA-IAGT 479
GL+YLHE S+++IIHRD+KASNILLD+ + K+ADFG AR F D++ T IAGT
Sbjct: 454 IARGLLYLHEDSQLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKRIAGT 513
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516
GYMAPEYL HGQ++ K+DVYSFG++LLE+++G +NN
Sbjct: 514 RGYMAPEYLNHGQISAKSDVYSFGVMLLEMISGERNN 550
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 608 (219.1 bits), Expect = 5.3e-71, Sum P(2) = 5.3e-71
Identities = 120/241 (49%), Positives = 164/241 (68%)
Query: 281 RKRRGSNDAEKLVKTLND----DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD 336
+K R + + E L + +D SL F + +E AT F E NKLGQGGFG VYKG+ P
Sbjct: 313 KKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPS 372
Query: 337 GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396
G ++AVKRL + F NEV +++ ++H+NLVRLLG E +LVYEF+PN+SL
Sbjct: 373 GVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSL 432
Query: 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456
D FIFDS L W +RY+II G G++YLH+ S++ IIHRD+KA NILL + AKI
Sbjct: 433 DYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKI 492
Query: 457 ADFGLARSFQEDKSHISTA-IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515
ADFG+AR F D++ +T I GT GYM+PEY +GQ + K+DVYSFG+L+LEI++G++N
Sbjct: 493 ADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKN 552
Query: 516 N 516
+
Sbjct: 553 S 553
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9CAL3 | CRK2_ARATH | 2, ., 7, ., 1, 1, ., - | 0.7072 | 0.9812 | 0.8043 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 532 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-25 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-14 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 1e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 6e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-04 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 9e-54
Identities = 72/193 (37%), Positives = 105/193 (54%), Gaps = 10/193 (5%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVRLLGCS 378
LG+GGFGTVY G+++A+K + + E+ I+ + H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
LV E+ SL + + L+ ++ I+L +EGL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 439 RDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEK 496
RD+K NILLDS + K+ADFGL++ DKS + T I GT YMAPE L G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEK 174
Query: 497 ADVYSFGMLLLEI 509
+D++S G++L E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-50
Identities = 73/200 (36%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHR----AANFYNEVNIISSVEHKNLVRL 374
KLG G FGTVYK G+ +AVK R E+ I+ + H N+VRL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKI--LKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ LV E+ L ++ ++ L+ ++ +I L + GL YLH
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL- 493
IIHRD+K NILLD KIADFGLA+ + S T GT YMAPE L G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFVGTPWYMAPEVLLGGNGY 176
Query: 494 TEKADVYSFGMLLLEIVTGR 513
K DV+S G++L E++TG+
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-48
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLG 376
KLG+G FG VY G+ +A+K + + E+ I+ ++H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 377 CSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
+ LV E+ L + +A+ + + L YLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEYLHSK 116
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRD+K NILLD K+ADFGLAR + + GT YMAPE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT--FVGTPEYMAPEVLLGK 171
Query: 492 QLTEKADVYSFGMLLLEIVTGR 513
+ D++S G++L E++TG+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 319 NKLGQGGFGTVYKGVLPDG----REIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
KLG+G FG VYKG L E+AVK L + R F E ++ + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVEGLV 426
RLLG LV E++ L ++ F S + TL+ + + +G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG----- 481
YL + + +HRD+ A N L+ L KI+DFGL+R +D + T G
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIR 172
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+MAPE L G T K+DV+SFG+LL EI T
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 5e-45
Identities = 73/204 (35%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 320 KLGQGGFGTVYKGVL---PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVR 373
KLG+G FG VYKG L +G E AVK L F E +I+ + H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
LLG G +V E++P L F+ + LT + ++ L +G+ YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY-----MAPEYL 488
+HRD+ A N L+ L KI+DFGL+R D G MAPE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 489 AHGQLTEKADVYSFGMLLLEIVTG 512
G+ T K+DV+SFG+LL EI T
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 68/202 (33%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 320 KLGQGGFGTVYKGVL-----PDGREIAVKRLFFNNRHRA-----ANFYNEVNIISSVEHK 369
KLG+G FG VYKG L E+AVK L + A F E I+ ++H
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL----KEDASEQQIEEFLREARIMRKLDHP 61
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
N+V+LLG +V E++ L ++ L+ L G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
+ IHRD+ A N L+ L KI+DFGL+R +D + + +MAPE L
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
G+ T K+DV+SFG+LL EI T
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 5e-44
Identities = 70/202 (34%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 320 KLGQGGFGTVYKGVL-----PDGREIAVKRLFFNNRHRA-----ANFYNEVNIISSVEHK 369
KLG+G FG VYKG L E+AVK L + A F E I+ ++H
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKLDHP 61
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
N+V+LLG ++V E++P L ++ + + K L+ L G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE 120
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
+ IHRD+ A N L+ L KI+DFGL+R +D + + +MAPE L
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
G+ T K+DV+SFG+LL EI T
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 9e-44
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 319 NKLGQGGFGTVYKGVLPD-GREIAVKRLFF--NNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG+G FG+VY + D G +AVK + ++ E+ I+SS++H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 376 GCSCS-GPESLLVY-EFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYL 428
G +L ++ E++ SL + + T + IL EGL YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ-----IL---EGLAYL 117
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTAIAGTLGYMAPEY 487
H I+HRDIK +NIL+DS K+ADFG A+ + + + ++ GT +MAPE
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ + AD++S G ++E+ TG+
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 7e-41
Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 8/200 (4%)
Query: 315 FDEANKLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
F+ K+G+GGFG VYK G+E+A+K + ++ + NE+ I+ +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
G E +V EF SL + + +TLT + + ++GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
IIHRDIKA+NILL S K+ DFGL+ + K+ + + GT +MAPE +
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT--MVGTPYWMAPEVINGKPY 174
Query: 494 TEKADVYSFGMLLLEIVTGR 513
KAD++S G+ +E+ G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 28/207 (13%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNLVRLL 375
+ +G+G FG VYKG+ L G +A+K++ A + E++++ +++H N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE---------IILGTVEGLV 426
G + ++ E+ N SL + I K++ + ++GL
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQVLQGLA 113
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLHEQ +IHRDIKA+NIL K+ADFG+A + S ++ GT +MAPE
Sbjct: 114 YLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPYWMAPE 169
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ + +D++S G ++E++TG
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (326), Expect = 3e-33
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
KLG+G FG VY D + +A+K L + F E+ I++S+ N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
LV E++ SL+ + + L+ + I+ + L YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 436 IIHRDIKASNILLDSRL-RAKIADFGLARSFQEDKSH-----ISTAIAGTLGYMAPEYLA 489
IIHRDIK NILLD K+ DFGLA+ + S + + GT GYMAPE L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 490 HGQL---TEKADVYSFGMLLLEIVTGR 513
L + +D++S G+ L E++TG
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-32
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
FD KLG+G +G+VYK + G+ +A+K E++I+ + +V
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIV 61
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA--KTLTWEKRYEIILGTVEGLVYLHE 430
+ G + +V E+ S + D K KTLT E+ I+ T++GL YLH
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ IHRDIKA NILL+ +AK+ADFG++ + + +T I GT +MAPE +
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQE 173
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
KAD++S G+ +E+ G+
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNLVRLL 375
++G+G FG VY DG+ +K + +N + NEV I+ + H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKI 434
+ +V E+ L + I K E++ + + L YLH +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
+I+HRDIK NI L S K+ DFG+++ T + GT Y++PE +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181
Query: 495 EKADVYSFGMLLLEIVTGR 513
K+D++S G +L E+ T +
Sbjct: 182 YKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 321 LGQGGFGTVYKGV-LPDGR----EIAVKRLFFNNRHRAAN--FYNEVNIISSVEHKNLVR 373
LG G FGTVYKGV +P+G +A+K L AN +E +++SV+H ++VR
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA----KTLTWEKRYEIILGTVEGLVYLH 429
LLG C + L+ + +P L ++ + L W + +G+ YL
Sbjct: 74 LLGI-CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMAPEYL 488
E+ R++HRD+ A N+L+ + KI DFGLA+ D+ + +MA E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
H T K+DV+S+G+ + E++T
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 69/198 (34%), Positives = 106/198 (53%), Gaps = 7/198 (3%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
F KLG G FG V++G+ + +A+K L ++ + +F EV + + HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 375 LG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
CS P ++ E + SL F+ S + + L ++ EG+ YL EQ
Sbjct: 68 FAVCSVGEP-VYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
IHRD+ A NIL+ L K+ADFGLAR +ED ++S+ + APE +HG
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAPEAASHGTF 181
Query: 494 TEKADVYSFGMLLLEIVT 511
+ K+DV+SFG+LL E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 76/199 (38%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ G ++AVK L A F E I+ + H LV+L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAV-C 70
Query: 380 SGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S E + +V E++ SL F+ S + K L + ++ EG+ YL + IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLTE 495
RD+ A NIL+ L KIADFGLAR ++D TA G + + APE +G+ T
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 496 KADVYSFGMLLLEIVT-GR 513
K+DV+SFG+LL EIVT GR
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 320 KLGQGGFGTVYKGVL-PDGREIAVKRLFF----NNRHRAANFYNEVNIISSVEHKNLVRL 374
LGQG G VYK P G+ A+K++ R + E+ + S E +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLR---ELKTLRSCESPYVVKC 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV-----EGLVYLH 429
G E +V E++ SL + K + E +L + +GL YLH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIP-----EPVLAYIARQILKGLDYLH 116
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA------GTLGYM 483
+K IIHRDIK SN+L++S+ KIADFG+++ + + GT+ YM
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYM 167
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+PE + + AD++S G+ LLE G+
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 65/194 (33%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS 380
+G+G FG V G G+++AVK L ++ A F E ++++++ H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 381 GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRD 440
G +V E++ SL ++ +A +T ++ L EG+ YL E+ +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 441 IKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVY 500
+ A N+L+ L AK++DFGLA+ + S + + + APE L + + K+DV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKE--ASQGQDSGKLP--VKWTAPEALREKKFSTKSDVW 183
Query: 501 SFGMLLLEIVT-GR 513
SFG+LL EI + GR
Sbjct: 184 SFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 8/199 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+ K+G+G G VYK G+E+A+K++ +++ NE+ I+ +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPNIVD 79
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
G E +V E++ SL I + + + + ++GL YLH Q
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQIAYVCREVLQGLEYLHSQ-- 135
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+IHRDIK+ NILL K+ADFG A ++KS ++ + GT +MAPE +
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRKDY 193
Query: 494 TEKADVYSFGMLLLEIVTG 512
K D++S G++ +E+ G
Sbjct: 194 GPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 319 NKLGQGGFGTVYKGV--LPDGREIAVKRLFFNNRHRAAN---FYNEVNIISSVEHKNLVR 373
+LG G FG+V KGV + G+E+ V H AA F E ++++ ++H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFD--SAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
L+G C G +LV E P L +++ L E+ G+ YL +
Sbjct: 61 LIGV-CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLK-----ELAHQVAMGMAYLESK 114
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYLA 489
+HRD+ A N+LL +R +AKI+DFG++R+ + AG L + APE +
Sbjct: 115 ---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
+G+ + K+DV+S+G+ L E +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 69/195 (35%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ G ++A+K L + A F E N++ ++H LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVVT 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P ++ E++ N SL F+ K LT K ++ EG+ ++ ++ IHR
Sbjct: 72 QEP-IYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKN---YIHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+NIL+ L KIADFGLAR ++++ + + APE + +G T K+DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR 513
+SFG+LL EIVT GR
Sbjct: 187 WSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 68/205 (33%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 321 LGQGGFGTVY----KGVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
LG+G FG V K G+ A+K L R + E NI+S + H +V+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 374 LLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLT--WEKRY--EIILGTVEGLVYL 428
L + E L LV E+ P L + +K + + Y EI+L L YL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLA----LEYL 109
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H II+RD+K NILLD+ K+ DFGLA+ + S +T GT Y+APE L
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVL 165
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ D +S G+LL E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRL-FFNNRHRAA-NFYNEVNIISSVEHKNLVRLL 375
NK+G G FG VY V L G +AVK + +N + +E+ ++ ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G + + E+ +L+ + + + + Y + L +EGL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQL--LEGLAYLHSH---G 119
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG---YMAPEYLAHGQ 492
I+HRDIK +NI LD K+ DFG A + + + + + G YMAPE + G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 493 LTEK---ADVYSFGMLLLEIVTGR 513
AD++S G ++LE+ TG+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 66/201 (32%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRL 374
LGQG FG VY D GRE+AVK++ F+ + E+ ++ +++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 375 LGCSCSGPESLLVY-EFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
GC E+L ++ E++P S+ D+ A +T+T + +I+ EG+ YLH
Sbjct: 70 YGCL-RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN- 123
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TAIAGTLGYMAPEYLAH 490
I+HRDIK +NIL DS K+ DFG ++ Q S + ++ GT +M+PE ++
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 491 GQLTEKADVYSFGMLLLEIVT 511
KADV+S G ++E++T
Sbjct: 182 EGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 39/212 (18%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH--------RAANFYNEVNIISSVEHKN 370
KLG+G +G VYK G +A+K++ +N R E++++ ++H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR------EISLLKELKHPN 59
Query: 371 LVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVE 423
+V+LL L LV+E+ + L +++ K++ ++ +L
Sbjct: 60 IVKLL-DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ-----LL---R 109
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GL Y H RI+HRD+K NIL++ K+ADFGLAR+F + + TL Y
Sbjct: 110 GLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYR 165
Query: 484 APEYL--AHGQLTEKADVYSFGMLLLEIVTGR 513
APE L + T D++S G + E++TG+
Sbjct: 166 APEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 319 NKLGQGGFGTVYKGVLP-----DGREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNL 371
+LG+G FG V G ++AVK L +HR+ +F E+ I+ +++H+N+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRS-DFEREIEILRTLDHENI 68
Query: 372 VRLLGCSCS--GPESLLVYEFLPNQSLD---RFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
V+ G G L+ E+LP+ SL + D K L + +G+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL---LFS--SQICKGMD 123
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--YMA 484
YL Q R IHRD+ A NIL++S KI+DFGLA+ EDK + G + A
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVT 511
PE L + + +DV+SFG+ L E+ T
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 319 NKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+KLG G +G VY+GV +AVK L + F E ++ ++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
P ++ EF+ +L ++ + + + + + + YL +++ I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLT 494
HRD+ A N L+ K+ADFGL+R D TA AG + + APE LA+ + +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 495 EKADVYSFGMLLLEIVT 511
K+DV++FG+LL EI T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH--------RAANFYNEVNIISSVEHK 369
++G+G +G VYK G +A+K++ N R E+ ++ + H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR------EIKLLQKLRHP 58
Query: 370 NLVRLLG--CSCSGPESLLVYEFLPN--QSLDR---FIFDSAKAKTLTWEKRYEIILGTV 422
N+VRL S +V+E++ + L F ++ K +++
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM----KQLL---- 110
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
EGL YLH I+HRDIK SNIL+++ K+ADFGLAR + + S T TL Y
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 483 MAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR 513
PE L + + D++S G +L E+ G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNL 371
F+ NK+G+G FG V+K V D R A+K++ + +R +E +++ ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
+R + +V E+ N L + + + + L ++ + + + GL +LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
+I+HRDIK+ N+ LD+ KI D G+A+ D ++ + I GT Y++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDK 176
Query: 492 QLTEKADVYSFGMLLLEIVTGR 513
EK+DV++ G++L E TG+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 320 KLGQGGFGTVYKG--VLPDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
KLG G FG V +G G+ I AVK L + +F E I+ S++H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT---WEKRYEIILGTVEGLVYLHEQ 431
G + P ++V E P SL + A L + +I G+ YL +
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLA 489
R IHRD+ A NILL S + KI DFGL R+ +++ H + + APE L
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
+ +DV+ FG+ L E+ T
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-26
Identities = 65/192 (33%), Positives = 99/192 (51%), Gaps = 5/192 (2%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ G + ++AVK L A F E N++ +++H LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
++ E++ SL F+ K L K + EG+ Y+ ++ IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIERKN---YIHR 127
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+N+L+ L KIADFGLAR ++++ + + APE + G T K+DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 500 YSFGMLLLEIVT 511
+SFG+LL EIVT
Sbjct: 188 WSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 63/198 (31%), Positives = 108/198 (54%), Gaps = 13/198 (6%)
Query: 321 LGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL 375
+G G FG V +G L P +EI A+K L + + +F E +I+ +H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G +++ E++ N SLD+F+ T + ++ G G+ YL S++
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG--TLGYMAPEYLAHGQL 493
+HRD+ A NIL++S L K++DFGL+R ED T G + + APE +A+ +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 494 TEKADVYSFGMLLLEIVT 511
T +DV+SFG+++ E+++
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V++G+ + +AVK L +F E I+ + H L++L
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
+V E + SL ++ A + L + ++ G+ YL Q+ IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLTEK 496
D+ A N+L+ K+ADFGLAR +ED I A G + + APE + + + K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKED---IYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 497 ADVYSFGMLLLEIVT-GR 513
+DV+SFG+LL EIVT GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKR----LFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
K+G+G FG VYKGVL E+AVK L + + + F E I+ +H N+V+L+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK---FLQEAEILKQYDHPNIVKLI 58
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G +V E +P SL F+ K LT +K ++ L G+ YL ++
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN--- 113
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT----LGYMAPEYLAHG 491
IHRD+ A N L+ KI+DFG++R E++ I T G + + APE L +G
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 492 QLTEKADVYSFGMLLLEIVTG 512
+ T ++DV+S+G+LL E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 60/199 (30%), Positives = 113/199 (56%), Gaps = 14/199 (7%)
Query: 321 LGQGGFGTVYKGVL--PDGRE--IAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRL 374
+G G FG V++G+L P +E +A+K L + + R +F +E +I+ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ-DFLSEASIMGQFSHHNIIRL 71
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G ++++ E++ N +LD+++ D + + ++ G G+ YL S +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SDM 126
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--YMAPEYLAHGQ 492
+HRD+ A NIL++S L K++DFGL+R ++D T G + + APE +A+ +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 493 LTEKADVYSFGMLLLEIVT 511
T +DV+SFG+++ E+++
Sbjct: 187 FTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 18/200 (9%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEH---KNLVRLL 375
+G+G +G VY+G +P GR +A+K + + ++ EV ++S + N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE--IILGTVEGLVYLHEQSK 433
G GP ++ E+ S+ + KA + ++Y II + L Y+H K
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPI--AEKYISVIIREVLVALKYIH---K 119
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+ +IHRDIKA+NIL+ + K+ DFG+A ++ S ST GT +MAPE + G+
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKY 178
Query: 494 TE-KADVYSFGMLLLEIVTG 512
+ KAD++S G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 320 KLGQGGFGTVYK-GVLPDGREIAVKRLFFNNRHR--AANFYNEVNIISSVEHKNLVRLLG 376
++G+G G V+K G +A+K++ E+ + + +H +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
G +LV E++P+ L + D + K Y +L ++G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHAN---GI 120
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ--LT 494
+HRD+K +N+L+ + KIADFGLAR F E++ + + T Y APE L +G
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL-YGARKYD 179
Query: 495 EKADVYSFGMLLLEIVTGR 513
D+++ G + E++ G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 27/206 (13%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRL 374
LG G FG+VY+G+ L DG AVK + + + E+ ++S ++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 375 LGCSCSGPESLLVY-EFLPNQSLDRFI--FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LG ++L ++ E +P SL + + + S + R +I+LG L YLH++
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLG----LEYLHDR 121
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLAR---SFQEDKSHISTAIAGTLGYMAPEYL 488
+HRDIK +NIL+D+ K+ADFG+A+ F KS G+ +MAPE +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-----FKGSPYWMAPEVI 173
Query: 489 AH-GQLTEKADVYSFGMLLLEIVTGR 513
A G AD++S G +LE+ TG+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 316 DEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVR 373
+ N++G G GTVYK + P GR A+K ++ N+ E+ I+ V H N+V+
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 374 LLGCSCSGPESLLVYEFLPNQSLD-RFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
E ++ EF+ SL+ I D + + IL G+ YLH +
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ-----IL---SGIAYLHRR- 187
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY----L 488
I+HRDIK SN+L++S KIADFG++R + ++++ GT+ YM+PE L
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDL 244
Query: 489 AHGQLTEKA-DVYSFGMLLLEIVTGR 513
HG A D++S G+ +LE GR
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 42/223 (18%)
Query: 321 LGQGGFGTVYKGVL-PDGREIAVKRL--FFNNRHRAANF-YNEVNIISSVE-HKNLVRLL 375
+G+G F TV +E A+K L + + + E +++ + H +++L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 376 GCSCSGPESL-LVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+ E+L V E+ PN L ++I D R+ + L YLH
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-------RF-YAAEILLALEYLH 119
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA------------ 477
IIHRD+K NILLD + KI DFG A+ + S S
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 478 -------GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
GT Y++PE L + +D+++ G ++ +++TG+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 66/205 (32%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN---EVNIISSVEHKNLVRL 374
+G G VY + LP+ ++A+KR+ + + EV +S H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGLVYLHEQSK 433
G E LV +L SL + S L E +L ++GL YLH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-EAIIATVLKEVLKGLEYLHSN-- 121
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQED---KSHISTAIAGTLGYMAPEYLA- 489
IHRDIKA NILL KIADFG++ S + + GT +MAPE +
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 490 -HGQLTEKADVYSFGMLLLEIVTGR 513
HG KAD++SFG+ +E+ TG
Sbjct: 181 VHG-YDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN------FYNEVNIISS 365
+ +LG G G V K + P G+ +AVK + N E++I+
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI-----RLEINEAIQKQILRELDILHK 55
Query: 366 VEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA-KTLTWEKRYEIILGTVEG 424
+V G + + + E++ SLD+ + + K I + ++G
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK---IAVAVLKG 112
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L YLHE+ KI IHRD+K SNIL++SR + K+ DFG++ ++ GT YMA
Sbjct: 113 LTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMA 167
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE + + K+D++S G+ L+E+ TGR
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 321 LGQGGFGTVYKGVLPD------GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVR 373
LGQG FG VY+G+ +A+K + N + F NE +++ ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTVEGLV 426
LLG +G +L+V E + L ++ ++ T +K ++ +G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMAP 485
YL + + +HRD+ A N ++ L KI DFG+ R ++ D + +MAP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVT 511
E L G T K+DV+SFG++L E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 16/214 (7%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA---ANFYNEVNIISSVEHKNLVRLLG 376
++G G FG V+ G + R++A+K + R A +F E ++ + H LV+L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
LV+EF+ + L ++ A+ + E + L EG+ YL + +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
IHRD+ A N L+ K++DFG+ R +D+ ST + + +PE + + + K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 497 ADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSL 527
+DV+SFG+L+ E+ + G+ NRS NSE +++
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRS-NSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ ++AVK + + A F E N++ +++H LV+L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P ++ EF+ SL F+ S + K + EG+ ++ +++ IHR
Sbjct: 72 KEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+NIL+ + L KIADFGLAR ++++ + + APE + G T K+DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR 513
+SFG+LL+EIVT GR
Sbjct: 187 WSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 26/218 (11%)
Query: 321 LGQGGFGTVYK---GVLPD--GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG+G FG+V L D G +AVK+L + +F E+ I+ S++H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 376 G-CSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVEGLVY 427
G C +G +L LV E+LP SL ++ D K + +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAP 485
L + R +HRD+ NIL++S R KI DFGL + +DK + G + + AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523
E L + + +DV+SFG++L E+ T + S +E+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 67/202 (33%), Positives = 111/202 (54%), Gaps = 21/202 (10%)
Query: 321 LGQGGFGTVYKGV-LPDGREI----AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
LG G FGTVYKG+ +P+G + A+K L +A F +E I++S++H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRYEIILGTVEGLVYLHE 430
LG C P LV + +P+ L ++ + L W + +G++YL E
Sbjct: 75 LGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYMAPEYLA 489
+ R++HRD+ A N+L+ S KI DFGLAR + D K + + + +MA E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
+ + T ++DV+S+G+ + E++T
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 34/214 (15%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNI---ISSVEH 368
++E ++G+G +GTVYK L GR +A+K++ + E+ + + S EH
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 369 KNLVRLLGCSCSGPES------LLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRY 415
N+VRLL C GP + LV+E + +Q L ++ K L +
Sbjct: 61 PNIVRLLDV-CHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ--- 115
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
+L G+ +LH RI+HRD+K NIL+ S + KIADFGLAR + + + T+
Sbjct: 116 --LLR---GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTS 165
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
+ TL Y APE L D++S G + E+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 38/230 (16%)
Query: 311 ATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANF--YNEVNIISSVE 367
++ KLG+G FG VYK + GR +A+K++ +N E+ I+ ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 368 HKNLVRLLGCSCSGPESLL-----VYEFLPNQSLD--------RFIFDSAKAKTLTWEKR 414
H N+V L+ + P+ VY P D ++ K
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC------ 119
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
+L +EG+ YLHE I+HRDIKA+NIL+D++ KIADFGLAR + +
Sbjct: 120 --YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 475 AIAG----------TLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR 513
G T Y PE L + T D++ G + E+ T R
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 9/207 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNL 371
++ +G+G FGTV K DG+ + K + + N +EVNI+ ++H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 372 VRLLGCSCSGPESLL--VYEFLPNQSLDRFIFDSAKAKT-LTWEKRYEIILGTVEGLVYL 428
VR L V E+ L + I K + + E + I+ + L
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 429 H--EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
H ++HRD+K +NI LD+ K+ DFGLA+ D S T GT YM+PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPE 180
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
L H EK+D++S G L+ E+
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN-----EVNIISSVEH 368
+++ KLG+G + VYK GR +A+K++ R A + N E+ ++ ++H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
N++ LL LV+EF+ L++ I D K+ LT +L T+ GL YL
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYL 118
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H I+HRD+K +N+L+ S K+ADFGLARSF ++ + T Y APE L
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL 174
Query: 489 AHG--QLTEKADVYSFGMLLLEIVTGR 513
G D++S G + E++
Sbjct: 175 -FGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFF--NNRHRAANFYNEVNIISSVEHKN 370
E ++LG+G G+V K L + I + N E+ I S +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 371 LVRLLGCSCSGPESLLVY---EFLPNQSLDRFIFDSAKAKT-LTWEKRYEIILGTV---- 422
+V+ G + S + E+ SLD I+ K + EK +LG +
Sbjct: 61 IVKYYG-AFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEK----VLGKIAESV 114
Query: 423 -EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
+GL YLH + +IIHRDIK SNILL + + K+ DFG++ S T GT
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN--SLAGTFT-GTSF 168
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
YMAPE + + +DV+S G+ LLE+ R
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKR--LFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
K+G+G +G VYK G +A+K+ L F + E+ ++ + H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ LV+EF+ + L + I D + L + ++GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL-AHGQLTE 495
+HRD+K N+L+++ K+ADFGLARSF + + T Y APE L +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYST 178
Query: 496 KADVYSFGMLLLEIVTGR 513
D++S G + E+++ R
Sbjct: 179 PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ G ++AVK L + F E I+ + H LV+L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P +V E++ SL F+ D + + L ++ G+ Y+ ++ IHR
Sbjct: 72 EEP-IYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++++NIL+ L KIADFGLAR ++++ + + APE +G+ T K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR-----QNNR 517
+SFG+LL E+VT GR NNR
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNR 210
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
LG G FG VYK + G A K + + +F E++I+S +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
+ ++ EF +LD + + + LT + + +E L +LH ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 440 DIKASNILLDSRLRAKIADFGL-ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE--- 495
D+KA NILL K+ADFG+ A++ + T I GT +MAPE +A E
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVA----CETFK 181
Query: 496 ------KADVYSFGMLLLEIVTGR 513
KAD++S G+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 321 LGQGGFGTVYKGVLPDGRE--IAVKRLFFNN-------RHRAANF---YNEVNII-SSVE 367
LG G FG VYK + + +A+K + +N R R + +EV II +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
H N+VR +V + + L + F K + T E+ + I + V L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH++ RI+HRD+ +NI+L + I DFGLA+ Q + T++ GT+ Y PE
Sbjct: 128 YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSCPE 183
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVT 511
+ + EKADV++FG +L ++ T
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 62/201 (30%), Positives = 114/201 (56%), Gaps = 16/201 (7%)
Query: 321 LGQGGFGTVYKGVL--PDGREI--AVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRL 374
+G G FG V +G L P REI A+K L + + R +F +E +I+ +H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIMGQFDHPNIIHL 70
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G +++ EF+ N +LD F+ + T+ + ++ G G+ YL E +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYLSEMN-- 126
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH--ISTAIAGTLG--YMAPEYLAH 490
+HRD+ A NIL++S L K++DFGL+R ++D S ++++ G + + APE +A+
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 491 GQLTEKADVYSFGMLLLEIVT 511
+ T +DV+S+G+++ E+++
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 315 FDEANK---LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN 370
+DE + LG+G +G VY L IA+K + + + E+ + S ++H+N
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGT---VEGLVY 427
+V+ LG + E +P SL + +K L + II T +EGL Y
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLK-DNEQTIIFYTKQILEGLKY 123
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
LH+ +I+HRDIK N+L+++ KI+DFG ++ T GTL YMAPE
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPE 179
Query: 487 YLAHGQ--LTEKADVYSFGMLLLEIVTGR 513
+ G AD++S G ++E+ TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 315 FDEANKLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
D K+G+G G V GR++AVK++ + R +NEV I+ +H N+V
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ G E +V EFL +L D + E+ + L ++ L +LH Q
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQED----KSHISTAIAGTLGYMAPEYLA 489
+IHRDIK+ +ILL S R K++DFG ++ KS + GT +MAPE ++
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAPEVIS 188
Query: 490 HGQLTEKADVYSFGMLLLEIVTG 512
+ D++S G++++E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 321 LGQGGFGTVYKG----VLPDGRE--IAVKRL---FFNNRHRAANFYNEVNIISSVEHKNL 371
LG+G FG V+ G + P+ + +AVK L N+ + +F E ++++ +H+N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK--DFEREAELLTNFQHENI 70
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRF---------IFDSAKAKT--LTWEKRYEIILG 420
V+ G G ++V+E++ + L++F S + LT + +I +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGT 479
G+VYL Q +HRD+ N L+ L KI DFG++R + D +
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +M PE + + + T ++DV+SFG++L EI T G+Q
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 10/198 (5%)
Query: 320 KLGQGGFGTVYK-GVLPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNLVRLLG 376
KLG+G +G+VYK L D + A+K + + + + NE+ I++SV H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKIR 435
G + +V E+ P L + I K + L E+ + I + + GL LHEQ +
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---K 123
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
I+HRD+K++NILL + KI D G+++ K +++ GT YMAPE +
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 496 KADVYSFGMLLLEIVTGR 513
K+D++S G LL E+ T
Sbjct: 181 KSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 322 GQGGFGTVYKGVLPDGREI-AVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRLL 375
G+G FG V D +++ A+K + N + N NE I+ + H LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMK--YMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLHEQSK 433
LV + L L R+ + K + EI+L L YLH +
Sbjct: 67 YSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLA----LEYLHSK-- 119
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
IIHRDIK NILLD + I DF +A D ++T+ +GT GYMAPE L
Sbjct: 120 -GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGY 176
Query: 494 TEKADVYSFGMLLLEIVTGRQ----NNRSKNSEYTDSLLT 529
+ D +S G+ E + G++ ++R+ + T
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET 216
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-23
Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 317 EANKLGQGGFGTVYKGVLPDGREIAVKR--LFFNNRHRAANFYN----EVNIISSVEHKN 370
+ LG+G +GTVY G+ G+ IAVK+ L +N A Y EV+++ S++H N
Sbjct: 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 371 LVRLLGCSCSGPESLLVY-EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+V+ LG +C ++ ++ EF+P S+ + + K + IL +G+ YLH
Sbjct: 64 IVQYLG-TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLH 119
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-----SFQEDKSHISTAIAGTLGYMA 484
++HRDIK +N++L K+ DFG AR S++ ++ GT +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE + K+D++S G + E+ TG+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA----ANFYNEVNIISSVEHKNLVRL 374
+G+G FG VYK + + +A+K + + A + E+ +S + +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVI---DLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G G + ++ E+ S D K L I+ + GL YLHE+ KI
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKI 120
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
HRDIKA+NILL K+ADFG++ S +T GT +MAPE +
Sbjct: 121 ---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQSGYD 176
Query: 495 EKADVYSFGMLLLEIVTG 512
EKAD++S G+ +E+ G
Sbjct: 177 EKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 63/195 (32%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLLGCS 378
LG G G+V K +P G +A K + + E+ I+ +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ + EF+ SLDR K + E +I + VEGL YL+ RI+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRI---YKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMH 127
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RDIK SNIL++SR + K+ DFG++ E + I+ GT YM+PE + G+ T K+D
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 499 VYSFGMLLLEIVTGR 513
V+S G+ ++E+ G+
Sbjct: 185 VWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-23
Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLGQG FG V+ G ++A+K L A F E I+ + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P +V EF+ SL F+ K L + ++ +G+ Y+ ++ IHR
Sbjct: 72 EEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+NIL+ L KIADFGLAR ++++ + + APE +G+ T K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR 513
+SFG+LL E+VT GR
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA----NFYNEVNIISSVEHKNLVRLLG 376
LG G FG V+ G ++A+K + A +F E ++ + H NLV+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-----REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 377 -CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
C+ P +V E++ N L ++ + L E ++ E + YL
Sbjct: 67 VCTKQRP-IFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG--- 120
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
IHRD+ A N L+ K++DFGLAR +D+ S + + PE + + +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 496 KADVYSFGMLLLEIVTGRQN--NRSKNSEYTDSLLT 529
K+DV+SFG+L+ E+ + + R NSE +S+
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 1e-22
Identities = 61/199 (30%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 321 LGQGGFGTVYKGVL--PDGREIAVK----RLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+G G FG V G L P REI V + + + R +F +E +I+ +H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR-DFLSEASIMGQFDHPNIIHL 70
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G ++V E++ N SLD F+ T+ + ++ G G+ YL S +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI--QLVGMLRGIASGMKYL---SDM 125
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--YMAPEYLAHGQ 492
+HRD+ A NIL++S L K++DFGL+R ++D T G + + APE +A+ +
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 493 LTEKADVYSFGMLLLEIVT 511
T +DV+S+G+++ E+++
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 57/214 (26%), Positives = 109/214 (50%), Gaps = 32/214 (14%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRL----FFNNRHRA------ANFYNEVNIISSVEHK 369
+G+G +G VY + + G +AVK++ RH + +E+ + ++H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 370 NLVRLLGCSCSGPESLLVY-EFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVE 423
N+V+ LG + E L ++ E++P S+ + F+ + T + +E
Sbjct: 69 NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS-TAIAGTLGY 482
GL YLH + I+HRD+KA N+L+D+ KI+DFG+++ + + ++ G++ +
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 483 MAPE--YLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
MAPE + + K D++S G ++LE+ GR+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 31/213 (14%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFF-------NNRHRA--ANFYNEVNIISSVEHKN 370
+G G FG+VY G+ G +AVK++ +R R+ E+ ++ ++H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGL 425
+V+ LG S + E++P S+ + F+ + + ++GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF--------VRQILKGL 119
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST-----AIAGTL 480
YLH + IIHRDIK +NIL+D++ KI+DFG+++ + + T ++ G++
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+MAPE + T KAD++S G L++E++TG+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 15/197 (7%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
+G+G FG V +G G+++AVK + + +A F E +++ + HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA--FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 380 SGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
L +V E + +L F+ +A + + L EG+ YL +SK +++H
Sbjct: 70 H--NGLYIVMELMSKGNLVNFLRTRGRALVSV-IQLLQFSLDVAEGMEYL--ESK-KLVH 123
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD+ A NIL+ AK++DFGLAR ++ + + + APE L H + + K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKSD 179
Query: 499 VYSFGMLLLEIVT-GRQ 514
V+S+G+LL E+ + GR
Sbjct: 180 VWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLGQG FG V+ G +A+K L A F E ++ + H+ LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P +V E++ SL F+ K L + ++ G+ Y+ ++ +HR
Sbjct: 72 EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+NIL+ L K+ADFGLAR ++++ + + APE +G+ T K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR 513
+SFG+LL E+ T GR
Sbjct: 187 WSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 21/202 (10%)
Query: 321 LGQGGFGTVYKGV-LPDGR--EIAVKRLFFNNRHRAANFY---NEVNIISSVEHKNLVRL 374
LG G FGTV+KG+ +P+G +I V +R F + + + S++H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA----KTLTWEKRYEIILGTVEGLVYLHE 430
LG C G LV + P SL + + + L W + +G+ YL E
Sbjct: 75 LGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE 127
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHISTAIAGTLGYMAPEYLA 489
R++HR++ A NILL S +IADFG+A + +DK + + + +MA E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
G+ T ++DV+S+G+ + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 67/228 (29%), Positives = 121/228 (53%), Gaps = 26/228 (11%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
+F + KLG+G + TVYKG EI A+K + + + E++++ ++H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFI--------FDSAKAKTLTWEKRYEIILGTVE 423
VRL + + +LV+E++ ++ L +++ D K+ T++ ++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ + HE R++HRD+K N+L++ R K+ADFGLAR+F + S + TL Y
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYR 167
Query: 484 APEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530
AP+ L + + D++S G ++ E++TGR N+E D LL I
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 321 LGQGGFGTVYKG--VLPDGRE----IAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVR 373
LG+G FG VYKG P+ R +A+K L N + F E ++S ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEKRYEIIL 419
LLG C+ P +L +E+L + L F+ D +L I +
Sbjct: 73 LLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAG 478
G+ YL S +HRD+ A N L+ L KI+DFGL+R + D + +
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
+ +M PE + +G+ T ++D++SFG++L EI
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 70/207 (33%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 321 LGQGGFGTVYKGVL--PDGREI--AVKRLFFNNR----HRAANFYNEVNIISSVEHKNLV 372
+G+G FG VY G L DG++I AVK L NR F E I+ H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL---NRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 373 RLLGCSCSGPES--LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII---LGTVEGLVY 427
LLG C E L+V ++ + L FI T+ ++I L +G+ Y
Sbjct: 60 SLLGI-CLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEY 113
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE---DKSHISTAIAGTLGYMA 484
L + + +HRD+ A N +LD K+ADFGLAR + H T + +MA
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVT 511
E L + T K+DV+SFG+LL E++T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
++ ++G G +G VYK + G +A+K + E++++ H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE---GLVYLHE 430
G + +V E+ SL I+ T +I E GL YLHE
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQD-IYQ----VTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLA----RSFQEDKSHISTAIAGTLGYMAPE 486
K IHRDIK +NILL K+ADFG++ + + KS I GT +MAPE
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPE 171
Query: 487 YLA---HGQLTEKADVYSFGMLLLE 508
A G K D+++ G+ +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 73/218 (33%), Positives = 113/218 (51%), Gaps = 32/218 (14%)
Query: 321 LGQGGFGTVYKG----VLPDGRE---IAVKRLFFNNRHRA-----ANFYNEVNIISSVEH 368
LG G FG VY+G +L G +AVK L R A F E +++S+ H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL----RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 369 KNLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT----LTWEKRYEIILGTVE 423
N+V+LLG C + P+ +++ E + L ++ D+ + LT ++ +I L +
Sbjct: 59 PNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 424 GLVYLHEQSKIRIIHRDIKASNILL-----DSRLRAKIADFGLARS-FQEDKSHISTAIA 477
G VYL ++ IHRD+ A N L+ D+ KI DFGLAR ++ D
Sbjct: 118 GCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +MAPE L G+ T ++DV+SFG+L+ EI+T G+Q
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 319 NKLGQGGFGTVYKGVL------PDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNL 371
LG G FG VY+G+ ++AVK L + ++F E I+S H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRYEIILGTVEGLVY 427
VRL+G S ++ E + L F+ ++ + +LT + +G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 428 LHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARS-FQEDKSHISTAIAGTLGYM 483
L E IHRDI A N LL + AKIADFG+AR ++ + +M
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEI 509
PE G T K DV+SFG+LL EI
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKN 370
+F + K+G+G +G VYK G +A+K RL + E++++ + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+V+LL + + LV+EFL +Q L +F+ D++ + + ++GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
R++HRD+K N+L+++ K+ADFGLAR+F + + TL Y APE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG 174
Query: 491 GQLTEKA-DVYSFGMLLLEIVTGR 513
+ A D++S G + E+VT R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 320 KLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+G+G G V GR++AVK + + R +NEV I+ +H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
G E ++ EFL +L D L E+ + ++ L YLH Q +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RDIK+ +ILL R K++DFG +D ++ GT +MAPE ++ + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 499 VYSFGMLLLEIVTG 512
++S G++++E+V G
Sbjct: 200 IWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 312 TGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRL----FFNNRHRAANFYNEVNIISSV 366
G+F K+G+G F VYK + L DGR +A+K++ + + R + E++++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ-DCLKEIDLLKQL 59
Query: 367 EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGL 425
+H N+++ L E +V E L R I K K L E+ ++ + L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
++H + RI+HRDIK +N+ + + K+ D GL R F K+ + ++ GT YM+P
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSP 175
Query: 486 EYLAHGQLTEKADVYSFGMLLLEI 509
E + K+D++S G LL E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+GQG GTVY + + G+E+A+K++ + + NE+ ++ +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 379 CSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G E +V E+L SL + D + + E ++ L +LH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALEFLHSN--- 134
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
++IHRDIK+ NILL K+ DFG ++S ST + GT +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 495 EKADVYSFGMLLLEIVTG 512
K D++S G++ +E+V G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRHRA--ANFYNEVNIISSVEHKN 370
+++ K+G+G +GTV+K + EI A+KR+ ++ ++ E+ ++ ++HKN
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+VRL S + LV+E+ +Q L ++ FDS + E + ++GL + H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHS 117
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
++HRD+K N+L++ K+ADFGLAR+F S + TL Y P+ L
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFG 173
Query: 491 GQL-TEKADVYSFGMLLLEIVTG 512
+L + D++S G + E+
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 34/221 (15%)
Query: 321 LGQGGFGTVYKGV------LPDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVR 373
LG+G FG V K +AVK L N + + +E N++ V H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIIL 419
L G CS GP LL+ E+ SL F+ +S K + L + +
Sbjct: 68 LYGACSQDGP-LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 420 GTV--------EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471
G + G+ YL E ++++HRD+ A N+L+ + KI+DFGL+R E+ S+
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 472 ISTAIAGT-LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ + + +MA E L T ++DV+SFG+LL EIVT
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 320 KLGQGGFGTVY----KGVLPDGRE--IAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG V+ +LP+ + +AVK L + +F E +++ ++H+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRF---------IFDSAKAKT---LTWEKRYEIILGT 421
G G L+V+E++ + L+RF I + LT + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTL 480
G+VYL + + +HRD+ N L+ L KI DFG++R + D + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+M PE + + + T ++D++SFG++L EI T G+Q
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 9e-21
Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 320 KLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+G+G G V G+++AVK++ + R +NEV I+ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
G E +V EFL +L D + E+ + L + L YLH Q +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RDIK+ +ILL S R K++DFG ++ ++ GT +MAPE ++ + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 499 VYSFGMLLLEIVTG 512
++S G++++E++ G
Sbjct: 201 IWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 315 FDEANKLGQGGFGTV-YKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
D K+G+G G V V G+ +AVK++ + R +NEV I+ +H+N+V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ G E +V EFL +L D + E+ + L ++ L LH Q
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG- 136
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+IHRDIK+ +ILL R K++DFG ++ ++ GT +MAPE ++
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPELISRLPY 193
Query: 494 TEKADVYSFGMLLLEIVTG 512
+ D++S G++++E+V G
Sbjct: 194 GPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 14/196 (7%)
Query: 320 KLGQGGFGTVYKGVL---PDGREIAVKRLFFNNRHRAAN--FYNEVNIISSVEHKNLVRL 374
+LG G FGTV KG+ + +AVK L +N A E N++ +++ +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G C +LV E L++F+ K K +T + E++ G+ YL E +
Sbjct: 62 IGI-CEAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYLAHGQ 492
+HRD+ A N+LL ++ AKI+DFGL+++ D+++ G + + APE + + +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 493 LTEKADVYSFGMLLLE 508
+ K+DV+SFG+L+ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 321 LGQGGFGTVYKGVL-----PDGR-EIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLV 372
LG+G FG V K P+ +AVK L + ++ +E+ ++ + +HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 373 RLLG-CSCSGPESLLV--------YEFL----PNQSLDRFIFDSAKAKTLTWEKRYEIIL 419
LLG C+ GP ++V +FL P +TLT +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
G+ +L + + IHRD+ A N+L+ KIADFGLAR D HI T
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTT 192
Query: 480 LG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
G +MAPE L T ++DV+SFG+LL EI T
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 320 KLGQGGFGTVYKGVLPDGR---EIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVRLL 375
+LG G FG V KGV + ++A+K L N + E I+ +++ +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G C +LV E L++F+ S K +T E++ G+ YL ++
Sbjct: 62 GV-CEAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYLAHGQL 493
+HRD+ A N+LL ++ AKI+DFGL+++ D S+ AG L + APE + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 494 TEKADVYSFGMLLLE 508
+ ++DV+S+G+ + E
Sbjct: 176 SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 21/211 (9%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLF--FNNRHRAANFYNEVNIISSV-EHKN 370
++ KLG+G +G V+K + +E+ A+K++F F N A + E+ + + +H N
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 371 LVRLLGC--SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVY 427
+V+LL + + + LV+E++ L I +A L KRY I+ ++ L Y
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLLKALKY 122
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF----QEDKSHISTAIAGTLGYM 483
+H +IHRD+K SNILL+S R K+ADFGLARS + ++ + T T Y
Sbjct: 123 IHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 484 APEYL-AHGQLTEKADVYSFGMLLLEIVTGR 513
APE L + T+ D++S G +L E++ G+
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 321 LGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-----H--KNLV 372
+G G G VYK G +AVK++ R N I+ ++ H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM-----RRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG-----TVEGLVY 427
+ G + + + E L + LD K E ILG V+ L Y
Sbjct: 78 KCYGYFITDSDVFICME-LMSTCLD-------KLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
L E K +IHRD+K SNILLD+ K+ DFG++ + K+ T AG YMAPE
Sbjct: 130 LKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPER 185
Query: 488 L----AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
+ + + +ADV+S G+ L+E+ TG+ ++ +E+ +LT +
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 4e-20
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+GQG GTV+ + + G+E+A+K++ + + NE+ ++ +++ N+V L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 379 CSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G E +V E+L SL + D A+ + E ++ L +LH
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE--------CLQALEFLHAN--- 134
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
++IHRDIK+ N+LL K+ DFG ++S ST + GT +MAPE +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 495 EKADVYSFGMLLLEIVTG 512
K D++S G++ +E+V G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 61/191 (31%), Positives = 97/191 (50%), Gaps = 10/191 (5%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
LG+G FG V+KG L D +AVK + + F +E I+ +H N+V+L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
+V E +P D F K L ++ + L G+ YL ++ IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLAHGQLTEKA 497
D+ A N L+ KI+DFG++R QED S++ + + APE L +G+ + ++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 498 DVYSFGMLLLE 508
DV+S+G+LL E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 61/204 (29%), Positives = 110/204 (53%), Gaps = 21/204 (10%)
Query: 321 LGQGGFGTV----YKGVLPDG----REIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNL 371
LG+G FG V Y P+G ++AVK L + + A+ E+ I+ ++ H+N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 372 VRLLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
V+ G C+ G + L+ EFLP+ SL ++ + L + +Y + + +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI--CKGMDYLG 126
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH--ISTAIAGTLGYMAPEY 487
+ + +HRD+ A N+L++S + KI DFGL ++ + DK + + + + + APE
Sbjct: 127 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 488 LAHGQLTEKADVYSFGMLLLEIVT 511
L + +DV+SFG+ L E++T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAA-NFYNEVN-IISSVEHKNLVRLLGC 377
+G+G FGTV K + G +AVKR+ + +++ ++ S + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEI---ILG-----TVEGLVYLH 429
+ + E L + SLD+F K + + I ILG TV+ L YL
Sbjct: 72 LFREGDCWICME-LMDISLDKF------YKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
E +++IIHRD+K SNILLD K+ DFG++ + S T AG YMAPE +
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERID 180
Query: 490 HGQLTE---KADVYSFGMLLLEIVTGR 513
++DV+S G+ L E+ TG+
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFF--NNRHRAANFY----NEVNIISSVEHKNLVR 373
LG G F + Y+ + G +AVK++ + N E+ +++ + H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+LG +C L E++ S+ + K E +L GL YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLHEN-- 122
Query: 434 IRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKS---HISTAIAGTLGYMAPEYLA 489
+IIHRD+K +N+L+DS R +IADFG A + + GT+ +MAPE L
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
Q DV+S G +++E+ T +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRHRAANFYN--EVNIISSVEHKNL 371
F++ N++G+G +G VY+ EI A+K++ +N + E+ ++ ++ H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 372 VRLL----GCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILG 420
V L G +S+ LV E+ Q L + F ++ K L L
Sbjct: 69 VELKEVVVGKHL---DSIFLVMEYC-EQDLASLLDNMPTPFSESQVKCLM--------LQ 116
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL YLHE IIHRD+K SN+LL + KIADFGLAR++ + T TL
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVVTL 172
Query: 481 GYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTGR 513
Y APE L T D+++ G +L E++ +
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNN-RHRAANFYNEVNIISSVEHKNLV 372
F + ++G+G FG VYKG+ +E+ A+K + + E+ ++S + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
R G G + ++ E+L S D K L I+ ++GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
KI HRDIKA+N+LL + K+ADFG+A + + +T + GT +MAPE +
Sbjct: 122 KI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177
Query: 493 LTEKADVYSFGMLLLEIVTGRQNN 516
KAD++S G+ +E+ G N
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+GQG GTVY + + G+E+A+K++ + + NE+ ++ ++ N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 379 CSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G E +V E+L SL + D + + E ++ L +LH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALDFLHSN--- 134
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
++IHRDIK+ NILL K+ DFG ++S ST + GT +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 495 EKADVYSFGMLLLEIVTG 512
K D++S G++ +E+V G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 24/205 (11%)
Query: 320 KLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYN----EVNIISSVEHKNLVRL 374
+G+G +G V K G +A+K+ F + EV ++ + H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKK--FKESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 375 LGCSCSGPESLLVYEFLPN---QSLDRFI--FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
LV+E++ + L+ ++ W+ ++ + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCH 117
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
IIHRDIK NIL+ K+ DFG AR+ + + T T Y APE L
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 490 HGQLTEKA-DVYSFGMLLLEIVTGR 513
K DV++ G ++ E++ G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 9/203 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNL 371
+ + K+G+G +G VYKG G+ +A+K++ + + E++++ ++H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
V L L++EFL + L +++ K + + E + ++G+++ H +
Sbjct: 62 VCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
R++HRD+K N+L+D++ K+ADFGLAR+F + T TL Y APE L
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGS 176
Query: 492 QL-TEKADVYSFGMLLLEIVTGR 513
+ D++S G + E+ T +
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 321 LGQGGFGTVYKGV-LPDGREI----AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
LG G FGTVYKG+ +PDG + A+K L N +A +E +++ V + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRYEIILGTVEGLVYLHE 430
LG C LV + +P L ++ ++ L W + +G+ YL E
Sbjct: 75 LGI-CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE 127
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYL 488
+R++HRD+ A N+L+ S KI DFGLAR D++ A G + +MA E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADGGKVPIKWMALESI 183
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
H + T ++DV+S+G+ + E++T
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 57/213 (26%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 320 KLGQGGFGTVY----KGVLPDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG V+ + P+ +I AVK L + + +F+ E ++++++H+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFI----------FDSAKAKTLTWEKRYEIILGTVE 423
G G ++V+E++ + L++F+ + + LT + I
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGY 482
G+VYL Q +HRD+ N L+ L KI DFG++R + D + + +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
M PE + + + T ++DV+S G++L EI T G+Q
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE---IAVKRLFFNN-RHRAANFYNEVNIISSVEHKN 370
F + ++G+G FG V+KG+ D R +A+K + + E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQS-LDRF---IFDSAKAKTLTWEKRYEIILGTVEGLV 426
+ + G G + ++ E+L S LD FD + T+ E ++GL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE--------ILKGLD 115
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + KI HRDIKA+N+LL + K+ADFG+A + + +T + GT +MAPE
Sbjct: 116 YLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 171
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516
+ KAD++S G+ +E+ G N
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRL 374
LGQG FG VY D GRE+AVK++ F+ E+ ++ ++ H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 375 LGCSCSGPESLL--VYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
GC E L E +P S+ D+ A + +T + +I+ EG+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHSN 125
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED--KSHISTAIAGTLGYMAPEYLA 489
I+HRDIK +NIL DS K+ DFG ++ Q ++ GT +M+PE ++
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
KAD++S G ++E++T +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 321 LGQGGFGTVYK-GVLPDGREIAVKRLFFNNRHRAAN-----FYNEVNIISSVEHKNLVRL 374
LG GGFG V V R A+K RH ++E I+ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKC--VKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 375 LGCSCSGPESLLVY---EFLPNQSL-----DRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
+ + +Y E+ L DR +FD A+ I V
Sbjct: 59 Y---RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF--------YIACVVLAFE 107
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTAIAGTLGYMAP 485
YLH + II+RD+K N+LLDS K+ DFG A+ + K+ GT Y+AP
Sbjct: 108 YLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAP 161
Query: 486 EY-LAHGQLTEKADVYSFGMLLLEIVTGRQ 514
E L G D +S G+LL E++TGR
Sbjct: 162 EIILNKGY-DFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRH---RAANFYNEVNIISSVEHKN 370
F + ++G G FG VY E+ A+K++ ++ + + + EV + + H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ GC + LV E+ + D I + K K L + I G ++GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHS 133
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY-LA 489
+I HRDIKA NILL K+ADFG A S + GT +MAPE LA
Sbjct: 134 HERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185
Query: 490 --HGQLTEKADVYSFGMLLLEI 509
GQ K DV+S G+ +E+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-19
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 321 LGQGGFGTV----YKGVLPD-GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRL 374
LG+G FG V Y G +AVK L + + + E+NI+ ++ H+N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 375 LGCSCSGPES--LLVYEFLPNQSLDRFI--FDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
GC L+ E++P SL ++ A+ L + ++ EG+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYLHS 125
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYL 488
Q IHRD+ A N+LLD+ KI DFGLA++ E + G + + A E L
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
+ + +DV+SFG+ L E++T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 5e-19
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 10/209 (4%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-CS 378
+LG G FG V G ++A+K + F E ++ + H+ LV+L G C+
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
P +V E++ N L ++ + K + E+ EG+ YL +SK + IH
Sbjct: 70 KQRP-IYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYL--ESK-QFIH 123
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD+ A N L+D + K++DFGL+R +D+ S + + PE L + + + K+D
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 499 VYSFGMLLLEIVT-GRQN-NRSKNSEYTD 525
V++FG+L+ E+ + G+ R NSE +
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVE 212
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-19
Identities = 69/272 (25%), Positives = 127/272 (46%), Gaps = 37/272 (13%)
Query: 252 IVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKA 311
+ + A +VLA+ + + ++E KR + D + DS K T+
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG--TWELQFFDSKVSKSITINDI 688
Query: 312 TGSFDEANKLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYNEVNIISS----- 365
S E N + +G G YKG + +G + VK + N+VN I S
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI------------NDVNSIPSSEIAD 736
Query: 366 ---VEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV 422
++H N+V+L+G S + L++E++ ++L + + L+WE+R +I +G
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIA 790
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLG 481
+ L +LH + ++ ++ I++D + + L D K IS+A
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------ 843
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE +TEK+D+Y FG++L+E++TG+
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV--LPDGREIAVKRLFFNNR---HRAANFYNEVNIISSVEHKNLVRL 374
+G+G FG VY+GV P+ +IAV N F E I+ +H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFI---FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
+G + +V E P L ++ S +L Y L T L YL
Sbjct: 73 IGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLI---LYSYQLST--ALAYLE-- 124
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
R +HRDI A N+L+ S K+ DFGL+R +++ + ++ + +MAPE +
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 492 QLTEKADVYSFGMLLLEI 509
+ T +DV+ FG+ + EI
Sbjct: 184 RFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 321 LGQGGFGTVYKGVL--PDGR--EIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRL 374
LG+G FG+V +G L DG ++AVK + + F +E + +H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 375 LGCSCSG------PESLLVYEFLPNQSLDRFIFDSAKA---KTLTWEKRYEIILGTVEGL 425
+G P+ +++ F+ + L F+ S + L + + ++ G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMA 484
YL S IHRD+ A N +L + +ADFGL++ + IA + ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVT 511
E LA T K+DV++FG+ + EI T
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKNL 371
+ + K+G+G +G VYK G +A+K RL + + E++++ + H N+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE--KRYEIILGTVEGLVYLH 429
VRLL S + LV+EFL + L +++ DS+ L K Y + ++G+ Y H
Sbjct: 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSY--LYQLLQGIAYCH 116
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
R++HRD+K N+L+D K+ADFGLAR+F + + TL Y APE L
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 172
Query: 490 HG-QLTEKADVYSFGMLLLEIVTGR 513
Q + D++S G + E+V R
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 48/152 (31%), Positives = 83/152 (54%), Gaps = 8/152 (5%)
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
E ++ +V H +++R+ SG + +V LP+ S D + + + +++ L ++ I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+EGL YLH Q RIIHRD+K NI ++ + I D G A+ + + +AG
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--GLAG 218
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510
T+ APE LA + KAD++S G++L E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 32/206 (15%)
Query: 320 KLGQGGFGTVYK------GVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG G FG VYK G L + I K + ++ E+ I+++ H +V+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVK 73
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGLVYLHEQS 432
LLG + ++ EF P ++D + + + T E + ++I +E L YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHSM- 129
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLA----RSFQEDKSHISTAIAGTLGYMAPEYL 488
+IIHRD+KA N+LL K+ADFG++ ++ Q S I GT +MAPE +
Sbjct: 130 --KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVV 182
Query: 489 AHGQLTE-----KADVYSFGMLLLEI 509
+ + KAD++S G+ L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANF- 356
D F + +++ K+GQG FG V+K + +A+K++ N F
Sbjct: 1 DQYEFPFC---DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG--FP 55
Query: 357 ---YNEVNIISSVEHKNLVRLLGCSCSGPES---------LLVYEFLPNQSLDRFIFDSA 404
E+ I+ ++H+N+V L+ C + LV+EF L + S
Sbjct: 56 ITALREIKILQLLKHENVVNLIEI-CRTKATPYNRYKGSFYLVFEFC-EHDLAGLL--SN 111
Query: 405 KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464
K T + +++ + GL Y+H +I+HRD+KA+NIL+ K+ADFGLAR+
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168
Query: 465 F---QEDKSHISTAIAGTLGYMAPEYL 488
F + K + T TL Y PE L
Sbjct: 169 FSLSKNSKPNRYTNRVVTLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRH---RAANFYNEVNIISSVEHKN 370
F +++G G FG VY E+ AVK++ ++ + + + EV + ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ GC + LV E+ + D K L + I G ++GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY--- 487
+ I HRDIKA NILL + K+ADFG A KS + + GT +MAPE
Sbjct: 140 HNMI---HRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILA 191
Query: 488 LAHGQLTEKADVYSFGMLLLEI 509
+ GQ K DV+S G+ +E+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 32/206 (15%)
Query: 320 KLGQGGFGTVYK------GVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG G FG VYK GVL + I K + ++ E++I++S +H N+V+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVK 66
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG-TVEGLVYLHEQS 432
LL ++ EF ++D + + + T E + ++ T+E L YLHE
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN- 122
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLA----RSFQEDKSHISTAIAGTLGYMAPEYL 488
+IIHRD+KA NIL K+ADFG++ R+ Q S I GT +MAPE +
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVV 175
Query: 489 AHGQLTE-----KADVYSFGMLLLEI 509
+ KADV+S G+ L+E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 20/205 (9%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRL 374
LGQG FG VY D GRE+A K++ F+ + E+ ++ +++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 375 LGC-SCSGPESLLVY-EFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
GC ++L ++ E++P S+ D+ A +++T + +I+ EG+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHSN 125
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE---DKSHISTAIAGTLGYMAPEYL 488
I+HRDIK +NIL DS K+ DFG ++ Q + I + + GT +M+PE +
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVI 181
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ KADV+S G ++E++T +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREI----AVKRLFFNNRHRA-ANFYNEVNIISSVEH 368
F + LG G FGTVYKG+ +P+G ++ A+K L +A +E +++SV++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRYEIILGTVEG 424
++ RLLG C L+ + +P L ++ + L W + +G
Sbjct: 69 PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYM 483
+ YL E+ R++HRD+ A N+L+ + KI DFGLA+ D K + + + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVT 511
A E + H T ++DV+S+G+ + E++T
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 43/111 (38%), Positives = 59/111 (53%), Gaps = 26/111 (23%)
Query: 416 EIILGTV-----EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG--------LA 462
E ILG + GL YL E K +I+HRD+K SNIL++SR K+ DFG +A
Sbjct: 98 ENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155
Query: 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
SF GT YM+PE L T ++D++S G+ L+E+ GR
Sbjct: 156 NSF-----------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 320 KLGQGGFGTVYKG--VLP---DGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+ FG +YKG LP + +A+K L NN + F E ++++ + H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIF--------------DSAKAKTLTWEKRYEIIL 419
LLG +++E+L L F+ D +L I +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAG 478
G+ YL S +H+D+ A NIL+ +L KI+D GL+R + D +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ +M PE + +G+ + +D++SFG++L EI +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 4e-18
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+GQG GTVY + + G+E+A++++ + + NE+ ++ ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 379 CSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G E +V E+L SL + D + + E ++ L +LH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALEFLHSN--- 135
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
++IHRDIK+ NILL K+ DFG ++S ST + GT +MAPE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 495 EKADVYSFGMLLLEIVTG 512
K D++S G++ +E++ G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 38/220 (17%)
Query: 321 LGQGGFGTVYK----GVLPDGRE--IAVKRLFFNNRHRA-----ANFYNEVNIISSVEHK 369
+GQG FG V++ G+LP +AVK L + A A+F E +++ +H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML----KEEASADMQADFQREAALMAEFDHP 68
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD-SAKAKT------------------LT 410
N+V+LLG G L++E++ L+ F+ S +A+ L+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 411 WEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDK 469
++ I G+ YL E+ + +HRD+ N L+ + KIADFGL+R+ + D
Sbjct: 129 CTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
S A + +M PE + + + T ++DV+++G++L EI
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 320 KLGQGGFGTVY----KGVLP--DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG V+ + P D +AVK L +F E ++++++H+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRF----------IFDSAKAKT---LTWEKRYEIILG 420
G G ++V+E++ + L++F + D + L + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGT 479
G+VYL Q +HRD+ N L+ + L KI DFG++R + D +
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +M PE + + + T ++DV+SFG++L EI T G+Q
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G G +G V GR++A+K+L F + H A Y E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH-AKRTYRELRLLKHMDHENVIGLLD 81
Query: 377 CSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
SL LV + L+ + K + L+ + ++ + GL Y+H
Sbjct: 82 VFTP-ASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YL 488
IIHRD+K SNI ++ KI DFGLAR T T Y APE L
Sbjct: 136 SA---GIIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIML 188
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ D++S G ++ E++TG+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFN-NRHRAANFYNEVNI-ISSVEHKNLVRLLGC 377
LG+G +G V K +P G +AVKR+ N +++I + SV+ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 378 SCSGPESLLVYEFLPNQSLDRF---IFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ + E + + SLD+F ++D K T+ + +I + V+ L YLH + +
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSK--L 123
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY----LAH 490
+IHRD+K SN+L++ + K+ DFG+ S S T AG YMAPE L
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVDSVAKTIDAGCKPYMAPERINPELNQ 181
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
K+DV+S G+ ++E+ TGR
Sbjct: 182 KGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 315 FDEANKLGQGGFGTVYKG--VLPDGREIAVKRLFFNNRHRAA--NFYNEVNII---SSVE 367
++ ++G+G +G V+K + GR +A+KR+ + EV ++ + E
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 368 HKNLVRLLG-CSCSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV 422
H N+VRL C+ S + LV+E + +Q L ++ D + E +++ +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLL 120
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR--SFQEDKSHISTAIAGTL 480
GL +LH R++HRD+K NIL+ S + K+ADFGLAR SFQ T++ TL
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTL 173
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
Y APE L D++S G + E+
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 48/219 (21%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G V V GR++A+K++ F++ A E+ ++ + H+N++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL-- 65
Query: 378 SCSGPESL-------LVYEFLP---------NQSLD----RFIFDSAKAKTLTWEKRYEI 417
P S +V E + Q L ++ Y+I
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFL-------------YQI 112
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TA 475
+ G L YLH + +IHRD+K SNIL++S KI DFGLAR D+ T
Sbjct: 113 LRG----LKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 476 IAGTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGR 513
T Y APE L+ + T+ D++S G + E++T +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 309 EKATGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRA--ANFYNEVNIISS 365
++ FD ++G+G +G VYK D G +A+K++ +N E+ I+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 366 VEHKNLVRLLGCSCSGPESL----------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
+ H+N+V L ++L LV+E++ D + ++ + + + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDH 117
Query: 416 --EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473
+ +EGL Y H K +HRDIK SNILL+++ + K+ADFGLAR + ++S
Sbjct: 118 IKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 474 TAIAGTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGR 513
T TL Y PE L + DV+S G +L E+ T +
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVK--RLFFNNRHRAANFYNEVNIISSVE---H 368
++ ++G G +GTVYK P G +A+K R+ N + EV ++ +E H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 369 KNLVRLLG-CSCSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
N+VRL+ C+ S + LV+E + +Q L R D L E +++ +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDL-RTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS-TAIAGTLGY 482
GL +LH I+HRD+K NIL+ S + K+ADFGLAR + ++ T + TL Y
Sbjct: 120 GLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWY 173
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEI 509
APE L D++S G + E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 320 KLGQGGFGTVY-----KGV----LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN 370
+LG+G FGTVY K V L +EI V L N +A E ++S ++H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDHPA 63
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA-KTLTWEKRYEIILGTVEGLVYLH 429
+V+ ++ E+ + LD + + KTL+ + E + + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ RI+HRD+KA NI L + L KI DFG++R ++T GT YM+PE L
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLATTFTGTPYYMSPEALK 178
Query: 490 HGQLTEKADVYSFGMLLLEI 509
H K+D++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 320 KLGQGGFGTVY----KGVLPDGRE--IAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
+LGQG FG VY KGV+ D E +A+K + R F NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTV-EGL 425
RLLG G +L++ E + L ++ ++ + K+ + G + +G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--YM 483
YL+ + +HRD+ A N ++ KI DFG+ R E + G L +M
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWM 188
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVT 511
+PE L G T +DV+SFG++L EI T
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE---IAVKRLFFNNRH---RAANFYNEVNIISSVEH 368
F + ++G G FG VY D R +A+K++ ++ + + + EV + ++H
Sbjct: 27 FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
N + GC + LV E+ + D K L + I G ++GL YL
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY- 487
H + +IHRDIKA NILL + K+ADFG A S + GT +MAPE
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 488 --LAHGQLTEKADVYSFGMLLLEI 509
+ GQ K DV+S G+ +E+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS 380
+G+G FG V G G ++AVK + N A F E ++++ + H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 381 GPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
L +V E++ SL ++ ++ L + + L E + YL + +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLAR--SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKA 497
D+ A N+L+ AK++DFGL + S +D + + + APE L + + K+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTAPEALREKKFSTKS 180
Query: 498 DVYSFGMLLLEIVT-GR 513
DV+SFG+LL EI + GR
Sbjct: 181 DVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE---IAVKRLFFNN-RHRAANFYNEVNIISSVEHKN 370
F + K+G+G FG V+KG+ D R +A+K + + E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ + G + ++ E+L S D + L + I+ ++GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ KI HRDIKA+N+LL K+ADFG+A D GT +MAPE +
Sbjct: 120 EKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 491 GQLTEKADVYSFGMLLLEIVTG 512
KAD++S G+ +E+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 321 LGQGGFGTVYKG-VLPDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
LG G GTVYK L R +AVK + + +E+ I+ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ EF+ SLD ++ L I + V+GL YL ++I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLW---SLKILH 118
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD+K SN+L+++R + K+ DFG++ + I+ GT YMAPE ++ Q +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 499 VYSFGMLLLEIVTGR 513
V+S G+ +E+ GR
Sbjct: 176 VWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 321 LGQGGFGTVYKGVLPD-GRE-----IAVKRLFFNNR--HRAANFYNEVNIISSV-EHKNL 371
LG G FG V + + +AVK L R A +E+ I+S + H+N+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA-LMSELKIMSHLGNHENI 101
Query: 372 VRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
V LLG C+ GP L++ E+ L F+ + LT E +G+ +L
Sbjct: 102 VNLLGACTIGGP-ILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLA 489
++ IHRD+ A N+LL KI DFGLAR D +++ A + +MAPE +
Sbjct: 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
+ T ++DV+S+G+LL EI +
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 320 KLGQGGFGTVY----KGVLP---------DGRE--IAVKRLFFNNRHRAAN-FYNEVNII 363
KLG+G FG V+ +G+ DG+ +AVK L + A N F E+ I+
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
S +++ N++RLLG S ++ E++ N L++F+ T T I ++
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT--HANNIPSVSIA 129
Query: 424 GLVYLHEQ--------SKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHIST 474
L+Y+ Q + + +HRD+ N L+ + KIADFG++R+ + D I
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ +MA E + G+ T +DV++FG+ L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 31/217 (14%)
Query: 321 LGQGGFGTVYK----GVLPDGRE----IAVKRLFFNNRHR-AANFYNEVNIISSV-EHKN 370
LG+G FG V + G+ + +AVK L N + A+ +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 371 LVRLLG-CSCSGPESLLVYEFLPNQSLDRFI-----------FDSAKA--KTLTWEKRYE 416
++ LLG C+ GP ++V E+ +L F+ FD K + L+++
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
G+ YL + R IHRD+ A N+L+ KIADFGLAR + + T+
Sbjct: 139 CAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS- 194
Query: 477 AGTL--GYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
G L +MAPE L T ++DV+SFG+L+ EI T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 5e-17
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
+LG G FG+VY G +A+K++ F + N EV + + EH N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNIVKLK 64
Query: 376 GCSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
E V+E++ +L + + D K K + II ++GL ++
Sbjct: 65 -------EVFRENDELYFVFEYM-EGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHI 115
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-Y 487
H+ HRD+K N+L+ KIADFGLAR + + T T Y APE
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTRWYRAPEIL 170
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGR 513
L + D+++ G ++ E+ T R
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 320 KLGQGGFGTVYKGVL-------PDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
+LGQG FG VY+G + R +AVK + + R F NE +++ ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIF----DSAKAKTLTWEKRYEIILGTVE---G 424
VRLLG G +L+V E + + L ++ ++ E+I E G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GY 482
+ YL+ + + +HRD+ A N ++ KI DFG+ R E + G L +
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRW 187
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
MAPE L G T +D++SFG++L EI +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 37/216 (17%)
Query: 321 LGQGGFGTVYKGVLP-DGREIA-----VKRLFFNNRHRAANFYNEVNIISSV-EHKNLVR 373
+G+G FG V + ++ DG ++ +K N HR +F E+ ++ + H N++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR--DFAGELEVLCKLGHHPNIIN 67
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILG 420
LLG + + E+ P +L F+ S A TLT ++ +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
G+ YL E+ + IHRD+ A N+L+ L +KIADFGL+R + + T+
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKTM 177
Query: 481 G-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
G +MA E L + T K+DV+SFG+LL EIV+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLV 372
F++ ++LG G G V+K P G +A K + + N E+ ++ +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
G S E + E + SLD+ + KA + + ++ + ++GL YL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
KI +HRD+K SNIL++SR K+ DFG++ + ++ + GT YM+PE L
Sbjct: 124 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH 178
Query: 493 LTEKADVYSFGMLLLEIVTGR 513
+ ++D++S G+ L+E+ GR
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 308 LEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH-RAANFYNEVNII-- 363
L TG F+ +G+G +G VYK G+ +A+K + + E NI+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEEIKEEYNILRK 58
Query: 364 -SSVEHKNLVRLLGC------SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE 416
S+ H N+ G + + LV E S + D K KR +
Sbjct: 59 YSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLK 111
Query: 417 ------IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470
I+ T+ GL YLHE ++IHRDIK NILL K+ DFG++
Sbjct: 112 EEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG 168
Query: 471 HISTAIAGTLGYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
+T I GT +MAPE +A + + ++DV+S G+ +E+ G
Sbjct: 169 RRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE-IAVK--RLFFNNRHRAANFYNEVNIISSVEHKNL 371
+++ K+G+G +G VYK E IA+K RL + + E++++ ++H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAK-AKTLTWEKRYEIILGTVEGLVYLHE 430
VRL S LV+E+L + L + + S AK K Y + + G+ Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY--LYQILRGIAYCHS 120
Query: 431 QSKIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YL 488
R++HRD+K N+L+D R A K+ADFGLAR+F + + TL Y APE L
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILL 176
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ D++S G + E+V +
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 321 LGQGGFGTVY---KGVLPDGREI-AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+ +G +G V+ K D I +K+ +++ E +I+S + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
S G ++L LV E+LP L + D A+ EI+L L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI----AEIVLA----LEYLH- 110
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-------SFQEDKSHISTAIAGTLGYM 483
IIHRD+K NIL+DS K+ DFGL++ D I GT Y+
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTG 512
APE + ++ D +S G +L E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 41/221 (18%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREI-AVKRL-FFNNRH-------RAANFYNEVNIIS 364
+++ N++ +G +G VY+ EI A+K+L + R E+NI+
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR------EINILL 59
Query: 365 SVEHKNLVRL----LGCSCSGPESL-LVYEFLPN--QSL-DRF--IFDSAKAKTLTWEKR 414
++H N+V + +G S + + +V E++ + +SL + F ++ K L
Sbjct: 60 KLQHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL----- 111
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
+L + G+ +LH+ I+HRD+K SN+LL++R KI DFGLAR + T
Sbjct: 112 ---MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-T 164
Query: 475 AIAGTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ TL Y APE L + + D++S G + E++T +
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 315 FDEANKLGQGGFGTVYK-GVLPDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLV 372
F+ ++LG G G V K P G +A K + + N E+ ++ +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
G S E + E + SLD+ + +AK + E ++ + + GL YL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE-- 121
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
K +I+HRD+K SNIL++SR K+ DFG++ + ++ + GT YM+PE L
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH 178
Query: 493 LTEKADVYSFGMLLLEIVTGR 513
+ ++D++S G+ L+E+ GR
Sbjct: 179 YSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 321 LGQGGFGTVYKGVLP-DGREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G FG V+ P DG+ +A+K++ F N + E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 378 ----SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK--RYEIILGTVEGLVYLHEQ 431
E + V L L + I S + + K Y+I+ GL YLH
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQIL----RGLKYLHSA 122
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRDIK N+L++S KI DFGLAR + D+S T T Y APE L
Sbjct: 123 ---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 492 Q-LTEKADVYSFGMLLLEIVTGR 513
+ T D++S G + E++ R
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 40/209 (19%)
Query: 321 LGQGGFGTV----YKGVLPDGREIAVKRLFFNN--RHR-AANFYNEVNIISSVEHKNLVR 373
LG G FG V +K G+ A+K L + + + NE I+ S+ H LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 374 LLGCSCSGPESL-LVYEFLPNQSL-------DRFIFDSAKAKTLTWEKRY--EIILGTVE 423
L G S +L LV E++P L RF + Y +++L
Sbjct: 66 LYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRF--------PEPVARFYAAQVVLA--- 113
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L YLH I++RD+K N+LLDS KI DFG A+ + T + GT Y+
Sbjct: 114 -LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYT-LCGTPEYL 165
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTG 512
APE + + D ++ G+L+ E++ G
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 320 KLGQGGFGTVY------------KGVLPDGRE-----IAVKRLFFN-NRHRAANFYNEVN 361
KLG+G FG V+ K + +AVK L + + + +F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 362 IISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI--------FDSAKAKTLTWEK 413
I+S + N+ RLLG P ++ E++ N L++F+ + +K+L++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHI 472
+ G+ YL + +HRD+ N L+ KIADFG++R+ + D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ +MA E + G+ T K+DV++FG+ L EI+T
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 40/210 (19%)
Query: 321 LGQGGFG--TVYK----GVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
LG+G FG T+Y+ L +E+ + RL R A NE+ I+S ++H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIAY 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFI----------FDS-AKAKTLTWEKRYEI--ILGT 421
F+ + +L I +D + K +E+ + +
Sbjct: 65 YN------------HFMDDNTL--LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
V + Y+H+ I+HRDIK NI L K+ DFG+++ + S T + GT
Sbjct: 111 VSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPY 166
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
YM+PE + K+D+++ G +L E++T
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 321 LGQGGFGTVYKGVL--PDGREIAVK----RLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
LG G FG + +G L P RE+ V R +++ R F E + +H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVRL 71
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G G ++V E++ N +LD F+ L + ++ G G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEMG-- 127
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG------YMAPEYL 488
+H+ + A +L++S L KI+ F R QEDKS AI T+ + APE +
Sbjct: 128 -YVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSE---AIYTTMSGKSPVLWAAPEAI 180
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
+ + +DV+SFG+++ E+++
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 42/236 (17%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGR---EIAVKRLF--FNNRHRAANFYNEVNIISSVEHK 369
+ + ++G G +GTV + D R ++A+K+L+ F + A Y E+ ++ ++H+
Sbjct: 17 YRDLKQVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----- 416
N++ LL F P+ SLDRF + K + EK E
Sbjct: 75 NVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
++ ++GL Y+H IIHRD+K N+ ++ KI DFGLAR Q D T
Sbjct: 123 LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSE--MTGY 175
Query: 477 AGTLGYMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
T Y APE L T+ D++S G ++ E++TG+ K ++ D L+ I+
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP--LFKGHDHLDQLMEIM 229
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH---RAANFYNEVNIISSVEHKN 370
F + ++G G FG VY + + +A+K++ ++ + + + EV + + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++ GC + LV E+ + D K L + + G ++GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY--- 487
+ +IHRD+KA NILL K+ DFG A + GT +MAPE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILA 185
Query: 488 LAHGQLTEKADVYSFGMLLLEI 509
+ GQ K DV+S G+ +E+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFN-NRHRAANFYN----EVNIISSVEHKNLVRL 374
LG+G FG VY D GRE+AVK++ F+ + + N E+ ++ ++ H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 375 LGCSCSGPESLL--VYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
GC E L E++P S+ D+ A + +T +I+ +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLHSN 125
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE---DKSHISTAIAGTLGYMAPEYL 488
I+HRDIK +NIL DS K+ DFG ++ Q + I + + GT +M+PE +
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVI 181
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
+ KADV+S ++E++T
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRL----FFNNRHRAANFYNEVNIISSVE 367
+F K+G+G F VY+ L DG +A+K++ + + RA + E++++ +
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLN 60
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLV 426
H N+++ E +V E L R I K K L EK ++ + L
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
++H + R++HRDIK +N+ + + K+ D GL R F K+ + ++ GT YM+PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE 176
Query: 487 YLAHGQLTEKADVYSFGMLLLEI 509
+ K+D++S G LL E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 37/223 (16%)
Query: 321 LGQGGFGTVYKGVLPDGRE----IAVKRL----FFNNRHRAANFYNEVNIISSVEHKNLV 372
LG+GG+G V++ G + A+K L N+ A+ E NI+ +V+H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 373 RLLGCSCSGPESLLVYEFLPN----QSLDR---FIFDSAKAKTLTWEKRY--EIILGTVE 423
L+ +G + L+ E+L L+R F+ D+A Y EI L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF--------YLSEISLA--- 112
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L +LH+Q II+RD+K NILLD++ K+ DFGL + + + T GT+ YM
Sbjct: 113 -LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYM 167
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR----QNNRSKNSE 522
APE L + D +S G L+ +++TG NR K +
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 33/214 (15%)
Query: 321 LGQGGFGTVYKG-VLPDGREI--AVKRLF-FNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
+G+G FG V K + DG + A+KR+ + ++ +F E+ ++ + H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILGTV 422
G L E+ P+ +L F+ S + A TL+ ++
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG- 481
G+ YL S+ + IHRD+ A NIL+ AKIADFGL+R QE + T+G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QE------VYVKKTMGR 184
Query: 482 ----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+MA E L + T +DV+S+G+LL EIV+
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 69/242 (28%), Positives = 102/242 (42%), Gaps = 56/242 (23%)
Query: 321 LGQGGFGTVYKGVLPDGREI---AVK--RLFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG+G FG+V +G L I AVK ++ R +F +E + +H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 376 GCSCSGPE--------------------SLLVYE-------FLPNQSLDRFIFDSAKAKT 408
G E S L+Y +LP Q L +F+ D A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS--- 123
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
G+ YL S IHRD+ A N +L+ + +ADFGL++
Sbjct: 124 ---------------GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165
Query: 469 KSHISTAIAGT-LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS--KNSEYTD 525
+ IA + ++A E LA T K+DV+SFG+ + EI T Q +NSE D
Sbjct: 166 DYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225
Query: 526 SL 527
L
Sbjct: 226 YL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 18/197 (9%)
Query: 320 KLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHR-----AANFYNEVNIISSVEHKNLVR 373
++G+G FG V+ G L D +AVK R A F E I+ H N+VR
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
L+G +V E + Q D F + L ++ +++ G+ YL +SK
Sbjct: 58 LIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESK 113
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLAHG 491
IHRD+ A N L+ + KI+DFG++R +ED + ST + + APE L +G
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 492 QLTEKADVYSFGMLLLE 508
+ + ++DV+SFG+LL E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 315 FDEANKLGQGGFGTV---YKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHK 369
+ + +G G G V + VL G +AVK+L F N+ A Y E+ ++ V HK
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----I 417
N++ LL F P +SL+ F + D+ + + E +E +
Sbjct: 81 NIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477
+ + G+ +LH IIHRD+K SNI++ S KI DFGLAR+ + + T
Sbjct: 129 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYV 183
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
T Y APE + E D++S G ++ E+V G
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA---NFYNEVNIISSVEHKNLVRLLG 376
+LG G FG V+ G ++A+K + A +F E ++ + H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+V EF+ N L ++ + L+ + + EG+ YL S
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---F 121
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
IHRD+ A N L+ S K++DFG+ R +D+ S+ + + PE + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 497 ADVYSFGMLLLEIVT 511
+DV+SFG+L+ E+ T
Sbjct: 182 SDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 319 NKLGQGGFGTVYKG--VLPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL 375
+KLG+G + TVYKG L D +A+K + + A EV+++ ++H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
+ LV+E+L ++ L +++ D + + K + + + GL Y H + +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR---K 124
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLT 494
++HRD+K N+L++ R K+ADFGLAR+ S + TL Y P+ L +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYS 183
Query: 495 EKADVYSFGMLLLEIVTGR 513
+ D++ G + E+ TGR
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 321 LGQGGFGTV---YKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+G G G V Y V G+ +A+K+L F N A Y E+ ++ V HKN++ LL
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 376 GCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----IILGTVE 423
F P +SL+ F + D+ + + + +E ++ +
Sbjct: 82 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC 129
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ +LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 184
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE + E D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 62/204 (30%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+GGFG V + G+ A K+L R NE I+ V + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 377 CSCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+ + LV + L I F A+A +II G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYA----AQIICG----LEHLH 112
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ RI++RD+K N+LLD +I+D GLA + K AGT GYMAPE L
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQ 167
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
D ++ G L E++ GR
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 321 LGQGGFGTV---YKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+G G G V Y +L R +A+K+L F N+ A Y E+ ++ V HKN++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 376 GCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----IILGTVE 423
F P +SL+ F + D+ + + E +E ++ +
Sbjct: 90 NV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ +LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 192
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE + E D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 36/207 (17%)
Query: 321 LGQGGFGTV---YKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+G G G V Y VL R +A+K+L F N+ A Y E+ ++ V HKN++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 376 GCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----IILGTVE 423
F P +SL+ F + D+ + + E +E ++ +
Sbjct: 83 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ +LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 185
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIV 510
APE + E D++S G ++ E+V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G+V + G ++A+K+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 378 SCSGPESLLVYEF---LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
S +F +P D L+ +K ++ + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY-LAHGQL 493
IIHRD+K N+ ++ KI DFGLAR + T T Y APE L
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWMHY 192
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
+ D++S G ++ E++TG+ K +Y D L I+
Sbjct: 193 NQTVDIWSVGCIMAEMLTGK--TLFKGKDYLDQLTQIL 228
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRL----FFNNRHRAANFYNEVNIISSVEH 368
+F K+G+G F VY+ L D + +A+K++ + + R + E++++ + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ-DCVKEIDLLKQLNH 61
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVY 427
N+++ L E +V E L + I K K L E+ ++ + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
+H + R++HRDIK +N+ + + K+ D GL R F K+ + ++ GT YM+PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPER 177
Query: 488 LAHGQLTEKADVYSFGMLLLEI 509
+ K+D++S G LL E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLV 372
+ + +G+G +G V P G ++A+K++ F ++ E+ I+ +H+N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 373 RLLGCSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+L P S +V E + L + I K + L+ + + + GL
Sbjct: 67 GILDIIR--PPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGL 119
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF--QEDKSHISTAIAGTLGYM 483
Y+H + ++HRD+K SN+LL++ KI DFGLAR + D + T T Y
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 484 APEYLAHGQLTEKA-DVYSFGMLLLEIVTGR 513
APE + + + KA D++S G +L E+++ R
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 37/216 (17%)
Query: 321 LGQGGFGTVYKGVLP-DGREI--AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVR 373
+G+G FG V K + DG + A+KR+ + HR +F E+ ++ + H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIIN 60
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILG 420
LLG L E+ P+ +L F+ S + A TL+ ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
G+ YL ++ + IHRD+ A NIL+ AKIADFGL+R + + T+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170
Query: 481 G-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
G +MA E L + T +DV+S+G+LL EIV+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 321 LGQGGFGTVYK----GVLPD----GREIAVKRLFFNNRHR-AANFYNEVNIISSV-EHKN 370
LG+G FG V G+ D +AVK L + + ++ +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 371 LVRLLG-CSCSGPESLLVYEFLPNQSLDRFI-----------FDSAK--AKTLTWEKRYE 416
++ LLG C+ GP +LV E+ +L ++ FD+ K + LT++
Sbjct: 80 IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTA 475
G+ YL Q + IHRD+ A N+L+ KIADFGLAR D +T
Sbjct: 139 CAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ +MAPE L T ++DV+SFG+LL EI T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 314 SFDEANKLGQGGFGTVY------------KGVLPDGRE-----IAVKRLFFN-NRHRAAN 355
+F E KLG+G FG V+ K D +AVK L + N++ +
Sbjct: 8 TFKE--KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 356 FYNEVNIISSVEHKNLVRLLG-CSCSGPESLLVYEFLPNQSLDRFI--------FDSAKA 406
F E+ I+S ++ N++RLL C S P ++ E++ N L++F+ + A
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMIT-EYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-F 465
T+++ + G+ YL S + +HRD+ N L+ KIADFG++R+ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
D I + +M+ E + G+ T +DV++FG+ L EI+T
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 321 LGQGGFGTVY----KGVLPDGRE--IAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVR 373
LG+G FG V+ KG+ +G E + VK L + + + F E+++ + HKN+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVEGLV 426
LLG C + P ++ E+ L +F+ + K L+ +++ + G+
Sbjct: 73 LLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMAP 485
+L S R +HRD+ A N L+ S+ K++ L++ + + + A+ L ++AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVT 511
E + + K+DV+SFG+L+ E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 323 QGGFGTVYKGVLPDG-----REIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G FG ++ G+L D E+ VK + + + + E ++ + H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 377 CSCSGPESLLVYEFLPNQS-LDRF-----IFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
E V N L F + ++ + L+ ++ + + G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--------Y 482
K +IH+DI A N ++D L+ KI D L+R H LG +
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------CLGDNENRPVKW 185
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
MA E L + + + +DV+SFG+LL E++T
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 51/229 (22%)
Query: 315 FDEANKLGQGGFGTVYKGVL---PDGREIAVKRLFFNNRHRAANF----YNEVNIISSVE 367
++ +G+G +G VYK DG+E A+K+ F ++ + E+ ++ ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60
Query: 368 HKNLVRLLG-CSCSGPESL-LVYEFLP---------NQSLDRFIFDSAKAKTLTWEKRYE 416
H+N+V L+ +S+ L++++ ++ R + K+L W+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ---- 116
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLARSFQ------ 466
IL G+ YLH ++HRD+K +NIL+ R KI D GLAR F
Sbjct: 117 -IL---NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 467 --EDKSHISTAIAGTLGYMAPEYL--AHGQLTEKADVYSFGMLLLEIVT 511
D + T+ Y APE L A T+ D+++ G + E++T
Sbjct: 170 ADLDP------VVVTIWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 63/206 (30%), Positives = 84/206 (40%), Gaps = 29/206 (14%)
Query: 321 LGQGGFGTV----YKGVLPDGREIAVKRL---FFNNRHRAANFYNEVNI---ISSVEHKN 370
LG+G FG V YK G A+K L R + E I +S H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLV 426
LV L C + V E+ L I F +A V GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC--------VVLGLQ 115
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLHE +I++RD+K N+LLD+ KIADFGL + ST GT ++APE
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPE 171
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTG 512
L T D + G+L+ E++ G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 12/204 (5%)
Query: 314 SFDEANKLGQGGFGTVYKG--VLPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKN 370
++ + KLG+G + TV+KG L + +A+K + + A EV+++ ++H N
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+V L + LV+E+L ++ L +++ D ++ K + + + GL Y H
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHR 122
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLA 489
+ +++HRD+K N+L++ R K+ADFGLAR+ S + TL Y P+ L
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
+ + + D++ G + E+ +GR
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 18/219 (8%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISS 365
+L T +++ +G+G +G VYK DG AVK + E NI+ S
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQS 74
Query: 366 V-EHKNLVRLLGC-----SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL 419
+ H N+V+ G G + LV E S+ + E IL
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 420 -GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
G + GL +LH RIIHRD+K +NILL + K+ DFG++ + +T++ G
Sbjct: 135 YGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-G 190
Query: 479 TLGYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
T +MAPE +A Q + + DV+S G+ +E+ G
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 321 LGQGGFGTVY---KGVLPD-GREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNL 371
LGQG FG V+ K PD G+ A+K L +R R E +I++ V H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM---ERDILAEVNHPFI 60
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE-GLVYLHE 430
V+L + + L+ +FL L F + + E+ + L + L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ II+RD+K NILLD K+ DFGL++ D + + GT+ YMAPE +
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 491 GQLTEKADVYSFGMLLLEIVTG 512
T+ AD +SFG+L+ E++TG
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 35/216 (16%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL---LG 376
LG G G V+ V D + +AVK++ + + E+ II ++H N+V++ LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 377 CSCSG-PESL----------LVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGT 421
S S E + +V E++ L + A+ ++
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQ--------L 123
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL Y+H + ++HRD+K +N+ +++ L KI DFGLAR SH G +
Sbjct: 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 481 G--YMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGR 513
Y +P L T+ D+++ G + E++TG+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVN 361
+ T+ + T + + +G G FG V G+ +A+K++ F+ A Y E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 362 IISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKR------ 414
++ + H+N++ L S E + V E L L R + ++ L EK+
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLL----TSRPL--EKQFIQYFL 114
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
Y+I+ GL Y+H ++HRD+K SNIL++ KI DFGLAR Q+ T
Sbjct: 115 YQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR-IQD---PQMT 163
Query: 475 AIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGR 513
T Y APE + Q + D++S G + E++ G+
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 21/191 (10%)
Query: 337 GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL-VYEFLP 392
G E+A+K L H+ A F E + + + H N+V LL + P L V+E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 393 NQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL--- 448
++L + D A L + ++L ++ L H Q I+HRD+K NI++
Sbjct: 63 GRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115
Query: 449 DSRLRAKIADFGL------ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSF 502
R AK+ DFG+ R +T + GT Y APE L +T +D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 503 GMLLLEIVTGR 513
G++ LE +TG+
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKN 370
++++ K+G+G +G VYK G+ +A+K RL + E++++ +
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 371 -LVRLLGC----SCSGPESL-LVYEFLPNQSLDRFI----------FDSAKAKTLTWEKR 414
+VRLL +G SL LV+E+L + L +F+ + K+
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFM---- 116
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQEDKSHIS 473
Y+++ G + + H K ++HRD+K N+L+D + KIAD GL R+F +
Sbjct: 117 YQLLKG----VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 474 TAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTG 512
I TL Y APE L + D++S G + E+
Sbjct: 170 HEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-14
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 38 NSSIFVPNFVTTMENISEQMRTS---GFGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYA 94
+S F N + ++S +S GF +G+ D YGLAQC GDLS DC C A
Sbjct: 15 ANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLA 74
Query: 95 EARTLLPQCYPYN-GGRIYLDGCFMRSENYSF 125
A + L +C P GGRI+ D CF+R E+Y F
Sbjct: 75 TAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNII 363
T+ + + + +G G +G+V G +AVK+L F + A Y E+ ++
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLT 410
++H+N++ LL F P +SL+ F + + K + LT
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 411 WEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470
+ +I + GL Y+H IIHRD+K SN+ ++ KI DFGLAR ++
Sbjct: 119 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM- 174
Query: 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR 513
T T Y APE + + + D++S G ++ E++TGR
Sbjct: 175 ---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 321 LGQGGFGTVY--------KGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
+G+G FG V+ K V+ ++I V+++ + R A N E ++ + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQN---ECQVLKLLSHPNII 62
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
++V E+ P +L +I + +L E I+ V+ L+ LH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDED--TILHFFVQILLALHHVH 118
Query: 433 KIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRD+K NILLD + KI DFG+++ KS T + GT Y++PE
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTVV-GTPCYISPELCEGK 176
Query: 492 QLTEKADVYSFGMLLLEIVT 511
+K+D+++ G +L E+ +
Sbjct: 177 PYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 313 GSFDEANKLGQGGFGTVYKGVLPDGREI-AVKR-----LFFNNRHRAANFYNEVNIISSV 366
F ++GQGG+G V+ D EI A+KR LF N R + E +I+++
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVR--HVLTERDILTTT 58
Query: 367 EHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+ + LV+LL + E L L E++P + + R+ + E +
Sbjct: 59 KSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMA-EMFEAV 114
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
LHE + IHRD+K N L+D+ K+ DFGL++ + ++ G+ YMAP
Sbjct: 115 DALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAP 167
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTG 512
E L D +S G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 321 LGQGGFGTVY--------KGVLPDGREIAVKRLFFNNRHR-AANFYNEVNIISSV-EHKN 370
LG+G FG V K + +AVK L + + ++ +E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 371 LVRLLG-CSCSGPESLLVYEFLPNQSLDRFI-----------FDSAKA--KTLTWEKRYE 416
++ LLG C+ GP ++V E+ +L ++ +D A+ + +T++
Sbjct: 83 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
G+ YL Q + IHRD+ A N+L+ KIADFGLAR + T
Sbjct: 142 CTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT- 197
Query: 477 AGTL--GYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
G L +MAPE L T ++DV+SFG+L+ EI T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 42/121 (34%), Positives = 66/121 (54%), Gaps = 14/121 (11%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EIILG L ++H + +++RD+K +NILLD +I+D GLA F + K H S
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 156
Query: 476 IAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR---QNNRSKNSEYTDSLLTIV 531
GT GYMAPE L G AD +S G +L +++ G + +++K+ D + +
Sbjct: 157 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 214
Query: 532 S 532
+
Sbjct: 215 A 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 323 QGGFGTVY--KGVLPDGREIAVKRLFFNN---RHRAANFYNE-VNIISSVEHKNLVRLLG 376
+G FG+VY K G A+K L ++ +++ N E ++ E + +L
Sbjct: 6 KGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTL-----TWEKRYEIILGTVEGLVYLHEQ 431
S LV E+L I KTL W K+Y I V G+ LH++
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQY--IAEVVLGVEDLHQR 116
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
IIHRDIK N+L+D K+ DFGL+R+ E+K GT Y+APE +
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGV 168
Query: 492 QLTEKADVYSFGMLLLEIVTG 512
+ +D +S G ++ E + G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 10/198 (5%)
Query: 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLLG 376
+KLG+G + TV+KG +A+K + + A EV+++ +++H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ LV+E+L + L +++ + ++ K + L + GL Y H++ +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQL--LRGLSYCHKR---KI 124
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLTE 495
+HRD+K N+L++ + K+ADFGLAR+ S + TL Y P+ L + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 496 KADVYSFGMLLLEIVTGR 513
D++ G +L E+ TGR
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 42/99 (42%), Positives = 61/99 (61%), Gaps = 9/99 (9%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EI+L L +LH K+ II+RDIK NILLDS + DFGL++ F ED+ + +
Sbjct: 113 EIVLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165
Query: 476 IAGTLGYMAPEYLAHGQLT-EKA-DVYSFGMLLLEIVTG 512
GT+ YMAP+ + G +KA D +S G+L+ E++TG
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 38/226 (16%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFN------------------NRHRAANFYNEVN 361
KLG+G FG V+ + + +++ + FN N++ +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 362 IISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI----------------FDSAK 405
I+S ++ N++RLLG ++ E++ N L++F+ +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 406 AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS- 464
+++ + L G+ YL S + +HRD+ N L+ L KIADFG++R+
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510
+ D I + +MA E + G+ T +DV++FG+ L EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 39/98 (39%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EI+LG L +LHE+ II+RD+K N+LLDS KIADFG+ + ST
Sbjct: 104 EIVLG----LQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST- 155
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
GT Y+APE L++ D ++ G+LL E++ G+
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 321 LGQGGFGTVYKGVL---PD------GREIAVKRLFFNNRHRAA-NFYNEVNIISSVEHKN 370
LGQG F +YKGVL D G+E++V + HR + F+ +++S + HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
LV+L G C E+++V E++ LD F+ +L W + ++ L YL +
Sbjct: 63 LVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 431 QSKIRIIHRDIKASNILL-------DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
+ +++H ++ NIL+ K++D G+ + + + ++
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----PWI 171
Query: 484 APEYLAHGQ--LTEKADVYSFGMLLLEI 509
APE + +GQ LT AD +SFG LLEI
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 320 KLGQGGFGTVYKGVLPDG---REIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLL 375
++G G FG V G + G ++ VK L + + F E S++H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 376 G-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR------YEIILGTVEGLVYL 428
G C+ P LLV EF P L ++ KA+ +T + EI L GL++L
Sbjct: 62 GQCTEVTP-YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL----GLLHL 116
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHISTAIAGTLGYMAPEY 487
H+ + IH D+ N LL + L KI D+GL+ ++ED + L ++APE
Sbjct: 117 HKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 488 L--AHGQL-----TEKADVYSFGMLLLEI 509
+ HG L T++++V+S G+ + E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 308 LEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV- 366
L G F+ +G G +G VYKG ++A ++ E+N++
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 367 EHKNLVRLLGCSCS-GPESL-----LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
H+N+ G P + LV EF S+ I + K TL E I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICRE 119
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL +LH+ ++IHRDIK N+LL K+ DFG++ +T I GT
Sbjct: 120 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 175
Query: 481 GYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
+MAPE +A + + K+D++S G+ +E+ G
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 44/122 (36%), Positives = 67/122 (54%), Gaps = 19/122 (15%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EIIL L +LH K+ I++RDIK NILLDS + DFGL++ F ++ + +
Sbjct: 113 EIILA----LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 476 IAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTGR-----QNNRSKNSEYTDS 526
GT+ YMAPE + HG+ D +S G+L+ E++TG + R+ SE +
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTLEGERNTQSEVSRR 222
Query: 527 LL 528
+L
Sbjct: 223 IL 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-13
Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 2/98 (2%)
Query: 139 GNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSSS 198
GN T NS+F ES A++ +++S ++ SGAA + Y L C L++S
Sbjct: 10 GNYTTANSTF-ESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASD 68
Query: 199 CEACLANASASILGCLPWS-EGRALNTGCFMRYSDKDF 235
C +CLA A + + C P GR CF+RY F
Sbjct: 69 CRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 314 SFDEANKLGQGGFGTVYK-GVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
+F + LG+GGFG V V G+ A K+L R + NE I+ V +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE-GLVYL 428
+V L + LV + L I+ +A E R + GL L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE--EGRAVFYAAEICCGLEDL 118
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H++ RI++RD+K NILLD +I+D GLA E ++ GT+GYMAPE +
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVV 173
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ + T D ++ G LL E++ G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 315 FDEANKLGQGGFGTVY--KGVLPDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHK 369
++ K+G+G FG +Y K D +K + + + A+ EV +++ ++H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHP 59
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDS-----AKAKTLTWEKRYEIILGTVEG 424
N+V +V E+ L + I ++ + L+W + + G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------G 113
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L ++H++ +I+HRDIK+ NI L + AK+ DFG+AR D ++ GT Y+
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYL 169
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVT 511
+PE + K D++S G +L E+ T
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA------------NF--YNEVNII 363
LG+G +G V K G+ +A+K++ +F E+ I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT-LTWEKRYEIILGTV 422
+ ++H+N++ L+ G LV + + S + + D K LT + I+L +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVVDR---KIRLTESQVKCILLQIL 129
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF-------------QEDK 469
GL LH K +HRD+ +NI ++S+ KIADFGLAR + +
Sbjct: 130 NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 470 SHISTAIAGTLGYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTGR 513
T+ TL Y APE L + D++S G + E++TG+
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 320 KLGQGGFGTV----YKGVLPDGREIAVKRL--FFNNRHRAANFYNEVNIISSV-EHKNLV 372
+LGQG +G V + +A+K++ F+ + A E+ ++ HKN+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 373 RLLGCSCSGPES---LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
L P + L +YE L L + I + LT I + GL Y+H
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIH 122
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK----SHISTAIAGTLGYMAP 485
+ ++HRD+K N+L+++ KI DFGLAR F E+ ++ +A T Y AP
Sbjct: 123 SAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYRAP 178
Query: 486 EYLAHGQLTEKA-DVYSFGMLLLEIVTGR 513
E + Q KA DV+S G +L E++ +
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 15/120 (12%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EIILG L ++H + +++RD+K +NILLD +I+D GLA F + K H S
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 156
Query: 476 IAGTLGYMAPEYLAHGQLTE-KADVYSFGMLLLEIVTG----RQNNRSKNSEYTDSLLTI 530
GT GYMAPE L G + AD +S G +L +++ G RQ+ E LT+
Sbjct: 157 --GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 43/223 (19%)
Query: 321 LGQGGFGTVYKGVLPDG-----------REIAVKRLFFNNRHR-AANFYNEVNIISSV-E 367
LG+G FG V V+ + ++AVK L + + ++ +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 368 HKNLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEK 413
HKN++ LLG C+ GP ++V E+ +L ++ + L+++
Sbjct: 83 HKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473
G+ YL + + IHRD+ A N+L+ KIADFGLAR D HI
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 194
Query: 474 TAIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
T G +MAPE L T ++DV+SFG+LL EI T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAAN--FYNEV 360
KY L +G+G +G V K + G+ +A+K+ + + E+
Sbjct: 2 KYENLGL----------VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI 51
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
++ + H+NLV L+ LV+EF+ + LD L + + +
Sbjct: 52 RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQ 108
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ G+ + H + IIHRDIK NIL+ K+ DFG AR+ + T T
Sbjct: 109 ILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVATR 164
Query: 481 GYMAPEYLAHGQLTEKA-DVYSFGMLLLEIVTG 512
Y APE L +A D+++ G L+ E++TG
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 39/113 (34%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR---SFQEDKSHISTAIAGTL 480
GL Y+H + +IHRD+K SN+L++ +I DFG+AR S + + T T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 481 GYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIVS 532
Y APE L+ + T D++S G + E++ RQ KN Y L I+S
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN--YVHQLKLILS 226
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 321 LGQGGFGTVYKGVLP----DGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRL 374
LG+G FG+V + L +++AVK L + F E + +H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 375 LGCSCSG------PESLLVYEFLPNQSLDRFIFDSAKAK---TLTWEKRYEIILGTVEGL 425
+G S P +++ F+ + L F+ S + TL + ++ G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMA 484
YL S IHRD+ A N +L+ + +ADFGL++ + D A + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS--KNSEYTDSLL 528
E LA T +DV++FG+ + EI+T Q + +NSE + L+
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 56/153 (36%), Positives = 76/153 (49%), Gaps = 19/153 (12%)
Query: 367 EHKNLVRLLGCSCSGPESLL-VYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILG 420
EH L L C+ E L V E+L L I FD A+A+ EII G
Sbjct: 54 EHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA----AEIICG 108
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
L +LH++ II+RD+K N+LLD KIADFG+ + + ST GT
Sbjct: 109 ----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTP 160
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE L + E D +SFG+LL E++ G+
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLL 375
++LG+G +G+VYK VL P G +A+K + + + E++I+ +V
Sbjct: 7 DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G + E++ SLD+ + + + I V+GL +L E+ I
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI- 124
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL------A 489
IHRD+K +N+L++ + K+ DFG+ S S T I G YMAPE +
Sbjct: 125 -IHRDVKPTNVLVNGNGQVKLCDFGV--SGNLVASLAKTNI-GCQSYMAPERIKSGGPNQ 180
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
+ T ++DV+S G+ +LE+ GR
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 321 LGQGGFGTV----YKGVLPDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVR 373
+G+G +G V ++ DG++ +K+L N R R A E ++S ++H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAA-EQEAQLLSQLKHPNIVA 63
Query: 374 LLGCSCSGPESLL--VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
S G + LL V F L + K K L + E + L YLHE+
Sbjct: 64 YRE-SWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRD+K N+ L K+ D G+AR + ST I GT YM+PE ++
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNK 177
Query: 492 QLTEKADVYSFGMLLLEIVTGRQ--NNRSKNS 521
K+DV++ G + E+ T + N + NS
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 314 SFDEANKLGQGGFGTVYK-GVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
+F LG+GGFG V V G+ A K+L R A NE I+ V +
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTV 422
+V L + LV + L I FD +A EI G
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA----AEITCG-- 114
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
L LH + RI++RD+K NILLD +I+D GLA E ++ I + GT+GY
Sbjct: 115 --LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGY 167
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
MAPE + + + T D + G L+ E++ G+
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 321 LGQGGFGTVYKGVLPDGRE-IAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G+V R+ +AVK+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 378 SCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKRYEIILGTVEG 424
F P S++ F + + K + L+ E +I + G
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L Y+H IIHRD+K SN+ ++ +I DFGLAR ++ T T Y A
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRA 183
Query: 485 PEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
PE + + + D++S G ++ E++ G+ ++Y D L I+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKA--LFPGNDYIDQLKRIM 229
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAA-NFYNEVNIISSVEHKNL 371
S+++ KLG+G + TVYKG +G+ +A+K + E +++ ++H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 372 VRLLGCSCSGPESLLVYEFLPN---QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
V L + LV+E++ Q +D+ L E + + GL Y+
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDK------HPGGLHPENVKLFLFQLLRGLSYI 119
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-Y 487
H++ I+HRD+K N+L+ K+ADFGLAR+ + SH + TL Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVL 175
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTG 512
L + + D++ G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
E++I+ ++ H+ ++ L+ +V +P D F + L E+ I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSG-PLPLEQAITIQ 191
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST---- 474
+E L YLH + IIHRD+K NI LD A + DFG A H T
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTPQCY 245
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT------GRQNNRS 518
+GTL +PE LA K D++S G++L E+ G+Q S
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
|
Length = 392 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 38/99 (38%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EI+L L +LH ++ II+RDIK NILLDS + DFGL++ F ++ + +
Sbjct: 113 EIVLA----LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
Query: 476 IAGTLGYMAPEYLAHGQL--TEKADVYSFGMLLLEIVTG 512
GT+ YMAPE + G + D +S G+L E++TG
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+++LH + I++RD+K N+LLD + +++D GLA ++ K+ T AGT GYM
Sbjct: 107 GILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYM 161
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE L + D ++ G + E+V GR
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHISTAIAGTL 480
GL +LH + II+RD+K N++LD+ KIADFG+ + + K+ + GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE +A+ + D ++FG+LL E++ G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-12
Identities = 65/250 (26%), Positives = 98/250 (39%), Gaps = 60/250 (24%)
Query: 313 GSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRL---FFNNRHRAANFYNEVNIISSVEH 368
+D +G+GG G VY P R +A+K++ N F E I + + H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 369 KNLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTL---TWEKR---------- 414
+V + CS P VY +P +I + K+L W+K
Sbjct: 62 PGIVPVYSICSDGDP----VYYTMP------YI-EGYTLKSLLKSVWQKESLSKELAEKT 110
Query: 415 --------YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF- 465
+ I T+E Y+H + ++HRD+K NILL I D+G A
Sbjct: 111 SVGAFLSIFHKICATIE---YVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164
Query: 466 --QEDKSHISTA--------------IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
+ED I I GT YMAPE L +E D+Y+ G++L ++
Sbjct: 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
Query: 510 VTGRQNNRSK 519
+T R K
Sbjct: 225 LTLSFPYRRK 234
|
Length = 932 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAAN------FYNEVNIISSVEHKNLV 372
+++G G FG V G G ++ R+ +A F EV + H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG--TVEGLVYLH 429
+ LG C S P LLV EF P L ++ + +K + GL++LH
Sbjct: 59 QCLGQCIESIP-YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMAPEYL 488
+ IH D+ N L + L KI D+GLA + ED A L ++APE +
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 489 AHGQ-------LTEKADVYSFGMLLLEIVT 511
T+K++++S G+ + E+ T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 320 KLGQGGFGTVYKGVL------PDGREIAVKRLFFNNRHRAA---NFYNEVNIISSVEHKN 370
+LG+ FG VYKG L + +A+K L ++ F +E + S ++H N
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEKRYEI 417
+V LLG +++ + + L F+ D TL I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAI 476
+ G+ +L S ++H+D+ N+L+ +L KI+D GL R + D +
Sbjct: 130 VTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ +M+PE + +G+ + +D++S+G++L E+ +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 46/175 (26%), Positives = 96/175 (54%), Gaps = 3/175 (1%)
Query: 338 REIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLD 397
++ K + N+ +AA +E++ +++ +H +V+ S + LL+ E+ L+
Sbjct: 94 EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153
Query: 398 RFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457
+ I K L + + YE+ L + ++ L E +++HRD+K++NI L K+
Sbjct: 154 KQIKQRLKEH-LPF-QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211
Query: 458 DFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
DFG ++ + + S ++++ GT Y+APE + ++KAD++S G++L E++T
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 21/231 (9%)
Query: 294 KTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA 353
++L+D L S L G F+ +G G +G VYKG ++A ++
Sbjct: 1 RSLDDIDL----SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE 56
Query: 354 ANFYNEVNIISSV-EHKNLVRLLGC----SCSGPES--LLVYEFLPNQSLDRFIFDSAKA 406
E+N++ H+N+ G S G + LV EF S+ + + K
Sbjct: 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKG 115
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466
L + I + GL +LH ++IHRDIK N+LL K+ DFG++
Sbjct: 116 NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172
Query: 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
+T I GT +MAPE +A + + ++D++S G+ +E+ G
Sbjct: 173 RTVGRRNTFI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 321 LGQGGFGTVYKGVL--PDGREIAVKRLFFNNRHRA-ANFYNEVNIISSV-EHKNLVRLLG 376
+G+G +G V+K VL +G + AVK L + H E NI+ ++ +H N+V+ G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 377 C-----SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV-----EGLV 426
+G + LV E S + D K E+ E I+ + GL
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGS----VTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
+LH + IHRD+K +NILL + K+ DFG++ + +T++ GT +MAPE
Sbjct: 139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPE 194
Query: 487 YLAHGQ-----LTEKADVYSFGMLLLEIVTG 512
+A Q + DV+S G+ +E+ G
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 8/92 (8%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS--FQEDKSHISTAIAGTLG 481
GL +LH + II+RD+K N++LD KIADFG+ + F +++ ++ GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPD 161
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE L + T D +SFG+LL E++ G+
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 54/232 (23%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG V+ D ++ A+K L R++ A+ E +I++ + +V+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 377 CSCSGPESL-LVYEFLPNQSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYL 428
S E L LV E++P L + +F + Y E++L L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFYIAELVLA-------L 114
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS------------------ 470
K+ IHRDIK NIL+D+ K+ADFGL + + K
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 471 ----------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
+ + GT Y+APE L + D +S G++L E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 34/76 (44%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
IHRD+ A NILL KI DFGLAR +D ++ A L +MAPE + T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 496 KADVYSFGMLLLEIVT 511
++DV+SFG+LL EI +
Sbjct: 255 QSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 321 LGQGGFGTVYKGV---LPDGR-----EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
LGQG F ++KG+ + D E+ +K L ++R+ + +F+ +++S + HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
G G ES++V E++ SLD ++ + ++W + E+ L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 433 KIRIIHRDIKASNILL---DSRLRA-----KIADFGLARSFQEDKSHISTAIAGTLGYMA 484
+ H ++ A N+LL + R K++D G++ + K + I ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-KEILLERIP----WVP 172
Query: 485 PEYLAHGQ-LTEKADVYSFGMLLLEIVTG 512
PE + + Q L+ AD +SFG L EI +G
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 12/207 (5%)
Query: 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAA-NFYNEVNIISSVEH 368
A S+ KLG+G + TVYKG+ +G+ +A+K + E +++ ++H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 369 KNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
N+V LL E+L V+E++ + L +++ L + + GL Y
Sbjct: 63 ANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYM--IQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
+H Q I+HRD+K N+L+ K+ADFGLAR+ + S ++ TL Y P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYRPPDV 174
Query: 488 L-AHGQLTEKADVYSFGMLLLEIVTGR 513
L + D++ G + +E++ G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE-IAVKRLFFNNRHR---AANFYNEVNIISSVEHKN 370
+ +G G FG V+ A+K + R + +NE ++ V H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGL 425
++RL ++ E++P L ++ F ++ E V L
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE--------IVCAL 114
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLH + I++RD+K NILLD K+ DFG A+ + D++ + GT Y+AP
Sbjct: 115 EYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTW---TLCGTPEYLAP 167
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520
E + + D ++ G+L+ E++ G N
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G+G +G V + ++A+K++ F+NR A E+ ++ ++H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK-- 70
Query: 378 SCSGPES-------LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
P +VYE L + L + I S +TL+ + + + GL Y+H
Sbjct: 71 DIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ ++HRD+K SN+LL++ KI DFGLAR+ +K T T Y APE L +
Sbjct: 127 AN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 491 -GQLTEKADVYSFGMLLLEIVTGRQ 514
+ T DV+S G + E++ GR+
Sbjct: 183 CSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 314 SFDEANKLGQGGFGTVYK-GVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
+F LG+GGFG V V G+ A K+L R A NE I+ V +
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTV 422
+V L + LV + L I FD +A I
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----------IFYAA 109
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E L + + RI++RD+K NILLD R +I+D GLA E ++ GT+GY
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGY 167
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
MAPE + + + T D + G L+ E++ G+
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 35/98 (35%), Positives = 58/98 (59%), Gaps = 4/98 (4%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
+ GL +LH++ RII+RD+K N+LLD+ +I+D GLA ++ +S + AGT G
Sbjct: 107 ISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPG 162
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519
+MAPE L + D ++ G+ L E++ R R++
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
++ ++G G +G VYK L G AVK + + E+ ++ +H N+V
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
G S + + E+ SL + L + Y + T++GL YLH + K
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL--QIAY-VCRETLQGLAYLHSKGK 127
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA---H 490
+ HRDIK +NILL K+ADFG+A + + I GT +MAPE A +
Sbjct: 128 M---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKN 183
Query: 491 GQLTEKADVYSFGMLLLEI 509
G + D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GL +LH + II+RD+K N++LDS KIADFG+ + D T GT Y+
Sbjct: 113 GLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPDYI 168
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE +A+ + D +++G+LL E++ G+
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 62/203 (30%), Positives = 88/203 (43%), Gaps = 24/203 (11%)
Query: 321 LGQGGFGTVYKGVLP-DGREIAVKRL----FFNNRHRAANFYNEVNIIS-SVEHKNLVRL 374
LG+G FG V L GR AVK L + E I+S + H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTM-TEKRILSLARNHPFLTQL 61
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
C + V EF+ L I FD A+A+ E L++LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLH 113
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ II+RD+K N+LLD K+ADFG+ + + ST GT Y+APE L
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQ 169
Query: 490 HGQLTEKADVYSFGMLLLEIVTG 512
D ++ G+LL E++ G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 10/210 (4%)
Query: 314 SFDEANKLGQGGFGTVYK-GVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
+F + LG+GGFG V V G+ A KRL R + NE I+ V +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+V L + LV + L I++ E+ + GL LH
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLH 119
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ ++RD+K NILLD +I+D GLA E +S GT+GYMAPE L
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLN 174
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519
+ + T D + G L+ E++ G+ R +
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 68/258 (26%), Positives = 109/258 (42%), Gaps = 38/258 (14%)
Query: 287 NDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLF 346
N EK+V+ K L+ +D +G+G FG V +++ +L
Sbjct: 26 NRYEKIVR---------KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 347 FN----NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI- 400
R +A F+ E +I++ +V+L C+ + L +V E++P L +
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMS 135
Query: 401 -FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459
+D + W K Y T E ++ L + +IHRD+K N+LLD K+ADF
Sbjct: 136 NYDVPE----KWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
Query: 460 GLARSFQED-KSHISTAIAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTGRQ 514
G E TA+ GT Y++PE L G + D +S G+ L E++ G
Sbjct: 187 GTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG-- 243
Query: 515 NNRSKNSEYTDSLLTIVS 532
Y DSL+ S
Sbjct: 244 ----DTPFYADSLVGTYS 257
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GL +LH + II+RD+K N++LDS KIADFG+ + D T GT Y+
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYI 168
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE +A+ + D ++FG+LL E++ G+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
F+ ++G G +G VYK + G A+K + A E+ ++ +H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
G + + EF SL + L+ + + T++GL YLH + K
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGK 127
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA------GTLGYMAPEY 487
+ HRDIK +NILL K+ADFG++ + I+ IA GT +MAPE
Sbjct: 128 M---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAPEV 177
Query: 488 LA---HGQLTEKADVYSFGMLLLEI 509
A G + D+++ G+ +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNR-----HRAANFYNEVNIISSVEH 368
+++ +K+G+G +G V+K + G+ +A+K+ F + + A E+ ++ ++H
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKK-FVESEDDPVIKKIA--LREIRMLKQLKH 59
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPN---QSLDRFI--FDSAKAKTLTWEKRYEIILGTVE 423
NLV L+ + LV+E+ + L++ K + W+ T++
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQ 111
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
+ + H+ + IHRD+K NIL+ + + K+ DFG AR + +A T Y
Sbjct: 112 AVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYR 167
Query: 484 APEYL-AHGQLTEKADVYSFGMLLLEIVTG 512
APE L Q DV++ G + E++TG
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 34/78 (43%), Positives = 46/78 (58%), Gaps = 1/78 (1%)
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQL 493
+ IHRD+ A NILL KI DFGLAR +D ++ A L +MAPE +
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 494 TEKADVYSFGMLLLEIVT 511
T ++DV+SFG+LL EI +
Sbjct: 254 TTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EII G L +LH + I++RD+K NILLD+ KIADFG+ + + T
Sbjct: 104 EIICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT- 155
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
GT Y+APE L + D +SFG+LL E++ G+
Sbjct: 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVK--RLFFNNRHRAANF--YNEVNIISSVEH 368
++ + +KLG+G + TVYKG G+ +A+K RL A F E +++ ++H
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL---EHEEGAPFTAIREASLLKDLKH 62
Query: 369 KNLVRLLGCSCSGPESL-LVYEFLPN---QSLDRF--IFDSAKAKTLTWEKRYEIILGTV 422
N+V L ++L LV+E+L Q +D + ++ +
Sbjct: 63 ANIV-TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ--------LL 113
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG---T 479
GL Y H++ R++HRD+K N+L+ R K+ADFGLAR+ KS S + T
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNEVVT 166
Query: 480 LGYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTGR 513
L Y P+ L + + D++ G + E+ TGR
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 33/76 (43%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
+HRD+ A N+L+ KI DFGLAR D ++IS L +MAPE + + T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 496 KADVYSFGMLLLEIVT 511
+DV+SFG+LL EI T
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 38/108 (35%), Positives = 61/108 (56%), Gaps = 1/108 (0%)
Query: 405 KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464
+AKT + +E L ++ L+ +H +IHRDIK++NILL S K+ DFG ++
Sbjct: 133 RAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192
Query: 465 FQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ S + GT Y+APE ++KAD++S G+LL E++T
Sbjct: 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 29/240 (12%)
Query: 317 EANKLGQGGFGTVYKGVLPDG---REIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
E K+G+G +G VYK DG +E A+K++ +A E+ ++ ++H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIA 62
Query: 374 L--LGCSCSGPESLLVYEFLPNQSLDRFIFDSA-----KAKTLTWEKRYEIILGTVEGLV 426
L + S S + L++++ + F A K L ++ ++G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 427 YLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLARSFQEDKSHIS--TAIAGTL 480
YLH ++HRD+K +NIL+ R R KIAD G AR F ++ + T
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 481 GYMAPEYLAHGQLTEKA-DVYSFGMLLLEIVTG------RQNN-RSKNSEYTDSLLTIVS 532
Y APE L + KA D+++ G + E++T RQ + ++ N + D L I S
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 47/215 (21%)
Query: 319 NKLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHR---AANFYNEVNIISSVE-HKNLVR 373
K+G+G F V K G+ A+K + + N E+ + + H N++R
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 374 LLGC---SCSGPESLL-------VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
L+ +G +L+ +YE + + + + K+ ++ ++
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQ--------LLK 111
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS------FQEDKSHISTAIA 477
L ++H + I HRDIK NIL+ + K+ADFG R + E +IST
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTE---YISTR-- 162
Query: 478 GTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVT 511
Y APE L G K D+++ G + EI++
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 28/233 (12%)
Query: 290 EKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREI-AVKRLF-F 347
EK + + + + FD +G+G FG V +++ A+K L F
Sbjct: 29 EKAAEKITKLRMKAE---------DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF 79
Query: 348 N--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSA 404
R +A F+ E +I++ + +V+L + + L +V E++P L + +
Sbjct: 80 EMIKRSDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYD 138
Query: 405 KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464
+ W + Y V L +H + IHRD+K N+LLD K+ADFG
Sbjct: 139 IPEK--WARFY--TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 465 FQED-KSHISTAIAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTG 512
+ TA+ GT Y++PE L G + D +S G+ L E++ G
Sbjct: 192 MDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 32/74 (43%), Positives = 45/74 (60%), Gaps = 1/74 (1%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
IHRD+ A N+LL AKI DFGLAR D +++ A + +MAPE + T
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 496 KADVYSFGMLLLEI 509
++DV+S+G+LL EI
Sbjct: 294 QSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 7/155 (4%)
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
E +I+ ++ H ++++L G + L+ LP D + + +AK + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK-RNIAICDILAIE 188
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+ + YLHE RIIHRDIKA NI ++ + DFG A + ++ AG
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
T+ APE LA D++S G++L E+ T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 34/78 (43%), Positives = 46/78 (58%), Gaps = 1/78 (1%)
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQL 493
+ IHRD+ A NILL KI DFGLAR +D ++ A L +MAPE +
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258
Query: 494 TEKADVYSFGMLLLEIVT 511
T ++DV+SFG+LL EI +
Sbjct: 259 TIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 25/176 (14%)
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK-RY---EIILGTVE 423
H LV L C + V EF+ L +F + + L E R+ EI L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA--- 108
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L +LHE+ II+RD+K N+LLD+ K+ D+G+ + ST GT Y+
Sbjct: 109 -LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR--------QNNRSKNSEYTDSLLTIV 531
APE L D ++ G+L+ E++ GR +N +N+E D L ++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE--DYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 68/254 (26%), Positives = 117/254 (46%), Gaps = 42/254 (16%)
Query: 276 QRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP 335
+RS D EK++ D+ +N S+ N +G G FG VY+ +
Sbjct: 39 ERSHNNNAGEDEDEEKMI----DNDIN------RSPNKSYKLGNIIGNGSFGVVYEAICI 88
Query: 336 DGRE-IAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL-----LGCSCSGPESL---L 386
D E +A+K++ + +++ E+ I+ ++ H N++ L C +++ +
Sbjct: 89 DTSEKVAIKKVLQDPQYKN----RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144
Query: 387 VYEFLPNQSLDRFIFDSAK---AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKA 443
V EF+P Q++ +++ A+ A L K Y L L Y+H SK I HRD+K
Sbjct: 145 VMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYIH--SKF-ICHRDLKP 198
Query: 444 SNILLDSRLRA-KIADFGLARSF---QEDKSHISTAIAGTLGYMAPE-YLAHGQLTEKAD 498
N+L+D K+ DFG A++ Q S+I + Y APE L T D
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHID 253
Query: 499 VYSFGMLLLEIVTG 512
++S G ++ E++ G
Sbjct: 254 LWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 26/198 (13%)
Query: 325 GFGTVYKGVLPDGREIAVKRLFFNNRHRAANFY-NEVNIISSVEHKNLVRLLGCSCSGPE 383
G + +G R IA KR+ RAA NE+ + + H+N++++ E
Sbjct: 181 GVNSTNQGKPKCERLIA-KRV--KAGSRAAIQLENEILALGRLNHENILKI--------E 229
Query: 384 SLLVYE---FLPNQSLD----RFIFDSA---KAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+L E ++ Q D F++D A K + L + R I+ + + Y+H++
Sbjct: 230 EILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK-- 286
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
++IHRDIK NI L+ + + DFG A F++++ GT+ +PE LA
Sbjct: 287 -KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345
Query: 494 TEKADVYSFGMLLLEIVT 511
E D++S G++LL++++
Sbjct: 346 CEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 32/74 (43%), Positives = 46/74 (62%), Gaps = 1/74 (1%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
IHRD+ A NILL KI DFGLAR + D +++ A + +MAPE + + T
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 496 KADVYSFGMLLLEI 509
++DV+S+G+LL EI
Sbjct: 296 ESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 29/235 (12%)
Query: 317 EANKLGQGGFGTVYKGVLPDG---REIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
E K+G+G +G VYK DG R+ A+K++ +A E+ ++ ++H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVIS 62
Query: 374 L--LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY---- 427
L + S + + L++++ + F A +K ++ G V+ L+Y
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILD 119
Query: 428 -LHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLARSFQEDKSHIS--TAIAGTL 480
+H ++HRD+K +NIL+ R R KIAD G AR F ++ + T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 481 GYMAPEYLAHGQLTEKA-DVYSFGMLLLEIVTG------RQNN-RSKNSEYTDSL 527
Y APE L + KA D+++ G + E++T RQ + ++ N + D L
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 321 LGQGGFGTVYKGVLP-DGREIAVKRL---FFNNRHRAANFYNEVNII-SSVEHKNLVRLL 375
+G+G FG V DG+ AVK L NR + E N++ +V+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
+ + V +F+ L F + ++ + L YLH I
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
I++RD+K NILLDS+ + DFGL + +S +T GT Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 496 KADVYSFGMLLLEIVTG 512
D + G +L E++ G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 321 LGQGGFGTVYKGVLPDGREI----AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG V + D + I +++ +R + E +++ V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
S PE L LV F+ L + FD ++A+ T E L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRAR-----------FYTAELLCALEN 108
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
K +I+RD+K NILLD + + DFGL + +D +T GT Y+APE L
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLG 167
Query: 491 GQLTEKADVYSFGMLLLEIVTG 512
T+ D ++ G+LL E++TG
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV---RLLGC 377
LG+G FG V +L RE A + + A + II+ E + + R+L
Sbjct: 3 LGKGTFGKV---ILV--REKATGKYY------AMKILKKEVIIAKDEVAHTLTESRVLQN 51
Query: 378 SCSGPESLLVYEFLPNQSLDR--FIFDSAKAKTLTWEKRYEIILG----------TVEGL 425
+ + L Y F Q+ DR F+ + A L + E + V L
Sbjct: 52 TRHPFLTALKYSF---QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 108
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLH +++RD+K N++LD KI DFGL + D + + T GT Y+AP
Sbjct: 109 GYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 164
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L D + G+++ E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 52/236 (22%), Positives = 96/236 (40%), Gaps = 44/236 (18%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN----NRHRAANFYNEVNIISSVEHKN 370
F+ +G+G FG V D I ++ + + A+ E +I+ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+V++ L+ EFLP + + K TL+ E I TV + +H+
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGL----------------------------- 461
+ IHRDIK N+LLD++ K++DFGL
Sbjct: 120 ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 462 -----ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
A ++++++ ++ + GT Y+APE + D +S G+++ E++ G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 320 KLGQGGFGTVYKGVL----PDGR-----EIAVKRLFFNNRHRAANFYNEVNIISSVEHKN 370
K+G+G FG K +L DG+ EI + ++ R + EV ++S+++H N
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN 60
Query: 371 LVRL------LGC------SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
+V+ G C G + +Y+ + Q F D + L W +I
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGD---LYKKINAQRGVLFPED----QILDW--FVQIC 111
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
L L ++H++ +I+HRDIK+ NI L K+ DFG+AR T I G
Sbjct: 112 LA----LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-G 163
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
T Y++PE + K+D+++ G +L E+ T
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 40/161 (24%)
Query: 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445
L+ EFLP + + K TLT E+ I TV + +H+ + IHRDIK N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDN 131
Query: 446 ILLDSRLRAKIADFGL----------------------------------ARSFQEDKSH 471
+LLDS+ K++DFGL A +++ ++
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
++ + GT Y+APE + D +S G+++ E++ G
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 53/236 (22%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG V D I A+K+L + + + A+ E +I++ ++ +V+L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY- 67
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
S L L+ E+LP + + K T T E+ I T+ + +H K+
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIH---KLG 121
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST--------------------- 474
IHRDIK N+LLD++ K++DFGL + KSH +
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 475 --------------AIA----GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
A+A GT Y+APE ++ D +S G+++ E++ G
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ ++HE+ R++HRDIK+ NI L + K+ DFG AR ++ T + GT Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKN 520
PE + K+D++S G +L E+ T + Q N KN
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 9/202 (4%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNL 371
F+ +G+G +G V K + +EI + F + N E+ ++ +++ +N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
V L + LV+E++ L+ + + EK I ++ + + H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPP-EKVRSYIYQLIKAIHWCH-- 117
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
K I+HRDIK N+L+ K+ DFG AR+ E + T T Y +PE L
Sbjct: 118 -KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 492 QLTEKADVYSFGMLLLEIVTGR 513
+ D++S G +L E+ G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
V L YLH + +++RDIK N++LD KI DFGL + D + + T GT
Sbjct: 105 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPE 160
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE L D + G+++ E++ GR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G+G +G V + G ++A+K++ F + A E+ ++ + H ++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 378 SCSGPES-------LLVYEFLPNQSLDRFIFDSAKAKT-LTWEKRYEIILGTVEGLVYLH 429
P S +V+E L L + I KA LT E + + L Y+H
Sbjct: 68 ML--PPSRREFKDIYVVFE-LMESDLHQVI----KANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHIS-TAIAGTLGYMAPEY 487
+ + HRD+K NIL ++ + KI DFGLAR +F + + I T T Y APE
Sbjct: 121 TAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 488 LA--HGQLTEKADVYSFGMLLLEIVTGR 513
+ T D++S G + E++TG+
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 30/76 (39%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
+HRD+ A N+LL KI DFGLAR D +++S + +MAPE + T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 496 KADVYSFGMLLLEIVT 511
+DV+S+G+LL EI +
Sbjct: 319 LSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
V L YLH + + ++RD+K N++LD KI DFGL + +D + + T GT
Sbjct: 105 VSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPE 161
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE L D + G+++ E++ GR
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 41/208 (19%), Positives = 77/208 (37%), Gaps = 23/208 (11%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+ K P +AVK++ ++ + E+ ++H N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 379 CSGPESLLVYEFLPNQS---LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
E +V + S L + F + + I+ + L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI---AF-ILKDVLNALDYIH---SKG 121
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSF-QEDKSH-----ISTAIAGTLGYMAPEYLA 489
IHR +KAS+ILL + ++ + S + K + L +++PE L
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 490 ---HGQLTEKADVYSFGMLLLEIVTGRQ 514
G EK+D+YS G+ E+ G
Sbjct: 182 QNLQG-YNEKSDIYSVGITACELANGHV 208
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 34/122 (27%), Positives = 58/122 (47%), Gaps = 12/122 (9%)
Query: 401 FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460
FD +++ E L++LH +I+RD+K NILLD+ K+ADFG
Sbjct: 93 FDEPRSRFYAAE--------VTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFG 141
Query: 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520
+ + +T GT Y+APE L + D ++ G+L+ E++ G+ + N
Sbjct: 142 MCKE-GILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
Query: 521 SE 522
+
Sbjct: 201 ED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 38/106 (35%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L YLH + I++RD+K NILLDS+ + DFGL + E ST GT Y+
Sbjct: 108 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYL 163
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS-EYTDSLL 528
APE L D + G +L E++ G S+N+ E D++L
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 7e-09
Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQEDKSHISTA 475
II VE L LH K IIH DIK N+L D ++ R + D+GL + +
Sbjct: 114 IIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGTPSC 165
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
GTL Y +PE + D ++ G+L E++TG
Sbjct: 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
V L YLH +I++RD+K N++LD KI DFGL + D + + T GT
Sbjct: 105 VSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPE 160
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE L D + G+++ E++ GR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 29/86 (33%), Positives = 47/86 (54%), Gaps = 7/86 (8%)
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + II+RD+K N+LLD++ K+ DFG A+ + + + GT Y+APE
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPE 185
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTG 512
+ + D ++ G+LL E + G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 14/116 (12%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L YLHE+ II+RD+K N+LLDS K+ D+G+ + ++ GT Y+
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCGTPNYI 163
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR--------QNNRSKNSEYTDSLLTIV 531
APE L D ++ G+L+ E++ GR +N +N+E D L ++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--DYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + II+RD+K NILLDS+ + DFGL + E ST GT Y+APE
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPE 166
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN-SEYTDSLL 528
L D + G +L E++ G S++ +E D++L
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 26/244 (10%)
Query: 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN----NRHRAA 354
D++N K L ++ +G+G FG V R++ +L R +A
Sbjct: 30 DTIN-KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 355 NFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI--FDSAKAKTLTWE 412
F+ E +I++ +V+L +V E++P L + +D + W
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE----KWA 144
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472
+ Y T E ++ L + IHRD+K N+LLD K+ADFG ++
Sbjct: 145 RFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199
Query: 473 STAIAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLL 528
GT Y++PE L G + D +S G+ L E++ G Y DSL+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADSLV 253
Query: 529 TIVS 532
S
Sbjct: 254 GTYS 257
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG VY+ D R I A+K L + A+ E NI+ ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTW---------EKRYEI-ILGTVEGLV 426
L + F + L + D L W E R + I V L
Sbjct: 61 ---------LKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE 110
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
+LH+ I++RD+K NILLD+ + DFGL+++ D +T GT Y+APE
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPE 166
Query: 487 YLAHGQ-LTEKADVYSFGMLLLEIVTG 512
L + T+ D +S G+L+ E+ G
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 4/86 (4%)
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + II+RD+K NILLDS+ + DFGL + E + ST GT Y+APE
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPE 166
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTG 512
L D + G +L E++ G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGR--EIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
F+ LG G FG V + +A+KR + + + ++E I++ + H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG----L 425
V L G LV EF+ F F L KR+ +G L
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEF--FTF-------LRRNKRFPNDVGCFYAAQIVL 142
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
++ + QS + I++RD+K N+LLD K+ DFG A+ + + GT Y+AP
Sbjct: 143 IFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAP 197
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTG 512
E L + + AD ++ G+ + EI+ G
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E ++ +H ++ +HRDIK N+L+D K+ADFG A +K S GT Y
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 483 MAPEYL------AHGQLTEKADVYSFGMLLLEIVTGR 513
+APE L G + D +S G++ E++ GR
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E ++ +H ++ +HRDIK N+LLD ++ADFG +D + S+ GT Y
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 483 MAPEYL-----AHGQLTEKADVYSFGMLLLEIVTG 512
++PE L G+ + D +S G+ + E++ G
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 7/143 (4%)
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
LV L C + LV E++ L +F + + L E L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ II+RD+K N+LLD+ K+ D+G+ + ST GT Y+APE L
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRG 170
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
+ D ++ G+L+ E++ GR
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 35/241 (14%)
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREI----AVKRLFFNNRHRAANFYNE 359
KY E ++ K+G G FG V+ +E A+ R ++ E
Sbjct: 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-QLVIE 62
Query: 360 VNIISSVEHKNLVRLLG--CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YE 416
VN++ ++HKN+VR + + + + ++ EF L R I K E +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 417 IILGTVEGLVYLHE----QSKIRIIHRDIKASNILLDSRLR-----------------AK 455
I + L Y H + R++HRD+K NI L + +R AK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 456 IADFGLARSFQ-EDKSHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTG 512
I DFGL+++ E +H + GT Y +PE L H +K+D+++ G ++ E+ +G
Sbjct: 183 IGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 513 R 513
+
Sbjct: 240 K 240
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 13/155 (8%)
Query: 358 NEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEI 417
+E ++ + H ++ LL G + LV LP D + + A+ + L + +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAV 265
Query: 418 ---ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-IS 473
+L ++ Y+H + IIHRDIK N+L++ + DFG A + S
Sbjct: 266 ARQLLSAID---YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319
Query: 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLE 508
IAGT+ APE LA T D++S G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 321 LGQGGFGTVYKGVL-----------------------PDGREIAVKRLFFNNRHR--AAN 355
LGQG +Y G L +GRE+ V + HR A
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 356 FYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
F+ +++S V H +L + G G E+++V EF+ + LD + + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-------KIADFGL---ARSF 465
+ L YL +++ ++H ++ A NILL A K++D G+ A S
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 466 QEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEI 509
+E I ++APE + G L+ AD +SFG LLEI
Sbjct: 178 EERVERIP--------WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E ++ + ++ +HRDIK NIL+D ++ADFG ED + S+ GT Y
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 169
Query: 483 MAPEYL-----AHGQLTEKADVYSFGMLLLEIVTG 512
++PE L G+ + D +S G+ + E++ G
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E ++ + ++ +HRDIK N+LLD ++ADFG D + S GT Y
Sbjct: 110 EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169
Query: 483 MAPEYL-----AHGQLTEKADVYSFGMLLLEIVTG 512
++PE L G+ + D +S G+ + E++ G
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 38/194 (19%), Positives = 84/194 (43%), Gaps = 19/194 (9%)
Query: 329 VYKGVLPDGREIAVKRL-FFNNRHRAA--NFYNEVNIISSVEHKNLVRLLG----CSCSG 381
+YKG+ + +E+ ++ F+ H+ NE+ + ++ N++++ G
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDI 441
P L+ E+ L + K K L+++ + ++ + +GL L+ ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNL 149
Query: 442 KASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH--GQLTEKADV 499
+ + L+ + KI GL + + Y + + L + T K D+
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDI 205
Query: 500 YSFGMLLLEIVTGR 513
YS G++L EI TG+
Sbjct: 206 YSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 32/123 (26%), Positives = 48/123 (39%), Gaps = 42/123 (34%)
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ--------EDKSHI------------ 472
K+ IHRDIK NIL+D K+ DFGL F+ + H
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 473 ----------------------STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510
+ ++ GT Y+APE L T+ D +S G++L E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 511 TGR 513
G+
Sbjct: 239 VGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 34/112 (30%), Positives = 48/112 (42%), Gaps = 29/112 (25%)
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL------------------- 461
TV L YLH I+HRD+K N+L+ S K+ DFGL
Sbjct: 110 TVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 462 -ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
R F DK + GT Y+APE + + D ++ G++L E + G
Sbjct: 167 DTREFL-DKQ-----VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 62/253 (24%), Positives = 97/253 (38%), Gaps = 56/253 (22%)
Query: 314 SFDEANKLGQGGFGTVY----KGVLPDGREIAVKRL------FFNNRHRAANFYNEVNII 363
F + LG+G G V+ KG G+ A+K L N R E I+
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLT---EQEIL 55
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE--KRY--EIIL 419
++++H L L + LV ++ P L R + K L+ E + Y E++L
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLSEEVARFYAAEVLL 114
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILL-------------------DSRLRAKIADFG 460
L YLH I++RD+K NILL + +K G
Sbjct: 115 A----LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 461 LARSFQ-----EDKSHISTAIA----GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
RS E S + + GT Y+APE ++ D ++ G+LL E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227
Query: 512 GRQNNRSKNSEYT 524
G + N + T
Sbjct: 228 GTTPFKGSNRDET 240
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 58/254 (22%), Positives = 98/254 (38%), Gaps = 66/254 (25%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNN---RHRAANFYNEVNIISSVEHKN 370
F + LG G FG V D + + A+K L + R++ A+ E +I++ +++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRF-----IFDSAKAKTLTWEKRYEIILGTVEGL 425
+VRL V +++P + IF A+ E + VE +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE-----LTCAVESV 117
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ------------------- 466
K+ IHRDIK NIL+D K+ DFGL F+
Sbjct: 118 ------HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 467 ------EDKSH---------------------ISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D ++ ++ ++ GT Y+APE L T+ D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 500 YSFGMLLLEIVTGR 513
+S G++L E++ G+
Sbjct: 232 WSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 321 LGQGGFGTVYKGVLPD-----------GREIAVKRLFFNNRHR--AANFYNEVNIISSVE 367
LG+G +Y G+L +EI V + HR + F+ +++ V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
HK++V L G E+++V EF+ LD F+ + T W ++++ L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 428 LHEQSKIRIIHRDIKASNILL-------DSRLRAKIADFGL---ARSFQEDKSHISTAIA 477
L ++ ++H ++ NILL + K++D G+ S QE I
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP---- 173
Query: 478 GTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEI 509
++APE + + L+ AD +SFG L EI
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 61/255 (23%), Positives = 101/255 (39%), Gaps = 68/255 (26%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFN---NRHRAANFYNEVNIISSVEHKN 370
F + LG G FG V D + A+K L NR++ A+ E +I++ +++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 371 LVRLLGCSCSGPESL-LVYEFLPNQSLDRF-----IFDSAKAKTLTWEKRYEIILGTVEG 424
+V+L S ++L V +++P + +F A R+ I E
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA-------RFYI----AEL 110
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ--------EDKSHI---- 472
+ + K+ IHRDIK NIL+D K+ DFGL F+ + SHI
Sbjct: 111 TLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170
Query: 473 ----------------------------------STAIAGTLGYMAPEYLAHGQLTEKAD 498
+ ++ GT Y+APE L T+ D
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 499 VYSFGMLLLEIVTGR 513
+S G++L E++ G+
Sbjct: 231 WWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 7/86 (8%)
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
LH + I+ RD+ +NILLD R ++ F ++ S A+ Y APE
Sbjct: 101 LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVENM--YCAPEV 153
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGR 513
+ TE D +S G +L E++TG+
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 34/146 (23%), Positives = 55/146 (37%), Gaps = 15/146 (10%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV--RLLGC 377
L G VY D +K +R + A+ EV I+ + K L ++L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLK--INPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
S S L+ E++ ++LD + E E + L LH+ + +
Sbjct: 62 GESDGWSYLLMEWIEGETLD-------EVSEEEKEDIAEQLAEL---LAKLHQLPLLVLC 111
Query: 438 HRDIKASNILLDSRLRAKIADFGLAR 463
H D+ NIL+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 40/217 (18%)
Query: 321 LGQGGFGTVY----------------KGVLPDGREIAVKRLFFNN---RHRAANFYNEVN 361
+G GGFG VY K + I ++ L +NN + A + N N
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 362 IISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAK--AKTLTWEKRY--EI 417
I +H + + GC S + Y F+ L++ + ++ + + K+ I
Sbjct: 80 I----DHLGIPKYYGCG-SFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNI 131
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477
+ + L Y+HE I H DIK NI++D R I D+G+A F HI +
Sbjct: 132 MKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188
Query: 478 ------GTLGYMAPEYLAHGQLTEKADVYSFGMLLLE 508
GTL Y + +T + D+ S G +L+
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 320 KLGQGGFGTVYKGVL---PDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVRLL 375
++G G FG V + + VK L N + N F + + ++H N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRY-EIILGTVEGLVYLHE 430
G LLV+E+ L ++ ++ L ++ EI G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTHMH- 116
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMAPEYLA 489
K +H D+ N L S L K+ D+G+ S ++ED L ++APE +
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 490 --HGQL-----TEKADVYSFGMLLLEI 509
HG L T+ ++V++ G+ L E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 30/94 (31%), Positives = 42/94 (44%), Gaps = 20/94 (21%)
Query: 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV------EGLVYLHEQSKIRIIHR 439
L+ EFLP L +T +Y+ V E ++ + K+ IHR
Sbjct: 78 LIMEFLPGGDL------------MTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473
DIK NIL+D K++DFGL+ F K H S
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFH--KQHDS 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 19/109 (17%)
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD----FGLARSFQEDKS-- 470
I+ G + GL YLH+ IHR+IKAS+IL+ ++ + L R+ Q+ K
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 471 ---HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGR 513
ST++ L +++PE L +G K+D+YS G+ E+ TGR
Sbjct: 163 DFPQFSTSV---LPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 31/114 (27%), Positives = 51/114 (44%), Gaps = 22/114 (19%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR----------------LRAKIADF 459
+II T L Y H +++ ++H D+K NIL+++ R +I D
Sbjct: 235 QIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
G D+ H TAI T Y +PE + D++S G ++ E+ TG+
Sbjct: 293 GGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 43/183 (23%), Positives = 66/183 (36%), Gaps = 56/183 (30%)
Query: 319 NKLGQGGFGTVYKGVLPD-----GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
KLG+G FG VYK L + + +K+ A Y V I + + + R
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKK---------ATEYGAVEIWMN---ERVRR 185
Query: 374 LLGCSCS--------------GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL 419
SC+ E LV+ + +L D ++K + +L
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTL----ADLMQSKEFPYNVE-PYLL 240
Query: 420 GTVEGLVY-LHEQSKI------------------RIIHRDIKASNILLDSRLRA-KIADF 459
G V+ L L ++KI I+HRD+K NI+ + KI D
Sbjct: 241 GKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 460 GLA 462
G A
Sbjct: 301 GAA 303
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 17/39 (43%), Positives = 24/39 (61%), Gaps = 3/39 (7%)
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463
L YLH IIHRD+K N+L+ + K+ DFGL++
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 33/164 (20%), Positives = 60/164 (36%), Gaps = 35/164 (21%)
Query: 318 ANKLGQGGFGTVYKGVLPDGREIAVK---------------RLFFNNRHRAANFYNEVNI 362
K+G G VY + P GR++AVK R + ++ + Y V+
Sbjct: 96 GTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLY--VSR 153
Query: 363 ISS-VEHKNLVRLLGCSCSGPESL------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
+++ E + L RL P+ + +V E++ L R + ++
Sbjct: 154 LAAEREFEALQRLYPEGVKVPKPIAWNRHAVVMEYIEGVELYR-----LRLDVENPDEIL 208
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459
+ IL V I+H D+ NIL+ + D+
Sbjct: 209 DKILEEVRKAYRRG------IVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 28/89 (31%), Positives = 39/89 (43%), Gaps = 18/89 (20%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILL--DSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
++ L L E HR K+ NILL D L+ G +F+ +
Sbjct: 24 LQCLGALREL------HRQAKSGNILLTWDGLLKL----DGSV-AFKTPEQSRPDPY--- 69
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLE 508
+MAPE + TEKAD+YS G+ L E
Sbjct: 70 --FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 532 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.44 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.21 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.1 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.08 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.89 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.7 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.54 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.27 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.24 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.23 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.17 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.15 | |
| PLN02236 | 344 | choline kinase | 97.14 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.1 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.94 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.9 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.65 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.17 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.07 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.06 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.03 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.9 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.86 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.79 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.62 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.34 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.95 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.81 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=388.68 Aligned_cols=231 Identities=51% Similarity=0.809 Sum_probs=203.3
Q ss_pred CCCCcChhhHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeee
Q 009543 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378 (532)
Q Consensus 299 ~~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 378 (532)
....|.+.++..+|++|...+.||+|+||.||+|.+++|+.||||++.....+...+|.+|++++.+++|||||+++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45568999999999999999999999999999999999999999988765543145699999999999999999999999
Q ss_pred ecCCc-ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 379 CSGPE-SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 379 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
.+.+. .+||+|||++|+|+++|+..... .++|.+|++|+.++|+||+|||+..+++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99984 99999999999999999764443 89999999999999999999999988899999999999999999999999
Q ss_pred ecCCccccCC-CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcccccccccc
Q 009543 458 DFGLARSFQE-DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531 (532)
Q Consensus 458 Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~~~l~~~~ 531 (532)
|||+++..+. ........ .||.+|++||++..+..+.|+|||||||+++||+||++|.....+.....+++|+
T Consensus 220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999976654 22221111 7999999999999999999999999999999999999999876655555576663
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=357.88 Aligned_cols=201 Identities=33% Similarity=0.547 Sum_probs=182.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.++|...++||+|.||+||+|+++ ++.+||||.+... .+...+.+..|+++|+.++|||||++++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468999999999999999999975 6899999999766 5566677899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC------CcEEEeecCCc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR------LRAKIADFGLA 462 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~------~~~kl~Dfgl~ 462 (532)
|||.||+|.++++. .+.+++.....++.|++.||++||+++ ||||||||+||||+.. -.+||+|||++
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999953 457999999999999999999999998 9999999999999875 46899999999
Q ss_pred cccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+...+.. .....+|++-|||||+++.++|+.|+|+||+|+|+|||++|+.||...+
T Consensus 163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9887443 3356799999999999999999999999999999999999999998543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=338.20 Aligned_cols=203 Identities=29% Similarity=0.435 Sum_probs=183.7
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++++.||+|+||+||.++.+ +++.+|+|++.+. .....+...+|..+|..++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 578999999999999999999965 6889999999754 234567788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
+||+.||.|..+| +++..+++....-++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999 45678999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
... .+...+||+.|||||++.+..|+..+|+||||+++|||++|.+||...+.
T Consensus 178 ~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 178 DGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred CCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 332 34457999999999999999999999999999999999999999988764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=334.32 Aligned_cols=197 Identities=31% Similarity=0.500 Sum_probs=178.1
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc-ceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE-SLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~ 390 (532)
+.+.++.||+|..|+|||++++ +++.+|+|++... +....+++.+|++++...+||+||+++|.|..... ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4566789999999999999986 6888999999554 44556789999999999999999999999999885 9999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|++|+|++++. ..+.+++...-+|+.++++||.|||+ ++ ||||||||+|||++..|++||+|||.+..+.+.
T Consensus 160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999994 34679999999999999999999996 55 999999999999999999999999999877655
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
...+.+||..|||||.+++..|+.++||||||+.++|+.+|+.||...
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 345688999999999999999999999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=349.81 Aligned_cols=201 Identities=30% Similarity=0.481 Sum_probs=185.0
Q ss_pred CCccccccccccCceeEEEEEe-cCCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
..|...+.||+|||+.||+++. .+|+.||+|++... .....+.+.+||++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999997 78999999999753 3445577899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
|+|++++|..++. +.+.+++.+++.++.||+.||.|||+++ |+|||||..|+||+++.++||+|||||.....+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999983 5688999999999999999999999998 999999999999999999999999999988754
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ...+.+|||.|.|||++.+..++..+||||+|||||.|+.|++||+.++
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence 33 3456899999999999999999999999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=326.24 Aligned_cols=207 Identities=26% Similarity=0.440 Sum_probs=181.8
Q ss_pred CCccccccccccCceeEEEEE-ecCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeee-eeecCCc-ceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLG-CSCSGPE-SLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 387 (532)
.+|++.++||+|.||+|||+. +.+|..+|.|.+... +.+..+....|+.+|++|+|||||++++ .+.++.+ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468999999999999999999 468999999998754 3455677899999999999999999999 4555555 7899
Q ss_pred EEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 388 YEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSK-IRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
||++..|+|.+.+...+ ..+.+++..+|+++.|++.||.++|++-+ ..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999996543 35679999999999999999999998431 13999999999999999999999999999988
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..... .....+|||.||+||.+.+.+|+.||||||+||++|||+.=+.||.+.+
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 76543 3466899999999999999999999999999999999999999998864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=344.07 Aligned_cols=203 Identities=37% Similarity=0.585 Sum_probs=177.4
Q ss_pred ccccccccccCceeEEEEEecCCCEEEEEEeeccChh--hHHHHHHHHhHhhcCccceeeeeeeeeecCC-cceEEEEec
Q 009543 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKNLVRLLGCSCSGP-ESLLVYEFL 391 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 391 (532)
..+.+.||+|+||+||+|.++....||||++...... ..++|.+|+.+|.+++|||||+++|++.+.. ...+||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3445669999999999999965445999999765322 2568999999999999999999999999888 789999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCccccCCCCc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDKS 470 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~~~~~~~ 470 (532)
++|+|.++++.. ....+++..+++++.+||+||.|||++++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999754 46789999999999999999999999874 99999999999999998 99999999998765432
Q ss_pred ccccccccccccccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLA--HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
...+...||+.|||||++. ...++.|+||||||+++|||+||+.||.....
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 2233467999999999999 66899999999999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=316.85 Aligned_cols=199 Identities=28% Similarity=0.415 Sum_probs=182.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|+.++.||.|+||.|.+.+.+ +|..+|+|++.... ....+...+|..+|+.+.||+++++.+.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57899999999999999999975 68899999997653 334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||.+||.|..+|+ +...+++.....++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+++.....
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999994 4567999999999999999999999998 999999999999999999999999999987655
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
+-+.+|||.|+|||+++.+.+..++|+|||||++|||+.|..||...++
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3458999999999999999999999999999999999999999998765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.69 Aligned_cols=206 Identities=32% Similarity=0.513 Sum_probs=184.7
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
..+..+++||+|.||+||.|.++....||+|.+... ....+.|.+|+++|++|+|+|||++++++..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345667899999999999999987789999999765 3445789999999999999999999999999899999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
.|+|.++|.. .....+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||++....+.+..
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999965 34677999999999999999999999998 9999999999999999999999999999766666655
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEY 523 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~~ 523 (532)
.....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+...+..+
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e 412 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE 412 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH
Confidence 566667889999999999999999999999999999999 999998765443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.55 Aligned_cols=207 Identities=30% Similarity=0.473 Sum_probs=183.2
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--CcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 386 (532)
.+.|+.+++||+|.||.||+++. .+|+.||+|++.... ........+||.||++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45688899999999999999995 579999999998765 34456788999999999999999999988776 67899
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
|+|||++ +|..++. ...-.+++.++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+||||++.+.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999987 6666663 34567999999999999999999999999 9999999999999999999999999999888
Q ss_pred CCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~ 524 (532)
.......+..+-|++|.|||++.+. .|+.++|+||.||||.||+.|++.|.+.++-++
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ 328 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ 328 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH
Confidence 7776666777889999999998764 799999999999999999999999998776544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=326.88 Aligned_cols=201 Identities=29% Similarity=0.429 Sum_probs=175.1
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccCh-------hhHHHHHHHHhHhhcCccceeeeeeeeeecCC
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNR-------HRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 382 (532)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++....- .......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788999999999999999996 4799999999965421 12234679999999999999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC---CcEEEeec
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADF 459 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~---~~~kl~Df 459 (532)
..||||||++||+|.+.+. .++.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999984 4566788888999999999999999999 9999999999999766 78999999
Q ss_pred CCccccCCCCcccccccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ---LTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 460 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
|+++...+ .....+.+|||.|.|||++..+. +..++|+||+||+||-+++|.+||+..
T Consensus 324 GlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 324 GLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred chhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence 99998763 33456789999999999997653 345889999999999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=311.90 Aligned_cols=202 Identities=24% Similarity=0.396 Sum_probs=178.4
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
+.|+.+.++|+|+||.|||++++ +|+.||||++..+. +...+-.+||+++|++++|||+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999976 69999999996543 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|++..-|+++- .....++...+.+++.|+++|+.|+|+++ +|||||||+||||+.+|.+||+|||+|+.+.. .
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 99886666543 23467899999999999999999999998 99999999999999999999999999998874 3
Q ss_pred ccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
....+..+.|.+|.|||.+.+ -+|+..+||||+||++.||++|.+.|-+.++
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 334566788999999999876 6899999999999999999999999977653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=329.96 Aligned_cols=214 Identities=25% Similarity=0.385 Sum_probs=185.4
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
-.++|++++.||+|+||+||+++-+ +|..+|+|++.... ....+.+..|-.+|...++|.||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999965 69999999997664 3445678889999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+|||++..+| .+...+++.....++.+++-||+.||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 45678999999999999999999999999 9999999999999999999999999984321
Q ss_pred CC-----------------------Cc-----c------------------cccccccccccccccccccCCCCchhhHH
Q 009543 467 ED-----------------------KS-----H------------------ISTAIAGTLGYMAPEYLAHGQLTEKADVY 500 (532)
Q Consensus 467 ~~-----------------------~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 500 (532)
.. .. . .....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 00 0 01235899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCccc-cccccc
Q 009543 501 SFGMLLLEIVTGRQNNRSKNSEYT-DSLLTI 530 (532)
Q Consensus 501 SlGvll~el~tG~~p~~~~~~~~~-~~l~~~ 530 (532)
|||||+|||+.|.+||.+.++.+. ..|+.|
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw 403 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNW 403 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999999999998765433 344443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=347.27 Aligned_cols=213 Identities=27% Similarity=0.460 Sum_probs=186.0
Q ss_pred hcCCccccccccccCceeEEEEEec------CCCEEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
...+.+..++||+|.||+||+|+.. +.+.||||.++..... ...+|.+|++++..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3456778899999999999999953 3467999999876554 77899999999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhcc-------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC
Q 009543 384 SLLVYEFLPNQSLDRFIFDSA-------K----AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~ 452 (532)
.+||+|||..|+|.+||.... . ..+++..+.+.|+.|||.||+||-++. ++||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999996321 1 223889999999999999999999987 99999999999999999
Q ss_pred cEEEeecCCccccCCCCccc-ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 009543 453 RAKIADFGLARSFQEDKSHI-STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDS 526 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~~~~~ 526 (532)
.+||+||||++..-..+++. .....-+.+|||||.+..++|+.+||||||||+|||+++ |+.||.+...++...
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 99999999999876655553 334566889999999999999999999999999999999 999998876655443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=326.44 Aligned_cols=204 Identities=27% Similarity=0.409 Sum_probs=180.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 386 (532)
..+|...+.||+|+|++|++++.. +++++|||++.... +...+-+.+|-..|.+| .||.|++|+..|+++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 467888999999999999999954 79999999986442 22334466788899999 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
|+||+++|+|.++|. +.+.+++...+.++.+|+.||+|||++| ||||||||+|||||+||++||+|||-++.+.
T Consensus 152 vLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999994 4578999999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCcc----------cc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 467 EDKSH----------IS--TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
..... .. ...+||..|.+||++.++..+..+|+|+||||||+|+.|++||...++
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 43221 11 457999999999999999999999999999999999999999988653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=323.75 Aligned_cols=198 Identities=31% Similarity=0.486 Sum_probs=180.1
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|-+.+.||+|.||.||||+.+ +.+.||+|.+.+. .++..+.+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999965 6889999988654 34456779999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+.| +|..+| ...+.++++++..|+.++..||.|||+.. |+|||+||+|||++.+|.+|++|||+++......
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 999999 34577999999999999999999999998 9999999999999999999999999999876543
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
...+.+.|||.|||||++.++.|+..+|+||+|||+|||++|++||..
T Consensus 155 -~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred -eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 345667899999999999999999999999999999999999999965
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=293.52 Aligned_cols=202 Identities=30% Similarity=0.476 Sum_probs=178.1
Q ss_pred CCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChh--hHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.+|...++||+|.||.||+|++ .+|+.||||++...... ......|||+.|+.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688899999999999999996 47999999999876432 24578999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
||+. +|+.++.+ +...++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9964 89998854 5578999999999999999999999999 9999999999999999999999999999887544
Q ss_pred ccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.. .+..+-|.+|.|||.+.+ ++|+..+||||.|||+.||+-|.+-|-+.++
T Consensus 156 ~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD 207 (318)
T KOG0659|consen 156 RI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD 207 (318)
T ss_pred cc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence 33 233377999999998865 5799999999999999999999998877654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=321.48 Aligned_cols=204 Identities=26% Similarity=0.448 Sum_probs=179.7
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc----Ch-hhHHHHHHHHhHhhcCc-cceeeeeeeeeecCC
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN----NR-HRAANFYNEVNIISSVE-HKNLVRLLGCSCSGP 382 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 382 (532)
...++|.+.+.||+|.||+|++|... +++.||+|.+... .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34678999999999999999999864 7899999976543 12 23456778999999999 999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecCC
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGL 461 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfgl 461 (532)
..++||||+.+|+|.+++.. ...+.+.+...++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999943 567889999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCCcccccccccccccccccccccCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ-L-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+.... .........+|++.|+|||++.+.. | +.++||||+||+||.|++|+.||...+
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 99875 2223445679999999999999866 6 588999999999999999999998854
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=326.80 Aligned_cols=206 Identities=28% Similarity=0.417 Sum_probs=183.5
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcce
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 385 (532)
..++|..++.||+|.||+|+++..+ +++.+|||++++.. ....+..+.|.+++... +||.+++++.+|++.++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3578999999999999999999976 68899999998663 45567888899998887 5999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||..||++..+ +....+++.++..++..|+.||.|||+++ ||+||||.+|||||.+|++||+|||+++.-
T Consensus 446 fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999995433 35578999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~ 524 (532)
-.... .+.+.+|||.|||||++.+..|+..+|+|||||+||||+.|+.||.+.++++.
T Consensus 519 m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~ 576 (694)
T KOG0694|consen 519 MGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV 576 (694)
T ss_pred CCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 43333 45668999999999999999999999999999999999999999998776654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.06 Aligned_cols=199 Identities=30% Similarity=0.516 Sum_probs=183.5
Q ss_pred CCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
..|...++||+|..|.||.++. .+++.||||++........+-+++|+.+|+..+|+|||++++.+...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4678888999999999999984 578999999998888888888999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
+||+|.+++ ....+++.++..|.+++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+......
T Consensus 353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999998 4456999999999999999999999999 999999999999999999999999999887665543
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....+||+.|||||++....|++|+||||||++++||+-|++||-..
T Consensus 426 -R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE 472 (550)
T KOG0578|consen 426 -RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE 472 (550)
T ss_pred -cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC
Confidence 34578999999999999999999999999999999999999999764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=310.25 Aligned_cols=203 Identities=33% Similarity=0.533 Sum_probs=174.9
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC--cceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP--ESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 388 (532)
..+|...+.||+|.||+||++... +|+..|||.+...+....+.+.+|+.+|.+++|||||+.+|...... ..+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 346788899999999999999975 48999999987765444677999999999999999999999855544 588999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-CCcEEEeecCCccccCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQE 467 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfgl~~~~~~ 467 (532)
||+++|+|.+++.... ..+++..+..+..||++||+|||+++ |+|+||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999995432 27999999999999999999999998 999999999999999 79999999999987764
Q ss_pred --CCcccccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 --DKSHISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 --~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
..........||+.|||||++..+. ...++|||||||++.||+||++||...
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 2222334578999999999998643 345999999999999999999999873
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.44 Aligned_cols=198 Identities=36% Similarity=0.558 Sum_probs=168.6
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhc--CccceeeeeeeeeecCC----cce
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISS--VEHKNLVRLLGCSCSGP----ESL 385 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~ 385 (532)
....+..+.||+|.||.||||.++ ++.||||++.. +..+.|++|-+|++. ++|+||+++++...... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345677889999999999999995 59999999954 445678888888776 58999999999876555 789
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEccCCCCCEEEcCCCcEEEeec
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ------SKIRIIHRDIKASNILLDSRLRAKIADF 459 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------~~~~iiH~Dlkp~NiLl~~~~~~kl~Df 459 (532)
||+||.+.|+|.++| +...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|++..|+||
T Consensus 285 LVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999 557899999999999999999999964 4678999999999999999999999999
Q ss_pred CCccccCCCCcc-cccccccccccccccccccCC------CCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 460 GLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQ------LTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 460 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
|++..+...... .....+||.+|||||++.+.. .-.+.||||+|.+||||++.-.-+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 999988755443 334478999999999986532 2247899999999999999877664
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.74 Aligned_cols=205 Identities=28% Similarity=0.515 Sum_probs=179.7
Q ss_pred CCccccccccccCceeEEEEEecC----CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
....+.+.||.|.||+|++|+++- ...||||.++... +....+|+.|..||.+++||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345678999999999999999852 3469999998775 34457899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
+|||++|+|+.||.. +..++++.+...++++|+.||.||.+.+ ++||||.++||||+.+..+|++|||+++.+.+
T Consensus 709 TEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999964 4467999999999999999999999998 99999999999999999999999999998866
Q ss_pred CCccccccc--ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 009543 468 DKSHISTAI--AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSE 522 (532)
Q Consensus 468 ~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~ 522 (532)
+.....+.. .-+.+|.|||.+..++++.+||||||||+|||.++ |.+||...+..
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH
Confidence 653333222 23679999999999999999999999999999776 99999776543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=312.57 Aligned_cols=203 Identities=26% Similarity=0.405 Sum_probs=178.7
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChh-hHHHHHHHHhHhhcCc-cceeeeeeeeeecCC-cceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRH-RAANFYNEVNIISSVE-HKNLVRLLGCSCSGP-ESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~l 386 (532)
..++|..+++||.|.||.||+|+. .+|..||||+++..-.. ....-+||+..|++++ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346899999999999999999995 57999999998755332 2234568999999998 999999999999988 8999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
|||||+ .+|.+++.++ ...+++..+..|+.||++||+|+|++| +.||||||+|||+..+..+||+|||+++...
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 4899998653 788999999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCcccccccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.... .+..+.|.+|.|||++. .+.|+.+.|||++|||++|+.+=++.|-+.++
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 6554 36678999999999875 56899999999999999999999999977554
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=285.33 Aligned_cols=202 Identities=29% Similarity=0.444 Sum_probs=182.0
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.... .+...++.+|+++-+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 468999999999999999999965 67889999997653 34456899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
+||.++|++...|.. .....+++...+.++.|+|.|+.|+|... +|||||||+|+|++..+.+||+|||.+..-+.
T Consensus 101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999953 35677999999999999999999999988 99999999999999999999999999876542
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ...+.+||..|.+||...+..++..+|+|++|++.||++.|.+||++..
T Consensus 177 ~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 177 N---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred C---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 2 2345789999999999999999999999999999999999999998865
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=295.28 Aligned_cols=205 Identities=27% Similarity=0.416 Sum_probs=177.1
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhh--HHHHHHHHhHhhcCccceeeeeeeeeec--CCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHR--AANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 387 (532)
++|+.+++|++|.||.||+|+++ +++.||+|+++...... .-.-++||.+|.+.+|||||.+..+..- -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56899999999999999999975 68899999998764322 2457899999999999999999887754 4568999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||++. +|..++.. ...++...+..-++.|+++|++|||++. |+||||||+|+|++..|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999976 78888743 3367999999999999999999999999 99999999999999999999999999998876
Q ss_pred CCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~ 524 (532)
... ..+..+-|.+|.|||.+.+ ..|+...|+||+|||+.||+++++.|.+..+-++
T Consensus 230 p~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ 286 (419)
T KOG0663|consen 230 PLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ 286 (419)
T ss_pred Ccc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH
Confidence 533 3456778999999999876 4699999999999999999999999988765433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.95 Aligned_cols=207 Identities=28% Similarity=0.390 Sum_probs=181.7
Q ss_pred hcCCccccccccccCceeEEEEE-ecCCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
..+.|++.+.||.|.-++||+|+ .+.++.||||++....- ...+.+.+|+..++.++||||++.+..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34689999999999999999999 46789999999986643 33588999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
.||.+|++.+++...- ...+++..+..|.+++++||.|||+++ .||||||+.||||+.+|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999997643 345999999999999999999999999 999999999999999999999999987655443
Q ss_pred Ccc---ccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 469 KSH---ISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 469 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
... ..+..+||+.|||||++.. ..|+.|+||||||++.+||.+|+.||....+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 322 1256789999999999643 4689999999999999999999999988653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.04 Aligned_cols=202 Identities=27% Similarity=0.425 Sum_probs=175.9
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 68999999986532 233456788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++. +...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999984 3457899999999999999999999998 999999999999999999999999998754321
Q ss_pred Cc----------------------------------ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 009543 469 KS----------------------------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514 (532)
Q Consensus 469 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~ 514 (532)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123579999999999998899999999999999999999999
Q ss_pred CCCCCC
Q 009543 515 NNRSKN 520 (532)
Q Consensus 515 p~~~~~ 520 (532)
||...+
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=301.14 Aligned_cols=202 Identities=25% Similarity=0.457 Sum_probs=182.6
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
...+|++.+.||+|.||.|-++.. ..|+.||||.++.. +++..-.+.+||+||+.|+||||+.++.+|+..+.+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345789999999999999999985 57999999988654 45556678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||..+|.|.+++ .....+++.+..++++||.+|+.|+|++. ++|||||.+|||||.|+++||+|||++..+.
T Consensus 131 vMEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999 45577999999999999999999999998 9999999999999999999999999998876
Q ss_pred CCCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .-++.+|++.|.+||++++.+| ++.+|-|||||+||.|+.|.-||++.+
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 543 2356899999999999998877 689999999999999999999998753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=314.45 Aligned_cols=209 Identities=29% Similarity=0.498 Sum_probs=177.2
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
.+++...+.+.+.+.||+|.||+||+|+|. ..||||++.... ....+.|++|+..+++-+|.||+-+.|++...+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 344555567788899999999999999996 469999997663 4567899999999999999999999999988777
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.+|+.||+|.+|..+++- ....++..+.+.|++||++||.|||.++ |||||||..||+|.+++.+||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 999999999999999964 3467999999999999999999999998 9999999999999999999999999985
Q ss_pred ccCCC-Cccccccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 464 SFQED-KSHISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 464 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
.-..- ........-|...|||||++.. .+|+..+||||||+++|||++|..||...+.+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d 599 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD 599 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence 43211 1111122347788999999863 46899999999999999999999999965444
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.10 Aligned_cols=198 Identities=24% Similarity=0.384 Sum_probs=175.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999975 68999999986542 233456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999843 456899999999999999999999998 999999999999999999999999998865432
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred c----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 23568999999999998889999999999999999999999997754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.36 Aligned_cols=202 Identities=25% Similarity=0.380 Sum_probs=174.5
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.|++++.||+|+||+||+++.. +++.+|+|++.... ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999864 68899999996542 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999843 456889999999999999999999998 9999999999999999999999999976432100
Q ss_pred c----------------------------------------------ccccccccccccccccccccCCCCchhhHHHHH
Q 009543 470 S----------------------------------------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFG 503 (532)
Q Consensus 470 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG 503 (532)
. .......||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001235799999999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCCC
Q 009543 504 MLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 504 vll~el~tG~~p~~~~~~ 521 (532)
|++|||++|+.||...+.
T Consensus 236 ~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP 253 (381)
T ss_pred hHHHHHHhCCCCCcCCCH
Confidence 999999999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=299.86 Aligned_cols=201 Identities=29% Similarity=0.420 Sum_probs=175.2
Q ss_pred CccccccccccCceeEEEEEe-cCCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.|+..+.||+|+||+||++.. .+++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999996 478999999986442 2233467899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|..++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998887532 2346899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 2 234568999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=311.57 Aligned_cols=188 Identities=29% Similarity=0.509 Sum_probs=169.3
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
.++-||.|+.|.||+|+++ ++.||||+++.-. ..+|+.|++|+||||+.|.|+|.....++||||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3567999999999999995 7999999885322 2478899999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccc
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 476 (532)
.++| .....++......|..+||.||.|||.+. |||||||.-||||..+..+||+|||-++..... .....+
T Consensus 200 ~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF 271 (904)
T KOG4721|consen 200 YEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF 271 (904)
T ss_pred HHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence 9999 35678999999999999999999999998 999999999999999999999999998876543 234457
Q ss_pred ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 477 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+||..|||||++.+.+.+.|+|||||||+||||+||..||..-+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 89999999999999999999999999999999999999998754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=314.66 Aligned_cols=202 Identities=26% Similarity=0.430 Sum_probs=175.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999975 68999999997532 233456788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999843 356899999999999999999999998 999999999999999999999999998754321
Q ss_pred Ccc-------------------------------------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 009543 469 KSH-------------------------------------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511 (532)
Q Consensus 469 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t 511 (532)
... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112468999999999998899999999999999999999
Q ss_pred CCCCCCCCC
Q 009543 512 GRQNNRSKN 520 (532)
Q Consensus 512 G~~p~~~~~ 520 (532)
|+.||...+
T Consensus 235 G~~Pf~~~~ 243 (364)
T cd05599 235 GYPPFCSDN 243 (364)
T ss_pred CCCCCCCCC
Confidence 999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=291.10 Aligned_cols=205 Identities=29% Similarity=0.473 Sum_probs=175.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChh--hHHHHHHHHhHhhcCccce-eeeeeeeeecCC-----
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKN-LVRLLGCSCSGP----- 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~----- 382 (532)
...|+.+++||+|.||+||+|+.. +|+.||+|++....+. ......+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345778889999999999999964 7899999999876442 3456789999999999999 999999998877
Q ss_pred -cceEEEEecCCCChhHHhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 383 -ESLLVYEFLPNQSLDRFIFDSAKA-KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
..++|+||++ .+|.+++...... ..++...+..++.||+.||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7889999994 5898888543322 46777899999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
+++.+.-... ..+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|.+..+
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 9996653332 23456789999999998876 799999999999999999999999987654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=314.69 Aligned_cols=204 Identities=25% Similarity=0.340 Sum_probs=176.2
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
...++|++.+.||+|+||.||+++.. +++.+|+|++... .......+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999975 5889999998642 2233456889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998832 35889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHG----QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
............||+.|+|||.+... .++.++||||||+++|||++|+.||...+
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 54333233456799999999998653 37889999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=309.09 Aligned_cols=198 Identities=25% Similarity=0.374 Sum_probs=176.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||++++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57999999999999999999975 68999999986542 233467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999843 456889999999999999999999998 999999999999999999999999999866433
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 2 23568999999999998889999999999999999999999997654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=310.11 Aligned_cols=199 Identities=26% Similarity=0.407 Sum_probs=177.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.++||+|+||.||++++. +++.||+|++.... ......+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 58999999987542 233457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999984 3456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...+.
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 22345789999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=311.54 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=179.1
Q ss_pred CCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
+-|+..+.||.|+-|.|-+|++ .+|+..|||++.... ......+.+||-+|+.+.||||+++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5688999999999999999996 489999999996552 233456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|.|.+++. ..+.+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|....++
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999995 4577999999999999999999999998 999999999999999999999999999875443
Q ss_pred CcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .-.+-+|+|.|.+||++++.+| +.++||||.|||||.|+||+.||++.+
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 3 2345689999999999998876 789999999999999999999998643
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=314.91 Aligned_cols=202 Identities=26% Similarity=0.411 Sum_probs=174.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.++||+|+||+||+++.. +++.||||++.... ....+.+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999864 78999999986532 233467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999984 3456889999999999999999999998 999999999999999999999999998643211
Q ss_pred Ccc----------------------------------------------cccccccccccccccccccCCCCchhhHHHH
Q 009543 469 KSH----------------------------------------------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSF 502 (532)
Q Consensus 469 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl 502 (532)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 009543 503 GMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 503 Gvll~el~tG~~p~~~~~ 520 (532)
||++|||++|+.||...+
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN 252 (377)
T ss_pred chhhhhhhcCCCCCCCCC
Confidence 999999999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.99 Aligned_cols=207 Identities=32% Similarity=0.541 Sum_probs=180.5
Q ss_pred cCCccccccccccCceeEEEEEec--CCC----EEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP--DGR----EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~--~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
..+.+..+.||+|.||.||+|... +|. .||||.+... +.+...+|.+|..+|+.++||||++++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 456677889999999999999964 343 3899988755 566778999999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 385 LLVYEFLPNQSLDRFIFDSA----KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
++++|||++|+|..||.+.. ....++..+.+.++.+||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999996531 2467899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCcccc-cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 461 LARSFQEDKSHIS-TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 461 l~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
+++.+...+++.. ....-+.+|||||.+.++.++.|+|||||||++||++| |..||...+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 9996554444433 23355789999999999999999999999999999999 9999987654
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=309.20 Aligned_cols=199 Identities=26% Similarity=0.375 Sum_probs=175.4
Q ss_pred cCCccccccccccCceeEEEEEecC--CCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD--GREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.+.||+|+||.||+++++. +..||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998643 3689999986432 2334678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999984 3456899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 183 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 183 TRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred CCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 322 23568999999999988889999999999999999999999998754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=315.18 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=173.7
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
+|+++++||+|+||+||+++.. +++.+|+|++.... ......+.+|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6889999999999999999964 68899999986542 2344678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|.+++.. ...+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999843 356889999999999999999999998 9999999999999999999999999975331100
Q ss_pred ----------------------------------------------cccccccccccccccccccccCCCCchhhHHHHH
Q 009543 470 ----------------------------------------------SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFG 503 (532)
Q Consensus 470 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG 503 (532)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234689999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 009543 504 MLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 504 vll~el~tG~~p~~~~~ 520 (532)
|++|||++|+.||...+
T Consensus 236 vil~elltG~~Pf~~~~ 252 (382)
T cd05625 236 VILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=311.95 Aligned_cols=206 Identities=24% Similarity=0.329 Sum_probs=177.4
Q ss_pred HHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
+....++|++.+.||+|+||.||+++.. +++.+|+|++... .......+.+|+.+++.++||||+++++.+.++..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3444578999999999999999999976 6889999998642 22334567889999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999998842 35888999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcccccccccccccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHG----QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..............||+.|+|||++... .++.++|||||||++|||++|+.||...+
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 7654333333456799999999998653 37889999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=315.05 Aligned_cols=203 Identities=25% Similarity=0.373 Sum_probs=174.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|+++++||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 46899999999999999999965 68999999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999843 456889999999999999999999998 999999999999999999999999997532100
Q ss_pred C------------------------------------------cccccccccccccccccccccCCCCchhhHHHHHHHH
Q 009543 469 K------------------------------------------SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506 (532)
Q Consensus 469 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll 506 (532)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001234799999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCC
Q 009543 507 LEIVTGRQNNRSKNS 521 (532)
Q Consensus 507 ~el~tG~~p~~~~~~ 521 (532)
|||++|+.||...+.
T Consensus 235 yell~G~~Pf~~~~~ 249 (376)
T cd05598 235 YEMLVGQPPFLADTP 249 (376)
T ss_pred eehhhCCCCCCCCCH
Confidence 999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.77 Aligned_cols=206 Identities=32% Similarity=0.501 Sum_probs=176.8
Q ss_pred HHHhcCCccccccccccCceeEEEEEecC--C--CE-EEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeee
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLPD--G--RE-IAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 379 (532)
++...++....++||+|+||.||+|++.. + .. ||+|..... ......++++|.+++++++|||||+++|+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33445566677999999999999999753 2 23 899988752 3666789999999999999999999999999
Q ss_pred cCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeec
Q 009543 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (532)
Q Consensus 380 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Df 459 (532)
.+..+++|||+++||+|+++|.. ....++..+++.++.+.+.||+|||+++ +|||||.++|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k--~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKK--NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999954 2336999999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCccccc-ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 460 GLARSFQEDKSHIST-AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 460 gl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
|+++.-.. ..... ...-+..|+|||.+..+.++.++|||||||++||+++ |..||....
T Consensus 307 GLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 307 GLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred ccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 99876541 11111 1235789999999999999999999999999999999 899998765
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=296.57 Aligned_cols=197 Identities=30% Similarity=0.482 Sum_probs=168.3
Q ss_pred HHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhc--CccceeeeeeeeeecCC---
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISS--VEHKNLVRLLGCSCSGP--- 382 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~--- 382 (532)
.+.+..+..+.+.||+|.||+||+|.|+ |+.||||++...++ ..+.+|.++++. ++|+||+.+++.-..+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3455678899999999999999999995 89999999975543 567888888886 49999999999876544
Q ss_pred -cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 383 -ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-----QSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
++|||++|.+.|||.+|| ....++.+..++++..+|.||++||- ++++.|.|||||+.||||.+++.+.|
T Consensus 282 TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 578999999999999999 34779999999999999999999994 57889999999999999999999999
Q ss_pred eecCCccccCCCCcc---cccccccccccccccccccCC------CCchhhHHHHHHHHHHHHhC
Q 009543 457 ADFGLARSFQEDKSH---ISTAIAGTLGYMAPEYLAHGQ------LTEKADVYSFGMLLLEIVTG 512 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvll~el~tG 512 (532)
+|+||+...+..... ..+..+||.+|||||++.+.- .-..+||||||.++||+.-.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 999999888766543 345678999999999986532 13468999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.88 Aligned_cols=206 Identities=30% Similarity=0.430 Sum_probs=171.8
Q ss_pred cCCccccccccccCceeEEEEEe------cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCC-
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP- 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~- 382 (532)
.++|++.++||+|+||.||++.+ .+++.||+|++.... ......+.+|+.++..+ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999974 235689999986543 23346789999999999 8999999999887644
Q ss_pred cceEEEEecCCCChhHHhhhccC---------------------------------------------------------
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAK--------------------------------------------------------- 405 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 405 (532)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999854211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc-ccccccccccc
Q 009543 406 --AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGY 482 (532)
Q Consensus 406 --~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y 482 (532)
...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788899999999999999999998 999999999999999999999999999865433222 12233467889
Q ss_pred ccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 483 ~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999988899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.54 Aligned_cols=203 Identities=28% Similarity=0.408 Sum_probs=170.5
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--------------hhHHHHHHHHhHhhcCccceeeee
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--------------HRAANFYNEVNIISSVEHKNLVRL 374 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~ 374 (532)
+..++|++.+.||+|.||.|-+++.. +++.||||++..... ...+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999965 789999999854321 123578899999999999999999
Q ss_pred eeeeec--CCcceEEEEecCCCChhHHhhhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC
Q 009543 375 LGCSCS--GPESLLVYEFLPNQSLDRFIFDSAKAKT-LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR 451 (532)
Q Consensus 375 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~ 451 (532)
+.+..+ .+.+|||+||+..|.+...- ..+. +++.+.+++++++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 999765 46789999999999886543 2334 899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCcc----cccccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 452 LRAKIADFGLARSFQEDKSH----ISTAIAGTLGYMAPEYLAHGQ----LTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 452 ~~~kl~Dfgl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
|++||+|||.+..+...... .-...+|||.|+|||....+. .+.+.||||+||+||.|+.|+.||-..
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 99999999998876332211 112368999999999987632 367889999999999999999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.39 Aligned_cols=195 Identities=25% Similarity=0.339 Sum_probs=170.3
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
+.||+|+||.||+++.. +|+.+|+|++.... ......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999987542 233456789999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccc
Q 009543 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474 (532)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~ 474 (532)
+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 9999884 3457899999999999999999999998 99999999999999999999999999875332221 223
Q ss_pred ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 475 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 4568999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.01 Aligned_cols=195 Identities=27% Similarity=0.359 Sum_probs=170.0
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999965 6899999998754 2334456788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccc
Q 009543 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474 (532)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~ 474 (532)
+|..++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 9998884 3456899999999999999999999998 99999999999999999999999999875432221 123
Q ss_pred ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 475 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 3568999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=289.10 Aligned_cols=207 Identities=26% Similarity=0.332 Sum_probs=180.8
Q ss_pred CCccccccccccCceeEEEEEecC-CCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|+.+++||+|.-|+||++++.+ +..+|+|++.... ++...+...|-+||+.++||.++.|+..++.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567888999999999999999874 5889999997553 445567788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
|||+||+|..+++ .+..+.+++..+..++.+++-||+|||-.| ||.|||||+||||.++|++-|+||.|+......
T Consensus 157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999998874 466788999999999999999999999999 999999999999999999999999996432110
Q ss_pred ----------------------------------Cc---------------------ccccccccccccccccccccCCC
Q 009543 469 ----------------------------------KS---------------------HISTAIAGTLGYMAPEYLAHGQL 493 (532)
Q Consensus 469 ----------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~ 493 (532)
.. ..+...+||..|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 01234689999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 009543 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523 (532)
Q Consensus 494 ~~~~Dv~SlGvll~el~tG~~p~~~~~~~~ 523 (532)
+.++|+|+|||++|||+.|+.||.+.+.++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~ 342 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE 342 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh
Confidence 999999999999999999999999976543
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.11 Aligned_cols=203 Identities=25% Similarity=0.335 Sum_probs=175.2
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
..++|++.++||+|+||.||+++.. +++.+|+|++... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468999999999999999999975 6889999998643 22334567889999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998842 35788899999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHG----QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...........||+.|+|||.+... .++.++|||||||++|||++|+.||...+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 4332223445799999999998643 47889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=296.85 Aligned_cols=202 Identities=23% Similarity=0.365 Sum_probs=175.4
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|++.+.||+|+||.||+++++ +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999986 68899999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|++++.+..+.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2356899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
........|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 333334568999999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=289.80 Aligned_cols=210 Identities=28% Similarity=0.460 Sum_probs=180.6
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEee--ccChhhHHHHHHHHhHhhcCccceeeeeeeeeec-----C
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-----G 381 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 381 (532)
.+...|...+.||+|+||.|.++... +|+.||||++. ..+....++..+|+++|+.++|+||+.+.+++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34566777899999999999999975 78999999997 4566667889999999999999999999998865 3
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
...|+|+|+| +.+|.+++. .+..++......++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 4679999999 668999883 3455999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccccc
Q 009543 462 ARSFQEDKSH-ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDS 526 (532)
Q Consensus 462 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~~~ 526 (532)
++........ ..+..+-|.+|.|||++.. ..|+...||||+|||+.||++|++-|-+.+.-.+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 9988654211 2356788999999998754 679999999999999999999999998876544433
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=303.02 Aligned_cols=203 Identities=24% Similarity=0.338 Sum_probs=175.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++.. +++.||+|++... .....+.+.+|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999975 6899999998642 2233456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999843 2456899999999999999999999998 999999999999999999999999998766544
Q ss_pred Cccccccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.........||+.|+|||++.. +.++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 3333334568999999999863 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=299.78 Aligned_cols=193 Identities=26% Similarity=0.345 Sum_probs=169.3
Q ss_pred ccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 5889999998643 233456788999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccc
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 476 (532)
.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 999843 456899999999999999999999998 99999999999999999999999999875432222 22345
Q ss_pred ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 477 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 78999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.91 Aligned_cols=195 Identities=25% Similarity=0.355 Sum_probs=170.3
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 6899999998754 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccc
Q 009543 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474 (532)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~ 474 (532)
+|..++. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 9998884 3456899999999999999999999998 99999999999999999999999999875432221 123
Q ss_pred ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 475 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 4568999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=303.79 Aligned_cols=203 Identities=25% Similarity=0.330 Sum_probs=175.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++.. +++.||+|++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999975 6788999998643 2233455788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999953 2356899999999999999999999998 999999999999999999999999999876544
Q ss_pred Cccccccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.........|++.|+|||++.. +.++.++||||||+++|||++|+.||...+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 3333334569999999999865 467889999999999999999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.74 Aligned_cols=203 Identities=27% Similarity=0.424 Sum_probs=176.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 68999999986432 233457888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++. +...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999998754321
Q ss_pred Cc----------------------------------ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 009543 469 KS----------------------------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514 (532)
Q Consensus 469 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~ 514 (532)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 01123479999999999998899999999999999999999999
Q ss_pred CCCCCCC
Q 009543 515 NNRSKNS 521 (532)
Q Consensus 515 p~~~~~~ 521 (532)
||...+.
T Consensus 235 Pf~~~~~ 241 (360)
T cd05627 235 PFCSETP 241 (360)
T ss_pred CCCCCCH
Confidence 9977543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=298.17 Aligned_cols=202 Identities=26% Similarity=0.447 Sum_probs=181.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..|...++||+|.||.||||.+. +++.||+|++.... +...+++.+|+.++.+++++||.+.++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777899999999999999965 68899999997653 45568899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+.||++.+.| .....+++..+.-|++++..|+.|||.++ .+|||||+.|||+..+|.+||+|||.+........
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 33445588888899999999999999998 99999999999999999999999999987765554
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.. .+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 44 668999999999999988999999999999999999999999988765
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=302.72 Aligned_cols=200 Identities=25% Similarity=0.373 Sum_probs=172.8
Q ss_pred CccccccccccCceeEEEEEe----cCCCEEEEEEeeccC----hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcc
Q 009543 314 SFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFNN----RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 384 (532)
+|++.++||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++..+ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999885 358899999986432 23345678899999999 599999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++|+|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999843 456899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.............||+.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 544333333446799999999998764 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.63 Aligned_cols=201 Identities=28% Similarity=0.452 Sum_probs=176.7
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999976 68889999887553 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999843 356899999999999999999999853 39999999999999999999999999987654322
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.40 Aligned_cols=202 Identities=28% Similarity=0.403 Sum_probs=178.4
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.++||+|+||+||+++.. +++.||||++.... ......+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999975 68999999987542 234467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999853 367899999999999999999999988 999999999999999999999999999866543
Q ss_pred C----------------------------cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 K----------------------------SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3 112234568999999999999899999999999999999999999997754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=301.50 Aligned_cols=203 Identities=24% Similarity=0.337 Sum_probs=174.4
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.++||+|+||+||+++++ +++.+|+|++... .......+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999976 5788999998542 2223345788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999953 2356899999999999999999999998 999999999999999999999999998765443
Q ss_pred Ccccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 333333457999999999986 3467889999999999999999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=291.21 Aligned_cols=198 Identities=30% Similarity=0.486 Sum_probs=167.2
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc-----ceEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE-----SLLV 387 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~lv 387 (532)
.|...+.+|.|.||.||+|++. ++++||||+...+.+-. -+|+++|+.++|||||+++.+|..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5777899999999999999975 57999999987654422 368999999999999999998865332 3489
Q ss_pred EEecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecCCcccc
Q 009543 388 YEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSF 465 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfgl~~~~ 465 (532)
|||||. +|.+++... ..+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 788888543 22467888888999999999999999988 9999999999999987 89999999999988
Q ss_pred CCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
...... .....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+++.
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~ 231 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS 231 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence 766554 34556899999999876 5799999999999999999999999988543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=299.28 Aligned_cols=200 Identities=26% Similarity=0.353 Sum_probs=172.0
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 388 (532)
+|++.+.||+|+||.||+++.. +++.+|+|++.... ....+.+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999976 57899999987542 22334567788888777 5899999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++. ....+++.++..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999998884 3356899999999999999999999998 999999999999999999999999998754322
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ......||+.|+|||++....++.++|||||||++|||++|+.||...+
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 21 2234578999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.85 Aligned_cols=200 Identities=25% Similarity=0.351 Sum_probs=171.6
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccc-eeeeeeeeeecCCcceEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHK-NLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 388 (532)
+|++.+.||+|+||.||+++.. +++.||+|++... .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999975 5789999998653 223446688899999999765 5888999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999884 3456899999999999999999999998 999999999999999999999999998753222
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 21 2234568999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=299.38 Aligned_cols=198 Identities=29% Similarity=0.418 Sum_probs=169.6
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHh---hcCccceeeeeeeeeecCCcceEE
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNII---SSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
|++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++ +.++||||+++++++.+....++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999965 68999999987442 22345566666554 567899999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|...+. ...+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 356899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 154 FGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 222 2234578999999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=299.05 Aligned_cols=196 Identities=29% Similarity=0.438 Sum_probs=169.2
Q ss_pred cccccccCceeEEEEEe----cCCCEEEEEEeeccC----hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 318 ANKLGQGGFGTVYKGVL----PDGREIAVKRLFFNN----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
+++||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36799999999999985 357899999986432 2233567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++. +...+.+..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 81 YLSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999884 3456788899999999999999999998 9999999999999999999999999987543222
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 2 2234578999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.38 Aligned_cols=201 Identities=26% Similarity=0.448 Sum_probs=171.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.++||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56999999999999999999975 68999999986543 22345678999999999999999999999999899999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 88888743 2345789999999999999999999998 99999999999999999999999999876543222
Q ss_pred cccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...+
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 159 T-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred c-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 233467899999998865 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=293.78 Aligned_cols=206 Identities=28% Similarity=0.449 Sum_probs=172.8
Q ss_pred cCCccccccccccCceeEEEEEecC-----------------CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeee
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD-----------------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVR 373 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 373 (532)
.++|++.++||+|+||.||++.+++ +..||+|.+.... .....++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578999999999999999998532 3369999887543 334567999999999999999999
Q ss_pred eeeeeecCCcceEEEEecCCCChhHHhhhcc----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 009543 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSA----------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437 (532)
Q Consensus 374 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ii 437 (532)
+++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999985321 1135788899999999999999999998 99
Q ss_pred EccCCCCCEEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCC
Q 009543 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT--GRQ 514 (532)
Q Consensus 438 H~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t--G~~ 514 (532)
||||||+|||++.++.+||+|||+++........ ......++..|+|||.+..+.++.++||||||+++|||++ |..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865443322 2233456789999999988889999999999999999987 567
Q ss_pred CCCCCC
Q 009543 515 NNRSKN 520 (532)
Q Consensus 515 p~~~~~ 520 (532)
||...+
T Consensus 241 p~~~~~ 246 (304)
T cd05096 241 PYGELT 246 (304)
T ss_pred CCCcCC
Confidence 776543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.61 Aligned_cols=195 Identities=28% Similarity=0.398 Sum_probs=166.5
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhc-CccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISS-VEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||+++.. +++.||+|++.... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57899999986532 2333455667777765 4899999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
|+|..++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999988843 356899999999999999999999998 9999999999999999999999999987643322 223
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 34578999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.92 Aligned_cols=204 Identities=22% Similarity=0.351 Sum_probs=178.6
Q ss_pred CccccccccccCceeEEEEEec-C-CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-D-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.|.+.+.||+|+||.||++... + ++.|++|++..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4899999999999999999854 3 6788999876666565667888999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 392 PNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 392 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
++|+|.+++... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988543 23456899999999999999999999998 99999999999999999999999999987654322
Q ss_pred c-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 H-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 2344579999999999998899999999999999999999999997643
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=303.30 Aligned_cols=203 Identities=26% Similarity=0.327 Sum_probs=176.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++.. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999975 68999999987542 234456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998542 357899999999999999999999998 999999999999999999999999999876554
Q ss_pred Ccccccccccccccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLA------HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||...+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 433334457899999999986 4567889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=299.79 Aligned_cols=206 Identities=27% Similarity=0.431 Sum_probs=182.0
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhh-HHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR-AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
+...+.++||+|.||+|.++....+.+||+|+++...... ..+|.+|+++|.+++||||++++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4567789999999999999999888999999998775444 488999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++|+|.+|+..... ..+......+|+.||+.||+||.+.+ ++||||.++|+|++.++++||+|||+++.+...+++
T Consensus 618 EnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999965432 22566777889999999999999987 999999999999999999999999999966555444
Q ss_pred -cccccccccccccccccccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCCc
Q 009543 472 -ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV--TGRQNNRSKNSE 522 (532)
Q Consensus 472 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~--tG~~p~~~~~~~ 522 (532)
.....+-+.+|||||.+.-++++.++|||+||+++||++ +..+||+....+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 555667889999999999999999999999999999965 599999887554
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=300.95 Aligned_cols=196 Identities=25% Similarity=0.350 Sum_probs=169.5
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
+.||+|+||.||+++.. +++.||+|++... .......+.+|++++..++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 6899999998653 2234456788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
+|..++. ....+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 9998884 34568999999999999999999997 56 99999999999999999999999999875432222 12
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 335689999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=306.08 Aligned_cols=202 Identities=29% Similarity=0.466 Sum_probs=178.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCC------cc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ES 384 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 384 (532)
..|...+.||+|+||.||+|+++ +|+.||||.+.... ....+.+.+|++++++++|||||+++++-.+.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 45677889999999999999964 79999999987643 344577899999999999999999999866543 46
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC--CC--cEEEeecC
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS--RL--RAKIADFG 460 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~--~~--~~kl~Dfg 460 (532)
.++||||.+|+|...|.+..+...+++.+.+.++..+..||.|||+++ |+||||||.||++-. +| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 799999999999999998888899999999999999999999999988 999999999999943 23 57999999
Q ss_pred CccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.|+..+.+. ..+..+||+.|.+||.+.+ +.|+..+|.|||||++||..||..||...
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 999887655 4567899999999999985 88999999999999999999999999764
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.67 Aligned_cols=195 Identities=26% Similarity=0.382 Sum_probs=168.6
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57899999986532 23345677888888866 799999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 99998884 3456899999999999999999999998 99999999999999999999999999875432222 22
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 34568999999999998899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=287.19 Aligned_cols=203 Identities=24% Similarity=0.425 Sum_probs=172.9
Q ss_pred CCccccccccccCceeEEEEEec----CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
++|++.+.||+|+||.||+|.++ .+..||+|++.... ......+.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56889999999999999999863 35689999987653 33446789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999853 2357899999999999999999999998 99999999999999999999999998765432
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
..........++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 22221222335678999999988899999999999999999775 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=292.55 Aligned_cols=201 Identities=26% Similarity=0.450 Sum_probs=171.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||.||+++.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 689999999865432 233567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|++ ++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577777643 3456899999999999999999999998 9999999999999999999999999987543222
Q ss_pred ccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12233567899999998865 45788999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.08 Aligned_cols=194 Identities=23% Similarity=0.313 Sum_probs=168.7
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.++||+|+||.||++... +++.||+|+.. ...+.+|++++++++||||+++++++......++++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999974 68899999653 23567899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+. ++|..++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 85 678887733 356899999999999999999999998 99999999999999999999999999875433222
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||-.
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 223345799999999999988999999999999999999999988754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=295.34 Aligned_cols=201 Identities=27% Similarity=0.457 Sum_probs=175.5
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||.||++.+. ++..+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999976 67889999886542 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++.. ...+++.....++.|++.||.|||+.. +|+|+||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999843 456889999999999999999999753 39999999999999999999999999987653321
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 233468999999999988889999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=295.20 Aligned_cols=195 Identities=29% Similarity=0.415 Sum_probs=168.3
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||+++.+ +++.||+|++.... ....+.+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999986432 23345677888888876 699999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|.+++. +...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 99998884 3456899999999999999999999998 99999999999999999999999999875432221 22
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 34568999999999998889999999999999999999999997754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.11 Aligned_cols=200 Identities=26% Similarity=0.365 Sum_probs=171.5
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 388 (532)
+|+..+.||+|+||+||+++.. +|+.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999965 68899999987532 233456778888888885 577888999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++. ....+++.+++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999884 3356899999999999999999999998 999999999999999999999999998754322
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 21 2234568999999999998889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=296.54 Aligned_cols=200 Identities=26% Similarity=0.441 Sum_probs=168.6
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-----cce
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-----ESL 385 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 385 (532)
+|++.++||+|+||.||+++.. +++.||||++... .......+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999965 6899999998643 2233456889999999999999999999875432 478
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||++ ++|.+++. ....+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888873 3456899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCcc--ccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSH--ISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... ......|++.|+|||++.. ..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 332211 2234578999999999865 678999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=286.87 Aligned_cols=196 Identities=28% Similarity=0.430 Sum_probs=169.9
Q ss_pred ccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
||+|+||+||++... +++.+|+|++.... ....+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999975 68999999986542 22335678899999999999999999999999999999999999999
Q ss_pred hHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccccc
Q 009543 397 DRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475 (532)
Q Consensus 397 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 475 (532)
..++.... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 98875422 3457899999999999999999999998 999999999999999999999999998766443322 233
Q ss_pred cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 476 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=297.03 Aligned_cols=204 Identities=25% Similarity=0.434 Sum_probs=183.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc-ceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE-SLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 388 (532)
++|..++.+|+|+||.++..+.+ ++..+++|++.... ....+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57899999999999999999875 67899999997653 2333478899999999999999999999999998 89999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
+|++||+|.+.+.+. +...++++++..++.|++.|+.|||+.. |+|||||+.||+++.+..+||+|||+++...+.
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999999653 4678999999999999999999999876 999999999999999999999999999998776
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
... ....+||+.||.||.+.+.+|+.|+|||||||.+|||++=+++|+..+.
T Consensus 160 ~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 160 DSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred hhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 533 3457899999999999999999999999999999999999999987654
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=287.98 Aligned_cols=201 Identities=29% Similarity=0.420 Sum_probs=174.8
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
+|++.+.||+|+||+||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999974 68999999986542 2223457889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888542 3356899999999999999999999998 9999999999999999999999999987654332
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....|++.|+|||.+.+..++.++||||+|+++|||++|+.||....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 2 223468999999999988889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=288.58 Aligned_cols=192 Identities=18% Similarity=0.340 Sum_probs=166.2
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhh---HHHHHHHHhHhhcCccceeeeeeeeeec----CCcceEEEEe
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR---AANFYNEVNIISSVEHKNLVRLLGCSCS----GPESLLVYEF 390 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~ 390 (532)
...||+|++|.||+|++ +|+.||||++....... .+.+.+|+.++.+++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 35799999999999998 68999999987543222 4678899999999999999999999876 3467899999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
+++|+|.+++.. ...+++...++++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999943 45789999999999999999999985 5 7899999999999999999999999988654322
Q ss_pred ccccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 23457899999999976 678999999999999999999999998754
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=283.99 Aligned_cols=204 Identities=31% Similarity=0.525 Sum_probs=177.7
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.++|++.++||+|+||.||+|...+++.|++|.+.... ...+.+.+|+.+++.++||||+++++.+......+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35789999999999999999998888899999886543 33578899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++... ....+++.+++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998542 3456899999999999999999999987 999999999999999999999999999876543322
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
......++..|+|||.+..+.++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 209 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence 2233346778999999988889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=294.77 Aligned_cols=193 Identities=25% Similarity=0.358 Sum_probs=167.8
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||++++. +++.||+|++.... ......+.+|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999975 68899999997532 23345678899999888 799999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|.+++. +...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence 99988874 3457999999999999999999999998 99999999999999999999999999875322111 22
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 345789999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.53 Aligned_cols=193 Identities=25% Similarity=0.365 Sum_probs=167.2
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||+++.. +++.+|+|++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 6789999998754 233445677899888776 899999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 99988874 3457899999999999999999999998 99999999999999999999999999875332221 22
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 345789999999999988999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=295.96 Aligned_cols=195 Identities=27% Similarity=0.381 Sum_probs=166.3
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHh-HhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVN-IISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||+||+++.. +|+.+|+|++.... ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 68999999986432 223345555554 56778999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|..++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 99988884 3457899999999999999999999998 99999999999999999999999999875432221 22
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 34578999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.37 Aligned_cols=210 Identities=25% Similarity=0.337 Sum_probs=178.3
Q ss_pred HHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC--
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-- 382 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 382 (532)
.....++|++.+.||+|+||+||+++.. +|+.||||++... .......+.+|+.++..++|+||++++..+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445679999999999999999999864 7999999998654 3344567889999999999999999988765432
Q ss_pred ------cceEEEEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEE
Q 009543 383 ------ESLLVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAK 455 (532)
Q Consensus 383 ------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~k 455 (532)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 2579999999999999986432 3457899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 456 IADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 456 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999876433222 2344679999999999999899999999999999999999999997644
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=294.27 Aligned_cols=194 Identities=24% Similarity=0.339 Sum_probs=168.1
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||+||+++.. +++.+|+|++.... ....+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 67899999997542 23345688899999888 699999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 99998884 3456999999999999999999999998 99999999999999999999999999875322211 22
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 3457899999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=291.61 Aligned_cols=195 Identities=28% Similarity=0.403 Sum_probs=166.8
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhc-CccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISS-VEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||++++. +++.||+|++.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999987542 2334556677788776 4899999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
|+|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999998843 356899999999999999999999998 99999999999999999999999999875322221 12
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 34568999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=294.35 Aligned_cols=195 Identities=27% Similarity=0.391 Sum_probs=166.0
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHh-HhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVN-IISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||+||+++.. +|+.||+|++.... ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68999999986532 222344555554 56789999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|..++. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 99999884 3457899999999999999999999998 9999999999999999999999999987543222 122
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 34568999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=293.27 Aligned_cols=195 Identities=30% Similarity=0.384 Sum_probs=167.0
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhc-CccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISS-VEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||++++. +|+.||+|++.... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 68899999987542 2234556778888775 4899999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|..++.. ...+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ce
Confidence 999988843 456899999999999999999999998 99999999999999999999999999874322211 22
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 34578999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.91 Aligned_cols=206 Identities=30% Similarity=0.447 Sum_probs=173.2
Q ss_pred cCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 383 (532)
.++|++.+.||+|+||.||++++. ++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457999999999999999998842 34579999997543 33456788999999999 89999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhcc-----------------------------------------------------------
Q 009543 384 SLLVYEFLPNQSLDRFIFDSA----------------------------------------------------------- 404 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 404 (532)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999985321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc-cccc
Q 009543 405 --------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTA 475 (532)
Q Consensus 405 --------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~ 475 (532)
....+++.++++++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1134788999999999999999999998 999999999999999999999999998765433222 1122
Q ss_pred cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 476 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
..++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 335678999999988899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.15 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=175.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.++||+|+||.||+|.+. +|+.||+|++.... ....+++.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999975 68999999986432 233467899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 389 EFLPNQSLDRFIFDSA--------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999985321 1234567788999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCc-----------------ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 461 LARSFQEDKS-----------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 461 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9986622110 0112346999999999999889999999999999999999999999764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=281.39 Aligned_cols=202 Identities=27% Similarity=0.445 Sum_probs=175.0
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.+.||+|+||.||++.++++..+|+|.+... ......+.+|+.+++.++||||+++++++.+....+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458889999999999999999988889999987543 2334678899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988532 246899999999999999999999998 9999999999999999999999999988654333322
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 223345678999999988889999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=293.44 Aligned_cols=195 Identities=26% Similarity=0.378 Sum_probs=165.3
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHh-HhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVN-IISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999986432 222334555554 67889999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|...+. +...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99988874 3456889999999999999999999998 9999999999999999999999999987532222 122
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 34568999999999988889999999999999999999999997754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=293.18 Aligned_cols=204 Identities=28% Similarity=0.419 Sum_probs=182.3
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChh---hHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcc
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH---RAANFYNEVNIISSVE-HKNLVRLLGCSCSGPES 384 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 384 (532)
.....|++.+.||+|.||.||+++.+ +|+.+|+|.+...... ..+.+.+|+.+|+++. ||||+.+.+.+.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 44568999999999999999999976 5999999999765432 3468999999999998 99999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC----CcEEEeecC
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR----LRAKIADFG 460 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~----~~~kl~Dfg 460 (532)
++|||++.||.|.+.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999654 3999999999999999999999998 9999999999999543 479999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
++..... .......+||+.|+|||++....++..+||||+||++|.|++|..||...++.
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh
Confidence 9998876 33445679999999999999999999999999999999999999999887643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=297.34 Aligned_cols=205 Identities=29% Similarity=0.433 Sum_probs=173.0
Q ss_pred cCCccccccccccCceeEEEEEe------cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 383 (532)
.++|++.+.||+|+||.||++++ .++..||||++.... ....+.+.+|+.++..+ +||||+++++++.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999974 246689999986443 33446788999999999 89999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhcc-----------------------------------------------------------
Q 009543 384 SLLVYEFLPNQSLDRFIFDSA----------------------------------------------------------- 404 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 404 (532)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999985421
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 405 -------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 405 -------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1125788999999999999999999998 999999999999999999999999999866443322
Q ss_pred -cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 472 -ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 472 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 1122335678999999998899999999999999999998 89999764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.34 Aligned_cols=201 Identities=28% Similarity=0.471 Sum_probs=166.9
Q ss_pred CCccccccccccCceeEEEEEec--CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcC---ccceeeeeeeeeec-----
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP--DGREIAVKRLFFNN--RHRAANFYNEVNIISSV---EHKNLVRLLGCSCS----- 380 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----- 380 (532)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46899999999999999999863 46889999886543 22234566777776655 69999999998752
Q ss_pred CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 381 GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
....++||||++ ++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 5888888532 2346899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++...... .......|++.|+|||.+....++.++||||||+++|||++|+.||...+
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99765433 22234568999999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=292.91 Aligned_cols=195 Identities=26% Similarity=0.361 Sum_probs=164.5
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHH-hHhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEV-NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||+++.. +++.+|+|++.... ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57889999986432 12223444444 456788999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|.+++.. ...+.+.....++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999998843 456788899999999999999999998 99999999999999999999999999875432221 22
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 34578999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.00 Aligned_cols=200 Identities=29% Similarity=0.457 Sum_probs=170.9
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-----cce
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-----ESL 385 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 385 (532)
+|++.++||+|+||.||++... +++.||||++... .....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999964 7899999998643 2334567889999999999999999999988766 789
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+|+||+. ++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 57777763 3457899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
............+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 44333333345678999999998764 57899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.23 Aligned_cols=195 Identities=31% Similarity=0.390 Sum_probs=169.8
Q ss_pred ccccccCceeEEEEEe----cCCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 319 NKLGQGGFGTVYKGVL----PDGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
+.||+|+||.||+++. .+|+.+|+|++..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 3688999999875422 233467789999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++. +...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 999999884 3456899999999999999999999998 99999999999999999999999999876543322 2
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 234578999999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.19 Aligned_cols=196 Identities=30% Similarity=0.464 Sum_probs=166.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|+..++||+|+||.||++++. +++.||||++.... ......+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999975 68999999986543 33446789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|... ...++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999998643 23567788899999999999999998 99999999999999999999999999987643321
Q ss_pred cccccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......|+..|+|||.+.. ...+.++|||||||++|||++|+.||...
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1234578999999998743 23456899999999999999999999743
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=269.25 Aligned_cols=199 Identities=27% Similarity=0.470 Sum_probs=174.7
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--------hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--------RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 381 (532)
-++|+..+.||+|..+.|-+..++ +|++.|+|++.... ....+.-.+|+.+|+++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456888899999999999998865 78999999985432 12234567899999998 699999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
...++|+|.|+.|.|.++|. ..-.+++.+..+|++|+.+|++|||.++ |+||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999993 4567999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLA------HGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
+..++..... ...+|||+|.|||.+. ...|+..+|+|+.|||+|.|+.|-+||..
T Consensus 170 a~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 170 ACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred eeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 9988765543 4579999999999874 35689999999999999999999999854
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=279.97 Aligned_cols=202 Identities=27% Similarity=0.452 Sum_probs=174.7
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.+.||+|+||.||++.+.++..+|+|.+.... ...+++.+|+.++.+++||||+++++++.+....+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578899999999999999998777789999886433 334678999999999999999999999998888999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998532 336899999999999999999999998 9999999999999999999999999987654433222
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.....++..|++||.+....++.++||||||+++|||++ |+.||...+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 222345678999999988889999999999999999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.81 Aligned_cols=195 Identities=28% Similarity=0.395 Sum_probs=168.2
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||+||++++. +++.||+|++.... ......+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57899999987542 23345677888998887 799999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|..++. +...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 99998884 3356899999999999999999999998 99999999999999999999999999875322221 12
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 33468999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.31 Aligned_cols=202 Identities=27% Similarity=0.489 Sum_probs=171.5
Q ss_pred CCccccccccccCceeEEEEEec-CCC----EEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.+|++.+.||+|+||.||+|++. +++ .||+|++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46999999999999999999864 333 38999986543 34457789999999999999999999988764 5789
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
++||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999854 2346889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccc-ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 467 EDKSHI-STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
...... .....++..|++||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 443321 122334678999999998899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=280.14 Aligned_cols=204 Identities=30% Similarity=0.470 Sum_probs=176.4
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.++|++.+.||+|++|.||++.+.+++.||+|.+.... ...+++.+|+.++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45789999999999999999998888899999986543 33567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999998542 2456899999999999999999999998 999999999999999999999999999876533222
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.......+..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1222233568999999988889999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=280.15 Aligned_cols=193 Identities=29% Similarity=0.424 Sum_probs=167.1
Q ss_pred ccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
||+|+||.||+++.. +|+.+|+|++.... ......+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999975 68999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccc
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 476 (532)
.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9887542 3345899999999999999999999998 99999999999999999999999999876654322 2335
Q ss_pred ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 477 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.|++.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 6899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=285.46 Aligned_cols=208 Identities=27% Similarity=0.422 Sum_probs=182.5
Q ss_pred HhcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++.+-|...+.||+|.|..|-++++ -+|++||||++.... ......+.+|++.|+.++|||||+++.+..++..+||
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 3557799999999999999999985 389999999997664 3334678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc-CCCcEEEeecCCcccc
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSF 465 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~-~~~~~kl~Dfgl~~~~ 465 (532)
|.|+-++|+|.+|+.. ....+.+....+++.||+.|+.|+|+.. ++||||||+||.+- .-|-+||+|||++..+
T Consensus 95 iLELGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999999964 3457899999999999999999999987 99999999998775 5689999999999888
Q ss_pred CCCCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~ 524 (532)
.+.... +..+|+..|-|||++.+..| .+++||||||||||.|++|+.||...+..+.
T Consensus 170 ~PG~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 170 QPGKKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred CCcchh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 765543 45789999999999988776 4688999999999999999999998765544
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=282.92 Aligned_cols=206 Identities=29% Similarity=0.528 Sum_probs=175.0
Q ss_pred CCccccccccccCceeEEEEEecC------CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
++|++.+.||+|+||.||+|.... ...|++|.+.... ......+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998643 2579999886543 334567899999999999999999999999988999
Q ss_pred EEEEecCCCChhHHhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC
Q 009543 386 LVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~ 452 (532)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 146889999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCccccCCCCc-ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 453 RAKIADFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
.+||+|||++........ .......+++.|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999876543322 12233456889999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=282.56 Aligned_cols=205 Identities=28% Similarity=0.502 Sum_probs=176.0
Q ss_pred CCccccccccccCceeEEEEEecC------CCEEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD------GREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
++|.+.+.||+|+||.||+|.+.+ ++.||+|++...... ..+.+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568889999999999999998643 478999998765443 4578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 386 LVYEFLPNQSLDRFIFDSA-----------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
++|||+++++|.+++.... ....+++.++..++.|++.|+.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986421 2345889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 455 KIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
||+|||++......... ......+++.|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999998765433221 2233446788999999999999999999999999999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=293.69 Aligned_cols=207 Identities=27% Similarity=0.390 Sum_probs=174.2
Q ss_pred HhcCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCc-cceeeeeeeeeecC
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSG 381 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 381 (532)
...++|++.++||+|+||.||+|++. .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34578999999999999999999853 23479999996543 333467999999999996 99999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccC--------------------------------------------------------
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAK-------------------------------------------------------- 405 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 405 (532)
...++||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999998854210
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 406 -------------------------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 406 -------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
...+++.+++.++.|+++||.|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 134788899999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 449 DSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999865433222 2223456788999999988889999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=280.45 Aligned_cols=205 Identities=33% Similarity=0.534 Sum_probs=180.4
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
...+|++.++||+|+||.||+|.+.+++.+++|.+..........+.+|+.+++.++||||+++++++.+....+++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578999999999999999999988999999999776665667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++.+++.++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999543 3456899999999999999999999998 99999999999999999999999999976643322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
. .....++..|++||.+..+.++.++||||||+++|||++ |+.||...+
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 2 223345778999999988889999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=276.51 Aligned_cols=201 Identities=30% Similarity=0.472 Sum_probs=174.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-----hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++|++.+.||+|++|.||++... +++++++|.+.... ......+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999964 68999999886432 1234578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 356889999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCcccc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 467 EDKSHIS--TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 467 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 3322211 3345788999999999888999999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=279.82 Aligned_cols=201 Identities=36% Similarity=0.613 Sum_probs=169.4
Q ss_pred cccccccccCceeEEEEEec-----CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 316 DEANKLGQGGFGTVYKGVLP-----DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 316 ~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++.+.||.|.||.||+|.+. .+..|+||.+.... ....+.+.+|++.+++++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999986 35689999996543 3446889999999999999999999999998888999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|.++|... ....+++.+++.|+.|+++||.|||+++ ++|+||+++|||+++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999653 3467899999999999999999999998 9999999999999999999999999998763322
Q ss_pred c-ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 470 S-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 470 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
. ........+..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2 22333457789999999998889999999999999999999 789987653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=277.17 Aligned_cols=201 Identities=26% Similarity=0.431 Sum_probs=172.6
Q ss_pred CccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+|++.+.||+|+||.||++.++++..+|+|++.... .....+.+|+++++.++||||+++++++.+....++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 578889999999999999998877889999885432 2345788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|.+++... ...+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999998542 346899999999999999999999998 99999999999999999999999999876543322222
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
....++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 22234568999999988889999999999999999999 899997643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=280.59 Aligned_cols=199 Identities=29% Similarity=0.413 Sum_probs=173.3
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
|+..+.||+|+||+||++... +++.+|+|++.... ......+.+|+.+++.++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999975 68899999886542 22235577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988542 3346899999999999999999999988 99999999999999999999999999876543322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 12346899999999999889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=281.37 Aligned_cols=208 Identities=27% Similarity=0.474 Sum_probs=174.4
Q ss_pred hcCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
..++|++.++||+|+||.||+|.+. ++..||+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999853 35679999885432 3344678899999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAK-------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
.++||||+++++|.+++..... ...+++..++.++.|+++||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234678899999999999999999987 999999999999999999999
Q ss_pred eecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 457 ADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
+|||+++........ ......+++.|+|||.+..+.++.++||||||+++|||++ |..||.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999998765433322 1122345788999999998889999999999999999999 7899876543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=280.77 Aligned_cols=200 Identities=30% Similarity=0.426 Sum_probs=173.8
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
|+..+.||+|+||+||++.+. +++.+|+|.+.... ......+.+|+++++.++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677889999999999999975 68999999986542 22334578899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888542 2346999999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 233468999999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=281.28 Aligned_cols=205 Identities=27% Similarity=0.488 Sum_probs=173.7
Q ss_pred CCccccccccccCceeEEEEEe-----cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
+.|++.++||+|+||.||+|.+ .+++.+++|.+.... ......+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999984 246789999986433 3444678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC
Q 009543 387 VYEFLPNQSLDRFIFDSAK--------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~ 452 (532)
+|||+++++|.+++..... ...+++.+.+.++.|++.||.|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 235789999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCccccCCCCc-ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 453 RAKIADFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999986543322 12233345778999999988889999999999999999998 999996643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.06 Aligned_cols=207 Identities=26% Similarity=0.381 Sum_probs=176.5
Q ss_pred hcCCccccccccccCceeEEEEEecCC-CEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeee-ec------C
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDG-REIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCS-CS------G 381 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-~~------~ 381 (532)
...++++.+.|.+|||+.||.+.+..+ .++|+|++...++...+...+||++|++|+ |||||.+++.. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 445788899999999999999998765 999999999889999999999999999997 99999999932 21 1
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
-+.+|.||||++|.|-+++..+.... |++.++++|+.++++|+++||... +||||||||.+||||+.+++.||+|||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 25679999999999999997655444 999999999999999999999985 7899999999999999999999999999
Q ss_pred ccccCCCCccc--------cccccccccccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 462 ARSFQEDKSHI--------STAIAGTLGYMAPEYL---AHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 462 ~~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+.......... .-...-|+-|.+||.+ .+...+.|+|||+|||+||-|+....||+..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 86543322110 0112348999999986 4667899999999999999999999999875
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=277.92 Aligned_cols=201 Identities=26% Similarity=0.385 Sum_probs=174.2
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.++||+|+||.||+|+. .+++.+|+|++..........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999996 46889999999766555556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ...+++.++..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998843 356899999999999999999999988 99999999999999999999999999986643221
Q ss_pred ccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 122346788999999874 345788999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=277.00 Aligned_cols=203 Identities=30% Similarity=0.478 Sum_probs=173.5
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.++|++.++||+|+||.||+|++.++..||+|++.... ...+.+.+|+++++.++||||+++++.+. ....+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35799999999999999999998777789999986433 23467899999999999999999999774 45679999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++... ....+++..++.++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999542 2346899999999999999999999988 999999999999999999999999999866544332
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
......++..|++||...++.++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 2233456778999999988889999999999999999999 888987654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=261.39 Aligned_cols=209 Identities=25% Similarity=0.316 Sum_probs=178.7
Q ss_pred HhcCCccccccccccCceeEEEEE-ecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc-----
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE----- 383 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 383 (532)
...++|.+.++||+|||.-||+++ ..+++.+|+|++...+.+..+..++|++..++++||||++++++...+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999999 56899999999988887888899999999999999999999998765443
Q ss_pred ceEEEEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
.|++++|...|+|.+.+.... ++..+++.+++.|+.++++||++||+.. +++.||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999986543 4558999999999999999999999986 58999999999999999999999999987
Q ss_pred cccCCCCcc--------cccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 463 RSFQEDKSH--------ISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 463 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....-.-.. .......|..|.|||.+. +...+.++|||||||++|+|+.|..||+..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 654221110 112234689999999985 345689999999999999999999999753
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=276.75 Aligned_cols=203 Identities=29% Similarity=0.464 Sum_probs=174.9
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
..|++.++||+|+||.||++.+. +++.|++|++... .....++.+|+++++.++||||+++++++..+...+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999975 5888999988643 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998542 3456899999999999999999999988 999999999999999999999999999876543322
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 2222334678999999988889999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=290.14 Aligned_cols=199 Identities=30% Similarity=0.425 Sum_probs=169.2
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-----
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----- 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 382 (532)
..++|++.+.||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999975 6899999998643 2344567889999999999999999999886543
Q ss_pred -cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 383 -ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
..++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999976 4555542 24788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 87543322 2234568999999999998899999999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=280.23 Aligned_cols=205 Identities=27% Similarity=0.479 Sum_probs=175.6
Q ss_pred CCccccccccccCceeEEEEEec------CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.+|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++.+++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999842 345689998876666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 387 VYEFLPNQSLDRFIFDSA----------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
+|||+++++|.+++.... ....+++.+++.++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999985322 2235899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 457 ADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999998865433221 1223345778999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=282.51 Aligned_cols=203 Identities=30% Similarity=0.415 Sum_probs=181.3
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.+.|..-+.||+||||.|+-+..+ +|+.+|.|++... .++...-.++|-.+|.+++.+.||.+-..+++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456888899999999999999865 7999999988543 334445678999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
+..|.||+|.-+|+... +..+++.+.+.++.+|+-||++||+.. |+.|||||+|||||+.|+++|+|.|++..+..
T Consensus 264 LtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999886543 368999999999999999999999998 99999999999999999999999999998876
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... ...+||.+|||||+++++.|+...|+|||||+||||+.|+.||+...
T Consensus 340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 6544 33489999999999999999999999999999999999999997653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=267.44 Aligned_cols=201 Identities=27% Similarity=0.435 Sum_probs=175.4
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.+++|++.+.||+|.|+.|++... ++|+.+|+|++... .....+++.+|++|.+.++||||+++.....+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356899999999999999999885 57999999987543 334567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC---CcEEEeecCCccc
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARS 464 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~---~~~kl~Dfgl~~~ 464 (532)
+|+|+|++|..-+..+ ..+++...-..++||+++|.|+|.++ |+|||+||+|+|+-+. --+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997666432 45778888999999999999999998 9999999999999543 3699999999998
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
... ...-...+|||+|||||++.+.+|+..+|||+-||+||-|+.|.+||.+.
T Consensus 163 l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~ 215 (355)
T KOG0033|consen 163 VND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 215 (355)
T ss_pred eCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence 772 22334578999999999999999999999999999999999999999873
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=281.70 Aligned_cols=201 Identities=27% Similarity=0.482 Sum_probs=177.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..+|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999964 6899999999776655667889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++. ...+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999883 245889999999999999999999998 99999999999999999999999999876543322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 223468899999999988888999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=275.73 Aligned_cols=204 Identities=32% Similarity=0.527 Sum_probs=175.8
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..+.|++.++||+|+||.||++..++++.+|+|.+.... .....+.+|+.+++.++||||+++++.+ .....+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 346789999999999999999999889999999986543 3346789999999999999999999876 45678999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999988542 3457899999999999999999999988 99999999999999999999999999987653332
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.......++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 22233446778999999988889999999999999999999 999997544
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=283.74 Aligned_cols=201 Identities=25% Similarity=0.460 Sum_probs=170.9
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|.+.++||+|+||.||+++.. +++.||+|++..... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999975 678899999875432 2335678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++ +|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 78777743 2345889999999999999999999998 99999999999999999999999999876533222
Q ss_pred cccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred c-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 223457899999998865 468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.09 Aligned_cols=202 Identities=28% Similarity=0.510 Sum_probs=177.7
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|++.+.||+|++|.||+++.. +++.+++|.+... .......+.+|+++++.++||||+++++.+.+.+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999975 6899999998643 344557789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998643 3467899999999999999999999988 99999999999999999999999999887654332
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....+++.|+|||++.+..++.++|+||||++++||++|+.||...+
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 2 233467899999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=272.37 Aligned_cols=204 Identities=26% Similarity=0.359 Sum_probs=180.9
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|+.++.||+|.||.|-+++-+ +++.+|||+++.. .+.....-+.|-++|+..+||.+..+-..|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367889999999999999999965 7899999998755 344455667899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||..||.|.-+| .+...+++.....+-..|..||.|||+++ |+.||||.+|.|||.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999888 45678999999999999999999999998 99999999999999999999999999986433
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
... .....+|||.|+|||++.+..|+..+|+|.+||++|||++|+.||...+-+
T Consensus 321 ~g~-t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 321 YGD-TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred ccc-eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 322 345689999999999999999999999999999999999999999886544
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=296.69 Aligned_cols=200 Identities=24% Similarity=0.398 Sum_probs=164.5
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecC--------
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-------- 381 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------- 381 (532)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3468999999999999999999974 68999999885432 2335799999999999999998876432
Q ss_pred CcceEEEEecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeec
Q 009543 382 PESLLVYEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADF 459 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Df 459 (532)
...++||||+++ +|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 666666432 23567899999999999999999999998 99999999999999765 7999999
Q ss_pred CCccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 460 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99987644322 223568999999998865 468999999999999999999999997653
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=278.70 Aligned_cols=203 Identities=28% Similarity=0.455 Sum_probs=170.2
Q ss_pred CCccccccccccCceeEEEEEec-CCC----EEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++|++.+.||+|+||+||+|.+. +++ .+++|++.... .....++..|+..++.++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46888899999999999999974 444 47788775433 233467888999999999999999999875 456789
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
++||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999953 3356899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 467 EDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
..... ......++..|++||.+..+.++.++||||||+++|||++ |+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 217 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 33222 2233456788999999988899999999999999999998 9999977543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=274.55 Aligned_cols=203 Identities=32% Similarity=0.519 Sum_probs=173.9
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.++|++.++||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357889999999999999999988888999999865433 3467899999999999999999999874 45689999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++... ....+++.+++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998542 3356899999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
......++..|+|||.+....++.++|+||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 2223345678999999988889999999999999999999 899996643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.62 Aligned_cols=199 Identities=28% Similarity=0.454 Sum_probs=173.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.++||+|+||.||++.+. ++..+++|.+... ......++.+|++++.+++||||+++++++.+++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999975 6788899988654 233446788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
+++++|.+++.. ...+++..+..++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999843 35689999999999999999999974 5 9999999999999999999999999987553321
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....+++.|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 233568899999999988889999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=275.80 Aligned_cols=203 Identities=28% Similarity=0.525 Sum_probs=174.1
Q ss_pred CCccccccccccCceeEEEEEecC----CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
++|++.+.||+|+||.||+|.+.. ...||+|++.... ......+.+|+.+++.++||||+++++.+.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999999742 4579999886543 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999854 2347899999999999999999999988 99999999999999999999999999987753
Q ss_pred CCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 468 DKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 468 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.... ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 2222 1222345678999999998889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=278.84 Aligned_cols=205 Identities=27% Similarity=0.468 Sum_probs=175.7
Q ss_pred CCccccccccccCceeEEEEEec------CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999842 345689998876666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc
Q 009543 387 VYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR 453 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~ 453 (532)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985422 1235899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 454 AKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 454 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+||+|||++......... ......++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999998765433221 2233456788999999988889999999999999999999 999986644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=274.60 Aligned_cols=199 Identities=31% Similarity=0.506 Sum_probs=178.4
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
-|.++++||+|+||.||++.++ .|+.+|||++... ...+++..|+.++++.+.|++|+++|.+.....+|+|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4788999999999999999976 6999999998654 346789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
.|+..+++. .+++++++.++..+++..++||+|||... -||||||+.||||+-+|+.||+|||.+-.+..... .
T Consensus 112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K 185 (502)
T KOG0574|consen 112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K 185 (502)
T ss_pred CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence 999999995 46789999999999999999999999886 79999999999999999999999999865432221 2
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....||+.|||||++..-.|..++||||||+...||..|++||....
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 345689999999999999999999999999999999999999998754
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=275.85 Aligned_cols=193 Identities=28% Similarity=0.440 Sum_probs=170.2
Q ss_pred CCccccccccccCceeEEEEEe-cCCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.+.||+|+||.||++.+ .+++.+|+|++... .......+.+|++++.+++||||+++++.+...+..+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999996 47889999998654 234456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999996542 4678889999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2335789999999999988899999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=276.10 Aligned_cols=201 Identities=26% Similarity=0.397 Sum_probs=175.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.++||+|+||.||+++.. +++.+|+|.+..........+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357889999999999999999965 6889999998766555556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++. ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999884 3456899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......|++.|+|||.+. ...++.++|+|||||++|||++|+.||...
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 223456899999999874 456788999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=274.37 Aligned_cols=203 Identities=22% Similarity=0.417 Sum_probs=175.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+++++.++||||+++++.+.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999965 7899999987542 2344467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 389 EFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
||+++++|.+++.... ....+++..++.++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 2356889999999999999999999998 99999999999999999999999999887654
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.... .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 3221 22346788999999998888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=309.57 Aligned_cols=206 Identities=27% Similarity=0.335 Sum_probs=184.4
Q ss_pred HHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
++.-.++|++++.||+|+||.|..++.+ +++.+|+|++..- .+....-|..|-.+|..-+.+-|++++-.|++...
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 4444678999999999999999999976 5788899998652 34445668899999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
+|+|||||+||+|-.++. +...+++.....++..|.-||.-||+.| +|||||||.|||||..|++||+|||.+-
T Consensus 150 LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred eEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999993 3347999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcccccccccccccccccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLA----H-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....+....+...+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||...
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 88877777777889999999999985 2 67999999999999999999999999764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.26 Aligned_cols=209 Identities=31% Similarity=0.505 Sum_probs=180.7
Q ss_pred ccccccccccCceeEEEEEe-cCCC----EEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 315 FDEANKLGQGGFGTVYKGVL-PDGR----EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
....++||+|+||+||+|.+ ++|+ +||||++... ..+...++++|+-+|.+++||||+++++++.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45578999999999999996 4444 6899988654 4556789999999999999999999999998766 88999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
+|+|.|+|.++++. ....+.....+.|..||++||.|||++. ++||||..+||||.+-.++||.|||+++....+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999964 4567888999999999999999999987 999999999999999999999999999998776
Q ss_pred Ccccc-cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCcccccccc
Q 009543 469 KSHIS-TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLT 529 (532)
Q Consensus 469 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~~~~~l~~ 529 (532)
..... ....-.+.|||-|.+..+.++.++|||||||++||++| |.+|+.....++.-++++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 65532 22334678999999999999999999999999999998 999999987766655543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=270.06 Aligned_cols=197 Identities=29% Similarity=0.480 Sum_probs=169.4
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCChh
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLD 397 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 397 (532)
+.||+|+||.||+|...+++.+|+|++.... ......+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998889999999886553 333457889999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccccccc
Q 009543 398 RFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477 (532)
Q Consensus 398 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 477 (532)
+++.. ....+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 98843 2346899999999999999999999998 999999999999999999999999998754433222222234
Q ss_pred cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 478 gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
++..|+|||++..+.++.++||||||+++|||++ |..||....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 4678999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=277.18 Aligned_cols=202 Identities=29% Similarity=0.441 Sum_probs=175.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.+.|++.++||+|+||.||+|+.. +++.+++|.+...+....+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367999999999999999999975 5889999999877766778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|..++.. ....+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999888743 2356899999999999999999999988 99999999999999999999999999875433211
Q ss_pred ccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......+++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 123345788999999984 345678999999999999999999999664
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.43 Aligned_cols=193 Identities=28% Similarity=0.392 Sum_probs=162.8
Q ss_pred ccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC---ccceeeeeeeeeecCCcceEEEEecCC
Q 009543 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV---EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
||+|+||+||+++.. +++.||+|++.... ......+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999975 68999999986432 12233455666776655 699999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|.+++. +...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 99998884 3456899999999999999999999998 99999999999999999999999999875432222 22
Q ss_pred cccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 345789999999998754 47899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.72 Aligned_cols=214 Identities=25% Similarity=0.332 Sum_probs=180.2
Q ss_pred CCcChhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-c-----ceeee
Q 009543 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-H-----KNLVR 373 (532)
Q Consensus 301 ~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~ 373 (532)
..+.+..-+.+..+|++.+.||+|.||.|.++.+. +++.||||+++.. .....+-..|+.+|..++ | -|+|+
T Consensus 174 ~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr 252 (586)
T KOG0667|consen 174 GDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVR 252 (586)
T ss_pred CceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence 33443333444458999999999999999999965 6999999999643 445567788999999996 4 47999
Q ss_pred eeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-
Q 009543 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL- 452 (532)
Q Consensus 374 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~- 452 (532)
++++|...++.+||+|.+ ..+|.+++... +...++...+..++.||+.+|.+||+.+ |||.||||+||||.+-+
T Consensus 253 m~d~F~fr~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r 327 (586)
T KOG0667|consen 253 MLDYFYFRNHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKR 327 (586)
T ss_pred eeeccccccceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCc
Confidence 999999999999999998 56999999653 4567999999999999999999999988 99999999999997644
Q ss_pred -cEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 009543 453 -RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524 (532)
Q Consensus 453 -~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~ 524 (532)
.+||+|||.+........ ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|-+.++.++
T Consensus 328 ~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred CceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 799999999986554332 34557899999999999999999999999999999999999988765544
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=279.09 Aligned_cols=202 Identities=28% Similarity=0.485 Sum_probs=178.5
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
...+|++.++||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346899999999999999999996 4799999999976655556778999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++. ...+++.++..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999883 245889999999999999999999988 9999999999999999999999999987654332
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .....+++.|++||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 223467889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=277.60 Aligned_cols=198 Identities=29% Similarity=0.409 Sum_probs=175.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||++.+. +++.+|+|++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999975 68999999886432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 367899999999999999999999988 999999999999999999999999998876544
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....+++.|+|||.+.....+.++||||||+++|||++|+.||...+
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 223468899999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.76 Aligned_cols=205 Identities=30% Similarity=0.442 Sum_probs=171.3
Q ss_pred cCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeec-CC
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCS-GP 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~ 382 (532)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457999999999999999999742 35789999986443 33346788999999999 89999999998765 45
Q ss_pred cceEEEEecCCCChhHHhhhccC---------------------------------------------------------
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAK--------------------------------------------------------- 405 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 405 (532)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999853211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc-cccccccccccc
Q 009543 406 -AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYM 483 (532)
Q Consensus 406 -~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~ 483 (532)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......... ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999988 999999999999999999999999999876443322 222345677899
Q ss_pred cccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 484 APEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 484 aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=273.15 Aligned_cols=201 Identities=29% Similarity=0.439 Sum_probs=171.1
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-----hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--Ccc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PES 384 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 384 (532)
.+|++.+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999975 58999999885332 22346788999999999999999999988764 456
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
+++|||+++++|.+++.. ...+++...+.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 799999999999998843 345789999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 5432111 123345888999999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=273.90 Aligned_cols=198 Identities=35% Similarity=0.563 Sum_probs=174.3
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHH--HHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
|++.+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999976 5678999999877544332 3456999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++. +...+++..++.++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTS
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999995 4567899999999999999999999998 99999999999999999999999999876422 122
Q ss_pred cccccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......++..|+|||.+. ....+.++||||+|+++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 334567899999999998 788999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=278.36 Aligned_cols=200 Identities=27% Similarity=0.500 Sum_probs=177.5
Q ss_pred CCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.+|+..+.||.|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5699999999999999999986 478999999987665555678899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++. ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999999883 345899999999999999999999998 999999999999999999999999998765443222
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....++..|+|||.+....++.++||||||+++|||++|+.||...+
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223467889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=272.97 Aligned_cols=205 Identities=34% Similarity=0.514 Sum_probs=177.5
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..++|++.++||+|+||.||++.+++++.+++|.+.... ...+++.+|+.++++++||||+++++++......+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 356899999999999999999998888899999886543 3346789999999999999999999999988899999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++.++..++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998542 2356899999999999999999999998 99999999999999999999999999887654322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.......++..|+|||.+.+..++.++|+||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22222335678999999988889999999999999999998 999996643
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=287.23 Aligned_cols=202 Identities=27% Similarity=0.447 Sum_probs=179.6
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
-.+.|.+.+.||+|.|++|.++++. ++.+||||.+.... ......+.+|+++|..++|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3578999999999999999999965 79999999886552 33345589999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||..+|.+.+++. +...+.+.....++.|+.++++|||++. |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999995 4455666888999999999999999998 99999999999999999999999999988763
Q ss_pred CCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......+|++.|.|||++.+.++ ++++|+||+|+++|-|+.|..||++.+
T Consensus 208 ~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 208 G--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred c--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 3 33456799999999999987665 789999999999999999999998754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=265.97 Aligned_cols=205 Identities=26% Similarity=0.411 Sum_probs=174.4
Q ss_pred ChhhHHHhcCCccccccccccCceeEEEEE-ecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecC
Q 009543 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSG 381 (532)
Q Consensus 304 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 381 (532)
+|.+.-+.+ .+.||+|+|+.|-.++ +.+|.++|||++.+.......+..+|++++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 445555554 3679999999999988 6789999999998887777889999999999985 99999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC---cEEEee
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIAD 458 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~---~~kl~D 458 (532)
...|||||-|.||.|...+. +...+++.+..+++.+|+.||.+||.++ |.||||||+|||-.... -+||+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 99999999999999999984 5677999999999999999999999999 99999999999996554 489999
Q ss_pred cCCccccCCCCc--c----cccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 459 FGLARSFQEDKS--H----ISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 459 fgl~~~~~~~~~--~----~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
|.+..-+..... . .-.+.+|+..|||||+.. ...|..+.|.||||||+|-|++|.+||.+.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 998764432211 1 123457889999999863 236788999999999999999999999775
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.06 Aligned_cols=213 Identities=25% Similarity=0.433 Sum_probs=174.3
Q ss_pred hhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC
Q 009543 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG 381 (532)
Q Consensus 305 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 381 (532)
+...+...++|+++++||+|+||+||++++. +++.+|+|.+... .......+.+|+.++..++||||+++++++...
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3334455678999999999999999999975 5778899988643 334456789999999999999999999988653
Q ss_pred --CcceEEEEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEccCCCCCEEEcC----
Q 009543 382 --PESLLVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSK----IRIIHRDIKASNILLDS---- 450 (532)
Q Consensus 382 --~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~iiH~Dlkp~NiLl~~---- 450 (532)
...++||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 45789999999999999985422 23579999999999999999999998542 34999999999999964
Q ss_pred -------------CCcEEEeecCCccccCCCCccccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCC
Q 009543 451 -------------RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQN 515 (532)
Q Consensus 451 -------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p 515 (532)
.+.+||+|||++....... ......||+.|+|||++.. ..++.++|||||||+||||++|+.|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 2358999999998654332 2234578999999999854 4588999999999999999999999
Q ss_pred CCCC
Q 009543 516 NRSK 519 (532)
Q Consensus 516 ~~~~ 519 (532)
|...
T Consensus 243 F~~~ 246 (1021)
T PTZ00266 243 FHKA 246 (1021)
T ss_pred CCcC
Confidence 9754
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=271.56 Aligned_cols=197 Identities=28% Similarity=0.463 Sum_probs=167.3
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
++||+|+||.||++++. +++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 78999999876432 34456799999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc-ccc
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI-STA 475 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~-~~~ 475 (532)
.+++.. ....+++.+++.++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999843 2346899999999999999999999998 9999999999999999999999999987654322111 111
Q ss_pred cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 476 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
...+..|+|||.+..+.++.++||||||+++|||++ |..||....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 123567999999998889999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=285.12 Aligned_cols=198 Identities=27% Similarity=0.458 Sum_probs=168.6
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecC-----
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG----- 381 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 381 (532)
...++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999964 68899999986432 22345678999999999999999999987543
Q ss_pred -CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 382 -PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 382 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
...++++|++ +++|.+++ +...+++..+..++.|+++||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468899987 78888877 2356999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+++..... .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99865432 233568999999999876 56889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=276.07 Aligned_cols=205 Identities=28% Similarity=0.477 Sum_probs=174.7
Q ss_pred CCccccccccccCceeEEEEEec------CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.+|+..++||+|+||.||++... ++..+++|.+..........+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999742 356789998876666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 387 VYEFLPNQSLDRFIFDSAK------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
+|||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 455 KIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
||+|||++......... ......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 99999998765433221 1222345788999999988889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=274.71 Aligned_cols=202 Identities=30% Similarity=0.490 Sum_probs=171.6
Q ss_pred CCccccccccccCceeEEEEEe-----cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec--CCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 385 (532)
.+|++.+.||+|+||.||++.. .+++.|++|++........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788999999999999999974 2578999999877666667789999999999999999999998654 34578
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+|+||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999853 2346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 466 QEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 543322 111223445699999998888999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.89 Aligned_cols=199 Identities=29% Similarity=0.407 Sum_probs=169.4
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC------
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------ 381 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 381 (532)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999965 6889999998653 233446788999999999999999999987543
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346899999975 6666652 24788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++...... ......+++.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 98654322 2234568999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=271.41 Aligned_cols=202 Identities=33% Similarity=0.498 Sum_probs=172.5
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.++||+|++|.||++.++.+..+++|++.... ...+.+.+|+.+++.++|||++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688999999999999999998877789999876443 33467889999999999999999998875 456889999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999998542 3345899999999999999999999988 9999999999999999999999999997664433222
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.....++..|+|||......++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 223345778999999988889999999999999999999 999997653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=280.84 Aligned_cols=197 Identities=27% Similarity=0.429 Sum_probs=161.0
Q ss_pred cccccccCceeEEEEEec---CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec--CCcceEEEEecC
Q 009543 318 ANKLGQGGFGTVYKGVLP---DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLLVYEFLP 392 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 392 (532)
.++||+|+||+||+++.. +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999964 46789999885432 23457889999999999999999998854 445789999986
Q ss_pred CCChhHHhhhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE----cCCCcEEEeecCCc
Q 009543 393 NQSLDRFIFDS------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLA 462 (532)
Q Consensus 393 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl----~~~~~~kl~Dfgl~ 462 (532)
+ +|.+++... .....+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 777776421 12235899999999999999999999998 9999999999999 45679999999999
Q ss_pred cccCCCCcc--ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+........ ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876543221 2234578999999999876 458899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.08 Aligned_cols=198 Identities=25% Similarity=0.360 Sum_probs=171.3
Q ss_pred hcCCccccccccccCceeEEEEEec---CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP---DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
...+|++.++||+|+||.||++... .++.|++|.+... ....+|+++++.++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999753 4678999987543 2346899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
||++. ++|.+++ .....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99986 5787777 23467999999999999999999999998 99999999999999999999999999976654
Q ss_pred CCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 3322 2234578999999999998899999999999999999999999997654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=275.25 Aligned_cols=201 Identities=27% Similarity=0.492 Sum_probs=171.6
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788999999999999999975 68999999986542 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
++ ++|.+++........+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 588888754444467999999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 12234568899999987654 5788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=274.46 Aligned_cols=201 Identities=30% Similarity=0.450 Sum_probs=173.6
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
.|++.++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+......++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3678899999999999999976 577889998876666667789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|..++.. ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999988743 2357899999999999999999999998 99999999999999999999999999876533221 2
Q ss_pred ccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....+++.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 23346889999999974 3457789999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=270.89 Aligned_cols=203 Identities=26% Similarity=0.466 Sum_probs=177.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||++... +|+.+++|.+... .....+.+.+|++++++++|+||+++++.+.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999986 7999999988642 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 389 EFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
||+++++|.+++.... ....+++.+++.++.++++||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999885432 2456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 3221 22345788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=275.61 Aligned_cols=203 Identities=29% Similarity=0.443 Sum_probs=177.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.++||+|+||.||++.+. +++.+++|.+........+.+.+|+++++.++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999975 6889999999877767778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999999843 2356899999999999999999999998 99999999999999999999999998876533222
Q ss_pred ccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......+++.|++||.+. ...++.++|+||||+++|||++|+.||...+
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 123346889999999875 3346789999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=271.98 Aligned_cols=200 Identities=29% Similarity=0.492 Sum_probs=173.5
Q ss_pred CccccccccccCceeEEEEEecCCCEEEEEEeeccC------hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
+|+..+.||+|+||+||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998889999999886432 22235688999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
+||+++++|.+++.+ ...+++..+..++.|++.+|+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 346889999999999999999999988 99999999999999999999999999876532
Q ss_pred CC-----cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 DK-----SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 11 11122346889999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.52 Aligned_cols=199 Identities=29% Similarity=0.407 Sum_probs=169.2
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-----
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----- 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 382 (532)
..++|++.+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 6889999998653 2334567889999999999999999999876433
Q ss_pred -cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 383 -ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
..+++|||+++ +|.+.+. ..+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999976 5655552 24789999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98654322 2234568999999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=274.71 Aligned_cols=206 Identities=33% Similarity=0.492 Sum_probs=172.7
Q ss_pred cCCccccccccccCceeEEEEEecC------CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.+.||+|+||.||++.+.+ +..|++|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999753 5678999876443 33446789999999999999999999999998899
Q ss_pred eEEEEecCCCChhHHhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC---cEEEe
Q 009543 385 LLVYEFLPNQSLDRFIFDSAK----AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIA 457 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~---~~kl~ 457 (532)
+++|||+++++|.+++..... ...+++..+++++.||+.||+|||+++ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999854321 236899999999999999999999998 99999999999998765 59999
Q ss_pred ecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 458 DFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 458 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999876432221 1112234568999999988899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=275.96 Aligned_cols=201 Identities=26% Similarity=0.481 Sum_probs=172.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.+.||+|+||.||++.+. +++.+|+|.+... .......+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999976 7899999988654 334456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
+++++|..++........+++..+..++.|+++||.|||+. + |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999885433345789999999999999999999974 5 9999999999999999999999999987653322
Q ss_pred cccccccccccccccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHG------QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.....+++.|+|||.+... .++.++|+||||+++|||++|+.||...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 2234578899999998544 3478999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=277.12 Aligned_cols=204 Identities=25% Similarity=0.423 Sum_probs=172.0
Q ss_pred CccccccccccCceeEEEEEec------CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
+|++.++||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++..++||||+++++.+.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4778899999999999999863 257899999875433 334678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc
Q 009543 387 VYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR 453 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~ 453 (532)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985211 1235888999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 454 AKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 454 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+||+|||+++........ ......+++.|+|||.+..+.++.++||||||+++|||++ |..||....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999998865433221 2223345789999999988889999999999999999998 888987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=274.86 Aligned_cols=206 Identities=29% Similarity=0.491 Sum_probs=175.3
Q ss_pred cCCccccccccccCceeEEEEEecC------CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.+.||+|+||.||++...+ +..|++|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578899999999999999998642 4689999986543 33446788999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 385 LLVYEFLPNQSLDRFIFDSA-------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 1235789999999999999999999988 9999999999999999999999
Q ss_pred ecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 458 DFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 458 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
|||+++........ ......++..|+|||.+..+.++.++||||||+++|||++ |+.||...+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 99998865443321 2233456789999999988889999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=276.20 Aligned_cols=207 Identities=27% Similarity=0.466 Sum_probs=172.6
Q ss_pred hcCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
..++|++.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24579999876443 2334568899999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAK-------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
.+++|||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 234577888999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 457 ADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.||....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999998865433222 1122345678999999988889999999999999999999 788987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=286.91 Aligned_cols=211 Identities=28% Similarity=0.449 Sum_probs=184.9
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEecC-CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
++++....+....++||-|.||.||.|.|+. .-.||||.++ .+....++|+.|..+|+.++|||+|+++|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444444556778999999999999999874 6679999985 4456678999999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
|||+|||..|+|.++|.+. +...++....+.++.||..||+||..++ +|||||.++|+|+.++..+|++||||++.
T Consensus 339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999654 3456777888999999999999999988 99999999999999999999999999999
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
...+.+.......-+..|.|||.+....++.|+|||+|||+|||+.| |-.||-+.+.
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 88777665444556889999999999999999999999999999998 8889876543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=269.12 Aligned_cols=201 Identities=31% Similarity=0.511 Sum_probs=177.4
Q ss_pred cCCccccccccccCceeEEEEEecC-CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.++||+|+||.||++.+.+ ++.+++|.+..... .+++.+|+++++.++||||+++++.+.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3679999999999999999999864 78999999865433 67899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999843 3467899999999999999999999988 99999999999999999999999999887654322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 2233457889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=270.80 Aligned_cols=204 Identities=31% Similarity=0.516 Sum_probs=175.2
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..++|++.++||+|+||.||++.+.++..+++|.+.... ...+.+.+|+++++.++|+||+++.+.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 346899999999999999999998788889999886443 345678999999999999999999999877 778999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999998542 3456889999999999999999999988 99999999999999999999999999876644332
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.......++..|+|||.+..+.++.++|+||||+++|||++ |+.||...+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 22223345678999999988889999999999999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=275.75 Aligned_cols=199 Identities=29% Similarity=0.480 Sum_probs=165.1
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcC---ccceeeeeeeeeecC-----C
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSV---EHKNLVRLLGCSCSG-----P 382 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~ 382 (532)
+|++.+.||+|+||+||+++.. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999975 688999998865322 2223556677777665 799999999987642 3
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..+++|||+++ +|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 46899999985 788877432 2345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
........ .....+++.|+|||.+.+..++.++|||||||++|||++|++||...
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 156 RIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 86643222 23356789999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=274.37 Aligned_cols=201 Identities=26% Similarity=0.411 Sum_probs=173.1
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|+..+.||+|+||.||++++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999976 68999999886442 2233567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|..++. ....+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888763 3346899999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2 1223457889999999865 457899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=272.26 Aligned_cols=199 Identities=26% Similarity=0.388 Sum_probs=162.7
Q ss_pred ccccccCceeEEEEEecC---CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 319 NKLGQGGFGTVYKGVLPD---GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
++||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999998543 3568888775443 334467889999999999999999999999999999999999999
Q ss_pred ChhHHhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc-
Q 009543 395 SLDRFIFDSAK--AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH- 471 (532)
Q Consensus 395 ~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~- 471 (532)
+|.+++..... ....++...+.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865322 234568888999999999999999998 999999999999999999999999998754332221
Q ss_pred ccccccccccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAH-------GQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
......++..|+|||++.. ..++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 1233446778999998743 356789999999999999999 888887643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=272.23 Aligned_cols=203 Identities=24% Similarity=0.434 Sum_probs=176.2
Q ss_pred CCccccccccccCceeEEEEEe-cCCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||++.. .+++.++||.+... ......++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999996 47899999987643 2334467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 389 EFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
||+++++|.+++.... ....+++..++.++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885322 2456899999999999999999999998 99999999999999999999999999876644
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 3321 22346889999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=274.29 Aligned_cols=203 Identities=29% Similarity=0.486 Sum_probs=170.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCC----EEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
.++|++.++||+|+||+||+|++. +++ .||+|++... .......+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357889999999999999999853 454 4899988654 33445678899999999999999999998865 4578
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999853 2356899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 466 QEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
...... ......+++.|++||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 543322 1122345678999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=274.65 Aligned_cols=200 Identities=30% Similarity=0.489 Sum_probs=168.5
Q ss_pred CCc-cccccccccCceeEEEEEe-----cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--Cc
Q 009543 313 GSF-DEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PE 383 (532)
Q Consensus 313 ~~~-~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 383 (532)
++| ++.+.||+|+||+||++.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8899999999999988653 357889999986543 23456788999999999999999999987654 34
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.+++|||+++++|.+++.. ..+++.+++.++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 7899999999999999843 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 464 SFQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 464 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
........ ......++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 76543221 112234566799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=271.43 Aligned_cols=203 Identities=25% Similarity=0.462 Sum_probs=169.8
Q ss_pred ccccccccccCceeEEEEEecC----CCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc-----
Q 009543 315 FDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE----- 383 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 383 (532)
|++.+.||+|+||.||+|.+.. +..||+|++.... ......+.+|+++++.++||||+++++.+...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999999642 3679999987542 3445678999999999999999999998866554
Q ss_pred -ceEEEEecCCCChhHHhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeec
Q 009543 384 -SLLVYEFLPNQSLDRFIFDSA---KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (532)
Q Consensus 384 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Df 459 (532)
.++++||+++++|..++.... ....+++...+.++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 2346899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 460 GLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 460 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
|+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 999876543322 1222335678999999988889999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=276.32 Aligned_cols=203 Identities=31% Similarity=0.460 Sum_probs=169.4
Q ss_pred CCccccccccccCceeEEEEEecC-CC--EEEEEEeecc-ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD-GR--EIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 387 (532)
++|++.+.||+|+||.||++.+.+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++.+....+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999753 33 4788887642 334456789999999999 799999999999999999999
Q ss_pred EEecCCCChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 388 YEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
||+|||++........ ......+..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999864322111 111123567999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=269.90 Aligned_cols=195 Identities=29% Similarity=0.507 Sum_probs=164.1
Q ss_pred cccccCceeEEEEEec---CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCC
Q 009543 320 KLGQGGFGTVYKGVLP---DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQS 395 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 395 (532)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 355799998865533 33467899999999999999999999875 457899999999999
Q ss_pred hhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc--c
Q 009543 396 LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI--S 473 (532)
Q Consensus 396 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~--~ 473 (532)
|.+++.. ....+++..+++++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999853 3457899999999999999999999998 9999999999999999999999999998654433221 1
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 12233578999999988889999999999999999996 999997643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=285.73 Aligned_cols=208 Identities=28% Similarity=0.425 Sum_probs=174.1
Q ss_pred HHhcCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCc-cceeeeeeeeeec
Q 009543 309 EKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNLVRLLGCSCS 380 (532)
Q Consensus 309 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 380 (532)
+...++|.+.++||+|+||.||++++. .++.||+|++.... ....+.+.+|++++.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 334467888999999999999999863 34689999997543 233457889999999997 9999999999999
Q ss_pred CCcceEEEEecCCCChhHHhhhcc--------------------------------------------------------
Q 009543 381 GPESLLVYEFLPNQSLDRFIFDSA-------------------------------------------------------- 404 (532)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 404 (532)
.+..++||||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986421
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 009543 405 ---------------------------------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (532)
Q Consensus 405 ---------------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (532)
....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 1124678889999999999999999987 9999999999
Q ss_pred EEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 446 ILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 446 iLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999865432221 1223456789999999988889999999999999999998 89999654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.99 Aligned_cols=195 Identities=25% Similarity=0.353 Sum_probs=168.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
...|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|++++++++||||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999976 578999996432 2456899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+. ++|.+++.. ....+++.+++.|+.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 688887743 2347999999999999999999999998 99999999999999999999999999986643322
Q ss_pred c-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 471 H-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 471 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
. ......||+.|+|||++.+..++.++|||||||++|||++|..|+-.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 2 22345799999999999988999999999999999999999876543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=269.77 Aligned_cols=203 Identities=26% Similarity=0.383 Sum_probs=178.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+++++.++||||+++++.+......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367999999999999999999975 5788999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ....+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999998843 2357899999999999999999999988 99999999999999999999999999876543321
Q ss_pred ccccccccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHG---QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......++..|+|||.+... .++.++|+||||+++|||++|+.||...+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12334678899999998766 78899999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=275.00 Aligned_cols=204 Identities=31% Similarity=0.444 Sum_probs=171.6
Q ss_pred CccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
+|++.+.||+|+||.||+|+.. ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999853 23568888876543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 009543 387 VYEFLPNQSLDRFIFDSA---------------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (532)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985321 1235889999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 446 ILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 446 iLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999998765433222 1222345678999999988889999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=273.15 Aligned_cols=200 Identities=28% Similarity=0.426 Sum_probs=176.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.+.||.|++|.||++++. +++.+++|.+.... ......+.+|+.+++.++||||+++++.+.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999975 68899999987553 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ..+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999999843 37899999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 2233467889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=271.87 Aligned_cols=203 Identities=28% Similarity=0.496 Sum_probs=172.6
Q ss_pred CCccccccccccCceeEEEEEec-C---CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-D---GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
++|++.+.||+|+||.||+|.+. + +..+|+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999864 2 3368999886543 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999853 2356899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 468 DKSHIS--TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
...... ....++..|++||.+..+.++.++|+||||+++||+++ |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 332211 11223568999999998889999999999999999887 999997643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=270.71 Aligned_cols=199 Identities=27% Similarity=0.404 Sum_probs=164.4
Q ss_pred ccccccCceeEEEEEecC---CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 319 NKLGQGGFGTVYKGVLPD---GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
+.||+|+||.||+|.+.+ +..+++|++.... ......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998643 4579999886553 233457889999999999999999999999999999999999999
Q ss_pred ChhHHhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc-
Q 009543 395 SLDRFIFDSA--KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH- 471 (532)
Q Consensus 395 ~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~- 471 (532)
+|.+++.... .....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 2235677888899999999999999998 999999999999999999999999998754332221
Q ss_pred cccccccccccccccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHG-------QLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
......++..|+|||++... .++.++|+||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 22334578889999988642 35789999999999999996 999997643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=273.31 Aligned_cols=204 Identities=28% Similarity=0.446 Sum_probs=172.3
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC------
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG------ 381 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------ 381 (532)
.+++.|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.++..+ +||||+++++.+...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999975 58889999986543 3346788999999998 799999999998753
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
...+++|||+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 357899999999999999854 23456899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+........ ......|++.|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 876543221 223456899999999985 345788999999999999999999999643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=271.16 Aligned_cols=204 Identities=28% Similarity=0.556 Sum_probs=173.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCC---EEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGR---EIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.++|+..+.||+|+||.||++++. +++ .+++|++.... ....+.+.+|++++..++||||+++.+++......++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888999999999999999975 333 68999886553 3445678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
+|||+++++|.+++.. ....+++.+++.++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999853 3356899999999999999999999998 9999999999999999999999999987665
Q ss_pred CCCcccc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 467 EDKSHIS--TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
....... .....+..|+|||.+..+.++.++||||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 4332211 11223457999999988889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=277.96 Aligned_cols=204 Identities=31% Similarity=0.457 Sum_probs=170.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCC--EEEEEEeecc-ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGR--EIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.+.||+|+||.||++.+. ++. .+++|++... .......+.+|++++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357899999999999999999975 454 4577776543 334456788999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc
Q 009543 387 VYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR 453 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~ 453 (532)
+|||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986432 1236889999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 454 AKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 454 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+||+|||++....... ......++..|+|||.+....++.++||||||+++|||+| |..||...+
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9999999986432111 1112234668999999988888999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=269.51 Aligned_cols=194 Identities=31% Similarity=0.511 Sum_probs=164.6
Q ss_pred cccccCceeEEEEEec---CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 320 KLGQGGFGTVYKGVLP---DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
+||+|+||.||+|.++ +++.+|+|++.... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999753 57889999886443 334567899999999999999999999875 45678999999999
Q ss_pred ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc--
Q 009543 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI-- 472 (532)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~-- 472 (532)
+|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999984 3356899999999999999999999998 9999999999999999999999999998765443221
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.....++..|+|||.+....++.++|+||||+++|||++ |+.||....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 122234678999999988888999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=269.10 Aligned_cols=202 Identities=22% Similarity=0.351 Sum_probs=176.1
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
+|++.++||+|+||.||++... +++.+++|.+... .....+.+.+|+.+++.++||||+++++.+.+....+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999975 6899999988643 3344567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++.. .....+++...+.++.|++.||.|||+++ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999998743 23456899999999999999999999998 99999999999999999999999999876643322
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 2233568899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=273.16 Aligned_cols=206 Identities=25% Similarity=0.447 Sum_probs=174.9
Q ss_pred cCCccccccccccCceeEEEEEecC-----CCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeec-CCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD-----GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 384 (532)
.++|++.+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678999999999999999999765 688999988644 33445778899999999999999999998766 4678
Q ss_pred eEEEEecCCCChhHHhhhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeec
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKA-----KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Df 459 (532)
++++||+++++|.+++...... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998543222 56899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 460 GLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 460 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
|+++.+...... ......++..|+|||.+....++.++||||||+++||+++ |+.||...+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 999866443322 2223345778999999988889999999999999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=269.54 Aligned_cols=201 Identities=29% Similarity=0.456 Sum_probs=171.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-----hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--Ccc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PES 384 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 384 (532)
.+|+..+.||+|+||.||++... +++.+++|++.... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999975 68999999886432 23345688999999999999999999988753 557
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 345889999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 5432211 112345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.78 Aligned_cols=196 Identities=31% Similarity=0.496 Sum_probs=170.9
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccCh---hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.|+.++.||.|+||.||-+++. +.+.||||++...-+ ..+.+++.|+..|.+++|||++.+.|++..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4777889999999999999964 778899999976543 345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
||-| +-.+++. ...+++.+.++..|..+.++||+|||+++ .||||||+.||||++.|.+||+|||.+....+.
T Consensus 107 YClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9954 5555552 23467899999999999999999999998 999999999999999999999999998765543
Q ss_pred cccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..++|||.|||||++. .++|+-|+||||||++-.||...++|.-..+
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN 229 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 229 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence 3578999999999874 6899999999999999999999999986543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=269.49 Aligned_cols=206 Identities=27% Similarity=0.399 Sum_probs=173.7
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
..++++.....||+|+||.||+|++. ++..|++|.+........+.+.+|+++++.++||||+++++++..++..++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 44566667789999999999999965 67889999987766666778999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-CCcEEEeecCCccccCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQE 467 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfgl~~~~~~ 467 (532)
||+++++|.+++.........++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999854322112378889999999999999999988 999999999999986 67999999999876543
Q ss_pred CCcccccccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
... ......+++.|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 162 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 162 INP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 222 12234578999999998654 3788999999999999999999999653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=269.82 Aligned_cols=202 Identities=28% Similarity=0.484 Sum_probs=166.8
Q ss_pred ccccccccccCceeEEEEEecCC-C--EEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC------Cc
Q 009543 315 FDEANKLGQGGFGTVYKGVLPDG-R--EIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------PE 383 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~g-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 383 (532)
+.+.+.||+|+||.||+|++.+. + .+|+|.+... .....+.+.+|+++++.++||||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999997643 3 5899987654 344567889999999999999999999976432 24
Q ss_pred ceEEEEecCCCChhHHhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 384 SLLVYEFLPNQSLDRFIFDS---AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
.+++|||+++++|.+++... .....+++.....++.|++.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 12345899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 461 LARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 461 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
+++........ ......+++.|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99876543322 1222345778999999998889999999999999999999 89999653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=275.44 Aligned_cols=205 Identities=26% Similarity=0.423 Sum_probs=171.2
Q ss_pred CCccccccccccCceeEEEEEecC---------------CCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeee
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD---------------GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLG 376 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~ 376 (532)
++|++.++||+|+||.||+++..+ ...||+|++... .......+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999987642 224899988654 3334567999999999999999999999
Q ss_pred eeecCCcceEEEEecCCCChhHHhhhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEE
Q 009543 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAK---------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447 (532)
Q Consensus 377 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiL 447 (532)
++......++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999853211 124788999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 009543 448 LDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT--GRQNNRSKN 520 (532)
Q Consensus 448 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t--G~~p~~~~~ 520 (532)
+++++.+||+|||++......... ......++..|+|||.+..+.++.++||||||+++|||++ |..||...+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999998765433221 1223345778999999988889999999999999999998 667876543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=277.40 Aligned_cols=197 Identities=27% Similarity=0.428 Sum_probs=160.6
Q ss_pred cccccccCceeEEEEEec---CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec--CCcceEEEEecC
Q 009543 318 ANKLGQGGFGTVYKGVLP---DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLLVYEFLP 392 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 392 (532)
..+||+|+||+||+++.. ++..+|+|.+.... ....+.+|+.+++.++||||+++++++.. +...++++||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999965 45789999886432 23467899999999999999999998854 456789999987
Q ss_pred CCChhHHhhhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE----cCCCcEEEeecCCc
Q 009543 393 NQSLDRFIFDS------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLA 462 (532)
Q Consensus 393 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl----~~~~~~kl~Dfgl~ 462 (532)
+ +|.+++... .....+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 666665321 12335889999999999999999999998 9999999999999 56679999999999
Q ss_pred cccCCCCcc--ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+........ ......+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876543222 2234568999999999876 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=277.33 Aligned_cols=206 Identities=28% Similarity=0.414 Sum_probs=172.6
Q ss_pred cCCccccccccccCceeEEEEEec--------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 381 (532)
.++|.+.++||+|+||.||+++.. ++..+|+|.+.... .....++.+|++++..+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999852 23579999987542 33456788999999999 799999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
...++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999964321 235899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 449 DSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999998765432211 1112234568999999988889999999999999999998 889987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=269.80 Aligned_cols=192 Identities=27% Similarity=0.441 Sum_probs=162.5
Q ss_pred ccccccCceeEEEEEecC-------------CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 319 NKLGQGGFGTVYKGVLPD-------------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
+.||+|+||.||+|++.+ ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258889886655555678899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc-------EEEee
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR-------AKIAD 458 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~-------~kl~D 458 (532)
++|||+++++|+.++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988843 3356899999999999999999999988 999999999999987664 89999
Q ss_pred cCCccccCCCCcccccccccccccccccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCC
Q 009543 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIV-TGRQNNRSKN 520 (532)
Q Consensus 459 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvll~el~-tG~~p~~~~~ 520 (532)
||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|+.||....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9998755322 2235678899999886 456899999999999999997 6888887643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=268.56 Aligned_cols=196 Identities=32% Similarity=0.504 Sum_probs=169.3
Q ss_pred ccccccCceeEEEEEecC--C--CEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLPD--G--REIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|++|.||++.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999743 3 3689999976655 556789999999999999999999999888 888999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc--
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-- 471 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-- 471 (532)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865322 57899999999999999999999998 999999999999999999999999999876543222
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1123456789999999988889999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=275.80 Aligned_cols=201 Identities=26% Similarity=0.462 Sum_probs=170.9
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.++||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999975 68899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
++ ++|.+++.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 588888743 2356889999999999999999999998 99999999999999999999999999876443222
Q ss_pred ccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1233568899999987653 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=276.37 Aligned_cols=207 Identities=29% Similarity=0.431 Sum_probs=175.0
Q ss_pred hcCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCC
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 382 (532)
..++|++.+.||+|+||.||++... ....+|+|++.... .....++.+|+.++..+ +||||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3467899999999999999999864 23678999886542 33446788999999999 8999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhc-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~ 449 (532)
..+++|||+++++|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998542 22457899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 450 SRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 450 ~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 9999999999999876543322 1222335678999999988889999999999999999998 999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=270.62 Aligned_cols=203 Identities=29% Similarity=0.530 Sum_probs=171.5
Q ss_pred CCccccccccccCceeEEEEEecC-C---CEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD-G---REIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
+.|++.+.||+|+||.||+|.+.. + ..|++|.+... ......++.+|+.+++.++||||+++++++.++...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999999753 3 36999998654 344557899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999853 2456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCccc--ccccc--cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 468 DKSHI--STAIA--GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
..... ..... .+..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 32211 11111 2457999999998899999999999999999886 999996643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=269.73 Aligned_cols=200 Identities=29% Similarity=0.526 Sum_probs=172.3
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccCh---------hhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---------HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999964 688999998864322 123568899999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999943 356889999999999999999999988 9999999999999999999999999988
Q ss_pred ccCCCCcc-----cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 464 SFQEDKSH-----ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 464 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
........ ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 76532211 112245788999999998888999999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=276.57 Aligned_cols=199 Identities=29% Similarity=0.504 Sum_probs=173.6
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
.|.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 4455677999999999999964 688999999876665666779999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++. ...+++.+++.++.||+.||.|||+++ |+||||||+||++++++.+||+|||++........ .
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 999999873 245899999999999999999999998 99999999999999999999999999876543222 1
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 233468899999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=266.90 Aligned_cols=202 Identities=24% Similarity=0.376 Sum_probs=176.8
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|+..+.||+|+||.||.++.. +++.+++|++... +.....++.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999864 6889999988654 344556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++.++..++.|++++|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999998542 2456899999999999999999999988 99999999999999999999999999886644332
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 2234568999999999988888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=274.92 Aligned_cols=202 Identities=23% Similarity=0.371 Sum_probs=172.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||++... +++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999975 57899999886543 233457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 356899999999999999999999988 999999999999999999999999998642111
Q ss_pred Cc--------------ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KS--------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .......++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 00 01122457889999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=319.20 Aligned_cols=193 Identities=26% Similarity=0.488 Sum_probs=164.1
Q ss_pred HhcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.....+...+.||+|+||.||+|+. .+++.||+|++...... ..+|++.+++++||||+++++++.+.+..++||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3345678888999999999999997 47899999988643321 234688899999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++. .++|.++.+++.|+++||+|||+...++|+||||||+||+++.++.+++. ||........
T Consensus 763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999999999983 38999999999999999999996655569999999999999999988875 6655433221
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
....+++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 223678999999999999999999999999999999999999854
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=272.99 Aligned_cols=206 Identities=28% Similarity=0.453 Sum_probs=174.5
Q ss_pred cCCccccccccccCceeEEEEEecC-----------------CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeee
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD-----------------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVR 373 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 373 (532)
.++|++.++||+|+||.||++++.+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999988642 2458999887553 344567899999999999999999
Q ss_pred eeeeeecCCcceEEEEecCCCChhHHhhhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 009543 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSA--------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (532)
Q Consensus 374 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (532)
+++++..++..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1236899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 009543 446 ILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT--GRQNNRSKN 520 (532)
Q Consensus 446 iLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t--G~~p~~~~~ 520 (532)
|+++.++.++|+|||+++........ ......+++.|+|||.+..+.++.++||||||+++|||++ |..||...+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999998765433222 2234456789999999988889999999999999999998 778886543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=276.24 Aligned_cols=197 Identities=30% Similarity=0.505 Sum_probs=172.4
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
|+...+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++.+..+...++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444568999999999999975 6899999998765555567788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|..++. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 99998773 346899999999999999999999998 99999999999999999999999999875543322 12
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3356889999999998888999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=272.75 Aligned_cols=198 Identities=28% Similarity=0.481 Sum_probs=173.1
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++.+......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4777889999999999999865 57889999886443 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++. ...+++..+..++.|+++|+.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999883 356899999999999999999999988 99999999999999999999999999876543322
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 122345788999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=267.27 Aligned_cols=199 Identities=30% Similarity=0.495 Sum_probs=174.3
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC-----hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
+|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999976 78999999886543 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
+||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 346889999999999999999999998 99999999999999999999999999876544
Q ss_pred CCcccccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ......++..|++||.+.... ++.++|+||||+++|||++|+.||....
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 33 223456889999999987766 8999999999999999999999996643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=270.77 Aligned_cols=204 Identities=24% Similarity=0.394 Sum_probs=173.8
Q ss_pred CCccccccccccCceeEEEEEec------CCCEEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
++|++.+.||+|+||.||+++.+ +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999964 2467899988654433 4567999999999999999999999999988999
Q ss_pred EEEEecCCCChhHHhhhccCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeec
Q 009543 386 LVYEFLPNQSLDRFIFDSAKA------KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Df 459 (532)
+||||+++++|.+++...... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998543321 26899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 460 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
|++...............++..|++||.+.+...+.++||||||+++|||++ |..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9987554333322333456788999999988888999999999999999999 88898653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.31 Aligned_cols=205 Identities=29% Similarity=0.447 Sum_probs=177.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.+.||.|+||+||++... ++..+++|++.... ......+.+|+++++.++|+||+++++.+......++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999964 68899999986543 23557899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++........+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999864333357899999999999999999999998 99999999999999999999999999876654332
Q ss_pred c---cccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 H---ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......++..|++||.+... .++.++|+||||+++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 2 22334688999999998876 78999999999999999999999997643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=267.24 Aligned_cols=202 Identities=26% Similarity=0.508 Sum_probs=173.9
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
.+|++.+.||+|+||.||++.+.+++.+++|++.... .....+.+|++++++++|||++++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688899999999999999998778899999886443 234578899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++.. ....+++..++.++.|++.+++|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999998843 2346889999999999999999999998 9999999999999999999999999987654332222
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.....++..|+|||.+..+.++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 223345678999999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=274.45 Aligned_cols=205 Identities=29% Similarity=0.439 Sum_probs=174.1
Q ss_pred cCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 383 (532)
.++|++.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+.+++++ +||||+++++.+...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357999999999999999999742 34579999886543 33446789999999999 79999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.+++|||+++++|.+++... ....+++.++..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999998542 2344899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 464 SFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
........ ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 66443321 1222345778999999988889999999999999999998 999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=269.70 Aligned_cols=202 Identities=26% Similarity=0.409 Sum_probs=171.1
Q ss_pred CCccccccccccCceeEEEEEecC----CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
++|.+.++||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ +..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 468889999999999999998643 2468999886554 4455789999999999999999999998765 567899
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999953 2346899999999999999999999988 99999999999999999999999999886654
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
..........++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 43222223344578999999988889999999999999999996 999997654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=275.50 Aligned_cols=206 Identities=28% Similarity=0.421 Sum_probs=173.5
Q ss_pred cCCccccccccccCceeEEEEEec--------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 381 (532)
.++|.+.+.||+|+||.||+++.. ++..||+|.+.... .....++.+|+.+++.+ +||||+++++.+...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467889999999999999999741 34579999886432 34456789999999999 899999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
...+++|||+++++|.+++.... ....+++.+++.++.|+++||.|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999986432 1245888999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 449 DSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999876543322 1222345678999999988889999999999999999998 888886644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=275.24 Aligned_cols=204 Identities=26% Similarity=0.370 Sum_probs=176.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh---hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|++++..++||||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999976 589999999875532 24567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998853 23467899999999999999999999998 999999999999999999999999998755322
Q ss_pred Ccc----------------------------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSH----------------------------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 111 1123467889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.31 Aligned_cols=206 Identities=26% Similarity=0.421 Sum_probs=172.2
Q ss_pred cCCccccccccccCceeEEEEEec-----------------CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeee
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-----------------DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVR 373 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 373 (532)
.++|++.++||+|+||.||++... ++..+|+|++... .......+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998642 2346899988654 3344568999999999999999999
Q ss_pred eeeeeecCCcceEEEEecCCCChhHHhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 009543 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAK--------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (532)
Q Consensus 374 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (532)
+++++...+..+++|||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999854221 235788899999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 009543 446 ILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT--GRQNNRSKN 520 (532)
Q Consensus 446 iLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t--G~~p~~~~~ 520 (532)
||++.++.++|+|||++......... ......++..|++||....+.++.++||||||+++|||++ |..||...+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999998865433222 1222344678999999888889999999999999999998 778886543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=292.97 Aligned_cols=202 Identities=23% Similarity=0.305 Sum_probs=163.7
Q ss_pred HHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc------cceeeeeeeeeec
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE------HKNLVRLLGCSCS 380 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~ 380 (532)
+....++|++.++||+|+||+||++++. +++.||||++.... .....+..|+.++..++ |++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445689999999999999999999975 57889999986432 22334556666666654 4568889888876
Q ss_pred C-CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCC------
Q 009543 381 G-PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRL------ 452 (532)
Q Consensus 381 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~------ 452 (532)
. ...++|||++ +++|.+++. +...+++..+..|+.||+.||.|||++ + |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 4678889887 778888874 335799999999999999999999974 6 99999999999998765
Q ss_pred ----------cEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 453 ----------RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 453 ----------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998754322 22346789999999999999999999999999999999999999987543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=264.21 Aligned_cols=205 Identities=28% Similarity=0.454 Sum_probs=173.1
Q ss_pred CCccccccccccCceeEEEEEec---C--CCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeec-CCcc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP---D--GREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPES 384 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 384 (532)
..|+.+.+||+|.||.||++.-. + ..++|||+++..+. .......+|+.+++.++||||+.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46889999999999999999643 2 33789999975532 223578899999999999999999999987 7889
Q ss_pred eEEEEecCCCChhHHhh--hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC----CcEEEee
Q 009543 385 LLVYEFLPNQSLDRFIF--DSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR----LRAKIAD 458 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~--~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~----~~~kl~D 458 (532)
++++||.+. +|..+++ +..+.+.++...+.+|+.||+.|+.|||++. |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 6666664 2334568999999999999999999999999 9999999999999887 8999999
Q ss_pred cCCccccCCCCcc--cccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 459 FGLARSFQEDKSH--ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 459 fgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
||+++.+.+.-.. .....+-|.+|.|||.+.+. .|+.+.|||++|||+.||+|-++-|....+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 9999998655433 23456789999999998774 689999999999999999999999987543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=267.40 Aligned_cols=201 Identities=28% Similarity=0.435 Sum_probs=171.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc-----ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC--Ccc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PES 384 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 384 (532)
.+|++.+.||+|+||.||++.+. +++.+++|.+... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999975 6899999987532 123446788999999999999999999988664 457
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998842 345889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCc--ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKS--HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
...... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 543211 1122346889999999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=266.51 Aligned_cols=198 Identities=32% Similarity=0.535 Sum_probs=173.8
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.+.||+|+||.||++... |+.||+|++..... ..+++.+|+.+++.++|+||+++++++.+....++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 57888999999999999999974 89999999976544 56789999999999999999999999998899999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999998542 2236899999999999999999999998 99999999999999999999999999987633221
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
....+..|+|||.+..+.++.++||||||+++|||++ |+.||...+
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 2234668999999988889999999999999999997 999986653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=272.75 Aligned_cols=201 Identities=28% Similarity=0.493 Sum_probs=176.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999864 6889999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++. ...+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999983 245789999999999999999999998 99999999999999999999999998876544332
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....+++.|++||.+..+.++.++|+||||+++|||++|+.||...+
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 223457889999999988888999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=264.66 Aligned_cols=202 Identities=26% Similarity=0.408 Sum_probs=173.3
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeec-CCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 389 (532)
.|++.+.||+|++|.||+++.. +++.+++|++.... ....+.+.+|++++++++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999975 57899999986432 3445678899999999999999999988764 345789999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++... ....+++.+++.++.+++.++.+||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998542 3456899999999999999999999998 9999999999999999999999999988664332
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......+++.|+|||.+.+..++.++||||||++++||++|+.||...+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 2 2234567899999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=269.24 Aligned_cols=200 Identities=27% Similarity=0.476 Sum_probs=175.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..|+..++||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45788899999999999999975 58899999887543 34557789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++. ...+++.+...++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999883 346889999999999999999999988 99999999999999999999999999876644322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2233467889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=266.56 Aligned_cols=199 Identities=35% Similarity=0.559 Sum_probs=173.1
Q ss_pred ccccccCceeEEEEEecC----CCEEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLPD----GREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|++++..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999754 788999998765433 367889999999999999999999999999999999999999
Q ss_pred CChhHHhhhccC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 394 QSLDRFIFDSAK------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 394 g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
++|.+++..... ...+++.+++.++.|+++||.|||+++ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999954321 377999999999999999999999988 99999999999999999999999999987755
Q ss_pred CCc-ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 468 DKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 468 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
... .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 432 12233457889999999988889999999999999999999 699997753
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=270.71 Aligned_cols=203 Identities=29% Similarity=0.507 Sum_probs=172.1
Q ss_pred CCccccccccccCceeEEEEEec-CCC----EEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++|++.+.||+|+||.||+|.+. +|+ .+|+|.+.... .....++.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888999999999999999964 333 58999876553 3445778999999999999999999999877 78899
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
+|||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999853 2345899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccc-ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 467 EDKSHI-STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
...... .....++..|++||.+....++.++|+||||+++|||++ |+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 433221 112224568999999988889999999999999999999 9999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=270.44 Aligned_cols=200 Identities=26% Similarity=0.453 Sum_probs=173.8
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|++.+.||+|+||.||++.+. +|+.|++|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999975 68999999987654 33356789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+ +++|.+++... ...+++.+++.++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988542 366999999999999999999999998 99999999999999999999999999987655433
Q ss_pred ccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.......++..|+|||.+... .++.++||||+|++++||++|++||...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 223345688999999988654 4689999999999999999998888654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=269.92 Aligned_cols=200 Identities=30% Similarity=0.415 Sum_probs=177.0
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
+|++.+.||+|+||.||++.+. +++.+++|.+.... ....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999976 68999999986542 2445789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999843 357899999999999999999999998 9999999999999999999999999988765432
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
......++..|+|||.+....++.++|+||||+++|+|++|+.||...+.
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 22335678899999999888899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=278.68 Aligned_cols=205 Identities=27% Similarity=0.470 Sum_probs=177.3
Q ss_pred CCccccccccccCceeEEEEEec---CCC--EEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP---DGR--EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~---~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
+.....++||.|.||.||+|... .|+ .||||..+.+ .....+.|+.|..+|+.++||||++++|++.+ ...|+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34455678999999999999953 233 4788988764 34456789999999999999999999999865 46899
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
|||.++-|.|..+|.. +...++......+..||..||+|||+.. ++||||..+|||+.+..-+||+|||+++...
T Consensus 468 vmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999954 4467888999999999999999999987 9999999999999999999999999999988
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEY 523 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~~ 523 (532)
.+..+......-+..|||||.++-++++.+||||.|||.+||+++ |.+||.+....+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 777665555556889999999999999999999999999999887 999998754433
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=272.98 Aligned_cols=201 Identities=26% Similarity=0.430 Sum_probs=172.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|++.++||+|+||.||++.++ +++.+|+|++..... ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999986 589999998754322 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.++.. ....+++.+++.++.|++++|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988763 2345899999999999999999999998 9999999999999999999999999988654433
Q ss_pred ccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|++||....
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred c-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 2 2233467889999998865 457889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=272.15 Aligned_cols=200 Identities=30% Similarity=0.436 Sum_probs=174.6
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888999999999999999965 68899999886543 33457789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
+++++|.+++.. ...+++..+..++.+++.+|.|||+. + ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998843 35689999999999999999999974 5 9999999999999999999999999986543221
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.....|+..|+|||.+..+.++.++|+||||+++|||++|+.||.....
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 1235689999999999888899999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=271.78 Aligned_cols=205 Identities=28% Similarity=0.490 Sum_probs=173.1
Q ss_pred cCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.++||+|+||.||++... ++..+|+|++.... ......+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 46789999886543 33456788999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhcc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 009543 385 LLVYEFLPNQSLDRFIFDSA-------------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (532)
+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 1235788999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 446 ILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 446 iLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
|+++.++.+||+|||++......... .......+..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998765433221 1222334678999999988889999999999999999998 88898654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=266.76 Aligned_cols=200 Identities=31% Similarity=0.544 Sum_probs=175.2
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|+..+.||+|+||.||++... +++.+++|.+..... ...+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999965 689999999876544 3567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ...+++..++.++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999843 345889999999999999999999998 99999999999999999999999999887654433
Q ss_pred ccc---cccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HIS---TAIAGTLGYMAPEYLAHGQ---LTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
... ....+++.|++||.+.... .+.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 221 1346788999999988765 789999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=275.55 Aligned_cols=199 Identities=20% Similarity=0.293 Sum_probs=165.9
Q ss_pred cccccccc--CceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 317 EANKLGQG--GFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 317 ~~~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
++++||+| +|++||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999864 78999999986542 333456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998532 2345899999999999999999999998 999999999999999999999999865433211110
Q ss_pred ------ccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 472 ------ISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 472 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 1112346778999999875 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.38 Aligned_cols=201 Identities=27% Similarity=0.506 Sum_probs=173.5
Q ss_pred CccccccccccCceeEEEEEe-cCCCEEEEEEeeccC------hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
+|+..+.||+|+||.||+++. .+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999996 578999999886432 1234678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCcccc
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSF 465 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~~ 465 (532)
|+||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 356899999999999999999999998 99999999999998876 6999999998776
Q ss_pred CCCCcc---cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSH---ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... ......++..|+|||.+....++.++||||+|++++||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 543211 1223467889999999988888999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=275.34 Aligned_cols=206 Identities=28% Similarity=0.423 Sum_probs=172.1
Q ss_pred cCCccccccccccCceeEEEEEec--------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 381 (532)
.++|.+.++||+|+||.||+++.. ....+|+|++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999742 24568999886543 34456788999999999 699999999999988
Q ss_pred CcceEEEEecCCCChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
...+++|||+++++|.+++.... ....+++.++.+++.|++.||.|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 89999999999999999996422 1246899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCccc-ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 449 DSRLRAKIADFGLARSFQEDKSHI-STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
++++.+||+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |+.||...+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999998765332211 112234567999999988889999999999999999999 899986643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=270.32 Aligned_cols=192 Identities=26% Similarity=0.402 Sum_probs=160.8
Q ss_pred cccccCceeEEEEEecC-------------------------CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeee
Q 009543 320 KLGQGGFGTVYKGVLPD-------------------------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 374 (532)
+||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13588998866555555778999999999999999999
Q ss_pred eeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC--
Q 009543 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-- 452 (532)
Q Consensus 375 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-- 452 (532)
++++.+....++||||+++++|+.++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998843 3456899999999999999999999987 99999999999997654
Q ss_pred -----cEEEeecCCccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHH-HhCCCCCCCCCC
Q 009543 453 -----RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEI-VTGRQNNRSKNS 521 (532)
Q Consensus 453 -----~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el-~tG~~p~~~~~~ 521 (532)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||.....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3899999987643222 12346788999998865 5689999999999999998 579999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=264.29 Aligned_cols=197 Identities=33% Similarity=0.521 Sum_probs=169.5
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCChh
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLD 397 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 397 (532)
++||+|+||.||++.+.+++.|++|++...... ....+.+|++++++++||||+++++++.+....+++|||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999988755433 4568999999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc-ccc
Q 009543 398 RFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS-TAI 476 (532)
Q Consensus 398 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~ 476 (532)
+++.. ....+++..++.++.+++.+|.|||+++ ++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99853 2346889999999999999999999998 99999999999999999999999999876543222111 122
Q ss_pred ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 477 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.++..|+|||.+..+.++.++|+||||+++|||++ |..||....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 34667999999988889999999999999999999 899987654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=266.87 Aligned_cols=201 Identities=29% Similarity=0.457 Sum_probs=178.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.+.||+|++|.||+++.. +++.+++|++..... .....+.+|+..+..++||||+++++.+......+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46889999999999999999976 599999999876544 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
+++++|.+++.. ...+++..++.++.|+++++.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999943 3678999999999999999999999 87 9999999999999999999999999988765433
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .....++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 32 123457889999999998889999999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=277.74 Aligned_cols=205 Identities=30% Similarity=0.430 Sum_probs=169.6
Q ss_pred cCCccccccccccCceeEEEEEe------cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC-C
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG-P 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 382 (532)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999973 357889999986543 33346788999999999 689999999987654 4
Q ss_pred cceEEEEecCCCChhHHhhhccC---------------------------------------------------------
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAK--------------------------------------------------------- 405 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 405 (532)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc-cccccc
Q 009543 406 -------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIA 477 (532)
Q Consensus 406 -------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~ 477 (532)
...+++.++..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788889999999999999999998 999999999999999999999999998765433221 122234
Q ss_pred cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 478 gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 5678999999988889999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=270.15 Aligned_cols=200 Identities=28% Similarity=0.492 Sum_probs=170.0
Q ss_pred CCccccccccccCceeEEEEEe-----cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--Ccc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PES 384 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 384 (532)
..|++.++||+|+||.||+++. .++..||+|.+.... ......+.+|+.+++.++||||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478899999999999999984 357889999986553 34456799999999999999999999988775 567
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999843 2346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
....... ......++..|+|||.+.+..++.++||||||+++|||++++.|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 6543321 1223456778999999988889999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.14 Aligned_cols=213 Identities=25% Similarity=0.399 Sum_probs=176.2
Q ss_pred cChhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeee-
Q 009543 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSC- 379 (532)
Q Consensus 303 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~- 379 (532)
+.++.+..+.++|++.+.||+|+||.||+++.. +++.+++|++.... .....+.+|+.++..+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334556677899999999999999999999975 68899999875432 2235678899999999 6999999999874
Q ss_pred ----cCCcceEEEEecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 380 ----SGPESLLVYEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 380 ----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345679999999999999987532 23456899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCCccccccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
||+|||++........ ......|++.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999876543222 2233468999999998753 447889999999999999999999997643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=266.09 Aligned_cols=197 Identities=31% Similarity=0.475 Sum_probs=163.7
Q ss_pred ccccccCceeEEEEEecC-CC--EEEEEEeecc-ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLPD-GR--EIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||++++.+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 43 4688887643 344456788999999999 799999999999999999999999999
Q ss_pred CChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 394 QSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 394 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985422 1235889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
++....... .......+..|+|||++....++.++||||||+++|||++ |+.||...+
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 986432111 1111223567999999988889999999999999999997 999996543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=266.07 Aligned_cols=190 Identities=28% Similarity=0.491 Sum_probs=161.9
Q ss_pred ccccccCceeEEEEEecCCC-----------EEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 319 NKLGQGGFGTVYKGVLPDGR-----------EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986433 5788877544433 6788999999999999999999999888 778999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-------cEEEeecC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-------RAKIADFG 460 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-------~~kl~Dfg 460 (532)
|||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998542 237899999999999999999999988 99999999999999888 79999999
Q ss_pred CccccCCCCcccccccccccccccccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
++...... ....++..|+|||++... .++.++||||||+++|||++ |..||....
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 98865431 223467789999998776 78999999999999999999 688886653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=270.86 Aligned_cols=201 Identities=25% Similarity=0.391 Sum_probs=174.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|++.++||+|+||.||++.+. +++.|++|++.... ....+.+.+|+++++.++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999976 58899999886432 3344678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|++++.+..+.. +...+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877776552 3355899999999999999999999998 9999999999999999999999999988766554
Q ss_pred cccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
........++..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3233345678899999999887 7899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.25 Aligned_cols=202 Identities=28% Similarity=0.474 Sum_probs=176.7
Q ss_pred CccccccccccCceeEEEEEec--CCC--EEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP--DGR--EIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.....++||+|.||.|++|.|. .|+ .||||.+...... ...+|++|+.+|.+|+|||+++++|+..+ ....||+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 4556789999999999999986 354 4799999876544 66899999999999999999999999987 7789999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
|+++.|+|.+-|+. .....+.....-.++.|||.||.||.++. +|||||..+|+||-....+||+||||.+.+...
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999976 45667888888999999999999999998 999999999999999999999999999988665
Q ss_pred Ccc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 469 KSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 469 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+.. ......-+..|+|||.+..+.++.++|||+|||+||||+| |+.||.+-.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 543 2223345778999999999999999999999999999999 899997753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=271.52 Aligned_cols=205 Identities=26% Similarity=0.349 Sum_probs=175.1
Q ss_pred CCccccccccccCceeEEEEEecC-CCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 387 (532)
.+|..+..||+|+||.|.++..+. .+.+|||+++..- ....+--+.|-++|... +-|.+++++.++++-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468889999999999999999764 5678999986542 12223345677777776 678999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+.||+|--.+ ++-..+.+.....++.+|+-||-+||+++ ||.||||..|||||.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999998777 44566888899999999999999999999 99999999999999999999999999975322
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~ 524 (532)
. ...+.+.+|||.|+|||++...+|+..+|+|||||+||||+.|++||++.++++.
T Consensus 503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el 558 (683)
T KOG0696|consen 503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 558 (683)
T ss_pred C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 2 2234568999999999999999999999999999999999999999999776543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=270.17 Aligned_cols=201 Identities=27% Similarity=0.474 Sum_probs=170.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.+.||+|++|.||++..+ +++.||+|.+..... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999976 689999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++ +|.+++... ...+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 898887532 346899999999999999999999998 99999999999999999999999999875432221
Q ss_pred cccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 122346889999998865 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=263.92 Aligned_cols=196 Identities=29% Similarity=0.471 Sum_probs=168.1
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeee-cCCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC-SGPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 391 (532)
.+|++.+.||+|+||.||++... |..+++|.+.... ..+.+.+|+.+++.++|+|++++++++. +....+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999874 7889999885432 3467899999999999999999999764 456789999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998542 2345899999999999999999999998 9999999999999999999999999987654322
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
....++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12334678999999988889999999999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=269.77 Aligned_cols=202 Identities=26% Similarity=0.438 Sum_probs=169.3
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++++|.+.+.||+|+||.||+|... +++.+++|++..... .....+.+|+.+++.++|+||+++.+++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 689999999865432 22346788999999999999999999999998999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||++ ++|.+++.. ....+++.++..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 677666633 2346788889999999999999999998 999999999999999999999999998754332
Q ss_pred CcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 21 12233568899999998754 5788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=268.03 Aligned_cols=203 Identities=28% Similarity=0.508 Sum_probs=173.1
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
+|++.++||+|++|.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999975 688999999875533 23456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++ +|.+++........+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888755444457899999999999999999999998 99999999999999999999999999876543222
Q ss_pred cccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
......++..|++||.+.+. .++.++||||||+++|||++|+.||...+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 12234568899999987653 568899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=278.48 Aligned_cols=191 Identities=26% Similarity=0.380 Sum_probs=164.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..+|++.+.||+|+||.||+++.. +++.||+|+.... ....|+.++++++||||+++++++......++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999975 5778999975322 235689999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+. ++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 95 578887743 3457899999999999999999999998 9999999999999999999999999987533222
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~ 516 (532)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123356899999999999889999999999999999999966665
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=276.34 Aligned_cols=205 Identities=29% Similarity=0.415 Sum_probs=172.0
Q ss_pred CCccccccccccCceeEEEEEec--------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 382 (532)
.+|++.+.||+|+||.||++... .+..||+|.+.... ....+++.+|++++.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46899999999999999999742 12368999886432 34457889999999999 8999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~ 449 (532)
..++++||+++++|.+++.... ....+++.+++.++.|+++||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986421 2345889999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 450 SRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 450 ~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999866443222 1122234568999999998899999999999999999998 889987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=262.69 Aligned_cols=195 Identities=31% Similarity=0.521 Sum_probs=164.6
Q ss_pred ccccccCceeEEEEEecC----CCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLPD----GREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+.+++.+.||||+++++++. ....+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 26899999875543 34567899999999999999999999765 5568999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|.+++.. ...+++..++.++.|++.+|.|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999953 347899999999999999999999988 99999999999999999999999999987644332211
Q ss_pred --cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 474 --TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 474 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
....++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 11223567999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=272.63 Aligned_cols=202 Identities=31% Similarity=0.537 Sum_probs=169.0
Q ss_pred CCccccccccccCceeEEEEEec-CCC----EEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++|+..+.||+|+||.||++.+. +++ .+|+|.+.... .....++.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCcee
Confidence 56788999999999999999864 444 47888876543 2334578899999999999999999998865 45679
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
++||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999853 2346899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 467 EDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
..... ......++..|++||.+....++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 43322 1223345778999999988889999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=268.70 Aligned_cols=200 Identities=27% Similarity=0.377 Sum_probs=171.2
Q ss_pred CccccccccccCceeEEEEEe----cCCCEEEEEEeeccC----hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcc
Q 009543 314 SFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFNN----RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 384 (532)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+.++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999986 368999999986532 22346688899999999 599999999999998889
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 356889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcccccccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.............|+..|++||.+... .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 654333323345688999999998653 4678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=266.81 Aligned_cols=199 Identities=28% Similarity=0.524 Sum_probs=172.6
Q ss_pred CccccccccccCceeEEEEEe-cCCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCc---cceeeeeeeeeecCCcceEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 388 (532)
.|+..+.||+|+||.||+|.+ .+++.+++|.+... ......++.+|+.+++.++ |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 578889999999999999996 47899999988654 3344567889999999986 999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ..+++...+.++.|+++||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998832 36899999999999999999999998 999999999999999999999999998876544
Q ss_pred CcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .....|+..|+|||.+..+ .++.++|+||||+++|||++|+.||....
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 2334688999999988654 46889999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=268.76 Aligned_cols=212 Identities=28% Similarity=0.404 Sum_probs=175.8
Q ss_pred ChhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC
Q 009543 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (532)
Q Consensus 304 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 381 (532)
....+..++++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++..+ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34555667899999999999999999999974 68899999886432 2345677899999998 899999999988754
Q ss_pred -----CcceEEEEecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEE
Q 009543 382 -----PESLLVYEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAK 455 (532)
Q Consensus 382 -----~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~k 455 (532)
...++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3578999999999999988532 23457899999999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCCCcccccccccccccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 456 IADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG-----QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 456 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|+|||++......... .....++..|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 169 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 169 LVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred Eeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 9999998865433221 2234678999999987643 26789999999999999999999997643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.43 Aligned_cols=210 Identities=30% Similarity=0.448 Sum_probs=180.0
Q ss_pred hHHHhcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 307 TLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 307 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
.+...+-+|+...+||.|.||.||.+.. ++|...|+|-+.... ......+.+|+.++..++|||+|+.+|+-.+++.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 3455677899999999999999999995 568889999876543 3344678899999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.+|.||||++|+|.+.+. .+...++.....+..|++.|+.|||+++ |+||||||.||+|+.+|.+|++|||.+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence 999999999999999983 3445677777788899999999999999 9999999999999999999999999999
Q ss_pred ccCCCCcc---cccccccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 464 SFQEDKSH---ISTAIAGTLGYMAPEYLAHG---QLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 464 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
.+.+.... .-+..+||+-|||||++.+. ....+.||||+||+++||+||++||...+.+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 88766422 12456899999999999653 4567899999999999999999999876543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.75 Aligned_cols=196 Identities=33% Similarity=0.488 Sum_probs=172.4
Q ss_pred cccccCceeEEEEEecC-CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCChhH
Q 009543 320 KLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 398 (532)
.||+|.||+||-|++.+ ...+|||.+...+....+.+.+||.+-++++|.|||+.+|.+.+++..-+.||-+|||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999764 55789999987777777889999999999999999999999999999999999999999999
Q ss_pred HhhhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc-CCCcEEEeecCCccccCCCCcccccc
Q 009543 399 FIFDSAKAKTL--TWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQEDKSHISTA 475 (532)
Q Consensus 399 ~l~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~-~~~~~kl~Dfgl~~~~~~~~~~~~~~ 475 (532)
+|.. +-+++ .+..+-.+.+||++||.|||++. |+|||||-.|||++ -.|.+||+|||-++.+..-.. .+.+
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TET 735 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTET 735 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-cccc
Confidence 9953 45566 67778889999999999999998 99999999999996 478999999999988754333 3445
Q ss_pred cccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 476 IAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 476 ~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.-||..|||||++..+ .|+.++|||||||++.||.||++||....+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 6799999999999765 589999999999999999999999976543
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=262.63 Aligned_cols=201 Identities=34% Similarity=0.568 Sum_probs=172.6
Q ss_pred ccccccccccCceeEEEEEecC-----CCEEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 315 FDEANKLGQGGFGTVYKGVLPD-----GREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
+++.+.||+|+||.||++++.+ +..||+|++...... ..+.+.+|+.++..++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999753 378999999655433 5678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999985321 122899999999999999999999998 999999999999999999999999999876554
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
.........+++.|++||.+....++.++||||||++++||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3322222336789999999988889999999999999999998 88888754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=264.96 Aligned_cols=199 Identities=26% Similarity=0.461 Sum_probs=170.0
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccCh----------hhHHHHHHHHhHhhcCccceeeeeeeeeecCC
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR----------HRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 382 (532)
+|.+.+.||+|+||.||+|... +|+.+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999864 689999998854211 11346788999999999999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999843 357899999999999999999999988 999999999999999999999999998
Q ss_pred cccCCCCcc-cccccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 463 RSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQ--LTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 463 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
......... ......++..|+|||.+.... ++.++|+||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 765432211 123346788999999987654 78999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=261.66 Aligned_cols=201 Identities=22% Similarity=0.387 Sum_probs=174.7
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|++.++||+|+||.||+++.. +|+.+++|++... ......++.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999964 6899999998643 234456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988532 2345789999999999999999999988 99999999999999999999999999876644322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
. .....|++.|+|||.+.++..+.++|+||||++++||++|+.||...
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 157 L-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred h-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 1 22345788999999998888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=271.87 Aligned_cols=205 Identities=25% Similarity=0.413 Sum_probs=170.8
Q ss_pred CccccccccccCceeEEEEEec---CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--Ccce
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP---DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESL 385 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 385 (532)
.|++.++||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999975 47899999987633 33446788999999999999999999999887 7789
Q ss_pred EEEEecCCCChhHHhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC----CCcEEEeec
Q 009543 386 LVYEFLPNQSLDRFIFDSA--KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS----RLRAKIADF 459 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~----~~~~kl~Df 459 (532)
+||||+++ +|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5666553222 2236899999999999999999999998 999999999999999 999999999
Q ss_pred CCccccCCCCc--cccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 460 GLARSFQEDKS--HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 460 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
|++........ .......++..|+|||.+.+ ..++.++||||||++++||++|+.||.....+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 99887644332 12234467889999998765 45789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=266.45 Aligned_cols=200 Identities=30% Similarity=0.458 Sum_probs=166.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhH-hhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNI-ISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|++.+.||+|+||.||++.+. +|+.||+|++.... ......+..|+.+ ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999975 68999999986543 2333455666665 566789999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 390 FLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 390 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|++ ++|.+++... .....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6787777432 2345789999999999999999999986 6 99999999999999999999999999876543
Q ss_pred CCccccccccccccccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAH----GQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.. ......++..|+|||.+.. ..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 22 1223467889999998754 4568899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=266.41 Aligned_cols=199 Identities=30% Similarity=0.514 Sum_probs=173.9
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3555679999999999999964 688999999876655556778999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++.. ..+++..+..++.|++.+|+|||+++ |+||||+|+||+++.++.++|+|||++.........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 9999998843 46899999999999999999999998 999999999999999999999999988765433221
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....|++.|+|||.+....++.++||||||+++|||++|+.||...+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 223468899999999988889999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=263.24 Aligned_cols=202 Identities=30% Similarity=0.477 Sum_probs=172.1
Q ss_pred CccccccccccCceeEEEEEecC--CCEEEEEEeecc----------ChhhHHHHHHHHhHhhc-Cccceeeeeeeeeec
Q 009543 314 SFDEANKLGQGGFGTVYKGVLPD--GREIAVKRLFFN----------NRHRAANFYNEVNIISS-VEHKNLVRLLGCSCS 380 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 380 (532)
+|++.+.||+|+||.||++.+.. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 688999987532 12234567788888875 799999999999999
Q ss_pred CCcceEEEEecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEEEcCCCcEEEee
Q 009543 381 GPESLLVYEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIAD 458 (532)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiLl~~~~~~kl~D 458 (532)
.+..+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887432 234578999999999999999999996 45 99999999999999999999999
Q ss_pred cCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 459 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
||++....... ......++..|++||.+.++.++.++||||||+++|||++|+.||....
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 99998765433 2234568899999999998889999999999999999999999996643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=266.28 Aligned_cols=204 Identities=29% Similarity=0.494 Sum_probs=178.6
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
...+.|+..+.||+|++|.||++.++ +++.+++|++..... ..+.+.+|+++++.++|+||+++++.+......++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35567889999999999999999986 689999999976554 5567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999995422 47999999999999999999999988 999999999999999999999999998765433
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ......++..|++||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1223457889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=265.56 Aligned_cols=199 Identities=29% Similarity=0.485 Sum_probs=175.1
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|+..+.||+|+||.||++.+. +++.+++|++.... .....++.+|+++++.++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888899999999999999986 68999999887653 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
+++++|.+++... ...+++..+..++.|++++|.|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999998542 2678999999999999999999999 77 9999999999999999999999999987653322
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 1256788999999998889999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=268.37 Aligned_cols=198 Identities=26% Similarity=0.443 Sum_probs=167.9
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|++.+.||+|+||.||+++.. +|+.+++|++.... ......+.+|+.+++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888999999999999999975 68999999986542 22235678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++ +|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 974 77777643 2356899999999999999999999998 99999999999999999999999999886543322
Q ss_pred ccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 1 2234578899999988664 478999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=281.06 Aligned_cols=194 Identities=30% Similarity=0.506 Sum_probs=167.2
Q ss_pred ccccccccCceeEEEEEec-CCCEEEEEEeec----cChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc--ceEEEE
Q 009543 317 EANKLGQGGFGTVYKGVLP-DGREIAVKRLFF----NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE--SLLVYE 389 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e 389 (532)
....||+|.|-+||||.+. +|-+||--.++. .+....++|..|+.+|+.|+||||++++..+.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3567999999999999985 577776433322 234556889999999999999999999999987665 779999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecCCccccCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQED 468 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfgl~~~~~~~ 468 (532)
.+..|+|..|+. +.+.++...+..|++||++||.|||++. +||||||||-.||+|+.+ |.+||+|+|||......
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999994 5567889999999999999999999986 799999999999999876 79999999999876544
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.. ....|||.|||||... ..|...+||||||+-++||+|+..||+.
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 32 3478999999999986 7899999999999999999999999964
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=264.10 Aligned_cols=199 Identities=27% Similarity=0.473 Sum_probs=173.1
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
-|++.++||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++..++||||+++++.+..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778889999999999999864 68899999876443 334467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999883 346899999999999999999999988 99999999999999999999999999876543321
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......++..|++||.+....++.++|+||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 1233467889999999988888999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.12 Aligned_cols=201 Identities=23% Similarity=0.397 Sum_probs=161.0
Q ss_pred hcCCccccccccccCceeEEEEEecC--CCEEEEE------------------EeeccChhhHHHHHHHHhHhhcCccce
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPD--GREIAVK------------------RLFFNNRHRAANFYNEVNIISSVEHKN 370 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 370 (532)
..++|+++++||+|+||+||++.++. +...++| ++. ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 111 11223456889999999999999
Q ss_pred eeeeeeeeecCCcceEEEEecCCCChhHHhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAK--AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 371 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
|+++++++...+..++++|++. ++|.+++..... .......+...++.||+.||.|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 466666643211 122345677889999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 009543 449 DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~ 516 (532)
+.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999877554433334467999999999999989999999999999999999988654
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=282.16 Aligned_cols=203 Identities=27% Similarity=0.449 Sum_probs=178.0
Q ss_pred cCCccccccccccCceeEEEEEecCCC-EEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGR-EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.+.|+++..||.|+||.||++..++.. .-|.|++...+....++++-||+||...+||+|+++++.|..++.+|++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 356888999999999999999987544 4577888888888889999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
|.||-.+.++.. -...+++.++.-+..|++.||.|||++. |||||||+.|||++-+|.++|+|||.+..... ..
T Consensus 111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~ 184 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TR 184 (1187)
T ss_pred cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HH
Confidence 999999999864 3567999999999999999999999998 99999999999999999999999998754221 11
Q ss_pred ccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.......|||.|||||++. +.+|..++||||||+.|.||..+.+|-...+
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 1234578999999999874 5689999999999999999999999987654
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=264.77 Aligned_cols=194 Identities=29% Similarity=0.420 Sum_probs=167.4
Q ss_pred ccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
||+|+||+||++... +|+.+++|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 68999999986532 22344567899999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccc
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 476 (532)
.+++.... ...+++.+++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 99985432 246899999999999999999999998 9999999999999999999999999987654322 12234
Q ss_pred ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 477 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.++..|++||.+.++.++.++||||||++++||++|+.||....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 57889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=268.24 Aligned_cols=200 Identities=31% Similarity=0.469 Sum_probs=170.3
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccChh-----hHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH-----RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
+|++.+.||+|+||.||+|... +++.|++|++...... ....+.+|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999975 6899999999755322 335677899999999999999999999998999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+ +++|.+++... ...+++..++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 89999998432 236999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||...+
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 3222 122346788999998854 467899999999999999999988876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=260.70 Aligned_cols=201 Identities=22% Similarity=0.424 Sum_probs=173.9
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|+..+.||+|+||.||++... +++.+++|++... .......+.+|+++++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999974 6889999998654 233456789999999999999999999999988999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfgl~~~~~~~~ 469 (532)
+++++|.+++... ....+++..++.++.+++++|.|||+++ ++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999542 2456899999999999999999999998 9999999999999865 468999999998765432
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 2 223467889999999988888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=261.36 Aligned_cols=195 Identities=32% Similarity=0.472 Sum_probs=160.0
Q ss_pred ccccccCceeEEEEEec----CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeee-cCCcceEEEEecC
Q 009543 319 NKLGQGGFGTVYKGVLP----DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSC-SGPESLLVYEFLP 392 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 392 (532)
+.||+|+||.||+|.+. +...+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 2457999988543 3344578889999999999999999999765 4556789999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc-
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH- 471 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~- 471 (532)
+++|.+++.. .....++..+..++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999853 2345678888999999999999999987 999999999999999999999999998765432211
Q ss_pred --cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q 009543 472 --ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG-RQNNRS 518 (532)
Q Consensus 472 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG-~~p~~~ 518 (532)
......++..|+|||.+....++.++||||||+++|||++| ..||..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 11223457789999999888899999999999999999995 555643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=262.67 Aligned_cols=198 Identities=21% Similarity=0.353 Sum_probs=159.8
Q ss_pred ccccccCceeEEEEEecCC---CEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 319 NKLGQGGFGTVYKGVLPDG---REIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
++||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986443 345677665443 344578999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc-cc
Q 009543 395 SLDRFIFDSAK-AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS-HI 472 (532)
Q Consensus 395 ~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~-~~ 472 (532)
+|.+++..... ....++..++.++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999864322 345677788899999999999999988 99999999999999999999999999764322211 12
Q ss_pred cccccccccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAH-------GQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 234567889999998753 235779999999999999997 57788643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=265.87 Aligned_cols=201 Identities=29% Similarity=0.505 Sum_probs=170.4
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|+..+.||+|++|.||+++.. +++.|+||++.... ......+.+|++++++++||||+++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999975 68999999886443 22335788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
++ ++|..++... ....+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5888887542 3457899999999999999999999998 99999999999999999999999999876543322
Q ss_pred ccccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||...+
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 22335688999999886544 6889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=264.51 Aligned_cols=192 Identities=27% Similarity=0.399 Sum_probs=159.4
Q ss_pred cccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhh---cCccceeeeeeeeeecCCcceEEEEecC
Q 009543 320 KLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIIS---SVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++. ..+||||+++++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 68899999886432 122233445544433 4479999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 999999884 3456999999999999999999999998 99999999999999999999999999875543221
Q ss_pred cccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....|++.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 23468999999999864 557899999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=268.54 Aligned_cols=211 Identities=28% Similarity=0.428 Sum_probs=176.6
Q ss_pred hhhHHHhcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChh-------hHHHHHHHHhHhhcCccceeeeeee
Q 009543 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRH-------RAANFYNEVNIISSVEHKNLVRLLG 376 (532)
Q Consensus 305 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~ 376 (532)
|.+-....++|-.+++||+|||++||++.+ ...+.||+|+-...... -.+...+|..|-+.|+||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 344455667899999999999999999994 56888999987544322 1245778999999999999999999
Q ss_pred eeec-CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---CC
Q 009543 377 CSCS-GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RL 452 (532)
Q Consensus 377 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~~ 452 (532)
++.- .+..+-|+||++|.+|+-+| +..+.+++.+...|+.||..||.||.+.. +||||-||||.||||-. -|
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccc
Confidence 9865 45567899999999999999 35677999999999999999999999874 78999999999999954 47
Q ss_pred cEEEeecCCccccCCCCcc------ccccccccccccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 453 RAKIADFGLARSFQEDKSH------ISTAIAGTLGYMAPEYLAH----GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.+||+|||++++.+.+... .+....||.+|++||.+-- .+.+.|+||||+|||+|..+.|++||...
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 8999999999988665433 2334579999999998743 35788999999999999999999999874
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=264.52 Aligned_cols=198 Identities=34% Similarity=0.535 Sum_probs=166.7
Q ss_pred ccccccCceeEEEEEecC-------CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 319 NKLGQGGFGTVYKGVLPD-------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999999642 2578999876443 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-----cEEEeecCC
Q 009543 391 LPNQSLDRFIFDSA----KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-----RAKIADFGL 461 (532)
Q Consensus 391 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-----~~kl~Dfgl 461 (532)
+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996432 2245789999999999999999999987 99999999999999887 899999999
Q ss_pred ccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 462 ARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 462 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
+......... ......++..|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 8765433221 1222345788999999998899999999999999999998 99999654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=267.20 Aligned_cols=195 Identities=29% Similarity=0.497 Sum_probs=171.2
Q ss_pred ccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCC
Q 009543 317 EANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQS 395 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 395 (532)
...+||+|+||.||++... +++.||+|++..........+.+|+.+++.++||||+++++.+...+..+++|||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3468999999999999874 789999999876555566779999999999999999999999999999999999999999
Q ss_pred hhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccccc
Q 009543 396 LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475 (532)
Q Consensus 396 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 475 (532)
|.+++. ...+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 104 L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 104 LTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 999873 345899999999999999999999998 99999999999999999999999999876543221 1233
Q ss_pred cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 476 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
..+++.|++||.+....++.++|+||||+++|||++|+.||...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 46789999999998888899999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=257.22 Aligned_cols=199 Identities=34% Similarity=0.560 Sum_probs=177.6
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
.|+..+.||+|++|.||++... +++.+++|++..........+.+|+++++.++||||+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999986 689999999977665566789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++... ...+++..+..++.|++++|.+||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999998432 257899999999999999999999987 99999999999999999999999999887655432
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.....++..|++||.+.....+.++||||||++++||++|+.||...
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23456788999999998888899999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=265.46 Aligned_cols=208 Identities=27% Similarity=0.443 Sum_probs=172.8
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeec---
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCS--- 380 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--- 380 (532)
..+....+.|++.+.||+|+||.||++++. +++.+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 344456688999999999999999999974 68899999886543 3345688899999998 69999999998853
Q ss_pred ---CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 381 ---GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 381 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
....+++|||+++++|.+++.. .....+++..++.++.|+++||.|||+.+ |+|+||||+||++++++.++|+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHH-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 3467899999999999998854 23456888999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCcccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 458 DFGLARSFQEDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 458 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
|||++........ ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9999876543221 123356889999999875 345788999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=261.61 Aligned_cols=196 Identities=31% Similarity=0.516 Sum_probs=167.8
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.+.||+|+||.||++.. +++.+|+|++.... ..+.+.+|+.+++.++||||+++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999986 67889999886432 346788999999999999999999988654 5799999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998543 2346899999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.....+..|+|||.+..+.++.++|+||||+++|||++ |+.||...+
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 12234678999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=264.18 Aligned_cols=205 Identities=30% Similarity=0.464 Sum_probs=173.4
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCC-----
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP----- 382 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~----- 382 (532)
..+++|++.+.||+|++|.||++... +++.+++|++..... ..+.+.+|+.+++++ +||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999975 678999998865543 346789999999999 7999999999987654
Q ss_pred -cceEEEEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 383 -ESLLVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
..+++|||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3799999999999999885422 2467899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9876543222 1233458899999998753 34678999999999999999999999754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=265.90 Aligned_cols=201 Identities=27% Similarity=0.449 Sum_probs=170.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecC--CcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 387 (532)
++|++.+.||+|+||.||+|..+ +++.+++|.+..... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46889999999999999999976 588999999875432 2234577899999999999999999998877 789999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++ +|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 898887432 246899999999999999999999998 99999999999999999999999999887654
Q ss_pred CCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3221 2234578899999988654 46889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=260.30 Aligned_cols=203 Identities=29% Similarity=0.474 Sum_probs=173.5
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeec--CCcceEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLLVY 388 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 388 (532)
+|++.+.||.|+||.||++... +++.+++|++... .....+.+.+|+++++.++||||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788999999999999999864 6889999988643 33445678899999999999999999997764 34578999
Q ss_pred EecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 389 EFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLH-----EQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 389 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
||+++++|.+++... .....+++..++.++.|+++||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998543 22467899999999999999999999 555 999999999999999999999999999
Q ss_pred cccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......... .....+++.|++||.+....++.++|+||||+++++|++|+.||...+
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 876544321 223468999999999988889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=273.24 Aligned_cols=221 Identities=26% Similarity=0.397 Sum_probs=184.6
Q ss_pred ChhhHHHh---cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeee
Q 009543 304 KYSTLEKA---TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLG 376 (532)
Q Consensus 304 ~~~~l~~~---~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~ 376 (532)
.|..+..+ ..-|..++.||-|+||+|-++.. ++...+|+|.+.+.+ +......+.|-.||...+.+-||+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 34444444 34588899999999999999884 456778999987654 344556788999999999999999999
Q ss_pred eeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 377 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
.|.+.+.+|+||||++||++-.+|. +-..+.+.....++.++..|+++.|+.| +|||||||.|||||.+|++||
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceee
Confidence 9999999999999999999999884 4567889999999999999999999998 999999999999999999999
Q ss_pred eecCCcccc---------CCCC-----------------c---------------ccccccccccccccccccccCCCCc
Q 009543 457 ADFGLARSF---------QEDK-----------------S---------------HISTAIAGTLGYMAPEYLAHGQLTE 495 (532)
Q Consensus 457 ~Dfgl~~~~---------~~~~-----------------~---------------~~~~~~~gt~~y~aPE~~~~~~~~~ 495 (532)
+||||+.-+ .... . ......+||+.|+|||++.+..++.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 999997432 1100 0 0113468999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCcccc-ccccc
Q 009543 496 KADVYSFGMLLLEIVTGRQNNRSKNSEYTD-SLLTI 530 (532)
Q Consensus 496 ~~Dv~SlGvll~el~tG~~p~~~~~~~~~~-~l~~~ 530 (532)
.+|+||.|||||||+.|+.||-...+.+.+ .++.|
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 999999999999999999999887766553 45555
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=272.57 Aligned_cols=200 Identities=27% Similarity=0.466 Sum_probs=167.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-----cc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-----ES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 384 (532)
.++|++.++||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999964 68999999986432 334467889999999999999999998865443 46
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++++||+++ +|.+++ ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 777766 3356999999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCcc--ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5433221 1123467899999998654 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=259.91 Aligned_cols=192 Identities=28% Similarity=0.395 Sum_probs=169.2
Q ss_pred ccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
||.|+||.||+++.. +++.+++|++.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999975 58999999986542 23446789999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccc
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 476 (532)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999843 345899999999999999999999988 9999999999999999999999999998765432 12234
Q ss_pred ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 477 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.+++.|++||.+....++.++|+||||+++|||++|+.||....
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 67889999999988888999999999999999999999998765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=263.32 Aligned_cols=201 Identities=28% Similarity=0.395 Sum_probs=172.6
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--CcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 388 (532)
++|+..+.||.|++|.||++.+. +++.+|+|.+.... ......+.+|+++++.++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999975 68899999887543 34457799999999999999999999988654 3678999
Q ss_pred EecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 389 EFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 389 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 23456889999999999999999999998 99999999999999999999999999875533
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
... ....++..|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 221 2345688999999998889999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=264.99 Aligned_cols=203 Identities=30% Similarity=0.492 Sum_probs=172.8
Q ss_pred CCccccccccccCceeEEEEEec-----CCCEEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeec--CCcc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-----DGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCS--GPES 384 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 384 (532)
..|++.+.||+|+||.||++++. +++.+|+|++...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999863 3678999998765443 46789999999999999999999998877 5578
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
+++|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999532 236899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....... ......++..|++||.+....++.++||||||++++||++|+.|+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 7533221 1122345667999999988889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=263.76 Aligned_cols=191 Identities=26% Similarity=0.442 Sum_probs=161.3
Q ss_pred ccccccCceeEEEEEecC--------CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 319 NKLGQGGFGTVYKGVLPD--------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+.||+|+||.||+|.... ..++++|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888888655555567889999999999999999999999998999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc--------EEEeecCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR--------AKIADFGLA 462 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~--------~kl~Dfgl~ 462 (532)
+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998532 346899999999999999999999998 999999999999988765 699999988
Q ss_pred cccCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCC-CCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR-QNNRSK 519 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~-~p~~~~ 519 (532)
...... ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+...
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 654322 224578899999999764 5789999999999999999995 666544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=259.40 Aligned_cols=194 Identities=24% Similarity=0.333 Sum_probs=162.0
Q ss_pred hcCCccccccc--cccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKL--GQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~l--G~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 386 (532)
..++|++.+.+ |+|+||.||++..+ +++.+++|.+........ |+.....+ +||||+++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34567777776 99999999999965 678899998864322111 22222222 79999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCcccc
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSF 465 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~~ 465 (532)
||||+++++|.+++.. ...+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999843 347999999999999999999999998 99999999999999998 9999999998765
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... ...++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 4322 2357889999999998889999999999999999999999998543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=270.03 Aligned_cols=201 Identities=23% Similarity=0.401 Sum_probs=171.7
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeec--cChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFF--NNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 388 (532)
...|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+.+|.+|+ |.+|++++++-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 356999999999999999999998889999988754 35667788999999999995 999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
|+= ..+|..+|... ...++.-.++.+..||+.++.++|+++ |||.||||.|+|+- .|.+||+|||++..+..+
T Consensus 440 E~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 975 56899988542 222332377888999999999999999 99999999999995 579999999999988877
Q ss_pred Ccc-cccccccccccccccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 469 KSH-ISTAIAGTLGYMAPEYLAHG-----------QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 469 ~~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
... .....+||+.||+||.+... +.++++||||+|||||+|+.|+.||...
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 655 45667999999999987422 2578999999999999999999999753
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=264.64 Aligned_cols=202 Identities=25% Similarity=0.431 Sum_probs=168.1
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCc-----
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPE----- 383 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----- 383 (532)
++|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999975 689999998765432 23457888999999995 6999999999877665
Q ss_pred ceEEEEecCCCChhHHhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-CCcEEEeecC
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAK--AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFG 460 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfg 460 (532)
.+++|||+++ +|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78888754322 356899999999999999999999998 999999999999999 8899999999
Q ss_pred CccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
++..+...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 98865432221 122356888999998765 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=265.50 Aligned_cols=197 Identities=30% Similarity=0.465 Sum_probs=168.4
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
...|++.+.||+|+||.||+++.. +++.|++|++.... ......+.+|+++++.++||||+++.+++.+....++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999975 68999999886432 23345788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
+||++ |++.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 566666632 2346899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
. ....+++.|+|||.+. .+.++.++||||||+++|||++|+.||...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 2 2345788999999874 456889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=235.14 Aligned_cols=200 Identities=29% Similarity=0.470 Sum_probs=169.9
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|...++||+|.||+||+++.. +++.||+|+++..+ +.......+|+-+++.++|+|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5777889999999999999965 67889999997654 33346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+. .+|..+.. .-++.++.+...+++.|+++||.++|+++ +.||||||.|.|++.+|++||+|||+++-+.-...
T Consensus 83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 47777763 34578999999999999999999999998 99999999999999999999999999998765433
Q ss_pred ccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.. ...+-|.+|.+|.++.+. -|+...|+||-|||+.|+.. |++.|-+.+
T Consensus 157 cy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 157 CY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred ee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 32 234568999999998764 58899999999999999988 555565543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=240.21 Aligned_cols=206 Identities=28% Similarity=0.408 Sum_probs=171.1
Q ss_pred HhcCCccccccccccCceeEEEEEe-cCCCEEEEEEeecc-ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 386 (532)
...+....+..||+|++|.|-+.++ .+|+..|+|++... ..+..++.++|+.+..+- ..|.+|+++|....+...++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3344555677899999999998886 47999999999765 345567788888877654 79999999999999999999
Q ss_pred EEEecCCCChhHHhhh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 387 VYEFLPNQSLDRFIFD-SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
.||.|. .+|+.+-.+ ..++..+++.-+-+|+..+.+||.|||++- .+||||+||+|||++.+|++||+|||++-.+
T Consensus 123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999994 477766432 245678999999999999999999999875 5999999999999999999999999999876
Q ss_pred CCCCccccccccccccccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAH----GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.++-. .+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.||....
T Consensus 200 ~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 200 VDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 54432 233457889999998753 478999999999999999999999998754
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=262.70 Aligned_cols=200 Identities=30% Similarity=0.471 Sum_probs=171.1
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--CcceEEEE
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLVYE 389 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 389 (532)
|++.++||+|+||.||+++.. +++.+++|++.... ......+.+|+++++.++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999976 58899999997653 33346788999999999999999999999887 78999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++ +|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888887432 257899999999999999999999998 9999999999999999999999999998765543
Q ss_pred ccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 322333456888999997764 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-33 Score=271.54 Aligned_cols=195 Identities=29% Similarity=0.438 Sum_probs=170.1
Q ss_pred cccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 318 ANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
.+.||.|.||+||-|+++ +|+.||||++.+. ......++.+|+.||+.+.||.||.+...+++.+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999975 7999999998643 2344578899999999999999999999999999999999999665
Q ss_pred ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC---CcEEEeecCCccccCCCCcc
Q 009543 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~---~~~kl~Dfgl~~~~~~~~~~ 471 (532)
-|+-+| . .+...+++.....++.||+.||.|||.++ |+|-||||+||||.+. -++||+|||+++.+.+..-.
T Consensus 649 MLEMIL-S-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMIL-S-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHH-H-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 454444 3 34567899999999999999999999998 9999999999999654 37999999999998765433
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
...+|||.|+|||++.++.|...-|+||+|||+|--++|..||...
T Consensus 724 --rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 724 --RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred --hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 4578999999999999999999999999999999999999999753
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=261.27 Aligned_cols=191 Identities=27% Similarity=0.407 Sum_probs=159.5
Q ss_pred cccccCceeEEEEEec-CCCEEEEEEeeccCh---hhHHHHHHHH---hHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 320 KLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEV---NIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
.||+|+||.||++... +++.||+|.+..... .....+.+|. .+++...||||+++++.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 688999998865421 1122233443 34445689999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++. +...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998884 3457999999999999999999999988 9999999999999999999999999987654322
Q ss_pred ccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 1234689999999998754 5889999999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=259.60 Aligned_cols=203 Identities=27% Similarity=0.461 Sum_probs=167.3
Q ss_pred ccccccccccCceeEEEEEec----CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC------
Q 009543 315 FDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ 382 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 382 (532)
|.+.+.||+|+||.||+|.+. +++.||||++... .....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999863 3688999988654 3344567899999999999999999999876532
Q ss_pred cceEEEEecCCCChhHHhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeec
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSA---KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Df 459 (532)
..++++||+++++|.+++.... +...+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 2235789999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 460 GLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 460 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||...+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 998866433321 1222345678999999988888999999999999999999 899987543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=270.89 Aligned_cols=199 Identities=29% Similarity=0.404 Sum_probs=169.5
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC------
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------ 381 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 381 (532)
..++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999965 7899999988543 233446778899999999999999999987643
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346899999964 77777632 2889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++....... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 986543322 233457889999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=262.69 Aligned_cols=201 Identities=27% Similarity=0.442 Sum_probs=167.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|++.+.||+|++|.||+|++. +++.|++|++..... .....+.+|+++++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999975 689999998865432 334578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-CCcEEEeecCCccccCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQED 468 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfgl~~~~~~~ 468 (532)
|++ ++|.+++... ....+++..++.++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 4777776432 2334688889999999999999999998 999999999999985 557999999999765432
Q ss_pred Cccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.. ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 1223457889999998865 45789999999999999999999999764
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=264.96 Aligned_cols=204 Identities=29% Similarity=0.463 Sum_probs=170.6
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCC----
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP---- 382 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 382 (532)
...++|++.+.||+|+||.||+|.++ +++.||+|++.... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 58899999987543 223356788999999999999999999887654
Q ss_pred ------cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 383 ------ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 383 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
..++++||+++ ++...+.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 68899999986 66666632 2457899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 457 ADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+|||++...............++..|++||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998765443222223346788999998764 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=260.48 Aligned_cols=194 Identities=27% Similarity=0.409 Sum_probs=168.7
Q ss_pred ccccCceeEEEEEec-CCCEEEEEEeeccCh---hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
||+|+||.||+++.. +|+.+++|.+..... ...+.+.+|++++..++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 499999999865433 4456788999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc------
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS------ 470 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~------ 470 (532)
.+++.. ...+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999853 247899999999999999999999998 99999999999999999999999999876543321
Q ss_pred -ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 -HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.......++..|++||.......+.++||||||+++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12233457889999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=261.26 Aligned_cols=199 Identities=30% Similarity=0.491 Sum_probs=168.6
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
|++.++||+|++|.||++.+. +|+.|++|++.... ......+.+|+++++.++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999975 79999999987543 223357889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
+ ++|.+++... ....+++..++.++.|+++||.|||+++ ++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 6898888432 2246899999999999999999999987 999999999999999999999999998765432221
Q ss_pred cccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1223568899999987654 5688999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=258.20 Aligned_cols=201 Identities=24% Similarity=0.418 Sum_probs=173.2
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|++.+.||+|+||.||++..+ +|..+|+|.+.... ....+.+.+|+++++.++||||+++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999976 58899999986542 23345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~~~~~~ 469 (532)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2345799999999999999999999988 99999999999999886 57999999987765432
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.. .....|++.|+|||.+....++.++|+||||++++||++|+.||...
T Consensus 157 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 157 EL-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred cc-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 21 22345888999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=265.82 Aligned_cols=202 Identities=30% Similarity=0.466 Sum_probs=168.7
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecC--CcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 386 (532)
.++|++.+.||+|+||.||++.+. +|+.||+|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999975 689999999865432 2233567899999999999999999998755 45799
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++ +|.+++... ...+++.+++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 788877432 356899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 43221 222345788999998865 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=257.64 Aligned_cols=191 Identities=28% Similarity=0.370 Sum_probs=161.7
Q ss_pred ccccccCceeEEEEEec-CCCEEEEEEeeccCh---hhHHHHHHHHhH-hhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNI-ISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+|+||.||++... +++.||+|.+..... .....+..|..+ ....+|||++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999975 689999999864432 222334455444 4455899999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
++|.+++. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++..... .
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999984 3356899999999999999999999988 99999999999999999999999999875433 2
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....++..|++||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 23457889999999988888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=265.35 Aligned_cols=203 Identities=29% Similarity=0.455 Sum_probs=167.7
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc-----
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE----- 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 383 (532)
-++|++.++||+|+||.||+++.. +++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999975 68999999886543 2223456789999999999999999998876543
Q ss_pred ---ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 384 ---SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 384 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
.++||||+.+ +|.+.+.. ....+++.+++.++.|+++||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4899999975 77777732 2346899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCcc---cccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSH---ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99866433221 11234578899999987654 46889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=254.50 Aligned_cols=199 Identities=28% Similarity=0.508 Sum_probs=175.9
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|++.+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++++++|||++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999875 678999999976543 4557899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ...+++..++.++.|++.+|.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999843 367899999999999999999999998 99999999999999999999999999987755433
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
. .....++..|++||.......+.++||||||+++|||++|+.||...
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 2 23346788999999988877899999999999999999999999754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=262.89 Aligned_cols=202 Identities=22% Similarity=0.306 Sum_probs=154.6
Q ss_pred hcCCccccccccccCceeEEEEEecC----CCEEEEEEeeccChhhH-----------HHHHHHHhHhhcCccceeeeee
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFNNRHRA-----------ANFYNEVNIISSVEHKNLVRLL 375 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~ 375 (532)
..++|++.++||+|+||.||+|.+.+ +..+++|+......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999999754 34566665433222110 1122334455677899999999
Q ss_pred eeeecCCc----ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC
Q 009543 376 GCSCSGPE----SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR 451 (532)
Q Consensus 376 ~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~ 451 (532)
++...... .++++|++.. ++.+.+. .....++..+..++.|+++||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 97655432 3567776643 5555552 2234578889999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 452 LRAKIADFGLARSFQEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 452 ~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+.++|+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999876432211 112346899999999999999999999999999999999999999875
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=254.93 Aligned_cols=201 Identities=30% Similarity=0.469 Sum_probs=177.1
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecC--CcceEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLVY 388 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 388 (532)
+|++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 689999999876542 4567889999999999999999999999888 7889999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ...+++..++.++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999843 238999999999999999999999987 999999999999999999999999998877654
Q ss_pred Ccc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... ......++..|++||.+.....+.++||||||++++||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 421 1233567889999999988889999999999999999999999997754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=262.04 Aligned_cols=200 Identities=28% Similarity=0.394 Sum_probs=170.8
Q ss_pred CccccccccccCceeEEEEEe----cCCCEEEEEEeeccC----hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcc
Q 009543 314 SFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFNN----RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 384 (532)
+|++.+.||+|++|.||+++. .+++.+|||.+.... ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999985 357889999886432 22345688999999999 599999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++++|.+++.. ...+++..+..++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999843 356899999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCCcccccccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQ--LTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.............++..|++||.+.+.. .+.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 6544333233456889999999987654 788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=261.25 Aligned_cols=202 Identities=27% Similarity=0.428 Sum_probs=176.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 387 (532)
++|.+.+.||+|+||.||+++.. +++.+++|++... .......+.+|++++.+++ ||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999975 7899999988643 2334467889999999998 99999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 347999999999999999999999998 99999999999999999999999999886654
Q ss_pred CCc-------------------ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKS-------------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .......++..|++||.+.....+.++|+||||++++||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 332 11223457889999999988888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=266.98 Aligned_cols=199 Identities=27% Similarity=0.496 Sum_probs=169.3
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC----
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP---- 382 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 382 (532)
...++|++.+.||+|+||.||++... +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 45678999999999999999999864 7899999988543 2333456889999999999999999999887654
Q ss_pred --cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 383 --ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 383 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
..++||||+ +++|.+++. ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 348999998 778988873 356899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++....... ....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...+
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 987654322 23456889999999875 458899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=268.60 Aligned_cols=201 Identities=32% Similarity=0.509 Sum_probs=168.8
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC--Ccc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG--PES 384 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~ 384 (532)
..++|++.+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999975 6889999988542 233445678899999999 999999999987653 357
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||++ ++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588888732 27889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCcc----ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSH----ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 6443321 2233468899999998754 45788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=255.96 Aligned_cols=202 Identities=31% Similarity=0.477 Sum_probs=176.3
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|++.++||+|+||.||+++.. +++.+++|++.... .....++.+|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788999999999999999865 68899999986542 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999985422 2356899999999999999999999998 9999999999999999999999999998765542
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.....+++.|++||.+.+..++.++|+||||+++|||++|+.||...+.
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2234578899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=266.75 Aligned_cols=202 Identities=28% Similarity=0.458 Sum_probs=169.1
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecC-
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG- 381 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 381 (532)
.++..++++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34556778999999999999999999986 478999999986432 23346788999999999999999999987543
Q ss_pred -----CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 382 -----PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 382 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
...+++++++ +++|.+++. ...+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 2356777776 788988773 345899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 457 ADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 162 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred eccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999998764322 223467889999998765 46788999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=253.85 Aligned_cols=203 Identities=26% Similarity=0.448 Sum_probs=178.2
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|++.+.||+|+||.||++.+. +++.+++|++..... .....+.+|+++++.++|||++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788999999999999999975 689999999876533 4556789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
+++++|.+++.... ....+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999985422 2467999999999999999999999998 9999999999999999999999999988765443
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.......+++.|+|||......++.++|+||+|+++++|++|+.||...+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 22233568899999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-33 Score=255.15 Aligned_cols=203 Identities=32% Similarity=0.472 Sum_probs=166.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhc-CccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISS-VEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++.+.+..||.|.||+|+|-.++ .|+..|||+++.... ...++++.|.+...+ -+.||||+++|....++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34556778999999999999875 799999999987643 556778888876554 479999999999999999999999
Q ss_pred ecCCCChhHHhhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 390 FLPNQSLDRFIFD--SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 390 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
.|+ .+|+.+-.. ..+...+++.-.-.|......||.||.+.- +|||||+||+|||||..|.+||+|||++-.+..
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 994 466654321 233466888888889899999999998754 599999999999999999999999999876543
Q ss_pred CCccccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+ ...+.-.|-..|||||.+.. ..|..+|||||||++|+|+.||+.|+...+
T Consensus 221 S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 221 S--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred H--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 3 23455678899999999853 358999999999999999999999998754
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=258.43 Aligned_cols=197 Identities=26% Similarity=0.374 Sum_probs=164.2
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCc-cceeeeeeeeeecC--CcceEEEE
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSG--PESLLVYE 389 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 389 (532)
|++.++||+|+||.||+++.. +++.+|+|++.... ........+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999965 68999999886542 222234567888888885 99999999999887 88899999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++ +|.+++.. ....+++.+++.++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 77777743 2357899999999999999999999998 999999999999999 999999999998664332
Q ss_pred cccccccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ....++..|+|||.+. .+.++.++||||||+++|||++|+.||...+
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 22 2345788999999764 4567889999999999999999999997654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=289.27 Aligned_cols=196 Identities=34% Similarity=0.546 Sum_probs=160.6
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC-------
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------- 381 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 381 (532)
-..+|+.++.||+||||.|||++.+ ||+.+|||++... +......+.+|+.++++++|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467999999999999999999976 8999999999765 344456789999999999999999987642100
Q ss_pred --------------------------------------------------------------------------------
Q 009543 382 -------------------------------------------------------------------------------- 381 (532)
Q Consensus 382 -------------------------------------------------------------------------------- 381 (532)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 009543 382 --------------------------------PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429 (532)
Q Consensus 382 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH 429 (532)
..+||-||||+..++.+++.+.. ..-.....|+++++|++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~--~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH--FNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc--cchhhHHHHHHHHHHHHHHHHHH
Confidence 02478899999988888884321 11157788999999999999999
Q ss_pred hCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC-----------------CCcccccccccccccccccccccC-
Q 009543 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-----------------DKSHISTAIAGTLGYMAPEYLAHG- 491 (532)
Q Consensus 430 ~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~~- 491 (532)
+++ ||||||||.||++|++..+||+|||++..... ......+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 99999999999999999999999999987210 011134567899999999999764
Q ss_pred --CCCchhhHHHHHHHHHHHHh
Q 009543 492 --QLTEKADVYSFGMLLLEIVT 511 (532)
Q Consensus 492 --~~~~~~Dv~SlGvll~el~t 511 (532)
.|+.|+|+||||||++||+.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999984
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=261.16 Aligned_cols=195 Identities=30% Similarity=0.488 Sum_probs=166.9
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.|+..+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+++++.++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999964 68899999986442 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++ +|.+.+.. ....+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 77776643 2456899999999999999999999998 999999999999999999999999998754322
Q ss_pred cccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....+++.|+|||.+. .+.++.++||||||+++|||++|+.||...
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 2345788999999873 456889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=267.73 Aligned_cols=201 Identities=25% Similarity=0.442 Sum_probs=169.4
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeec----CCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 384 (532)
.++|++.+.||+|+||.||++... +|+.|++|++.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999965 69999999986542 2344677889999999999999999998753 3457
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+. ++|.+++. ....+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999996 58888883 3455899999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCcc---ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSH---ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 5433221 1233468899999998765 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=260.45 Aligned_cols=200 Identities=30% Similarity=0.454 Sum_probs=165.8
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+|+..+.||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5667789999999999999975 68999999986543 334567889999999996 99999999999998899999999
Q ss_pred cCCCChhHHhhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 391 LPNQSLDRFIFD--SAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 391 ~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
++. ++.++... ......+++..+..++.|+++||+|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55443311 12346789999999999999999999975 5 99999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHG---QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
... .....|++.|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 322 1234578899999998765 6889999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=266.50 Aligned_cols=201 Identities=27% Similarity=0.455 Sum_probs=169.3
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC-----C
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-----P 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 382 (532)
+.++|.+.+.||+|+||+||+++.. +++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3467999999999999999999964 6899999988643 233345678899999999999999999987654 2
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..++++||+. ++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4799999996 68888873 3457999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 8664432 12233457889999998765 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=266.17 Aligned_cols=200 Identities=29% Similarity=0.473 Sum_probs=172.6
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-----cce
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-----ESL 385 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 385 (532)
+|++.+.||+|++|.||+++.. +++.+++|++.... ....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 58999999986543 344567899999999999999999999988765 789
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
++|||+++ +|.+++. ....+++..++.++.|+++||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 7888874 3347999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCc--ccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKS--HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 55431 112334678899999999877 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=262.90 Aligned_cols=199 Identities=27% Similarity=0.440 Sum_probs=169.1
Q ss_pred HHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeec-CCcc
Q 009543 309 EKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPES 384 (532)
Q Consensus 309 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 384 (532)
..++++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++..++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 446789999999999999999999965 7899999988543 22334678899999999999999999998865 5578
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++++||+ +++|.+++. ...+++.....++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568888773 346788889999999999999999998 99999999999999999999999999875
Q ss_pred cCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
..... ....++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 158 QDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43221 23456889999998765 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=262.72 Aligned_cols=203 Identities=32% Similarity=0.512 Sum_probs=167.0
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCC------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 382 (532)
.++|++.++||+|+||.||++++. +++.+++|++..... .....+.+|+++++.++||||+++++.+.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 689999998865432 22346788999999999999999999875543
Q ss_pred --cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 383 --ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 383 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
..++++||+++ +|...+.. ....+++..+..++.|+++||.|||+++ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999975 56666532 3457999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCcc----------ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSH----------ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++......... ..+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 99765433221 1123456888999998765 357899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=268.87 Aligned_cols=202 Identities=24% Similarity=0.356 Sum_probs=178.8
Q ss_pred CCccccccccccCceeEEEEEecCCC-EEEEEEeec---cChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGR-EIAVKRLFF---NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.+++.+..||-|+||.|=+...+... .+|+|.++. -+....+.+..|-.+|...+.|.||+++-.|.++...|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34566778999999999999875433 367776654 35566678899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
|-|-||.|...|. ..+.++......++..+.+|++|||+++ ||.|||||+|.+||.+|-+||.|||+++.+...
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999994 4567899999999999999999999999 999999999999999999999999999988765
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
.. +-+.+|||.|.|||++.++.....+|.||||+++|||++|++||+..++-
T Consensus 574 ~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 574 RK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred Cc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 54 34579999999999999999999999999999999999999999987654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=242.99 Aligned_cols=199 Identities=28% Similarity=0.484 Sum_probs=166.3
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEe
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+.+.+..||.|.-|.||+.+.. +|..+|||.+... +....++++..+.++..- +.|.||+.+|+|..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 4556778999999999999975 6889999998655 455667777778777665 489999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
|. .-++.++.. -.+++++.-+-++...+.+||.||.+++ .|+|||+||+|||+|+.|++||+|||++-.+-....
T Consensus 173 Ms-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 173 MS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 84 355666643 2356888888899999999999998766 499999999999999999999999999987655443
Q ss_pred ccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+ +...|-+.|||||.+. ...|..++||||||+.++||.||+.||..-
T Consensus 248 h--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 248 H--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred c--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 3 4557899999999985 347899999999999999999999999873
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=256.59 Aligned_cols=199 Identities=28% Similarity=0.473 Sum_probs=171.2
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
|++.+.||+|++|.||++... +++.+++|++..... .....+.+|+++++.++||||+++++.+......++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999975 688999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++ +|.+++.. ....+++..++.++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 88887743 2357899999999999999999999998 9999999999999999999999999988765543 1
Q ss_pred cccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12234578899999998776 78999999999999999999999996644
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=262.69 Aligned_cols=202 Identities=28% Similarity=0.420 Sum_probs=167.5
Q ss_pred cCCccc-cccccccCceeEEEEEec-CCCEEEEEEeeccChhh--------------HHHHHHHHhHhhcCccceeeeee
Q 009543 312 TGSFDE-ANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHR--------------AANFYNEVNIISSVEHKNLVRLL 375 (532)
Q Consensus 312 ~~~~~~-~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 375 (532)
.++|.. .+.||+|+||.||++.+. +++.||+|++....... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 467999999999999965 68999999986543221 12577899999999999999999
Q ss_pred eeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEE
Q 009543 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAK 455 (532)
Q Consensus 376 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~k 455 (532)
+++...+..+++|||++ ++|.+++. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 58888883 3456899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCC-------------cccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 456 IADFGLARSFQEDK-------------SHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 456 l~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|+|||++....... ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999987654111 0111223468889999998754 46899999999999999999999997654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=263.37 Aligned_cols=196 Identities=27% Similarity=0.491 Sum_probs=165.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 382 (532)
.++|.+.+.||+|+||.||+|+.. +|+.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999964 6899999988643 2223456889999999999999999999886543
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..++++||+.. +|..++ ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999964 666554 235899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 165 RHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred cCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 7643321 23457889999999876 468899999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=255.67 Aligned_cols=199 Identities=31% Similarity=0.488 Sum_probs=166.7
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcC---ccceeeeeeeeeecCCc-----
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSV---EHKNLVRLLGCSCSGPE----- 383 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 383 (532)
|++.+.||+|+||.||+++++ +++.+|+|++..... .....+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999986 489999999964322 2234566787777665 69999999999988776
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.+++|||+++ +|.+++... ....+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 788877432 2346899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
........ ....++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 156 IYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 76443221 22347889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=265.30 Aligned_cols=200 Identities=25% Similarity=0.432 Sum_probs=167.3
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecC---------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--------- 381 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------- 381 (532)
.++|++.+.||+|+||.||+|... +++.|++|++........+.+.+|+++++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999975 6899999998776666667889999999999999999999876543
Q ss_pred -----CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-CCcEE
Q 009543 382 -----PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAK 455 (532)
Q Consensus 382 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-~~~~k 455 (532)
...+++|||++ ++|.+++. ...+++..++.++.|+++||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 24689999997 58888773 346899999999999999999999998 999999999999974 56799
Q ss_pred EeecCCccccCCCCcc--ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 456 IADFGLARSFQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 456 l~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
|+|||++......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998765432211 1122357889999998754 46788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=247.48 Aligned_cols=202 Identities=23% Similarity=0.343 Sum_probs=177.7
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcce
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 385 (532)
..++|..++.||+|+|.+|..+++. +.+.+|+|+++.. +.......+.|-.++.+. +||.+|.+..+|+++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3478999999999999999999975 6788999988653 344556677888888776 7999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+|.||.+||+|--++ +++..++++....+..+|.-||.|||+++ ||.||||..|||+|.+|++||+|+|+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999996665 56678999999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
-... ..+.+.+|||.|.|||++.+..|+..+|+|+|||+++||+.|+.||..-
T Consensus 402 l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 402 LGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred CCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 3322 2345689999999999999999999999999999999999999999754
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=259.39 Aligned_cols=198 Identities=19% Similarity=0.255 Sum_probs=164.0
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCC
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
+.+.+|.|+++.|++++. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+....+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445556666666666555 6899999998754 3445578999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc---
Q 009543 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH--- 471 (532)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~--- 471 (532)
+|.+++... ....+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||.+.........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999998543 2346889999999999999999999998 999999999999999999999999988755322111
Q ss_pred ---ccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 472 ---ISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 472 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......++..|+|||.+.. ..++.++|+||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1123456788999999865 35788999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=256.83 Aligned_cols=194 Identities=31% Similarity=0.497 Sum_probs=165.5
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
|...++||+|+||+||+|+.. +++.|++|++.... ......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999974 68899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
++ +++.+++.. ....+++.+++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 467666633 3356899999999999999999999998 99999999999999999999999998864322
Q ss_pred ccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.....|+..|+|||.+. .+.++.++||||||+++|||++|+.||...
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12346788999999974 456888999999999999999999998664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=256.78 Aligned_cols=199 Identities=27% Similarity=0.484 Sum_probs=165.5
Q ss_pred cCCccccccccccCceeEEEEEecC-CCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.++|++.+.||+|+||.||++++++ ++.||||++.... ......+.+|+.++... .||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3678899999999999999999864 8999999986543 23345667787777666 4999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
||+++ ++.+++.. ....+++..+..++.|+++||.|||+. + |+||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 67776643 234789999999999999999999974 5 99999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQ----LTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.... ....++..|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 2221 2335788999999986543 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=253.60 Aligned_cols=199 Identities=28% Similarity=0.428 Sum_probs=168.1
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEEEec
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
|++.+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+.+++ ||||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999986 578899998865432 22234567999999998 999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
+++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 78998888532 2357899999999999999999999998 99999999999999999999999999886644322
Q ss_pred cccccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 22345788999999875 4457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=258.64 Aligned_cols=198 Identities=23% Similarity=0.346 Sum_probs=163.1
Q ss_pred cccccc--CceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQG--GFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.||+| +||+||++++. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467776 99999999974 79999999986542 33446788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc--
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-- 471 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-- 471 (532)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999885432 345899999999999999999999988 999999999999999999999999865433221111
Q ss_pred ----cccccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ----ISTAIAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......++..|++||++.+. .++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 01112345679999998764 47899999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=246.97 Aligned_cols=193 Identities=31% Similarity=0.425 Sum_probs=168.9
Q ss_pred ccccCceeEEEEEec-CCCEEEEEEeeccCh---hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
||+|+||.||++... +++.+++|.+..... .....+.+|+.+++.++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 589999999865432 2456789999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccc
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 476 (532)
.+++.. ...+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999843 346899999999999999999999988 99999999999999999999999999877644321 22345
Q ss_pred ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 477 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.++..|++||...+...+.++|+||||+++|||++|+.||...+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 67889999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=255.90 Aligned_cols=196 Identities=29% Similarity=0.478 Sum_probs=166.9
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
..|+..+.||+|+||.||+|+.. +++.+++|.+... ......++.+|+++++.++|||++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999975 6788999988643 2334457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+. +++.+++.. ....+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 577776643 2346899999999999999999999988 999999999999999999999999998765432
Q ss_pred Ccccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....+++.|+|||.+. .+.++.++||||||+++|||++|+.||...
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 2345788999999874 356788999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=253.05 Aligned_cols=199 Identities=30% Similarity=0.502 Sum_probs=170.9
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
|+..+.||+|++|.||+++.. +++.+++|++.... ....+.+.+|+.+++.++||||+++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567789999999999999976 58999999987653 333467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
+ ++|.+++... ...+++..++.++.|+++||.|||+++ |+||||+|+||++++++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 5899998542 146999999999999999999999998 999999999999999999999999998876443221
Q ss_pred cccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....++..|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 2233457789999998766 78999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=258.20 Aligned_cols=200 Identities=28% Similarity=0.435 Sum_probs=164.6
Q ss_pred CccccccccccCceeEEEEEec-C--CCEEEEEEeecc--ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC----Cc
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-D--GREIAVKRLFFN--NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG----PE 383 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~--g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~ 383 (532)
+|++.+.||+|+||.||+++.. + +..+|+|++... .....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999975 3 778999988643 222346788899999999 599999999875432 34
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++++||+. ++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 68888873 3457899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc---ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSH---ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
........ ......|++.|+|||.+.. ..++.++|+||||+++|||++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 66433221 1233468999999998765 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=244.16 Aligned_cols=199 Identities=26% Similarity=0.316 Sum_probs=167.4
Q ss_pred hcCCcccc-ccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeec----CCc
Q 009543 311 ATGSFDEA-NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCS----GPE 383 (532)
Q Consensus 311 ~~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~ 383 (532)
++++|++. +.||-|-.|.|..+..+ +++++|+|++... ....+|+++-... .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666654 57999999999999875 7899999988533 2345788876665 69999999998754 456
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---CCcEEEeecC
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFG 460 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~~~~kl~Dfg 460 (532)
+.+|||.|+||.|..-+.+ .....+++.+.-.|+.||..|+.|||+.+ |.||||||+|+|... |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999988854 34567999999999999999999999998 999999999999965 4579999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+++...... .-.+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||.+..
T Consensus 210 FAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 210 FAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred cccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 999765432 2244678999999999999999999999999999999999999997753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=261.54 Aligned_cols=199 Identities=27% Similarity=0.485 Sum_probs=169.4
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc---
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE--- 383 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 383 (532)
...++|++.+.||+|++|.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 5889999988643 22334667889999999999999999998776554
Q ss_pred ---ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 384 ---SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 384 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
.++|+||+ +++|.+++. ...+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 668988873 356999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98865433 223457889999998865 367889999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=246.25 Aligned_cols=206 Identities=27% Similarity=0.480 Sum_probs=171.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeec--------C
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCS--------G 381 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 381 (532)
+.|+...+||+|.||+||+++.. +|+.||+|++....+ .-.....+|+.+|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45777889999999999999965 688899988765432 223677899999999999999999998753 2
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
...|+|+++++. +|..+|. .....++..++.+++.++.+||.|+|+.. |+|||+||.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347899999976 6777662 23467899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCcc---ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 009543 462 ARSFQEDKSH---ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524 (532)
Q Consensus 462 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~ 524 (532)
++.+...... ..+..+-|..|.+||.+.+ +.++++.|||.-|||+.||+||.+-+.+.++...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq 237 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ 237 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH
Confidence 9877655443 2344567999999998765 6799999999999999999999999988655443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=248.00 Aligned_cols=201 Identities=28% Similarity=0.415 Sum_probs=166.7
Q ss_pred CccccccccccCceeEEEEEecC-CCEEEEEEeecc-----ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
+|.+.++||+|+||.||++++.. +..+++|.+... ......++.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57889999999999999998753 445555554321 122334677899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 388 YEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
+||+++++|.+++... .....+++.+++.++.|+++||.|||+.+ ++|+||+|+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988542 23467999999999999999999999988 999999999999975 569999999987664
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.... ......+++.|++||.+....++.++|+||||+++|+|++|+.||...
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3322 222345788999999988888889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=275.93 Aligned_cols=145 Identities=26% Similarity=0.359 Sum_probs=131.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|.+.++||+|+||.||++.+. +++.||||++.... ......+.+|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999976 68999999986542 333467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 346889999999999999999999988 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=245.91 Aligned_cols=203 Identities=28% Similarity=0.451 Sum_probs=171.9
Q ss_pred ccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC-----CcceE
Q 009543 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-----PESLL 386 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 386 (532)
.+-.+.||-|+||.||..+++ +|+.|++|++..- +-...+.+.+|+++|..++|.|++..+++.... .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 445678999999999999975 8999999988533 223457899999999999999999998876543 25678
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
++|.| ..+|.+++. ....++...+.-+..||++||.|||+.+ |.||||||.|.|+++|..+||+|||+++..+
T Consensus 135 ~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 89988 457888874 4467888888899999999999999998 9999999999999999999999999999887
Q ss_pred CCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~~ 524 (532)
.++....+..+-|-.|.|||++++ +.|+.+.||||+|||+.||+..+..|...++-+.
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ 266 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ 266 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH
Confidence 776665555667899999999987 4689999999999999999999999987665433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=263.53 Aligned_cols=203 Identities=24% Similarity=0.351 Sum_probs=153.9
Q ss_pred cCCccccccccccCceeEEEEEe-----------------cCCCEEEEEEeeccChhhHHHH--------------HHHH
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-----------------PDGREIAVKRLFFNNRHRAANF--------------YNEV 360 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~E~ 360 (532)
.++|++.++||+|+||.||+|.+ .+++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 2356899999865443333333 3466
Q ss_pred hHhhcCcccee-----eeeeeeeec--------CCcceEEEEecCCCChhHHhhhcc---------------------CC
Q 009543 361 NIISSVEHKNL-----VRLLGCSCS--------GPESLLVYEFLPNQSLDRFIFDSA---------------------KA 406 (532)
Q Consensus 361 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~ 406 (532)
.++.+++|.++ +++++++.. .+..++||||+++++|.++++... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777766654 566776643 356799999999999999986421 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccccccccccccc
Q 009543 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486 (532)
Q Consensus 407 ~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE 486 (532)
..+++..++.++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23567888999999999999999988 999999999999999999999999999765433222222223578999999
Q ss_pred ccccCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCC
Q 009543 487 YLAHGQ--------------------L--TEKADVYSFGMLLLEIVTGRQ-NNR 517 (532)
Q Consensus 487 ~~~~~~--------------------~--~~~~Dv~SlGvll~el~tG~~-p~~ 517 (532)
.+.... + ..+.||||+||+++||++|.. |+.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 875332 1 134799999999999999986 664
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=243.03 Aligned_cols=181 Identities=24% Similarity=0.212 Sum_probs=153.9
Q ss_pred cCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCChhHHhhh
Q 009543 324 GGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD 402 (532)
Q Consensus 324 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 402 (532)
|.+|.||++++. +++.+|+|++.... .+.+|...+....||||+++++++.+....+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999975 68999999986543 223444555556799999999999999999999999999999998843
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccccccccc
Q 009543 403 SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482 (532)
Q Consensus 403 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 482 (532)
...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 345899999999999999999999988 9999999999999999999999999876554321 123456789
Q ss_pred ccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 483 ~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+|||.+....++.++||||+|+++|||++|+.|+...
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 9999998888899999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=274.57 Aligned_cols=208 Identities=31% Similarity=0.447 Sum_probs=175.6
Q ss_pred HHHhcCCccccccccccCceeEEEEEec----C----CCEEEEEEeecc-ChhhHHHHHHHHhHhhcC-ccceeeeeeee
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP----D----GREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGC 377 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 377 (532)
++...++..+.+.||+|.||.|++|... . ...||||.+... .....+.+..|++++..+ +||||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3334455566779999999999999853 1 356899998754 335567899999999998 69999999999
Q ss_pred eecCCcceEEEEecCCCChhHHhhhcc-----C------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCC
Q 009543 378 SCSGPESLLVYEFLPNQSLDRFIFDSA-----K------A--KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKAS 444 (532)
Q Consensus 378 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~ 444 (532)
+...+..++|+||++.|+|.++|.... . . ..++....+.++.||+.||+||++.. ++||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999996543 0 0 23889999999999999999999987 999999999
Q ss_pred CEEEcCCCcEEEeecCCccccCCCCcccccccc--cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 009543 445 NILLDSRLRAKIADFGLARSFQEDKSHISTAIA--GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRS 518 (532)
Q Consensus 445 NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~ 518 (532)
|||+.++..+||+|||+++..........+.-. -+..|||||.+....|+.|+|||||||+||||+| |..||..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999976665554322222 3567999999999999999999999999999999 8899976
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=253.20 Aligned_cols=197 Identities=26% Similarity=0.410 Sum_probs=169.9
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChh--------hHHHHHHHHhHhhcCc---cceeeeeeeeeec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH--------RAANFYNEVNIISSVE---HKNLVRLLGCSCS 380 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 380 (532)
.+|...+.||+|+||.|+++.++ +..+|+||.+++..-- ..-....||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45889999999999999999986 5678899988654211 1123456999999997 9999999999999
Q ss_pred CCcceEEEEec-CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeec
Q 009543 381 GPESLLVYEFL-PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (532)
Q Consensus 381 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Df 459 (532)
++.+||+||-. ++.+|.+++ .....+++.+...|+.|++.|+++||+++ |+|||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999987 677899998 34567999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 460 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
|.+....... ....+||..|.|||++.+.+| +..-|||++|++||.++....||..
T Consensus 715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9987655433 345789999999999988776 6678999999999999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=232.97 Aligned_cols=198 Identities=32% Similarity=0.492 Sum_probs=172.8
Q ss_pred ccccccccccCceeEEEEEecC-CCEEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+..++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999875 899999999766544 56788999999999999999999999999899999999999
Q ss_pred CCChhHHhhhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 393 NQSLDRFIFDSAKAKT-LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
+++|.+++... .. +++...+.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998432 23 899999999999999999999997 999999999999999999999999998877554311
Q ss_pred ccccccccccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334577889999998 666778899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=255.33 Aligned_cols=196 Identities=32% Similarity=0.413 Sum_probs=165.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++.|+....+|.|+|+.|-++... +++..++|++.... .+-.+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888899999999999999864 68999999996552 2334577666665 79999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE-cCCCcEEEeecCCccccCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL-DSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl-~~~~~~kl~Dfgl~~~~~~~ 468 (532)
.+.++-+.+-+.. ..... .++..|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999888777632 22222 777789999999999999998 9999999999999 68999999999999876654
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
....+-|..|.|||++....++.++|+||||++||||++|+.||.....+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 12235588999999999999999999999999999999999999886544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=244.50 Aligned_cols=216 Identities=22% Similarity=0.312 Sum_probs=179.2
Q ss_pred CCCCCcChhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCcc--c----e
Q 009543 298 DDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEH--K----N 370 (532)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----n 370 (532)
+....+.+......+++|.+..++|+|.||.|-...++ .+..||||+++.-.+ -.+..+-|++++.++.+ | -
T Consensus 74 D~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 74 DKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceE
Confidence 34444556666667899999999999999999999975 468899998864432 23556778999999832 2 2
Q ss_pred eeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC
Q 009543 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS 450 (532)
Q Consensus 371 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~ 450 (532)
++++.+||.-.++.++|+|.+ |-|+.++|.. .+..+++..++..++.|+++++++||+.+ ++|.||||+|||+-+
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvs 227 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVS 227 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEec
Confidence 788889999999999999988 6789999943 34567999999999999999999999998 999999999999932
Q ss_pred --------------------CCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 009543 451 --------------------RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510 (532)
Q Consensus 451 --------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~ 510 (532)
+..+||+|||.+....+.. ..++.|..|.|||++.+-.++.++||||+||||+|+.
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 3468999999998655443 3467899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcc
Q 009543 511 TGRQNNRSKNSEY 523 (532)
Q Consensus 511 tG~~p~~~~~~~~ 523 (532)
+|...|...+.-+
T Consensus 304 tG~~LFqtHen~E 316 (415)
T KOG0671|consen 304 TGETLFQTHENLE 316 (415)
T ss_pred ccceecccCCcHH
Confidence 9999998866444
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=239.70 Aligned_cols=215 Identities=25% Similarity=0.383 Sum_probs=181.4
Q ss_pred HHHhcCCccccccccccCceeEEEEEec------CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeec
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS 380 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 380 (532)
+..-..+++..-.+-+|.||.||+|.|. +.+.|-+|.++.. ++-....++.|..++..+.|||+.++.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3334467888888999999999999764 3456778877644 34455678899999999999999999998865
Q ss_pred -CCcceEEEEecCCCChhHHhh-----hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 381 -GPESLLVYEFLPNQSLDRFIF-----DSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 381 -~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
....+.++.++.-|+|..||. +......++-.+...++.|++.|++|||+++ +||.||.++|++||+..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeE
Confidence 456789999999999999997 4444567888899999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 009543 455 KIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTD 525 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~~~~ 525 (532)
||+|=.+++.+.+.+++ .......+..||+||.+.+..|+..+|||||||++|||+| |+.|+..-++.+..
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 99999999987666554 4445556889999999999999999999999999999998 99999887765544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=256.45 Aligned_cols=211 Identities=27% Similarity=0.419 Sum_probs=178.4
Q ss_pred ChhhHHHhcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeec-
Q 009543 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCS- 380 (532)
Q Consensus 304 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~- 380 (532)
.+..+...++-|++.+.||.|.+|.||+++. ++++..|+|++.... ...++...|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444455677899999999999999999995 578999999886654 3346677888899887 69999999999863
Q ss_pred ----CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 381 ----GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 381 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
++++|||||||.+|+.-+++..-. ...+.|+.+..|++.++.|+.+||... ++|||||-.|||++.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 568999999999999999986544 788999999999999999999999987 999999999999999999999
Q ss_pred eecCCccccCCCCcccccccccccccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 457 ADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG-----QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.|||.+....... ....+..||+.|||||++... .|+..+|+||||++..||--|.+|+-...
T Consensus 165 vDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred eeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 9999987654322 223456899999999998643 46778999999999999999999997654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=260.96 Aligned_cols=200 Identities=23% Similarity=0.296 Sum_probs=143.5
Q ss_pred hcCCccccccccccCceeEEEEEec-C----CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeee------ee
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-D----GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC------SC 379 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~ 379 (532)
..++|++.++||+|+||.||+|++. + +..||+|++...... +.+.+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3578999999999999999999975 4 689999987543221 112221 1112222222222221 23
Q ss_pred cCCcceEEEEecCCCChhHHhhhccC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 009543 380 SGPESLLVYEFLPNQSLDRFIFDSAK-----------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK 442 (532)
Q Consensus 380 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlk 442 (532)
.....++|+||+++++|.+++..... ........+..++.|++.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56678999999999999998853211 011123446689999999999999998 9999999
Q ss_pred CCCEEEcC-CCcEEEeecCCccccCCCCcccccccccccccccccccccC----------------------CCCchhhH
Q 009543 443 ASNILLDS-RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG----------------------QLTEKADV 499 (532)
Q Consensus 443 p~NiLl~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 499 (532)
|+|||++. ++.+||+|||+++..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987654444444556789999999965322 23456799
Q ss_pred HHHHHHHHHHHhCCCCCC
Q 009543 500 YSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 500 ~SlGvll~el~tG~~p~~ 517 (532)
|||||++|||+++..|+.
T Consensus 363 wSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHHhCcCCCc
Confidence 999999999999877654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-29 Score=220.32 Aligned_cols=193 Identities=21% Similarity=0.406 Sum_probs=165.2
Q ss_pred cCCccccccccccCceeEEEEE-ecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecC--CcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSG--PESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 387 (532)
.++|++.+++|+|.|++||.|. ..++++++||++++-. .+.+.+|+.+|..+. ||||++++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4689999999999999999999 4578999999996443 456889999999997 99999999998764 456799
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecCCccccC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQ 466 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfgl~~~~~ 466 (532)
+||..+.+...+- ..++...+..++.++++||.|+|++| |.|||+||.|+++|.. -.++|+|+|++..+.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876654 45778889999999999999999999 9999999999999875 479999999999887
Q ss_pred CCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
..... ...+.+..|.-||.+-+ ..|...-|+|||||++.+|+..+.||-.
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 65543 33456788999998865 5678889999999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=228.05 Aligned_cols=186 Identities=32% Similarity=0.475 Sum_probs=164.9
Q ss_pred CceeEEEEEec-CCCEEEEEEeeccChhh-HHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCChhHHhhh
Q 009543 325 GFGTVYKGVLP-DGREIAVKRLFFNNRHR-AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD 402 (532)
Q Consensus 325 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 402 (532)
+||.||+++.. +++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999997665444 67899999999999999999999999998999999999999999999843
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccccccccc
Q 009543 403 SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482 (532)
Q Consensus 403 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 482 (532)
...+++..++.++.++++++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 223899999999999999999999998 9999999999999999999999999998765542 22345578899
Q ss_pred ccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 483 ~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
++||.+....++.++||||||++++||++|+.||..
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-28 Score=249.24 Aligned_cols=197 Identities=32% Similarity=0.494 Sum_probs=161.6
Q ss_pred ccccccccccCcee-EEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEecC
Q 009543 315 FDEANKLGQGGFGT-VYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 315 ~~~~~~lG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
|...+.+|.|..|+ ||+|.. +|++||||++-... ..-..+||..|+.- +||||+++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44556789999876 599999 68999999985433 34567899999887 69999999999999999999999995
Q ss_pred CCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---C--CcEEEeecCCccccC
Q 009543 393 NQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---R--LRAKIADFGLARSFQ 466 (532)
Q Consensus 393 ~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~--~~~kl~Dfgl~~~~~ 466 (532)
-+|++++... ...........+.+..|+++||++||+.+ |+||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999998542 11111111445778899999999999987 999999999999976 3 479999999999987
Q ss_pred CCCcccc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 009543 467 EDKSHIS--TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG-RQNNRSK 519 (532)
Q Consensus 467 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG-~~p~~~~ 519 (532)
.+..... ....||.+|+|||++....-+.++||||+||++|+.++| ..||...
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 7665533 346799999999999988888899999999999998886 9999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=219.78 Aligned_cols=197 Identities=31% Similarity=0.437 Sum_probs=166.8
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC------
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------ 381 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 381 (532)
...+|..++.+|.|.- .|-.+.+. .++.||+|++... .....++..+|..++..++|+||++++.++...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3457888889999988 55555543 6899999988544 334457788999999999999999999998654
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
.+.|+|||+|. .+|..++. -.++-+++..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 35689999994 58888774 34677888899999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
++....+ ...+..+.|..|.|||++.+..+...+||||+||++.||++|+.-|.+.
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 9876544 3456678899999999999888999999999999999999999999764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-27 Score=231.09 Aligned_cols=221 Identities=22% Similarity=0.248 Sum_probs=187.5
Q ss_pred hhhcCCCCCcChhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-----
Q 009543 294 KTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE----- 367 (532)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----- 367 (532)
..|++-...+.+...+...++|.+....|+|-|++|.+|.+. -|+.||||++.... ...+.=+.|+++|.+|+
T Consensus 413 DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 413 DNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPE 491 (752)
T ss_pred cCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCch
Confidence 334444555666666777889999999999999999999975 48899999997553 33455678999999984
Q ss_pred -cceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCE
Q 009543 368 -HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNI 446 (532)
Q Consensus 368 -h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~Ni 446 (532)
--+.++++-.|...++++||+|-+ ..+|.++|........|....+..++.|+.-||..|..-+ |+|.||||.||
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNi 567 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNI 567 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccce
Confidence 347889999999999999999987 5699999988888888999999999999999999999988 99999999999
Q ss_pred EEcCCC-cEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 447 LLDSRL-RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 447 Ll~~~~-~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
|+++.- .+||+|||.|.....+.. +.+.-+..|.|||++.+-.|....|+||+||.||||.||+..|-+.+..
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred EeccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 999864 789999999987765543 3344567899999999999999999999999999999999999876543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=211.73 Aligned_cols=196 Identities=22% Similarity=0.397 Sum_probs=158.9
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeee-eecCCcceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC-SCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~ 388 (532)
.+.|.+.+.||+|.||.+-+++++ ..+.+++|-+.. ......+|.+|..---.| .|.||+.-+++ |+..+...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467999999999999999999987 467888887743 345567899998876666 58999988775 55666777999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE-cCC-CcEEEeecCCccccC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL-DSR-LRAKIADFGLARSFQ 466 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl-~~~-~~~kl~Dfgl~~~~~ 466 (532)
||+|.|+|..-+ ....+.+....+++.|+++||.|||+++ ++|||||.+|||| +.| ..+||+|||+.+...
T Consensus 102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999998766 4467888999999999999999999998 9999999999999 333 389999999987654
Q ss_pred CCCccccccccccccccccccccc---C--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAH---G--QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.-... ..-+..|.+||.... + +..+.+|+|.||++++..+||+.||...
T Consensus 175 ~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 175 TTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 33222 223567999997642 2 3467899999999999999999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=202.63 Aligned_cols=183 Identities=38% Similarity=0.636 Sum_probs=158.9
Q ss_pred ccccCceeEEEEEecC-CCEEEEEEeeccChh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCChhH
Q 009543 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 398 (532)
||+|.+|.||++...+ ++++++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998765432 34678999999999999999999999999899999999999999999
Q ss_pred HhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-CCcEEEeecCCccccCCCCcccccccc
Q 009543 399 FIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQEDKSHISTAIA 477 (532)
Q Consensus 399 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 477 (532)
++... ...+++..++.++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 98432 146899999999999999999999998 999999999999999 89999999999987654431 122345
Q ss_pred cccccccccccccC-CCCchhhHHHHHHHHHHH
Q 009543 478 GTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEI 509 (532)
Q Consensus 478 gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el 509 (532)
+...|++||..... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 68899999998877 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=217.34 Aligned_cols=170 Identities=21% Similarity=0.203 Sum_probs=132.9
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEec--CCCEEEEEEeecc-----ChhhHHHHHHHHhHhhcCccceeeeeeeee
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVLP--DGREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRLLGCS 378 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 378 (532)
+......++|++.+.||+|+||+||+|.+. +++.+|||++... .....+.+.+|++++++++|+|+++.+..
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 344566788999999999999999999864 5777899987533 12234568999999999999999853322
Q ss_pred ecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC-CCCCEEEcCCCcEEEe
Q 009543 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDI-KASNILLDSRLRAKIA 457 (532)
Q Consensus 379 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dl-kp~NiLl~~~~~~kl~ 457 (532)
.+..++||||+++++|.... .. . ...++.+++++|.|||+++ |+|||| ||+|||++.++.+||+
T Consensus 90 --~~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --cCCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 24679999999999996321 11 1 1467889999999999998 999999 9999999999999999
Q ss_pred ecCCccccCCCCccc-------ccccccccccccccccccC
Q 009543 458 DFGLARSFQEDKSHI-------STAIAGTLGYMAPEYLAHG 491 (532)
Q Consensus 458 Dfgl~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 491 (532)
|||+++.+....... -+...+++.|++||.+...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999998765433211 1345788999999998643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=217.08 Aligned_cols=211 Identities=27% Similarity=0.466 Sum_probs=172.2
Q ss_pred HHHhcCCccccccccccCceeEEEEEec----CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCC
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 382 (532)
+....+.|..+++||+|.|++||++++. ..+.||+|.+...+. ...+.+|+++|..+ -+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445677999999999999999999953 467899999865543 34688999999998 5999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecCC
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGL 461 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfgl 461 (532)
+..+|+||++.....++.. .++..++..++..+..||.++|+++ ||||||||+|+|.+.. +.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999998873 3668889999999999999999999 9999999999999865 5789999999
Q ss_pred ccccCCCC--------------c-----------------------------cccccccccccccccccccc-CCCCchh
Q 009543 462 ARSFQEDK--------------S-----------------------------HISTAIAGTLGYMAPEYLAH-GQLTEKA 497 (532)
Q Consensus 462 ~~~~~~~~--------------~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 497 (532)
+...+... . .......||++|.|||++.+ +..++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87211100 0 00113479999999999865 5678999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCccccccccc
Q 009543 498 DVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530 (532)
Q Consensus 498 Dv~SlGvll~el~tG~~p~~~~~~~~~~~l~~~ 530 (532)
||||.|||++-+++++.||-... ++.+.|.++
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~-dd~~al~ei 291 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAK-DDADALAEI 291 (418)
T ss_pred ceeeccceeehhhccccccccCc-cccchHHHH
Confidence 99999999999999999996643 344444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-26 Score=229.52 Aligned_cols=202 Identities=25% Similarity=0.387 Sum_probs=176.9
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
...++|+.+..+|.|.||.|||+++. .++..|+|+++........-.++|+-+++..+||||+.++|.+......++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 34578999999999999999999964 78999999998887777788889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+.+|+|++.-+ -...+++.++..+.+...+|+.|||+++ -+|||||-.|||+++.|.+|+.|||.+-.+...
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999998753 4577999999999999999999999998 799999999999999999999999987655432
Q ss_pred Cccccccccccccccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYL---AHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
- .......||+.|||||+. ..+.|..++|||++|+...|+-.=+.|--.
T Consensus 166 i-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd 217 (829)
T KOG0576|consen 166 I-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD 217 (829)
T ss_pred h-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence 2 123457899999999986 356789999999999999998877777533
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=207.84 Aligned_cols=131 Identities=31% Similarity=0.441 Sum_probs=111.4
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-----c---ceeeeeeeeeec---
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-----H---KNLVRLLGCSCS--- 380 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~--- 380 (532)
++|-+.++||-|.|++||++.+. +.+.||+|+.+.. +.-.+..+.||++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 78999999999999999999975 5678999988543 444577889999999883 3 359999999864
Q ss_pred -CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 381 -GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 381 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
+.+.+||+|++ |.+|..++.. ...+.++...+.+|++||+.||.|||.+. .|||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999998 7788888754 35677999999999999999999999987 69999999999999
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=208.46 Aligned_cols=202 Identities=23% Similarity=0.340 Sum_probs=166.2
Q ss_pred CccccccccccCceeEEEEEecCC--CEEEEEEeeccChhhHHHHHHHHhHhhcCcc----ceeeeeeeee-ecCCcceE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLPDG--REIAVKRLFFNNRHRAANFYNEVNIISSVEH----KNLVRLLGCS-CSGPESLL 386 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l 386 (532)
+|.+.++||+|+||.||++...+. ..+|+|............+..|+.++..+.. +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788887765533333367788888888873 5788888888 46777899
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-----CcEEEeecCC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-----LRAKIADFGL 461 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-----~~~kl~Dfgl 461 (532)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 889999774433 678999999999999999999999999 9999999999999765 4699999999
Q ss_pred cc--ccCCCCc-----c-c-ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 AR--SFQEDKS-----H-I-STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++ .+..... . . .....||..|++++...+...+.+.|+||++.++.|++.|..||....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 98 4322211 1 1 123459999999999999999999999999999999999999997654
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=175.15 Aligned_cols=98 Identities=39% Similarity=0.704 Sum_probs=75.8
Q ss_pred ccccC---Cccc-CCCCchHHHHHHHHHHHHHhhhcC---CceeeeecCCCCcEEEEEecCCCCChhhhHHHHHHHHhhC
Q 009543 28 NITCG---HQLE-HNSSIFVPNFVTTMENISEQMRTS---GFGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLL 100 (532)
Q Consensus 28 ~~~C~---~~~~-~~~~~~~~~l~~l~~~l~~~~~~~---~~~~~~~g~~~~~vy~~~~C~~d~~~~~C~~Cl~~a~~~~ 100 (532)
++.|+ +.+| +++++|+.+|++||+.|..+++.+ +|+++..|.+++++||++||++|+++++|..||+.|...+
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 35798 3366 678889999999999999998753 8999988999999999999999999999999999999999
Q ss_pred c-cCCCCCcEEEEcCcceeccccCCC
Q 009543 101 P-QCYPYNGGRIYLDGCFMRSENYSF 125 (532)
Q Consensus 101 ~-~c~~~~~~~i~~~~C~~ry~~~~f 125 (532)
+ .|+.+++|+||++.|+||||+++|
T Consensus 81 ~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHhCCCCceEEEECCCEEEEEECCCC
Confidence 9 899999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=190.17 Aligned_cols=202 Identities=21% Similarity=0.365 Sum_probs=169.3
Q ss_pred cCCccccccccccCceeEEEEE-ecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCcc-ceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH-KNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|.++++||.|+||.+|.|. ..+|++||||.-+... ...++.-|..+...++| ..|..+..+..+.....+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 5789999999999999999999 5689999999765433 23467788899999875 677788888888888999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC---CcEEEeecCCccccC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQ 466 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~---~~~kl~Dfgl~~~~~ 466 (532)
.+ |-+|++++.-. ...++..+++.++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.|+|||+++.+-
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 77898887422 356889999999999999999999998 9999999999999654 468999999999875
Q ss_pred CCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 467 EDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
..... ......||.+|.+-....+-..+.+.|+-|+|.+|.+.--|..||.+...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 44322 33456799999998887777889999999999999999999999988654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=192.86 Aligned_cols=201 Identities=20% Similarity=0.350 Sum_probs=170.0
Q ss_pred CCccccccccccCceeEEEEE-ecCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
-+|.+.++||+|.||.++.|+ +-+++.||||.-... ....++..|.+..+.| ..++|...+-+-.++....||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999999 458999999965333 3335677788888877 579999999888888899999998
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-----CcEEEeecCCcccc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-----LRAKIADFGLARSF 465 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-----~~~kl~Dfgl~~~~ 465 (532)
+ |-+|+++..- -...++..++..++.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+++.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7788887632 3467999999999999999999999998 9999999999999643 36899999999987
Q ss_pred CCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 466 QEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 466 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
...... ..+...||.+||+-....+++.+.+.|+-|||-++.+.+-|..||.+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 544332 33567899999999999999999999999999999999999999988653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-23 Score=229.84 Aligned_cols=148 Identities=19% Similarity=0.230 Sum_probs=113.9
Q ss_pred cCcc-ceeeeeeeee-------ecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 009543 365 SVEH-KNLVRLLGCS-------CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436 (532)
Q Consensus 365 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 436 (532)
.++| +||.++++++ .+....++++|++ +++|.++|.. ....+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5777788876 2334567888887 5699999943 2456999999999999999999999998 9
Q ss_pred EEccCCCCCEEEcCC-------------------CcEEEeecCCccccCCCCc---------------cccccccccccc
Q 009543 437 IHRDIKASNILLDSR-------------------LRAKIADFGLARSFQEDKS---------------HISTAIAGTLGY 482 (532)
Q Consensus 437 iH~Dlkp~NiLl~~~-------------------~~~kl~Dfgl~~~~~~~~~---------------~~~~~~~gt~~y 482 (532)
+||||||+||||+.. +.+||+|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4556666666653211000 001124578899
Q ss_pred ccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 483 ~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
||||++.+..++.++|||||||+||||++|..|+..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999998999999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=192.79 Aligned_cols=201 Identities=32% Similarity=0.505 Sum_probs=171.0
Q ss_pred ccccccccccCceeEEEEEecCCCEEEEEEeeccChh---hHHHHHHHHhHhhcCccc-eeeeeeeeeecCCcceEEEEe
Q 009543 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH---RAANFYNEVNIISSVEHK-NLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 390 (532)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999987 88899988765332 367899999999999988 799999999777778999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~~~~~~ 469 (532)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .+++.|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977632211136899999999999999999999998 99999999999999998 79999999998655443
Q ss_pred cc-----ccccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SH-----ISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ......|+..|++||.+.. .......|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 2356689999999999987 578899999999999999999999976654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=187.83 Aligned_cols=172 Identities=12% Similarity=0.094 Sum_probs=134.3
Q ss_pred HhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhH---HH------HHHHHhHhhcCccceeeeeeeeeec
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA---AN------FYNEVNIISSVEHKNLVRLLGCSCS 380 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~h~niv~~~~~~~~ 380 (532)
...++|+..+.||.|+||.||+... ++..+|||.+........ .. +.+|+..+.+++||+|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3578999999999999999999655 677899999965432222 22 5789999999999999999888653
Q ss_pred C--------CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC
Q 009543 381 G--------PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (532)
Q Consensus 381 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~ 452 (532)
. ...+++|||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999987641 222 24568999999999998 99999999999999998
Q ss_pred cEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 009543 453 RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~ 510 (532)
++|+|||.......+... ..+.....+..++|+||||+.+....
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987755322211 11344555668999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=181.86 Aligned_cols=140 Identities=17% Similarity=0.170 Sum_probs=110.1
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChh--h------------------------HHHHHHHHhHhhcCcccee
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--R------------------------AANFYNEVNIISSVEHKNL 371 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 371 (532)
...||+|+||.||+|...+|+.||||++...... . .....+|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999889999999999754211 0 0122359999999988877
Q ss_pred eeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEccCCCCCEEEcC
Q 009543 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL-HEQSKIRIIHRDIKASNILLDS 450 (532)
Q Consensus 372 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~iiH~Dlkp~NiLl~~ 450 (532)
........ ...++||||++++++..... ....+++.+...++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 23489999999987765532 235688999999999999999999 6877 99999999999998
Q ss_pred CCcEEEeecCCccccC
Q 009543 451 RLRAKIADFGLARSFQ 466 (532)
Q Consensus 451 ~~~~kl~Dfgl~~~~~ 466 (532)
++.++|+|||++....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=176.07 Aligned_cols=141 Identities=21% Similarity=0.183 Sum_probs=112.3
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChh--------------------------hHHHHHHHHhHhhcCcccee
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--------------------------RAANFYNEVNIISSVEHKNL 371 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 371 (532)
...||+|+||.||+|.+.+|+.||||++...... ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999878999999998754211 01234578999999999987
Q ss_pred eeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEEEcC
Q 009543 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDS 450 (532)
Q Consensus 372 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiLl~~ 450 (532)
.....+... ..++||||++++++..... ....++..+...++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554443332 3589999999886544321 23457888999999999999999999 87 99999999999999
Q ss_pred CCcEEEeecCCccccCC
Q 009543 451 RLRAKIADFGLARSFQE 467 (532)
Q Consensus 451 ~~~~kl~Dfgl~~~~~~ 467 (532)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=170.13 Aligned_cols=189 Identities=15% Similarity=0.061 Sum_probs=142.9
Q ss_pred cccccccccCceeEEEEEecCCCEEEEEEeeccChhh----HHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEEEe
Q 009543 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR----AANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 316 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.+...|++|+||+|+.+.. .+.+++.+.+....... ...+.+|+++|++++ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997666 67888888776543311 124789999999995 5889999886 356999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC-CCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDI-KASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dl-kp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
++|.+|.+.+. . ....++.|++++|.++|+++ |+|||| ||+|||+++++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99999865431 1 11357789999999999998 999999 7999999999999999999998655433
Q ss_pred cc----c--------ccccccccccccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 470 SH----I--------STAIAGTLGYMAPEYLA--HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 470 ~~----~--------~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
.. . ..-...++.|++|+... ...--...++++-|..+|.++||+.|.-+.+++
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 10 0 11123577788887532 222225678899999999999999998776654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=170.50 Aligned_cols=107 Identities=28% Similarity=0.310 Sum_probs=94.0
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
|+|.+++.. ....+++.+++.|+.|+++||.|||+++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 688898853 2456999999999999999999999875 999999999999999 99987654322
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
..|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25789999999999999999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-21 Score=172.90 Aligned_cols=198 Identities=22% Similarity=0.365 Sum_probs=157.9
Q ss_pred ccccccccccCceeEEEEEecCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
.....+|.+...|+.|+|+++ |..+++|++.... .....+|.+|.-.|+.+.||||+++++.|...++..++..|||
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344568899999999999995 6677778775442 3334678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEe--ecCCccccCCCCc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA--DFGLARSFQEDKS 470 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~--Dfgl~~~~~~~~~ 470 (532)
.|+|..+|+. ...-.++-.+..+++.++++|++|||+..+ -|.---|.+..+++|++.+.+|+ |--++. +.
T Consensus 271 ~gslynvlhe-~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf--qe--- 343 (448)
T KOG0195|consen 271 FGSLYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE--- 343 (448)
T ss_pred chHHHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee--ec---
Confidence 9999999975 334567888999999999999999999872 23344689999999999987775 322221 11
Q ss_pred ccccccccccccccccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQL---TEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlGvll~el~tG~~p~~~~~~~~ 523 (532)
....-.|.||+||.+++++. -..+|+|||++++|||.|...||...++-+
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 11234688999999987654 357899999999999999999998876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=166.00 Aligned_cols=137 Identities=17% Similarity=0.266 Sum_probs=106.8
Q ss_pred cccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-----ccceeeeeeeeeecCC---cce-E
Q 009543 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-----EHKNLVRLLGCSCSGP---ESL-L 386 (532)
Q Consensus 316 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-l 386 (532)
...+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ +||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467899999999996 443333479988765555567899999999999 5799999999998864 323 7
Q ss_pred EEEe--cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEccCCCCCEEEcC----CCcEEEeec
Q 009543 387 VYEF--LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL-VYLHEQSKIRIIHRDIKASNILLDS----RLRAKIADF 459 (532)
Q Consensus 387 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~iiH~Dlkp~NiLl~~----~~~~kl~Df 459 (532)
|+|| .++++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 668999999943 235555 35677888777 9999998 999999999999974 348999995
Q ss_pred CCcc
Q 009543 460 GLAR 463 (532)
Q Consensus 460 gl~~ 463 (532)
+.+.
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 4443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=195.97 Aligned_cols=195 Identities=20% Similarity=0.216 Sum_probs=159.9
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc---cceeeeeeeeeecCCcceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 388 (532)
...|.+.+.||+|+||+||+|...+|+.||+|+-+..+.... .-=.+++.+|+ -+.|+++...+.-.+..++|+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 356889999999999999999988899999998876654432 11112223333 355667777777788899999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-------CCcEEEeecCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-------RLRAKIADFGL 461 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-------~~~~kl~Dfgl 461 (532)
||.+.|+|.+++. ..+.++|..++.++.|++..++.||..+ |||+||||+|+||.. +..++|+|||.
T Consensus 774 ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 9999999999994 6678999999999999999999999998 999999999999942 34699999999
Q ss_pred ccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 009543 462 ARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515 (532)
Q Consensus 462 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p 515 (532)
+.....-... .....++|-.+-.+|...++.++.+.|.|.|+-+++-|+.|+.-
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 8765433322 34567889999999999999999999999999999999999753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.9e-21 Score=192.33 Aligned_cols=185 Identities=28% Similarity=0.309 Sum_probs=155.8
Q ss_pred ccccCceeEEEEE----ecCCCEEEEEEeeccChh--hHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEEEecCC
Q 009543 321 LGQGGFGTVYKGV----LPDGREIAVKRLFFNNRH--RAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 321 lG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+|+|.||.|++.. .+.|..+|+|.+...... .......|..++...+ ||.++++...++.+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999865 235777888887654211 1114556778888886 99999999999999999999999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
|.|...+ .+...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-....
T Consensus 82 g~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 82 GDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred chhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 9998777 34556777777788889999999999998 99999999999999999999999999987644332
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999998 567789999999999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-20 Score=196.39 Aligned_cols=200 Identities=27% Similarity=0.358 Sum_probs=159.6
Q ss_pred cccccccccCceeEEEEEec-CCCEEEEEEee----cc-C-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 316 DEANKLGQGGFGTVYKGVLP-DGREIAVKRLF----FN-N-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 316 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~----~~-~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
...+.+|.|.+|.|+..... .....+.|... .. . .+....+..|.-+-..+.|||++..+....+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988877643 33334444332 11 1 122223667888888899999998888887777777679
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++ +|..++. ....+...++..++.|+..|+.|||+.+ |.|||||++|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999883 3346888899999999999999999999 999999999999999999999999998877544
Q ss_pred Cc---ccccccccccccccccccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 469 KS---HISTAIAGTLGYMAPEYLAHGQLTE-KADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 469 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
.. ......+|+..|+|||.+...+|.+ ..||||.|+++..|++|+.||.....+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 33 3456678999999999998888765 579999999999999999999875433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-18 Score=161.93 Aligned_cols=144 Identities=18% Similarity=0.194 Sum_probs=112.3
Q ss_pred CccccccccccCceeEEEEE--ecCCCEEEEEEeeccChh------------------------hHHHHHHHHhHhhcCc
Q 009543 314 SFDEANKLGQGGFGTVYKGV--LPDGREIAVKRLFFNNRH------------------------RAANFYNEVNIISSVE 367 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 367 (532)
-|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 568999999998754210 1123568999999997
Q ss_pred cce--eeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 009543 368 HKN--LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (532)
Q Consensus 368 h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (532)
+.+ +.++++. ...++||||+++.+|..... ....+...+...++.|++.++.+||+++ .|+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 633 3344432 24589999999988876542 2234566677899999999999999886 49999999999
Q ss_pred EEEcCCCcEEEeecCCccccCC
Q 009543 446 ILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 446 iLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|+++ ++.++|+|||.+.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999875443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.6e-18 Score=159.21 Aligned_cols=135 Identities=21% Similarity=0.247 Sum_probs=114.4
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeeccCh--------hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR--------HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
+.||+|++|.||+|.+ +|..+++|+...... .....+.+|+.++..++|++|.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 678899997653321 1124578899999999999998887777777888999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999988421 12 78899999999999999998 99999999999999 789999999998753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-18 Score=164.98 Aligned_cols=203 Identities=21% Similarity=0.296 Sum_probs=134.1
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCc----------cceeeeeeeeee
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVE----------HKNLVRLLGCSC 379 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~~~~~~~ 379 (532)
.+...+.||.|+++.||.+++. +++++|+|+..... ....+++.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456788999999999999986 58999999886543 234567777776655532 223333333221
Q ss_pred ---------cCC--------cceEEEEecCCCChhHHhh---hccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 009543 380 ---------SGP--------ESLLVYEFLPNQSLDRFIF---DSAK-AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438 (532)
Q Consensus 380 ---------~~~--------~~~lv~e~~~~g~L~~~l~---~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH 438 (532)
... ..+++|+-+ .++|.+++. .... ...+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 234567666 568877753 2111 123445556778899999999999999 999
Q ss_pred ccCCCCCEEEcCCCcEEEeecCCccccCCCCcccccccccccccccccccccC--------CCCchhhHHHHHHHHHHHH
Q 009543 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG--------QLTEKADVYSFGMLLLEIV 510 (532)
Q Consensus 439 ~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~SlGvll~el~ 510 (532)
+||+|+|++++++|.++|+||+........... ...+..|.+||..... .++.+.|.|+||+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999877654432211 2345789999976432 4688999999999999999
Q ss_pred hCCCCCCCCCCccc
Q 009543 511 TGRQNNRSKNSEYT 524 (532)
Q Consensus 511 tG~~p~~~~~~~~~ 524 (532)
+|+.||....++..
T Consensus 245 C~~lPf~~~~~~~~ 258 (288)
T PF14531_consen 245 CGRLPFGLSSPEAD 258 (288)
T ss_dssp HSS-STCCCGGGST
T ss_pred HccCCCCCCCcccc
Confidence 99999987654433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=155.04 Aligned_cols=138 Identities=22% Similarity=0.266 Sum_probs=109.6
Q ss_pred CccccccccccCceeEEEEEecCCCEEEEEEeeccChh----------------------hHHHHHHHHhHhhcCccce-
Q 009543 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH----------------------RAANFYNEVNIISSVEHKN- 370 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n- 370 (532)
.|.+.+.||+|+||.||++..++|+.||||++...... ......+|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 47788999999999999999888999999987543210 1123567888898888874
Q ss_pred -eeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc
Q 009543 371 -LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (532)
Q Consensus 371 -iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~ 449 (532)
+.+.++ ....+++|||+++++|..... ......++.+++.++.++|+.+ |+||||||+||+++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~ 159 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD 159 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence 444443 245689999999999876541 0335678899999999999988 99999999999999
Q ss_pred CCCcEEEeecCCccccCC
Q 009543 450 SRLRAKIADFGLARSFQE 467 (532)
Q Consensus 450 ~~~~~kl~Dfgl~~~~~~ 467 (532)
+++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=154.96 Aligned_cols=131 Identities=21% Similarity=0.298 Sum_probs=107.8
Q ss_pred cccccCceeEEEEEecCCCEEEEEEeeccC--------hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNN--------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.||+|+||.||+|.+ ++..+++|+..... .....++.+|++++..++|+++.....+.......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 67889999864321 112356778999999999988766665666677789999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~------~----~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D----ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH------H----HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998873211 0 78999999999999998 99999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=178.36 Aligned_cols=140 Identities=19% Similarity=0.266 Sum_probs=114.0
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeecc--------ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--------NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 382 (532)
....|...++||+|+||+||++.+.+. .+++|+.... .....+.+.+|++++..++|++++....+.....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556788999999999999998544 4444433211 1122356889999999999999998887777777
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ .++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999999883 35678999999999999998 9999999999999 6789999999999
Q ss_pred cccC
Q 009543 463 RSFQ 466 (532)
Q Consensus 463 ~~~~ 466 (532)
+...
T Consensus 475 ~~~~ 478 (535)
T PRK09605 475 KYSD 478 (535)
T ss_pred ccCC
Confidence 8653
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.6e-18 Score=139.20 Aligned_cols=89 Identities=35% Similarity=0.665 Sum_probs=71.2
Q ss_pred CchHHHHHHHHHHHHHHHhcCCC--CCceeEeeeecCCCCcceeeeeccccccChhhHHHHHHHHHhhhhccCC-CCCCc
Q 009543 144 KNSSFQESARKAVMRAVASAPSN--GGYARVQVQVSGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLP-WSEGR 220 (532)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~a~~~--~~~~~~~~~~~~~~~~~~y~l~QC~~dls~~~C~~Cl~~a~~~~~~c~~-~~~g~ 220 (532)
+++.|..++..+|..+...++.. .+|+++.. +.+.+++|||+||++||++.+|..||+.++..++.||+ ..+|+
T Consensus 15 ~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~---~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~ 91 (106)
T PF01657_consen 15 DNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA---GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGR 91 (106)
T ss_dssp TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE-----ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEE
T ss_pred CCchHHHHHHHHHHHHHHHHhhccccCcEEeec---CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEE
Confidence 45669999999999999887753 68888763 55778999999999999999999999999999999666 77899
Q ss_pred cccccccccccCCcc
Q 009543 221 ALNTGCFMRYSDKDF 235 (532)
Q Consensus 221 v~~~~C~lry~~~~f 235 (532)
++.++|++||++++|
T Consensus 92 v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 92 VWYDSCFLRYENYPF 106 (106)
T ss_dssp EEESSEEEEEESS--
T ss_pred EECCCEEEEEECCCC
Confidence 999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-18 Score=183.23 Aligned_cols=196 Identities=21% Similarity=0.263 Sum_probs=151.5
Q ss_pred CccccccccccCceeEEEEEecCCCEEEEEEeeccC-hhhHHHHH---HHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN-RHRAANFY---NEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++...+.||.+.|=+|.++++++|. |+||++.... .-....+. +|++ ...++|||.+++.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677889999999999999998888 9999987654 22333444 4444 556699999999988888888899999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc--CC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF--QE 467 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~--~~ 467 (532)
|..+ +|.+-+ .....+...+..-|+.|++.||..+|+.+ |+|||||.+||||+.-..+.|+||.--+.. +.
T Consensus 102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9855 677766 34456778888899999999999999998 999999999999999999999999865532 22
Q ss_pred CCcccc----cccccccccccccccccC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 009543 468 DKSHIS----TAIAGTLGYMAPEYLAHG-----------QLTEKADVYSFGMLLLEIVT-GRQNNRS 518 (532)
Q Consensus 468 ~~~~~~----~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGvll~el~t-G~~p~~~ 518 (532)
+..... .+-..-..|.|||.+... ..+++-||||+||++.||++ |++||.-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 221111 111223469999976431 14678999999999999988 7888853
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.6e-16 Score=143.92 Aligned_cols=138 Identities=20% Similarity=0.262 Sum_probs=97.8
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChh--hHHHH----------------------HHHHhHhhcCccce--e
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--RAANF----------------------YNEVNIISSVEHKN--L 371 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i 371 (532)
.+.||+|+||+||++...+++.||||++...... ..... ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 11111 24555555554332 3
Q ss_pred eeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEEEcC
Q 009543 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDS 450 (532)
Q Consensus 372 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiLl~~ 450 (532)
.+.+++ ...+++|||++++.+........ ... .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 333332 24689999999955432211100 011 5678899999999999999 77 99999999999999
Q ss_pred CCcEEEeecCCccccCC
Q 009543 451 RLRAKIADFGLARSFQE 467 (532)
Q Consensus 451 ~~~~kl~Dfgl~~~~~~ 467 (532)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.6e-16 Score=135.99 Aligned_cols=135 Identities=24% Similarity=0.242 Sum_probs=114.7
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCcc--ceeeeeeeeeecCCcceEEEEecCCC
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH--KNLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| +++++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999854 7899998865433 4678899999999977 58899998888888899999999988
Q ss_pred ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
.+..+ +......++.++++++.+||......++|+||+|+||++++++.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5566778899999999999987545699999999999999999999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.3e-17 Score=171.74 Aligned_cols=169 Identities=24% Similarity=0.367 Sum_probs=124.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..+|+.++.|..|+||.||..+++ +.+.+|+|+-+.+. +.+ .++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilR--nilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILR--NILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhh--ccccccCCccee------------------
Confidence 467999999999999999999986 46778885332111 111 034444455544
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
|+-...+ +..+.++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++.......
T Consensus 136 ---gDc~tll---k~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2333333 12222332 2277899999998 99999999999999999999999999876422111
Q ss_pred --------------ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 009543 471 --------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523 (532)
Q Consensus 471 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~ 523 (532)
...+..+||+.|.|||++....|+..+|+|++|+|+||.+-|..||.++.+++
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 01234589999999999999999999999999999999999999999885543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-17 Score=165.13 Aligned_cols=192 Identities=22% Similarity=0.335 Sum_probs=138.4
Q ss_pred CCccccccccccCceeEEEEEecCC----CEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeee-------eee-
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDG----REIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLG-------CSC- 379 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~-------~~~- 379 (532)
....+.+-.++..++.++......+ ..+.-+.....+-.......+++-.+... .|++.+. .. .+.
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~-~d~~~s~~~~~~~ 322 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSIL-EDLRPSLFESSKR 322 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccc-cCCCCchhhhccc
Confidence 3445556666777777766553322 23344433333312222333344444444 3444332 22 111
Q ss_pred ----cCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEE
Q 009543 380 ----SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAK 455 (532)
Q Consensus 380 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~k 455 (532)
.....++.|+++...+|.++|.........++...+.++.|++.++.| ++ .+|+|+||.||+...+..+|
T Consensus 323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhh
Confidence 122478999999999999999776677788999999999999999999 55 89999999999999999999
Q ss_pred EeecCCccccCCCC-----cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 009543 456 IADFGLARSFQEDK-----SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511 (532)
Q Consensus 456 l~Dfgl~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t 511 (532)
|.|||+........ ....+...||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99999987665544 123355689999999999999999999999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-16 Score=152.95 Aligned_cols=145 Identities=26% Similarity=0.369 Sum_probs=109.3
Q ss_pred ccceeeeeeeeeecC---------------------------CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHH
Q 009543 367 EHKNLVRLLGCSCSG---------------------------PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL 419 (532)
Q Consensus 367 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 419 (532)
+|||||++.+.|.++ ...|+||.-.+. +|.+++. ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh----cCCCchHHHHHHHH
Confidence 699999999876532 245788877744 7888773 34456677777899
Q ss_pred HHHHHHHHHHhCCCCCeEEccCCCCCEEE--cCCC--cEEEeecCCccccCCCCc-----cccccccccccccccccccc
Q 009543 420 GTVEGLVYLHEQSKIRIIHRDIKASNILL--DSRL--RAKIADFGLARSFQEDKS-----HISTAIAGTLGYMAPEYLAH 490 (532)
Q Consensus 420 ~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl--~~~~--~~kl~Dfgl~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~ 490 (532)
|+++|+.|||+++ |.|||+|++|||+ |+|+ .+.|+|||.+---+.... ...-..-|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 4444 588999998643322111 11223457778999998753
Q ss_pred C--C----CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 491 G--Q----LTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 491 ~--~----~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
. + .-.|+|.|+.|.+.||+++...||.+.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 2 2 245899999999999999999999873
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5e-16 Score=158.31 Aligned_cols=155 Identities=32% Similarity=0.518 Sum_probs=128.8
Q ss_pred hhcCccceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 009543 363 ISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK 442 (532)
Q Consensus 363 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlk 442 (532)
|+.+.|.|+.+++|.+.+++..+.|.+|++.|+|.+.+.. ....+++.-...++++|+.||.|||+.. -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999999999999999999999999954 4567899999999999999999999865 23999999
Q ss_pred CCCEEEcCCCcEEEeecCCccccCCC-CcccccccccccccccccccccC-------CCCchhhHHHHHHHHHHHHhCCC
Q 009543 443 ASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYMAPEYLAHG-------QLTEKADVYSFGMLLLEIVTGRQ 514 (532)
Q Consensus 443 p~NiLl~~~~~~kl~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvll~el~tG~~ 514 (532)
++|+++|....+||+|||+....... .........-...|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998776421 11111222235679999998653 14677999999999999999999
Q ss_pred CCCCCCC
Q 009543 515 NNRSKNS 521 (532)
Q Consensus 515 p~~~~~~ 521 (532)
||.....
T Consensus 157 ~~~~~~~ 163 (484)
T KOG1023|consen 157 PFDLRNL 163 (484)
T ss_pred ccccccc
Confidence 9987543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.4e-15 Score=142.36 Aligned_cols=137 Identities=18% Similarity=0.236 Sum_probs=105.4
Q ss_pred ccccc-ccCceeEEEEEecCCCEEEEEEeeccC-------------hhhHHHHHHHHhHhhcCcccee--eeeeeeeecC
Q 009543 318 ANKLG-QGGFGTVYKGVLPDGREIAVKRLFFNN-------------RHRAANFYNEVNIISSVEHKNL--VRLLGCSCSG 381 (532)
Q Consensus 318 ~~~lG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~ 381 (532)
...|| .||.|+||+.... +..++||++.... ......+.+|++++..++|++| ++.++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34687 8999999998884 7889999874321 1223467889999999998885 6677664432
Q ss_pred Cc----ceEEEEecCC-CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 382 PE----SLLVYEFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 382 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
.. .++|||++++ .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 689888732 234443 3568899999999998 999999999999999999999
Q ss_pred eecCCccccC
Q 009543 457 ADFGLARSFQ 466 (532)
Q Consensus 457 ~Dfgl~~~~~ 466 (532)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999887643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=6e-14 Score=145.25 Aligned_cols=142 Identities=20% Similarity=0.198 Sum_probs=100.0
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhhHH----------------------------------------HHH
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA----------------------------------------NFY 357 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~----------------------------------------~~~ 357 (532)
.+.||.|++|+||+|++++|+.||||+.......... ++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999998654211100 234
Q ss_pred HHHhHhhcCc-----cceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 009543 358 NEVNIISSVE-----HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE-GLVYLHEQ 431 (532)
Q Consensus 358 ~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~~ 431 (532)
+|...+.+++ +++|.-..-+....+..++||||++|++|.++..... ...+ +..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555554442 3333222222223456799999999999988764211 1222 3456666665 46778988
Q ss_pred CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 432 ~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
+ ++|+|+||.||++++++.++++|||++..+..
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 99999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-15 Score=162.28 Aligned_cols=207 Identities=26% Similarity=0.340 Sum_probs=165.1
Q ss_pred cCCccccccccccCceeEEEEEecC--CCEEEEEEeeccC--hhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD--GREIAVKRLFFNN--RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 386 (532)
...|.+.+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3467788889999999998887643 4456666665443 233344555777777776 9999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCccc
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH-EQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARS 464 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~ 464 (532)
+.+|..++++.+.+.. ......+....-.++.|+..++.|+| +.+ +.|+||||+|.+++..+ .+|++|||++..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999887731 12225566677789999999999999 777 99999999999999999 999999999987
Q ss_pred cCC-CC-ccccccccc-ccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 465 FQE-DK-SHISTAIAG-TLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 465 ~~~-~~-~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
+.. .. .......+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 765 22 223345678 9999999998774 5577899999999999999999999876543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=6e-13 Score=139.38 Aligned_cols=145 Identities=19% Similarity=0.225 Sum_probs=92.8
Q ss_pred CCccccccccccCceeEEEEEecC-CCEEEEEEeeccChhh----------------------------------HHH--
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHR----------------------------------AAN-- 355 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~----------------------------------~~~-- 355 (532)
..|+. +.||.|++|+||++++++ |++||||++.+.-... .+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34666 789999999999999987 9999999997542110 111
Q ss_pred ----HHHHHhHhhcCc----cceeeeeeeeeec-CCcceEEEEecCCCChhHHhhhccCCC---CCCHHHHHHHHHHHHH
Q 009543 356 ----FYNEVNIISSVE----HKNLVRLLGCSCS-GPESLLVYEFLPNQSLDRFIFDSAKAK---TLTWEKRYEIILGTVE 423 (532)
Q Consensus 356 ----~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~---~l~~~~~~~i~~~ia~ 423 (532)
+.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-.-...+. .+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 233333333332 3333333233322 456789999999999987531111110 1222222233333
Q ss_pred HHHHHHhCCCCCeEEccCCCCCEEEcCCC----cEEEeecCCccccCCC
Q 009543 424 GLVYLHEQSKIRIIHRDIKASNILLDSRL----RAKIADFGLARSFQED 468 (532)
Q Consensus 424 ~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~----~~kl~Dfgl~~~~~~~ 468 (532)
++..+ ++|+|+||.||+++.++ .+++.|||++..++..
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 34566 99999999999999988 9999999999877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.5e-12 Score=116.17 Aligned_cols=131 Identities=19% Similarity=0.122 Sum_probs=97.3
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceee-eeeeeeecCCcceEEEEecCCCCh
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
++.|+.|.++.||+.+.. ++.+++|....... ....+.+|+.++..+.+.+++ +++... ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999874 78899998754432 223467899999988665544 444432 3346899999999887
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS--KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
.... .....++.+++++|..||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 111245678999999999886 23369999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-11 Score=126.40 Aligned_cols=166 Identities=16% Similarity=0.222 Sum_probs=127.0
Q ss_pred ecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHH
Q 009543 334 LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK 413 (532)
Q Consensus 334 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~ 413 (532)
..++.+|.|...........+...+-++.|+.++||||++++..+.+++..|+|+|-+. -|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34788999988876666445667888999999999999999999999999999999874 35555522 23455
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccccccccccccccccccccCCC
Q 009543 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493 (532)
Q Consensus 414 ~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 493 (532)
.--.+.||+.||.|||+.+ .++|++|.-..|+|++.|+.||++|-++........ .......-..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 5667889999999999766 499999999999999999999999998765443321 111112223466676553322
Q ss_pred CchhhHHHHHHHHHHHHhC
Q 009543 494 TEKADVYSFGMLLLEIVTG 512 (532)
Q Consensus 494 ~~~~Dv~SlGvll~el~tG 512 (532)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.4e-11 Score=107.66 Aligned_cols=137 Identities=15% Similarity=0.111 Sum_probs=98.8
Q ss_pred ccccccCceeEEEEEecC-------CCEEEEEEeeccC-----h-----------------hhHH----HHHHHHhHhhc
Q 009543 319 NKLGQGGFGTVYKGVLPD-------GREIAVKRLFFNN-----R-----------------HRAA----NFYNEVNIISS 365 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-----~-----------------~~~~----~~~~E~~~l~~ 365 (532)
..||.|.-+.||.|...+ +..+|||+.+... . .... ...+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4799999874321 0 0011 23379999988
Q ss_pred Ccc--ceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEccCC
Q 009543 366 VEH--KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL-HEQSKIRIIHRDIK 442 (532)
Q Consensus 366 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~iiH~Dlk 442 (532)
+.. -++.+++++ ...++||||+.+..+..-.. +...++..+...+..+++.+|..| |+.+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 854 355566654 56789999997754422211 122345566677889999999998 7777 9999999
Q ss_pred CCCEEEcCCCcEEEeecCCccccC
Q 009543 443 ASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 443 p~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
+.|||++ ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.6e-12 Score=127.27 Aligned_cols=199 Identities=24% Similarity=0.307 Sum_probs=158.3
Q ss_pred CCccccccccc--cCceeEEEEEe---cCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcc
Q 009543 313 GSFDEANKLGQ--GGFGTVYKGVL---PDGREIAVKRLFFN--NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 313 ~~~~~~~~lG~--G~fg~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 384 (532)
..+.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. .......-.+|......+ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677888999 99999999987 36889999984432 223334445666666666 599999998899999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeec
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE----GLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADF 459 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Df 459 (532)
++-+|++. .+|..+.+. ....++....+.+..+..+ |+.++|... ++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 677777643 3455778888888888888 999999998 9999999999999999 89999999
Q ss_pred CCccccCCCCcc----cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 460 GLARSFQEDKSH----ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 460 gl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
|+...+...... ......|...|++||..+ +.++..+|+|++|.++.|..+|-.+...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccC
Confidence 999887655422 122335788999999874 4678899999999999999888777644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-10 Score=100.43 Aligned_cols=144 Identities=22% Similarity=0.247 Sum_probs=110.2
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEeecc-C-------hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFN-N-------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~-~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
....|-+|+-+.|+++.+ .|+...||.-... - +-...+.++|++++.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999999 4777777744322 1 122356788999999987767766666777888889999
Q ss_pred EecCC-CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC---cEEEeecCCccc
Q 009543 389 EFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIADFGLARS 464 (532)
Q Consensus 389 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~---~~kl~Dfgl~~~ 464 (532)
||+++ .++.+++..... ..........++..|-+.+.-||... |||+||..+||+|.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~-~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME-DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHcc-CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 578888865332 23333344778888899999999998 99999999999997766 468999999865
Q ss_pred c
Q 009543 465 F 465 (532)
Q Consensus 465 ~ 465 (532)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-10 Score=109.77 Aligned_cols=143 Identities=17% Similarity=0.232 Sum_probs=109.5
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccc--eeeeeeeeeecC---CcceEEEEec
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHK--NLVRLLGCSCSG---PESLLVYEFL 391 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~ 391 (532)
.+.|+.|..+.||+++..+|+.+++|....... .....+.+|.+++..+.+. ++.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999987778999998754432 1345688999999998753 456677766553 2568999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS--------------------------------------- 432 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------- 432 (532)
+|.++.+.+. ...++..+...++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9998876542 135677777888888888888888521
Q ss_pred --------------CCCeEEccCCCCCEEEcC--CCcEEEeecCCccc
Q 009543 433 --------------KIRIIHRDIKASNILLDS--RLRAKIADFGLARS 464 (532)
Q Consensus 433 --------------~~~iiH~Dlkp~NiLl~~--~~~~kl~Dfgl~~~ 464 (532)
+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.5e-10 Score=99.71 Aligned_cols=132 Identities=20% Similarity=0.282 Sum_probs=102.3
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeecc---C-----hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFN---N-----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~---~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..+++|+-+.++.+.+. |.++++|.-... . +-..+.-.+|..++.+++--.|....-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999874 445666633221 1 11234567899999999877777777777788888999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
.+|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..-
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888432 2456677777788899998 99999999999997765 999999998754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.7e-10 Score=107.01 Aligned_cols=152 Identities=22% Similarity=0.321 Sum_probs=116.3
Q ss_pred hhcCccceeeeeeeeeec-----CCcceEEEEecCCCChhHHhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 009543 363 ISSVEHKNLVRLLGCSCS-----GPESLLVYEFLPNQSLDRFIFDSAK-AKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436 (532)
Q Consensus 363 l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 436 (532)
|-++.|.||++++.++.+ .....+++|||+.|++..+|.+..+ +..+......+|.-||..||.|||+-. ++|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence 445679999999998754 3456899999999999999975433 456778888899999999999999975 789
Q ss_pred EEccCCCCCEEEcCCCcEEEeecCCccccCCCCc----ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhC
Q 009543 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKS----HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512 (532)
Q Consensus 437 iH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG 512 (532)
+|+++.-+-|++..+|-+||.----.. ...... .......+-++|.+||.=.-.+.+-.+|||+||.-.+||.-|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999999985322111 111110 111223467899999986555667789999999999999988
Q ss_pred CCCC
Q 009543 513 RQNN 516 (532)
Q Consensus 513 ~~p~ 516 (532)
..--
T Consensus 279 Eiq~ 282 (458)
T KOG1266|consen 279 EIQS 282 (458)
T ss_pred eecc
Confidence 7654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3e-09 Score=106.84 Aligned_cols=169 Identities=24% Similarity=0.370 Sum_probs=129.3
Q ss_pred ceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec----CCcceEEEEecCC-CChhHH
Q 009543 326 FGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPESLLVYEFLPN-QSLDRF 399 (532)
Q Consensus 326 fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~L~~~ 399 (532)
-.+.||+... ||..+++|+++....+.......-++.++++.|+|||++.+++.. +..+.+|++|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3577898854 899999999943322222223345778999999999999998873 3457899999986 567665
Q ss_pred hhhc------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 400 IFDS------------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 400 l~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
-+.. ..+...++..+|.++.|+..||.++|+.| +.-+-|.|++||++.+..++|+..|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5421 22345788999999999999999999998 88899999999999999999999988776655
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p 515 (532)
+.. |-+.. -.+-|.=.||.+++.|.||...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 441 11111 2256888999999999999765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.9e-09 Score=96.88 Aligned_cols=126 Identities=26% Similarity=0.359 Sum_probs=83.3
Q ss_pred eEEEEEecCCCEEEEEEeeccC--------------h------------hhHHHHHHHHhHhhcCccc--eeeeeeeeee
Q 009543 328 TVYKGVLPDGREIAVKRLFFNN--------------R------------HRAANFYNEVNIISSVEHK--NLVRLLGCSC 379 (532)
Q Consensus 328 ~Vy~~~~~~g~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 379 (532)
.||.|...+|.++|+|..+... . .......+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999874321 0 0123567899999999765 456666542
Q ss_pred cCCcceEEEEecC--CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 380 SGPESLLVYEFLP--NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY-LHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 380 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
...+||||++ |..+..+... .++......++.+++..+.. +|+.+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 5689999998 6556554321 11133455677777775555 57877 9999999999999988 9999
Q ss_pred eecCCccccC
Q 009543 457 ADFGLARSFQ 466 (532)
Q Consensus 457 ~Dfgl~~~~~ 466 (532)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.4e-10 Score=124.88 Aligned_cols=205 Identities=21% Similarity=0.257 Sum_probs=151.3
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.+.+.+.+-+-+|.++.++...-. .|...++|...... ....+....+-.++-..+||-++...-.+.-....+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 456778888999999999987743 34334444332221 12223344444455555678888776666667788999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
++|..+++|...|+. ....+.+-....+..+.+++++||... +.|+|++|.|+|...+++.+++|||.......
T Consensus 883 ~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999888853 234566666677778889999999886 89999999999999999999999984322110
Q ss_pred C---------------------C---------cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 468 D---------------------K---------SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 468 ~---------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
. . ........+|+.|.+||...+......+|+|++|+.++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 011234578999999999999999999999999999999999999998
Q ss_pred CCCCc
Q 009543 518 SKNSE 522 (532)
Q Consensus 518 ~~~~~ 522 (532)
....+
T Consensus 1037 a~tpq 1041 (1205)
T KOG0606|consen 1037 AETPQ 1041 (1205)
T ss_pred Ccchh
Confidence 76543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.2e-10 Score=117.35 Aligned_cols=197 Identities=21% Similarity=0.230 Sum_probs=148.1
Q ss_pred hcCCccccccccccCceeEEEEEec--CCCEEEEEEeeccChhhHHH--HHHHHhHhhcC-ccceeeeeeeeeecCCcce
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP--DGREIAVKRLFFNNRHRAAN--FYNEVNIISSV-EHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 385 (532)
...+|..+..||.|.|+.|++...+ ++..+++|.+...-.....+ -..|+.+...+ .|.+++.....+..-+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567899999999999999997743 57788999775543322222 23455555555 5888888877777778888
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecCCccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARS 464 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfgl~~~ 464 (532)
+--||++++++...+ .-...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||....
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999887766 23346788889999999999999999887 9999999999999886 7899999998864
Q ss_pred cCCCCcccccccccccccc--cccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYM--APEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
+.-.. .......++. +|+......+..+.|++|||.-+.|.++|..--.
T Consensus 417 ~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 417 LAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred cceec----ccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 21111 1111223344 4555556678899999999999999999876543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-08 Score=98.26 Aligned_cols=134 Identities=17% Similarity=0.084 Sum_probs=97.2
Q ss_pred ceeEEEEEecCCCEEEEEEeeccChh-hH----------HHHHHHHhHhhcCccceee--eeeeeeec-----CCcceEE
Q 009543 326 FGTVYKGVLPDGREIAVKRLFFNNRH-RA----------ANFYNEVNIISSVEHKNLV--RLLGCSCS-----GPESLLV 387 (532)
Q Consensus 326 fg~Vy~~~~~~g~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~niv--~~~~~~~~-----~~~~~lv 387 (532)
...|.+..+ +|+.+.||+....... .. ..+.+|...+..+...+|. +++++... ....++|
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 344667766 6789999977433211 11 1377888888887544443 33444432 2346899
Q ss_pred EEecCCC-ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-------CCcEEEeec
Q 009543 388 YEFLPNQ-SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-------RLRAKIADF 459 (532)
Q Consensus 388 ~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-------~~~~kl~Df 459 (532)
+|++++. +|.+++.... ....+......++.+++..+.-||+.+ |+|+|++++|||++. +..+.|+||
T Consensus 114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 9999986 8988874221 234566778899999999999999999 999999999999975 468999999
Q ss_pred CCccc
Q 009543 460 GLARS 464 (532)
Q Consensus 460 gl~~~ 464 (532)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.7e-08 Score=94.51 Aligned_cols=137 Identities=19% Similarity=0.236 Sum_probs=96.8
Q ss_pred ccccccccccCceeEEEEEecCCCEEEEEEeeccCh----------------------hhHHHHHHHHhHhhcCccc--e
Q 009543 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR----------------------HRAANFYNEVNIISSVEHK--N 370 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 370 (532)
..+.++||-|.-+.||.|..++|.++|||.-+.... .......+|.+.|..|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345689999999999999999999999996532210 0112456899999988655 6
Q ss_pred eeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC
Q 009543 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS 450 (532)
Q Consensus 371 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~ 450 (532)
+.+.+++ +...+|||+++|-.|...-. ..-.... ++..|+.-+.-+-..| ++|+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-----cccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777664 45679999999977654321 1222333 3333333333333555 999999999999999
Q ss_pred CCcEEEeecCCccccC
Q 009543 451 RLRAKIADFGLARSFQ 466 (532)
Q Consensus 451 ~~~~kl~Dfgl~~~~~ 466 (532)
+|.+.++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998776443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.7e-08 Score=103.87 Aligned_cols=142 Identities=19% Similarity=0.209 Sum_probs=95.0
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeeccChhhHH----------------------------------------HHHH
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA----------------------------------------NFYN 358 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~----------------------------------------~~~~ 358 (532)
+-|+.++-|+||+|++++|++||||+.++.-..... ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 578999999999999999999999988654222111 1233
Q ss_pred HHhHhhcCc-----cceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 009543 359 EVNIISSVE-----HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG-LVYLHEQS 432 (532)
Q Consensus 359 E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~~~ 432 (532)
|..-+.+++ .|++.-..=++.-.+...|+|||++|..+.++..- +...++...+ +..++++ +..+=..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 444444432 33333222233445678899999999999888532 2244553333 3333322 22222345
Q ss_pred CCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 433 ~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
++|.|.+|.||+++.+|.+.+.|||+...++..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999998876654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.2e-07 Score=91.41 Aligned_cols=195 Identities=14% Similarity=0.174 Sum_probs=130.0
Q ss_pred cccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeee------ecCCc-ceEEE
Q 009543 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS------CSGPE-SLLVY 388 (532)
Q Consensus 316 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~------~~~~~-~~lv~ 388 (532)
...+.||+|+.+.+|-.-- -..-+.|++.........+...| +...-.||-+-.-+.|= -++.. .-+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVAE--LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHHHHHH--hccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3467899999999986321 12245576654433322222222 22333566544312211 12222 56788
Q ss_pred EecCCCChhHHhh----hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 389 EFLPNQSLDRFIF----DSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 389 e~~~~g~L~~~l~----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
..+++..--..++ +.+.-...+|.-.++.++.++.+.+-||+.+ ..-+|+.++|+|+.+++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 8877653222222 2233456789999999999999999999999 89999999999999999999998764433
Q ss_pred cCCCCcccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTG-RQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG-~~p~~~~ 519 (532)
-.+.. ...-.+|...|.+||... +-.-+..+|.|.|||+|++++.| +.||++.
T Consensus 167 ~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 NANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 32222 223356889999999865 22346679999999999998886 9999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.8e-07 Score=87.25 Aligned_cols=107 Identities=22% Similarity=0.243 Sum_probs=82.3
Q ss_pred HHHHHHHhHhhcCccce--eeeeeeeeecC----CcceEEEEecCC-CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHH
Q 009543 354 ANFYNEVNIISSVEHKN--LVRLLGCSCSG----PESLLVYEFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426 (532)
Q Consensus 354 ~~~~~E~~~l~~l~h~n--iv~~~~~~~~~----~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~ 426 (532)
....+|...+..+...+ ..+.+++.... ...++|+|++++ .+|.+++... ...+......++.++++.+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHHH
Confidence 45777888777775433 33455554432 235899999998 4799888431 22667778899999999999
Q ss_pred HHHhCCCCCeEEccCCCCCEEEcCCC---cEEEeecCCccccC
Q 009543 427 YLHEQSKIRIIHRDIKASNILLDSRL---RAKIADFGLARSFQ 466 (532)
Q Consensus 427 ~LH~~~~~~iiH~Dlkp~NiLl~~~~---~~kl~Dfgl~~~~~ 466 (532)
-||+.+ |+|+|+++.|||++.+. .+.++||+-++...
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999 99999999999999887 89999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.4e-06 Score=82.30 Aligned_cols=140 Identities=19% Similarity=0.222 Sum_probs=84.7
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCcccee--eeeeeeeecCCcceEEEEecCCCC-
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL--VRLLGCSCSGPESLLVYEFLPNQS- 395 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~g~- 395 (532)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-++ .+.+++....+...++||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999983 25567888775433 33456889999988864443 566777666777789999999963
Q ss_pred hhHHhh--------------------hccCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeEEccCC
Q 009543 396 LDRFIF--------------------DSAKAKTLTWEKRYE-IIL----------GTVE-GLVYLHEQ-SKIRIIHRDIK 442 (532)
Q Consensus 396 L~~~l~--------------------~~~~~~~l~~~~~~~-i~~----------~ia~-~l~~LH~~-~~~~iiH~Dlk 442 (532)
+...+. ............... +-. .+.+ ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 221110 000000111111100 000 0001 12222211 23457899999
Q ss_pred CCCEEEcCCCcEEEeecCCccc
Q 009543 443 ASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 443 p~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999988 99999997754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.9e-06 Score=79.06 Aligned_cols=139 Identities=17% Similarity=0.181 Sum_probs=101.9
Q ss_pred ccccCceeEEEEEecCCCEEEEEEeeccC------hhhHHHHHHHHhHhhcCccce--eeeeeeeeec----CCcceEEE
Q 009543 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNN------RHRAANFYNEVNIISSVEHKN--LVRLLGCSCS----GPESLLVY 388 (532)
Q Consensus 321 lG~G~fg~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~----~~~~~lv~ 388 (532)
-|+||-+.|++-.. +|+.+-+|+....- +.....|.+|...+..+..-+ +.++...... .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 36788899999777 45578889774111 234568999999999985433 4444422111 11357999
Q ss_pred EecCC-CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc--EEEeecCCccc
Q 009543 389 EFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR--AKIADFGLARS 464 (532)
Q Consensus 389 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~--~kl~Dfgl~~~ 464 (532)
|-+++ .+|.+++.+. ...+.+...+..++.++++.+.-||+.+ +.|+|+-+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 6888887332 2345678888899999999999999999 999999999999987676 99999986654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.7e-06 Score=79.16 Aligned_cols=153 Identities=20% Similarity=0.176 Sum_probs=99.0
Q ss_pred cChhhHHHhcCCccccc---cccccCceeEEEEEecCCCEEEEEEeeccChhhH------------------------HH
Q 009543 303 FKYSTLEKATGSFDEAN---KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA------------------------AN 355 (532)
Q Consensus 303 ~~~~~l~~~~~~~~~~~---~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------~~ 355 (532)
.+...+..+.++..+.. .|..|.-+.||+|.-.++..+|+|++........ ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34455555555555444 4567888899999988899999999864321110 11
Q ss_pred HHHHHhHhhcCc--cceeeeeeeeeecCCcceEEEEecCCCC-hhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 009543 356 FYNEVNIISSVE--HKNLVRLLGCSCSGPESLLVYEFLPNQS-LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-Q 431 (532)
Q Consensus 356 ~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~ 431 (532)
...|..-|.++. +-.+.+.+.+ .+..|||||+.... -.-.| +..++...+...+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 234555555543 2233344433 24579999996541 11111 22233344567777788888888766 4
Q ss_pred CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 432 ~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
+ ++|+||+.-|||+. ++.+.|+|||.+.....
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 4 99999999999999 88999999999876653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.7e-06 Score=78.29 Aligned_cols=138 Identities=16% Similarity=0.163 Sum_probs=92.0
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHH---------HHHHhHhhcCccce---eeeeeee-
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANF---------YNEVNIISSVEHKN---LVRLLGC- 377 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h~n---iv~~~~~- 377 (532)
..++|...+.+-......|.+-.. +|+.+++|..........+.| .+++..+..++..+ ...++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467888888888877777777666 679999998866543322222 23444344443222 2222222
Q ss_pred ----eecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc
Q 009543 378 ----SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR 453 (532)
Q Consensus 378 ----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~ 453 (532)
+......+++|||++|..|.++. .+++ .+...+.+.+.-||+.| +.|+|.+|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 22234456899999998886653 1222 24456778899999999 99999999999998654
Q ss_pred EEEeecCCccc
Q 009543 454 AKIADFGLARS 464 (532)
Q Consensus 454 ~kl~Dfgl~~~ 464 (532)
++++||+.-+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.5e-06 Score=81.00 Aligned_cols=144 Identities=22% Similarity=0.214 Sum_probs=84.8
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce--eeeeeeeeec---CCcceEEEEecC
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGCSCS---GPESLLVYEFLP 392 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~---~~~~~lv~e~~~ 392 (532)
++.|+.|..+.||+....+ +.+++|..... .....+.+|..++..+.... +.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999876 69999987544 44567778888888885433 4556653322 234689999999
Q ss_pred CCChhH----------------Hh---hhc-cCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 009543 393 NQSLDR----------------FI---FDS-AKAKTLTWEKR---------YEI------------ILGTVE-GLVYLHE 430 (532)
Q Consensus 393 ~g~L~~----------------~l---~~~-~~~~~l~~~~~---------~~i------------~~~ia~-~l~~LH~ 430 (532)
+..+.. .+ +.. .......+... ... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 11 111 01111111110 000 111222 2333332
Q ss_pred ----CCCCCeEEccCCCCCEEEc-CCCcEEEeecCCccc
Q 009543 431 ----QSKIRIIHRDIKASNILLD-SRLRAKIADFGLARS 464 (532)
Q Consensus 431 ----~~~~~iiH~Dlkp~NiLl~-~~~~~kl~Dfgl~~~ 464 (532)
.....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666678999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.9e-06 Score=88.48 Aligned_cols=144 Identities=13% Similarity=0.177 Sum_probs=92.7
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeeccChhhH-------------------------------H------HHHHHHh
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA-------------------------------A------NFYNEVN 361 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------------------~------~~~~E~~ 361 (532)
+.||.-+.|.||++++++|+.||||+.++.-+... + +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67999999999999999999999998755422110 0 2333443
Q ss_pred HhhcC----ccce---eeeeeeee-ecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 009543 362 IISSV----EHKN---LVRLLGCS-CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433 (532)
Q Consensus 362 ~l~~l----~h~n---iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 433 (532)
-..++ +|-+ -|.+=.++ .-.....|+|||++|..+.+.-. .....++...+..-+.+...-+- =..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qI--f~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQI--FKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHH--HhcC-
Confidence 33322 3444 11121222 23456789999999998877642 23345666554444433322222 2234
Q ss_pred CCeEEccCCCCCEEEcC----CCcEEEeecCCccccCCCC
Q 009543 434 IRIIHRDIKASNILLDS----RLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 434 ~~iiH~Dlkp~NiLl~~----~~~~kl~Dfgl~~~~~~~~ 469 (532)
++|.|=+|.||+++. ++.+.+-|||+...+....
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 999999999999984 5689999999988765543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-05 Score=77.11 Aligned_cols=140 Identities=13% Similarity=0.109 Sum_probs=84.6
Q ss_pred ccccCc-eeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEEEecCCCChhH
Q 009543 321 LGQGGF-GTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398 (532)
Q Consensus 321 lG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 398 (532)
|-.|.. ..||+.... +..+.+|+..... ...+.+|++++..+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 788998764 4788888775432 335667888888773 3445577777766667899999999988764
Q ss_pred Hhh------------------hccC--CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----CC
Q 009543 399 FIF------------------DSAK--AKTLTW--EKRYEIIL--------------------GTVEGLVYLHE----QS 432 (532)
Q Consensus 399 ~l~------------------~~~~--~~~l~~--~~~~~i~~--------------------~ia~~l~~LH~----~~ 432 (532)
... .... ...+.. ........ .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 421 0000 001110 00000000 01111222211 12
Q ss_pred CCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 433 ~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++.++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35599999999999999988889999997754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.8e-07 Score=96.62 Aligned_cols=196 Identities=17% Similarity=0.121 Sum_probs=140.6
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce-eeeeeeeeecCCcc
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN-LVRLLGCSCSGPES 384 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~ 384 (532)
.+++..+..+...+.+++|.+++++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..+...
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 3444556667778889999999999987644455555555332 34456889999999999 77777777777788
Q ss_pred eEEEEecCCC-ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 385 LLVYEFLPNQ-SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 385 ~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
++.++++..+ +-..... .....+...+...+.+.-.+++++||+.. =+|+| ||+..+ +..|..||+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPP 379 (829)
T ss_pred chhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCc
Confidence 8999999876 2211110 01122333444555666678899999864 48888 777765 688999999877
Q ss_pred ccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.+.... ......+++.+++||......+....|+|++|+--.+|--|-.|-..
T Consensus 380 ~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 380 QLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 654433 23456789999999999999999999999999877788878777654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.6e-07 Score=96.54 Aligned_cols=95 Identities=25% Similarity=0.505 Sum_probs=75.5
Q ss_pred HHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc--------cccccccccccccccccccC
Q 009543 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH--------ISTAIAGTLGYMAPEYLAHG 491 (532)
Q Consensus 420 ~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~ 491 (532)
+++.|+.|+|... .+||++|.|++|.++.++..||..|+.+......... ..--..-...|.|||++...
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4458999999876 5999999999999999999999999987765442111 11112346689999999988
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCC
Q 009543 492 QLTEKADVYSFGMLLLEIVTGRQNN 516 (532)
Q Consensus 492 ~~~~~~Dv~SlGvll~el~tG~~p~ 516 (532)
..+.++|+||+|+++|.+..|.++-
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i 209 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSI 209 (700)
T ss_pred cccccccceeeeeEEEEEecCCcch
Confidence 8899999999999999999555553
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.1e-05 Score=73.78 Aligned_cols=106 Identities=21% Similarity=0.194 Sum_probs=83.6
Q ss_pred HHHHhHhhcCcc-ceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 009543 357 YNEVNIISSVEH-KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435 (532)
Q Consensus 357 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 435 (532)
.+|.-+++.+++ +++++++|+| ..+++.||.+.+++...-..-..-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 6999999998 34789999987766422100012234689999999999999999999865555
Q ss_pred eEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 436 iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
+.--|++|+|+-+++++++|++|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.5e-05 Score=86.90 Aligned_cols=149 Identities=12% Similarity=0.207 Sum_probs=92.4
Q ss_pred cccccccCceeEEEEEecCC---CEEEEEEeeccCh-hhHHHHHHHHhHhhcCc-ccee--eeeeeeeecC---CcceEE
Q 009543 318 ANKLGQGGFGTVYKGVLPDG---REIAVKRLFFNNR-HRAANFYNEVNIISSVE-HKNL--VRLLGCSCSG---PESLLV 387 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 387 (532)
.+.|+.|.+..+|+....++ ..+++|+...... .....+.+|.++++.+. |+++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999887654 4677887643321 22356889999999985 6665 6777776654 457899
Q ss_pred EEecCCCChhHH-----------------------hhhccC--------CCCCCH--HHHHHHH---------------H
Q 009543 388 YEFLPNQSLDRF-----------------------IFDSAK--------AKTLTW--EKRYEII---------------L 419 (532)
Q Consensus 388 ~e~~~~g~L~~~-----------------------l~~~~~--------~~~l~~--~~~~~i~---------------~ 419 (532)
|||++|..+.+. |+.... ..+..+ .++..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999998653211 111000 001011 1111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeEEccCCCCCEEEcCC-C-cEEEeecCCccccC
Q 009543 420 GTVEGLVYLHEQSK--------IRIIHRDIKASNILLDSR-L-RAKIADFGLARSFQ 466 (532)
Q Consensus 420 ~ia~~l~~LH~~~~--------~~iiH~Dlkp~NiLl~~~-~-~~kl~Dfgl~~~~~ 466 (532)
.+.+.+.+|..+-+ ..++|+|+++.||+++.+ + ..-|.||.++..-+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 23344566644321 349999999999999853 3 35799999876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.5e-05 Score=70.06 Aligned_cols=129 Identities=22% Similarity=0.332 Sum_probs=90.9
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEeeccC----------------hhhHHHHHHHHhHhhcCc------cceeeee
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN----------------RHRAANFYNEVNIISSVE------HKNLVRL 374 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~ 374 (532)
....||+|+.-.||. +++.....||+..... .....+..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345799999999987 6666778888886555 122355666666665555 8889999
Q ss_pred eeeeecCCcceEEEEecCC--C----ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 375 LGCSCSGPESLLVYEFLPN--Q----SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 375 ~~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
+|+..++...-+|+|.+.+ | +|.+++ ....++. .....+.+ -..||-+.. |+.+||+|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999999743 2 566666 3344555 44444444 345666665 9999999999999
Q ss_pred cCCC----cEEEee
Q 009543 449 DSRL----RAKIAD 458 (532)
Q Consensus 449 ~~~~----~~kl~D 458 (532)
..+. .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5432 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.97 E-value=8e-05 Score=67.89 Aligned_cols=125 Identities=29% Similarity=0.433 Sum_probs=89.2
Q ss_pred CCccccccccccCc-eeEEEEEecCCCEEEEEEeec---cCh------------------hhHHHHHHHHhHhhcCc---
Q 009543 313 GSFDEANKLGQGGF-GTVYKGVLPDGREIAVKRLFF---NNR------------------HRAANFYNEVNIISSVE--- 367 (532)
Q Consensus 313 ~~~~~~~~lG~G~f-g~Vy~~~~~~g~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 367 (532)
.+++.++.||.|.. |.||+.++ +|+.+|+|.... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999999 578999999321 100 11235778888887774
Q ss_pred ccee--eeeeeeeecC------------------CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHH
Q 009543 368 HKNL--VRLLGCSCSG------------------PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427 (532)
Q Consensus 368 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~ 427 (532)
+.++ ++.+|+..-. ....||.||.+... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 5566 8999986322 11246777765432 122 2344566777888
Q ss_pred HHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 428 LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99998 999999999986 4578999854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=8.5e-05 Score=70.84 Aligned_cols=73 Identities=18% Similarity=0.284 Sum_probs=44.9
Q ss_pred ccccccCce-eEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccc---eeeeeeeeeecC---CcceEEEEec
Q 009543 319 NKLGQGGFG-TVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHK---NLVRLLGCSCSG---PESLLVYEFL 391 (532)
Q Consensus 319 ~~lG~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~ 391 (532)
+.|+.|+.. .||+. +..+++|.... ......+.+|.+++..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777776 48874 34577776543 22345788899998877532 233444433222 2347899999
Q ss_pred CCCChh
Q 009543 392 PNQSLD 397 (532)
Q Consensus 392 ~~g~L~ 397 (532)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.1e-05 Score=65.67 Aligned_cols=130 Identities=18% Similarity=0.226 Sum_probs=89.4
Q ss_pred ccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeee-eeeeeecCCcceEEEEecCC
Q 009543 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR-LLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~ 393 (532)
.+..+.|++|.+|.||+|.+. |.++|+|+-+.++. ...+..|+++|..++-.++-+ ++.+ +...+.|||..|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcC
Confidence 345678999999999999995 56899998765543 356788999998887666543 3333 233455999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC-CCCEEEcCCCcEEEeecCCccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK-ASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlk-p~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
-.|.+.-.. .+..++.. +++.---|...+ |-|+.|. |...+|-.++.+.|+||.-+..
T Consensus 97 ~~L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 888776521 13333333 344433455556 8888886 5555555666999999998873
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=5.9e-05 Score=72.94 Aligned_cols=139 Identities=14% Similarity=0.134 Sum_probs=79.4
Q ss_pred cccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCcccee-eeeeeeeecCCcceEEEEecCCCChhH
Q 009543 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEFLPNQSLDR 398 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~ 398 (532)
.+..|-...+|+... +++.+++|..............+|.++++.+...++ .+++... ..++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456688889998874 577888987644322221235678888888854333 3333332 2479999999876542
Q ss_pred H-----------------hhhcc-CCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEEccCCCCC
Q 009543 399 F-----------------IFDSA-KAKTLTWEKR-YEIILG---------TVEGLVYLHEQ-----SKIRIIHRDIKASN 445 (532)
Q Consensus 399 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~~l~~LH~~-----~~~~iiH~Dlkp~N 445 (532)
- ++... ....++.... ..+..+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 1112222211 111111 11112222111 13458999999999
Q ss_pred EEEcCCCcEEEeecCCccc
Q 009543 446 ILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 446 iLl~~~~~~kl~Dfgl~~~ 464 (532)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999887 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00013 Score=69.49 Aligned_cols=141 Identities=18% Similarity=0.229 Sum_probs=81.6
Q ss_pred cccccccCceeEEEEEecC--CCEEEEEEeeccChhhHHHHHHHHhHhhcCcccee-eeeeeeeecCCcceEEEEecCCC
Q 009543 318 ANKLGQGGFGTVYKGVLPD--GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 394 (532)
++.|..|-...+|+....+ ++.+++|+...... ......+|+.++..+...++ +++++.. + ..++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~-~---~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF-Q---NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe-C---CcEEEEeeCCC
Confidence 3567888889999988764 67899997654322 11233478888888754333 3343332 2 24899999997
Q ss_pred ChhHH-------h----------hhccCC--------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 009543 395 SLDRF-------I----------FDSAKA--------KTL-TWEKRYEIIL----------------------GTVEGLV 426 (532)
Q Consensus 395 ~L~~~-------l----------~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~~l~ 426 (532)
++... + +..... ... .+..+..+.. .+.+.+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76322 1 110100 111 1222222211 1111111
Q ss_pred HH----HhC-CCCCeEEccCCCCCEEEcC-CCcEEEeecCCcc
Q 009543 427 YL----HEQ-SKIRIIHRDIKASNILLDS-RLRAKIADFGLAR 463 (532)
Q Consensus 427 ~L----H~~-~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfgl~~ 463 (532)
.| ... .+..++|+|+.+.|||+++ ++.+.|+||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 111 2345999999999999998 5789999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00018 Score=71.00 Aligned_cols=79 Identities=10% Similarity=0.047 Sum_probs=56.2
Q ss_pred ccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCcc---ceeeeeeeeeec---CCcceEEE
Q 009543 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH---KNLVRLLGCSCS---GPESLLVY 388 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~ 388 (532)
....+.||.|..+.||+....++ .+.+|..+. ......+.+|.+.++.+.- -.+.++++++.. .+..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34466899999999999887655 466676432 1123577889998888742 357777876644 36689999
Q ss_pred EecCCCCh
Q 009543 389 EFLPNQSL 396 (532)
Q Consensus 389 e~~~~g~L 396 (532)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00048 Score=70.18 Aligned_cols=76 Identities=14% Similarity=0.194 Sum_probs=54.0
Q ss_pred cccccccCceeEEEEEecCC-CEEEEEEeecc-----C--hhhHHHHHHHHhHhhcCc---cceeeeeeeeeecCCcceE
Q 009543 318 ANKLGQGGFGTVYKGVLPDG-REIAVKRLFFN-----N--RHRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l 386 (532)
.+.||.|.+..||+....+| +.++||.-... . ....++...|.+.|..+. ...+++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999999877 58999974321 1 123456677888887762 2456667765 4456789
Q ss_pred EEEecCCCC
Q 009543 387 VYEFLPNQS 395 (532)
Q Consensus 387 v~e~~~~g~ 395 (532)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00069 Score=66.94 Aligned_cols=144 Identities=17% Similarity=0.170 Sum_probs=85.9
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce--eeeeeee------eecCCcceEEE
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGC------SCSGPESLLVY 388 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~ 388 (532)
..+.|..|....+|+.... +..+++|+... ........|++++..+.+.+ +.+++.. ....+..++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3567888888899998764 45788898754 22345667777777775333 3444332 12244568999
Q ss_pred EecCCCChhH----Hh----------hhccC--------CCCCCHHHHH----------HHHHHHHHHHHHHHh----CC
Q 009543 389 EFLPNQSLDR----FI----------FDSAK--------AKTLTWEKRY----------EIILGTVEGLVYLHE----QS 432 (532)
Q Consensus 389 e~~~~g~L~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~ia~~l~~LH~----~~ 432 (532)
+|++|..+.. .. +.... .....|.... .....+..++.++.+ ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999877532 11 11000 0111221111 011122334445443 12
Q ss_pred CCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 433 ~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
+..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23599999999999999988789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00089 Score=66.40 Aligned_cols=142 Identities=23% Similarity=0.283 Sum_probs=83.5
Q ss_pred ccccccCceeEEEEEecC-------CCEEEEEEeeccChhhHHHHHHHHhHhhcCcccee-eeeeeeeecCCcceEEEEe
Q 009543 319 NKLGQGGFGTVYKGVLPD-------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 390 (532)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+...++ .++++.+. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456667777899988655 5789999865433 223456678888887753333 34444442 2468999
Q ss_pred cCCCChhHHh-----------------hhccCCC------CCC--HHHHHH--------------------------HHH
Q 009543 391 LPNQSLDRFI-----------------FDSAKAK------TLT--WEKRYE--------------------------IIL 419 (532)
Q Consensus 391 ~~~g~L~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 419 (532)
++|..+.... +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764321 1110000 000 111111 111
Q ss_pred HHHHHHHHHHh------CCCCCeEEccCCCCCEEEcCC----CcEEEeecCCcccc
Q 009543 420 GTVEGLVYLHE------QSKIRIIHRDIKASNILLDSR----LRAKIADFGLARSF 465 (532)
Q Consensus 420 ~ia~~l~~LH~------~~~~~iiH~Dlkp~NiLl~~~----~~~kl~Dfgl~~~~ 465 (532)
.+...+..|.. ..+..++|+|+.|.|||++++ +.++++||..+..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22223334432 234569999999999999985 88999999987643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0031 Score=63.01 Aligned_cols=143 Identities=13% Similarity=0.168 Sum_probs=76.7
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce--eeeeeee------eecCCcceEEEE
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGC------SCSGPESLLVYE 389 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 389 (532)
.+.|+.|....+|+....+| .+++|+..... .+....|+.++..+...+ +.+++.. ....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677788889999887555 68889875212 223334455555443222 2233321 122455789999
Q ss_pred ecCCCChhH-----H------h---hhccC--------CCCCCH-HHHHH------------HHHH-HHHHHHHHHhC--
Q 009543 390 FLPNQSLDR-----F------I---FDSAK--------AKTLTW-EKRYE------------IILG-TVEGLVYLHEQ-- 431 (532)
Q Consensus 390 ~~~~g~L~~-----~------l---~~~~~--------~~~l~~-~~~~~------------i~~~-ia~~l~~LH~~-- 431 (532)
|++|..+.. . | +.... ...+.| ..... .+.+ +...+..+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 1 1 11000 011112 11111 1111 11122333211
Q ss_pred --CCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 432 --SKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 432 --~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
-+..++|+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999776668999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.004 Score=61.89 Aligned_cols=145 Identities=16% Similarity=0.170 Sum_probs=82.1
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce--eeeeeee------eecCCcceEEE
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGC------SCSGPESLLVY 388 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~ 388 (532)
..+.++.|....+|+....+| .+++|+..... ..+....|++++..+...+ +.+++.. ....+..++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 356677887789999876544 57788764422 1234455666666664222 3343332 12245568999
Q ss_pred EecCCCChhH----H----------hhhccCC------C---CCCHHHHH------------HHHHHHHHHHHHHHh---
Q 009543 389 EFLPNQSLDR----F----------IFDSAKA------K---TLTWEKRY------------EIILGTVEGLVYLHE--- 430 (532)
Q Consensus 389 e~~~~g~L~~----~----------l~~~~~~------~---~l~~~~~~------------~i~~~ia~~l~~LH~--- 430 (532)
||++|..+.. . ++..... . .-.|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999865421 0 1110000 0 01111110 001123334555532
Q ss_pred -CCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 431 -QSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 431 -~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
..+..++|+|+++.||++++++...|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2235699999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0023 Score=62.53 Aligned_cols=76 Identities=16% Similarity=0.196 Sum_probs=47.0
Q ss_pred ccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcC---ccceeeeeeeeeecCCcceEEEEec
Q 009543 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV---EHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.+..+.++.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.| .--.+.+++++....+..+|++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3456778989999999977 5788999998762 2224566677776666 3455778888887777789999999
Q ss_pred CCC
Q 009543 392 PNQ 394 (532)
Q Consensus 392 ~~g 394 (532)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0029 Score=62.33 Aligned_cols=143 Identities=20% Similarity=0.214 Sum_probs=97.2
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEeecc-----Ch--------------------hh-HHHHHHHHhHhhcCccce
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFN-----NR--------------------HR-AANFYNEVNIISSVEHKN 370 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~-----~~--------------------~~-~~~~~~E~~~l~~l~h~n 370 (532)
+...|..|.-+.||.+.-.+|..+|||+++.+ ++ .. ..+...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34568889999999999999999999987422 11 01 113345777777766554
Q ss_pred eeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC
Q 009543 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS 450 (532)
Q Consensus 371 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~ 450 (532)
|...--+.. ....|||+|+.... +-....+...++...+..+-.+++.-|.-|-+.. +++|.||+--|+|+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 432211111 13468999985321 1222234456777778888888888888887766 599999999999995
Q ss_pred CCcEEEeecCCccccCC
Q 009543 451 RLRAKIADFGLARSFQE 467 (532)
Q Consensus 451 ~~~~kl~Dfgl~~~~~~ 467 (532)
+|.+.|+|-+.+...+.
T Consensus 300 dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred CCEEEEEEccccccCCC
Confidence 57899999998765543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00034 Score=67.58 Aligned_cols=136 Identities=16% Similarity=0.193 Sum_probs=93.2
Q ss_pred CccccccccccCceeEEEEEecCCCEEEEEEeeccC---------h--------hh-----HHHHHHHHhHhhcCcc-c-
Q 009543 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN---------R--------HR-----AANFYNEVNIISSVEH-K- 369 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~---------~--------~~-----~~~~~~E~~~l~~l~h-~- 369 (532)
-+.+.++||-|.-+.||.+...+|++.++|.-+... + .. .-...+|...|+.+.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 367889999999999999999999999999542110 0 00 0123467777777743 2
Q ss_pred eeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc
Q 009543 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (532)
Q Consensus 370 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~ 449 (532)
-+.+.+++ ...++|||++.+-.|.++- ...+..++.. .+..-+.-|..+| +||+|..--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~---~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYD---DLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHH---HHHHHHHHHHHcC---ceecccchheeEEe
Confidence 24444443 3567899999887775543 1223333333 3333445566777 99999999999999
Q ss_pred CCCcEEEeecCCcccc
Q 009543 450 SRLRAKIADFGLARSF 465 (532)
Q Consensus 450 ~~~~~kl~Dfgl~~~~ 465 (532)
+++.++++||-.....
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999865543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00013 Score=82.77 Aligned_cols=161 Identities=10% Similarity=-0.031 Sum_probs=116.2
Q ss_pred HHHHHhHhhcCccceeeeeeeeee--cCCcceEEEEecCCCChhHHhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 009543 356 FYNEVNIISSVEHKNLVRLLGCSC--SGPESLLVYEFLPNQSLDRFIFDSAK-AKTLTWEKRYEIILGTVEGLVYLHEQS 432 (532)
Q Consensus 356 ~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~ 432 (532)
...|...++..+|+++.....=.. +..+.+..++|+.+|.+...+....+ ...++..-+.....+......-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445555666678998876554332 34456899999999999999865433 334444444433333344444544432
Q ss_pred --CCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 009543 433 --KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510 (532)
Q Consensus 433 --~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~ 510 (532)
...-+|++||+-|.+|..+..+|+.++|+.+...+.. .......+++.|+.|++.++-.++.++|+|..|..+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2336899999999999999999999999998433322 2234456788999999999889999999999999999999
Q ss_pred hCCCCCC
Q 009543 511 TGRQNNR 517 (532)
Q Consensus 511 tG~~p~~ 517 (532)
-|..+|.
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 9998874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0038 Score=63.02 Aligned_cols=143 Identities=20% Similarity=0.233 Sum_probs=82.7
Q ss_pred cccccccCceeEEEEEecC-----CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceee-eeeeeeecCCcceEEEEec
Q 009543 318 ANKLGQGGFGTVYKGVLPD-----GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~ 391 (532)
.+.|-.|-.-.+|+....+ ++.+++|+....... .-...+|..++..+..-++. ++++.+.. ..|.||+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECC----ceEEEee
Confidence 3456568888999987542 367889977554322 22336788888887544443 44555422 2689999
Q ss_pred CCCChhHH-----------------hhhcc-CC-C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh
Q 009543 392 PNQSLDRF-----------------IFDSA-KA-K-TLTWEKRYEIILGT-----------------VEGLVYL----HE 430 (532)
Q Consensus 392 ~~g~L~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~i-----------------a~~l~~L----H~ 430 (532)
++.++... +|... .. . ...+.++.++..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 88776422 11100 00 1 11233333333221 1112222 21
Q ss_pred -CCCCCeEEccCCCCCEEEcC-CCcEEEeecCCcccc
Q 009543 431 -QSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSF 465 (532)
Q Consensus 431 -~~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfgl~~~~ 465 (532)
..+..++|+|+++.|||+++ ++.+.++||..+..-
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22346899999999999986 468999999987643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0048 Score=60.23 Aligned_cols=32 Identities=25% Similarity=0.439 Sum_probs=26.5
Q ss_pred CCeEEccCCCCCEEEcCCCc-EEEeecCCcccc
Q 009543 434 IRIIHRDIKASNILLDSRLR-AKIADFGLARSF 465 (532)
Q Consensus 434 ~~iiH~Dlkp~NiLl~~~~~-~kl~Dfgl~~~~ 465 (532)
..++|+|++|.|||+++++. .-|+||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999998555 569999987654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0095 Score=58.73 Aligned_cols=143 Identities=15% Similarity=0.167 Sum_probs=83.6
Q ss_pred cccccccccCceeEEEEEecCCCEEEEEEee-ccChhhHHHHHHHHhHhhcCcc--ceeeeeeeeeecCC--cceEEEEe
Q 009543 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEH--KNLVRLLGCSCSGP--ESLLVYEF 390 (532)
Q Consensus 316 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~ 390 (532)
.+.+.+..|.--.+|..... +++.++++.. ...........+|..+++.+.- .-+.+.++.+.++. ..+.||+|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 34444544444445555543 7888888331 1233344556677777776632 22334455565554 56999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHH-HHHHHHHHHHH----------------------------------------
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEII-LGTVEGLVYLH---------------------------------------- 429 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~-~~ia~~l~~LH---------------------------------------- 429 (532)
.+|..+.+.+.. .... .+++ ..+++.|.-||
T Consensus 107 veGe~~~~~~~~----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 107 VEGEVVWSALPP----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred ecceeccCcCCc----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 998533222210 0000 1111 23333444444
Q ss_pred ----------hC-----CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 430 ----------EQ-----SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 430 ----------~~-----~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
.+ ++..++|+|+++.|++++.++.+=+.||+++..-++
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 22 246799999999999999999999999999876544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.003 Score=70.56 Aligned_cols=154 Identities=21% Similarity=0.241 Sum_probs=113.3
Q ss_pred HHHHHhHhhcCccceeeeeeeeeecCCcc----eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 009543 356 FYNEVNIISSVEHKNLVRLLGCSCSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431 (532)
Q Consensus 356 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~ 431 (532)
..-|.+.+..+.|+|++.++.+..+.... .+..++++.-++...+ +.-..++....+.+..+..+|+.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34466777888999999999987664432 3556777777777777 3446688888899999999999999998
Q ss_pred CCCCeEEccCCCC---CEEEcCCCcEEEe--ecCCccccCCCCcccccccccccccccccccccCCCC--chhhHHHHHH
Q 009543 432 SKIRIIHRDIKAS---NILLDSRLRAKIA--DFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT--EKADVYSFGM 504 (532)
Q Consensus 432 ~~~~iiH~Dlkp~---NiLl~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Dv~SlGv 504 (532)
. ..|.-|..+ +.-.+.++...++ ||+.++.......... ..-+..+.+||........ ...|+|.+|.
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence 5 666666555 5666777777777 9998887655443322 2335667888887665544 4479999999
Q ss_pred HHHHHHhCCCCCC
Q 009543 505 LLLEIVTGRQNNR 517 (532)
Q Consensus 505 ll~el~tG~~p~~ 517 (532)
+...+..|..+-.
T Consensus 381 l~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 381 LLLQLSQGEDISE 393 (1351)
T ss_pred HHhhhhhcCcccc
Confidence 9999999877653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.012 Score=59.84 Aligned_cols=74 Identities=15% Similarity=0.209 Sum_probs=50.1
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEeeccCh-------hhHHHHHHHHhHhhcCc---cceeeeeeeeeecCCcceE
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR-------HRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l 386 (532)
..+.||.|....||+.... ++.++||.-..... ....+-..|.+.|..+. ...+.+++.++. +...+
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3678999999999998874 56799997642111 12334445566665543 246777887765 55788
Q ss_pred EEEecCC
Q 009543 387 VYEFLPN 393 (532)
Q Consensus 387 v~e~~~~ 393 (532)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.015 Score=58.17 Aligned_cols=79 Identities=15% Similarity=0.120 Sum_probs=49.2
Q ss_pred cccccCceeEEEEEecCC-CEEEEEEeecc-------ChhhHHHHHHHHhHhhcCc--cc-eeeeeeeeeecCCcceEEE
Q 009543 320 KLGQGGFGTVYKGVLPDG-REIAVKRLFFN-------NRHRAANFYNEVNIISSVE--HK-NLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~~g-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~ 388 (532)
.||.|....||++..++| +.|+||.-..- -+...++..-|.+.|.... -| .+++++. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 589999999999998755 68999954211 1223344556667776542 23 3444443 3555667999
Q ss_pred EecCCC-ChhHHh
Q 009543 389 EFLPNQ-SLDRFI 400 (532)
Q Consensus 389 e~~~~g-~L~~~l 400 (532)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999643 343443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.012 Score=55.02 Aligned_cols=123 Identities=19% Similarity=0.188 Sum_probs=60.2
Q ss_pred CCEEEEEEeeccChhhHHHHHHHHhHhhcCcccee-eeeeeeeecCCcceEEEEecCCCChhHH-------h--------
Q 009543 337 GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEFLPNQSLDRF-------I-------- 400 (532)
Q Consensus 337 g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~~-------l-------- 400 (532)
++.|++|+.... ....-...+|..+++.+...++ .++++.+. -.+|.+|+++..|..- +
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~----~g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFE----NGRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEET----TEEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcC----CCcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 467888887655 3334566778888888865444 34455442 2367799977664221 1
Q ss_pred --hhc-c---CCCCCCHHHHHHH----------------------HHHHHHHHHHHHh-----CCCCCeEEccCCCCCEE
Q 009543 401 --FDS-A---KAKTLTWEKRYEI----------------------ILGTVEGLVYLHE-----QSKIRIIHRDIKASNIL 447 (532)
Q Consensus 401 --~~~-~---~~~~l~~~~~~~i----------------------~~~ia~~l~~LH~-----~~~~~iiH~Dlkp~NiL 447 (532)
+.. . ....--|.....+ +..+..-+..+.+ ..+..++|.||.|.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 100 0 0111112222222 0111122222211 11245889999999999
Q ss_pred E-cCCCcEEEeecCCccc
Q 009543 448 L-DSRLRAKIADFGLARS 464 (532)
Q Consensus 448 l-~~~~~~kl~Dfgl~~~ 464 (532)
+ +.++.++++||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.029 Score=56.35 Aligned_cols=141 Identities=14% Similarity=0.236 Sum_probs=79.4
Q ss_pred ccccccCceeEEEEEecC----CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceee-eeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLPD----GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~ 393 (532)
+.|..|-...+|+....+ +..+++|+...... ..-.-.+|..+++.+..-++- ++++++ ..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcC
Confidence 345557778889887543 24788897754332 223345788888888655543 445544 222 58999987
Q ss_pred CChhHH-------h----------hhcc-C-CC-CCCHHHHHHHHHHH----------------------HHHHHH----
Q 009543 394 QSLDRF-------I----------FDSA-K-AK-TLTWEKRYEIILGT----------------------VEGLVY---- 427 (532)
Q Consensus 394 g~L~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~~l~~---- 427 (532)
..+..- + |... . .. .-.|..+.++..++ .+-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 1110 0 01 11233332222221 111111
Q ss_pred HHh-CCCCCeEEccCCCCCEEEcC-CCcEEEeecCCccc
Q 009543 428 LHE-QSKIRIIHRDIKASNILLDS-RLRAKIADFGLARS 464 (532)
Q Consensus 428 LH~-~~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfgl~~~ 464 (532)
+.. ..+..++|.|+.+.|||+++ ++.++++||..+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 12345899999999999975 57899999998754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.059 Score=53.55 Aligned_cols=29 Identities=28% Similarity=0.367 Sum_probs=25.3
Q ss_pred CCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 434 IRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 434 ~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999988 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.026 Score=57.25 Aligned_cols=74 Identities=14% Similarity=0.130 Sum_probs=49.2
Q ss_pred cccccccCceeEEEEEecC-CCEEEEEEeec----c-C-hhhHHHHHHHHhHhhcCc--cc-eeeeeeeeeecCCcceEE
Q 009543 318 ANKLGQGGFGTVYKGVLPD-GREIAVKRLFF----N-N-RHRAANFYNEVNIISSVE--HK-NLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~----~-~-~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv 387 (532)
.+.||.|.-.-||++.+.+ ++.|+||.-.. . + +-..++..-|.+.|+... -| .+++++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5689999999999999853 67899995421 1 1 233455666777777652 34 34555543 55566789
Q ss_pred EEecCC
Q 009543 388 YEFLPN 393 (532)
Q Consensus 388 ~e~~~~ 393 (532)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.034 Score=54.99 Aligned_cols=71 Identities=21% Similarity=0.251 Sum_probs=55.0
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.|++|++. |+++. ..+...+++...++.+.+..+.-+..+- ++-|||+.-.||||+ +|++.|+||-+++
T Consensus 301 ~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 301 LYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence 35566654 44442 1234578899999999888888777654 699999999999999 9999999999998
Q ss_pred cc
Q 009543 464 SF 465 (532)
Q Consensus 464 ~~ 465 (532)
.-
T Consensus 370 l~ 371 (488)
T COG5072 370 LS 371 (488)
T ss_pred cc
Confidence 43
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.093 Score=48.75 Aligned_cols=75 Identities=20% Similarity=0.285 Sum_probs=49.7
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcC---ccceeeeeeeeeecCCcceEEEEecCCCC
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV---EHKNLVRLLGCSCSGPESLLVYEFLPNQS 395 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 395 (532)
+++.-|.--+-|.... +..++.+|+-. ......|..|+.-|..+ +.-++.+++.+-.+....|+|+||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444444444333 56788888653 33334566677666655 44567788888889999999999999876
Q ss_pred hh
Q 009543 396 LD 397 (532)
Q Consensus 396 L~ 397 (532)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.091 Score=52.39 Aligned_cols=141 Identities=22% Similarity=0.324 Sum_probs=81.8
Q ss_pred cccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce------eeeeee----eeecCCcceEEEE
Q 009543 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN------LVRLLG----CSCSGPESLLVYE 389 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~----~~~~~~~~~lv~e 389 (532)
.|.+ .-..+|+....+|+. ++|+.... ....++..|+..+..+.-.+ |..+=| ........+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556789988877777 88887655 34455666777777763222 122111 1112236678999
Q ss_pred ecCCCChhH-H----h----------hh----cc-----CCCCCCHHH-------------HHHHHHHHHHHHHHHHhC-
Q 009543 390 FLPNQSLDR-F----I----------FD----SA-----KAKTLTWEK-------------RYEIILGTVEGLVYLHEQ- 431 (532)
Q Consensus 390 ~~~~g~L~~-~----l----------~~----~~-----~~~~l~~~~-------------~~~i~~~ia~~l~~LH~~- 431 (532)
|++|..+.. - + +. .. ......|.. ......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988873 1 1 10 00 011223320 011233344444444432
Q ss_pred ---CC---CCeEEccCCCCCEEEcCCCc-EEEeecCCccc
Q 009543 432 ---SK---IRIIHRDIKASNILLDSRLR-AKIADFGLARS 464 (532)
Q Consensus 432 ---~~---~~iiH~Dlkp~NiLl~~~~~-~kl~Dfgl~~~ 464 (532)
-+ ..+||+|+.|.||+++.+.. ..+.||+-+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 11 22899999999999999885 89999997653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.03 Score=56.15 Aligned_cols=62 Identities=19% Similarity=0.209 Sum_probs=43.5
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS 450 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~ 450 (532)
...++=+|.+|.++..++. ....+++...+++.-.++|+.-|---. .++|.|+.|.||++..
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~----~~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVK----WKSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhh----cccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 3457777888989988883 344555666677766666665543322 2999999999999943
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.13 Score=51.01 Aligned_cols=32 Identities=19% Similarity=0.287 Sum_probs=28.3
Q ss_pred CCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 433 ~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
+..++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.2 Score=50.13 Aligned_cols=72 Identities=17% Similarity=0.090 Sum_probs=43.6
Q ss_pred cCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce--eeeee---e--eeecCCcceEEEEecCCCCh
Q 009543 324 GGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLL---G--CSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 324 G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~e~~~~g~L 396 (532)
+.-..||+...++++.+++|..... .....++..|++.+..+.... ++... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 3456799988878888999987533 223455666777776663211 22211 1 11224456789999987643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.25 Score=57.17 Aligned_cols=142 Identities=18% Similarity=0.247 Sum_probs=77.2
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-------ccceeeeeee-----eeec-CC--c
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-------EHKNLVRLLG-----CSCS-GP--E 383 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~-----~~~~-~~--~ 383 (532)
+.|+ |..-.+|+....+|+.+++|+....... .....|...+..+ .-|.+++-.+ .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4454 4557789888878889999998754322 2223344444433 2344443321 1111 22 3
Q ss_pred ceEEEEecCCCChhHH-------hh----------h------c-cCCCCCCHHH-----------------HHHHHHHHH
Q 009543 384 SLLVYEFLPNQSLDRF-------IF----------D------S-AKAKTLTWEK-----------------RYEIILGTV 422 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~-------l~----------~------~-~~~~~l~~~~-----------------~~~i~~~ia 422 (532)
.+-+++|++|..+.+. +. . . .....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999877551 10 0 0 0011122211 122222333
Q ss_pred HHHH-----HHHhCCCCCeEEccCCCCCEEEcCCC--cEE-EeecCCccc
Q 009543 423 EGLV-----YLHEQSKIRIIHRDIKASNILLDSRL--RAK-IADFGLARS 464 (532)
Q Consensus 423 ~~l~-----~LH~~~~~~iiH~Dlkp~NiLl~~~~--~~k-l~Dfgl~~~ 464 (532)
+... .+.+ -+..+||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2222 1211 133499999999999999875 555 999997653
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.25 Score=50.58 Aligned_cols=75 Identities=17% Similarity=0.296 Sum_probs=45.6
Q ss_pred cccccccCceeEEEEEecCC--CE-----EEEEEeeccChhhHHHHHHHHhHhhcCccceee-eeeeeeecCCcceEEEE
Q 009543 318 ANKLGQGGFGTVYKGVLPDG--RE-----IAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGCSCSGPESLLVYE 389 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e 389 (532)
.+.|..|-...+|+....++ .. |.++... ......-.-.+|+.+++.+...++- ++++.+. .+++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 44566688899999976543 22 3333321 1222222345688888888655544 4555542 369999
Q ss_pred ecCCCChh
Q 009543 390 FLPNQSLD 397 (532)
Q Consensus 390 ~~~~g~L~ 397 (532)
|++|..|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 532 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-44 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-26 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-16 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-119
Identities = 93/215 (43%), Positives = 135/215 (62%), Gaps = 2/215 (0%)
Query: 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA-ANFYNEVN 361
F L+ A+ +F N LG+GGFG VYKG L DG +AVKRL F EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 362 IISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILG 420
+IS H+NL+RL G + E LLVY ++ N S+ + + +++ L W KR I LG
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL YLH+ +IIHRD+KA+NILLD A + DFGLA+ +H++TA+ GT+
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515
G++APEYL+ G+ +EK DV+ +G++LLE++TG++
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-109
Identities = 94/240 (39%), Positives = 134/240 (55%), Gaps = 18/240 (7%)
Query: 303 FKYSTLEKATGSFDE------ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAAN- 355
F + L+ T +FDE NK+G+GGFG VYKG + + +AVK+L
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 356 ---FYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE 412
F E+ +++ +H+NLV LLG S G + LVY ++PN SL + L+W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF-QEDKSH 471
R +I G G+ +LHE IHRDIK++NILLD AKI+DFGLAR+ + ++
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIV 531
+++ I GT YMAPE L G++T K+D+YSFG++LLEI+TG LL I
Sbjct: 191 MTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDIK 247
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-106
Identities = 93/237 (39%), Positives = 138/237 (58%), Gaps = 5/237 (2%)
Query: 281 RKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREI 340
+ NDA + +S LE+AT +FD +G G FG VYKGVL DG ++
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 341 AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI 400
A+KR + F E+ +S H +LV L+G E +L+Y+++ N +L R +
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 401 FDSAKAKT-LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459
+ S ++WE+R EI +G GL YLH ++ IIHRD+K+ NILLD KI DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 460 GLARSF-QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515
G+++ + D++H+ST + GTLGY+ PEY G+LTEK+DVYSFG++L E++ R
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-78
Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 23/244 (9%)
Query: 297 NDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANF 356
+ ++ L + +G FG V+K +AVK ++ +
Sbjct: 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQ-SWQN 65
Query: 357 YNEVNIISSVEHKNLVRLLGCSCSGP----ESLLVYEFLPNQSLDRFIFDSAKAKTLTWE 412
EV + ++H+N+++ +G G + L+ F SL F+ KA ++W
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWN 121
Query: 413 KRYEIILGTVEGLVYLHE-------QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465
+ I GL YLHE K I HRDIK+ N+LL + L A IADFGLA F
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 466 QEDKSHI-STAIAGTLGYMAPEYLAHG-----QLTEKADVYSFGMLLLEIVTGRQNNRSK 519
+ KS + GT YMAPE L + D+Y+ G++L E+ +
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 520 NSEY 523
EY
Sbjct: 242 VDEY 245
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 5e-65
Identities = 72/242 (29%), Positives = 115/242 (47%), Gaps = 12/242 (4%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVL 334
+ + + ++ D ++ + L K+G G FGTV++
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLN-------IKEKIGAGSFGTVHRAEW 58
Query: 335 PDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392
G ++AVK L + H R F EV I+ + H N+V +G P +V E+L
Sbjct: 59 -HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117
Query: 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452
SL R + S + L +R + +G+ YLH I+HR++K+ N+L+D +
Sbjct: 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKY 176
Query: 453 RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
K+ DFGL+R + S + AGT +MAPE L EK+DVYSFG++L E+ T
Sbjct: 177 TVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 513 RQ 514
+Q
Sbjct: 236 QQ 237
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 8e-64
Identities = 67/245 (27%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEV 360
+ S + +G+G +G VYKG L D R +AVK F NR NF NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEK 56
Query: 361 NI--ISSVEHKNLVRLLGCSCSGPES-----LLVYEFLPNQSLDRFIFDSAKAKTLTWEK 413
NI + +EH N+ R + LLV E+ PN SL +++ T W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVS 112
Query: 414 RYEIILGTVEGLVYLHE------QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF-- 465
+ GL YLH K I HRD+ + N+L+ + I+DFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 466 -----QEDKSHISTAIAGTLGYMAPEYL-------AHGQLTEKADVYSFGMLLLEIVTGR 513
++ + + + GT+ YMAPE L ++ D+Y+ G++ EI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 514 QNNRS 518
+
Sbjct: 233 TDLFP 237
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 7e-62
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+ +G+G FG V K +++A+K++ + +A F E+ +S V H N+V+L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKL 66
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G C P L V E+ SL + + T L +G+ YLH
Sbjct: 67 YGA-CLNPVCL-VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 435 RIIHRDIKASNILLDSRLR-AKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+IHRD+K N+LL + KI DFG A D T G+ +MAPE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 494 TEKADVYSFGMLLLEIVTGRQ 514
+EK DV+S+G++L E++T R+
Sbjct: 181 SEKCDVFSWGIILWEVITRRK 201
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-59
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 16/203 (7%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKNLVRLLG 376
KL + G ++KG G +I VK L + ++ +F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 377 CSCSGPESLL--VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
S P + ++P SL + + + + + L G+ +LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL- 493
I + + ++++D + A+I+ + SFQ S ++APE L
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186
Query: 494 --TEKADVYSFGMLLLEIVTGRQ 514
AD++SF +LL E+VT
Sbjct: 187 TNRRSADMWSFAVLLWELVTREV 209
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-59
Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH-------RAANFYNEVNIISSV 366
+ ++G+GGFG V+KG + D +A+K L + + F EV I+S++
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 367 EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
H N+V+L G + P +V EF+P L + D KA + W + ++L G+
Sbjct: 81 NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIE 136
Query: 427 YLHEQSKIRIIHRDIKASNILLDSR-----LRAKIADFGLARSFQEDKSHISTAIAGTLG 481
Y+ I+HRD+++ NI L S + AK+ADFGL++ H + + G
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQ 191
Query: 482 YMAPEYLA--HGQLTEKADVYSFGMLLLEIVTGRQ 514
+MAPE + TEKAD YSF M+L I+TG
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-59
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA----NFYNEVNIISSVEHKNLVRL 374
+G GGFG VY+ G E+AVK + + N E + + ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G P LV EF L+R + K + + + G+ YLH+++ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 435 RIIHRDIKASNILLDSRLR--------AKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
IIHRD+K+SNIL+ ++ KI DFGLAR + + AG +MAPE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ ++ +DV+S+G+LL E++TG
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-58
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 319 NKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
LG+G FG K G + +K L + F EV ++ +EH N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG- 74
Query: 378 SCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ L + E++ +L I W +R G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---I 129
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-------------ISTAIAGTLGYM 483
IHRD+ + N L+ +ADFGLAR ++K+ + G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
APE + EK DV+SFG++L EI+
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-56
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
++G G FGTVYKG ++AVK L + A F NEV ++ H N++ +
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFM 86
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G + P+ +V ++ SL + +K +I T G+ YLH +S
Sbjct: 87 GY-STAPQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHISTAIAGTLGYMAPEYLAHGQL- 493
IIHRD+K++NI L KI DFGLA + SH ++G++ +MAPE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 494 --TEKADVYSFGMLLLEIVTGRQ 514
+ ++DVY+FG++L E++TG+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQL 223
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI--ISSVEHKNLVRLLG 376
++G+G +G V+ G G ++AVK F A+ ++ E I + H+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKV--FFTTEEAS-WFRETEIYQTVLMRHENILGFIA 98
Query: 377 CSCSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-- 430
G S L+ ++ N SL ++ K+ TL + ++ +V GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 431 ---QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI---STAIAGTLGYMA 484
Q K I HRD+K+ NIL+ IAD GLA F D + + GT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 485 PE------YLAHGQLTEKADVYSFGMLLLEIVTG 512
PE H Q AD+YSFG++L E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-54
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI--ISSVEHKNLVRLLG 376
+G+G +G V++G G +AVK F++R + ++ E + + H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKI--FSSRDEKS-WFRETELYNTVMLRHENILGFIA 69
Query: 377 CSCSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-- 430
+ S L+ + SL ++ + TL I+L GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 431 ---QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI---STAIAGTLGYMA 484
Q K I HRD+K+ NIL+ + IAD GLA + + + + GT YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 485 PE------YLAHGQLTEKADVYSFGMLLLEIVTG 512
PE + ++ D+++FG++L E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 29/225 (12%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI--ISSVEHKNLVRLLG 376
+G+G FG V++G G E+AVK F++R + ++ E I + H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKI--FSSREERS-WFREAEIYQTVMLRHENILGFIA 103
Query: 377 CSC----SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-- 430
+ + LV ++ + SL ++ T+T E ++ L T GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 431 ---QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI---STAIAGTLGYMA 484
Q K I HRD+K+ NIL+ IAD GLA I GT YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 485 PEYL------AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523
PE L H + ++AD+Y+ G++ EI R + + +Y
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDY 263
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-52
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG VY G E+A++ + + + F EV H+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
+C P L ++ ++L + D L K +I V+G+ YLH +
Sbjct: 97 -ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG--- 150
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLAR----SFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+H+D+K+ N+ D+ + I DFGL + G L ++APE +
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 492 QL---------TEKADVYSFGMLLLEIVTGRQ 514
++ +DV++ G + E+
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-45
Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 280 ERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGR 338
E + + +D E+L S + ++ + ++G+G F TVYKG+
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDI---------EIGRGSFKTVYKGLDTETTV 52
Query: 339 EIAVK--RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC---SCSGPESLLVY-EFLP 392
E+A + + F E ++ ++H N+VR + G + +++ E +
Sbjct: 53 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452
+ +L ++ + K + + ++GL +LH ++ IIHRD+K NI +
Sbjct: 113 SGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPT 168
Query: 453 -RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
KI D GLA + + A+ GT +MAPE E DVY+FGM +LE+ T
Sbjct: 169 GSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMAT 224
Query: 512 GR 513
Sbjct: 225 SE 226
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-41
Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 319 NKLGQGGFGTVYKGV---LPDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG+V L D AVK+L + +F E+ I+ S++H N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 374 LLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
G C +G +L L+ E+LP SL ++ + + K + +G+ YL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLA 489
R IHRD+ NIL+++ R KI DFGL + +DK G + APE L
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSL 527
+ + +DV+SFG++L E+ T + ++S +E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-41
Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 319 NKLGQGGFGTVYKGV---LPDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG+V L D AVK+L + +F E+ I+ S++H N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 374 LLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
G C +G +L L+ E+LP SL ++ + + K + +G+ YL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLA 489
R IHRD+ NIL+++ R KI DFGL + +DK + G + APE L
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSL 527
+ + +DV+SFG++L E+ T + ++S +E+ +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 7e-41
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 14/204 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE-----IAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG G FGTVYKG+ E +A+K L +A +E +++SV++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
RLLG C L+ + +P L ++ + + + +G+ YL ++
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMAPEYLAHG 491
R++HRD+ A N+L+ + KI DFGLA+ ++ + +MA E + H
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 492 QLTEKADVYSFGMLLLEIVT-GRQ 514
T ++DV+S+G+ + E++T G +
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 8e-41
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 319 NKLGQGGFGTVYKGVL---PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG+G FG V DG AVK L + + + + E++I+ ++ H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 373 RLLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ G C +G SL LV E++P SL ++ ++ + EG+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYL 488
Q IHRD+ A N+LLD+ KI DFGLA++ E + G + APE L
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-GRQN 515
+ +DV+SFG+ L E++T +
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 320 KLGQGGFGTVYKGVL-PDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVRLLG- 376
++G+G FG V+ G L D +AVK A F E I+ H N+VRL+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
C+ P +V E + F+ + L + +++ G+ YL +
Sbjct: 181 CTQKQP-IYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY----MAPEYLAHGQ 492
IHRD+ A N L+ + KI+DFG++R + + A G APE L +G+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYGR 291
Query: 493 LTEKADVYSFGMLLLEIVT-GRQ 514
+ ++DV+SFG+LL E + G
Sbjct: 292 YSSESDVWSFGILLWETFSLGAS 314
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 320 KLGQGGFGTVYKGVL-PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL 375
+LG G FG+V +GV ++I A+K L E I+ +++ +VRL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G C +LV E L +F+ K + + E++ G+ YL E+
Sbjct: 77 GV-CQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLAHGQL 493
+HRD+ A N+LL +R AKI+DFGL+++ D S+ + AG + APE + +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 494 TEKADVYSFGMLLLEIVT-GRQ 514
+ ++DV+S+G+ + E ++ G++
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQK 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 320 KLGQGGFGTVYKGVL--PDGREI--AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLV 372
KLG G FG V +G P G+ + AVK L + +F EVN + S++H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
RL G P +V E P SL + + EG+ YL +
Sbjct: 85 RLYGV-VLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAH 490
R IHRD+ A N+LL +R KI DFGL R+ ++ H + + APE L
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 491 GQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +D + FG+ L E+ T G++
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 319 NKLGQGGFGTVYKGV---LPDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
++LG+G FG+V L D AVK+L + + +F E+ I+ ++ +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 374 LLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
G G +SL LV E+LP+ L F+ L + +G+ YL +
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLA 489
R +HRD+ A NIL++S KIADFGLA+ DK + G + APE L+
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
+ ++DV+SFG++L E+ T
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 319 NKLGQGGFGTVYKGVLP-----DGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG+G FG V G ++AVK L + A+ E+ I+ ++ H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 373 RLLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ G C+ G + L+ EFLP+ SL ++ + +++ + + +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYL 488
+ + +HRD+ A N+L++S + KI DFGL ++ + DK + + + APE L
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
+ +DV+SFG+ L E++T
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLGQG FG V+ G +A+K L A F E ++ + H+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV- 247
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S +V E++ SL F+ K L + ++ G+ Y+ +H
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD++A+NIL+ L K+ADFGLAR ++++ + + APE +G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 499 VYSFGMLLLEIVT 511
V+SFG+LL E+ T
Sbjct: 364 VWSFGILLTELTT 376
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLG G FG V+ ++AVK + + A F E N++ +++H LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV- 251
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ ++ EF+ SL F+ + K + EG+ ++ ++ IH
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG---YMAPEYLAHGQLTE 495
RD++A+NIL+ + L KIADFGLAR ++++ TA G + APE + G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 496 KADVYSFGMLLLEIVT-GRQ 514
K+DV+SFG+LL+EIVT GR
Sbjct: 365 KSDVWSFGILLMEIVTYGRI 384
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 71/200 (35%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+LG G FG V+ G ++AVK L + A F E N++ ++H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV- 76
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ ++ E++ N SL F+ + LT K ++ EG+ ++ E+ IH
Sbjct: 77 VTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQLTE 495
RD++A+NIL+ L KIADFGLAR +++ TA G + APE + +G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 496 KADVYSFGMLLLEIVT-GRQ 514
K+DV+SFG+LL EIVT GR
Sbjct: 190 KSDVWSFGILLTEIVTHGRI 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-40
Identities = 60/193 (31%), Positives = 94/193 (48%), Gaps = 6/193 (3%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLGQG FG V+ G +A+K L A F E ++ + H+ LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV- 330
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S +V E++ SL F K L + ++ G+ Y+ +H
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD++A+NIL+ L K+ADFGLAR ++++ + + APE +G+ T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 499 VYSFGMLLLEIVT 511
V+SFG+LL E+ T
Sbjct: 447 VWSFGILLTELTT 459
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 22/231 (9%)
Query: 294 KTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA 353
+L D + + S + SF + LG G GT+ + D R++AVKR+
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECF 61
Query: 354 ANFYNEVNI-ISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTW 411
+ EV + S EH N++R C+ + + E +L ++ K
Sbjct: 62 SFADREVQLLRESDEHPNVIRYF-CTEKDRQFQYIAIELCAA-TLQEYV--EQKDFAHLG 117
Query: 412 EKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL-----DSRLRAKIADFGLARSFQ 466
+ ++ T GL +LH I+HRD+K NIL+ +++A I+DFGL +
Sbjct: 118 LEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 467 EDKSHIS--TAIAGTLGYMAPEYL---AHGQLTEKADVYSFGMLLLEIVTG 512
+ S + + GT G++APE L T D++S G + +++
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 319 NKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG- 376
+KLG G +G VY+GV +AVK L + F E ++ ++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 284
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
C+ P ++ EF+ +L ++ + + + ++ + + YL ++
Sbjct: 285 CTREPP-FYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
IHR++ A N L+ K+ADFGL+R D + + APE LA+ + + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 497 ADVYSFGMLLLEIVT 511
+DV++FG+LL EI T
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-39
Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 320 KLGQGGFGTVYKGVL-PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL 375
+LG G FG+V +GV ++I A+K L E I+ +++ +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G C +LV E L +F+ K + + E++ G+ YL E+
Sbjct: 403 GV-CQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 456
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAHGQL 493
+HR++ A N+LL +R AKI+DFGL+++ D S+ + AG APE + +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 494 TEKADVYSFGMLLLEIVT-GRQ 514
+ ++DV+S+G+ + E ++ G++
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQK 538
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-39
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
F E +G GGFG V+K DG+ +KR+ +NN EV ++ ++H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVH 68
Query: 374 LLGC-------------SCSGPESLLVY---EFLPNQSLDRFIFDSAKAKTLTWEKRYEI 417
GC + S ++ ++ EF +L+++I + + + L E+
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477
+G+ Y+H + ++I+RD+K SNI L + KI DFGL S + D T
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSK 182
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
GTL YM+PE ++ ++ D+Y+ G++L E++
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-C 377
+G+G FG V G G ++AVK + N A F E ++++ + H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
+V E++ SL ++ + L + + L E + YL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLT 494
HRD+ A N+L+ AK++DFGL + S+ + + APE L + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 495 EKADVYSFGMLLLEIVT-GRQ 514
K+DV+SFG+LL EI + GR
Sbjct: 365 TKSDVWSFGILLWEIYSFGRV 385
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 320 KLGQGGFGTVYKGVL-PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+LG G FGTV KG AVK L N+ E N++ +++ +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G C +LV E L++++ + + + + E++ G+ YL E
Sbjct: 84 IGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES--- 136
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLAHGQ 492
+HRD+ A N+LL ++ AKI+DFGL+++ + D+++ G + APE + + +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 493 LTEKADVYSFGMLLLEIVT-GRQ 514
+ K+DV+SFG+L+ E + G++
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE-----IAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG G FGTVYKG+ E +A+K L +A +E +++SV++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
RLLG C L+ + +P L ++ + + + + +G+ YL ++
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMAPEYLAHG 491
R++HRD+ A N+L+ + KI DFGLA+ ++ + +MA E + H
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 492 QLTEKADVYSFGMLLLEIVT 511
T ++DV+S+G+ + E++T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-39
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE----IAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
+G+G FG VY G D + A+K L + A F E ++ + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGLNHPNVL 85
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
L+G ++ ++ + L +FI + T + L G+ YL EQ
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQ 143
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYL 488
+ +HRD+ A N +LD K+ADFGLAR + + + + A E L
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ T K+DV+SFG+LL E++T G
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAP 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-39
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE-----IAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG G FGTV+KGV E + +K + + ++ + + I S++H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
RLLG C G LV ++LP SL + L + + +G+ YL E
Sbjct: 79 RLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH- 134
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMAPEYLAHG 491
++HR++ A N+LL S + ++ADFG+A D + + A T + +MA E + G
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 492 QLTEKADVYSFGMLLLEIVT-GRQ 514
+ T ++DV+S+G+ + E++T G +
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 9e-39
Identities = 51/201 (25%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-C 377
+LG G FG V G ++A+K + + F E ++ ++ H+ LV+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVC 88
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
+ P ++ E++ N L ++ ++ E+ E + YL + + +
Sbjct: 89 TKQRP-IFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQLT 494
HRD+ A N L++ + K++DFGL+R +D T+ G+ + PE L + + +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 495 EKADVYSFGMLLLEIVT-GRQ 514
K+D+++FG+L+ EI + G+
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKM 220
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 20/211 (9%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLG+GGF V L DG A+KR+ + + E ++ H N++RL+
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 379 CSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSK 433
+ L+ F +L I E + ++LG GL +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA--------GTLGYMAP 485
HRD+K +NILL + + D G A+ T+ Y AP
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 486 EYL---AHGQLTEKADVYSFGMLLLEIVTGR 513
E +H + E+ DV+S G +L ++ G
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
F+ LG+GGFG V++ D A+KR+ NR A EV ++ +EH +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 373 RLLGC---------SCSGPESLLVY---EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
R + +Y + ++L ++ + I L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA--- 477
E + +LH + ++HRD+K SNI K+ DFGL + +D+ +
Sbjct: 127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 478 --------GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
GT YM+PE + + K D++S G++L E++
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 49/223 (21%), Positives = 100/223 (44%), Gaps = 12/223 (5%)
Query: 294 KTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHR 352
++ + N + ++EK + K+G+G FG DGR+ +K + +
Sbjct: 9 SGVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 353 AA--NFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT 410
EV ++++++H N+V+ +V ++ L + I ++ K
Sbjct: 65 KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQ 123
Query: 411 WEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470
++ + + L ++H++ +I+HRDIK+ NI L ++ DFG+AR
Sbjct: 124 EDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
I GT Y++PE + K+D+++ G +L E+ T +
Sbjct: 181 LARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 320 KLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
LG+G FG VY+GV G +I AVK + F +E I+ +++H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + ++ E P L ++ +L L + + YL
Sbjct: 79 IGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLESI--- 132
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG-----YMAPEYLA 489
+HRDI NIL+ S K+ DFGL+R +++ ++ +M+PE +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----DYYKASVTRLPIKWMSPESIN 187
Query: 490 HGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ T +DV+ F + + EI++ G+Q
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRAA-NFYNEVNIISSVEHKNLVR 373
+G G G V G L P R++ A+K L R +F +E +I+ +H N++R
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L G + +++V E++ N SLD F+ T + ++ G G+ YL +
Sbjct: 115 LEGVVTRGRL-AMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAH 490
+HRD+ A N+L+DS L K++DFGL+R ++D T G + APE +A
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 491 GQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +DV+SFG+++ E++ G +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-CS 378
+LG G FG V G ++AVK + + F+ E + + H LV+ G CS
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE-FFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
P +V E++ N L ++ + K L + E+ EG+ +L + IH
Sbjct: 74 KEYP-IYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQLTE 495
RD+ A N L+D L K++DFG+ R +D + GT + APE + + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 496 KADVYSFGMLLLEIVT-GRQ 514
K+DV++FG+L+ E+ + G+
Sbjct: 185 KSDVWAFGILMWEVFSLGKM 204
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-C 377
++G G FG V+ G + ++A+K + F E ++ + H LV+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 72
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
P LV EF+ + L ++ + E + L EG+ YL E +I
Sbjct: 73 LEQAP-ICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQLT 494
HRD+ A N L+ K++DFG+ R +D T+ GT + +PE + + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 495 EKADVYSFGMLLLEIVT-GRQ 514
K+DV+SFG+L+ E+ + G+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 16/205 (7%)
Query: 320 KLGQGGFGTVYKGVL--PDGRE---IAVKRLFFNNRHRAA-NFYNEVNIISSVEHKNLVR 373
+G G FG VYKG+L G++ +A+K L + +F E I+ H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L G S P +++ E++ N +LD+F+ K + + ++ G G+ YL
Sbjct: 111 LEGVISKYKP-MMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAH 490
+HRD+ A NIL++S L K++DFGL+R ++D T G + APE +++
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 491 GQLTEKADVYSFGMLLLEIVT-GRQ 514
+ T +DV+SFG+++ E++T G +
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-C 377
+G+G FG V G G ++AVK + N A F E ++++ + H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
+V E++ SL ++ + L + + L E + YL +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFV 139
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLT 494
HRD+ A N+L+ AK++DFGL + S+ + + APE L + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKE-------ASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 495 EKADVYSFGMLLLEIVT-GRQ 514
K+DV+SFG+LL EI + GR
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
+G+G FG VY G L DG++I AVK L + + F E I+ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 89
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LLG C S L+V ++ + L FI + T + L +G+ YL +
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYL 488
+ +HRD+ A N +LD + K+ADFGLAR + + + G +MA E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ T K+DV+SFG+LL E++T G
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAP 231
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-38
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 320 KLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
+G+G FG V++G+ P+ + A+K F E + +H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + ++ E L F+ + +L L YL +
Sbjct: 82 IGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--- 135
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG-----YMAPEYLA 489
R +HRDI A N+L+ S K+ DFGL+R ++ T + G +MAPE +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPESIN 190
Query: 490 HGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ T +DV+ FG+ + EI+ G +
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 13/220 (5%)
Query: 298 DDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANF 356
D L + Y E LG+G +G VY G L + IA+K + + +
Sbjct: 12 SDLLEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL 66
Query: 357 YNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE 416
+ E+ + ++HKN+V+ LG + E +P SL + +
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDKSHISTA 475
+EGL YLH+ +I+HRDIK N+L+++ KI+DFG ++ T
Sbjct: 127 YTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET- 182
Query: 476 IAGTLGYMAPEYLAHGQL--TEKADVYSFGMLLLEIVTGR 513
GTL YMAPE + G + AD++S G ++E+ TG+
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
+G+G FG VY G L DG++I AVK L + + F E I+ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 153
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LLG C S L+V ++ + L FI + T + L +G+ +L +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYL 488
+ +HRD+ A N +LD + K+ADFGLAR + + G +MA E L
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ T K+DV+SFG+LL E++T G
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAP 295
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 66/254 (25%), Positives = 101/254 (39%), Gaps = 28/254 (11%)
Query: 271 TRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVY 330
+ W S + +R G + L + Y E+ ++G+G FG V+
Sbjct: 17 AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH-WMTHQPRVGRGSFGEVH 75
Query: 331 KGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389
+ G + AVK++ E+ + + +V L G GP + E
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFME 130
Query: 390 FLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKAS 444
L SL + I +A + L EGL YLH + RI+H D+KA
Sbjct: 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQ-----AL---EGLEYLHTR---RILHGDVKAD 179
Query: 445 NILLDSR-LRAKIADFGLARSFQEDKSHISTA----IAGTLGYMAPEYLAHGQLTEKADV 499
N+LL S RA + DFG A Q D S I GT +MAPE + K D+
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239
Query: 500 YSFGMLLLEIVTGR 513
+S ++L ++ G
Sbjct: 240 WSSCCMMLHMLNGC 253
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA---ANFYNEV 360
Y+TL F K+G+G F VY+ L DG +A+K++ + A A+ E+
Sbjct: 28 YNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIIL 419
+++ + H N+++ E +V E L R I K K L E+ ++ +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
L ++H + R++HRDIK +N+ + + K+ D GL R F + + + GT
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 199
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
YM+PE + K+D++S G LL E+ +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 15/205 (7%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRAA-NFYNEVNIISSVEHKNLVR 373
+G G FG V G L P +EI A+K L + +F E +I+ +H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L G + S P ++V E++ N SLD F+ T + ++ G G+ YL +
Sbjct: 111 LEGVVTKSKP-VMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAH 490
+HRD+ A NIL++S L K++DFGL R ++D T G + +PE +A+
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 491 GQLTEKADVYSFGMLLLEIVT-GRQ 514
+ T +DV+S+G++L E+++ G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-37
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 320 KLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
+G+G FG V++G+ P+ + A+K F E + +H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + ++ E L F+ + +L L YL +
Sbjct: 457 IGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG-----YMAPEYLA 489
R +HRDI A N+L+ S K+ DFGL+R ++ T + G +MAPE +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPESIN 565
Query: 490 HGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ T +DV+ FG+ + EI+ G +
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-37
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 19/219 (8%)
Query: 306 STLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN-----RHRAANFYNE 359
S E ++ +G G +G K DG+ + K L + + + +E
Sbjct: 3 SRAED----YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSE 55
Query: 360 VNIISSVEHKNLVRLLGC--SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YE 416
VN++ ++H N+VR + +V E+ L I K + E+
Sbjct: 56 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 417 IILGTVEGLVYLHEQ--SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
++ L H + ++HRD+K +N+ LD + K+ DFGLAR D S T
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ GT YM+PE + EK+D++S G LL E+
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 319 NKLGQGGFGTVYKGVLPDGR-EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG- 376
+KLG G +G VY+GV +AVK L + F E ++ ++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 77
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
C+ P ++ EF+ +L ++ + ++ + + YL ++
Sbjct: 78 CTREPP-FYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQL 493
IHRD+ A N L+ K+ADFGL+R D TA AG + APE LA+ +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 494 TEKADVYSFGMLLLEIVT-GRQ 514
+ K+DV++FG+LL EI T G
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMS 211
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 46/211 (21%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNL--VRL 374
++G GG V++ + + A+K + ++ NE+ ++ ++ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ +V E N L+ ++ K K++ +R +E + +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYMAPEYL----- 488
I+H D+K +N L+ K+ DFG+A Q D S + + GT+ YM PE +
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 489 ------AHGQLTEKADVYSFGMLLLEIVTGR 513
+ +++ K+DV+S G +L + G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 45/211 (21%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNL--VRL 374
++G GG V++ + + A+K + ++ NE+ ++ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ +V E N L+ ++ K K++ +R +E + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS-TAIAGTLGYMAPEYL----- 488
I+H D+K +N L+ K+ DFG+A Q D + + + GT+ YM PE +
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 489 ------AHGQLTEKADVYSFGMLLLEIVTGR 513
+ +++ K+DV+S G +L + G+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-36
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRLFFNN--RHRAANFYNEVNIISSVEHKNLV 372
LG+G FG+V +G L DG + AVK + +N + F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 373 RLLG-CSCSGPES----LLVYEFLPNQSLDRFIFDS---AKAKTLTWEKRYEIILGTVEG 424
RLLG C + +++ F+ L ++ S K + + + ++ G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--- 481
+ YL + +HRD+ A N +L + +ADFGL++ + G +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 482 --YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
++A E LA T K+DV++FG+ + EI T G
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-36
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 28/217 (12%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
LG+G FG+V + L DG + AVK L F E + +H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 373 RLLG-CSCSGPES-----LLVYEFLPNQSLDRFIFDS---AKAKTLTWEKRYEIILGTVE 423
+L+G S + +++ F+ + L F+ S L + ++
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG-- 481
G+ YL + IHRD+ A N +L + +ADFGL+R G
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----DYYRQGCASKL 201
Query: 482 ---YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
++A E LA T +DV++FG+ + EI+T G+
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-36
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+ K+GQG GTVY + + G+E+A++++ + + NE+ ++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
L G E +V E+L SL D + + + ++ L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
++IHRDIK+ NILL K+ DFG ++S ST + GT +MAPE +
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 494 TEKADVYSFGMLLLEIVTG 512
K D++S G++ +E++ G
Sbjct: 194 GPKVDIWSLGIMAIEMIEG 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 9/199 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
D K+G+G G V GR++AVK + + R +NEV I+ +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ G E ++ EFL +L D L E+ + ++ L YLH Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+IHRDIK+ +ILL R K++DFG +D + + GT +MAPE ++
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLY 218
Query: 494 TEKADVYSFGMLLLEIVTG 512
+ D++S G++++E+V G
Sbjct: 219 ATEVDIWSLGIMVIEMVDG 237
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH---RAANFYNEVNIISSVEHKNLVRLL 375
LGQG V++G G A+K FNN E ++ + HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 376 GC--SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ +L+ EF P SL + + + A L + ++ V G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 434 IRIIHRDIKASNILL----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
I+HR+IK NI+ D + K+ DFG AR ++D + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 490 HGQL--------TEKADVYSFGMLLLEIVTGR 513
L D++S G+ TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 42/220 (19%)
Query: 320 KLGQGGFGTVYKGVL--------PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL 371
LGQG F ++KGV E+ +K L +R+ + +F+ +++S + HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 372 VRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
V G C C ++LV EF+ SLD ++ + + W+ E+ + +L E
Sbjct: 75 VLNYGVCVCGDE-NILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFLEE 131
Query: 431 QSKIRIIHRDIKASNILLDSRLR--------AKIADFGLARSFQEDKSHISTAIAGTLGY 482
+IH ++ A NILL K++D G++ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------IL 177
Query: 483 ------MAPEYLAHGQL-TEKADVYSFGMLLLEIVT-GRQ 514
+ PE + + + D +SFG L EI + G +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 29/217 (13%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKN 370
+LGQG FG VY+GV D E A+K + + R R F NE +++ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 89
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRF-------IFDSAKAKTLTWEKRYEIILGTVE 423
+VRLLG G +L++ E + L + + ++ + K ++ +
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY- 482
G+ YL+ + +HRD+ A N ++ KI DFG+ R E G G
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRKGGKGLL 202
Query: 483 ----MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
M+PE L G T +DV+SFG++L EI T Q
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 59/227 (25%), Positives = 89/227 (39%), Gaps = 37/227 (16%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI-ISSVEHKNLVR 373
LG G GTV GR +AVKR+ E+ + S +H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 374 LLGCSCSGPESL-LVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYL 428
CS + L + E L N +L + K ++ G+ +L
Sbjct: 74 YY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 429 HEQSKIRIIHRDIKASNILLDS-------------RLRAKIADFGLARSFQEDKSHISTA 475
H +IIHRD+K NIL+ + LR I+DFGL + +S T
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 476 ---IAGTLGYMAPEYL-------AHGQLTEKADVYSFGMLLLEIVTG 512
+GT G+ APE L +LT D++S G + I++
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 60/227 (26%), Positives = 90/227 (39%), Gaps = 36/227 (15%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
F+E LGQG FG V K D R A+K++ + +EV +++S+ H+ +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVVR 66
Query: 374 LLGCSCSGPESL-------------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY-EIIL 419
+ + E+ N +L I Y +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFR 123
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA-- 477
+E L Y+H Q IIHRD+K NI +D KI DFGLA++ +
Sbjct: 124 QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 478 -----------GTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIVTG 512
GT Y+A E L G EK D+YS G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 49/255 (19%), Positives = 107/255 (41%), Gaps = 24/255 (9%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVL 334
K+ + + R D+ L +D + + + + ++G GG V++ +
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77
Query: 335 PDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNL--VRLLGCSCSGPESLLVYEF 390
+ A+K + ++ NE+ ++ ++ + +RL + +V E
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS 450
N L+ ++ K K++ +R +E + +H+ I+H D+K +N L+
Sbjct: 138 -GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD 190
Query: 451 RLRAKIADFGLARSFQEDKSHIS-TAIAGTLGYMAPEYL-----------AHGQLTEKAD 498
K+ DFG+A Q D + + + G + YM PE + + +++ K+D
Sbjct: 191 G-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 499 VYSFGMLLLEIVTGR 513
V+S G +L + G+
Sbjct: 250 VWSLGCILYYMTYGK 264
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
+LG+G FG V+ P ++ AVK L +F E ++++++H+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKRYEII 418
+ G C P ++V+E++ + L++F L + I
Sbjct: 81 KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
G+VYL Q +HRD+ N L+ + L KI DFG++R + G
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVG 192
Query: 479 TLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+M PE + + + T ++DV+SFG++L EI T G+Q
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 66/235 (28%), Positives = 112/235 (47%), Gaps = 12/235 (5%)
Query: 282 KRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREI 340
K+ + ++ + + L K E F++ ++LG G G V+K P G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 341 AVK--RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398
A K L R E+ ++ +V G S E + E + SLD+
Sbjct: 62 ARKLIHLEIKPAIRNQII-RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 399 FIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458
+ KA + + ++ + ++GL YL E+ KI +HRD+K SNIL++SR K+ D
Sbjct: 121 VL---KKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCD 175
Query: 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
FG+ S Q S ++ + GT YM+PE L + ++D++S G+ L+E+ GR
Sbjct: 176 FGV--SGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
+LG+ FG VYKG L P + A+K L F +E + + ++H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 372 VRLLG-CSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKRYEI 417
V LLG + P +++ + + L F D L +
Sbjct: 75 VCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477
+ G+ YL ++H+D+ N+L+ +L KI+D GL R
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----DYYKL 186
Query: 478 GTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+MAPE + +G+ + +D++S+G++L E+ + G Q
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-35
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH---RAANFYNEVNIISSVEHKNLVRLL 375
LGQG V++G G A+K FNN E ++ + HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 376 GC--SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ +L+ EF P SL + + + A L + ++ V G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 434 IRIIHRDIKASNILL----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
I+HR+IK NI+ D + K+ DFG AR ++D + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 490 HGQL--------TEKADVYSFGMLLLEIVTGR 513
L D++S G+ TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLV 372
F + K+G+G FG V+KG+ + +A+K + + E+ ++S + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGLVYLHEQ 431
+ G + ++ E+L S D + L E + IL ++GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-ETQIATILREILKGLDYLHSE 138
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
+ IHRDIKA+N+LL K+ADFG+A + + +T + GT +MAPE +
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 194
Query: 492 QLTEKADVYSFGMLLLEIVTG 512
KAD++S G+ +E+ G
Sbjct: 195 AYDSKADIWSLGITAIELARG 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
+LG+G FG V+ P+ ++ AVK L + +F E +++ ++H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRF------------IFDSAKAKTLTWEKRYEIIL 419
R G C+ P L+V+E++ + L+RF + L + +
Sbjct: 107 RFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
G+VYL +HRD+ N L+ L KI DFG++R G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYRVGG 218
Query: 480 LG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+M PE + + + T ++DV+SFG++L EI T G+Q
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 319 NKLGQGGFGTVYKGVL-PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSV-EHKNLV 372
+ +G+G FG V K + DG + A+KR+ + + +F E+ ++ + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-DFAGELEVLCKLGHHPNII 89
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKRYEIIL 419
LLG L E+ P+ +L F ++ A TL+ ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
G+ YL S+ + IHRD+ A NIL+ AKIADFGL+R + T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------QEVYVKKT 199
Query: 480 LG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+G +MA E L + T +DV+S+G+LL EIV+ G
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 2e-34
Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 309 EKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRAANFYNEVNII 363
+ G ++ +LG GGFG V + + G ++A+K L NR R + E+ I+
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER---WCLEIQIM 66
Query: 364 SSVEHKNLVRLL------GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEI 417
+ H N+V LL E+ L +++ L E
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIRT 125
Query: 418 ILG-TVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGLARSFQEDKSHIS 473
+L L YLHE RIIHRD+K NI+L RL KI D G A+ + +
Sbjct: 126 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCT 181
Query: 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ GTL Y+APE L + T D +SFG L E +TG
Sbjct: 182 EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 63/211 (29%), Positives = 84/211 (39%), Gaps = 25/211 (11%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSV-EHK 369
SF ++LG G +G V+K DGR AVKR R A EV V +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVE 423
VRL G L E SL + A+ + T+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD--------TLL 168
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L +LH Q ++H D+K +NI L R R K+ DFGL + G YM
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYM 223
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
APE L G ADV+S G+ +LE+ +
Sbjct: 224 APE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 73/236 (30%), Positives = 121/236 (51%), Gaps = 16/236 (6%)
Query: 278 SIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPD 336
S+E + + +L K L++DSL ++ FD KLG+G +G+VYK +
Sbjct: 1 SLETVQLRNPPRRQL-KKLDEDSLT------KQPEEVFDVLEKLGEGSYGSVYKAIHKET 53
Query: 337 GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396
G+ +A+K++ E++I+ + ++V+ G + +V E+ S+
Sbjct: 54 GQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111
Query: 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456
I + KTLT ++ I+ T++GL YLH R IHRDIKA NILL++ AK+
Sbjct: 112 SDII--RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKL 166
Query: 457 ADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
ADFG+A + + +T I GT +MAPE + AD++S G+ +E+ G
Sbjct: 167 ADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 66/216 (30%), Positives = 86/216 (39%), Gaps = 27/216 (12%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
LG G FG VY+G + D + AVK L + +F E IIS H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVY 427
VR +G S ++ E + L F+ ++ +L + G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 428 LHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY-- 482
L E IHRDI A N LL AKI DFG+AR S G
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAMLP 208
Query: 483 ---MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
M PE G T K D +SFG+LL EI + G
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL-FFNNRHRAANFYNEVNII-SSVEHKNL 371
+ ++G+G +G+V K V P G+ +AVKR+ + +++++ S + +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLH 429
V+ G + + E + + S D+F + +I L TV+ L +L
Sbjct: 84 VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
E KI IHRDIK SNILLD K+ DFG+ S Q S T AG YMAPE +
Sbjct: 143 ENLKI--IHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 490 HGQL----TEKADVYSFGMLLLEIVTGR 513
++DV+S G+ L E+ TGR
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 320 KLGQGGFGTVYKGVLPD---GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
KLG GG TVY D ++A+K + F EV+ S + H+N+V
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
++ LV E++ +L +I L+ + ++G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM-- 130
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
RI+HRDIK NIL+DS KI DFG+A++ E + + GT+ Y +PE
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 494 TEKADVYSFGMLLLEIVTGRQ 514
E D+YS G++L E++ G
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP 210
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 65/216 (30%), Positives = 85/216 (39%), Gaps = 27/216 (12%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
LG G FG VY+G + D + AVK L + +F E IIS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVY 427
VR +G S ++ E + L F+ ++ +L + G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 428 LHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY-- 482
L E IHRDI A N LL AKI DFG+AR G
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLP 249
Query: 483 ---MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
M PE G T K D +SFG+LL EI + G
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 285
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 37/225 (16%)
Query: 319 NKLGQGGFGTVYKGVL------PDGREIAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG+G FG V + R +AVK L + A +E+ I+ + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHL 91
Query: 370 NLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV------ 422
N+V LLG C+ G +++ EF +L ++ ++ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 423 -------EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
+G+ +L + + IHRD+ A NILL + KI DFGLAR +D
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDY 204
Query: 476 IAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +MAPE + T ++DV+SFG+LL EI + G
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+GGF ++ A K + H+ E++I S+ H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVYLHEQSKIR 435
+V E +SL + K LT E RY + V G YLH R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARY-YLRQIVLGCQYLHRN---R 161
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
+IHRD+K N+ L+ L KI DFGLA + D + GT Y+APE L+ +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 496 KADVYSFGMLLLEIVTGR 513
+ DV+S G ++ ++ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
++ +LG G FG VYK G A K + + ++ E+ I+++ +H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGLVYLHEQS 432
LLG + ++ EF P ++D + + LT E + +++ +E L +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLT-EPQIQVVCRQMLEALNFLHSK- 136
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
RIIHRD+KA N+L+ ++ADFG++ + + I GT +MAPE +
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCET 193
Query: 493 LTE-----KADVYSFGMLLLEIVTG 512
+ + KAD++S G+ L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFN-NRHRAANFYNEVNII- 363
++E + +LG+G +G V K +P G+ +AVKR+ N +++I
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-FDSAKAKTLTWEKRYEIILG-- 420
+V+ V G + + E + + SLD+F K +T+ E ILG
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP-----EDILGKI 114
Query: 421 ---TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG----LARSFQEDKSHIS 473
V+ L +LH + + IHRD+K SN+L+++ + K+ DFG L +D
Sbjct: 115 AVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--- 169
Query: 474 TAIAGTLGYMAPE----YLAHGQLTEKADVYSFGMLLLEIVTGR 513
AG YMAPE L + K+D++S G+ ++E+ R
Sbjct: 170 ---AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG G FG V + + +AVK L + R A +E+ ++S + H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHM 87
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRF---------------IFDSAKAKTLTWEKR 414
N+V LLG G +L++ E+ L F L E
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
+G+ +L + IHRD+ A NILL KI DFGLAR + D S
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKND----SN 200
Query: 475 AIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +MAPE + + T ++DV+S+G+ L E+ + G
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG G FG V + + +AVK L + + A +E+ I+S + +H+
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHE 110
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRF-----------IFDSAKAKTLTWEKRYEII 418
N+V LLG G L++ E+ L F + T +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+G+ +L + IHRD+ A N+LL + AKI DFGLAR D S I
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYIVK 223
Query: 479 TLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+MAPE + T ++DV+S+G+LL EI + G
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 28/219 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC 377
L +GGF VY+ + GRE A+KRL N + EV + + H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 378 SCSGPES--------LLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYL 428
+ G E LL+ E Q ++ +++ +I T + ++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA----------- 477
H Q K IIHRD+K N+LL ++ K+ DFG A + + +A
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 478 GTLGYMAPE---YLAHGQLTEKADVYSFGMLLLEIVTGR 513
T Y PE ++ + EK D+++ G +L + +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 43/231 (18%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSVEHKN 370
LG+G FG V K + +AVK L + +E N++ V H +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVNHPH 87
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE------- 423
+++L G LL+ E+ SL F+ +S K +++
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 424 --------------GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469
G+ YL ++++++HRD+ A NIL+ + KI+DFGL+R E+
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE- 203
Query: 470 SHISTAIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ + + G +MA E L T ++DV+SFG+LL EIVT G
Sbjct: 204 ---DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+GGF ++ A K + H+ E++I S+ H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVYLHEQSKIR 435
+V E +SL + K LT E RY + V G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARY-YLRQIVLGCQYLHRN---R 135
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
+IHRD+K N+ L+ L KI DFGLA + D + GT Y+APE L+ +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 496 KADVYSFGMLLLEIVTGR 513
+ DV+S G ++ ++ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 57/226 (25%), Positives = 89/226 (39%), Gaps = 38/226 (16%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE--------IAVKRL--FFNNRHRAANFYNEVNIISSV-E 367
LG+G FG V + +AVK L + + +E+ ++ + +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV----- 422
HKN++ LLG ++ E+ +L ++ + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 423 --------EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
G+ YL Q + IHRD+ A N+L+ KIADFGLAR
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DY 212
Query: 475 AIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
T G +MAPE L T ++DV+SFG+L+ EI T G
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 50/224 (22%), Positives = 84/224 (37%), Gaps = 33/224 (14%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKR--LFFNNRHRAANFYNEVNIISSV-EHKN 370
F E K+G G FG+V+K V DG A+KR N EV + + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLH 429
+VR L+ E+ SL I ++ + + E +++L GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 430 EQSKIRIIHRDIKASNILLD-------------------SRLRAKIADFGLARSFQEDKS 470
++H DIK SNI + +++ KI D G +
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 471 HISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
G ++A E L KAD+++ + ++
Sbjct: 190 EE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 38/226 (16%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE--------IAVKRL--FFNNRHRAANFYNEVNIISSV-E 367
LG+G FG V + +AVK L + + +E+ ++ + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 145
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKR 414
HKN++ LLG ++ E+ +L + + + +T++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
G+ YL Q + IHRD+ A N+L+ KIADFGLAR
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DY 258
Query: 475 AIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
T G +MAPE L T ++DV+SFG+L+ EI T G
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEH 368
F N LG+G F VY+ + G E+A+K + NEV I ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVY 427
+++ L LV E N ++R++ + K + E R+ + + G++Y
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARH-FMHQIITGMLY 127
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
LH I+HRD+ SN+LL + KIADFGLA + T + GT Y++PE
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEI 183
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGR 513
++DV+S G + ++ GR
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 20/236 (8%)
Query: 286 SNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKR 344
S + K L ++ + + ++G G G V+K G IAVK+
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEIND-----LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ 57
Query: 345 LFFN-NRHRAANFYNEVNII-SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD 402
+ + N+ +++++ S + +V+ G + + + E + ++
Sbjct: 58 MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK-- 114
Query: 403 SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462
+ ++ + V+ L YL E+ + IHRD+K SNILLD R + K+ DFG+
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGI- 171
Query: 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTGR 513
S + AG YMAPE + T+ +ADV+S G+ L+E+ TG+
Sbjct: 172 -SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 58/231 (25%), Positives = 91/231 (39%), Gaps = 43/231 (18%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG G FG V + +AVK L ++ R A +E+ +++ + H+
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHE 109
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE------ 423
N+V LLG L++E+ L ++ + + + E
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 424 --------------GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469
G+ +L +HRD+ A N+L+ KI DFGLAR D
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 225
Query: 470 SHISTAIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
S + +MAPE L G T K+DV+S+G+LL EI + G
Sbjct: 226 ---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 45/232 (19%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSVEHKN 370
+G+G FG V++ P +AVK L + +A +F E +++ ++ N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DFQREAALMAEFDNPN 111
Query: 371 LVRLLG-CSCSGPESLLVYEFLPNQSLDRF---------------------IFDSAKAKT 408
+V+LLG C+ P L++E++ L+ F S
Sbjct: 112 IVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
L+ ++ I G+ YL E+ + +HRD+ N L+ + KIADFGL+R+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 469 KSHISTAIAGTLGY-----MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
A M PE + + + T ++DV+++G++L EI + G Q
Sbjct: 228 ----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 38/226 (16%)
Query: 319 NKLGQGGFGTVYKGVLPD--------GREIAVKRL--FFNNRHRAANFYNEVNIISSV-E 367
LG+G FG V ++AVK L + + +E+ ++ + +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGK 133
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV----- 422
HKN++ LLG ++ E+ +L ++ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 423 --------EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
G+ YL + + IHRD+ A N+L+ KIADFGLAR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----DY 246
Query: 475 AIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
T G +MAPE L T ++DV+SFG+LL EI T G
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 292
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 320 KLGQGGFGTVYKGVLPD---GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
LG GG V+ D R++AVK L + F E +++ H +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 374 LL--GCSCSGPESL--LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+ G + + L +V E++ +L + +T ++ E+I + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI--STAIAGTLGYMAPEY 487
+ IIHRD+K +NI++ + K+ DFG+AR+ + + + + A+ GT Y++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ ++DVYS G +L E++TG
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 43/216 (19%), Positives = 78/216 (36%), Gaps = 19/216 (8%)
Query: 312 TGSFDEANKLGQG--GFGTVYKGV-LPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSV 366
G ++ +G+G TV P G + V+R+ E+++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 367 EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGL 425
H N+V + E +V F+ S + + + + E IL G ++ L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMN-ELAIAYILQGVLKAL 141
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI------AGT 479
Y+H + HR +KAS+IL+ + ++ S
Sbjct: 142 DYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 480 LGYMAPEYLAHGQL--TEKADVYSFGMLLLEIVTGR 513
L +++PE L K+D+YS G+ E+ G
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 25/274 (9%), Positives = 58/274 (21%), Gaps = 42/274 (15%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV- 333
R K + ++ S L + L G V+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83
Query: 334 LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEHKNLVRLLGC------------- 377
+ + A+K N+R + + + ++
Sbjct: 84 VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143
Query: 378 -------------SCSGPESLLVYEFLP---NQSLDRFIFDSAKAKTLTWEKRYEIILGT 421
+ LL+ F + +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
+ L + ++H N+ + R + D A + +
Sbjct: 204 IRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVT 256
Query: 482 YMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGR 513
Y E+L T + + G+ + +
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 14/200 (7%)
Query: 320 KLGQGGFGTVYKG---VLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
+G+GG G VY+ V R +A+K + ++ E ++ ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ + + + L + L + I+ L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
HRD+K NIL+ + A + DFG+A + ++K GTL YMAPE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 494 TEKADVYSFGMLLLEIVTGR 513
T +AD+Y+ +L E +TG
Sbjct: 213 TYRADIYALTCVLYECLTGS 232
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 15/211 (7%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLV 372
++ +G G V P ++A+KR+ + E+ +S H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV-----EGLVY 427
E LV + L S+ I E + T+ EGL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFG----LARSFQEDKSHISTAIAGTLGYM 483
LH+ +I HRD+KA NILL +IADFG LA ++ + GT +M
Sbjct: 137 LHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 484 APEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
APE + + KAD++SFG+ +E+ TG
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-31
Identities = 46/204 (22%), Positives = 79/204 (38%), Gaps = 25/204 (12%)
Query: 320 KLGQGGFGTVYKG---VLPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL 375
+ GG G +Y + +GR + +K L + A A E ++ V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 376 -----GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
P +V E++ QSL R + L + +L + L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+++ D+K NI+L + K+ D G + GT G+ APE +
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IVR 250
Query: 491 GQLTEKADVYSFGMLLLEIVTGRQ 514
T D+Y+ G L +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLP 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 28/240 (11%)
Query: 280 ERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGR 338
R GS + + D +S L + +G G FG VY + +
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKLFSDLRE----------IGHGSFGAVYFARDVRNSE 80
Query: 339 EIAVKRLFFNNRHRAANFY---NEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQS 395
+A+K++ ++ + + EV + + H N ++ GC + LV E+ +
Sbjct: 81 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 140
Query: 396 LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAK 455
D K L + + G ++GL YLH +IHRD+KA NILL K
Sbjct: 141 SD---LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 194
Query: 456 IADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE---KADVYSFGMLLLEIVTG 512
+ DFG A S + GT +MAPE + + K DV+S G+ +E+
Sbjct: 195 LGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 62/205 (30%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA---ANFYNEVNIISSVEH 368
F+ LG+G FG VY +A+K LF +A EV I S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
N++RL G L+ E+ P ++ R + K ++ I L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 125
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H + R+IHRDIK N+LL S KIADFG + + + GTL Y+ PE +
Sbjct: 126 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMI 179
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
EK D++S G+L E + G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 36/230 (15%), Positives = 73/230 (31%), Gaps = 23/230 (10%)
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGV------LPDGREIAVKRLFFNNRHRAANFY 357
+ + + + LG+G F VY+ + ++ +K N
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 358 NEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI--FDSAKAKTLTWEKRY 415
+ + ++ S+LV E +L I + + K +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-----------KIADFGLARS 464
+ + + +H+ IIH DIK N +L + + D G +
Sbjct: 176 SFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 465 FQ-EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ K I TA T G+ E L++ + D + + ++ G
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 33/238 (13%), Positives = 68/238 (28%), Gaps = 53/238 (22%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA------------------------- 354
LGQ + G V +F R +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 355 ---NFYNEVNIISSVEHKNLVRLLGC--SCSGPESLLVYEFLPNQSLDRF--IFD-SAKA 406
F +++ + K ++R+ +Y + + + S+
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466
K+L R ++ L + L LH ++H ++ +I+LD R + F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 467 EDKSHISTAIAGTLGYMAPEYLAH-----------GQLTEKADVYSFGMLLLEIVTGR 513
+ + G+ PE A +T D ++ G+++ I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 312 TGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHK 369
G F+ +G G +G VYKG + G+ A+K + E+N++ H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHR 81
Query: 370 NLVRLLGC-----SCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTV 422
N+ G + L LV EF S+ + + K TL E+ I +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLK-EEWIAYICREIL 139
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
GL +LH+ ++IHRDIK N+LL K+ DFG++ +T I GT +
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYW 195
Query: 483 MAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
MAPE +A + + K+D++S G+ +E+ G
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 30/232 (12%), Positives = 60/232 (25%), Gaps = 42/232 (18%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNR-------------------------HRAA 354
LGQ + G V +F R +A
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 355 NFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP-------NQSLDRFIFDSAKA- 406
+ V+ +++ + ++ F Q+ + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466
K+L R ++ L + L LH ++H ++ +I+LD R + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 467 EDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGR 513
A L +T D ++ G+ + I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN-----EVNI---IS 364
++ ++G G +GTVYK G +A+K + N EV + +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 365 SVEHKNLVRLL----GCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL 419
+ EH N+VRL+ + LV+E + +Q L ++ D A L E +++
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 127
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
+ GL +LH I+HRD+K NIL+ S K+ADFGLAR + + T + T
Sbjct: 128 QFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVVVT 182
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
L Y APE L D++S G + E+ +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 63/248 (25%), Positives = 105/248 (42%), Gaps = 26/248 (10%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDE------ANKLGQGGFGT 328
ER S L + F + + G+ + LG G FG
Sbjct: 45 NADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQ 104
Query: 329 VYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385
V+K G ++A K R NE+++++ ++H NL++L S + +
Sbjct: 105 VHKCEETATGLKLAAK--IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162
Query: 386 LVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKAS 444
LV E++ L DR I ++ LT + EG+ ++H+ I+H D+K
Sbjct: 163 LVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPE 216
Query: 445 NILLDSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSF 502
NIL +R KI DFGLAR ++ + GT ++APE + + ++ D++S
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274
Query: 503 G----MLL 506
G MLL
Sbjct: 275 GVIAYMLL 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 16/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+G+G F V + + G++ AVK + + + E +I ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 374 LLGCSCSGPESL-LVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LL + S L +V+EF+ L + + + + +E L Y H+
Sbjct: 91 LLE-TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 432 SKIRIIHRDIKASNILLDSRLRA---KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
IIHRD+K +LL S+ + K+ FG+A E GT +MAPE +
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTPHFMAPEVV 205
Query: 489 AHGQLTEKADVYSFGMLL 506
+ DV+ G++L
Sbjct: 206 KREPYGKPVDVWGCGVIL 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-29
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 32/223 (14%)
Query: 308 LEKATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNE 359
++ +T F + LG+G FG V G+E AVK + + + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 360 VNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSL-DRFI----FDSAKAKTLTWEK 413
V ++ ++H N+++L LV E L D I F A +
Sbjct: 77 VQLLKQLDHPNIMKLYE-FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII--- 132
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKS 470
+L + Y+H+ I+HRD+K N+LL+S+ +I DFGL+ F+ K
Sbjct: 133 --RQVLSGIT---YMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
GT Y+APE L HG EK DV+S G++L +++G
Sbjct: 185 M--KDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGC 224
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 56/252 (22%), Positives = 102/252 (40%), Gaps = 30/252 (11%)
Query: 286 SNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRL 345
+ + L N LN +K + L QG F + D + A+K+
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKY 62
Query: 346 F-----------------FNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388
+ + + +F NE+ II+ ++++ + G + E ++Y
Sbjct: 63 EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122
Query: 389 EFLPNQSL-----DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKA 443
E++ N S+ F+ D + + II + Y+H ++ I HRD+K
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKP 180
Query: 444 SNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT--EKADVYS 501
SNIL+D R K++DFG + + K S GT +M PE+ ++ K D++S
Sbjct: 181 SNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 502 FGMLLLEIVTGR 513
G+ L +
Sbjct: 238 LGICLYVMFYNV 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEH 368
FD LG+G FG VY + +A+K LF E+ I S + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVE 423
N++R+ L+ EF P L + + FD ++ T E +
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LAD 125
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L Y HE+ ++IHRDIK N+L+ + KIADFG + + T + GTL Y+
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYL 179
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE + EK D++ G+L E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN-----EVNIISSVE 367
+++ + LG+G F TVYK + +A+K++ +R A + N E+ ++ +
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
H N++ LL LV++F+ L+ I D++ T + K Y +L T++GL Y
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEY 127
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
LH+ I+HRD+K +N+LLD K+ADFGLA+SF + T T Y APE
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPEL 183
Query: 488 LAHGQL-TEKADVYSFGMLLLEIVTGR 513
L ++ D+++ G +L E++
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 36/216 (16%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--------RAANFYNEVNIISS 365
+ + K+G+G +G VYK GR +A+KR+ + R E++++
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR------EISLLKE 75
Query: 366 VEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEII 418
+ H N+V L+ L LV+EF+ + L + + ++ K ++
Sbjct: 76 LHHPNIVSLIDV-IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQ------ 127
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+ G+ + H+ RI+HRD+K N+L++S K+ADFGLAR+F T
Sbjct: 128 --LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV 181
Query: 479 TLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
TL Y AP+ L + + D++S G + E++TG+
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 44/236 (18%)
Query: 306 STLEKATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVKRL-------------FF 347
+ K G E+ KLG G +G V E A+K +
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 348 NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKA 406
N YNE++++ S++H N+++L + LV EF L F+
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGEL----FEQIIN 139
Query: 407 KTLTWEKRY------EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIA 457
+ ++ I+ + G+ YLH+ + I+HRDIK NILL+++ L KI
Sbjct: 140 R-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191
Query: 458 DFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
DFGL+ F +D GT Y+APE L + EK DV+S G+++ ++ G
Sbjct: 192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGY 244
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 23/244 (9%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDE----ANKLGQGGFGTVY 330
+ + ND +K + + + +E GS + +LG G FG V+
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKK---YVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 331 KGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389
+ V GR K + NE++I++ + H L+ L E +L+ E
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128
Query: 390 FLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448
FL L DR A+ ++ + + EGL ++HE I+H DIK NI+
Sbjct: 129 FLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMC 182
Query: 449 DSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFG--- 503
+++ + KI DFGLA D+ T + APE + + D+++ G
Sbjct: 183 ETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
Query: 504 -MLL 506
+LL
Sbjct: 241 YVLL 244
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 29/247 (11%)
Query: 280 ERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGR 338
+ L F S + + KLG G +G V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 339 EIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQS 395
E A+K + + + + EV ++ ++H N+++L + LV E
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD-FFEDKRNYYLVMECYKGGE 122
Query: 396 LDRFIFDSAKAKTLTWEKRY------EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449
L FD + ++ II + G+ YLH+ + I+HRD+K N+LL+
Sbjct: 123 L----FDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLE 170
Query: 450 SR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
S+ KI DFGL+ F+ K GT Y+APE L + EK DV+S G++L
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVL-RKKYDEKCDVWSIGVIL 227
Query: 507 LEIVTGR 513
++ G
Sbjct: 228 FILLAGY 234
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLF----FNNRHRAANFYNEVNI 362
T E+ ++ +G G FG V++ L + E+A+K++ F NR E+ I
Sbjct: 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR--------ELQI 85
Query: 363 ISSVEHKNLVRLLGCSCSGPESL------LVYEFLPNQSLDRFIFDSAKAK-TLTWEK-- 413
+ V+H N+V L S + LV E++P +++ R AK K T+
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIK 144
Query: 414 --RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQEDKS 470
Y+++ L Y+H I I HRDIK N+LLD K+ DFG A+ +
Sbjct: 145 LYMYQLL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 471 HISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
++S I + Y APE + T D++S G ++ E++ G+
Sbjct: 198 NVSY-IC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 314 SFDEANKLGQGGFGTVYKG--VLPDGREIAVKRLFFNNRH--------RAANFYNEVNI- 362
++ ++G+G +G V+K + GR +A+KR+ R EV +
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------EVAVL 65
Query: 363 --ISSVEHKNLVRLL----GCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
+ + EH N+VRL L LV+E + +Q L ++ D + E
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
+++ + GL +LH R++HRD+K NIL+ S + K+ADFGLAR + + T+
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TS 178
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ TL Y APE L D++S G + E+ +
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-28
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--------RAANFYNEVNIISSV 366
+ K+G+G +G VYK G A+K++ R E++I+ +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR------EISILKEL 57
Query: 367 EHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIIL 419
+H N+V+L + L LV+E L Q L + + +S AK+ +
Sbjct: 58 KHSNIVKLYDV-IHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ------- 108
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
+ G+ Y H++ R++HRD+K N+L++ KIADFGLAR+F T T
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVT 163
Query: 480 LGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
L Y AP+ L + + D++S G + E+V G
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 35/171 (20%), Positives = 65/171 (38%), Gaps = 14/171 (8%)
Query: 349 NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT 408
+ ++ + KN V L S + + ++L ++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
I + E + +LH + ++HRD+K SNI K+ DFGL + +D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 469 KSHISTAIA-----------GTLGYMAPEYLAHGQLTEKADVYSFGMLLLE 508
+ + GT YM+PE + + K D++S G++L E
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
KLG G FG V+ G E +K + ++ E+ ++ S++H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 378 SCSGPESL-LVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
++ +V E L +R + A+ K L+ E++ + L Y H Q
Sbjct: 89 -FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---H 144
Query: 436 IIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
++H+D+K NIL KI DFGLA F+ D+ T AGT YMAPE
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVF-KRD 201
Query: 493 LTEKADVYSFGMLL 506
+T K D++S G+++
Sbjct: 202 VTFKCDIWSAGVVM 215
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 48/240 (20%), Positives = 90/240 (37%), Gaps = 16/240 (6%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDE----ANKLGQGGFGTVY 330
+ R + + D + +E + +LG G FG V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 331 KGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389
+ G A K + + E+ +S + H LV L E +++YE
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 390 FLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448
F+ L ++ + ++ ++ E + +GL ++HE + +H D+K NI+
Sbjct: 235 FMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMF 288
Query: 449 DSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
++ K+ DFGL +S GT + APE + D++S G+L
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 37/217 (17%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH--------RAANFYNEVNIISS 365
+++ K+G+G +GTV+K +A+KR+ ++ R E+ ++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKE 57
Query: 366 VEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEII 418
++HKN+VRL + L LV+EF Q L ++ D K+ ++
Sbjct: 58 LKHKNIVRLHDV-LHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
++GL + H + ++HRD+K N+L++ K+A+FGLAR+F +A
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV 163
Query: 479 TLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQ 514
TL Y P+ L +L + D++S G + E+ +
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-----FYNEVNIISSVEHKNLV 372
LG+G FG V K +E AVK + N+ A N EV ++ ++H N++
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 373 RLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY------EIILGTVEGL 425
+L S +V E L FD + KR+ II G+
Sbjct: 85 KLFE-ILEDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIKQVFSGI 134
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
Y+H+ I+HRD+K NILL+S+ KI DFGL+ FQ++ GT Y
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYY 189
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+APE L G EK DV+S G++L +++G
Sbjct: 190 IAPEVL-RGTYDEKCDVWSAGVILYILLSGT 219
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
LG G F V+ G+ A+K + + R ++ NE+ ++ ++H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKIRII 437
S LV + + L FD + + EK +I + + YLHE I+
Sbjct: 76 ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIV 128
Query: 438 HRDIKASNILL-----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
HRD+K N+L +S++ I DFGL++ Q +ST GT GY+APE LA
Sbjct: 129 HRDLKPENLLYLTPEENSKI--MITDFGLSKMEQNGI--MST-ACGTPGYVAPEVLAQKP 183
Query: 493 LTEKADVYSFGMLL 506
++ D +S G++
Sbjct: 184 YSKAVDCWSIGVIT 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+LG+G F V + V + G+E A + + E I ++H N+VRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKI 434
S S L+++ + L F+ A+ E I +E +++ H+
Sbjct: 78 -SISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQMG-- 130
Query: 435 RIIHRDIKASNILLDSRLRA---KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
++HR++K N+LL S+L+ K+ADFGLA + ++ AGT GY++PE L
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEVLRKD 188
Query: 492 QLTEKADVYSFGMLL 506
+ D+++ G++L
Sbjct: 189 PYGKPVDLWACGVIL 203
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLLGC 377
LG+G FG V++ V + K F + E++I++ H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
S E ++++EF+ + +R A L + + E L +LH + I
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSHN---I 123
Query: 437 IHRDIKASNILLDSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
H DI+ NI+ +R + KI +FG AR + + + Y APE H ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVS 181
Query: 495 EKADVYSFG----MLL 506
D++S G +LL
Sbjct: 182 TATDMWSLGTLVYVLL 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 61/198 (30%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
LG+G FG V K +E AVK + EV ++ ++H N+++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST---ILREVELLKKLDHPNIMK 85
Query: 374 LLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQ 431
L S +V E L FD + E II G+ Y+H+
Sbjct: 86 LFE-ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 432 SKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
+ I+HRD+K NILL+S+ KI DFGL+ FQ++ GT Y+APE L
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVL 195
Query: 489 AHGQLTEKADVYSFGMLL 506
G EK DV+S G++L
Sbjct: 196 -RGTYDEKCDVWSAGVIL 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 24/198 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G F V + V G E A K +L + + E I ++H N+VR
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVR 69
Query: 374 LLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILGTVEGLVYLHEQ 431
L S LV++ + L F+ A+ + I +E + Y H
Sbjct: 70 LHD-SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 432 SKIRIIHRDIKASNILLDSRLRA---KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
I+HR++K N+LL S+ + K+ADFGLA + ++ AGT GY++PE L
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVL 179
Query: 489 AHGQLTEKADVYSFGMLL 506
++ D+++ G++L
Sbjct: 180 KKDPYSKPVDIWACGVIL 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 35/230 (15%)
Query: 293 VKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK----RLFF 347
++ + Y E+ LG G F V K G E A K R
Sbjct: 2 MEPFKQQKVEDFYDIGEE----------LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51
Query: 348 NNRHRA--ANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAK 405
+R EV+I+ V H N++ L + + +L+ E + L FD
Sbjct: 52 ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLA 107
Query: 406 AKTLTWEKRYEIILGT-VEGLVYLHEQSKIRIIHRDIKASNILLDSR----LRAKIADFG 460
K E+ + ++G+ YLH + I H D+K NI+L + K+ DFG
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFG----MLL 506
LA ++ I GT ++APE + + L +AD++S G +LL
Sbjct: 165 LAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 25/203 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRA--ANFYNEVNIISSVEHKNLV 372
+LG G F V K G E A K R +R EV+I+ V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV-EGLVYLHEQ 431
L + + +L+ E + L FD K E+ + + +G+ YLH +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 432 SKIRIIHRDIKASNILLDSR----LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
I H D+K NI+L + K+ DFGLA ++ I GT ++APE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 488 LAHGQLTEKADVYSFG----MLL 506
+ + L +AD++S G +LL
Sbjct: 190 VNYEPLGLEADMWSIGVITYILL 212
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 309 EKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLF----FNNRHRAANFYNEVNII 363
K F GQG FGTV G G +A+K++ F NR E+ I+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR--------ELQIM 70
Query: 364 ---SSVEHKNLVRLLGCSCSGPES-------LLVYEFLPNQSLDRFIFDSAKAK-TLTWE 412
+ + H N+V+L + E +V E++P +L R + + +
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPI 129
Query: 413 K----RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQE 467
+++I + LH S + + HRDIK N+L++ + K+ DFG A+
Sbjct: 130 LIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 468 DKSHISTAIAGTLGYMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGR 513
+ +++ I + Y APE + T D++S G + E++ G
Sbjct: 185 SEPNVAY-IC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 34/207 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL--------FFNNRHRAANFYNEVNIISSVEHKN 370
LG G G V +++A++ + A N E+ I+ + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSL-DRFI----FDSAKAKTLTWEKRYEIILGTVEGL 425
++++ + +V E + L D+ + A K Y++ + +
Sbjct: 202 IIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----YQM----LLAV 252
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
YLHE IIHRD+K N+LL S+ KI DFG ++ + S + T + GT Y
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRT-LCGTPTY 307
Query: 483 MAPEYLAHGQL---TEKADVYSFGMLL 506
+APE L D +S G++L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 57/233 (24%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN----------RHRAANFYNEVNI 362
+++ K+GQG FG V+K G+++A+K++ N R E+ I
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR--------EIKI 69
Query: 363 ISSVEHKNLVRLLG-------CSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKT 408
+ ++H+N+V L+ S+ LV++F L + F ++ K
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR 128
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
+ + GL Y+H +I+HRD+KA+N+L+ K+ADFGLAR+F
Sbjct: 129 VMQM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 469 KSHIS---TAIAGTLGYMAPEYLAHGQLTEKA-----DVYSFGMLLLEIVTGR 513
K+ T TL Y PE L L E+ D++ G ++ E+ T
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 36/216 (16%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRH-------RAANFYNEVNIISS 365
++ + +KLG+G + TVYKG +A+K + + R EV+++
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLKD 56
Query: 366 VEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEII 418
++H N+V L +SL LV+E+L ++ L +++ + K ++
Sbjct: 57 LKHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQ------ 108
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+ GL Y H Q +++HRD+K N+L++ R K+ADFGLAR+ +
Sbjct: 109 --LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV 162
Query: 479 TLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
TL Y P+ L + + D++ G + E+ TGR
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRA--ANFYNEVNIISSVEHKNLV 372
+LG G F V K G+E A K R ++R EVNI+ + H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILGTVEGLVYLHEQ 431
L + + +L+ E + L FD K +LT ++ + + ++G+ YLH +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 432 SKIRIIHRDIKASNILLDSRLRA----KIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
RI H D+K NI+L + K+ DFG+A + I GT ++APE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 488 LAHGQLTEKADVYSFG----MLL 506
+ + L +AD++S G +LL
Sbjct: 183 VNYEPLGLEADMWSIGVITYILL 205
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 306 STLEKATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRAANF 356
+ A+ F + +LG+G F V + V G E A K + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--L 75
Query: 357 YNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKR- 414
E I ++H N+VRL S LV++ + L F+ A+ E
Sbjct: 76 EREARICRKLQHPNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADA 130
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA---KIADFGLARSFQEDKSH 471
I +E + Y H I+HR++K N+LL S+ + K+ADFGLA + ++
Sbjct: 131 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
AGT GY++PE L ++ D+++ G++L
Sbjct: 188 --HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLF----FNNRHRAANFYNE 359
S+ + +G G FG VY+ L G +A+K++ F NR E
Sbjct: 46 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------E 97
Query: 360 VNIISSVEHKNLVRLLGCSCSGPESL------LVYEFLPNQSLDRFIFDSAKAK-TLTWE 412
+ I+ ++H N+VRL S E LV +++P +++ R ++AK TL
Sbjct: 98 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVI 156
Query: 413 K----RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQE 467
Y++ L Y+H I HRDIK N+LLD K+ DFG A+
Sbjct: 157 YVKLYMYQLF----RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 468 DKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
+ ++S I + Y APE + T DV+S G +L E++ G+
Sbjct: 210 GEPNVSY-IC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 41/221 (18%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH-------RAANFYNEVNIISS 365
F + KLG G + TVYKG+ G +A+K + ++ R E++++
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKE 59
Query: 366 VEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI-----------FDSAKAKTLTWEK 413
++H+N+VRL L LV+EF+ L +++ + K W+
Sbjct: 60 LKHENIVRLYDV-IHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473
++GL + HE +I+HRD+K N+L++ R + K+ DFGLAR+F + S
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS 166
Query: 474 TAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
+ + TL Y AP+ L + + D++S G +L E++TG+
Sbjct: 167 SEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 55/195 (28%), Positives = 82/195 (42%), Gaps = 21/195 (10%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC 377
LG+G F K V + AVK + ++ AN E+ + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKIRI 436
+ LV E L L F+ K K E I+ V + ++H+ +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---V 127
Query: 437 IHRDIKASNILL-----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
+HRD+K N+L + + KI DFG AR D + T TL Y APE L
Sbjct: 128 VHRDLKPENLLFTDENDNLEI--KIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLNQN 184
Query: 492 QLTEKADVYSFGMLL 506
E D++S G++L
Sbjct: 185 GYDESCDLWSLGVIL 199
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 53/244 (21%), Positives = 81/244 (33%), Gaps = 53/244 (21%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+GQG +G V + A+K ++ N EV ++ + H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 374 LLGC------------SCSGPE-------------------SLLVYEFLPNQSLDRFIFD 402
L C G + + + I
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 403 SAKAKTLTWEKRY------EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-- 454
S + + I+ L YLH Q I HRDIK N L +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 455 KIADFGLARSFQEDKSHIS---TAIAGTLGYMAPEYLAHGQL--TEKADVYSFGMLLLEI 509
K+ DFGL++ F + + T AGT ++APE L K D +S G+LL +
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 510 VTGR 513
+ G
Sbjct: 270 LMGA 273
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 27/198 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+G+G +G V V A K++ F E+ I+ S++H N++RL +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-T 74
Query: 379 CSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY------EIILGTVEGLVYLHEQ 431
+ LV E L F+ K + + I+ + + Y H+
Sbjct: 75 FEDNTDIYLVMELCTGGEL----FERVVHK-----RVFRESDAARIMKDVLSAVAYCHKL 125
Query: 432 SKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
+ HRD+K N L + K+ DFGLA F+ K GT Y++P+ L
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVL 180
Query: 489 AHGQLTEKADVYSFGMLL 506
G + D +S G+++
Sbjct: 181 -EGLYGPECDEWSAGVMM 197
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 25/203 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRA--ANFYNEVNIISSVEHKNLV 372
+LG G F V K G + A K R ++R + EV+I+ ++H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILGTVEGLVYLHEQ 431
L + + +L+ E + L FD K +LT E+ E + + G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 432 SKIRIIHRDIKASNILLDSRLRA----KIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
I H D+K NI+L R KI DFGLA I GT ++APE
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 188
Query: 488 LAHGQLTEKADVYSFG----MLL 506
+ + L +AD++S G +LL
Sbjct: 189 VNYEPLGLEADMWSIGVITYILL 211
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 310 KATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVK---------RLFFNNRHRAAN 355
+T F E LG+G V + + P +E AVK +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 356 FYNEVNIISSV-EHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAK-TLTWE 412
EV+I+ V H N+++L + LV++ + L FD K TL+ +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK 124
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472
+ +I+ +E + LH+ I+HRD+K NILLD + K+ DFG + +
Sbjct: 125 ETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL- 180
Query: 473 STAIAGTLGYMAPEYLAHGQL------TEKADVYSFGMLL 506
+ GT Y+APE + ++ D++S G+++
Sbjct: 181 -REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN--EVNIISSVEHKN 370
+ KLG+G +G VYK + +A+KR+ + EV+++ ++H+N
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 371 LVRLLGCSCSGPESL-LVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEG 424
++ L L L++E+ L +++ K+ ++ + G
Sbjct: 95 IIELKSV-IHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ--------LING 144
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRA-----KIADFGLARSFQEDKSHISTAIAGT 479
+ + H + R +HRD+K N+LL + KI DFGLAR+F T T
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEIIT 200
Query: 480 LGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
L Y PE L + + D++S + E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 57/245 (23%), Positives = 90/245 (36%), Gaps = 36/245 (14%)
Query: 276 QRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEA----NKLGQGGFGTVYK 331
E S + SL Y + + ++LG+G VY+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71
Query: 332 GV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYE 389
+ A+K E+ ++ + H N+++L P + LV E
Sbjct: 72 CKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHPNIIKLKE-IFETPTEISLVLE 128
Query: 390 FLPNQSLDRFIFDSAKAKTLTWEKRY------EIILGTVEGLVYLHEQSKIRIIHRDIKA 443
+ L FD K Y + + +E + YLHE I+HRD+K
Sbjct: 129 LVTGGEL----FDRIVEK-----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKP 176
Query: 444 SNILL-----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
N+L D+ L KIADFGL++ + + GT GY APE L + D
Sbjct: 177 ENLLYATPAPDAPL--KIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 499 VYSFG 503
++S G
Sbjct: 233 MWSVG 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 34/207 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL--------FFNNRHRAANFYNEVNIISSVEHKN 370
LG G G V +++A+K + A N E+ I+ + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSL-DRFI----FDSAKAKTLTWEKRYEIILGTVEGL 425
++++ + +V E + L D+ + A K Y++ + +
Sbjct: 77 IIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----YQM----LLAV 127
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
YLHE IIHRD+K N+LL S+ KI DFG ++ + S + T + GT Y
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRT-LCGTPTY 182
Query: 483 MAPEYLAHGQL---TEKADVYSFGMLL 506
+APE L D +S G++L
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 48/224 (21%)
Query: 320 KLGQGGFGTVYKGV---LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
K+G+G +G VYK D ++ A+K++ +A E+ ++ ++H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 85
Query: 377 -CSCSGPESL-LVYEFL-------------PNQSLDRFIFDSAKAKTLTWEKRYEIILGT 421
+ L++++ + K+L ++ IL
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-----IL-- 138
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA----KIADFGLARSFQEDK---SHIST 474
+G+ YLH ++HRD+K +NIL+ KIAD G AR F + +
Sbjct: 139 -DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 475 AIAGTLGYMAPEYLAHGQL-----TEKADVYSFGMLLLEIVTGR 513
+ T Y APE L L T+ D+++ G + E++T
Sbjct: 195 VVV-TFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 23/201 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA----NFYNEVNIISSVEH-KNLVR 373
+LG+G F V + + G+E A K F R R +E+ ++ + ++
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 374 LLGCSCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L + E +L+ E+ + + + A+ ++ +I +EG+ YLH+
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN- 150
Query: 433 KIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
I+H D+K NILL S KI DFG++R I GT Y+APE L
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILN 206
Query: 490 HGQLTEKADVYSFG----MLL 506
+ +T D+++ G MLL
Sbjct: 207 YDPITTATDMWNIGIIAYMLL 227
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 33/217 (15%)
Query: 306 STLEKATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEV 360
L + + F + +G G + + + E AVK + + E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEI 66
Query: 361 NII-SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY---- 415
I+ +H N++ L G +V E + L D + K +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQ-----KFFSERE 117
Query: 416 --EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR----LRAKIADFGLARSFQEDK 469
++ + + YLH Q ++HRD+K SNIL +I DFG A+ + +
Sbjct: 118 ASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
+ T T ++APE L D++S G+LL
Sbjct: 175 GLLMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN--EVNIISSVEHKNLVRLL 375
K+G+G +G V+K G+ +A+K+ + E+ ++ ++H NLV LL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
LV+E+ + ++ + + K T++ + + H+
Sbjct: 69 EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSI--TWQTLQAVNFCHKH---N 122
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
IHRD+K NIL+ K+ DFG AR + +A T Y +PE L
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYG 181
Query: 496 KA-DVYSFGMLLLEIVTGR 513
DV++ G + E+++G
Sbjct: 182 PPVDVWAIGCVFAELLSGV 200
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 69/252 (27%), Positives = 109/252 (43%), Gaps = 31/252 (12%)
Query: 277 RSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKAT-GSFDEANKLGQGGFGTVYKGVLP 335
R + A+ L + L +K+ + T +F + LG+GGFG V +
Sbjct: 147 RLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR 206
Query: 336 DGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEF 390
++ A K+L R A NE I+ V + +V L + ++L LV
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTL 265
Query: 391 LPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLHEQSKIRIIHRDI 441
+ + + F A+A Y EI G L LH + RI++RD+
Sbjct: 266 MNGGDLKFHIYHMGQAGFPEARAVF------YAAEICCG----LEDLHRE---RIVYRDL 312
Query: 442 KASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYS 501
K NILLD +I+D GLA E ++ GT+GYMAPE + + + T D ++
Sbjct: 313 KPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 502 FGMLLLEIVTGR 513
G LL E++ G+
Sbjct: 371 LGCLLYEMIAGQ 382
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL--------FFNNRHRAANFYNEVNIISSV-EHK 369
+G+G V + V G E AVK + E +I+ V H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 370 NLVRLLGCSCSGPESL-LVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
+++ L+ S + LV++ + L D + L+ ++ I+ +E + +
Sbjct: 161 HIITLID-SYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSF 215
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
LH I+HRD+K NILLD ++ +++DFG + + + + GT GY+APE
Sbjct: 216 LHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEI 270
Query: 488 LAHGQL------TEKADVYSFGMLL 506
L ++ D+++ G++L
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 64/237 (27%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK--------------------------RLFFNNRHRA 353
+G+G +G V D A+K R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 354 ANFYNEVNIISSVEHKNLVRLLGCSCSGPESL---------LVYEFLPNQSLDRFIFDSA 404
Y E+ I+ ++H N+V+L+ E L +V+E + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-------EVLDDPNEDHLYMVFELVNQGPV----MEVP 129
Query: 405 KAKTLTWEK---RY--EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459
K L+ E Y ++I G +E YLH Q +IIHRDIK SN+L+ KIADF
Sbjct: 130 TLKPLS-EDQARFYFQDLIKG-IE---YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT---EKADVYSFGMLLLEIVTGR 513
G++ F+ + +S GT +MAPE L+ + + DV++ G+ L V G+
Sbjct: 182 GVSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN--EVNIISSVEHKNLVRLL 375
+G+G +G V K GR +A+K+ ++ + E+ ++ + H+NLV LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 376 GCSCSGPESL-LVYEFLPN---QSLDRF--IFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
C + LV+EF+ + L+ F D + ++ + G+ + H
Sbjct: 91 EV-CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ--------IINGIGFCH 141
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL- 488
IIHRDIK NIL+ K+ DFG AR+ + T Y APE L
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPELLV 197
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ + DV++ G L+ E+ G
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 20/248 (8%)
Query: 277 RSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKAT-GSFDEANKLGQGGFGTVYKGVLP 335
R++ + E L L +K+ + F + LG+GGFG V+ +
Sbjct: 148 RAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 336 DGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEF 390
++ A K+L R E I++ V + +V L + L LV
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTI 266
Query: 391 LPNQSLDRFIFDSAKAKTLTWEKR---Y--EIILGTVEGLVYLHEQSKIRIIHRDIKASN 445
+ + I++ + E R Y +I+ G L +LH++ II+RD+K N
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPEN 319
Query: 446 ILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGML 505
+LLD +I+D GLA + ++ AGT G+MAPE L + D ++ G+
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 506 LLEIVTGR 513
L E++ R
Sbjct: 379 LYEMIAAR 386
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 309 EKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK--------RLFFNNRHRAANFYNE 359
+ + + + LG G FG V+ V +E+ VK + + E
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 360 VNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY---E 416
+ I+S VEH N++++L + LV E + LD F F + Y +
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
++ V YL + IIHRDIK NI++ K+ DFG A + K T
Sbjct: 139 LVSA-VG---YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTF- 189
Query: 477 AGTLGYMAPEYLAHGQLTE--KADVYSFGMLLLEIVTGR 513
GT+ Y APE L G + +++S G+ L +V
Sbjct: 190 CGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 33/209 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG V D +++ A+K + R+ N + E+ I+ +EH LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 377 CSCSGPESL-LVYEFLPNQSLDRF------IFDSAKAKTLTWEKRY--EIILGTVEGLVY 427
E + +V + L L R+ F K + E+++ L Y
Sbjct: 83 SFQD-EEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKL------FICELVMA----LDY 130
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
L Q RIIHRD+K NILLD I DF +A + + +AGT YMAPE
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEM 185
Query: 488 LAHGQL---TEKADVYSFGMLLLEIVTGR 513
+ + + D +S G+ E++ GR
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 32/225 (14%)
Query: 299 DSLNFKYSTLEKATGSFDE-----ANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHR 352
L + E + + LG G G V + G++ A+K L +
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YD 64
Query: 353 AANFYNEVNIISSV-EHKNLVRLLG----CSCSGPESLLVYEFLPNQSL-DRFIFDSAKA 406
+ EV+ ++V +L L++ E + L R
Sbjct: 65 SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGD 122
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL-----DSRLRAKIADFGL 461
+ T + EI+ + +LH + I HRD+K N+L D+ L K+ DFG
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL--KLTDFGF 177
Query: 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
A+ ++ + T T Y+APE L + + D++S G+++
Sbjct: 178 AKETTQNA--LQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN---------EVNIISSVEHK- 369
LG GGFG+VY G+ + D +A+K + + R +++ EV ++ V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHV---EKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 370 -NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY---EIILGTVEGL 425
++RLL +L+ E P D F F + + R +++ E +
Sbjct: 108 SGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVL----EAV 162
Query: 426 VYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
+ H ++HRDIK NIL+D R K+ DFG ++ + + GT Y
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDF-DGTRVYSP 216
Query: 485 PEYLA----HGQLTEKADVYSFGMLLLEIVTGR 513
PE++ HG+ A V+S G+LL ++V G
Sbjct: 217 PEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLL--- 375
LG GG G V+ V + +A+K++ + + E+ II ++H N+V++
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 376 -------GCSCSGPESL----LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVE 423
L +V E++ L + + L E R + +
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL----EQGPLLEEHARL-FMYQLLR 131
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHIS--TAIAGTL 480
GL Y+H + ++HRD+K +N+ +++ L KI DFGLAR SH + T
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 481 GYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y +P L+ T+ D+++ G + E++TG+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 28/205 (13%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCS 378
LG+G V + L +E AVK + H + + EV ++ + H+N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKIRII 437
LV+E + S+ + E ++ L +LH + I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133
Query: 438 HRDIKASNILL-----DSRLRAKIADFGLARSFQEDKSHISTA------IAGTLGYMAPE 486
HRD+K NIL S + KI DF L + + + G+ YMAPE
Sbjct: 134 HRDLKPENILCEHPNQVSPV--KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 487 YLAHGQLT-----EKADVYSFGMLL 506
+ ++ D++S G++L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 49/256 (19%), Positives = 104/256 (40%), Gaps = 68/256 (26%)
Query: 308 LEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF----FNNRHRAANFYNEVNI 362
LE ++ + LG G FG V + + G+ A+K++ + NR E++I
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR--------ELDI 53
Query: 363 ISSVEHKNLVRLLGCSCSGPESL------------------------------------- 385
+ ++H N+++L+ + +
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 386 -LVYEFLPNQSLDRFIFDSAKAK-TLTWEK----RYEIILGTVEGLVYLHEQSKIRIIHR 439
++ E++P +L + + ++ ++ Y++ + ++H + I HR
Sbjct: 114 NVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA----VGFIH---SLGICHR 165
Query: 440 DIKASNILLDSRL-RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLTEKA 497
DIK N+L++S+ K+ DFG A+ + ++ I + Y APE L + T
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY-IC-SRFYRAPELMLGATEYTPSI 223
Query: 498 DVYSFGMLLLEIVTGR 513
D++S G + E++ G+
Sbjct: 224 DLWSIGCVFGELILGK 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 30/206 (14%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANF-----YNEVNIISSVEHKNLVRL 374
+G+G F V + GRE+A+K + ++ + + EV I+ + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKII---DKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVEGLVYLH 429
+ L+ E+ + FD A EK +I+ V+ Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSA-VQ---YCH 131
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ RI+HRD+KA N+LLD+ + KIADFG + F + G Y APE
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF-CGAPPYAAPELFQ 186
Query: 490 HGQLTE--KADVYSFGMLLLEIVTGR 513
G+ + + DV+S G++L +V+G
Sbjct: 187 -GKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 7e-22
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNI---ISSVEHKNLVR 373
+G+GGFG VY D ++ A+K L + NE + +S+ + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 374 LLGCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVE 423
+ + P+ L + + + F + Y EIILG
Sbjct: 257 MSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF--------YAAEIILG--- 304
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L ++H + +++RD+K +NILLD +I+D GLA F + K H A GT GYM
Sbjct: 305 -LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYM 357
Query: 484 APEYLAHGQL-TEKADVYSFGMLLLEIVTG----RQNNRSKNSEYTDSLLT 529
APE L G AD +S G +L +++ G RQ+ E LT
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 53/244 (21%), Positives = 93/244 (38%), Gaps = 35/244 (14%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV- 333
Q ++ K + +++ Y + LG G G V +
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFN 83
Query: 334 LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC---SCSGPESL-LVY 388
+ A+K L EV + + ++VR++ +G + L +V
Sbjct: 84 KRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138
Query: 389 EFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447
E L L R + T + EI+ E + YLH + I HRD+K N+L
Sbjct: 139 ECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLL 193
Query: 448 L-----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSF 502
++ L K+ DFG A+ S ++T T Y+APE L + + D++S
Sbjct: 194 YTSKRPNAIL--KLTDFGFAKETTSHNS-LTT-PCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 503 GMLL 506
G+++
Sbjct: 250 GVIM 253
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-22
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG+G +G V + + AVK + + AN E+ ++ + HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 376 G-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLT-WE-KRY--EIILGTVEGLVYLH 429
+ + +V E+ + + DS K + Y ++I G +E YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDG-LE---YLH 126
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE--DKSHISTAIAGTLGYMAPEY 487
Q I+H+DIK N+LL + KI+ G+A + T+ G+ + PE
Sbjct: 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEI 182
Query: 488 LAHGQLTE--KADVYSFGMLLLEIVTGR 513
K D++S G+ L I TG
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNL 371
+ +G G G V R +A+K+L F N+ A Y E+ ++ V HKN+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 372 VRLLGCSCSGPESL------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+ LL +V E + +L + I L E+ ++ + G+
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMELDHERMSYLLYQMLCGI 140
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y AP
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAP 195
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E + E D++S G ++ E++ G
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-21
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNL 371
+ +G G G V R +A+K+L F N+ A Y E+ ++ V HKN+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 372 VRLLGCSCSGP------ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+ LL + LV E + +L + I L E+ ++ + G+
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI-----QMELDHERMSYLLYQMLCGI 177
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y AP
Sbjct: 178 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAP 232
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E + E D++S G ++ E+V +
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 31/214 (14%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLF-----------FNNRHRAANFYNEVNIISSVEH 368
+ G +G V GV +G +A+KR+F ++ E+ +++ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 369 KNLVRLLGCSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILG 420
N++ L LV E + L + I + ++ + +Y +
Sbjct: 89 PNILGLRDIFV--HFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQHIQY-FMYH 142
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL LHE ++HRD+ NILL I DF LAR D T
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHR 197
Query: 481 GYMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGR 513
Y APE + T+ D++S G ++ E+ +
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRL------FFNNRHRAANFYNEVNIISSV----EHK 369
LG+GGFGTV+ G L D ++A+K + ++ + EV ++ V H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 370 NLVRLLGCSCSGPESLLVYEF-LPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVE 423
++RLL + +LV E LP Q L FD K E + +++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDL----FDYITEKGPLGEGPSRCFFGQVV----A 150
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
+ + H + ++HRDIK NIL+D R AK+ DFG ++ GT Y
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVY 204
Query: 483 MAPEYLAHGQLT-EKADVYSFGMLLLEIVTGR 513
PE+++ Q A V+S G+LL ++V G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+G G +G+V + G ++A+K+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 376 G--CSCSGPESL----LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
S + LV F+ L + + K + +Y ++ ++GL Y+H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----GLKFSEEKIQY-LVYQMLKGLKYIH 143
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YL 488
++HRD+K N+ ++ KI DFGLAR + T T Y APE L
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVIL 196
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ + D++S G ++ E++TG+
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 41/220 (18%)
Query: 314 SFDEANKLGQGGFGTVY----KGVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSV 366
F LG+G F TV RE A+K L ++ E +++S +
Sbjct: 31 DFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 367 EHKNLVRLLGCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAK---AKTLTWEKRY 415
+H V+L + E L + N + + F + A
Sbjct: 88 DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA--------- 137
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EI+ L YLH + IIHRD+K NILL+ + +I DFG A+ +
Sbjct: 138 EIVSA----LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 476 -IAGTLGYMAPEYLAHGQLTEKA-DVYSFGMLLLEIVTGR 513
GT Y++PE L + K+ D+++ G ++ ++V G
Sbjct: 191 SFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN----EVNIISSVEHKNLVRLL 375
LG+G +G V V +AVK + + RA + E+ I + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFD--SAKAKTLTWEKRY---EIILGTVEGLVYLHE 430
G G L E+ L FD + + +++ G V YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAG-VV---YLHG 123
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS--HISTAIAGTLGYMAPEYL 488
I HRDIK N+LLD R KI+DFGLA F+ + ++ GTL Y+APE L
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL 179
Query: 489 A----HGQLTEKADVYSFGMLLLEIVTGR 513
H E DV+S G++L ++ G
Sbjct: 180 KRREFHA---EPVDVWSCGIVLTAMLAGE 205
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G V V G ++A+K+L+ F + A Y E+ ++ + H+N++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 378 SCSGPESL------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LV F+ L + + K + L ++ ++ ++GL Y+H
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY-LAH 490
IIHRD+K N+ ++ KI DFGLAR + T T Y APE L
Sbjct: 148 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVILNW 200
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
+ T+ D++S G ++ E++TG+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN----EVNIISSVEHKNLVRLL 375
LG+G +G V V +AVK + + RA + E+ I + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFD--SAKAKTLTWEKRY---EIILGTVEGLVYLHE 430
G G L E+ L FD + + +++ G V YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAG-VV---YLHG 123
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS--HISTAIAGTLGYMAPEYL 488
I HRDIK N+LLD R KI+DFGLA F+ + ++ GTL Y+APE L
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL 179
Query: 489 A----HGQLTEKADVYSFGMLLLEIVTGR 513
H + DV+S G++L ++ G
Sbjct: 180 KRREFHAE---PVDVWSCGIVLTAMLAGE 205
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 46/204 (22%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLG 376
KLG+G + V++ + + + ++ VK L + E+ I+ ++ N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 377 CSCSGPES---LLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVYLHEQS 432
P S LV+E + N + +TLT ++ R+ + ++ L Y H S
Sbjct: 99 IVKD-PVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRF-YMYEILKALDYCH--S 148
Query: 433 KIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRD+K N+++D R ++ D+GLA + + + + + PE L
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDY 205
Query: 492 QLTEKA-DVYSFGMLLLEIVTGRQ 514
Q+ + + D++S G +L ++ ++
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLV 372
+ + +G+G +G V + +A+K++ F ++ E+ I+ H+N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 373 RLLGCSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVEG 424
+ ++ +V + + L + + K + L+ + Y + + G
Sbjct: 89 GIN--DIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICY-FLYQILRG 140
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TAIAGTLGY 482
L Y+H + ++HRD+K SN+LL++ KI DFGLAR D H T T Y
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 483 MAPEY-LAHGQLTEKADVYSFGMLLLEIVTGR 513
APE L T+ D++S G +L E+++ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G+V G +AVK+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 378 SCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
SL LV + L+ + K + LT + +I + GL Y+H
Sbjct: 97 FTP-ARSLEEFNDVYLVTHLMGA-DLNNIV----KCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLA 489
IIHRD+K SN+ ++ KI DFGLAR ++ T T Y APE L
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRWYRAPEIMLN 203
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
+ D++S G ++ E++TGR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
LG+G +G V P G +A+K++ F+ A E+ I+ +H+N++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 378 SCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVEGLVYLH 429
P+S ++ E + L R I + L+ + +Y I T+ + LH
Sbjct: 78 QR--PDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY-FIYQTLRAVKVLH 129
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG-------- 481
+ +IHRD+K SN+L++S K+ DFGLAR E + S G
Sbjct: 130 GSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 482 -YMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGR 513
Y APE L + + DV+S G +L E+ R
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK---RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG G FG V G G ++AVK R + E+ + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVEGLVYLHEQ 431
+ + +V E++ L FD E R +I+ V+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSA-VD---YCHRH 130
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
++HRD+K N+LLD+ + AKIADFGL+ + D + T+ G+ Y APE ++ G
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTS-CGSPNYAAPEVIS-G 184
Query: 492 QLTE--KADVYSFGMLLLEIVTGR 513
+L + D++S G++L ++ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGT 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 20/200 (10%), Positives = 48/200 (24%), Gaps = 44/200 (22%)
Query: 320 KLGQGGFGTVYKGVLPD---GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
G ++ + D R++A+ + + +S ++ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+L + L+V E++ SL + + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+ S + + +A M
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA------- 179
Query: 494 TEKADVYSFGMLLLEIVTGR 513
+ D+ G L ++ R
Sbjct: 180 NPQDDIRGIGASLYALLVNR 199
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 30/207 (14%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+G FG V A+K L + A+ E ++ + H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 377 CSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLV 426
S + L V E+ F D A+ Y EI+ L
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF--------YGAEIVSA----LD 262
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH S+ +++RD+K N++LD KI DFGL + +D + + T GT Y+APE
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 319
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
L D + G+++ E++ GR
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 31/207 (14%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+G FG V A+K L + A+ E ++ + H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 377 CSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLV 426
+ + L V E+ F + A+ Y EI+ L
Sbjct: 73 AFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARF--------YGAEIVSA----LE 119
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + +++RDIK N++LD KI DFGL + D + + T GT Y+APE
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE 175
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
L D + G+++ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F+ +G+G FG V L + ++ A+K L R A F E +++ + + K
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 371 LVRLLGCSCSGPESL-LVYEFLP--------NQSLDRFIFDSAKAKTLTWEKRY--EIIL 419
+ L + +L LV ++ ++ DR + A+ Y E+++
Sbjct: 136 ITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF--------YLAEMVI 186
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
+ +H+ +HRDIK NIL+D ++ADFG ED + S+ GT
Sbjct: 187 A----IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 480 LGYMAPEYLAHGQLTEK-----ADVYSFGMLLLEIVTGR 513
Y++PE L + + D +S G+ + E++ G
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 8e-19
Identities = 40/244 (16%), Positives = 91/244 (37%), Gaps = 33/244 (13%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANK------LGQGGFGT 328
Q+ + + +++ + + +++ + + ++ +G G +G
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68
Query: 329 VYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385
V + + R +A+K++ F + E+ I++ + H ++V++L P+ +
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI--PKDV 126
Query: 386 -------LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVEGLVYLHEQSKIRII 437
+V E + LT + ++ + G+ Y+H I+
Sbjct: 127 EKFDELYVVLEIAD-SDFKKLF---RTPVYLTELHIKT-LLYNLLVGVKYVHSA---GIL 178
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH------G 491
HRD+K +N L++ K+ DFGLAR+ ++ S
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
Query: 492 QLTE 495
QLT
Sbjct: 239 QLTG 242
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 26/204 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK---RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+G FG V +++A+K R E++ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVEGLVYLHEQ 431
+ + ++V E+ + +FD K E R+ +II +E Y H
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICA-IE---YCHRH 127
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
+I+HRD+K N+LLD L KIADFGL+ + D + + T+ G+ Y APE + G
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTS-CGSPNYAAPEVIN-G 181
Query: 492 QLTE--KADVYSFGMLLLEIVTGR 513
+L + DV+S G++L ++ GR
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 47/221 (21%), Positives = 86/221 (38%), Gaps = 38/221 (17%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F+ +G+G F V + ++ A+K + R + F E +++ + + +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 371 LVRLLGCSCSGPESL-LVYEFLP--------NQSLDRFIFDSAKAKTLTWEKRY--EIIL 419
+ +L + L LV E+ ++ +R + A+ Y EI++
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF--------YLAEIVM 173
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
+ +H +HRDIK NILLD ++ADFG + D + S GT
Sbjct: 174 A----IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 480 LGYMAPEYLAHGQLTEKADVY-------SFGMLLLEIVTGR 513
Y++PE L Y + G+ E+ G+
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK---RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG G FG V G G ++AVK R + E+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVEGLVYLHEQ 431
+ + +V E++ L FD EK R +I+ G V+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSG-VD---YCHRH 135
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
++HRD+K N+LLD+ + AKIADFGL+ + D + T+ G+ Y APE ++ G
Sbjct: 136 ---MVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTS-CGSPNYAAPEVIS-G 189
Query: 492 QLTE--KADVYSFGMLLLEIVTGR 513
+L + D++S G++L ++ G
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGT 213
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 41/225 (18%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISS-VEHKNLVRL 374
KLG+G +G V+K + G +AVK++F F N A + E+ I++ H+N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 375 LGCSCSGPESL----LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVEGLVYLH 429
L + ++ LV++++ L I +A L K+Y ++ ++ + YLH
Sbjct: 75 L--NVLRADNDRDVYLVFDYME-TDLHAVI----RANILEPVHKQY-VVYQLIKVIKYLH 126
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++HRD+K SNILL++ K+ADFGL+RSF + +
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 490 HGQLTE--------------------KA-DVYSFGMLLLEIVTGR 513
LT+ K D++S G +L EI+ G+
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 29/215 (13%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
++ +G+G FG V R++ A+K L R +A F+ E +I++
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 370 NLVRLLGCSCSGPESL-LVYEFLPN----QSLDRFIFDSAKAKTLTWEKRY--EIILGTV 422
+V+L + L +V E++P + + A+ Y E++L
Sbjct: 130 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF------YTAEVVLA-- 180
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
L +H IHRD+K N+LLD K+ADFG ++ GT Y
Sbjct: 181 --LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 483 MAPEYL----AHGQLTEKADVYSFGMLLLEIVTGR 513
++PE L G + D +S G+ L E++ G
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 33/207 (15%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHR--AANFYNEVNIISSVEHKNLVRLLGC 377
+G G FG +AVK + R N E+ S+ H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI---ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFD--SAKAKTLTWEKRY---EIILGTVEGLVYLHEQS 432
+ ++ E+ L ++ + E R+ +++ G V Y H
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSG-VS---YCHSM- 135
Query: 433 KIRIIHRDIKASNILLDS--RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA- 489
+I HRD+K N LLD R KI DFG ++S S + + GT Y+APE L
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLR 191
Query: 490 ---HGQLTEKADVYSFGMLLLEIVTGR 513
G+ ADV+S G+ L ++ G
Sbjct: 192 QEYDGK---IADVWSCGVTLYVMLVGA 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 51/247 (20%), Positives = 90/247 (36%), Gaps = 67/247 (27%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G +G VY + +A+K++ F + E+ I++ ++ ++RL
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 377 CSCSGPESL-------LVYEFLP---------NQSLD----RFIFDSAKAKTLTWEKRYE 416
P+ L +V E L + I Y
Sbjct: 93 LII--PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL-------------YN 137
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
++L G ++HE IIHRD+K +N LL+ K+ DFGLAR+ +K
Sbjct: 138 LLL----GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 477 AGTLG---------------------YMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGRQ 514
Y APE L T+ D++S G + E++ Q
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 515 NNRSKNS 521
++ + +
Sbjct: 251 SHINDPT 257
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 321 LGQGGFGTVY---KGVLPDGREI-AVKRL----FFNNRHRAANFYNEVNIISSVEHKNLV 372
LG+GG+G V+ K + +I A+K L N A+ E NI+ V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 373 RLLGCSCSGPESL-LVYEFLPNQSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEG 424
L+ + L L+ E+L L IF A Y EI +
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF------YLAEISMA---- 133
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L +LH++ II+RD+K NI+L+ + K+ DFGL + D + T GT+ YMA
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMA 189
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE L D +S G L+ +++TG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 10/174 (5%)
Query: 343 KRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD 402
+ F + + A F + + ++ RL S + +S F+ +SL +
Sbjct: 122 RNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL--DSITSSQSSASSGFVEEKSLSDVEEE 179
Query: 403 SA----KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458
A LT E +G+ +L + + IHRD+ A NILL + KI D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 459 FGLARSFQEDKSHISTAIAGT-LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
FGLAR +D ++ A L +MAPE + T ++DV+SFG+LL EI +
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 42/200 (21%), Positives = 73/200 (36%), Gaps = 27/200 (13%)
Query: 319 NKLGQGGFGTVYKGVL------PDGREIAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG+G FG V + R +AVK L + A +E+ I+ + H
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHL 86
Query: 370 NLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
N+V LLG C+ G +++ EF +L ++ KR E + +G +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
+ + I D+K + S + + F E+KS + ++L
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFV------EEKSLSDVEEEEAPEDLYKDFL 190
Query: 489 AHGQLTEKADVYSFGMLLLE 508
L + + GM L
Sbjct: 191 TLEHLICYSFQVAKGMEFLA 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 6e-18
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
LG+G FG V E+ AVK L E +++ + L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C + + L V E++ Q + RF A Y EI +G L
Sbjct: 409 SCFQT-MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIG----L 455
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+L + II+RD+K N++LDS KIADFG+ + D T GT Y+AP
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAP 511
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E +A+ + D ++FG+LL E++ G+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 64/249 (25%), Positives = 105/249 (42%), Gaps = 34/249 (13%)
Query: 285 GSNDAEKLVKTLNDDSLNFKYSTLEKATGS-FDEANKLGQGGFGTVY---KGVLPDGREI 340
G + E+L+ ++ EK F+ LG G +G V+ K D ++
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 341 -AVKRL----FFNNRHRAANFYNEVNIISSVEHKN-LVRLLGCSCSGPESL-LVYEFLPN 393
A+K L + E ++ + LV L + L L+ +++
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYING 143
Query: 394 QSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLHEQSKIRIIHRDIKASNI 446
L R F + + Y EI+L L +LH+ II+RDIK NI
Sbjct: 144 GELFTHLSQRERFTEHEVQI------YVGEIVLA----LEHLHKLG---IIYRDIKLENI 190
Query: 447 LLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL--TEKADVYSFGM 504
LLDS + DFGL++ F D++ + GT+ YMAP+ + G + D +S G+
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 505 LLLEIVTGR 513
L+ E++TG
Sbjct: 251 LMYELLTGA 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/247 (23%), Positives = 97/247 (39%), Gaps = 33/247 (13%)
Query: 282 KRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGS---FDEANKLGQGGFGTVYKGVLPDGR 338
K+ ++ K + K+ T + T FD LG G FG V +
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 339 EI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPN 393
A+K L + + NE I+ +V LV+L S +L +V E++
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAG 125
Query: 394 QSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLHEQSKIRIIHRDIKASNI 446
+ F A+ Y +I+L YLH +I+RD+K N+
Sbjct: 126 GEMFSHLRRIGRFSEPHARF------YAAQIVLT----FEYLHSLD---LIYRDLKPENL 172
Query: 447 LLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
L+D + ++ DFG A+ K T + GT +APE + + D ++ G+L+
Sbjct: 173 LIDQQGYIQVTDFGFAK---RVKGRTWT-LCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 507 LEIVTGR 513
E+ G
Sbjct: 229 YEMAAGY 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 321 LGQGGFGTVY---KGVLPDGREI-AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRL 374
LGQG FG V+ K D R++ A+K L E +I+ V H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 375 LGCSCSGPESL-LVYEFLPNQSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEGLV 426
+ L L+ +FL L +F K Y E+ L L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF------YLAELALA----LD 140
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
+LH II+RD+K NILLD K+ DFGL++ + + + GT+ YMAPE
Sbjct: 141 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 196
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ T+ AD +SFG+L+ E++TG
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIIS-SVEHKNLVRLL 375
LG+G FG V+ + A+K L E ++S + EH L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
+ E+L V E+L QS +F A Y EIILG L
Sbjct: 85 CTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--------YAAEIILG----L 131
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+LH + I++RD+K NILLD KIADFG+ + + +T GT Y+AP
Sbjct: 132 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAP 187
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L + D +SFG+LL E++ G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 44/212 (20%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG G FG V+ A+K L + + +E ++S V H ++R+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 377 CSCSGPESL-LVYEFLPN-------QSLDRFIFDSAK---AKTLTWEKRYEIILGTVEGL 425
+ + + ++ +++ + RF AK A E+ L L
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---------EVCLA----L 119
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLH + II+RD+K NILLD KI DFG A+ T + GT Y+AP
Sbjct: 120 EYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT-LCGTPDYIAP 172
Query: 486 EYLA---HGQLTEKA-DVYSFGMLLLEIVTGR 513
E ++ + K+ D +SFG+L+ E++ G
Sbjct: 173 EVVSTKPYN----KSIDWWSFGILIYEMLAGY 200
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
LG+G FG V E+ AVK L E +++ + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C + + L V E++ Q + RF A Y EI +G L
Sbjct: 88 SCFQT-MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIG----L 134
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+L + II+RD+K N++LDS KIADFG+ + D T GT Y+AP
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAP 190
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E +A+ + D ++FG+LL E++ G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
LG+G FG V + + ++ AVK L E I+S H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C P+ L V EF+ Q RF A+ Y EII L
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--------YAAEIISA----L 137
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
++LH++ II+RD+K N+LLD K+ADFG+ + + +T GT Y+AP
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAP 193
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L D ++ G+LL E++ G
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
+G+G + V L I A++ + N+ E ++ H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C + L V E++ Q + + A+ Y EI L L
Sbjct: 120 SCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--------YSAEISLA----L 166
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLHE+ II+RD+K N+LLDS K+ D+G+ + ST GT Y+AP
Sbjct: 167 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAP 222
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L D ++ G+L+ E++ GR
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
+G+G + V L I A+K + N+ E ++ H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C + L V E++ Q + + A+ Y EI L L
Sbjct: 77 SCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--------YSAEISL----AL 123
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLHE+ II+RD+K N+LLDS K+ D+G+ + ST GT Y+AP
Sbjct: 124 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAP 179
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L D ++ G+L+ E++ GR
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 59/209 (28%), Positives = 86/209 (41%), Gaps = 34/209 (16%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNI-ISSVEHKNLVRLL 375
+G+G FG V AVK L + + +E N+ + +V+H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAK---AKTLTWEKRYEIILGTVEG 424
S + L V +++ Q F+ A+ A EI
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA---------EIASA---- 151
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L YLH + I++RD+K NILLDS+ + DFGL + E S ST GT Y+A
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLA 207
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE L D + G +L E++ G
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNR--HRAANFYNEVNIISSV---------- 366
KLG G F TV+ + + +A+K + ++ AA E+ ++ V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAED--EIKLLQRVNDADNTKEDS 82
Query: 367 -EHKNLVRLLGC-SCSGPESL---LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGT 421
++++LL + GP + +V+E L ++L I + + + +I
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQL 140
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA------KIADFGLARSFQEDKSHISTA 475
+ GL Y+H + IIH DIK N+L++ KIAD G A + ++ H + +
Sbjct: 141 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDE--HYTNS 195
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
I T Y +PE L AD++S L+ E++TG
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 59/256 (23%), Positives = 93/256 (36%), Gaps = 71/256 (27%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNI---ISSVE-----HKN 370
KLG G F TV+ + + +A+K + + H +E+ + + + + +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 371 LVRLLGC-SCSGPESL---LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
+V+LL SG +V+E L L ++I S + L +II ++GL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLD 160
Query: 427 YLHEQSKIRIIHRDIKASNILL-------------------------------------- 448
YLH +K RIIH DIK NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 449 -----------DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKA 497
+L+ KIAD G A + + T Y + E L A
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPA 274
Query: 498 DVYSFGMLLLEIVTGR 513
D++S + E+ TG
Sbjct: 275 DIWSTACMAFELATGD 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.5 bits (174), Expect = 9e-14
Identities = 40/248 (16%), Positives = 69/248 (27%), Gaps = 59/248 (23%)
Query: 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--------RHRAANFYNEVNI 362
T K+G+G FG V++ + D +A+K + + E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 363 ISSVE---------HKNLVRLLGCSC---SGPESLL----------------VYEFLPNQ 394
+ + + L C S P LL F +Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 395 SLDRFIFDSA-------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447
F+ + K + I+ L +R HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 448 LDSRLRAKIADFGLARSFQEDKSHISTAIA----------GTLGYM---APEYLAHGQLT 494
L K+ +S + +I G + + E L G
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254
Query: 495 EKADVYSF 502
+ D+Y
Sbjct: 255 YQFDIYRL 262
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 39/156 (25%), Positives = 61/156 (39%), Gaps = 26/156 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC 377
LG G G V + + A+K L EV + + ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 378 ---SCSGPESL-LVYEFLPNQSL-DRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQ 431
+G + L +V E L L R + E+ EI+ E + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 432 SKIRIIHRDIKASNILL-----DSRLRAKIADFGLA 462
+ I HRD+K N+L ++ L K+ DFG A
Sbjct: 137 N---IAHRDVKPENLLYTSKRPNAIL--KLTDFGFA 167
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 53/240 (22%), Positives = 97/240 (40%), Gaps = 59/240 (24%)
Query: 298 DDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK-----RLFFN--- 348
D + ++Y L+ +G+G FG V K + +A+K + F
Sbjct: 92 HDHVAYRYEVLKV----------IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA 141
Query: 349 ---------NRHRAANFYNEVNIISSVEHKN---LV-RLLGCSCSGPESLLVYEFLPNQS 395
+ N N ++++ + +N + LL + +YE +
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMN--------LYELIKKNK 193
Query: 396 LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA- 454
F +L +++ + ++ L LH K RIIH D+K NILL + R+
Sbjct: 194 FQGF--------SLPLVRKFAHSI--LQCLDALH---KNRIIHCDLKPENILLKQQGRSG 240
Query: 455 -KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
K+ DFG + ++ + T I + Y APE + + D++S G +L E++TG
Sbjct: 241 IKVIDFGSS-CYEHQ--RVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 35/196 (17%), Positives = 70/196 (35%), Gaps = 39/196 (19%)
Query: 319 NKLGQGGFGTVYKGV---------LPDGREIAVK------RLF----FNNRHRAANFYNE 359
+ + G +Y+ P ++ ++K RLF F R N+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 360 VNIISSVEHKNLVRLLGCSCSGPE-SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEI- 417
+ S + +G + LV L +SL D + L+ ++
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 418 --ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI--ADFGLARSFQEDKSHI- 472
+L +E +LHE +H ++ A NI +D ++++ A +G A + H+
Sbjct: 166 CRLLDALE---FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
Query: 473 -----STAIAGTLGYM 483
+ G L ++
Sbjct: 220 YVEGSRSPHEGDLEFI 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 42/247 (17%), Positives = 78/247 (31%), Gaps = 62/247 (25%)
Query: 275 KQRSIERKRRGSNDAEKL-VKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV 333
++ + + AE+ V + D + + +GQGGFG +Y
Sbjct: 6 AAQAGRQSSAKRHLAEQFAVGEIITDMAAAAW-KVGL---------PIGQGGFGCIYLAD 55
Query: 334 LPDGREIAVKRLFFNNRHRA--------ANFYNEVNIISSVEHKNLVRLLGCS------C 379
+ + + FY ++ R L
Sbjct: 56 MNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115
Query: 380 SGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV--------EG 424
SG ++ + L + I+++ K + TV +
Sbjct: 116 SGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANA-KRFS--------RKTVLQLSLRILDI 164
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKI--ADFGLARSFQEDKSHI------STAI 476
L Y+HE +H DIKASN+LL+ + ++ D+GLA + + H
Sbjct: 165 LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 477 AGTLGYM 483
GT+ +
Sbjct: 222 DGTIEFT 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 56/253 (22%), Positives = 94/253 (37%), Gaps = 57/253 (22%)
Query: 285 GSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK 343
G +D N + +Y +G+G FG V K + +A+K
Sbjct: 36 GYDDDNYDYIVKNGEKWMDRYEIDSL----------IGKGSFGQVVKAYDRVEQEWVAIK 85
Query: 344 -----RLFFN------------NRHRAANFYNEVNIISSVEHKN---LV-RLLGCSCSGP 382
+ F N N+H Y V++ +N LV +L +
Sbjct: 86 IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN---- 141
Query: 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK 442
+Y+ L N + +L +++ + L++L ++ IIH D+K
Sbjct: 142 ----LYDLLRNTNFRGV--------SLNLTRKFAQQM--CTALLFLA-TPELSIIHCDLK 186
Query: 443 ASNILLDSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVY 500
NILL + R+ KI DFG + I I + Y +PE L D++
Sbjct: 187 PENILLCNPKRSAIKIVDFGSS-CQLGQ--RIYQYIQ-SRFYRSPEVLLGMPYDLAIDMW 242
Query: 501 SFGMLLLEIVTGR 513
S G +L+E+ TG
Sbjct: 243 SLGCILVEMHTGE 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 43/197 (21%), Positives = 68/197 (34%), Gaps = 46/197 (23%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNR-----HRAANFYNEVN---IISSVEHKN 370
K+G GGFG +Y + A + + FY V I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 371 LVRLLG---CSCSGPESL-------LVYEFLPNQSLDRFIFDSAKA---KT---LTWEKR 414
+ LG SG +V E L L + I T L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKKSTVLQLGIR-- 159
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI--ADFGLARSFQEDKSHI 472
+L +E Y+HE +H DIKA+N+LL + ++ AD+GL+ + + +H
Sbjct: 160 ---MLDVLE---YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 473 ------STAIAGTLGYM 483
GT+ +
Sbjct: 211 QYQENPRKGHNGTIEFT 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 44/225 (19%), Positives = 91/225 (40%), Gaps = 36/225 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGC 377
++G+G FG +++G L + +++A+K + +E + + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAK--AKT---LTWEKRYEIILGTVEGLVYLHEQ 431
G ++LV + L SL D K KT + +L V+ +HE+
Sbjct: 75 GQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQ-----MLARVQ---SIHEK 125
Query: 432 SKIRIIHRDIKASNILLDSRLRAK-----IADFGLARSF--QEDKSHI----STAIAGTL 480
S +++RDIK N L+ + DFG+ + + K HI ++GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKNSE 522
YM+ + + + D+ + G + + + G Q ++ ++
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGC 377
K+G G FG +Y G + G E+A+K +H + E I ++ + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWC 73
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAK--AKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G +++V E L SL D F F S K KT+ + + + Y+H ++
Sbjct: 74 GAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLL-----LADQMISRIEYIHSKN-- 125
Query: 435 RIIHRDIKASNILLDSRLRAK---IADFGLARSF--QEDKSHI----STAIAGTLGYMAP 485
IHRD+K N L+ + I DFGLA+ + HI + + GT Y +
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKNSE 522
+ + + D+ S G +L+ G Q ++
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGC 377
K+G G FG +Y G + E+A+K +H E I ++ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKIYRILQGGTGIPNVRWF 71
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
G ++LV + L SL D F F S K T + ++ VE ++H +S
Sbjct: 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE---FVHSKS---F 124
Query: 437 IHRDIKASNILLDSRLRAK---IADFGLARSF--QEDKSHI----STAIAGTLGYMAPEY 487
+HRDIK N L+ RA I DFGLA+ + HI + + GT Y +
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNT 184
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKNSE 522
+ + + D+ S G +L+ + G Q ++ +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 46/220 (20%), Positives = 87/220 (39%), Gaps = 26/220 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH-KNLVRLLGC 377
K+G G FG + G L +A+K +R + E + + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP--QLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
G + +V E L SL D F +T + + I + + + Y+H ++ +
Sbjct: 74 GPCGKYNAMVLELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSKN---L 126
Query: 437 IHRDIKASNILLDSRLRAK-----IADFGLARSF--QEDKSHI----STAIAGTLGYMAP 485
I+RD+K N L+ I DF LA+ + E K HI ++ GT YM+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKNSE 522
+ + + D+ + G + + + G Q ++ +
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 68/294 (23%), Positives = 100/294 (34%), Gaps = 99/294 (33%)
Query: 275 KQRSIERKRRGSN--DAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKG 332
S R+ D LN + + K +G G FG V
Sbjct: 5 HHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRK----------MGDGTFGRVLLC 54
Query: 333 V-LPDGREIAVK--RLFFNNR--HRAANFYNEVNIISSV-----EHKNLVRLLGC----- 377
+ + + AVK R N + R+A E +I+ + + N+V+ G
Sbjct: 55 QHIDNKKYYAVKVVR---NIKKYTRSA--KIEADILKKIQNDDINNNNIVKYHGKFMYYD 109
Query: 378 -SCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
C L++E L SL I F K E IL + L YL
Sbjct: 110 HMC------LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE-----IL---KALNYLR 154
Query: 430 EQSKIRIIHRDIKASNILLDS-------------------------RLRAKIADFGLARS 464
K+ + H D+K NILLD K+ DFG A +
Sbjct: 155 ---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-T 210
Query: 465 FQEDKSHISTAIAGTLGYMAPE------YLAHGQLTEKADVYSFGMLLLEIVTG 512
F+ D + + I T Y APE + +D++SFG +L E+ TG
Sbjct: 211 FKSD--YHGSIIN-TRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 51/258 (19%), Positives = 85/258 (32%), Gaps = 79/258 (30%)
Query: 298 DDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV--LPDGREIAVK-----RLFFN-- 348
D L +Y + LG+G FG V + + ++A+K +
Sbjct: 14 GDWLQERYEIVGN----------LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA 63
Query: 349 ----------NRHRAANFYNEVNIISSVEHKN---LV-RLLGCSCSGPESLLVYEFLPNQ 394
N + V + + LLG + +EFL
Sbjct: 64 RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKN--------TFEFLKEN 115
Query: 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454
+ + + Y++ L +LH + ++ H D+K NIL +
Sbjct: 116 NFQPYPLPHVRHMA------YQLC----HALRFLH---ENQLTHTDLKPENILFVNSEFE 162
Query: 455 -------------------KIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLT 494
++ADFG A +F + H +T +A T Y PE L G
Sbjct: 163 TLYNEHKSCEEKSVKNTSIRVADFGSA-TFDHE--HHTTIVA-TRHYRPPEVILELG-WA 217
Query: 495 EKADVYSFGMLLLEIVTG 512
+ DV+S G +L E G
Sbjct: 218 QPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 57/263 (21%), Positives = 94/263 (35%), Gaps = 89/263 (33%)
Query: 298 DDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV--LPDGREIAVK-----RLFFN-- 348
D L+ +Y ++ LG+G FG V + + GR +AVK +
Sbjct: 9 GDVLSARYEIVDT----------LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA 58
Query: 349 ----------NRHRAANFYNEVNIISSVEHKN---LV-RLLGCSCSGPESLLVYEFLPNQ 394
N + + V ++ EH +V LLG S Y+F+
Sbjct: 59 RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLS--------TYDFIKEN 110
Query: 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---- 450
F D + Y+I + + +LH ++ H D+K NIL
Sbjct: 111 GFLPFRLDHIRKMA------YQIC----KSVNFLH---SNKLTHTDLKPENILFVQSDYT 157
Query: 451 ---------------RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE------YLA 489
K+ DFG A ++ ++ H ST ++ T Y APE +
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSA-TYDDE--HHSTLVS-TRHYRAPEVILALGW-- 211
Query: 490 HGQLTEKADVYSFGMLLLEIVTG 512
++ DV+S G +L+E G
Sbjct: 212 ----SQPCDVWSIGCILIEYYLG 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 1e-06
Identities = 85/606 (14%), Positives = 165/606 (27%), Gaps = 198/606 (32%)
Query: 1 MKKAFLFLVGSLLMLVRVAGDPRVHTVN-ITCGHQLEHNSSIFVPNFVTTMENISEQMRT 59
++ + FL+ + R P + T I +L +++ +F V+ ++ ++R
Sbjct: 87 LRINYKFLMSPIKTEQR---QPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY-LKLRQ 142
Query: 60 SGFGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIY-LDGCFM 118
+ L + I G+ G + V + QC I+ L+
Sbjct: 143 ALLELRP-AKNVLI-DGVLGS-GKTWVALDVC-----LSYKVQCKMDFK--IFWLN---- 188
Query: 119 RSENYSFFGEYEGPED----------RAVCGNGTRKNSSFQ-----ESARKAVMRAVASA 163
PE + +R + S S + + R + S
Sbjct: 189 -------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 164 PSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALN 223
P Y VL+N +A A N
Sbjct: 242 P----YEN-----------CLLVLLNVQ---------------NAKAW--------NAFN 263
Query: 224 TGCFM----RY-SDKDFLN---------KEPGKG----RSRGMIAAIVVSVVSALVVLAV 265
C + R+ DFL+ + ++ + L +
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL 323
Query: 266 GI------VIGTRV---------WKQRSIERKRR---------GSNDAEKLVKTLN--DD 299
+I + WK + ++ + K+ L+
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP 383
Query: 300 SLNFKYSTLE------KATGSFDEANKLGQGGFGTVYKGVL---PDGREIAVKRLFFNNR 350
S + L + NKL ++ P I++ ++ +
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKL-------HKYSLVEKQPKESTISIPSIYLELK 436
Query: 351 HRAANFYNEVNIISSVEHKNLV---RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAK 407
+ N Y H+++V + S + +P LD++ +
Sbjct: 437 VKLENEYA--------LHRSIVDHYNIPKTFDS-------DDLIPPY-LDQYFYS----- 475
Query: 408 TLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQ 466
+ + + H I R + LD R L KI A +
Sbjct: 476 -------H---------IGH-H-LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWN-- 515
Query: 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT--GRQNNRSKNSEYT 524
S +I TL + Y + + + Y L+ I+ + S+YT
Sbjct: 516 -----ASGSILNTLQQLK-FYKPY--ICDNDPKYE--RLVNAILDFLPKIEENLICSKYT 565
Query: 525 DSLLTI 530
D LL I
Sbjct: 566 D-LLRI 570
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 25/158 (15%), Positives = 52/158 (32%), Gaps = 28/158 (17%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVK------RLFFNNR----HRAANFYNEVNIISSVEH 368
+G+G V+ E VK F + + +F + E
Sbjct: 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 155
Query: 369 KNLVRLLGCSCSGPESL----LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
+ L +L G + + ++ E + + L + + ++ ++IL V
Sbjct: 156 RALQKLQGLAVPKVYAWEGNAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAK 208
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462
+ I+H D+ N+L+ I DF +
Sbjct: 209 FYHRG------IVHGDLSQYNVLVSEEGIWII-DFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 532 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.94 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.78 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.59 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.42 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.29 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.14 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.96 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.75 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.54 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.98 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.77 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.35 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.8 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.55 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.1 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.55 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=390.39 Aligned_cols=206 Identities=27% Similarity=0.472 Sum_probs=181.4
Q ss_pred CCccccccccccCceeEEEEEec------CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++|.+.++||+|+||+||+|++. +++.||||++...+....++|.+|++++++++|||||+++|++.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999864 477899999987777777889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhc----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 387 VYEFLPNQSLDRFIFDS----------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
||||+++|+|.++|... .....++|.+++.|+.||++||.|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999643 12457999999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 457 ADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
+|||+++........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999876544333 2334568999999999999999999999999999999999 9999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=392.86 Aligned_cols=200 Identities=29% Similarity=0.494 Sum_probs=182.1
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
..|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+.+++.++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 79999999997665555667899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+++.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999843 46999999999999999999999998 99999999999999999999999999987754432
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..+..+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2345789999999999999999999999999999999999999997754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=387.16 Aligned_cols=202 Identities=26% Similarity=0.398 Sum_probs=182.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999975 7999999999653 2334577999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||++||+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999953 457999999999999999999999998 999999999999999999999999999987544
Q ss_pred Cc-ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ......+||+.|||||++.+..++.++||||+||++|||++|+.||...+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33 23456789999999999999999999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=389.68 Aligned_cols=205 Identities=27% Similarity=0.471 Sum_probs=174.6
Q ss_pred CCccccccccccCceeEEEEEec------CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++|.+.++||+|+||+||+|+++ +++.||||++...+....++|.+|++++++++|||||+++|++.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778899999999999999864 478899999987777777889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 387 VYEFLPNQSLDRFIFDSA------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
||||+++|+|.++++... ....++|.+++.|+.||++||.|||+++ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996532 1246999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 455 KIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 99999999876544332 3445679999999999999999999999999999999999 999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=391.57 Aligned_cols=203 Identities=23% Similarity=0.388 Sum_probs=176.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|+++++||+|+||+||++++. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 6999999999754 34445789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|++||+|.+++.. .+...+++.+++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999954 23456899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 12345679999999999999999999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=387.25 Aligned_cols=206 Identities=24% Similarity=0.420 Sum_probs=179.2
Q ss_pred CCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
+++++.++||+|+||+||+|++. +++.||||++.... ....++|.+|+.++++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 35677899999999999999963 46789999996543 344578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC
Q 009543 386 LVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~ 452 (532)
+||||+++|+|.++|..... ...++|.++++|+.||++||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 346999999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 453 RAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
.+||+|||+++........ ..+...||+.|||||++.++.++.++|||||||++|||+| |+.||...+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999876543322 3445679999999999999999999999999999999999 8999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=379.17 Aligned_cols=201 Identities=30% Similarity=0.487 Sum_probs=170.3
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.+++++.++||+|+||+||+|++++ .||||+++.. +....+.|.+|++++++++|||||++++++. ++..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence 4678889999999999999999853 6999998644 3455678999999999999999999999875 467899999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|.++|.. ....++|.+++.|+.||++||+|||+++ ||||||||+||||++++.+||+|||+++......
T Consensus 112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999954 3457999999999999999999999998 9999999999999999999999999998765433
Q ss_pred c-cccccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 S-HISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .......||+.|||||++.. +.++.++|||||||++|||+||+.||...+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 2 23345689999999999863 468999999999999999999999997654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=393.99 Aligned_cols=201 Identities=28% Similarity=0.490 Sum_probs=182.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999975 6999999999876655667789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
++||+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+++.+.....
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999984 346999999999999999999999998 99999999999999999999999999987754432
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2345789999999999999999999999999999999999999997654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=380.98 Aligned_cols=199 Identities=28% Similarity=0.367 Sum_probs=173.9
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.+.|++.++||+|+||+||++++. +|+.||||++..... ..+|+.+++.++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888999999999999999975 699999999975432 24799999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCccccCCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDK 469 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~~~~~~ 469 (532)
++||+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.+| ++||+|||+++......
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999953 357999999999999999999999998 99999999999999998 69999999998775443
Q ss_pred cc----cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 470 SH----ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 470 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.. .....+||+.|||||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 21 22345799999999999999999999999999999999999999987544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=368.35 Aligned_cols=199 Identities=25% Similarity=0.448 Sum_probs=163.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 79999999996542 334567999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6799998843 457999999999999999999999998 999999999999999999999999999875443
Q ss_pred CcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||...+
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 2 2345689999999999988775 689999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=370.46 Aligned_cols=199 Identities=30% Similarity=0.463 Sum_probs=171.5
Q ss_pred CCc-cccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeec----CCcc
Q 009543 313 GSF-DEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPES 384 (532)
Q Consensus 313 ~~~-~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 384 (532)
++| ++.++||+|+||+||+|.+. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ +...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 66778999999999999975 6899999999654 34455779999999999999999999999865 3457
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-CCcEEEeecCCcc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLAR 463 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfgl~~ 463 (532)
+|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+++
T Consensus 105 ~lvmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 899999999999999953 457999999999999999999999875 36999999999999984 7999999999998
Q ss_pred ccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
..... .....+||+.|||||++.+ +++.++|||||||++|||+||+.||...
T Consensus 181 ~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 64332 2345689999999998864 6999999999999999999999999754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=379.29 Aligned_cols=202 Identities=29% Similarity=0.364 Sum_probs=171.7
Q ss_pred CCccccccccccCceeEEEEEec----CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++|++.+.||+|+||+||+++.. +++.||||++.... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 47899999986432 2223468899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||++||+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999953 457999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.... .....+||+.|||||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 178 ~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 231 (304)
T 3ubd_A 178 DHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231 (304)
T ss_dssp ---C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence 3322 23456899999999999999999999999999999999999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=376.12 Aligned_cols=214 Identities=29% Similarity=0.405 Sum_probs=183.1
Q ss_pred ChhhHHHhcCCccccccccccCceeEEEEEecC------CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCcc-ceeeeee
Q 009543 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEH-KNLVRLL 375 (532)
Q Consensus 304 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~~~ 375 (532)
....++...++|++.++||+|+||+||+|++.. ++.||||++.... ....+.|.+|++++.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 334455556789999999999999999998642 3579999997653 3445779999999999965 8999999
Q ss_pred eeeecC-CcceEEEEecCCCChhHHhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC
Q 009543 376 GCSCSG-PESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDI 441 (532)
Q Consensus 376 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dl 441 (532)
|+|.+. ...++||||+++|+|.++|..... ...+++.+++.++.||++||.|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 998764 568999999999999999965321 345899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 442 KASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 442 kp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
||+|||+++++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999977554433 3445679999999999999999999999999999999998 99999875
Q ss_pred C
Q 009543 520 N 520 (532)
Q Consensus 520 ~ 520 (532)
+
T Consensus 292 ~ 292 (353)
T 4ase_A 292 K 292 (353)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=363.70 Aligned_cols=200 Identities=26% Similarity=0.458 Sum_probs=163.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc-------
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE------- 383 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 383 (532)
++|++++.||+|+||+||++++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35899999999999999999975 79999999997654 3445679999999999999999999999875443
Q ss_pred -----ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEee
Q 009543 384 -----SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458 (532)
Q Consensus 384 -----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~D 458 (532)
.|+||||+++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999965544455677889999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCcc-----------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 459 FGLARSFQEDKSH-----------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 459 fgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
||+++........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9999877543321 1234579999999999999999999999999999999996 7754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=367.18 Aligned_cols=200 Identities=29% Similarity=0.408 Sum_probs=165.3
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC----cceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----ESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 388 (532)
.+|.+.++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++||||+++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999998 589999999865432 2233445777778899999999999998654 468999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-----SKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
||+++|+|.+++.. ..++|.++++++.|+++||+|||++ ..++|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 4689999999999999999999986 23359999999999999999999999999998
Q ss_pred ccCCCCcc---cccccccccccccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 464 SFQEDKSH---ISTAIAGTLGYMAPEYLAHG------QLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 464 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
........ .....+||+.|||||++.+. .++.++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 77554432 22345799999999998654 467899999999999999999887754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=364.24 Aligned_cols=202 Identities=26% Similarity=0.424 Sum_probs=173.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeec------CC
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCS------GP 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 382 (532)
.++|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 368999999999999999999975 79999999996542 3445678899999999999999999998754 35
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..|+||||++ |+|.+++. +...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67998884 4567999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCc---ccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKS---HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+.+..... ......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 87644322 233457899999999998764 56999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=355.75 Aligned_cols=202 Identities=25% Similarity=0.450 Sum_probs=173.3
Q ss_pred HHHhcCCccccccccccCceeEEEEEec----CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCC
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 382 (532)
+....++|++.++||+|+||+||+|+.+ +++.||||++.... ...++.+|++++..+ +||||+++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3456688999999999999999999853 46789999886543 345688999999988 6999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecCC
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGL 461 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfgl 461 (532)
..++||||+++|+|.+++ ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999988 24899999999999999999999998 9999999999999887 7999999999
Q ss_pred ccccCCCCcc---------------------------cccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCC
Q 009543 462 ARSFQEDKSH---------------------------ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR 513 (532)
Q Consensus 462 ~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~ 513 (532)
++........ ..+..+||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9865432211 12345799999999998765 5899999999999999999999
Q ss_pred CCCCCCC
Q 009543 514 QNNRSKN 520 (532)
Q Consensus 514 ~p~~~~~ 520 (532)
.||...+
T Consensus 245 ~Pf~~~~ 251 (361)
T 4f9c_A 245 YPFYKAS 251 (361)
T ss_dssp SSSSCCS
T ss_pred CCCCCCC
Confidence 9996543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=376.13 Aligned_cols=200 Identities=25% Similarity=0.373 Sum_probs=174.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHH---HHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAAN---FYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~---~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
++|++.+.||+|+||+||+++.. +|+.||||++.... ...... ..+++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999975 69999999996432 112222 334567778889999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||++||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++..
T Consensus 269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999953 467999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||...+.
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 5433 245689999999999975 4799999999999999999999999976443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=369.27 Aligned_cols=202 Identities=24% Similarity=0.403 Sum_probs=183.3
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.+.||+|+||.||+++.+ +|+.||+|++........+.+.+|+++|+.++||||+++++++.+....++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999975 7999999999877766677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC--CcEEEeecCCccccCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR--LRAKIADFGLARSFQED 468 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~--~~~kl~Dfgl~~~~~~~ 468 (532)
++||+|.+++.. +...+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999843 3457999999999999999999999998 9999999999999864 89999999999987654
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ....+||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 311 ~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 311 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp SE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred Cc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 33 244689999999999999999999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=330.26 Aligned_cols=219 Identities=41% Similarity=0.713 Sum_probs=191.1
Q ss_pred CcChhhHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecC
Q 009543 302 NFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG 381 (532)
Q Consensus 302 ~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 381 (532)
.+.+.++...+++|++.+.||+|+||.||+|++++++.||||++........+.+.+|+.+++.++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34555666788999999999999999999999988999999998777666678899999999999999999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAK-AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
+..++||||+++++|.+++..... ...+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999854322 246999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCc-ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 009543 461 LARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523 (532)
Q Consensus 461 l~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~ 523 (532)
+++....... .......||+.|+|||.+.++.++.++||||||+++|||++|+.||....+.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~ 248 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH
Confidence 9986543322 22344568999999999988899999999999999999999999998755443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.97 Aligned_cols=211 Identities=24% Similarity=0.317 Sum_probs=184.2
Q ss_pred hhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh---hhHHHHHHHHhHhhcCccceeeeeeeeeec
Q 009543 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNIISSVEHKNLVRLLGCSCS 380 (532)
Q Consensus 305 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 380 (532)
+..+....++|++.++||+|+||+||++++. +++.||+|++..... .....+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444556789999999999999999999986 578899999965321 222348899999999999999999999999
Q ss_pred CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 381 GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999953 2467999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCcccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 99877655544445578999999999987 5678999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=321.34 Aligned_cols=201 Identities=27% Similarity=0.490 Sum_probs=181.7
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.++||+|+||+||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999996 47899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999843 35899999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 172 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp C-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 334579999999999999999999999999999999999999997654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=325.05 Aligned_cols=201 Identities=27% Similarity=0.464 Sum_probs=179.8
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.++|++.+.||+|+||.||++++ .+|+.||||++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 47899999999999999999997 57999999999654 3445577899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999854 356999999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...+
T Consensus 168 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 168 GK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp CG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 32 345679999999999988776 479999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=325.77 Aligned_cols=201 Identities=27% Similarity=0.358 Sum_probs=179.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++.. +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57999999999999999999975 6899999999654 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999843 456899999999999999999999998 999999999999999999999999999864332
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 159 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 22 2345679999999999999999999999999999999999999997654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.92 Aligned_cols=218 Identities=43% Similarity=0.743 Sum_probs=191.3
Q ss_pred CCCcChhhHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeee
Q 009543 300 SLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCS 378 (532)
Q Consensus 300 ~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 378 (532)
...+.+.++....++|++.+.||+|+||.||++++.+++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456788899999999999999999999999999988899999999875432 2223689999999999999999999999
Q ss_pred ecCCcceEEEEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 379 CSGPESLLVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 379 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||++...+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999996543 23459999999999999999999999922239999999999999999999999
Q ss_pred ecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 458 DFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 458 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999998776555554555679999999999988889999999999999999999999995
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=339.07 Aligned_cols=207 Identities=24% Similarity=0.329 Sum_probs=181.0
Q ss_pred hHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCC
Q 009543 307 TLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (532)
Q Consensus 307 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 382 (532)
.+....++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++..++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999976 58899999986432 122245789999999999999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999843 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCcccccccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQ----LTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+.............+||+.|+|||++.... ++.++||||||+++|||++|+.||...+
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 877655443445678999999999997654 7899999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=319.40 Aligned_cols=204 Identities=28% Similarity=0.469 Sum_probs=175.4
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
..++|++.+.||+|+||.||++++. +++.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3578999999999999999999965 6899999998654 23445778999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 89 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999953 356999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 544334445679999999999999899999999999999999999999997654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=320.28 Aligned_cols=212 Identities=29% Similarity=0.458 Sum_probs=185.5
Q ss_pred CCcChhhHHHhcC----------CccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccc
Q 009543 301 LNFKYSTLEKATG----------SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHK 369 (532)
Q Consensus 301 ~~~~~~~l~~~~~----------~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 369 (532)
..+.++++..+++ .|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 3455555555543 2777889999999999999976 7999999999877666678899999999999999
Q ss_pred eeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc
Q 009543 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (532)
Q Consensus 370 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~ 449 (532)
||+++++++...+..++||||+++++|.+++. ...+++..++.++.|+++||.|||+++ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999883 356999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 450 SRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 450 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.++.+||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999876543322 234579999999999999899999999999999999999999997643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=317.79 Aligned_cols=204 Identities=27% Similarity=0.483 Sum_probs=181.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.++||+|+||+||++++. +++.||+|++...+....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367999999999999999999975 6899999998777777778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ....+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999954 2467999999999999999999999998 99999999999999999999999999987654332
Q ss_pred cc-------------ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HI-------------STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 21 114579999999999999999999999999999999999999997643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=336.50 Aligned_cols=210 Identities=22% Similarity=0.304 Sum_probs=183.0
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecC
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG 381 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 381 (532)
.+.....++|++.+.||+|+||+||+++.+ +|+.||||++.... ....+.+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344445688999999999999999999975 79999999996532 22234578999999999999999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence 9999999999999999999542 347999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLA-------HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 9877655443344568999999999987 3568999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.09 Aligned_cols=203 Identities=27% Similarity=0.401 Sum_probs=175.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999975 6899999999754 233456788999999988 79999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++|+|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999853 356999999999999999999999998 9999999999999999999999999998543
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+.
T Consensus 176 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 176 CNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 3222 23456799999999999988899999999999999999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=319.57 Aligned_cols=198 Identities=27% Similarity=0.395 Sum_probs=177.9
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57999999999999999999975 68999999996542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999953 456899999999999999999999998 999999999999999999999999999875432
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 234679999999999999899999999999999999999999997654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.09 Aligned_cols=202 Identities=27% Similarity=0.396 Sum_probs=180.0
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChh------hHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH------RAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
..++|++.+.||+|+||.||+++.. +|+.||+|++...... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4568999999999999999999975 6899999999754321 34678999999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC----cEEEeec
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL----RAKIADF 459 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~----~~kl~Df 459 (532)
.++||||+++|+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999994 3457999999999999999999999998 99999999999998877 7999999
Q ss_pred CCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 460 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 164 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp SSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99987654322 234679999999999998899999999999999999999999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=328.93 Aligned_cols=201 Identities=25% Similarity=0.344 Sum_probs=175.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357999999999999999999976 57889999997542 22334678899999887 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999853 356999999999999999999999998 9999999999999999999999999998633
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 222 2234568999999999999999999999999999999999999999653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=322.43 Aligned_cols=204 Identities=26% Similarity=0.387 Sum_probs=178.7
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcc
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 384 (532)
...++|++.+.||+|+||.||+++.+ +|+.||||++.... ....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 68999999997542 23456678899999876 999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++|+|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999853 356899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 168 NMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 433222 2345689999999999999899999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=326.06 Aligned_cols=201 Identities=29% Similarity=0.413 Sum_probs=178.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 58899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|..++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999984 3457999999999999999999999998 999999999999999999999999999876543
Q ss_pred Cccccccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
. ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 2 2345679999999999864 4589999999999999999999999976543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.79 Aligned_cols=207 Identities=28% Similarity=0.418 Sum_probs=179.4
Q ss_pred cCCccccccccccCceeEEEEEec--------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 381 (532)
.++|++.+.||+|+||.||++++. ++..||||++.... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999852 35679999997553 34457899999999999 899999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999965321 246899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 449 DSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999876544322 2233457889999999999999999999999999999999 9999987543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.00 Aligned_cols=207 Identities=34% Similarity=0.544 Sum_probs=172.0
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
..++|++.++||+|+||+||++++ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 346899999999999999999987 68899999986553 344567999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++........+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999964333345999999999999999999999875 35999999999999999999999999999754433
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 12334578999999999999999999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.43 Aligned_cols=205 Identities=18% Similarity=0.215 Sum_probs=174.9
Q ss_pred HHhcCCccccccccccCceeEEEEE------ecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc---cceeeeeeeeee
Q 009543 309 EKATGSFDEANKLGQGGFGTVYKGV------LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE---HKNLVRLLGCSC 379 (532)
Q Consensus 309 ~~~~~~~~~~~~lG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 379 (532)
....++|++.++||+|+||+||+|. ..+++.||||++..... .++.+|++++..++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3445789999999999999999994 34689999999965543 45666666666665 999999999999
Q ss_pred cCCcceEEEEecCCCChhHHhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-------
Q 009543 380 SGPESLLVYEFLPNQSLDRFIFDSA--KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS------- 450 (532)
Q Consensus 380 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~------- 450 (532)
..+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996422 3467999999999999999999999998 999999999999998
Q ss_pred ----CCcEEEeecCCccccCCCC-cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 451 ----RLRAKIADFGLARSFQEDK-SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 451 ----~~~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
++.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999997654222 22345567999999999999989999999999999999999999999653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.55 Aligned_cols=199 Identities=26% Similarity=0.362 Sum_probs=177.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 387 (532)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999975 6889999999754 334456788999999987 899999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999853 356999999999999999999999998 99999999999999999999999999986432
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 163 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 163 PGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 222 23456799999999999998999999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.87 Aligned_cols=202 Identities=26% Similarity=0.339 Sum_probs=178.7
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 478999999999999999999986 47899999997542 23456788999999988 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999853 356999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 173 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 2222 2345679999999999999999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.97 Aligned_cols=198 Identities=23% Similarity=0.326 Sum_probs=178.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999975 68999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999953 356999999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 195 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 195 T----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp B----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 2 34579999999999999899999999999999999999999997654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.92 Aligned_cols=204 Identities=30% Similarity=0.455 Sum_probs=176.5
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.+.||+|+||+||++++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 789999999865432 234668899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999883 3456999999999999999999999998 9999999999999999999999999998664332
Q ss_pred cc-cccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 470 SH-ISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 470 ~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 22 2345679999999999987765 7889999999999999999999976543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=312.93 Aligned_cols=205 Identities=27% Similarity=0.445 Sum_probs=175.8
Q ss_pred HhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
...++|++.++||+|+||+||++++.+|+.||+|++.... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3457899999999999999999999889999999986543 22346788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++ +|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 77777743 3456999999999999999999999998 99999999999999999999999999987653
Q ss_pred CCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 322 2234568999999999876 5689999999999999999999999977543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=309.56 Aligned_cols=218 Identities=41% Similarity=0.693 Sum_probs=190.5
Q ss_pred CCCCcChhhHHHhcCCcccc------ccccccCceeEEEEEecCCCEEEEEEeecc----ChhhHHHHHHHHhHhhcCcc
Q 009543 299 DSLNFKYSTLEKATGSFDEA------NKLGQGGFGTVYKGVLPDGREIAVKRLFFN----NRHRAANFYNEVNIISSVEH 368 (532)
Q Consensus 299 ~~~~~~~~~l~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 368 (532)
+...+.+.++..++++|... ++||+|+||.||+|+. +++.||+|++... .....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568888999999998877 8999999999999998 6899999998643 23345779999999999999
Q ss_pred ceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 369 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+++ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999965555667999999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 449 DSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
+.++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 99999999999999876543322 2334578999999998764 578999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=314.77 Aligned_cols=202 Identities=23% Similarity=0.342 Sum_probs=179.3
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
..++|++.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999976 68899999986543 345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC--CCcEEEeecCCccccCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS--RLRAKIADFGLARSFQE 467 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~--~~~~kl~Dfgl~~~~~~ 467 (532)
|+++++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999843 3357999999999999999999999998 999999999999987 78999999999987754
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 432 234568999999999998889999999999999999999999997754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=319.48 Aligned_cols=202 Identities=26% Similarity=0.433 Sum_probs=178.7
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
..++|++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999975 68999999997542 34456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC---cEEEeecCCccc
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIADFGLARS 464 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~---~~kl~Dfgl~~~ 464 (532)
|||+++++|.+++. ....+++..++.++.||++||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999884 3457899999999999999999999998 99999999999998654 599999999987
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 654332 234679999999999998899999999999999999999999997643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.08 Aligned_cols=202 Identities=28% Similarity=0.410 Sum_probs=168.8
Q ss_pred cCCccccccccccCceeEEEEEe----cCCCEEEEEEeeccC----hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFNN----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
.++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999997 478999999986542 2334567899999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999853 356899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 6433222 2334579999999999998899999999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=308.42 Aligned_cols=202 Identities=26% Similarity=0.480 Sum_probs=179.9
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.+.||+|+||.||++++.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5799999999999999999999889999999997543 234678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999953 3456899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.....+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 344567888999999998899999999999999999999 999997754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=316.24 Aligned_cols=204 Identities=25% Similarity=0.448 Sum_probs=171.1
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc--
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES-- 384 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 384 (532)
..++|++.+.||+|+||.||++++ .+++.||||++... .......+.+|+.++.+++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999996 57899999999754 233456789999999999999999999998776554
Q ss_pred --eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 385 --LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 385 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999953 356999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 876543322 2234568999999999999899999999999999999999999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=313.60 Aligned_cols=201 Identities=28% Similarity=0.415 Sum_probs=178.7
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChh------hHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH------RAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.+.||+|+||.||++... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456999999999999999999975 6899999998754321 356799999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC----cEEEeecC
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL----RAKIADFG 460 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~----~~kl~Dfg 460 (532)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999994 3467999999999999999999999998 99999999999999887 89999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++........ .....||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9987654332 234579999999999998899999999999999999999999997654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=315.29 Aligned_cols=204 Identities=28% Similarity=0.506 Sum_probs=175.7
Q ss_pred cCCccccccccccCceeEEEEEec----CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.+.||+|+||.||+|++. .+..||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999974 3456999999765 34455789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999953 3457999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 467 EDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
..... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 44322 2233356788999999998899999999999999999999 999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=321.30 Aligned_cols=202 Identities=26% Similarity=0.360 Sum_probs=169.3
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhH-hhcCccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNI-ISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999976 58899999997543 2334556777776 577899999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999853 456899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 191 EHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred cCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 3222 2345679999999999999999999999999999999999999997654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=318.28 Aligned_cols=204 Identities=25% Similarity=0.376 Sum_probs=178.0
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-----hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999975 68999999986432 123577999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc---EEEeecCC
Q 009543 386 LVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR---AKIADFGL 461 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~---~kl~Dfgl 461 (532)
+||||+++++|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988875432 3446899999999999999999999998 999999999999987655 99999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 987654332 233457999999999999889999999999999999999999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=316.97 Aligned_cols=201 Identities=31% Similarity=0.485 Sum_probs=173.3
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc----ceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE----SLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv 387 (532)
.++|++.++||+|+||+||+|++. ++.||||++..... ......+|+.++.+++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999985 79999999965433 33456679999999999999999999987544 5999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ----------SKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
|||+++|+|.+++.. ..+++..++.++.|+++||.|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999943 4599999999999999999999998 7 9999999999999999999999
Q ss_pred ecCCccccCCCCcc-ccccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 458 DFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 458 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999876554332 2334579999999999876 3566789999999999999999999987544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=314.74 Aligned_cols=203 Identities=25% Similarity=0.458 Sum_probs=174.5
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE------ 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 383 (532)
.++|++.+.||+|+||.||++++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357999999999999999999986 79999999997544 3345789999999999999999999998865442
Q ss_pred ---------------------------------------------------ceEEEEecCCCChhHHhhhccCCCCCCHH
Q 009543 384 ---------------------------------------------------SLLVYEFLPNQSLDRFIFDSAKAKTLTWE 412 (532)
Q Consensus 384 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~ 412 (532)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999765555667888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc-----------ccccccccccc
Q 009543 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS-----------HISTAIAGTLG 481 (532)
Q Consensus 413 ~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~gt~~ 481 (532)
.++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 99999999999999999999999999987765432 12234579999
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 482 y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999899999999999999999999988763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=315.77 Aligned_cols=200 Identities=25% Similarity=0.418 Sum_probs=175.6
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|.+.+.||+|+||.||++.+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999997 578999999986432 12235788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+ +|+|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 7888888853 356999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 332 234579999999999987765 789999999999999999999997654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=306.03 Aligned_cols=203 Identities=26% Similarity=0.434 Sum_probs=180.7
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.++|++.+.||+|+||.||++.++++..||+|++.... ...+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46799999999999999999999888899999986543 23467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++... ...+++.+++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999542 346899999999999999999999998 999999999999999999999999999876655444
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 3444556788999999998889999999999999999999 999997654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=318.91 Aligned_cols=202 Identities=26% Similarity=0.371 Sum_probs=180.4
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.+.||+|+||.||++... +|+.+|+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999975 6899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC--CCcEEEeecCCccccCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS--RLRAKIADFGLARSFQED 468 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~--~~~~kl~Dfgl~~~~~~~ 468 (532)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 3346899999999999999999999998 999999999999974 478999999999876544
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 32 233468999999999999899999999999999999999999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=312.23 Aligned_cols=204 Identities=25% Similarity=0.395 Sum_probs=177.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCC--cceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP--ESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 387 (532)
.++|++.++||+|+||+||++++. +++.||||++.... ....+.+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999976 58999999987543 334567889999999999999999999987655 67899
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE----cCCCcEEEeecCCcc
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLAR 463 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl----~~~~~~kl~Dfgl~~ 463 (532)
|||+++++|.+++........+++.+++.++.|+++||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555556999999999999999999999998 9999999999999 888899999999998
Q ss_pred ccCCCCcccccccccccccccccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLA--------HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 7654432 23456899999999886 4678999999999999999999999997543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=308.51 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=170.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--------------------------hhHHHHHHHHhHhh
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--------------------------HRAANFYNEVNIIS 364 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 364 (532)
.++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999975 688999999865431 11356889999999
Q ss_pred cCccceeeeeeeeeec--CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 009543 365 SVEHKNLVRLLGCSCS--GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK 442 (532)
Q Consensus 365 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlk 442 (532)
.++||||+++++++.+ ....++||||+++++|.+++ ....+++.+++.++.|+++||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999886 56789999999999998865 3457999999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEeecCCccccCCCCcccccccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 443 ASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ---LTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 443 p~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
|+|||++.++.+||+|||++......... .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999876544322 23457999999999987654 478899999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=324.97 Aligned_cols=204 Identities=24% Similarity=0.381 Sum_probs=177.8
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
...++|++.+.||+|+||.||++... +|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34567999999999999999999864 78999999987553 2345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc---CCCcEEEeecCCcc
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD---SRLRAKIADFGLAR 463 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~---~~~~~kl~Dfgl~~ 463 (532)
||||+++|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999998853 356999999999999999999999998 99999999999998 46789999999998
Q ss_pred ccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 7654332 2234679999999999998899999999999999999999999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=307.22 Aligned_cols=201 Identities=27% Similarity=0.453 Sum_probs=172.2
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.++||+|+||+||+++..+|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999998899999999865432 2246788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++ +|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 88888843 3467899999999999999999999998 99999999999999999999999999986643222
Q ss_pred cccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2233468999999999875 458999999999999999999999997643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.29 Aligned_cols=215 Identities=26% Similarity=0.325 Sum_probs=185.7
Q ss_pred hcCCCCCcChhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-----cc
Q 009543 296 LNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-----HK 369 (532)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~ 369 (532)
.+++...+.+.......++|++.++||+|+||+||++++. +++.||||++.. .......+.+|+.++..++ ||
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCC
Confidence 3444556777777778899999999999999999999974 689999999863 3344566788999999886 99
Q ss_pred eeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc
Q 009543 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (532)
Q Consensus 370 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~ 449 (532)
||+++++++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 9999999999999999999999 99999998543 3346999999999999999999999998 99999999999997
Q ss_pred C-------------------------CCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHH
Q 009543 450 S-------------------------RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGM 504 (532)
Q Consensus 450 ~-------------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv 504 (532)
. ++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 5 7899999999998654322 3457899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 009543 505 LLLEIVTGRQNNRSKN 520 (532)
Q Consensus 505 ll~el~tG~~p~~~~~ 520 (532)
++|||++|+.||...+
T Consensus 248 il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 248 VLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHSSCSCCCSS
T ss_pred HHHHHHHCCCCCCCCc
Confidence 9999999999997754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=319.87 Aligned_cols=204 Identities=28% Similarity=0.515 Sum_probs=166.2
Q ss_pred cCCccccccccccCceeEEEEEec----CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999975 5778999999765 34455789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++++|.+++.. ....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999953 3457999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccc--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 467 EDKSHI--STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
...... .....+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 443221 122345778999999999999999999999999999998 999997654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=313.77 Aligned_cols=203 Identities=20% Similarity=0.325 Sum_probs=177.9
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.+.||+|+||.||+++. .+++.||||++..... .+.+.+|+.+++.+ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999996 4789999999865432 24588999999999 99999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc-----EEEeecCCccc
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR-----AKIADFGLARS 464 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~-----~kl~Dfgl~~~ 464 (532)
|+ +++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998542 467999999999999999999999998 999999999999999887 99999999987
Q ss_pred cCCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 465 FQEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 465 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 6443321 124567999999999999999999999999999999999999999876544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=329.60 Aligned_cols=202 Identities=25% Similarity=0.345 Sum_probs=168.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|+||.||+++.. +|+.||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999965 6899999999753 333446788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999843 4579999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 301 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 301 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 3322 2344679999999999999999999999999999999999999997654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.98 Aligned_cols=203 Identities=29% Similarity=0.410 Sum_probs=180.4
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 79999999996532 23446788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999998542 2345999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 332 234579999999999998899999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=306.88 Aligned_cols=204 Identities=24% Similarity=0.425 Sum_probs=177.5
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..++|++.+.||+|+||.||++.+.+++.||+|++..... ..+++.+|++++..++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4568999999999999999999998888999999975432 346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999954 2356999999999999999999999998 99999999999999999999999999987654333
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.......+|+.|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 33334456788999999998899999999999999999998 999997654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.10 Aligned_cols=205 Identities=27% Similarity=0.412 Sum_probs=181.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|+||.||+++.. +|+.||+|++.... ......+.+|++++..++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999975 69999999996542 23346788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 388 YEFLPNQSLDRFIFDSAK-AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999864322 457999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 43322 234579999999999999899999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.68 Aligned_cols=197 Identities=27% Similarity=0.390 Sum_probs=171.0
Q ss_pred ccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCCCC
Q 009543 317 EANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQS 395 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 395 (532)
..+.||+|+||.||+++.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3678999999999999974 689999999987766667889999999999999999999999999999999999999999
Q ss_pred hhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE--cCCCcEEEeecCCccccCCCCcccc
Q 009543 396 LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL--DSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 396 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl--~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 9998854 3346899999999999999999999998 9999999999999 6678999999999987654432 2
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||++....++.++||||||+++|||++|+.||...+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 34569999999999998899999999999999999999999997654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=329.98 Aligned_cols=207 Identities=31% Similarity=0.508 Sum_probs=180.0
Q ss_pred HHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
++...++|++.++||+|+||.||+|.++++..||||++.... ...+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 334557899999999999999999999888999999997543 34678999999999999999999999886 6678999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999532 2246889999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
..........+++.|+|||.+..+.++.++||||||+++|||++ |+.||...+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 33222334456789999999998899999999999999999999 999997654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=307.82 Aligned_cols=204 Identities=29% Similarity=0.508 Sum_probs=162.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||.||++... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999975 689999999975543 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 390 FLPNQSLDRFIFDSA---KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
|++ ++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999885432 2246899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33222 234568999999999876 468999999999999999999999997654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=323.87 Aligned_cols=204 Identities=27% Similarity=0.436 Sum_probs=177.4
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467899999999999999999986 78999999987543 3344578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999954 2346899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccc-cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 470 SHIS-TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 470 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.... ....+++.|+|||.+..+.++.++||||||+++|||++ |+.||....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2211 12235778999999998899999999999999999998 999997654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=319.42 Aligned_cols=216 Identities=29% Similarity=0.415 Sum_probs=182.7
Q ss_pred CcChhhHHHhcCCccccccccccCceeEEEEEe------cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeee
Q 009543 302 NFKYSTLEKATGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVR 373 (532)
Q Consensus 302 ~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~ 373 (532)
.+....++...++|++.+.||+|+||.||++++ .+++.||||++.... ....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 445555566678999999999999999999984 246789999997643 34456799999999999 7999999
Q ss_pred eeeeeecCCc-ceEEEEecCCCChhHHhhhccC-----------------------------------------------
Q 009543 374 LLGCSCSGPE-SLLVYEFLPNQSLDRFIFDSAK----------------------------------------------- 405 (532)
Q Consensus 374 ~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 405 (532)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887554 8999999999999999965322
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 406 ----------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 406 ----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999998 9999999999999999999999999998764433
Q ss_pred cc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 470 SH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 470 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.. ......||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 32 3344568899999999999999999999999999999998 999997754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=304.19 Aligned_cols=198 Identities=26% Similarity=0.439 Sum_probs=171.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|++.++||+|+||+||++++. +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 68999999997543 3344778899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++ ++.+.+.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 45554432 3467999999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
. ......||+.|+|||.+.+.. ++.++||||||+++|||++|..||.
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 2 233457899999999987665 7999999999999999999998864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=308.71 Aligned_cols=203 Identities=29% Similarity=0.498 Sum_probs=173.5
Q ss_pred cCCccccccccccCceeEEEEEe-----cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec--CCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 384 (532)
.++|++.++||+|+||+||++++ .+++.||||++........+.+.+|+++++.++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999984 3688999999987777777889999999999999999999998854 3568
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++++|.+++... ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999542 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 6544322 223345778899999999999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.99 Aligned_cols=203 Identities=31% Similarity=0.519 Sum_probs=165.7
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCC--c
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGP--E 383 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~ 383 (532)
...++|++.+.||+|+||.||++.+. +|+.||||++... .......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999974 7899999998543 3455577889999999997 999999999987544 6
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999998 589888843 46899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCC--------------------ccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDK--------------------SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... ....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 654311 112234579999999999876 678999999999999999999999997754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=315.54 Aligned_cols=206 Identities=20% Similarity=0.302 Sum_probs=179.2
Q ss_pred cCCcccccccccc--CceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQG--GFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.++||+| +||.||+++.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999976 79999999997543 4445678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998543 3356999999999999999999999998 9999999999999999999999999886543
Q ss_pred CCCc------cccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 467 EDKS------HISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 2211 11223478999999999987 5789999999999999999999999977543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=329.80 Aligned_cols=206 Identities=28% Similarity=0.458 Sum_probs=181.8
Q ss_pred hcCCccccccccccCceeEEEEEecC-CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
...+|++.++||+|+||.||+|++.. +..||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678999999999999999999864 8899999986543 345789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999642 3456899999999999999999999998 9999999999999999999999999998775544
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
........+++.|+|||.+..+.++.++||||||+++|||++ |+.||...+.
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 333344556789999999998899999999999999999999 9999977543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=301.60 Aligned_cols=201 Identities=23% Similarity=0.357 Sum_probs=178.7
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
..++|++.++||+|+||.||++... ++..+|+|++........+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567999999999999999999976 577999999977655667789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE---cCCCcEEEeecCCccccC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL---DSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl---~~~~~~kl~Dfgl~~~~~ 466 (532)
|+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998853 356899999999999999999999998 9999999999999 888999999999998765
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 161 PGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp TTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 4332 234568999999998865 48999999999999999999999997754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.41 Aligned_cols=201 Identities=25% Similarity=0.381 Sum_probs=162.7
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
...++|++.+.||+|+||.||++++. +++.||||++.... ..+.+.+|++++..++||||+++++++.+....++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34578999999999999999999986 58899999987543 3456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---CCcEEEeecCCcccc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGLARSF 465 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~~~~kl~Dfgl~~~~ 465 (532)
||+++++|.+++. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999984 3456899999999999999999999998 999999999999975 889999999999866
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 4332 2234578999999999998899999999999999999999999997644
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=322.63 Aligned_cols=201 Identities=25% Similarity=0.448 Sum_probs=178.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999976 79999999996542 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++. +...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999984 3467999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...+
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 169 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp TCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 322 234579999999999987765 789999999999999999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.66 Aligned_cols=208 Identities=26% Similarity=0.464 Sum_probs=179.4
Q ss_pred HhcCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCC
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 382 (532)
...++|++.+.||+|+||.||++++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999974 34789999997553 344578999999999999999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAK---------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDI 441 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dl 441 (532)
..++||||+++++|.+++..... ...+++.+++.++.||++||.|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999965321 257999999999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 442 KASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 442 kp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
||+|||++.++.+||+|||+++........ ......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 999999999999999999999866433221 2234567899999999998899999999999999999999 99999765
Q ss_pred C
Q 009543 520 N 520 (532)
Q Consensus 520 ~ 520 (532)
.
T Consensus 281 ~ 281 (343)
T 1luf_A 281 A 281 (343)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.16 Aligned_cols=209 Identities=25% Similarity=0.422 Sum_probs=163.8
Q ss_pred HhcCCccccccccccCceeEEEEEecCC----CEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLPDG----REIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
...++|++.+.||+|+||.||++++... ..||||++... .....+.+.+|+++++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 4457899999999999999999997543 27999998654 33456789999999999999999999999987766
Q ss_pred c------eEEEEecCCCChhHHhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 384 S------LLVYEFLPNQSLDRFIFDSAK---AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 384 ~------~lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
. ++||||+++++|.+++..... ...+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 899999999999999864322 236899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 455 KIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 99999999876543322 2233456889999999999999999999999999999999 9999987543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=307.59 Aligned_cols=209 Identities=32% Similarity=0.450 Sum_probs=180.5
Q ss_pred hcCCccccccccccCceeEEEEEe------cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
..++|.+.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 346799999999999999999986 245789999997543 4455789999999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAK---------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK 442 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlk 442 (532)
.++||||+++++|.+++..... ...+++.+++.++.|+++||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999965332 234899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 443 ASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 443 p~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
|+|||++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 2233457889999999998889999999999999999999 999998765
Q ss_pred Cc
Q 009543 521 SE 522 (532)
Q Consensus 521 ~~ 522 (532)
.+
T Consensus 258 ~~ 259 (314)
T 2ivs_A 258 PE 259 (314)
T ss_dssp GG
T ss_pred HH
Confidence 43
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=337.31 Aligned_cols=204 Identities=25% Similarity=0.340 Sum_probs=179.3
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcce
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 385 (532)
..++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3478999999999999999999975 6889999999753 223446788899999987 7999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999954 356999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.
T Consensus 493 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 493 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp CCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 33222 23456899999999999999999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.65 Aligned_cols=200 Identities=26% Similarity=0.342 Sum_probs=166.0
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 478999999999999999999976 789999999965432 335688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc--EEEeecCCccccCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR--AKIADFGLARSFQED 468 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~--~kl~Dfgl~~~~~~~ 468 (532)
+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999853 346999999999999999999999998 999999999999988775 999999998754322
Q ss_pred CcccccccccccccccccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEK-ADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......||+.|+|||++.+..+..+ +||||||+++|||++|+.||....
T Consensus 172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 2 2234579999999999988777655 899999999999999999998743
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=323.23 Aligned_cols=199 Identities=29% Similarity=0.407 Sum_probs=167.9
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-----
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----- 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 382 (532)
..++|++.++||+|+||+||++.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999965 6899999999754 4445678899999999999999999999987654
Q ss_pred -cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 383 -ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
..++||||++++ |.+.+. ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 459999999865 555552 24899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++...... ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765432 2345679999999999999999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=315.82 Aligned_cols=207 Identities=28% Similarity=0.405 Sum_probs=179.8
Q ss_pred hcCCccccccccccCceeEEEEEec--------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeec
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCS 380 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 380 (532)
..++|++.++||+|+||.||++++. ++..||||++.... ......+.+|+++++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4568999999999999999999852 23579999997553 34457899999999999 99999999999999
Q ss_pred CCcceEEEEecCCCChhHHhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEE
Q 009543 381 GPESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447 (532)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiL 447 (532)
.+..++||||+++++|.+++..... ...+++.+++.++.|++.||.|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999965321 246999999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 448 LDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 448 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999876543322 2334467889999999999999999999999999999999 999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.94 Aligned_cols=206 Identities=32% Similarity=0.471 Sum_probs=176.9
Q ss_pred cCCccccccccccCceeEEEEEec------CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999953 4678999998654 344556789999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC---cEEEe
Q 009543 385 LLVYEFLPNQSLDRFIFDSA----KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIA 457 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~---~~kl~ 457 (532)
++||||+++|+|.+++.... ....+++.+++.++.||++||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996532 2246999999999999999999999998 99999999999999655 59999
Q ss_pred ecCCccccCCCCc-ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 458 DFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 458 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999976533222 22234567899999999999999999999999999999998 999997754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.96 Aligned_cols=213 Identities=26% Similarity=0.302 Sum_probs=176.6
Q ss_pred hhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc-----ChhhHHHHHHHHhHhhcCccceeeeeeeee
Q 009543 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRLLGCS 378 (532)
Q Consensus 305 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 378 (532)
-..+....++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 3455667789999999999999999999975 6889999998654 234457899999999999999999999999
Q ss_pred ecCCcceEEEEecCCCChhHHhhhccC-------------------------------------CCCCCHHHHHHHHHHH
Q 009543 379 CSGPESLLVYEFLPNQSLDRFIFDSAK-------------------------------------AKTLTWEKRYEIILGT 421 (532)
Q Consensus 379 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i 421 (532)
.+.+..++||||+++++|.+++..... ...+++..++.++.|+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 999999999999999999999842110 1124677888999999
Q ss_pred HHHHHHHHhCCCCCeEEccCCCCCEEEcCCC--cEEEeecCCccccCCCCc---cccccccccccccccccccc--CCCC
Q 009543 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRL--RAKIADFGLARSFQEDKS---HISTAIAGTLGYMAPEYLAH--GQLT 494 (532)
Q Consensus 422 a~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~--~~kl~Dfgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~ 494 (532)
++||.|||+++ |+||||||+|||++.++ .+||+|||++........ .......||+.|+|||.+.. ..++
T Consensus 178 ~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 178 FSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 99999999998 99999999999998777 899999999986543222 12345679999999999865 6789
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 495 EKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 495 ~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.++||||||+++|||++|+.||...+
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999997654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=299.54 Aligned_cols=201 Identities=32% Similarity=0.543 Sum_probs=166.6
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccCh----hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR----HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|+||.||++.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 368999999999999999999984 89999999865432 3346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC--------CCcEEEeec
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS--------RLRAKIADF 459 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~--------~~~~kl~Df 459 (532)
|||+++++|.+++ ....+++..++.++.|+++||.|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998 3457999999999999999999999987666999999999999986 778999999
Q ss_pred CCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 460 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|++........ ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99986544322 23568999999999998899999999999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=300.49 Aligned_cols=203 Identities=26% Similarity=0.466 Sum_probs=179.4
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.++|++.+.||+|+||.||++.+.+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357899999999999999999998889999999975433 3467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999954 3356899999999999999999999998 999999999999999999999999999876443322
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 3334567889999999998889999999999999999999 899997653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=302.87 Aligned_cols=205 Identities=23% Similarity=0.379 Sum_probs=165.0
Q ss_pred hcCCccccccccccCceeEEEEEecC----CCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
..++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++ .++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 34689999999999999999999743 457999988654 344457799999999999999999999987 456789
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999953 3356899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
............+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 5544333334456889999999998899999999999999999996 9999987543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.23 Aligned_cols=205 Identities=26% Similarity=0.480 Sum_probs=169.5
Q ss_pred cCCccccccccccCceeEEEEEec-CCCE----EEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGRE----IAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
.++|++.++||+|+||+||+|++. +++. ||+|++... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 357999999999999999999964 4443 588877543 334557899999999999999999999999875 478
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999954 3457999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 009543 466 QEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSE 522 (532)
Q Consensus 466 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~ 522 (532)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 226 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence 544332 2233456889999999999999999999999999999999 99999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=298.68 Aligned_cols=202 Identities=26% Similarity=0.439 Sum_probs=178.4
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
..++|++.++||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999975 6899999998654 334456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc---EEEeecCCccc
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR---AKIADFGLARS 464 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~---~kl~Dfgl~~~ 464 (532)
|||+++++|.+.+.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988853 356899999999999999999999998 999999999999987665 99999999977
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 654332 234578999999999999899999999999999999999999997643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=324.09 Aligned_cols=205 Identities=30% Similarity=0.474 Sum_probs=172.8
Q ss_pred HhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
...++|++.++||+|+||.||+|.++++..||||++.... ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3456789999999999999999999888889999997543 335679999999999999999999999866 67899999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|.+++... ....+++.+++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999532 2356899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
........++..|+|||.+..+.++.++||||||+++|||++ |+.||....
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 333334457889999999998999999999999999999999 999997654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=305.74 Aligned_cols=201 Identities=27% Similarity=0.402 Sum_probs=178.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChh------hHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH------RAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.+.||+|+||.||+++.. +|+.||+|++...... ..+.+.+|+.++..++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999975 6899999998754321 356799999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC----cEEEeecC
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL----RAKIADFG 460 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~----~~kl~Dfg 460 (532)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999994 3456899999999999999999999998 99999999999999988 79999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 9987654322 234568999999999998899999999999999999999999997643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=310.47 Aligned_cols=208 Identities=28% Similarity=0.430 Sum_probs=176.9
Q ss_pred HhcCCccccccccccCceeEEEEEe------cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecC
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 381 (532)
...++|++.+.||+|+||.||++++ .+++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999996 245689999997542 33446789999999999 899999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAK--------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDI 441 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dl 441 (532)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 999999999999999999964322 134899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 442 KASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 442 kp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
||+|||++.++.+||+|||++......... ......+|+.|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999876544332 2334567889999999998899999999999999999998 99999775
Q ss_pred C
Q 009543 520 N 520 (532)
Q Consensus 520 ~ 520 (532)
.
T Consensus 279 ~ 279 (344)
T 1rjb_A 279 P 279 (344)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.84 Aligned_cols=202 Identities=26% Similarity=0.362 Sum_probs=174.9
Q ss_pred CCccccccccccCceeEEEEEe----cCCCEEEEEEeeccC----hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFNN----RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 383 (532)
++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++..+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999997 378999999986432 22345677899999999 69999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999954 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 765444444445679999999999975 347899999999999999999999997643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=304.49 Aligned_cols=209 Identities=29% Similarity=0.452 Sum_probs=184.3
Q ss_pred HHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.+...++|++.++||+|+||.||++.+. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3345678999999999999999999986 48889999986543 345778999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999542 3456999999999999999999999998 9999999999999999999999999998776
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 555444445567889999999998899999999999999999999 9999987543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=303.69 Aligned_cols=198 Identities=25% Similarity=0.465 Sum_probs=167.0
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhc--CccceeeeeeeeeecC----Ccc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISS--VEHKNLVRLLGCSCSG----PES 384 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~ 384 (532)
..++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356899999999999999999998 6899999998643 33455666666665 7999999999986543 457
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH--------EQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
++||||+++|+|.+++ +...+++..++.++.|+++||.||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHH----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHH----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 8999999999999999 3457999999999999999999999 666 999999999999999999999
Q ss_pred eecCCccccCCCCccc---ccccccccccccccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCC
Q 009543 457 ADFGLARSFQEDKSHI---STAIAGTLGYMAPEYLAHG------QLTEKADVYSFGMLLLEIVTG----------RQNNR 517 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvll~el~tG----------~~p~~ 517 (532)
+|||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998765443321 2334799999999999876 455799999999999999999 88886
Q ss_pred CC
Q 009543 518 SK 519 (532)
Q Consensus 518 ~~ 519 (532)
..
T Consensus 235 ~~ 236 (301)
T 3q4u_A 235 DV 236 (301)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=310.10 Aligned_cols=201 Identities=22% Similarity=0.404 Sum_probs=170.1
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCcc--ceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEH--KNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~l 386 (532)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++..++| |||+++++++.+....++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34679999999999999999999988999999998754 34445788999999999986 999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||| +.+++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999953 457899999999999999999999998 99999999999997 6789999999998765
Q ss_pred CCCcc-ccccccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 467 EDKSH-ISTAIAGTLGYMAPEYLAH-----------GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
..... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 44332 2345679999999999864 67899999999999999999999999763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=307.00 Aligned_cols=193 Identities=28% Similarity=0.393 Sum_probs=151.8
Q ss_pred cccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEEEecCCCC
Q 009543 318 ANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFLPNQS 395 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~ 395 (532)
.+.||+|+||.||++.+. +++.||||++... ....+.+|+.++..++ ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 6899999998643 3456788999999997 9999999999999999999999999999
Q ss_pred hhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC---cEEEeecCCccccCCCCccc
Q 009543 396 LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 396 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~---~~kl~Dfgl~~~~~~~~~~~ 472 (532)
|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 9999953 457999999999999999999999998 99999999999998766 899999999986544332 2
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 234568999999999999999999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.29 Aligned_cols=204 Identities=30% Similarity=0.465 Sum_probs=171.0
Q ss_pred HhcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccCh-----hhHHHHHHHHhHhhcCc---cceeeeeeeeeec
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNR-----HRAANFYNEVNIISSVE---HKNLVRLLGCSCS 380 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 380 (532)
...++|++.++||+|+||+||++++ .+++.||||++..... .....+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3468999999999999999999996 4789999999864321 12345677887777765 9999999999887
Q ss_pred CC-----cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEE
Q 009543 381 GP-----ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAK 455 (532)
Q Consensus 381 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~k 455 (532)
.. ..+++|||++ ++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 4789999997 5999998542 2345999999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 456 IADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 456 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 161 LADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp ECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred EeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987654332 244678999999999999999999999999999999999999997654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=304.13 Aligned_cols=204 Identities=23% Similarity=0.308 Sum_probs=167.9
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++..++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999999999999975 68899999986542 3334778999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999953 356899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...........|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 543333345578999999999998899999999999999999999999997643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=319.04 Aligned_cols=199 Identities=29% Similarity=0.458 Sum_probs=173.0
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-cceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-ESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 390 (532)
.++|++.++||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467899999999999999999985 7899999997543 4567999999999999999999999987665 68999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++|+|.+++... ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 9999999999643 2345799999999999999999999998 9999999999999999999999999998543221
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+.
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 22356889999999999999999999999999999998 9999987543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=311.53 Aligned_cols=211 Identities=29% Similarity=0.438 Sum_probs=180.8
Q ss_pred hHHHhcCCccccccccccCceeEEEEEecC-C-----CEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeee
Q 009543 307 TLEKATGSFDEANKLGQGGFGTVYKGVLPD-G-----REIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCS 378 (532)
Q Consensus 307 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 378 (532)
..+...++|++.+.||+|+||.||++.... + ..||+|++.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344456889999999999999999999642 2 479999987553 34457799999999999 899999999999
Q ss_pred ecCCcceEEEEecCCCChhHHhhhccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEE
Q 009543 379 CSGPESLLVYEFLPNQSLDRFIFDSAK-----------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447 (532)
Q Consensus 379 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiL 447 (532)
.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 999999999999999999999864321 346899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 448 LDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 448 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 999999999999999876544332 2234457889999999998899999999999999999999 999997654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=305.50 Aligned_cols=198 Identities=31% Similarity=0.399 Sum_probs=166.4
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.++||+|+||+||+|++. +|+.||||++.... ......+..|+..+..+ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999986 79999999886532 33334555666665555 899999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 67898888543 456999999999999999999999998 99999999999999999999999999887644
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+..
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 32 2334568999999998875 789999999999999999999777644
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=304.23 Aligned_cols=207 Identities=28% Similarity=0.429 Sum_probs=180.2
Q ss_pred hcCCccccccccccCceeEEEEEe------cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCC
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 382 (532)
..++|++.+.||+|+||.||++++ .+++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 456899999999999999999985 356789999997553 34457799999999999 9999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEE
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAK---------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiL 447 (532)
..++||||+++++|.+++..... ...+++.+++.++.|+++||.|||+++ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999965322 225899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 448 LDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 448 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999877654432 2334457889999999998899999999999999999999 999997754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=304.64 Aligned_cols=203 Identities=23% Similarity=0.356 Sum_probs=171.6
Q ss_pred cCCcccc-ccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEE
Q 009543 312 TGSFDEA-NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.+.|++. +.||+|+||.||+++.. +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 78999999999999964 7899999999776666667899999999885 7999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc---EEEeecCCcccc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR---AKIADFGLARSF 465 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~---~kl~Dfgl~~~~ 465 (532)
||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999954 356899999999999999999999998 999999999999998876 999999998765
Q ss_pred CCCCc------cccccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKS------HISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 43221 11223468999999999875 567899999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=299.78 Aligned_cols=204 Identities=33% Similarity=0.535 Sum_probs=178.1
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..++|++.+.||+|+||.||++.+.+++.||+|++.... ...+.+.+|+++++.++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 346799999999999999999999888899999986543 34567899999999999999999999876 4568999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++..++.++.|+++||.|||+++ |+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999998432 1236899999999999999999999998 99999999999999999999999999987765443
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.......+++.|+|||.+..+.++.++||||||+++|||++ |+.||....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 33344567889999999988889999999999999999999 999997654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=298.31 Aligned_cols=203 Identities=27% Similarity=0.475 Sum_probs=158.1
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999997 479999999986442 12346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999853 3467899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 3221 223568999999999998889999999999999999999999997654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.58 Aligned_cols=201 Identities=24% Similarity=0.379 Sum_probs=171.6
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|++.++||+|+||+||++++. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999975 58999999886543 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999998873 3456999999999999999999999998 9999999999999999999999999998765333
Q ss_pred ccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 157 DY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 22 234568999999999875 678999999999999999999999997754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.64 Aligned_cols=198 Identities=27% Similarity=0.491 Sum_probs=168.1
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-----
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----- 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 382 (532)
..++|++.+.||+|+||.||++.+. +|+.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999974 7999999998543 3344567899999999999999999999987653
Q ss_pred -cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 383 -ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999843 46899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++..... .+...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9875432 234578999999999876 678999999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=309.79 Aligned_cols=201 Identities=27% Similarity=0.351 Sum_probs=175.6
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--------hhHHHHHHHHhHhhcCccceeeeeeeeeecC
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--------HRAANFYNEVNIISSVEHKNLVRLLGCSCSG 381 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 381 (532)
..++|++.+.||+|+||.||++++. +++.||||++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999964 688999999875431 1234577899999999999999999999999
Q ss_pred CcceEEEEecCCC-ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 382 PESLLVYEFLPNQ-SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 382 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
+..++||||+.+| +|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999776 9999884 3456999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
++........ .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 9987654432 234568999999999988776 88999999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=312.63 Aligned_cols=203 Identities=20% Similarity=0.305 Sum_probs=170.0
Q ss_pred hcCCccccccccccCceeEEEEEecC------CCEEEEEEeeccChhhH-----------HHHHHHHhHhhcCccceeee
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPD------GREIAVKRLFFNNRHRA-----------ANFYNEVNIISSVEHKNLVR 373 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 373 (532)
..++|++.++||+|+||.||+|.+.+ ++.||||++........ ..+.+|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999764 47899999876543211 12445666778889999999
Q ss_pred eeeeeecC----CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc
Q 009543 374 LLGCSCSG----PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (532)
Q Consensus 374 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~ 449 (532)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998765 3479999999 9999999854 3467999999999999999999999998 99999999999999
Q ss_pred --CCCcEEEeecCCccccCCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 450 --SRLRAKIADFGLARSFQEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 450 --~~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 8899999999999876543221 113345999999999999989999999999999999999999999853
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.39 Aligned_cols=204 Identities=30% Similarity=0.453 Sum_probs=178.4
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357999999999999999999975 68999999987543 3445778999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++. ....+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999883 3456999999999999999999999998 9999999999999999999999999998664332
Q ss_pred c-ccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 470 S-HISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 470 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
. .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 2 12344578999999999987665 7899999999999999999999977543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=306.41 Aligned_cols=212 Identities=27% Similarity=0.461 Sum_probs=181.7
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeee
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCS 378 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 378 (532)
++++...++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556688999999999999999999864 36789999987543 34456789999999999999999999999
Q ss_pred ecCCcceEEEEecCCCChhHHhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC
Q 009543 379 CSGPESLLVYEFLPNQSLDRFIFDSA-------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR 451 (532)
Q Consensus 379 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~ 451 (532)
.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999986422 1256799999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 452 LRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 452 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
+.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 99999999999866443322 2233457889999999998899999999999999999999 899997654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.36 Aligned_cols=194 Identities=24% Similarity=0.411 Sum_probs=155.3
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeec-----CCc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-----GPE 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~ 383 (532)
.++|++.+.||+|+||.||++++. +++.||||++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999975 7899999998653 34455789999999999999999999999844 356
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||+ +++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 568988884 3467999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCc--------------------------cccccccccccccccccc-ccCCCCchhhHHHHHHHHHHHHhC
Q 009543 464 SFQEDKS--------------------------HISTAIAGTLGYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTG 512 (532)
Q Consensus 464 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvll~el~tG 512 (532)
....... ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643221 112345789999999976 456799999999999999999993
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=297.78 Aligned_cols=202 Identities=27% Similarity=0.385 Sum_probs=178.9
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|+||.||++.+. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999976 5788999998654 234557789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ...+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998843 357899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 2234568999999999998889999999999999999999999997653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.18 Aligned_cols=199 Identities=30% Similarity=0.462 Sum_probs=166.2
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.+.||+|+||.||++++. ++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 57899999999999999999984 789999998543 34567899999999999999999999876 45899999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc-EEEeecCCccccCCCCcc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR-AKIADFGLARSFQEDKSH 471 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~-~kl~Dfgl~~~~~~~~~~ 471 (532)
+++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 9999999965444456899999999999999999999933233999999999999998886 7999999997654322
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 23468999999999998899999999999999999999999997643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=298.33 Aligned_cols=200 Identities=30% Similarity=0.462 Sum_probs=173.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999975 57799999986542 22346788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999853 356899999999999999999999998 99999999999999999999999999865443
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 162 SR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 22 234578999999999998889999999999999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.13 Aligned_cols=203 Identities=29% Similarity=0.459 Sum_probs=171.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCE----EEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGRE----IAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
++|++.+.||+|+||.||+|++. +++. |++|.+.... ......+.+|+.++..++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57999999999999999999964 4544 7888775432 233356778999999999999999999885 567899
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++|+|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999853 2356899999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 467 EDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
..... ......++..|+|||.+..+.++.++||||||+++|||++ |+.||.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 54332 2344567889999999998999999999999999999999 9999987553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.57 Aligned_cols=201 Identities=25% Similarity=0.396 Sum_probs=169.3
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC-----C
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-----P 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 382 (532)
..++|++.+.||+|+||.||++++. +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4578999999999999999999975 6889999999653 334557899999999999999999999998766 5
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..++||||++ ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999986 59999884 3466999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCcc---------------------ccccccccccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 463 RSFQEDKSH---------------------ISTAIAGTLGYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 463 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
+........ ..+...||+.|+|||++ ....++.++|||||||++|||++|..||..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 876543221 12456899999999986 556799999999999999999996666543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.18 Aligned_cols=198 Identities=24% Similarity=0.403 Sum_probs=171.4
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 388 (532)
..++|++.+.||+|+||.||+++.. +++.||||++..... ...+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467999999999999999999975 688999999965433 234688888887 7999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC----CcEEEeecCCccc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR----LRAKIADFGLARS 464 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~----~~~kl~Dfgl~~~ 464 (532)
||+++|+|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+|||+..+ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999984 3456999999999999999999999998 9999999999998543 3599999999987
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 654332 223457899999999998888899999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.14 Aligned_cols=202 Identities=16% Similarity=0.221 Sum_probs=164.6
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeecc---ChhhHHHHHHHH---hHhhcCccceeeeee-------e
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEV---NIISSVEHKNLVRLL-------G 376 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~ 376 (532)
..++|++.+.||+|+||+||+|++ .+|+.||||++... .....+.+.+|+ ++++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356899999999999999999996 46999999999743 334557889999 666667899999998 5
Q ss_pred eeecCC-----------------cceEEEEecCCCChhHHhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 009543 377 CSCSGP-----------------ESLLVYEFLPNQSLDRFIFDSAK----AKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435 (532)
Q Consensus 377 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 435 (532)
++.+.+ ..+++|||+ +|+|.+++..... ...+++..++.|+.||++||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 554443 278999999 6899999964321 122446888999999999999999998
Q ss_pred eEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccccccccccccccccccccC-----------CCCchhhHHHHHH
Q 009543 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG-----------QLTEKADVYSFGM 504 (532)
Q Consensus 436 iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGv 504 (532)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999986432 2234567 999999999877 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCC
Q 009543 505 LLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 505 ll~el~tG~~p~~~~~~ 521 (532)
++|||++|+.||.....
T Consensus 302 il~elltg~~Pf~~~~~ 318 (377)
T 3byv_A 302 VIYWIWCADLPITKDAA 318 (377)
T ss_dssp HHHHHHHSSCCC-----
T ss_pred HHHHHHHCCCCCccccc
Confidence 99999999999977543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=299.76 Aligned_cols=203 Identities=17% Similarity=0.302 Sum_probs=177.2
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 388 (532)
..++|++.+.||+|+||.||+++. .+++.||||++.... ..+.+.+|+.++..+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356899999999999999999996 578999999886443 234578899999999 7999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc-----EEEeecCCcc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR-----AKIADFGLAR 463 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~-----~kl~Dfgl~~ 463 (532)
||+ +++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 86 e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 9999999954 2356999999999999999999999998 999999999999988776 9999999998
Q ss_pred ccCCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 464 SFQEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 464 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 76544321 23445799999999999998999999999999999999999999987543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.86 Aligned_cols=197 Identities=29% Similarity=0.485 Sum_probs=172.6
Q ss_pred CCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
+.|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999996 478999999997543 233467899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||++ |+|.+++.. ....+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 577777743 2457999999999999999999999998 999999999999999999999999999865432
Q ss_pred Ccccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||++. .+.++.++||||||+++|||++|+.||...+
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2357899999999984 5678999999999999999999999997643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.27 Aligned_cols=207 Identities=28% Similarity=0.425 Sum_probs=177.9
Q ss_pred hcCCccccccccccCceeEEEEEec--------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeec
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCS 380 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 380 (532)
..++|++.+.||+|+||.||++++. +++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999863 46789999997553 34457789999999999 89999999999999
Q ss_pred CCcceEEEEecCCCChhHHhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEE
Q 009543 381 GPESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447 (532)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiL 447 (532)
.+..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+++ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999964321 235899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 448 LDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 448 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999876554332 2233457889999999988889999999999999999999 999997654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=314.67 Aligned_cols=199 Identities=22% Similarity=0.406 Sum_probs=169.8
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCc--cceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVE--HKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 388 (532)
.+|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++..++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 459999999999999999999888999999998654 3445678999999999996 599999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
| +.+++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 678899999854 347899999999999999999999998 99999999999995 589999999999876544
Q ss_pred Ccc-ccccccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 469 KSH-ISTAIAGTLGYMAPEYLAH-----------GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 469 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 322 2345679999999999864 46889999999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=303.82 Aligned_cols=202 Identities=27% Similarity=0.385 Sum_probs=179.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|.+.+.||+|+||.||++++. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999976 5789999998654 334557789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ...+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998843 357899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 322 2234578999999999998889999999999999999999999997643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=295.62 Aligned_cols=201 Identities=35% Similarity=0.606 Sum_probs=171.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhh-------HHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHR-------AANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
.++|++.+.||+|+||.||++++. +++.||+|++....... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999974 78999999986543211 167899999999999999999999986544
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc-----EEEee
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR-----AKIAD 458 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~-----~kl~D 458 (532)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999988853 3457999999999999999999999985 35999999999999988876 99999
Q ss_pred cCCccccCCCCcccccccccccccccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLA--HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 459 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
||+++..... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 173 fg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 173 FGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 9999754332 23457899999999984 45678999999999999999999999976543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.87 Aligned_cols=203 Identities=24% Similarity=0.374 Sum_probs=166.0
Q ss_pred HHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--------hhhHHHHHHHHhHhhcCccceeeeeeeeee
Q 009543 309 EKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--------RHRAANFYNEVNIISSVEHKNLVRLLGCSC 379 (532)
Q Consensus 309 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 379 (532)
....++|.+.++||+|+||+||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345689999999999999999999975 68999999986532 112235789999999999999999999875
Q ss_pred cCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC---cEEE
Q 009543 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKI 456 (532)
Q Consensus 380 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~---~~kl 456 (532)
.+..++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 455899999999999999883 4567999999999999999999999998 99999999999997654 5999
Q ss_pred eecCCccccCCCCcccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 457 ADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 9999998765432 234467999999999985 3567889999999999999999999997643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.32 Aligned_cols=203 Identities=29% Similarity=0.415 Sum_probs=172.9
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 457999999999999999999975 68999999987653 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE---cCCCcEEEeecCCcccc
Q 009543 390 FLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL---DSRLRAKIADFGLARSF 465 (532)
Q Consensus 390 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl---~~~~~~kl~Dfgl~~~~ 465 (532)
|+++++|.+++... .....+++..++.++.|+++||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988543 23467999999999999999999999998 9999999999999 55678999999999876
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..... .....|++.|+|||.+. +.++.++||||||+++|||++|+.||....
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 54322 23456899999999885 568899999999999999999999997654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=315.54 Aligned_cols=203 Identities=26% Similarity=0.395 Sum_probs=176.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCC--cceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP--ESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 387 (532)
.++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999976 58999999997543 334567889999999999999999999988755 67999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE----cCCCcEEEeecCCcc
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLAR 463 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl----~~~~~~kl~Dfgl~~ 463 (532)
|||+++++|.+++........+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965544555999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCCccccccccccccccccccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAH--------GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
....... .....||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 7654322 234578999999999864 56788999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.76 Aligned_cols=197 Identities=26% Similarity=0.323 Sum_probs=162.1
Q ss_pred CCcccc-ccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhh-cCccceeeeeeeeeec----CCcce
Q 009543 313 GSFDEA-NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIIS-SVEHKNLVRLLGCSCS----GPESL 385 (532)
Q Consensus 313 ~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~----~~~~~ 385 (532)
++|.+. +.||+|+||+||++.+. +++.||||++... ..+.+|+.++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 467766 78999999999999975 6899999998532 35667888874 4589999999998865 55689
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---CCcEEEeecCCc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGLA 462 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~~~~kl~Dfgl~ 462 (532)
+||||+++|+|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999542 2346999999999999999999999998 999999999999998 789999999999
Q ss_pred cccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 212 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 212 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 86543322 234678999999999999999999999999999999999999997654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=295.88 Aligned_cols=201 Identities=26% Similarity=0.420 Sum_probs=175.0
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh------hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR------HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356999999999999999999986 689999999865421 1357899999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC----cEEEeecC
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL----RAKIADFG 460 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~----~~kl~Dfg 460 (532)
++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999843 356899999999999999999999998 99999999999999887 89999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++........ .....|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 9987654322 234568999999999998899999999999999999999999997654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=304.19 Aligned_cols=215 Identities=29% Similarity=0.419 Sum_probs=181.5
Q ss_pred cChhhHHHhcCCccccccccccCceeEEEEEe------cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeee
Q 009543 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRL 374 (532)
Q Consensus 303 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~ 374 (532)
+.........++|++.+.||+|+||.||++++ .+++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44444555568899999999999999999984 356889999997643 33456789999999999 79999999
Q ss_pred eeeeecCC-cceEEEEecCCCChhHHhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcc
Q 009543 375 LGCSCSGP-ESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRD 440 (532)
Q Consensus 375 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~D 440 (532)
++++...+ ..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987655 48999999999999999964322 123899999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 009543 441 IKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRS 518 (532)
Q Consensus 441 lkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~ 518 (532)
|||+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876544332 2334567889999999998899999999999999999998 9999976
Q ss_pred CC
Q 009543 519 KN 520 (532)
Q Consensus 519 ~~ 520 (532)
..
T Consensus 254 ~~ 255 (316)
T 2xir_A 254 VK 255 (316)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=292.34 Aligned_cols=199 Identities=23% Similarity=0.370 Sum_probs=172.2
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--CcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 388 (532)
++|++.+.||+|+||.||+++++ ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57999999999999999999985 8999999997553 44456799999999999999999999999877 7789999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++... ....+++.+++.++.|+++||.|||+++ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999542 2346899999999999999999999874 4599999999999999999999999998765332
Q ss_pred CcccccccccccccccccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTE---KADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||...+
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2346799999999998665444 8999999999999999999997654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.72 Aligned_cols=203 Identities=33% Similarity=0.551 Sum_probs=163.6
Q ss_pred HhcCCccccccccccCceeEEEEEecCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
...++|++.++||+|+||+||++++. ..||+|++... .....+.+.+|+.+++.++||||++++++. ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34678999999999999999999874 35999998654 344557899999999999999999999954 56678999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999843 3467999999999999999999999998 99999999999999999999999999976543
Q ss_pred CCc-ccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKS-HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 222 2233457899999999986 5678889999999999999999999997643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=306.81 Aligned_cols=204 Identities=24% Similarity=0.447 Sum_probs=178.0
Q ss_pred HHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--------hhHHHHHHHHhHhhcC-ccceeeeeeee
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--------HRAANFYNEVNIISSV-EHKNLVRLLGC 377 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~ 377 (532)
.....++|++.+.||+|+||.||++++. +|+.||||++..... ...+.+.+|+.++..+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999985 799999999875431 1235678999999999 79999999999
Q ss_pred eecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 378 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
+......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999853 356999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCccccccccccccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 458 DFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH------GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 458 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
|||++........ .....||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 243 DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 243 DFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 9999987654332 234679999999999863 35788999999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=310.36 Aligned_cols=201 Identities=27% Similarity=0.469 Sum_probs=177.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||.||++.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999976 6899999998765 34445789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999953 34689999999999999999999986 7 999999999999999999999999998755322
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12345789999999999999999999999999999999999999976543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.02 Aligned_cols=201 Identities=26% Similarity=0.406 Sum_probs=175.1
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
..++|++.+.||+|+||.||+++.. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999975 789999999986655555678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE---cCCCcEEEeecCCccccC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL---DSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl---~~~~~~kl~Dfgl~~~~~ 466 (532)
|+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999853 356899999999999999999999998 9999999999999 788999999999987543
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 161 NGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp CBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 321 223468999999999998899999999999999999999999997643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=296.44 Aligned_cols=203 Identities=28% Similarity=0.503 Sum_probs=175.6
Q ss_pred CCccccc-cccccCceeEEEEEec---CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEAN-KLGQGGFGTVYKGVLP---DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
++|.+.+ .||+|+||.||+|.+. +++.||+|++... .....+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4667776 9999999999999863 5788999999764 344567899999999999999999999998 55678999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999843 3456999999999999999999999998 99999999999999999999999999987754
Q ss_pred CCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 468 DKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 468 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
.... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 4332 1223456889999999988889999999999999999999 9999977543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.48 Aligned_cols=205 Identities=30% Similarity=0.474 Sum_probs=178.5
Q ss_pred HhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
...++|++.++||+|+||.||+|++.++..||||++.... ...+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456789999999999999999999888899999997544 335689999999999999999999999866 67899999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|.+++... ....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999532 2356899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
........++..|+|||.+..+.++.++||||||+++|||++ |+.||....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 222233456789999999998999999999999999999999 999997654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=296.32 Aligned_cols=201 Identities=26% Similarity=0.466 Sum_probs=179.1
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.+.|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 357999999999999999999964 68999999997553 3446789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999983 356999999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 2 2234578999999999998899999999999999999999999997643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.49 Aligned_cols=204 Identities=25% Similarity=0.414 Sum_probs=172.1
Q ss_pred hcCCccccccccccCceeEEEEEecC----CCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
..++|++.+.||+|+||.||+|++.+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34689999999999999999998643 346999998765 33456789999999999999999999998764 5678
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999954 2356899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
............+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~ 219 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence 5544333344567889999999988899999999999999999998 999997543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=305.15 Aligned_cols=201 Identities=27% Similarity=0.463 Sum_probs=166.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhh-HHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHR-AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.++||+|+||+||+++.. +++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 78999999986543222 12456899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
++ ++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 98 588888854 3456899999999999999999999998 99999999999999999999999999986543322
Q ss_pred cccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2234568999999999876 568999999999999999999999997754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.58 Aligned_cols=201 Identities=26% Similarity=0.451 Sum_probs=171.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57999999999999999999975 58999999986543 3334668899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999988863 3456999999999999999999999998 9999999999999999999999999998664432
Q ss_pred cccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......|++.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 22345689999999998765 78999999999999999999999997754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=295.97 Aligned_cols=199 Identities=28% Similarity=0.436 Sum_probs=176.6
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999976 57889999986542 223467899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ...+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999854 346899999999999999999999998 999999999999999999999999998765432
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 2 234568999999999998889999999999999999999999997643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=299.34 Aligned_cols=196 Identities=27% Similarity=0.450 Sum_probs=171.6
Q ss_pred cCCccccccccccCceeEEEEEecC-C-------CEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD-G-------REIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
.++|++.+.||+|+||.||++++.. + ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3579999999999999999999653 3 4799999977766777889999999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc--------EE
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR--------AK 455 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~--------~k 455 (532)
.++||||+++++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999954 2344899999999999999999999998 999999999999999887 99
Q ss_pred EeecCCccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 456 IADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 456 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
|+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+.
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 9999998754322 23457889999999987 678999999999999999999655443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=302.15 Aligned_cols=217 Identities=24% Similarity=0.377 Sum_probs=182.2
Q ss_pred CCCCCcChhhHHHhcCCcccc-ccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcC-ccceee
Q 009543 298 DDSLNFKYSTLEKATGSFDEA-NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSV-EHKNLV 372 (532)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv 372 (532)
+...+..+...+...++|.+. +.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..+ +||||+
T Consensus 13 ~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv 92 (327)
T 3lm5_A 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92 (327)
T ss_dssp ---CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBC
T ss_pred ccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEE
Confidence 344456666677778889888 89999999999999975 68999999987542 33457889999999999 469999
Q ss_pred eeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC--
Q 009543 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-- 450 (532)
Q Consensus 373 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-- 450 (532)
++++++.+....++||||+++++|.+++.. .....+++.+++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 93 NLHEVYENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIY 168 (327)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBT
T ss_pred EEEEEEEeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCC
Confidence 999999999999999999999999998843 23467999999999999999999999998 999999999999998
Q ss_pred -CCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 451 -RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 451 -~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++.+||+|||+++....... .....||+.|+|||.+....++.++||||||+++|||++|+.||...+
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp TBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 78999999999987654322 234578999999999998999999999999999999999999997654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.19 Aligned_cols=201 Identities=28% Similarity=0.485 Sum_probs=173.5
Q ss_pred CCccccccccccCceeEEEEEe-----cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--Ccc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PES 384 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 384 (532)
++|++.++||+|+||.||++++ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4689999999999999999983 368899999987543 33457889999999999999999999999876 567
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999854 3356999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
....... ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 7654432 23345688889999999988999999999999999999999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=301.06 Aligned_cols=213 Identities=24% Similarity=0.426 Sum_probs=169.0
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEec----CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeee
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 379 (532)
..+....++|.+.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334445578999999999999999999864 3458999998654 3444577999999999999999999999988
Q ss_pred cCCc-----ceEEEEecCCCChhHHhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC
Q 009543 380 SGPE-----SLLVYEFLPNQSLDRFIFDS---AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR 451 (532)
Q Consensus 380 ~~~~-----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~ 451 (532)
+... .++||||+++++|.+++... .....+++..++.++.|+++||.|||+++ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7553 48999999999999998532 23467999999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 452 LRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 452 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
+.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 99999999999876543322 2233457889999999999899999999999999999999 9999977543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.84 Aligned_cols=202 Identities=29% Similarity=0.451 Sum_probs=178.1
Q ss_pred CCccccccccccCceeEEEEEe-----cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeee--cCCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC--SGPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~ 385 (532)
++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+++++.++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5799999999999999999984 368899999998777777788999999999999999999999886 445578
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999542 245899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 466 QEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 544332 233456888899999999888999999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.26 Aligned_cols=204 Identities=24% Similarity=0.415 Sum_probs=165.9
Q ss_pred HHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 309 EKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 309 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
....++|++.++||+|+||+||+++.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344578999999999999999999965 789999999965432 23456789999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE-----cCCCcEEEeecC
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL-----DSRLRAKIADFG 460 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl-----~~~~~~kl~Dfg 460 (532)
+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 99998843 356999999999999999999999998 9999999999999 455569999999
Q ss_pred CccccCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++........ ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 9987653322 22345689999999998764 58999999999999999999999997653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.32 Aligned_cols=205 Identities=26% Similarity=0.480 Sum_probs=168.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCE----EEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGRE----IAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
.++|++.++||+|+||.||++++. +++. |++|.+... .....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 468999999999999999999964 4554 577776543 344567899999999999999999999998865 488
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+++||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999854 3456999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 009543 466 QEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSE 522 (532)
Q Consensus 466 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~ 522 (532)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 543322 2233456889999999999999999999999999999999 99999876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=306.75 Aligned_cols=198 Identities=28% Similarity=0.473 Sum_probs=157.0
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC------
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------ 381 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 381 (532)
..++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4578999999999999999999964 6899999998653 334557788999999999999999999998654
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
...++++|++ +++|.+++. ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999998 789998883 356999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865432 234578999999999876 678999999999999999999999997754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=305.76 Aligned_cols=208 Identities=25% Similarity=0.373 Sum_probs=170.7
Q ss_pred hhhHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccC-----------hhhHHHHHHHHhHhhcCccceeee
Q 009543 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN-----------RHRAANFYNEVNIISSVEHKNLVR 373 (532)
Q Consensus 305 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~ 373 (532)
..++....++|++.+.||+|+||.||++...+|+.||||++.... ....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456677889999999999999999999998889999999985432 122377999999999999999999
Q ss_pred eeeeeecC-----CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 374 LLGCSCSG-----PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 374 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
+++++... ...++||||++ ++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99998543 35689999998 578777743 3457999999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 449 DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+.++.+||+|||++........ .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999975443322 234578999999999876 678999999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.31 Aligned_cols=203 Identities=28% Similarity=0.459 Sum_probs=172.6
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecC-------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSG------- 381 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 381 (532)
.++|++.++||+|+||.||+++. .+|+.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999997 4789999999865432 2345788999999999999999999998763
Q ss_pred -CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 382 -PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 382 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
+..++||||+++ +|.+.+.. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999986 67666643 3356999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCcc---ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSH---ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876533221 2244578999999998875 468999999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=294.96 Aligned_cols=203 Identities=28% Similarity=0.422 Sum_probs=173.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
++|.....||+|+||.||+|++. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34566679999999999999964 68899999998766666678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-CCcEEEeecCCccccCCCCc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-~~~~kl~Dfgl~~~~~~~~~ 470 (532)
++++|.+++........+++..++.++.|++.||.|||+++ |+|+||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999965444456789999999999999999999998 999999999999988 89999999999987644322
Q ss_pred ccccccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQ--LTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......|++.|+|||.+.... ++.++||||||+++|||++|+.||...
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 223456899999999987643 789999999999999999999999653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.50 Aligned_cols=201 Identities=28% Similarity=0.430 Sum_probs=172.2
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
..++|++.++||+|+||+||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4457999999999999999999975 68899999987543 23356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC---CcEEEeecCCccc
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARS 464 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~---~~~kl~Dfgl~~~ 464 (532)
|||+++|+|.+.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999998853 356899999999999999999999998 9999999999999764 4599999999987
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... .....||+.|+|||++. +.++.++||||||+++|||++|+.||...+
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 654332 23457999999999886 568999999999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=301.20 Aligned_cols=204 Identities=28% Similarity=0.534 Sum_probs=169.9
Q ss_pred cCCccccccccccCceeEEEEEecC-----CCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD-----GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678889999999999999998653 2359999987543 344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++++|.+++.. ....+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999954 3457999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 466 QEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
...... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 543322 1222346788999999998899999999999999999999 999997643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=316.47 Aligned_cols=202 Identities=31% Similarity=0.458 Sum_probs=174.9
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-------------hhHHHHHHHHhHhhcCccceeeeee
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-------------HRAANFYNEVNIISSVEHKNLVRLL 375 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~ 375 (532)
...++|++.++||+|+||+||+++.. +++.||+|++..... ...+.+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45678999999999999999999975 688999999865421 2346789999999999999999999
Q ss_pred eeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC---
Q 009543 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL--- 452 (532)
Q Consensus 376 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~--- 452 (532)
+++.+....++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999998853 356999999999999999999999998 99999999999998876
Q ss_pred cEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 453 RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.+||+|||++........ .....||+.|+|||++. +.++.++||||||+++|||++|+.||...+
T Consensus 187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 699999999987654432 23457999999999986 568999999999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.38 Aligned_cols=202 Identities=32% Similarity=0.485 Sum_probs=162.1
Q ss_pred CccccccccccCceeEEEEEec--CC--CEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeec-CCcceEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP--DG--REIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPESLLV 387 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv 387 (532)
.|++.+.||+|+||.||+|++. ++ ..||+|.+... .....+.+.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4777899999999999999964 22 35899988643 33456789999999999999999999998654 5578999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999953 3456899999999999999999999998 99999999999999999999999999986644
Q ss_pred CCcc---cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 468 DKSH---ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 468 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 3221 1233457889999999999999999999999999999999 777886654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.66 Aligned_cols=201 Identities=30% Similarity=0.455 Sum_probs=175.0
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
..++|++.++||+|+||+||+++.. +++.||||++.... ......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4467999999999999999999975 78999999986432 23457789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc---CCCcEEEeecCCccc
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD---SRLRAKIADFGLARS 464 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~---~~~~~kl~Dfgl~~~ 464 (532)
|||+++++|.+.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999998854 356999999999999999999999998 99999999999995 456799999999987
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...+
T Consensus 174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 654332 234579999999999865 58999999999999999999999997754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.32 Aligned_cols=210 Identities=26% Similarity=0.376 Sum_probs=163.8
Q ss_pred HHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeee------
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSC------ 379 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~------ 379 (532)
++....+|++.++||+|+||.||++++. +++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3334568999999999999999999975 78999999997777777788999999999996 999999999984
Q ss_pred --cCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 380 --SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 380 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
.....+++|||++ |+|.+++........+++.+++.++.|++.||.|||+++ .+|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence 2334689999996 789998865445667999999999999999999999874 359999999999999999999999
Q ss_pred ecCCccccCCCCcc-----------ccccccccccccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 458 DFGLARSFQEDKSH-----------ISTAIAGTLGYMAPEYL---AHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 458 Dfgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
|||++......... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||...
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 99999876543321 11134689999999998 5667899999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=303.88 Aligned_cols=204 Identities=29% Similarity=0.445 Sum_probs=168.9
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhh-----HHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHR-----AANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
...++|++.+.||+|+||.||++++. +|+.||||++....... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 68999999986542211 2467899999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||+++ +|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 88888743 3456889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 7654322 23345789999999998654 58999999999999999999999997653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=292.28 Aligned_cols=201 Identities=24% Similarity=0.426 Sum_probs=169.4
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|+||.||++++. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 478999999999999999999976 79999999986542 23346788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999953 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ccc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 322 233468999999999987665 689999999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=303.65 Aligned_cols=203 Identities=24% Similarity=0.418 Sum_probs=174.1
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecC-----Cc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-----PE 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 383 (532)
..++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999975 68899999997543 34457789999999999999999999998654 35
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||++ ++|.+++. ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 789999997 48988884 346999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc--ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 464 SFQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 464 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+.
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 76543322 1244579999999998654 4589999999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=296.79 Aligned_cols=201 Identities=25% Similarity=0.426 Sum_probs=167.3
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeee-----------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC----------- 379 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------- 379 (532)
.++|++.+.||+|+||.||++... +++.||+|++...+....+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999986 58999999998777777788999999999999999999998874
Q ss_pred ---cCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc-CCCcEE
Q 009543 380 ---SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAK 455 (532)
Q Consensus 380 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~-~~~~~k 455 (532)
+....++||||++ ++|.+++. ...+++..++.++.|+++||.|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3456789999998 59999883 356899999999999999999999998 99999999999997 567999
Q ss_pred EeecCCccccCCCCcc--ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 456 IADFGLARSFQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 456 l~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|+|||+++........ ......+++.|+|||.+.. ..++.++||||||+++|||++|+.||...+
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999876433221 2233457899999998765 678999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=298.83 Aligned_cols=200 Identities=29% Similarity=0.486 Sum_probs=173.0
Q ss_pred CCc-cccccccccCceeEEEEEec-----CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecC--Cc
Q 009543 313 GSF-DEANKLGQGGFGTVYKGVLP-----DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PE 383 (532)
Q Consensus 313 ~~~-~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 383 (532)
++| ++.++||+|+||+||++.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 345 99999999999999998642 68899999997653 34457799999999999999999999999874 56
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 7899999999999999843 35999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 464 SFQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 464 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
........ ......+|..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 77654332 233456788899999999888999999999999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.49 Aligned_cols=201 Identities=29% Similarity=0.433 Sum_probs=177.6
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
..++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999976 78999999986542 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE---cCCCcEEEeecCCcc
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL---DSRLRAKIADFGLAR 463 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl---~~~~~~kl~Dfgl~~ 463 (532)
||||+++++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999884 3456999999999999999999999998 9999999999999 567899999999998
Q ss_pred ccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...+
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 7654432 234569999999999865 68999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=305.43 Aligned_cols=200 Identities=21% Similarity=0.312 Sum_probs=166.1
Q ss_pred cCCccccccccccCceeEEEEEec----CCCEEEEEEeeccChh-----------hHHHHHHHHhHhhcCccceeeeeee
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFNNRH-----------RAANFYNEVNIISSVEHKNLVRLLG 376 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 376 (532)
.++|++.+.||+|+||.||++++. ++..+|+|+....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999975 5788999998755321 1124667888999999999999999
Q ss_pred eeec----CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC
Q 009543 377 CSCS----GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (532)
Q Consensus 377 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~ 452 (532)
++.. ....++||||+ +++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9887 67789999999 9999999843 337999999999999999999999998 99999999999999887
Q ss_pred --cEEEeecCCccccCCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 453 --RAKIADFGLARSFQEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 453 --~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999999876433211 12445799999999999988899999999999999999999999965
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=304.15 Aligned_cols=198 Identities=29% Similarity=0.408 Sum_probs=164.3
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 382 (532)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999965 6889999998753 3344567889999999999999999999987655
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..++||||+++ +|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 6777773 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8654332 2234578999999999998899999999999999999999999997754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.36 Aligned_cols=200 Identities=26% Similarity=0.398 Sum_probs=168.4
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc------ce
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE------SL 385 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~ 385 (532)
..+|++.+.||+|+||.||++++.++..+|+|++...... ..+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999987778999998654322 2369999999999999999999865433 67
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc-CCCcEEEeecCCccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARS 464 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~-~~~~~kl~Dfgl~~~ 464 (532)
+||||++++.+............+++..++.++.||++||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988655544433334567999999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... .....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 644332 2345789999999998654 58999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.96 Aligned_cols=208 Identities=28% Similarity=0.484 Sum_probs=167.1
Q ss_pred ChhhHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhc--CccceeeeeeeeeecC
Q 009543 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISS--VEHKNLVRLLGCSCSG 381 (532)
Q Consensus 304 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~ 381 (532)
.........++|++.++||+|+||.||++++. ++.||||++.... ...+.+|.+++.. ++||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 33334455678999999999999999999985 8999999986443 2334445555544 5999999999998877
Q ss_pred ----CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEccCCCCCEEEcCCC
Q 009543 382 ----PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS-----KIRIIHRDIKASNILLDSRL 452 (532)
Q Consensus 382 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~iiH~Dlkp~NiLl~~~~ 452 (532)
...++||||+++++|.+++.. ..+++..++.++.|++.||.|||++. +.+|+||||||+|||++.++
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 678999999999999999943 46899999999999999999999880 11299999999999999999
Q ss_pred cEEEeecCCccccCCCCcc---cccccccccccccccccccCCCCch------hhHHHHHHHHHHHHhC----------C
Q 009543 453 RAKIADFGLARSFQEDKSH---ISTAIAGTLGYMAPEYLAHGQLTEK------ADVYSFGMLLLEIVTG----------R 513 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlGvll~el~tG----------~ 513 (532)
.+||+|||++......... ......||+.|+|||.+.+.....+ +||||||+++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999999776544332 1234579999999999987665554 9999999999999999 6
Q ss_pred CCCCCC
Q 009543 514 QNNRSK 519 (532)
Q Consensus 514 ~p~~~~ 519 (532)
.||...
T Consensus 260 ~p~~~~ 265 (337)
T 3mdy_A 260 LPYHDL 265 (337)
T ss_dssp CTTTTT
T ss_pred ccHhhh
Confidence 677553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=292.88 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=172.6
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 386 (532)
..++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999976 7999999998754 234456788999999999 99999999999999999999
Q ss_pred EEEecCCCChhHHhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC--------------
Q 009543 387 VYEFLPNQSLDRFIFDSAK-AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-------------- 451 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-------------- 451 (532)
||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999964322 367899999999999999999999998 9999999999999844
Q ss_pred -----CcEEEeecCCccccCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 452 -----LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 452 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|++|+..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999998765432 23589999999998765 567899999999999999999987754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=297.75 Aligned_cols=205 Identities=26% Similarity=0.343 Sum_probs=173.9
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec----CCcce
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPESL 385 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 385 (532)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346899999999999999999997 5799999999987777777889999999999999999999999873 34678
Q ss_pred EEEEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 386 LVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
+||||+++++|.+++.... ....+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999986422 3467999999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCcc--------cccccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 465 FQEDKSH--------ISTAIAGTLGYMAPEYLAHGQ---LTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 465 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
....... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 5322111 012345799999999987543 68899999999999999999999954
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=295.94 Aligned_cols=204 Identities=24% Similarity=0.429 Sum_probs=166.8
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
.++|++.+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999996 47899999998753 344557789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 388 YEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999985422 3466899999999999999999999998 9999999999999999999999999988664
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 4322 223456899999999999889999999999999999999999999754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=301.79 Aligned_cols=202 Identities=25% Similarity=0.385 Sum_probs=177.4
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhh-----------------HHHHHHHHhHhhcCccceeeee
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR-----------------AANFYNEVNIISSVEHKNLVRL 374 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~~ 374 (532)
.++|++.+.||+|+||.||+++. +++.||+|++....... .+.+.+|+.++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999999999 89999999986542211 1789999999999999999999
Q ss_pred eeeeecCCcceEEEEecCCCChhHH------hhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEE
Q 009543 375 LGCSCSGPESLLVYEFLPNQSLDRF------IFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNIL 447 (532)
Q Consensus 375 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiL 447 (532)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.|++.||.|||+ ++ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 225779999999999999999999999 87 999999999999
Q ss_pred EcCCCcEEEeecCCccccCCCCcccccccccccccccccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 448 LDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTE-KADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 448 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999876443 23445789999999999877 5666 99999999999999999999987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.29 Aligned_cols=203 Identities=24% Similarity=0.419 Sum_probs=176.7
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---------hhhHHHHHHHHhHhhcCc-cceeeeeeeee
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---------RHRAANFYNEVNIISSVE-HKNLVRLLGCS 378 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 378 (532)
...++|++.+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999975 68999999986543 123456889999999995 99999999999
Q ss_pred ecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEee
Q 009543 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458 (532)
Q Consensus 379 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~D 458 (532)
......++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999953 356899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCcccccccccccccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLA------HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 459 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
||++........ .....|++.|+|||.+. ...++.++||||||+++|||++|+.||...+
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 999987654332 23456899999999885 4568899999999999999999999997643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=325.61 Aligned_cols=203 Identities=28% Similarity=0.495 Sum_probs=169.9
Q ss_pred CCccccc-cccccCceeEEEEEec---CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEAN-KLGQGGFGTVYKGVLP---DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
+++.+.+ +||+|+||.||+|.+. ++..||||++.... ....+++.+|+++++.++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3445555 7999999999999864 46679999997643 3456789999999999999999999999876 568999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999953 3457999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccc--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 468 DKSHI--STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 468 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
..... .....+++.|+|||++..+.++.++||||||+++|||++ |+.||...+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 33221 122345689999999998999999999999999999998 9999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.20 Aligned_cols=202 Identities=31% Similarity=0.495 Sum_probs=173.3
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
...++|++.+.||+|+||.||++.+. +|+.||+|++.... ..+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999976 58999999987543 3467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999843 3467999999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 22 223456899999999999888999999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.20 Aligned_cols=201 Identities=22% Similarity=0.303 Sum_probs=173.9
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC------ccceeeeeeeeeecCC
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV------EHKNLVRLLGCSCSGP 382 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~ 382 (532)
....+|++.+.||+|+||+||++... +++.||||++... ......+.+|+.++..+ +|+||+++++++....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 45678999999999999999999875 5899999998643 33445677888887776 5779999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc--EEEeecC
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR--AKIADFG 460 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~--~kl~Dfg 460 (532)
..++||||++ ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999996 6898888542 3346999999999999999999999998 999999999999999987 9999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 248 ~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 997654322 24578999999999999999999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=300.02 Aligned_cols=202 Identities=29% Similarity=0.500 Sum_probs=176.3
Q ss_pred cCCccccccccccCceeEEEEEe-----cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC--cc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP--ES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 384 (532)
.++|++.+.||+|+||.||++++ .+++.||+|++........+.+.+|+++++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35689999999999999999984 368899999998776666788999999999999999999999887644 68
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++++|.+++.. ....+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999954 2356899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 7554332 12334577889999999888899999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=293.57 Aligned_cols=197 Identities=30% Similarity=0.531 Sum_probs=173.0
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec---------
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--------- 380 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------- 380 (532)
..++|++.+.||+|+||.||++++. +++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467999999999999999999986 79999999997654 346789999999999999999998754
Q ss_pred -------CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc
Q 009543 381 -------GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR 453 (532)
Q Consensus 381 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~ 453 (532)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34478999999999999999542 3467999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 454 AKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 454 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999987654432 234568999999999998889999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=297.63 Aligned_cols=208 Identities=27% Similarity=0.406 Sum_probs=160.2
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
...++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++..++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34678999999999999999999964 68999999986543 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 388 YEFLPNQSLDRFIFDS-----AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
|||+++++|.+++... .....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998531 12456899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCc----cccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKS----HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
........ .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 76543321 12234568999999999875 568999999999999999999999997643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=293.53 Aligned_cols=204 Identities=32% Similarity=0.468 Sum_probs=170.4
Q ss_pred cCCccccccccccCceeEEEEEecC----CCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeee-cCCcce
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSC-SGPESL 385 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~ 385 (532)
..+|++.+.||+|+||.||+|++.+ ...+|+|++... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468899999999999999999642 235899988654 3445578999999999999999999999854 456789
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999953 3466899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc---cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 466 QEDKSH---ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 543321 2234567889999999998899999999999999999999 556665543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.42 Aligned_cols=202 Identities=23% Similarity=0.404 Sum_probs=168.0
Q ss_pred HHhcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecC------
Q 009543 309 EKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------ 381 (532)
Q Consensus 309 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 381 (532)
+...++|++.+.||+|+||.||++++ .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999996 47999999998654322 23799999999999999999998543
Q ss_pred --------------------------------CcceEEEEecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHH
Q 009543 382 --------------------------------PESLLVYEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYL 428 (532)
Q Consensus 382 --------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~L 428 (532)
...++||||++ ++|.+.+... .....+++..++.++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999998 4887777532 2356799999999999999999999
Q ss_pred HhCCCCCeEEccCCCCCEEEc-CCCcEEEeecCCccccCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHH
Q 009543 429 HEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLL 506 (532)
Q Consensus 429 H~~~~~~iiH~Dlkp~NiLl~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll 506 (532)
|+++ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||||+++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9998 99999999999998 688999999999987654432 2345689999999998764 589999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 009543 507 LEIVTGRQNNRSKN 520 (532)
Q Consensus 507 ~el~tG~~p~~~~~ 520 (532)
|||++|+.||...+
T Consensus 233 ~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 233 GELILGKPLFSGET 246 (383)
T ss_dssp HHHHHSSCSSCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.91 Aligned_cols=199 Identities=29% Similarity=0.429 Sum_probs=171.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeec----CCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 385 (532)
..|.+.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888899999999999999975 6889999998754 34456778999999999999999999998765 34578
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc-CCCcEEEeecCCccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARS 464 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~-~~~~~kl~Dfgl~~~ 464 (532)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999943 356899999999999999999999875 3599999999999998 789999999999975
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
..... .....|++.|+|||.+. +.++.++||||||+++|||++|+.||...
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 54332 23456899999999876 46899999999999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=298.29 Aligned_cols=204 Identities=27% Similarity=0.451 Sum_probs=172.6
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
..++|++.+.||+|+||.||++++. +++.||+|++........+.+.+|++++..++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3468999999999999999999986 589999999977666667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999998854 2456999999999999999999999998 9999999999999999999999999875432111
Q ss_pred ccccccccccccccccccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYL-----AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.......|++.|+|||.+ ....++.++||||||+++|||++|+.||...+
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 112234689999999998 35678899999999999999999999997643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.92 Aligned_cols=204 Identities=21% Similarity=0.363 Sum_probs=170.3
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeee-ecCCcceEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS-CSGPESLLVY 388 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 388 (532)
..++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+|+.++..++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 5789999998754432 23578899999999988877776655 5667779999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE---cCCCcEEEeecCCcccc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL---DSRLRAKIADFGLARSF 465 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl---~~~~~~kl~Dfgl~~~~ 465 (532)
||+ +++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999853 2456999999999999999999999998 9999999999999 78899999999999876
Q ss_pred CCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 466 QEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 466 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 554331 223457899999999999989999999999999999999999999875443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=309.44 Aligned_cols=198 Identities=29% Similarity=0.426 Sum_probs=164.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC------cce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~ 385 (532)
.+|++.+.||+|+||.||++++. +|+.||||++..... ...+|+++++.++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999985 689999999865432 2347999999999999999999885421 256
Q ss_pred EEEEecCCCChhHHhhh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecCCcc
Q 009543 386 LVYEFLPNQSLDRFIFD-SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLAR 463 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfgl~~ 463 (532)
+||||+++ +|.+++.. ......+++..++.++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 56555532 223567999999999999999999999998 9999999999999965 578999999998
Q ss_pred ccCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 7644332 2345789999999998764 78999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=293.99 Aligned_cols=208 Identities=26% Similarity=0.410 Sum_probs=174.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeee--cCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSC--SGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~l 386 (532)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999975 6899999999754 3445577999999999999999999999875 3567899
Q ss_pred EEEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 387 VYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQS--KIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999996532 2345999999999999999999999875 2349999999999999999999999999998
Q ss_pred ccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 7654322 1233468999999999998889999999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=298.02 Aligned_cols=201 Identities=24% Similarity=0.376 Sum_probs=169.5
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--------hhhHHHHHHHHhHhhcCccceeeeeeeeeecC
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG 381 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 381 (532)
..++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999975 68899999986432 12234588999999999999999999998665
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc---EEEee
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR---AKIAD 458 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~---~kl~D 458 (532)
. .++||||+++++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999884 4567999999999999999999999998 999999999999987665 99999
Q ss_pred cCCccccCCCCcccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 459 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
||++....... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99998764332 223456899999999974 4678899999999999999999999997653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=291.73 Aligned_cols=203 Identities=22% Similarity=0.376 Sum_probs=173.8
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeee-ecCCcceEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS-CSGPESLLVY 388 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 388 (532)
..++|++.+.||+|+||.||+++. .+++.||||++...... ..+.+|+.++..++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999996 57899999998654332 4688999999999988877666655 5566779999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE---cCCCcEEEeecCCcccc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL---DSRLRAKIADFGLARSF 465 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl---~~~~~~kl~Dfgl~~~~ 465 (532)
||+ +++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 9999999853 2456999999999999999999999998 9999999999999 48889999999999876
Q ss_pred CCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 466 QEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 466 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 554331 12445799999999999998999999999999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=293.82 Aligned_cols=202 Identities=28% Similarity=0.465 Sum_probs=171.8
Q ss_pred cCCccccc-cccccCceeEEEEEe---cCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 312 TGSFDEAN-KLGQGGFGTVYKGVL---PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 312 ~~~~~~~~-~lG~G~fg~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
.++|++.+ .||+|+||.||++.+ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35688888 999999999999964 246889999987543 23357799999999999999999999998 667789
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++++|.+++.. ...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999953 356999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccc--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 466 QEDKSHI--STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
....... .....+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 5544321 222346788999999988889999999999999999999 999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=301.06 Aligned_cols=198 Identities=30% Similarity=0.517 Sum_probs=160.9
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec-----CCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-----GPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l 386 (532)
.++|++.++||+|+||.||+|+. +++.||||++....... .....|+..+..++||||+++++.+.. ....++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 46899999999999999999987 68999999996543322 122344455566899999999985432 234689
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ---------SKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
||||+++|+|.+++.. ...++..++.++.|+++||.|||+. + |+||||||+|||++.++.+||+
T Consensus 90 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 9999999999999943 3458999999999999999999998 6 9999999999999999999999
Q ss_pred ecCCccccCCCCc-------cccccccccccccccccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 458 DFGLARSFQEDKS-------HISTAIAGTLGYMAPEYLAH-------GQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 458 Dfgl~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
|||+++....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|..||..
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 9999987654321 12234579999999999876 4567899999999999999999877644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=295.70 Aligned_cols=194 Identities=21% Similarity=0.363 Sum_probs=170.6
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeeec--CCcceEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCS--GPESLLV 387 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 387 (532)
.++|++.++||+|+||+||+++. .+++.||||++.... .+.+.+|+.++..++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999986 478999999986433 467889999999997 9999999999987 5678999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCccccC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQ 466 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~~~ 466 (532)
|||+++++|.+++. .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999872 3889999999999999999999998 99999999999999777 89999999998765
Q ss_pred CCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 4332 234568999999999876 67899999999999999999999999553
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=291.07 Aligned_cols=199 Identities=28% Similarity=0.410 Sum_probs=169.6
Q ss_pred CccccccccccCceeEEEEEec-CC---CEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc-eEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DG---REIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES-LLV 387 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv 387 (532)
.|+..++||+|+||+||+|++. ++ ..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999863 22 379999986543 34557899999999999999999999999876665 899
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999953 3567899999999999999999999998 99999999999999999999999999986544
Q ss_pred CCc---ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 468 DKS---HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 468 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
... .......+++.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 321 12234567899999999999899999999999999999999655543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=305.66 Aligned_cols=200 Identities=11% Similarity=0.086 Sum_probs=154.3
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh---hhHHHHHHHHhHhhcC--ccceeeeee-------eee
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNIISSV--EHKNLVRLL-------GCS 378 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~ 378 (532)
..+|++.+.||+|+||.||++++. +|+.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999975 789999999987542 3345677885544444 699988755 333
Q ss_pred ecC-----------------CcceEEEEecCCCChhHHhhhccCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 009543 379 CSG-----------------PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR------YEIILGTVEGLVYLHEQSKIR 435 (532)
Q Consensus 379 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~ 435 (532)
... ...++||||++ ++|.+++.... ..+++..+ +.++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 322 23799999999 89999996532 23455555 778899999999999998
Q ss_pred eEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCC
Q 009543 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGR 513 (532)
Q Consensus 436 iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~ 513 (532)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998654322 13456799999999987 67899999999999999999999
Q ss_pred CCCCCCCC
Q 009543 514 QNNRSKNS 521 (532)
Q Consensus 514 ~p~~~~~~ 521 (532)
.||.....
T Consensus 291 ~Pf~~~~~ 298 (371)
T 3q60_A 291 LPFGLVTP 298 (371)
T ss_dssp CSTTBCCT
T ss_pred CCCCCcCc
Confidence 99987643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=298.30 Aligned_cols=206 Identities=32% Similarity=0.480 Sum_probs=172.8
Q ss_pred cCCccccccccccCceeEEEEEe------cCCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.+.||+|+||.||++++ .+++.||||++... .......+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 25778999999644 344556799999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---CCcEEEe
Q 009543 385 LLVYEFLPNQSLDRFIFDSAK----AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIA 457 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~~~~kl~ 457 (532)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965321 245899999999999999999999998 999999999999994 4469999
Q ss_pred ecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 458 DFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 458 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 99998765433222 2234567899999999988899999999999999999998 999997654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=297.96 Aligned_cols=203 Identities=31% Similarity=0.467 Sum_probs=171.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEE--EEEEeecc-ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREI--AVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 387 (532)
++|++.+.||+|+||.||++++. +++.+ ++|++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999975 56644 99988643 233456789999999999 899999999999999999999
Q ss_pred EEecCCCChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 388 YEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
|||+++++|.+++.... ....+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999995432 2357999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
||+|||+++...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 999999987433221 1223456889999999988889999999999999999998 999997654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=290.78 Aligned_cols=205 Identities=24% Similarity=0.351 Sum_probs=171.2
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC----hhhHHHHHHHHhHhhcCccceeeeeeeeee--cCCc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN----RHRAANFYNEVNIISSVEHKNLVRLLGCSC--SGPE 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~ 383 (532)
..++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999975 68999999986542 234567999999999999999999999984 4557
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||++++ |.+++.. .....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999887 6666643 23567999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc-cccccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSH-ISTAIAGTLGYMAPEYLAHGQ--LTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
........ ......|++.|+|||.+.+.. .+.++||||||+++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 76533222 233456899999999987643 4789999999999999999999998643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=297.67 Aligned_cols=212 Identities=28% Similarity=0.448 Sum_probs=172.8
Q ss_pred cChhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeec
Q 009543 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCS 380 (532)
Q Consensus 303 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 380 (532)
+....+....++|++.+.||+|+||.||++++. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344445566789999999999999999999974 78999999986543 2346788999999998 89999999999876
Q ss_pred ------CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 381 ------GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 381 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 45789999999999999998543 3457899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCcccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
||+|||++........ ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...+
T Consensus 169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999886643322 123456899999999986 5678899999999999999999999997643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.44 Aligned_cols=201 Identities=29% Similarity=0.372 Sum_probs=171.8
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc--------cceeeeeeeeee--
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE--------HKNLVRLLGCSC-- 379 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~-- 379 (532)
..++|++.++||+|+||+||+++.. +++.||||++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 4588999999999999999999964 6889999998643 344577889999999986 888999999987
Q ss_pred --cCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCC----
Q 009543 380 --SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRL---- 452 (532)
Q Consensus 380 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~---- 452 (532)
.....++||||+ +++|.+.+... ....+++..++.++.||++||.|||++ + |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 556789999999 55666665432 335699999999999999999999998 7 99999999999999875
Q ss_pred ---------------------------------------------cEEEeecCCccccCCCCcccccccccccccccccc
Q 009543 453 ---------------------------------------------RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487 (532)
Q Consensus 453 ---------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~ 487 (532)
.+||+|||++...... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999876543 233578999999999
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 488 LAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 488 ~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
+.+..++.++||||||+++|||++|+.||...+.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 9998999999999999999999999999987543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=297.32 Aligned_cols=206 Identities=27% Similarity=0.438 Sum_probs=174.7
Q ss_pred cChhhHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhc--Cccceeeeeeeeeec
Q 009543 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISS--VEHKNLVRLLGCSCS 380 (532)
Q Consensus 303 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~ 380 (532)
..........++|++.+.||+|+||.||++++ +++.||||++... ....+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34444455678899999999999999999998 5899999998543 34567788888887 789999999999987
Q ss_pred CC----cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEccCCCCCEEE
Q 009543 381 GP----ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH--------EQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 381 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~iiH~Dlkp~NiLl 448 (532)
.. ..++||||+++++|.+++.. ..+++.+++.++.|++.||.||| +.+ |+||||||+|||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 76 78999999999999999943 46899999999999999999999 666 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcc---cccccccccccccccccccC------CCCchhhHHHHHHHHHHHHhC-------
Q 009543 449 DSRLRAKIADFGLARSFQEDKSH---ISTAIAGTLGYMAPEYLAHG------QLTEKADVYSFGMLLLEIVTG------- 512 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvll~el~tG------- 512 (532)
+.++.+||+|||++......... ......||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999876554432 22445789999999998765 234789999999999999999
Q ss_pred ---CCCCCCC
Q 009543 513 ---RQNNRSK 519 (532)
Q Consensus 513 ---~~p~~~~ 519 (532)
+.||...
T Consensus 261 ~~~~~p~~~~ 270 (342)
T 1b6c_B 261 EDYQLPYYDL 270 (342)
T ss_dssp CCCCCTTTTT
T ss_pred cccccCcccc
Confidence 7888764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.77 Aligned_cols=208 Identities=24% Similarity=0.335 Sum_probs=162.0
Q ss_pred hhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc-
Q 009543 306 STLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE- 383 (532)
Q Consensus 306 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 383 (532)
.......++|++.+.||+|+||.||++++. +|+.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344556789999999999999999999975 68999999986543 223456778888899999999999999865433
Q ss_pred ------ceEEEEecCCCChhHHhh-hccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEccCCCCCEEEcC-CCc
Q 009543 384 ------SLLVYEFLPNQSLDRFIF-DSAKAKTLTWEKRYEIILGTVEGLVYLH--EQSKIRIIHRDIKASNILLDS-RLR 453 (532)
Q Consensus 384 ------~~lv~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~iiH~Dlkp~NiLl~~-~~~ 453 (532)
.++||||++++ |.+.+. .......+++..++.++.|++.||.||| +++ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 68999999874 444332 2245667899999999999999999999 777 999999999999997 899
Q ss_pred EEEeecCCccccCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 454 AKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 454 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+||+|||++........ .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999999987654432 2345689999999998654 48999999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=299.76 Aligned_cols=197 Identities=26% Similarity=0.475 Sum_probs=169.1
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc---
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES--- 384 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 384 (532)
..++|.+.+.||+|+||.||++.+. +|+.||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999975 6899999999754 334457789999999999999999999999877655
Q ss_pred ---eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 385 ---LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 385 ---~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
++||||++ ++|.+++ ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 5887776 234899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865432 234578999999999877 678999999999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=291.69 Aligned_cols=198 Identities=29% Similarity=0.464 Sum_probs=165.6
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecC-CcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-PESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~ 390 (532)
.++|++.+.||+|+||.||+++. +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46799999999999999999988 48899999986443 456789999999999999999999987654 478999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++++|.+++... ....+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999998542 2234789999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22356889999999998899999999999999999998 999997754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=325.65 Aligned_cols=196 Identities=29% Similarity=0.481 Sum_probs=166.1
Q ss_pred ccccccCceeEEEEEec---CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP---DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
++||+|+||.||+|.+. +++.||||++.... ....+++.+|++++.+++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 46789999997543 344678999999999999999999999886 4568899999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc--
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-- 471 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-- 471 (532)
|+|.+++. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999994 3457999999999999999999999998 999999999999999999999999999876544322
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
......+|+.|+|||++....++.++||||||+++|||++ |+.||...+.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 2233456789999999999999999999999999999998 9999987553
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.00 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=172.0
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecC-----Cc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-----PE 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 383 (532)
..++|++.+.||+|+||.||++++. +|+.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999975 68999999996543 34456788999999999999999999987654 66
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.++||||++ ++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 589888843 46999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc---------ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSH---------ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
........ ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 76533221 1123468999999998754 678999999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=303.89 Aligned_cols=199 Identities=18% Similarity=0.257 Sum_probs=170.5
Q ss_pred cCCccccccccccCceeEEEEEecC---------CCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeee---------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD---------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR--------- 373 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 373 (532)
.++|++.+.||+|+||.||++++.. ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999763 789999998644 35789999999999999988
Q ss_pred ------eeeeeec-CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCE
Q 009543 374 ------LLGCSCS-GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNI 446 (532)
Q Consensus 374 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~Ni 446 (532)
+++++.. ....++||||+ +++|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5566655 67789999999 99999999642 2367999999999999999999999998 99999999999
Q ss_pred EEcCCC--cEEEeecCCccccCCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 447 LLDSRL--RAKIADFGLARSFQEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 447 Ll~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
|++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876543221 12345799999999999988999999999999999999999999987
Q ss_pred CC
Q 009543 519 KN 520 (532)
Q Consensus 519 ~~ 520 (532)
..
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 53
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.72 Aligned_cols=201 Identities=23% Similarity=0.359 Sum_probs=175.2
Q ss_pred hcCCccccccccccCceeEEEEEe--cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce------eeeeeeeeecCC
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL--PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN------LVRLLGCSCSGP 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~ 382 (532)
..++|++.+.||+|+||.||++.. .+++.||||++... ....+.+.+|+.++..++|++ ++++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457899999999999999999986 36889999998643 344567889999999998775 999999999999
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC------------
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS------------ 450 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~------------ 450 (532)
..++||||+ +++|.+++... ....+++..++.++.|+++||.|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 88999998542 2346899999999999999999999998 999999999999988
Q ss_pred -------CCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 451 -------RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 451 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
++.+||+|||++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 6689999999998654332 345789999999999988999999999999999999999999987543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=291.95 Aligned_cols=203 Identities=31% Similarity=0.487 Sum_probs=165.5
Q ss_pred cCCccccccccccCceeEEEEEec--CCC--EEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP--DGR--EIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.+.||+|+||.||++++. +++ .||+|++... .....+.+.+|+++++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999863 333 6899988654 2345578999999999999999999999987654 8
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++++|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998542 356899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
....... ......+++.|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 7554332 2233457889999999988889999999999999999999 999997654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=290.64 Aligned_cols=202 Identities=27% Similarity=0.410 Sum_probs=159.9
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC-hh-hHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN-RH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.++|++.++||+|+||.||+++. .+|+.||+|++.... .. ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999997 478999999986542 22 2334555666688899999999999999999999999
Q ss_pred EecCCCChhHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 389 EFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 389 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||+++ +|.+++... .....+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99975 887777432 2456799999999999999999999997 7 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
.... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 4332 2334689999999996 4567899999999999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.01 Aligned_cols=203 Identities=26% Similarity=0.422 Sum_probs=155.2
Q ss_pred CCccc-cccccccCceeEEEEEec---CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec--CCcceE
Q 009543 313 GSFDE-ANKLGQGGFGTVYKGVLP---DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLL 386 (532)
Q Consensus 313 ~~~~~-~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 386 (532)
+.|++ .++||+|+||+||++++. +++.||||++.... ....+.+|+.+++.++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34665 458999999999999965 57899999986442 23468899999999999999999999954 667899
Q ss_pred EEEecCCCChhHHhhhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE----cCCCcEEE
Q 009543 387 VYEFLPNQSLDRFIFDSA------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL----DSRLRAKI 456 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl----~~~~~~kl 456 (532)
||||+++ +|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 7777764211 2235999999999999999999999998 9999999999999 77889999
Q ss_pred eecCCccccCCCCc--cccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 457 ADFGLARSFQEDKS--HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999987654322 12344678999999999877 4589999999999999999999999976543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=298.04 Aligned_cols=211 Identities=23% Similarity=0.302 Sum_probs=176.0
Q ss_pred CcChhhHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cc-----eeeee
Q 009543 302 NFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HK-----NLVRL 374 (532)
Q Consensus 302 ~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~ 374 (532)
.+.........++|++.+.||+|+||+||+|+.. +++.||||++... .....++.+|+.++..++ |+ +|+++
T Consensus 43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred cEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 3444445556789999999999999999999975 6889999998643 344566778888888775 44 49999
Q ss_pred eeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc--CCC
Q 009543 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD--SRL 452 (532)
Q Consensus 375 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~--~~~ 452 (532)
++++...+..++||||++ ++|.+++... ....+++..++.++.|++.||.|||.+ +.+|+||||||+|||++ .++
T Consensus 122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEEETTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred eeeeccCCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence 999999999999999996 4999988543 235689999999999999999999953 12399999999999994 578
Q ss_pred cEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 453 RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 199 ~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEEECCCTTCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEEeccCceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 89999999998764332 34578999999999999899999999999999999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=293.68 Aligned_cols=203 Identities=29% Similarity=0.472 Sum_probs=171.8
Q ss_pred hcCCccccccccccCceeEEEEEe--cCCCEEEEEEeeccCh--hhHHHHHHHHhHhhcC---ccceeeeeeeeee----
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL--PDGREIAVKRLFFNNR--HRAANFYNEVNIISSV---EHKNLVRLLGCSC---- 379 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---- 379 (532)
..++|++.+.||+|+||.||++++ .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 3688999999865432 2223566777777666 8999999999987
Q ss_pred -cCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEee
Q 009543 380 -SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458 (532)
Q Consensus 380 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~D 458 (532)
.....++||||++ ++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 5999998543 2345899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 459 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99998654322 2334578999999999998899999999999999999999999998654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=295.16 Aligned_cols=196 Identities=26% Similarity=0.468 Sum_probs=168.0
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc-----
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE----- 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 383 (532)
.++|.+.+.||+|+||.||++++. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 578999999999999999999975 6899999998654 33445678999999999999999999999987654
Q ss_pred -ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 384 -SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 384 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
.++||||++ ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58877762 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865432 233568999999999876 678999999999999999999999998754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=293.22 Aligned_cols=209 Identities=21% Similarity=0.401 Sum_probs=172.1
Q ss_pred cChhhHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCc--cceeeeeeeee
Q 009543 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVE--HKNLVRLLGCS 378 (532)
Q Consensus 303 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~ 378 (532)
+.+..+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++..++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3444444556789999999999999999999988999999998654 3445678999999999997 49999999999
Q ss_pred ecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEee
Q 009543 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458 (532)
Q Consensus 379 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~D 458 (532)
.+.+..++||| +.+++|.+++.. ...+++..++.++.|+++||.|||+++ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 678899999853 357899999999999999999999998 999999999999964 8999999
Q ss_pred cCCccccCCCCcc-ccccccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 459 FGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAH-----------GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 459 fgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
||++......... ......|++.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 9999876543322 2234568999999999865 46888999999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=286.67 Aligned_cols=202 Identities=30% Similarity=0.461 Sum_probs=175.4
Q ss_pred HhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
...++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999976 78999999986542 3345789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC---CcEEEeecCCcc
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLAR 463 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~---~~~kl~Dfgl~~ 463 (532)
||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999998853 346899999999999999999999998 9999999999999764 469999999998
Q ss_pred ccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
........ ....+++.|+|||.+.+ .++.++||||||+++|||++|+.||...+
T Consensus 173 ~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 173 CFQQNTKM--KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp TBCCCSSC--SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCCcc--ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 76543322 23458899999998865 58999999999999999999999997654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=304.57 Aligned_cols=203 Identities=22% Similarity=0.386 Sum_probs=173.1
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCcc-ceeeeeeeeeecCCcceEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH-KNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 388 (532)
..++|++.++||+|+||.||++++ .+++.||||++...... .++.+|++++..++| ++|..+..+..+....++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999996 47899999987654332 357889999999987 45555566667777889999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE---cCCCcEEEeecCCcccc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL---DSRLRAKIADFGLARSF 465 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl---~~~~~~kl~Dfgl~~~~ 465 (532)
||+ +++|.+++.. ....+++.+++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++..
T Consensus 83 e~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999 9999999853 2457999999999999999999999998 9999999999999 68899999999999876
Q ss_pred CCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 466 QEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 466 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 554322 12356799999999999999999999999999999999999999987554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=317.66 Aligned_cols=205 Identities=23% Similarity=0.369 Sum_probs=172.4
Q ss_pred HhcCCccccccccccCceeEEEEEecC----CCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
...++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345679999999999999999999742 457999988654 3344578999999999999999999999884 5678
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 999999999999999953 3346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
.............+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 75544333334557889999999998899999999999999999997 999997654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=291.16 Aligned_cols=201 Identities=22% Similarity=0.322 Sum_probs=172.8
Q ss_pred HhcCCccccccccccCceeEEEEEec-CC-CEEEEEEeeccChhhHHHHHHHHhHhhcCccce------eeeeeeeeecC
Q 009543 310 KATGSFDEANKLGQGGFGTVYKGVLP-DG-REIAVKRLFFNNRHRAANFYNEVNIISSVEHKN------LVRLLGCSCSG 381 (532)
Q Consensus 310 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~ 381 (532)
...++|++.+.||+|+||.||++... ++ +.||+|++... ....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 34689999999999999999999975 34 68999998643 344567889999999998877 89999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE-------------
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL------------- 448 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl------------- 448 (532)
+..++||||+ +++|.+++.. .....+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 9999999999 6667666643 23356999999999999999999999998 9999999999999
Q ss_pred ------cCCCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 449 ------DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 449 ------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+.++.+||+|||++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 667899999999998654322 34578999999999999899999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.09 Aligned_cols=202 Identities=30% Similarity=0.458 Sum_probs=153.4
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHh-HhhcCccceeeeeeeeeecCCcceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVN-IISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.++|++.+.||+|+||.||++... +|+.||||++.... .....++.+|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999975 78999999997653 334455666666 777889999999999999999999999
Q ss_pred EecCCCChhHHhhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 389 EFLPNQSLDRFIFD--SAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 389 e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
||+++ +|.+++.. ......+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 77777642 12256799999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCCccccccccccccccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
..... .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 44322 2334689999999998 4567899999999999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=285.67 Aligned_cols=194 Identities=31% Similarity=0.514 Sum_probs=162.0
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec----------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS---------- 380 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------- 380 (532)
.++|++.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457999999999999999999975 7899999998643 3445778999999999999999999998765
Q ss_pred ---CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 381 ---GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 381 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
....++||||+++++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3457899999999999999954 3346788999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCC-------------cccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHh
Q 009543 458 DFGLARSFQEDK-------------SHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVT 511 (532)
Q Consensus 458 Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~t 511 (532)
|||++....... ........|++.|+|||.+.+. .++.++||||||+++|||++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999998764321 1112345689999999998754 68999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.70 Aligned_cols=202 Identities=29% Similarity=0.471 Sum_probs=175.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeec------CCc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS------GPE 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 383 (532)
.++|++.++||+|+||.||++.+. +|+.||||++... .....+.+.+|++++..++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999974 6899999998654 34455779999999999999999999998765 667
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCc---EEEeecC
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR---AKIADFG 460 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~---~kl~Dfg 460 (532)
.++||||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557999999999999999999999998 999999999999997765 9999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9987654432 2346789999999999999999999999999999999999999965
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=290.31 Aligned_cols=202 Identities=31% Similarity=0.418 Sum_probs=164.5
Q ss_pred HHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChh------hHHHHHHHHhHhhcC----ccceeeeeee
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH------RAANFYNEVNIISSV----EHKNLVRLLG 376 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~~ 376 (532)
.+...++|++.+.||+|+||.||+++.. +++.||||++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3455688999999999999999999964 6899999998654321 223456789998888 8999999999
Q ss_pred eeecCCcceEEEEe-cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc-CCCcE
Q 009543 377 CSCSGPESLLVYEF-LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRA 454 (532)
Q Consensus 377 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~-~~~~~ 454 (532)
++...+..++|+|+ +++++|.+++.. ...+++..++.++.|+++||.|||+++ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999954 346899999999999999999999998 99999999999999 88999
Q ss_pred EEeecCCccccCCCCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
||+|||++....... .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999998765432 234568999999999877665 4589999999999999999999965
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=291.23 Aligned_cols=206 Identities=23% Similarity=0.389 Sum_probs=169.6
Q ss_pred hHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 307 TLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 307 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
..+...++|++.+.||+|+||.||+|++.+ .+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 333446789999999999999999999853 59999886542 22335678899999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++..
T Consensus 105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999943 3356899999999999999999999998 99999999999998 67999999999876
Q ss_pred cCCCCc----cccccccccccccccccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 465 FQEDKS----HISTAIAGTLGYMAPEYLAH---------GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... .......|++.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 532211 12233468999999999864 457889999999999999999999997654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.85 Aligned_cols=199 Identities=26% Similarity=0.355 Sum_probs=168.9
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-----------cceeeeeeeeee
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-----------HKNLVRLLGCSC 379 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 379 (532)
.++|++.+.||+|+||.||+++. .+++.||||++.. .....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999997 4789999999864 3344567889999998886 899999999987
Q ss_pred cCC----cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEc-----
Q 009543 380 SGP----ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLD----- 449 (532)
Q Consensus 380 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~----- 449 (532)
..+ ..+++|||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 678999999 89999998542 345699999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 450 -SRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 450 -~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 44589999999998765432 33578999999999999899999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=291.74 Aligned_cols=202 Identities=28% Similarity=0.412 Sum_probs=173.1
Q ss_pred HHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChh------hHHHHHHHHhHhhcCc--cceeeeeeeeee
Q 009543 309 EKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH------RAANFYNEVNIISSVE--HKNLVRLLGCSC 379 (532)
Q Consensus 309 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 379 (532)
+...++|++.+.||+|+||.||+++.. +++.||||++...... ....+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 345678999999999999999999964 7899999998654321 2245678999999996 599999999999
Q ss_pred cCCcceEEEEecCC-CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc-CCCcEEEe
Q 009543 380 SGPESLLVYEFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIA 457 (532)
Q Consensus 380 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~-~~~~~kl~ 457 (532)
..+..++|||++.+ ++|.+++.. ...+++..++.++.|+++||.|||+++ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999976 899999853 456899999999999999999999998 99999999999999 78999999
Q ss_pred ecCCccccCCCCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 458 DFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 458 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
|||++....... .....||+.|+|||.+....+ +.++||||||+++|||++|+.||...
T Consensus 193 Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 193 DFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp CCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred eCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 999998765432 234568999999999877665 68899999999999999999999653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.16 Aligned_cols=192 Identities=17% Similarity=0.196 Sum_probs=160.0
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccC--------hhhHHHHHHHHhHhhcCc---------cceeeee
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--------RHRAANFYNEVNIISSVE---------HKNLVRL 374 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~~ 374 (532)
.++|++.++||+|+||+||++++ +|+.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35799999999999999999998 78999999997653 223467889999988886 5555555
Q ss_pred ee-----------------eeec-------------CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHH
Q 009543 375 LG-----------------CSCS-------------GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424 (532)
Q Consensus 375 ~~-----------------~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 424 (532)
.+ ++.+ ....++||||+++|++.+.+. ...+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 44 4443 678899999999997766662 2568999999999999999
Q ss_pred HHHHH-hCCCCCeEEccCCCCCEEEcCCC--------------------cEEEeecCCccccCCCCcccccccccccccc
Q 009543 425 LVYLH-EQSKIRIIHRDIKASNILLDSRL--------------------RAKIADFGLARSFQEDKSHISTAIAGTLGYM 483 (532)
Q Consensus 425 l~~LH-~~~~~~iiH~Dlkp~NiLl~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~ 483 (532)
|.||| +++ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 888 99999999999999887 9999999999876532 347899999
Q ss_pred cccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCC
Q 009543 484 APEYLAHGQLTEKADVYSFGML-LLEIVTGRQNNRS 518 (532)
Q Consensus 484 aPE~~~~~~~~~~~Dv~SlGvl-l~el~tG~~p~~~ 518 (532)
|||++.+.. +.++|||||+++ .+++++|..||..
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 999998665 889999998776 7889999999853
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.71 Aligned_cols=194 Identities=24% Similarity=0.416 Sum_probs=168.1
Q ss_pred hcCCccccccccccCceeEEEEEec--CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc----
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP--DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE---- 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 383 (532)
..++|++.+.||+|+||.||++++. +|+.||||++... .......+.+|++++.+++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999975 6899999988644 33455678999999999999999999999987665
Q ss_pred -ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 384 -SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 384 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
.++||||+++++|.+++. ..+++.+++.++.||++||.|||+++ |+||||||+|||++.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 699999999999998762 26999999999999999999999998 9999999999999986 9999999999
Q ss_pred cccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+..... ....||+.|+|||++..+. +.++||||||+++|||++|..||...
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence 876543 3457899999999987654 88999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=288.76 Aligned_cols=199 Identities=23% Similarity=0.301 Sum_probs=146.7
Q ss_pred hcCCccccc-cccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec----CCcc
Q 009543 311 ATGSFDEAN-KLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPES 384 (532)
Q Consensus 311 ~~~~~~~~~-~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 384 (532)
..++|++.+ .||+|+||.||++++. +++.||||++.... . ...+....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 457899865 5999999999999976 69999999986432 1 12223334566799999999999876 3447
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---CCcEEEeecCC
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGL 461 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~~~~kl~Dfgl 461 (532)
++||||+++|+|.+++... ....+++.+++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 8999999999999999642 2357999999999999999999999998 999999999999986 45599999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+....... .....+|+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 98654322 234568999999999988889999999999999999999999997654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=298.83 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=158.5
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.+.|...+.||+|+||+||.....+|+.||||++.... .+.+.+|+.++..+ +||||+++++++.+....++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 34566678899999999987766689999999986532 35678899999876 899999999999999999999999
Q ss_pred cCCCChhHHhhhccCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-------------Cc
Q 009543 391 LPNQSLDRFIFDSAKAK----TLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-------------LR 453 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-------------~~ 453 (532)
++ |+|.+++....... ..++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 69999995432111 1133346789999999999999998 9999999999999754 48
Q ss_pred EEEeecCCccccCCCCcc---ccccccccccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 009543 454 AKIADFGLARSFQEDKSH---ISTAIAGTLGYMAPEYLAH-------GQLTEKADVYSFGMLLLEIVT-GRQNNRSK 519 (532)
Q Consensus 454 ~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvll~el~t-G~~p~~~~ 519 (532)
+||+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||...
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 999999999877554322 1234579999999999865 568999999999999999999 99999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=283.14 Aligned_cols=200 Identities=27% Similarity=0.445 Sum_probs=152.7
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh-hh-HHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HR-AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
.++|++.+.||+|+||.||++++. +|+.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367999999999999999999985 789999999976532 22 234455556788889999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
||+ ++.+..+... ....+++..++.++.|+++||.|||++ + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 5555555432 245789999999999999999999985 7 99999999999999999999999999976644
Q ss_pred CCcccccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
... .....+++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 322 23456899999999984 456889999999999999999999999763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=297.18 Aligned_cols=200 Identities=26% Similarity=0.409 Sum_probs=159.9
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
..+|++.+.||+|+||+||.....+++.||||++...... .+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3569999999999999976555568999999998654322 356899999999 799999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-----CCcEEEeecCCcccc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-----RLRAKIADFGLARSF 465 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-----~~~~kl~Dfgl~~~~ 465 (532)
++ |+|.+++... ...+.+..++.++.||++||.|||+++ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 5999998542 234555567899999999999999998 999999999999953 336889999999876
Q ss_pred CCCCc--ccccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 466 QEDKS--HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
..... .......||+.|+|||++. ...++.++||||||+++|||++ |+.||....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 54332 1234467999999999987 4567889999999999999999 999996543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=271.85 Aligned_cols=175 Identities=12% Similarity=0.057 Sum_probs=153.7
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
..++|++.+.||+|+||.||++++. +++.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3478999999999999999999986 58999999997553 3345789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++++|.+++.. . ....+..+++.|++.||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999832 2 466678999999999999999998 9999999999999999999998443
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
|++| ++.++||||||+++|||++|+.||...+.
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3333 68899999999999999999999987654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=284.38 Aligned_cols=201 Identities=18% Similarity=0.227 Sum_probs=155.4
Q ss_pred cCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccCh---hhHHHHHHHHhHhhcCcc-ceee--------------
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNR---HRAANFYNEVNIISSVEH-KNLV-------------- 372 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv-------------- 372 (532)
..+|...+.||+|+||.||+|++ .+|+.||||++..... ...+.+.+|+.++..++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 44578889999999999999996 4799999999874332 235678999999999977 2211
Q ss_pred -ee------eeeeec-----CCcceEEEEecCCCChhHHhhh----ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 009543 373 -RL------LGCSCS-----GPESLLVYEFLPNQSLDRFIFD----SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436 (532)
Q Consensus 373 -~~------~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 436 (532)
.+ ...... ....+++|++ .+++|.+++.. ......+++..++.++.|+++||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11 111111 1234556665 47899988842 122456788899999999999999999998 9
Q ss_pred EEccCCCCCEEEcCCCcEEEeecCCccccCCCCccccccccccccccccccc----------ccCCCCchhhHHHHHHHH
Q 009543 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL----------AHGQLTEKADVYSFGMLL 506 (532)
Q Consensus 437 iH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlGvll 506 (532)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998765432 334567 999999998 555688899999999999
Q ss_pred HHHHhCCCCCCCCCC
Q 009543 507 LEIVTGRQNNRSKNS 521 (532)
Q Consensus 507 ~el~tG~~p~~~~~~ 521 (532)
|||++|+.||...+.
T Consensus 308 ~elltg~~Pf~~~~~ 322 (413)
T 3dzo_A 308 YWIWCADLPNTDDAA 322 (413)
T ss_dssp HHHHHSSCCCCTTGG
T ss_pred HHHHHCCCCCCCcch
Confidence 999999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=264.61 Aligned_cols=177 Identities=25% Similarity=0.324 Sum_probs=151.1
Q ss_pred cCCcccc-ccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHh-hcCccceeeeeeeeeec----CCcc
Q 009543 312 TGSFDEA-NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNII-SSVEHKNLVRLLGCSCS----GPES 384 (532)
Q Consensus 312 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~ 384 (532)
.++|.+. +.||+|+||.||++... +++.||+|++... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567777 77999999999999974 7899999998532 3566788887 55699999999999876 6678
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---CCcEEEeecCC
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGL 461 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~~~~kl~Dfgl 461 (532)
++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999652 3357999999999999999999999998 999999999999998 78999999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+.... +..++.++||||||+++|||++|+.||....
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 86432 2346779999999999999999999997653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-31 Score=280.10 Aligned_cols=186 Identities=18% Similarity=0.212 Sum_probs=130.8
Q ss_pred cccccCceeEEEEE-ecCCCEEEEEEeeccC----------hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEE
Q 009543 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNN----------RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 320 ~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 387 (532)
..+.|++|.+..++ .-.|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34556666555544 2358999999986431 22346799999999999 799999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||++|++|.++|. ....++.. +|+.||+.||+|+|+++ ||||||||+||||+++|.+||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999994 34556654 48899999999999999 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~ 516 (532)
.... ....+||+.|||||++.+ .+..++|+||+|+++++|.+|..|+
T Consensus 392 ~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 4332 344679999999999865 5677899999999988876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-28 Score=258.04 Aligned_cols=185 Identities=17% Similarity=0.178 Sum_probs=148.6
Q ss_pred cccccccccCceeEEEEEecCCCEEEEEEeeccCh--------hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR--------HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 316 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
...+.||+|+||+||++.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 578899998644321 1234589999999999999999777777778888999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++++|.+++.. ++.++.|+++||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5689999999999999998 999999999999999 999999999998755
Q ss_pred CCccc------cccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 468 DKSHI------STAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 468 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
..... .....||+.|||||++.. ..|+..+|+||..+-.++.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 33221 235679999999999986 567888999999999999999988874
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=190.56 Aligned_cols=103 Identities=25% Similarity=0.441 Sum_probs=93.1
Q ss_pred CcceeccccCCcccCCCCchHHHHHHHHHHHHHhhhcC--Cceeeeec-CCCCcEEEEEecCCCCChhhhHHHHHHHHhh
Q 009543 23 RVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTS--GFGLAVTG-SGLDINYGLAQCYGDLSLLDCVLCYAEARTL 99 (532)
Q Consensus 23 ~~~~~~~~C~~~~~~~~~~~~~~l~~l~~~l~~~~~~~--~~~~~~~g-~~~~~vy~~~~C~~d~~~~~C~~Cl~~a~~~ 99 (532)
.+.++++.|++.+|+++++|++||+.||+.|+.+++.+ +|+++..| .++++||||+|||||+++++|+.||+.|+..
T Consensus 2 ~t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~ 81 (108)
T 3a2e_A 2 NTAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNR 81 (108)
T ss_dssp CCCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred CcceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence 45789999998899999999999999999999998764 45555555 4568999999999999999999999999999
Q ss_pred Cc-cCCCCCcEEEEcCcceeccccCCC
Q 009543 100 LP-QCYPYNGGRIYLDGCFMRSENYSF 125 (532)
Q Consensus 100 ~~-~c~~~~~~~i~~~~C~~ry~~~~f 125 (532)
++ .|+++++|+||++.|+||||+++|
T Consensus 82 ~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 82 IFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 98 899999999999999999999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=210.10 Aligned_cols=159 Identities=16% Similarity=0.130 Sum_probs=126.2
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccCh------------------hhHHHHHHHHhHhhcCccceee
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR------------------HRAANFYNEVNIISSVEHKNLV 372 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv 372 (532)
....|++.+.||+|+||.||++.+.+|+.||+|++..... .....+.+|+.+++.++ | +
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 3456777899999999999999997799999999864321 13456889999999999 4 5
Q ss_pred eeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC
Q 009543 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (532)
Q Consensus 373 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~ 452 (532)
++.+++. .+..++||||+++++|.+ +.. .....++.|+++||.|||+++ |+||||||+|||++ ++
T Consensus 165 ~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 165 AVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TT
T ss_pred CcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CC
Confidence 6666443 356799999999999988 411 224579999999999999998 99999999999999 99
Q ss_pred cEEEeecCCccccCCCCccccccccccccccccccccc----------CCCCchhhHHH
Q 009543 453 RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH----------GQLTEKADVYS 501 (532)
Q Consensus 453 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~S 501 (532)
.+||+|||+++. +..++|||++.+ ..++..+|+|.
T Consensus 230 ~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 230 GIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred cEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999863 335788998753 44566667765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=181.86 Aligned_cols=137 Identities=18% Similarity=0.190 Sum_probs=107.6
Q ss_pred ccccccccccCceeEEEEEe-cCCCE--EEEEEeeccChh------------------------hHHHHHHHHhHhhcCc
Q 009543 315 FDEANKLGQGGFGTVYKGVL-PDGRE--IAVKRLFFNNRH------------------------RAANFYNEVNIISSVE 367 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 367 (532)
|++.+.||+|+||.||+|.+ .+|+. ||||++...... ....+.+|+.++..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998 68999 999987543111 1236789999999999
Q ss_pred ccee--eeeeeeeecCCcceEEEEecCC-C----ChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEc
Q 009543 368 HKNL--VRLLGCSCSGPESLLVYEFLPN-Q----SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH-EQSKIRIIHR 439 (532)
Q Consensus 368 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~iiH~ 439 (532)
|+++ +.++.. ...++||||+.+ | +|.++... .++.....++.|++.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8864 333332 367899999942 4 66665421 234567789999999999999 887 9999
Q ss_pred cCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 440 DIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 440 Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+|||++. .++|+|||++....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999997653
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=146.26 Aligned_cols=102 Identities=20% Similarity=0.376 Sum_probs=85.8
Q ss_pred CCcceeecCCC-CCchHHHHHHHHHHHHHHHhcCC-CCCceeEeeeecCCCCcceeeeeccccccChhhHHHHHHHHHhh
Q 009543 132 PEDRAVCGNGT-RKNSSFQESARKAVMRAVASAPS-NGGYARVQVQVSGAANKSAYVLVNCWKTLNSSSCEACLANASAS 209 (532)
Q Consensus 132 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~a~~-~~~~~~~~~~~~~~~~~~~y~l~QC~~dls~~~C~~Cl~~a~~~ 209 (532)
...+..|+..+ ++++.|..++..+|..|...++. +.+|+++... +.+.++||||+||++|+++.+|..||+.++.+
T Consensus 4 ~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~--~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~ 81 (108)
T 3a2e_A 4 AFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAG--SGGAPTAYGRATCKQSISQSDCTACLSNLVNR 81 (108)
T ss_dssp CEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECC--STTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred ceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeecc--CCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence 44567798776 66788999999999999988765 4455554432 44568999999999999999999999999999
Q ss_pred hhccCC-CCCCccccccccccccCCcc
Q 009543 210 ILGCLP-WSEGRALNTGCFMRYSDKDF 235 (532)
Q Consensus 210 ~~~c~~-~~~g~v~~~~C~lry~~~~f 235 (532)
++.||+ ..+|+++.++|++||++++|
T Consensus 82 ~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 82 IFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 999777 67899999999999999987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=173.49 Aligned_cols=141 Identities=12% Similarity=0.159 Sum_probs=101.5
Q ss_pred CccccccccccCceeEEEEEecCCCEEEEEEeeccC--------------hhhHHHHHHHHhHhhcCccceeeeeeeeee
Q 009543 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--------------RHRAANFYNEVNIISSVEHKNLVRLLGCSC 379 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 379 (532)
-|++.+.||+|+||.||+|...+|+.||||+++... .........++++.....|+|+.+++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 389999999999999999999999999999875321 011122333333333444555544433222
Q ss_pred cC------CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-
Q 009543 380 SG------PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL- 452 (532)
Q Consensus 380 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~- 452 (532)
.. ...+|||||++|++|.++.. . .....++.|++.+|.+||+.+ ||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 11 23479999999988866541 1 123567899999999999998 99999999999998877
Q ss_pred ---------cEEEeecCCccccC
Q 009543 453 ---------RAKIADFGLARSFQ 466 (532)
Q Consensus 453 ---------~~kl~Dfgl~~~~~ 466 (532)
.+.|+||+.+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999887644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-12 Score=125.00 Aligned_cols=145 Identities=14% Similarity=0.056 Sum_probs=113.4
Q ss_pred hcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 389 (532)
.-+.|++...++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. +..+.+++++....+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456888888999999999998864 7899999986532222345788999998884 6778889998888888999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS------------------------------------- 432 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------- 432 (532)
|++|.+|.+.+. +......++.+++++|..||+..
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999987641 11223478889999999999811
Q ss_pred -------------------CCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 433 -------------------KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 433 -------------------~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
+..++|+|++|.||+++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14489999999999998766677999997653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.2e-11 Score=118.32 Aligned_cols=138 Identities=16% Similarity=0.119 Sum_probs=101.4
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce--eeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~ 390 (532)
..+.+....+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345554444456669999998877888999987543 2245778999998886544 45688888777788999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS-------------------------------------- 432 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 432 (532)
++|.+|. .. . .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 21 1 11 2256777788888888643
Q ss_pred -----------------CCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 433 -----------------KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 433 -----------------~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
+..++|+|++|.||++++++.+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876778999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1e-10 Score=114.95 Aligned_cols=187 Identities=20% Similarity=0.230 Sum_probs=123.1
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcC-ccce--eeeeeeeeecCC---cceEEEEec
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKN--LVRLLGCSCSGP---ESLLVYEFL 391 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~e~~ 391 (532)
.+.++.|....||+.. +.+++|+... ......+.+|.++++.+ .+.. +.+++....... ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 5688997642 23456788999999877 3333 334444433332 358899999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ---------------------------------------- 431 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------- 431 (532)
+|.+|.+... ..++..++..++.++++.+..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 2467777888888888888888862
Q ss_pred ---------------CCCCeEEccCCCCCEEEcC--CCcEEEeecCCccccCCCCcccccc-------------cccccc
Q 009543 432 ---------------SKIRIIHRDIKASNILLDS--RLRAKIADFGLARSFQEDKSHISTA-------------IAGTLG 481 (532)
Q Consensus 432 ---------------~~~~iiH~Dlkp~NiLl~~--~~~~kl~Dfgl~~~~~~~~~~~~~~-------------~~gt~~ 481 (532)
.+..++|+|++|.||++++ +..+.|+||+.+...+......... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1245899999999999998 5568899999886543221110000 000001
Q ss_pred ccc-ccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 482 YMA-PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 482 y~a-PE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
... |+.... .....+.|+++.++|++.+|+.+|-
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 222111 1123689999999999999998873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.8e-10 Score=113.58 Aligned_cols=143 Identities=13% Similarity=0.178 Sum_probs=107.5
Q ss_pred ccccccccCceeEEEEEecCCCEEEEEEee--ccC-hhhHHHHHHHHhHhhcCc--cceeeeeeeeeecC---CcceEEE
Q 009543 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLF--FNN-RHRAANFYNEVNIISSVE--HKNLVRLLGCSCSG---PESLLVY 388 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~ 388 (532)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4678999999999998875 4678888775 322 122356788999999886 45577888887665 3478999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS------------------------------------ 432 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 432 (532)
||++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998875422 234778889999999999999999731
Q ss_pred -------------------CCCeEEccCCCCCEEEcCCCc--EEEeecCCcccc
Q 009543 433 -------------------KIRIIHRDIKASNILLDSRLR--AKIADFGLARSF 465 (532)
Q Consensus 433 -------------------~~~iiH~Dlkp~NiLl~~~~~--~kl~Dfgl~~~~ 465 (532)
+..++|+|++|.|||++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999998753 689999988653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=6.7e-07 Score=87.59 Aligned_cols=138 Identities=17% Similarity=0.154 Sum_probs=95.4
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccc---eeeeeeeeee-cCCcceEEEEecCC
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHK---NLVRLLGCSC-SGPESLLVYEFLPN 393 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 393 (532)
.+.++.|....||+. |+.+++|+.. .......+.+|..++..+.+. .+.+.+.+.. ..+..+++||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888998999987 6778898752 333456788999999998642 2556666553 34557899999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ------------------------------------------ 431 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------------ 431 (532)
..+.+... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88876321 1234444555555555555555532
Q ss_pred ---------------CCCCeEEccCCCCCEEEcC---CCc-EEEeecCCccccC
Q 009543 432 ---------------SKIRIIHRDIKASNILLDS---RLR-AKIADFGLARSFQ 466 (532)
Q Consensus 432 ---------------~~~~iiH~Dlkp~NiLl~~---~~~-~kl~Dfgl~~~~~ 466 (532)
.+..++|+|++|.||+++. ++. ..|+||+.+..-+
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2335799999999999998 455 5899999876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=7.1e-07 Score=85.56 Aligned_cols=136 Identities=15% Similarity=0.112 Sum_probs=96.8
Q ss_pred cccccCce-eEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 320 KLGQGGFG-TVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 320 ~lG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445555 68988764 5678999976433 3456778988888773 33367788888888889999999999988
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS-------------------------------------------- 432 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------------- 432 (532)
.+.... .......+..+++..|.-||+..
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 776522 11223345666677777777421
Q ss_pred -----------CCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 433 -----------KIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 433 -----------~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
...++|+|+.+.|||++.++.+-|+||+.+...
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 234899999999999998877789999987643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=5e-07 Score=90.47 Aligned_cols=82 Identities=6% Similarity=0.015 Sum_probs=56.3
Q ss_pred ccccc-cccCceeEEEEEec-------CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCc-c--ceeeeeeeeeecC-
Q 009543 317 EANKL-GQGGFGTVYKGVLP-------DGREIAVKRLFFNN---RHRAANFYNEVNIISSVE-H--KNLVRLLGCSCSG- 381 (532)
Q Consensus 317 ~~~~l-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~- 381 (532)
..+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 35677 88999999998764 26788999764332 001245678888888874 3 2466777776554
Q ss_pred --CcceEEEEecCCCChhH
Q 009543 382 --PESLLVYEFLPNQSLDR 398 (532)
Q Consensus 382 --~~~~lv~e~~~~g~L~~ 398 (532)
+..++||||++|..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.1e-05 Score=81.96 Aligned_cols=76 Identities=13% Similarity=0.125 Sum_probs=50.0
Q ss_pred ccccccccCceeEEEEEec-CCCEEEEEEeeccCh-------hhHHHHHHHHhHhhcCcc--c-eeeeeeeeeecCCcce
Q 009543 317 EANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-------HRAANFYNEVNIISSVEH--K-NLVRLLGCSCSGPESL 385 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~ 385 (532)
..+.||.|..+.||++... +++.+++|....... .....+..|.++++.+.. | .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568999999999999864 478899997643211 122456778888887642 3 34455543 345678
Q ss_pred EEEEecCCC
Q 009543 386 LVYEFLPNQ 394 (532)
Q Consensus 386 lv~e~~~~g 394 (532)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=1.4e-05 Score=79.17 Aligned_cols=142 Identities=16% Similarity=0.230 Sum_probs=80.4
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccc--eeeeeee------eeecCCcceEEEE
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHK--NLVRLLG------CSCSGPESLLVYE 389 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e 389 (532)
.+.|+.|..+.||+....+| .+++|+.... . ..+..|..++..+... .+.+++. +....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666677899999887554 5889988642 2 2333455555555321 2333332 1123556789999
Q ss_pred ecCCCChh-----------H---HhhhccC----C-------CCCCHHHHH-----------------------------
Q 009543 390 FLPNQSLD-----------R---FIFDSAK----A-------KTLTWEKRY----------------------------- 415 (532)
Q Consensus 390 ~~~~g~L~-----------~---~l~~~~~----~-------~~l~~~~~~----------------------------- 415 (532)
|++|..+. + -++.... . ....|...+
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99987543 0 1111111 0 011232211
Q ss_pred --HHHHHHHHHHHHHHh----------CCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 416 --EIILGTVEGLVYLHE----------QSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 416 --~i~~~ia~~l~~LH~----------~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
.+...+..++.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223345666653 1234699999999999998888999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.93 E-value=2.6e-05 Score=79.79 Aligned_cols=80 Identities=11% Similarity=0.013 Sum_probs=49.6
Q ss_pred CCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccccccccccccccccccccC---CCCchhhHHHHHHHHHHH
Q 009543 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG---QLTEKADVYSFGMLLLEI 509 (532)
Q Consensus 433 ~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvll~el 509 (532)
...++|+|++|.|||++.++ ++|+||+.+..-+...........-...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34599999999999999877 99999998875432211100000012346666654321 112345666888888888
Q ss_pred HhCC
Q 009543 510 VTGR 513 (532)
Q Consensus 510 ~tG~ 513 (532)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.92 E-value=3e-05 Score=74.94 Aligned_cols=80 Identities=16% Similarity=0.162 Sum_probs=58.0
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-c--ceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-H--KNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~e 389 (532)
.....++.+|.|..+.||+.++.||+.+++|+...........+..|...|+.+. . --+.+++++ +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3566678899999999999999999999999875444333345778888888773 2 123444443 24589999
Q ss_pred ecCCCCh
Q 009543 390 FLPNQSL 396 (532)
Q Consensus 390 ~~~~g~L 396 (532)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00022 Score=69.60 Aligned_cols=140 Identities=16% Similarity=0.115 Sum_probs=93.2
Q ss_pred cccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc---cceeeeeeeeeecCCcceEEEEecC
Q 009543 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 316 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
...+.|+.|....+|+... +++.+++|+.... ....+..|...|+.+. ...+.+++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4467899999999999886 5678889987543 3456788988888874 2567788888777788999999999
Q ss_pred CCChhH--------H---hhhccC-C------------------CCCCHHHHH---HHH----------------HHHHH
Q 009543 393 NQSLDR--------F---IFDSAK-A------------------KTLTWEKRY---EII----------------LGTVE 423 (532)
Q Consensus 393 ~g~L~~--------~---l~~~~~-~------------------~~l~~~~~~---~i~----------------~~ia~ 423 (532)
+..+.. . |+.... . -.-+|.... ++. ..+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 886521 1 122111 0 012454322 111 11111
Q ss_pred H-HHHHHh-CCCCCeEEccCCCCCEEEcCCCcEEEeecC
Q 009543 424 G-LVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (532)
Q Consensus 424 ~-l~~LH~-~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfg 460 (532)
. ...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223432 2346799999999999999887 8999984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00032 Score=68.10 Aligned_cols=139 Identities=14% Similarity=0.079 Sum_probs=76.5
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCcccee-eeeeeeeecCCcceEEEEec-CCCC
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEFL-PNQS 395 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g~ 395 (532)
.+.|+.|....+|+. +.+++|+....... .....+|..+++.+...++ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 56888887543211 1123457777776643333 344443 344568999999 6655
Q ss_pred hhHH--------h----------hhccC--CCCCCH-HHHHHHHHH--------------HHHHH----HHHHh-CCCCC
Q 009543 396 LDRF--------I----------FDSAK--AKTLTW-EKRYEIILG--------------TVEGL----VYLHE-QSKIR 435 (532)
Q Consensus 396 L~~~--------l----------~~~~~--~~~l~~-~~~~~i~~~--------------ia~~l----~~LH~-~~~~~ 435 (532)
+... . +.... ....+. .....+... +.+.+ ..+.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5321 0 11000 000111 111111100 11111 11111 22345
Q ss_pred eEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 436 IIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 436 iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56677899999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00075 Score=66.00 Aligned_cols=144 Identities=12% Similarity=0.122 Sum_probs=80.0
Q ss_pred cccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce--eeeeeee------eecCCcceEEEE
Q 009543 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGC------SCSGPESLLVYE 389 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 389 (532)
.+.|+.|....+|+....+| .+++|+..... ..+.+..|+.++..+...+ +.+++.. ....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 45677888899999887655 68899876421 1234556777777664322 2333321 112345689999
Q ss_pred ecCCCChhH----H----------hhhccCC------CCC---CHHHHHH------------HHHHHHHHHHHHHhC---
Q 009543 390 FLPNQSLDR----F----------IFDSAKA------KTL---TWEKRYE------------IILGTVEGLVYLHEQ--- 431 (532)
Q Consensus 390 ~~~~g~L~~----~----------l~~~~~~------~~l---~~~~~~~------------i~~~ia~~l~~LH~~--- 431 (532)
|++|..+.. . ++..... ... .|...+. +...+.+.+..+++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865421 0 1111000 001 1222110 001134445555432
Q ss_pred -CCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 432 -SKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 432 -~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
.+..++|+|+++.|||+++++.+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234599999999999999876668999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00035 Score=71.49 Aligned_cols=73 Identities=15% Similarity=0.294 Sum_probs=50.3
Q ss_pred cccccccCceeEEEEEecC--------CCEEEEEEeeccChhhHHHHHHHHhHhhcCcccee-eeeeeeeecCCcceEEE
Q 009543 318 ANKLGQGGFGTVYKGVLPD--------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVY 388 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 388 (532)
.+.|+.|....+|+....+ ++.+++|+..... ..+.+.+|..++..+...++ .++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678889999999998753 5789999884321 12455678888888854444 456665432 3899
Q ss_pred EecCCCCh
Q 009543 389 EFLPNQSL 396 (532)
Q Consensus 389 e~~~~g~L 396 (532)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00099 Score=65.52 Aligned_cols=144 Identities=15% Similarity=0.103 Sum_probs=73.2
Q ss_pred cccccccCcee-EEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccc--eeeeeeeeeecCCcceEEEEecCCC
Q 009543 318 ANKLGQGGFGT-VYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHK--NLVRLLGCSCSGPESLLVYEFLPNQ 394 (532)
Q Consensus 318 ~~~lG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g 394 (532)
.+.|+.|.... +|+....+++.+++|....... ..+..|+.++..+... .+.+++.+..+ .-+++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCc
Confidence 34565555444 6777664477787876543221 2234566666655322 24455555332 237899999876
Q ss_pred ChhHHhhhc---------------------cC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH--
Q 009543 395 SLDRFIFDS---------------------AK--AKTLTWEKRY-------E-------------IILGTVEGLVYLH-- 429 (532)
Q Consensus 395 ~L~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~~ia~~l~~LH-- 429 (532)
.+.+.+... .. ...++..... . ....+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665433210 00 0112221110 0 0011112222221
Q ss_pred -hCCCCCeEEccCCCCCEEEcCC----CcEEEeecCCccccC
Q 009543 430 -EQSKIRIIHRDIKASNILLDSR----LRAKIADFGLARSFQ 466 (532)
Q Consensus 430 -~~~~~~iiH~Dlkp~NiLl~~~----~~~kl~Dfgl~~~~~ 466 (532)
...+..++|+|+.+.||+++.+ +.+.|+||+.+..-.
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1123469999999999999875 689999999887543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0012 Score=64.68 Aligned_cols=143 Identities=15% Similarity=0.119 Sum_probs=81.4
Q ss_pred ccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce--eeeeeee-----eecCCcceEEEEec
Q 009543 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGC-----SCSGPESLLVYEFL 391 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~ 391 (532)
+.|+ |....||+....+|+.+++|...... .....+..|..++..+.... +++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887778889999886331 12345667888777774322 3444443 11234457899999
Q ss_pred CCCChhH----H----------hhhcc------CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 009543 392 PNQSLDR----F----------IFDSA------KAKTLTWEKR----YEI---------------ILGTVEGLVYLHE-- 430 (532)
Q Consensus 392 ~~g~L~~----~----------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~-- 430 (532)
+|..+.. . ++... .....++... ..+ ...+...+..+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865421 1 11100 0111222211 001 0111122223321
Q ss_pred --CCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 431 --QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 431 --~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
..+..++|+|+++.|||++ + .+.|+||+.+..-
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1234589999999999999 4 8999999877543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00087 Score=67.15 Aligned_cols=142 Identities=16% Similarity=0.183 Sum_probs=84.4
Q ss_pred cccccccCceeEEEEEec--------CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccce-eeeeeeeeecCCcceEEE
Q 009543 318 ANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN-LVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 388 (532)
.+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+.-.+ ..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 456777888999998874 3578999986332 223456678999988874322 3456665543 3999
Q ss_pred EecCCCChhHH-----------------hhhc--cCCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 009543 389 EFLPNQSLDRF-----------------IFDS--AKAKTLT--WEKRYEIILGTVE-------------------GLVYL 428 (532)
Q Consensus 389 e~~~~g~L~~~-----------------l~~~--~~~~~l~--~~~~~~i~~~ia~-------------------~l~~L 428 (532)
||++|..|..- |+.. .-..... +.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665321 0111 0011222 4555555544322 22333
Q ss_pred ----Hh-CCCCCeEEccCCCCCEEEcCC----CcEEEeecCCccc
Q 009543 429 ----HE-QSKIRIIHRDIKASNILLDSR----LRAKIADFGLARS 464 (532)
Q Consensus 429 ----H~-~~~~~iiH~Dlkp~NiLl~~~----~~~kl~Dfgl~~~ 464 (532)
.. ..+..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 123469999999999999877 7899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.002 Score=66.34 Aligned_cols=74 Identities=14% Similarity=0.008 Sum_probs=47.3
Q ss_pred cccccccCceeEEEEEecC-CCEEEEEEeeccChhhHHHHHHHHhHhhcCcccee-eeeeeeeecCCcceEEEEecCCCC
Q 009543 318 ANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEFLPNQS 395 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~ 395 (532)
.+.|+.|-...+|+....+ ++.+++|+........ ....+|..++..+...++ .++++.+. ..+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence 5678889999999998765 5788899874322111 112478888887754444 45666652 236999999865
Q ss_pred h
Q 009543 396 L 396 (532)
Q Consensus 396 L 396 (532)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0011 Score=66.22 Aligned_cols=74 Identities=12% Similarity=0.100 Sum_probs=44.7
Q ss_pred cccccccCceeEEEEEecC---------CCEEEEEEeeccChhhHHHHHHHHhHhhcCccce-eeeeeeeeecCCcceEE
Q 009543 318 ANKLGQGGFGTVYKGVLPD---------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN-LVRLLGCSCSGPESLLV 387 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv 387 (532)
.+.|+.|....+|+....+ ++.+++|+....... ......|..++..+...+ ..++++.. .-++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 4567888889999988754 268888877543221 112356777887775333 34555543 24789
Q ss_pred EEecCCCCh
Q 009543 388 YEFLPNQSL 396 (532)
Q Consensus 388 ~e~~~~g~L 396 (532)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.012 Score=57.87 Aligned_cols=33 Identities=27% Similarity=0.318 Sum_probs=28.5
Q ss_pred CCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 433 ~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 356999999999999998889999999877643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.98 E-value=0.064 Score=54.34 Aligned_cols=141 Identities=11% Similarity=0.152 Sum_probs=84.5
Q ss_pred cccccccCceeEEEEEecC--------CCEEEEEEeeccChhhHHHHHHHHhHhhcCccce-eeeeeeeeecCCcceEEE
Q 009543 318 ANKLGQGGFGTVYKGVLPD--------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN-LVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 388 (532)
++.|..|-...+|+....+ ++.+++|+....... .....+|..+++.+...+ ..++++.+ .-++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 5667788889999998753 588999987443211 122356777777774323 34455432 247899
Q ss_pred EecCCCChhH-------H----------hhh--c-----c---CCCCCCHHHHHHHHHHH-------------------H
Q 009543 389 EFLPNQSLDR-------F----------IFD--S-----A---KAKTLTWEKRYEIILGT-------------------V 422 (532)
Q Consensus 389 e~~~~g~L~~-------~----------l~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a 422 (532)
||++|..|.. . |+. . . ...+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876421 0 011 0 0 11111244444443322 1
Q ss_pred HHHHHHH---------------------hCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 423 EGLVYLH---------------------EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 423 ~~l~~LH---------------------~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
..+..|. ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233332 112345899999999999 8888999999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.71 E-value=0.17 Score=45.75 Aligned_cols=103 Identities=16% Similarity=0.104 Sum_probs=66.7
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcccc
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~~ 473 (532)
-+|.++|.. ...+++++++|.++.|.+..|.-+-.+.. + ..+=+.|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 478888853 56789999999999999998877622110 1 1233457899999999988764 1110
Q ss_pred cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 009543 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515 (532)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p 515 (532)
.....+.+||... ...+.+.=|||||++||.-+-=..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122466888763 3456788999999999998764443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.77 E-value=0.29 Score=49.11 Aligned_cols=30 Identities=27% Similarity=0.438 Sum_probs=25.3
Q ss_pred CeEEccCCCCCEEE------cCCCcEEEeecCCccc
Q 009543 435 RIIHRDIKASNILL------DSRLRAKIADFGLARS 464 (532)
Q Consensus 435 ~iiH~Dlkp~NiLl------~~~~~~kl~Dfgl~~~ 464 (532)
.++|+|+.+.|||+ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567899999998754
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.35 E-value=0.016 Score=37.65 Aligned_cols=33 Identities=30% Similarity=0.320 Sum_probs=17.8
Q ss_pred eeEEeeeehhHHHHHHHhhheeeeeeeccchhh
Q 009543 249 IAAIVVSVVSALVVLAVGIVIGTRVWKQRSIER 281 (532)
Q Consensus 249 ~~~i~~~~v~~l~~~~~~~~~~~~~~~~r~~~~ 281 (532)
...|+.++++++++++++.+..+..+|+|++++
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~ 42 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIVR 42 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence 345666777666665555444444454444433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.80 E-value=1.3 Score=39.91 Aligned_cols=116 Identities=9% Similarity=0.045 Sum_probs=73.8
Q ss_pred ccceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCE
Q 009543 367 EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNI 446 (532)
Q Consensus 367 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~Ni 446 (532)
.||++++. .+..+++...+.++.-+ +...+- .-..++...+++++.+|+....+++. =+|--|+|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57877765 44455554444454433 232222 23457889999999999987765554 37888999999
Q ss_pred EEcCCCcEEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 447 LLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 447 Ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
+++.++.+++.=.|+-..+ +|.- .+...=.-.+=+++..+++++.+|.
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999877753322 2221 1111122255667778888877774
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.55 E-value=0.026 Score=36.58 Aligned_cols=32 Identities=19% Similarity=0.268 Sum_probs=17.2
Q ss_pred eEEeeeehhHHHHHHHhhheeeeeeeccchhh
Q 009543 250 AAIVVSVVSALVVLAVGIVIGTRVWKQRSIER 281 (532)
Q Consensus 250 ~~i~~~~v~~l~~~~~~~~~~~~~~~~r~~~~ 281 (532)
..|+.++++++++++++.+..+..||+|++++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 34666666666655554444444455544443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.10 E-value=0.1 Score=53.65 Aligned_cols=61 Identities=5% Similarity=0.044 Sum_probs=18.2
Q ss_pred cccccccccCceeEEEEEecC-CCEEEE------EEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeee
Q 009543 316 DEANKLGQGGFGTVYKGVLPD-GREIAV------KRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379 (532)
Q Consensus 316 ~~~~~lG~G~fg~Vy~~~~~~-g~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 379 (532)
.+.++|| ||.||+|.+.. ..+||+ |..... +......+.+|..++..++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4456777 99999999864 467888 665432 2233456888999999999999999988643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.55 E-value=1.3 Score=39.99 Aligned_cols=83 Identities=12% Similarity=0.029 Sum_probs=57.9
Q ss_pred ccceeeeeeeeeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEccCCCCC
Q 009543 367 EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLV-YLHEQSKIRIIHRDIKASN 445 (532)
Q Consensus 367 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~iiH~Dlkp~N 445 (532)
.||.+ -..+..+++...+.++.-+++.=...+ ..++...+++++.+|+.... +++. -+|--|+|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 334445566666666655443222223 34788999999999887666 4443 4788899999
Q ss_pred EEEcCCCcEEEeecCCc
Q 009543 446 ILLDSRLRAKIADFGLA 462 (532)
Q Consensus 446 iLl~~~~~~kl~Dfgl~ 462 (532)
|++|.++.++|.-.|+-
T Consensus 115 L~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK 131 (219)
T ss_dssp EEECTTCCEEESCCEET
T ss_pred EEEeCCCcEEEEEcCCc
Confidence 99999999999877753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 532 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-63 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-63
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 10/208 (4%)
Query: 308 LEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-FYNEVNIISS 365
+E F++ ++LG G G V+K P G +A K + + N E+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 366 VEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+V G S E + E + SLD+ + KA + + ++ + ++GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YL K +I+HRD+K SNIL++SR K+ DFG++ + + + GT YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L + ++D++S G+ L+E+ GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-62
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 10/205 (4%)
Query: 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
G ++G G FGTVYKG + + + + F NEV ++ H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
+G + P+ +V ++ SL + K +I T +G+ YLH +S
Sbjct: 68 LFMGY-STAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTAIAGTLGYMAPEYL--- 488
IIHRD+K++NI L L KI DFGLA SH ++G++ +MAPE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ ++DVY+FG++L E++TG+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-60
Identities = 67/196 (34%), Positives = 107/196 (54%), Gaps = 6/196 (3%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+LG G FG V+ G ++AVK L + A F E N++ ++H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV- 76
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ ++ E++ N SL F+ + K LT K ++ EG+ ++ E++ IH
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD++A+NIL+ L KIADFGLAR ++++ + + APE + +G T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 499 VYSFGMLLLEIVTGRQ 514
V+SFG+LL EIVT +
Sbjct: 193 VWSFGILLTEIVTHGR 208
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-58
Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 6/196 (3%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLGQG FG V+ G +A+K L A F E ++ + H+ LV+L
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV- 80
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S +V E++ SL F+ K L + ++ G+ Y+ +H
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 136
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD++A+NIL+ L K+ADFGLAR ++++ + + APE +G+ T K+D
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 499 VYSFGMLLLEIVTGRQ 514
V+SFG+LL E+ T +
Sbjct: 197 VWSFGILLTELTTKGR 212
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 7e-58
Identities = 47/200 (23%), Positives = 95/200 (47%), Gaps = 6/200 (3%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+LG G FG V G ++A+K + + F E ++ ++ H+ LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQL 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G ++ E++ N L ++ + ++ E+ E + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
+ +HRD+ A N L++ + K++DFGL+R +D+ S + + PE L + + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 495 EKADVYSFGMLLLEIVTGRQ 514
K+D+++FG+L+ EI + +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGK 199
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 2e-57
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F + ++G G FG VY + + +A+K++ + + + EV + + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++ GC + LV E+ + D K L + + G ++GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA- 489
+IHRD+KA NILL K+ DFG A S + GT +MAPE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILA 185
Query: 490 --HGQLTEKADVYSFGMLLLEIVTGR 513
GQ K DV+S G+ +E+ +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-57
Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 6/200 (3%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
++G G FG V+ G + ++A+K + +F E ++ + H LV+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 65
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G LV+EF+ + L ++ + E + L EG+ YL E
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA--- 120
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
+IHRD+ A N L+ K++DFG+ R +D+ ST + + +PE + + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 495 EKADVYSFGMLLLEIVTGRQ 514
K+DV+SFG+L+ E+ + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGK 200
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-55
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 319 NKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+LG G FG VYK + A K + + ++ E++I++S +H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
++ EF ++D + + + LT + + T++ L YLH+ +II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL---- 493
HRD+KA NIL K+ADFG++ + GT +MAPE +
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRP 191
Query: 494 -TEKADVYSFGMLLLEIVTGRQNNRSKNSE 522
KADV+S G+ L+E+ + N
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPM 221
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-55
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 9/207 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNL 371
++ +G G +G K DG+ + K L + + A +EVN++ ++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 372 VRLLGCSCSGPESLL--VYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILGTVEGLVYL 428
VR + L V E+ L I K + L E ++ L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 429 HEQSKI--RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
H +S ++HRD+K +N+ LD + K+ DFGLAR D S + A GT YM+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPE 184
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ EK+D++S G LL E+
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 4e-55
Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 19/225 (8%)
Query: 290 EKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFN 348
EKL ++ KY+ EK +GQG GTVY + + G+E+A++++
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEK----------IGQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 349 NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT 408
+ + NE+ ++ ++ N+V L G E +V E+L SL + +
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TC 112
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
+ + + ++ L +LH ++IHRDIK+ NILL K+ DFG +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+S ST + GT +MAPE + K D++S G++ +E++ G
Sbjct: 170 QSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-54
Identities = 57/205 (27%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 317 EANKLGQGGFGTVYKGVLPD---GREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNL 371
E +LG G FGTV KG + +AVK L N+ E N++ +++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
VR++G C +LV E L++++ + + + + E++ G+ YL E
Sbjct: 71 VRMIGI-CEAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST--AIAGTLGYMAPEYLA 489
+HRD+ A N+LL ++ AKI+DFGL+++ + D+++ + + APE +
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQ 514
+ + + K+DV+SFG+L+ E + Q
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-54
Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 10/210 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLV 372
+D LG+G +G V V +AVK + N E+ I + H+N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
+ G G L E+ L I + + G+VYLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI- 122
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYMAPEYLAHG 491
I HRDIK N+LLD R KI+DFGLA F+ + + + + GTL Y+APE L
Sbjct: 123 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 492 QL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520
+ E DV+S G++L ++ G +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-54
Identities = 60/203 (29%), Positives = 87/203 (42%), Gaps = 13/203 (6%)
Query: 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F+ LG+G FG VY +A+K L EV I S + H N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++RL G L+ E+ P ++ R + K ++ I L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHS 124
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ R+IHRDIK N+LL S KIADFG + + + GTL Y+ PE +
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEG 178
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
EK D++S G+L E + G+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-54
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 300 SLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLF--FNNRHRAANF 356
S + ++ + ++G+G F TVYKG+ + E+A L + F
Sbjct: 5 SNDGRFLKFDI---------EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF 55
Query: 357 YNEVNIISSVEHKNLVRLLGC---SCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWE 412
E ++ ++H N+VR + G + + LV E + + +L ++ + K + +
Sbjct: 56 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIK 112
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDKSH 471
++GL +LH ++ IIHRD+K NI + KI D GLA ++
Sbjct: 113 VLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRAS 168
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ A+ GT +MAPE + E DVY+FGM +LE+ T
Sbjct: 169 FAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSE 209
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-54
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+G+G FG V G G ++AVK + N A F E ++++ + H NLV+L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 375 LGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
LG L +V E++ SL ++ + L + + L E + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+HRD+ A N+L+ AK++DFGL + + + + APE L +
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKF 177
Query: 494 TEKADVYSFGMLLLEIVTGRQ 514
+ K+DV+SFG+LL EI + +
Sbjct: 178 STKSDVWSFGILLWEIYSFGR 198
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (463), Expect = 4e-54
Identities = 60/243 (24%), Positives = 107/243 (44%), Gaps = 32/243 (13%)
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRHRA- 353
LN K +LE + + +G+G FG V++ P +AVK L
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 354 ANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD----------- 402
A+F E +++ ++ N+V+LLG G L++E++ L+ F+
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 403 ----------SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452
S L+ ++ I G+ YL E+ + +HRD+ N L+ +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 453 RAKIADFGLARSFQE-DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
KIADFGL+R+ D A + +M PE + + + T ++DV+++G++L EI +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 512 GRQ 514
Sbjct: 238 YGL 240
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 2e-53
Identities = 58/230 (25%), Positives = 107/230 (46%), Gaps = 23/230 (10%)
Query: 303 FKYSTLEKATGSFDEA---------NKLGQGGFGTVYKGVLP----DGREIAVKRLFFNN 349
F + +A F + +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 350 RHRA-ANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT 408
+ +F +E +I+ +H N++ L G +++ EF+ N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
T + ++ G G+ YL + +HRD+ A NIL++S L K++DFGL+R ++D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 469 KSHI----STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
S + + + APE + + + T +DV+S+G+++ E+++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (456), Expect = 3e-53
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 6/201 (2%)
Query: 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+KLG G +G VY+GV +AVK L + F E ++ ++H NLV+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
LLG P ++ EF+ +L ++ + + + ++ + + YL ++
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK-- 134
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
IHRD+ A N L+ K+ADFGL+R D + + APE LA+ +
Sbjct: 135 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 494 TEKADVYSFGMLLLEIVTGRQ 514
+ K+DV++FG+LL EI T
Sbjct: 194 SIKSDVWAFGVLLWEIATYGM 214
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-53
Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 320 KLGQGGFGTVYKGVL---PDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+LG G FG+V +GV ++A+K L + E I+ +++ +VRL+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G C +LV E L +F+ K + + E++ G+ YL E++
Sbjct: 76 GV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 129
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TAIAGTLGYMAPEYLAHGQL 493
+HRD+ A N+LL +R AKI+DFGL+++ D S+ + +A L + APE + +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 494 TEKADVYSFGMLLLEIVTGRQ 514
+ ++DV+S+G+ + E ++ Q
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQ 210
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-52
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC-- 377
+G+G FG V++G G E+AVK + R+ E+ + H+N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 378 --SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ---- 431
+ + + LV ++ + SL ++ T+T E ++ L T GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 432 -SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA---IAGTLGYMAPEY 487
K I HRD+K+ NIL+ IAD GLA I A GT YMAPE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 488 L------AHGQLTEKADVYSFGMLLLEIVTGR 513
L H + ++AD+Y+ G++ EI
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRC 215
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (452), Expect = 7e-52
Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 10/197 (5%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+LG G FG V++ G A K + + E+ +S + H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
E +++YEF+ L + D + ++ ++ E + +GL ++HE +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVH 147
Query: 439 RDIKASNILLDSRL--RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
D+K NI+ ++ K+ DFGL +S T GT + APE +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYY 205
Query: 497 ADVYSFGMLLLEIVTGR 513
D++S G+L +++G
Sbjct: 206 TDMWSVGVLSYILLSGL 222
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-51
Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 13/216 (6%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGVLPDG-----REIAVKRLFFNNRHRA-ANFYNEV 360
T E +G G FG VYKG+L +A+K L + +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
I+ H N++RL G +++ E++ N +LD+F+ + K + + ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRG 118
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED--KSHISTAIAG 478
G+ YL +HRD+ A NIL++S L K++DFGL+R ++D ++ ++
Sbjct: 119 IAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ + APE +++ + T +DV+SFG+++ E++T +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 211
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-50
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 11/211 (5%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F LG+G F TV L RE A+K L ++ E +++S ++H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
V+L + + N L ++I K + V L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF-QEDKSHISTAIAGTLGYMAPEYLA 489
+ IIHRD+K NILL+ + +I DFG A+ E K + + GT Y++PE L
Sbjct: 127 K---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520
+ +D+++ G ++ ++V G R+ N
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-50
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 319 NKLGQGGFGTVYKGVLPD----GREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVR 373
+G+G FG VY G L D AVK L + + F E I+ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 374 LLGCSCSGPES-LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
LLG S L+V ++ + L FI + + T + L +G+ +L +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK- 149
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSF---QEDKSHISTAIAGTLGYMAPEYLA 489
+ +HRD+ A N +LD + K+ADFGLAR + D H T + +MA E L
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQ 514
+ T K+DV+SFG+LL E++T
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-49
Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGRE----IAVKRLFFNNRHRA-ANFYNEVNIISSVEH 368
F + LG G FGTVYKG+ +P+G + +A+K L +A +E +++SV++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
++ RLL C L+ + +P L ++ + + + + +G+ YL
Sbjct: 71 PHVCRLL-GICLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ-EDKSHISTAIAGTLGYMAPEY 487
++ R++HRD+ A N+L+ + KI DFGLA+ E+K + + + +MA E
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ H T ++DV+S+G+ + E++T
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-49
Identities = 62/209 (29%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 315 FDEANKLGQGGFGTVYKGVLP----DGREIAVKRL---FFNNRHRAANFYNEVNIISSVE 367
KLG G FG V +G +AVK L + +F EVN + S++
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
H+NL+RL G P +V E P SL + + EG+ Y
Sbjct: 70 HRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGY 126
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH--ISTAIAGTLGYMAP 485
L + R IHRD+ A N+LL +R KI DFGL R+ ++ H + + AP
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
E L + +D + FG+ L E+ T Q
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-49
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDG---REIAVKRL-FFNNRHRAANFYNEVNIISSVE-HK 369
+ +G+G FG V K + + A+KR+ + ++ +F E+ ++ + H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-------------FDSAKAKTLTWEKRYE 416
N++ LLG L E+ P+ +L F+ ++ A TL+ ++
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
G+ YL ++ + IHRD+ A NIL+ AKIADFGL+R + T
Sbjct: 132 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186
Query: 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ +MA E L + T +DV+S+G+LL EIV+
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (429), Expect = 1e-48
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+LG G FG V++ V GR K + NE++I++ + H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
E +L+ EFL L I +A+ ++ + + EGL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 439 RDIKASNILLDSR--LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
DIK NI+ +++ KI DFGLA D+ T T + APE + +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVGFY 208
Query: 497 ADVYSFGMLLLEIVTGR 513
D+++ G+L +++G
Sbjct: 209 TDMWAIGVLGYVLLSGL 225
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-48
Identities = 62/259 (23%), Positives = 104/259 (40%), Gaps = 35/259 (13%)
Query: 285 GSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD------GR 338
GS+D E + + K+ E + + LG G FG V
Sbjct: 12 GSSDNEYFYVDFREYEYDLKW---EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI 68
Query: 339 EIAVKRLFFN-NRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFLPNQSL 396
++AVK L + +E+ +++ + H+N+V LLG L++E+ L
Sbjct: 69 QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 397 DRFIFDSAK--------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
++ + LT+E +G+ +L +
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 185
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTE 495
+HRD+ A N+L+ KI DFGLAR D ++ + + +MAPE L G T
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245
Query: 496 KADVYSFGMLLLEIVTGRQ 514
K+DV+S+G+LL EI +
Sbjct: 246 KSDVWSYGILLWEIFSLGV 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-48
Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 11/200 (5%)
Query: 320 KLGQGGFGTVYKGVLPD----GREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
+G+G FG V++G+ +A+K F E + +H ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + ++ E L F+ + +L L YL +
Sbjct: 74 IGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
R +HRDI A N+L+ S K+ DFGL+R ++ + ++ + +MAPE + + T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 495 EKADVYSFGMLLLEIVTGRQ 514
+DV+ FG+ + EI+
Sbjct: 188 SASDVWMFGVCMWEILMHGV 207
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-47
Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 27/228 (11%)
Query: 319 NKLGQGGFGTVYKGVL------PDGREIAVKRL-FFNNRHRAANFYNEVNIISSVE-HKN 370
LG G FG V + +AVK L + +E+ ++S + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD---------------SAKAKTLTWEKRY 415
+V LLG G +L++ E+ L F+ L E
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-IST 474
+G+ +L + IHRD+ A NILL KI DFGLAR + D ++ +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522
+ +MAPE + + T ++DV+S+G+ L E+ + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-47
Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 8/200 (4%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+ +G+G +G V + +A+K++ F ++ E+ I+ H+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ + +L + ++ K + L+ + + + GL Y+H +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 130
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TAIAGTLGYMAPEYLAHGQL- 493
+HRD+K SN+LL++ KI DFGLAR D H T T Y APE + + +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 494 TEKADVYSFGMLLLEIVTGR 513
T+ D++S G +L E+++ R
Sbjct: 191 TKSIDIWSVGCILAEMLSNR 210
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (414), Expect = 3e-46
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 17/222 (7%)
Query: 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVKRL------FFNNRHRAANFYNEVNIISSVE 367
F +G+GGFG VY D G+ A+K L A N ++++S+ +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
+V + + + + + + L + + + + GL +
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEH 122
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
+H + +++RD+K +NILLD +I+D GLA F + K H S GT GYMAPE
Sbjct: 123 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 176
Query: 488 LAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLL 528
L G AD +S G +L +++ G R ++ +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-45
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 315 FDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVE 367
+ +LGQG FG VY+GV +A+K + R F NE +++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIF-------DSAKAKTLTWEKRYEIILG 420
++VRLLG G +L++ E + L ++ ++ + K ++
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTAIAGT 479
+G+ YL+ + +HRD+ A N ++ KI DFG+ R E D
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ +M+PE L G T +DV+SFG++L EI T +
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 2e-44
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 14/203 (6%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F LG G FG V+ +GR A+K L + + +E ++S V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++R+ G + ++ +++ L + S + + + L YLH
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC---LALEYLHS 122
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ II+RD+K NILLD KI DFG A+ + + GT Y+APE ++
Sbjct: 123 K---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVST 175
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
+ D +SFG+L+ E++ G
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-44
Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 11/197 (5%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
LG+G FG V++ V + K + + E++I++ H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S E ++++EF+ + I + A L + + E L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 439 RDIKASNILLDSR--LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
DI+ NI+ +R KI +FG AR + + + Y APE H ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTA 183
Query: 497 ADVYSFGMLLLEIVTGR 513
D++S G L+ +++G
Sbjct: 184 TDMWSLGTLVYVLLSGI 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 155 bits (393), Expect = 3e-44
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG GG V+ L R++AVK L + F E +++ H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 376 GC----SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
+ +GP +V E++ +L + +T ++ E+I + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN 130
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI--STAIAGTLGYMAPEYLA 489
IIHRD+K +NI++ + K+ DFG+AR+ + + + + A+ GT Y++PE
Sbjct: 131 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
+ ++DVYS G +L E++TG
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 6e-44
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 7/211 (3%)
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN-RHRAANFYNEVNI 362
+ E +D + LG G F V + +A+K + + + NE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 363 ISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV 422
+ ++H N+V L SG L+ + + L I + T +I +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
+ + YLH+ + + LD + I+DFGL++ ED + + GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGY 175
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+APE LA ++ D +S G++ ++ G
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-44
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA-----ANFYNEVNIISSVEHKNLV 372
+ LG+G F TVYK + +A+K++ +R A E+ ++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
LL LV++F+ + LT +L T++GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
I+HRD+K +N+LLD K+ADFGLA+SF T T Y APE L +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGAR 176
Query: 493 L-TEKADVYSFGMLLLEIVTGRQ 514
+ D+++ G +L E++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVP 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (391), Expect = 7e-44
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---------FFNNRHRAANFYNEVNIIS 364
++ LG+G V + + P +E AVK + + EV+I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 365 SV-EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
V H N+++L + LV++ + L ++ + TL+ ++ +I+ +E
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLE 121
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
+ LH+ I+HRD+K NILLD + K+ DFG + D + GT Y+
Sbjct: 122 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYL 176
Query: 484 APEYLA------HGQLTEKADVYSFGMLLLEIVTGR 513
APE + H ++ D++S G+++ ++ G
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-43
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 10/203 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKNL 371
F + K+G+G +G VYK G +A+K RL + E++++ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
V+LL + + LV+EFL +Q L +F+ D++ + + ++GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAH 490
R++HRD+K N+L+++ K+ADFGLAR+F + + TL Y APE L
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 177
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
+ D++S G + E+VT R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-43
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 319 NKLGQGGFGTVYKG--VLPDGREIAVKRLF--FNNRHRAANFYNEVNI---ISSVEHKNL 371
++G+G +G V+K + GR +A+KR+ + EV + + + EH N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDR---FIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
VRL L + +D+ D + E +++ + GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H R++HRD+K NIL+ S + K+ADFGLAR + + T++ TL Y APE L
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
D++S G + E+ +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (387), Expect = 3e-43
Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 8/197 (4%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
K+G+G +G VYK G A+K++ + + E++I+ ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ +LV+E L L +L + G+ Y H++ R+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
+HRD+K N+L++ KIADFGLAR+F + I + + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 497 ADVYSFGMLLLEIVTGR 513
D++S G + E+V G
Sbjct: 182 IDIWSVGCIFAEMVNGT 198
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-43
Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 12/204 (5%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIIS-SVEHK 369
F LG+G FG V+ + A+K L E ++S + EH
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
L + + V E+L L I + + GL +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLH 120
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
+ I++RD+K NILLD KIADFG+ + + +T GT Y+APE L
Sbjct: 121 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILL 176
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
+ D +SFG+LL E++ G+
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-43
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
S+ + +G G FG VY+ L D G +A+K++ + R E+ I+ ++H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 373 RLLGCSCSGPES------LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
RL S E LV +++P S +TL + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 427 YLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
Y+H I HRDIK N+LLD K+ DFG A+ + ++S + Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YYRAP 191
Query: 486 -EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
T DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-42
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 319 NKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNNRHR-AANFYNEVNIISSV-EH 368
LG+G FG V ++AVK L + + ++ +E+ ++ + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEKRY 415
KN++ LLG ++ E+ +L ++ + L+ +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST- 474
G+ YL + + IHRD+ A N+L+ KIADFGLAR + T
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ +MAPE L T ++DV+SFG+LL EI T
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-41
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 319 NKLGQGGFGTVYKGV------LPDGREIAVKRLFFNNRHRAA-NFYNEVNIISSVEHKNL 371
LG+G FG V + R +AVK L H +E+ I+ + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 372 VRLLGCSCSGPES--LLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEKRYE 416
V L +C+ P +++ EF +L ++ + LT E
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI-STA 475
+G+ +L + + IHRD+ A NILL + KI DFGLAR +D ++
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
L +MAPE + T ++DV+SFG+LL EI +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-40
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL------FFNNRHRAANFYNEVNIISSVEHKNLV 372
+LG G F V K G + A K + + EV+I+ ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L + + +L+ E + L F+ + ++LT E+ E + + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL- 132
Query: 433 KIRIIHRDIKASNILLDSR----LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
+I H D+K NI+L R R KI DFGLA I GT ++APE +
Sbjct: 133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIV 188
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522
+ L +AD++S G++ +++G +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 11/212 (5%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
FD LG+G FG V GR A+K L + A+ E ++ + H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
L L + V E+ L + ++ + T E+ V L YLH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS 123
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ +++RDIK N++LD KI DFGL + D + GT Y+APE L
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED 179
Query: 491 GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522
D + G+++ E++ GR +++ E
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-40
Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 19/205 (9%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF------FNNRHRAANFYNEVNIISSV--EHKN 370
LG GGFG+VY G+ + D +A+K + + EV ++ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++RLL +L+ E + L E +E + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN 128
Query: 431 QSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++HRDIK NIL+D +R K+ DFG ++ + T GT Y PE++
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIR 182
Query: 490 HGQL-TEKADVYSFGMLLLEIVTGR 513
+ + A V+S G+LL ++V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (364), Expect = 8e-40
Identities = 41/204 (20%), Positives = 83/204 (40%), Gaps = 17/204 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+G G FG +Y G + G E+A+K +H + E I ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWC 71
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ + ++ L SL+ ++ + + + + + Y+H + IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 439 RDIKASNILLDSR---LRAKIADFGLARSFQEDKSHI------STAIAGTLGYMAPEYLA 489
RD+K N L+ I DFGLA+ +++ ++H + + GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
+ + + D+ S G +L+ G
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGS 210
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-40
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 20/202 (9%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC- 377
LG G G V + + A+K L EV + + ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 378 --SCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + L +V E L L I D + T + EI+ E + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI--- 130
Query: 435 RIIHRDIKASNILLDSRL---RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I HRD+K N+L S+ K+ DFG A+ S + T Y+APE L
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 492 QLTEKADVYSFGMLLLEIVTGR 513
+ + D++S G+++ ++ G
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGY 210
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (363), Expect = 8e-40
Identities = 32/215 (14%), Positives = 82/215 (38%), Gaps = 19/215 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
++G+G FG +++G L + +++A+K R A +E + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
++ L SL+ + + + + + + +HE+ +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVY 124
Query: 439 RDIKASNILLDSRLR-----AKIADFGLARSFQEDKSHI------STAIAGTLGYMAPEY 487
RDIK N L+ + DFG+ + +++ + ++GT YM+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522
+ + + D+ + G + + + G + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 7e-39
Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 9/199 (4%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
K+G+G +GTV+K +A+K RL ++ ++ E+ ++ ++HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
S + LV+EF F + L E + ++GL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
++HRD+K N+L++ K+A+FGLAR+F S + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 496 KADVYSFGMLLLEIVTGRQ 514
D++S G + E+ +
Sbjct: 182 SIDMWSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (359), Expect = 1e-38
Identities = 52/239 (21%), Positives = 92/239 (38%), Gaps = 19/239 (7%)
Query: 284 RGSNDAEKLVKTLNDDSLNF--KYSTLEKATGS---FDEANKLGQGGFGTVYKGV-LPDG 337
+ ++ E + + L +F K+ T + T FD LG G FG V G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 338 REIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394
A+K L + + NE I+ +V LV+L +V E++
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454
+ + + + V YLH +I+RD+K N+L+D +
Sbjct: 127 EMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI 180
Query: 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
++ DFG A+ + + GT +APE + + D ++ G+L+ E+ G
Sbjct: 181 QVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHK 369
+++ K+GQG FG V+K G+++A+K++ N E+ I+ ++H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 370 NLVRLLGCSCSGPES--------LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGT 421
N+V L+ + LV++F + K T + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS---HISTAIAG 478
+ GL Y+H +I+HRD+KA+N+L+ K+ADFGLAR+F K+ + T
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 479 TLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
TL Y PE L + D++ G ++ E+ T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-36
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G G +G V V G ++A+K+L+ F + A Y E+ ++ + H+N++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 377 CSCSGPESLLVYEF-LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
+F L + + K + L ++ ++ ++GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---G 141
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLT 494
IIHRD+K N+ ++ KI DFGLAR + T T Y APE L + T
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYT 197
Query: 495 EKADVYSFGMLLLEIVTGR 513
+ D++S G ++ E++TG+
Sbjct: 198 QTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (326), Expect = 2e-34
Identities = 43/230 (18%), Positives = 94/230 (40%), Gaps = 23/230 (10%)
Query: 303 FKYSTLEKATGSFDE---ANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN 358
+ Y + G+ D+ KLG+G + V++ + + + ++ VK L +
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKR 78
Query: 359 EVNIISSV-EHKNLVRLLGCSCSGPESL--LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
E+ I+ ++ N++ L LV+E + N + +TLT
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIR 132
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHIST 474
+ ++ L Y H I+HRD+K N+++D + ++ D+GLA + + +
Sbjct: 133 FYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--N 187
Query: 475 AIAGTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523
+ + PE + + D++S G +L ++ ++ + Y
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 315 FDEANKLGQGGFGTVYKGVL----PDGREIAVKRL----FFNNRHRAANFYNEVNIISSV 366
F+ LG G +G V+ G+ A+K L + E ++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 367 EHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+ L + L L+ +++ L + + T + + V L
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLAL 142
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+LH+ II+RDIK NILLDS + DFGL++ F D++ + GT+ YMAP
Sbjct: 143 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 486 EYLAHGQ--LTEKADVYSFGMLLLEIVTGR 513
+ + G + D +S G+L+ E++TG
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 20/203 (9%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G G G V R +A+K+L F N+ A Y E+ ++ V HKN++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 377 C------SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ LV E + L E+ ++ + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS 137
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
IIHRD+K SNI++ S KI DFGLAR+ S + T T Y APE +
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILG 192
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
E D++S G ++ E+V +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 5e-32
Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+ +G G +G+V G +AVK+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 376 G-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ + +L + + + K + LT + +I + GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--- 140
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
IIHRD+K SN+ ++ KI DFGLAR + ++ +A L
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 197
Query: 495 EKADVYSFGMLLLEIVTGR 513
+ D++S G ++ E++TGR
Sbjct: 198 QTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 3e-29
Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 31/216 (14%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLG G F TV+ + + +A+K + ++ +E+ ++ V + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 379 CSGPESLLVY---------------EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
+ LL + E L L + L + K+ L +
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL--LL 136
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSR------LRAKIADFGLARSFQEDKSHISTAIA 477
GL Y+H + IIH DIK N+L++ ++ KIAD G A + E ++
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI---- 190
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
T Y +PE L AD++S L+ E++TG
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.5 bits (221), Expect = 3e-21
Identities = 25/157 (15%), Positives = 47/157 (29%), Gaps = 20/157 (12%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRL----------FFNNRHRAANFYNEVNIISSVEH 368
+G+G V+ E VK + +F + E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
+ L +L G + Y + N L I + E++ +E +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465
+ + I+H D+ N+L+ I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 532 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.66 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.12 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.18 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.69 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=370.25 Aligned_cols=200 Identities=27% Similarity=0.484 Sum_probs=181.6
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999964 79999999998766556678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++|+|.+++.. ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998743 46999999999999999999999998 99999999999999999999999999987754432
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......||+.|+|||++.++.++.++|||||||++|||++|+.||...+
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 2345679999999999999999999999999999999999999997654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=370.03 Aligned_cols=202 Identities=30% Similarity=0.457 Sum_probs=177.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999975 68999999987553 23346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+++|+|.+++. +...+++.+++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999983 4567999999999999999999999998 99999999999999999999999999987654432
Q ss_pred -ccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 -HISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 23455789999999999987775 678999999999999999999997654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=362.25 Aligned_cols=199 Identities=30% Similarity=0.468 Sum_probs=179.0
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999975 68999999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++.. ...+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999943 456999999999999999999999998 999999999999999999999999999866543
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 2 234679999999999999999999999999999999999999997754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=360.99 Aligned_cols=201 Identities=26% Similarity=0.469 Sum_probs=168.0
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.++||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++||||++++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5789999999999999999999889999999987543 345789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+|+|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999853 3467899999999999999999999998 9999999999999999999999999998776555444
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG-RQNNRSK 519 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG-~~p~~~~ 519 (532)
.....||+.|+|||++.++.++.++|||||||++|||+|| ++||...
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 4556789999999999999999999999999999999995 5555543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=365.37 Aligned_cols=202 Identities=26% Similarity=0.405 Sum_probs=177.6
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999975 7899999998643 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999884 3457999999999999999999999998 999999999999999999999999999877544
Q ss_pred Ccc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 332 3345679999999999999999999999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=363.57 Aligned_cols=208 Identities=26% Similarity=0.412 Sum_probs=168.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeec--CCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 387 (532)
++|++.+.||+|+||+||+++.. +|+.||||++.... +...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 68999999986543 3445678999999999999999999999865 4567999
Q ss_pred EEecCCCChhHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 388 YEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQS--KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999985432 3567999999999999999999999864 23599999999999999999999999999988
Q ss_pred cCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence 754332 23456799999999999999999999999999999999999999987543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=365.80 Aligned_cols=203 Identities=29% Similarity=0.434 Sum_probs=180.1
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
+.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 68999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++|+|.+++.. ....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 99999998753 2456999999999999999999999998 99999999999999999999999999976543211
Q ss_pred cccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 233467999999999984 45688999999999999999999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=375.04 Aligned_cols=201 Identities=27% Similarity=0.463 Sum_probs=178.8
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||+||+|++. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568999999999999999999975 68999999987553 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
|+++|+|.+++.+ ...+++..+..++.|+++||.|||++ + |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999953 35699999999999999999999974 6 999999999999999999999999999866432
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
..+..+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 22456899999999999999999999999999999999999999977543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-46 Score=364.68 Aligned_cols=207 Identities=29% Similarity=0.444 Sum_probs=183.0
Q ss_pred hHHHhcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 307 TLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 307 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
+++...++|++.++||+|+||+||+|++. +++.||||++.... ...+++.+|++++++++||||+++++++.+.+..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 33344568999999999999999999976 58899999986543 34578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++|+|.+++... ....+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999998643 3467999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
............|++.|+|||++.++.++.++|||||||++|||++|..||..
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 66555545556689999999999999999999999999999999997777643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=360.07 Aligned_cols=201 Identities=33% Similarity=0.540 Sum_probs=170.2
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||+||+|+++ ..||||++... +....+.|.+|+.++++++||||+++++++. ++..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 468999999999999999999875 36999998644 3455678999999999999999999999864 467899999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|.+++.. ....+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999953 3456999999999999999999999998 9999999999999999999999999998765433
Q ss_pred cc-ccccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SH-ISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~-~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. ......||+.|||||++.. +.++.++|||||||++|||+||+.||...+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 22 3345679999999999864 358999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=360.28 Aligned_cols=200 Identities=33% Similarity=0.525 Sum_probs=176.4
Q ss_pred cCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEec
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 391 (532)
.++|++.++||+|+||+||+|++++++.||||++.... ...+.|.+|++++++++||||+++++++. ++..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence 45789999999999999999999888999999996543 34567999999999999999999999875 45679999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++|+|.+++... ....+++.++++|+.||++||.|||+++ |+||||||+||||++++.+||+|||+++........
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999987432 2346999999999999999999999998 999999999999999999999999999987665554
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~ 517 (532)
......||+.|+|||++..+.++.++|||||||++|||+||..|+.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 5556678999999999998999999999999999999999665553
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=354.07 Aligned_cols=204 Identities=24% Similarity=0.427 Sum_probs=184.3
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.++||+|+||+||+|+++++++||||++.... ...++|.+|++++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888999999997543 345689999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+|+|.+++.. ....+++..+++++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999753 3457899999999999999999999998 9999999999999999999999999998776655544
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSE 522 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~ 522 (532)
.....||+.|+|||.+..+.++.++||||||+++|||+| |+.||...+.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 555679999999999999999999999999999999998 89999876543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=351.10 Aligned_cols=200 Identities=30% Similarity=0.455 Sum_probs=171.1
Q ss_pred CCc-cccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeec----CCcc
Q 009543 313 GSF-DEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPES 384 (532)
Q Consensus 313 ~~~-~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 384 (532)
++| +..++||+|+||+||+|++. +++.||+|++... .....+.+.+|++++++++||||+++++++.+ ....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 56678999999999999975 6889999998654 34455679999999999999999999999864 3457
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc-CCCcEEEeecCCcc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLAR 463 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~-~~~~~kl~Dfgl~~ 463 (532)
++||||+++|+|.+++.. ...+++..++.++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++
T Consensus 88 ~ivmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 899999999999999953 457999999999999999999999875 4599999999999996 57899999999998
Q ss_pred ccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... .....||+.|+|||++.+ +++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 164 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred eccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 644332 235689999999999865 69999999999999999999999997643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=362.93 Aligned_cols=202 Identities=27% Similarity=0.361 Sum_probs=181.3
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++++.||+|+||+||+++.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999974 7999999999754 2334577899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|.+++. +...+++..++.++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999984 3457899999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 32 23456899999999999999999999999999999999999999987653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-45 Score=362.25 Aligned_cols=202 Identities=25% Similarity=0.392 Sum_probs=163.6
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
+.+.|++.+.||+|+||+||++++. +|+.||||++.... ......+.+|+.++++++||||+++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999975 68999999987543 233456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc---CCCcEEEeecCCcccc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD---SRLRAKIADFGLARSF 465 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~---~~~~~kl~Dfgl~~~~ 465 (532)
||+++|+|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999994 3467999999999999999999999998 99999999999994 5789999999999866
Q ss_pred CCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
..... .....||+.|+|||++.++.++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 161 DPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 54332 234679999999999999999999999999999999999999997654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.9e-45 Score=360.00 Aligned_cols=198 Identities=27% Similarity=0.403 Sum_probs=178.8
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++.+.||+|+||+||+++.+ +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999974 6999999998643 2334577899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999884 4456889999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 158 T----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp B----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 2 34689999999999999999999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4e-45 Score=365.29 Aligned_cols=202 Identities=24% Similarity=0.399 Sum_probs=182.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
-++|++.+.||+|+||.||+++.. +|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999975 7899999999877766678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC--CCcEEEeecCCccccCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS--RLRAKIADFGLARSFQED 468 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~--~~~~kl~Dfgl~~~~~~~ 468 (532)
+++|+|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999843 3456999999999999999999999998 999999999999964 678999999999877544
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 33 244679999999999999999999999999999999999999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-45 Score=358.60 Aligned_cols=204 Identities=28% Similarity=0.513 Sum_probs=166.1
Q ss_pred CCccccccccccCceeEEEEEec-CCC---EEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGR---EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
++|++.++||+|+||+||+|+++ +++ .||||++... .....+.|.+|++++++++||||+++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 46788899999999999999975 332 5889988654 344557899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++|+|.+++.. ....+++.+++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998853 3457999999999999999999999998 99999999999999999999999999987754
Q ss_pred CCccc----ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 468 DKSHI----STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 468 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
..... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 43321 123457999999999999999999999999999999998 8999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-44 Score=361.60 Aligned_cols=202 Identities=26% Similarity=0.369 Sum_probs=181.9
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999974 7999999999877666667889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEc--CCCcEEEeecCCccccCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD--SRLRAKIADFGLARSFQED 468 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~--~~~~~kl~Dfgl~~~~~~~ 468 (532)
+++|+|.+++.. ....+++.+++.|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||++......
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887732 3456999999999999999999999998 99999999999998 6789999999999887654
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 33 344578999999999999999999999999999999999999997654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-45 Score=357.26 Aligned_cols=196 Identities=29% Similarity=0.491 Sum_probs=174.0
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
.|+++++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4899999999999999999964 78899999987553 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+++|+|..++. ....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 999999987663 3467999999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....||+.|||||++.+ +.++.++|||||||++|||++|+.||...+
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 34579999999999853 468999999999999999999999997653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=353.46 Aligned_cols=203 Identities=28% Similarity=0.500 Sum_probs=175.4
Q ss_pred CCccccc-cccccCceeEEEEEec---CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEAN-KLGQGGFGTVYKGVLP---DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 387 (532)
++|.+.+ +||+|+||+||+|.++ ++..||||++... .....++|.+|++++++++||||+++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999864 3557999998754 34456789999999999999999999998864 568999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++|+|.+++.. ....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998843 3457999999999999999999999998 99999999999999999999999999988765
Q ss_pred CCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 468 DKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 468 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
.... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||...+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 4433 2234568999999999999999999999999999999998 9999987553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=350.68 Aligned_cols=202 Identities=28% Similarity=0.410 Sum_probs=179.6
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC------hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 383 (532)
..++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3468999999999999999999974 79999999986432 1235789999999999999999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC----cEEEeec
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL----RAKIADF 459 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~----~~kl~Df 459 (532)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999953 357999999999999999999999998 99999999999998877 5999999
Q ss_pred CCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 460 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp TTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 99987654332 234578999999999999999999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=352.24 Aligned_cols=196 Identities=29% Similarity=0.486 Sum_probs=167.9
Q ss_pred ccccccCceeEEEEEec---CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecCC
Q 009543 319 NKLGQGGFGTVYKGVLP---DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (532)
Q Consensus 319 ~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 393 (532)
++||+|+||+||+|.++ .++.||||++... +....+++.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 3568999998643 23345689999999999999999999999854 567899999999
Q ss_pred CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc--
Q 009543 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-- 471 (532)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-- 471 (532)
|+|.+++. +...+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999984 3456999999999999999999999998 999999999999999999999999999877554433
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
......||+.|+|||.+.++.++.++|||||||++|||+| |+.||...+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 2334578999999999999999999999999999999998 9999987543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-44 Score=359.32 Aligned_cols=198 Identities=23% Similarity=0.326 Sum_probs=179.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 388 (532)
++|++++.||+|+||+||+++++ +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 79999999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~ 468 (532)
||+++|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999853 357999999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ....||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 195 ~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 195 T----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp B----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 2 34679999999999999999999999999999999999999997654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=357.02 Aligned_cols=207 Identities=28% Similarity=0.438 Sum_probs=175.9
Q ss_pred cCCccccccccccCceeEEEEEecC-C-----CEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD-G-----REIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPE 383 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 383 (532)
.++|++.++||+|+||+||+|++.. + ..||+|++.... ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4679999999999999999999643 2 368999886543 33446789999999998 89999999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCC
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAK--------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKA 443 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp 443 (532)
.++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999964321 245899999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 444 SNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 444 ~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
+|||++.++.+||+|||+++........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||...+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876554433 3345568999999999999999999999999999999998 8999987543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=350.09 Aligned_cols=200 Identities=30% Similarity=0.473 Sum_probs=169.3
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 392 (532)
++|++.++||+|+||+||+|++++++.||||++.... ...+.|.+|+.++++++||||+++++++. ++..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 5799999999999999999999888899999986443 34578999999999999999999999985 456899999999
Q ss_pred CCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCccc
Q 009543 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (532)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~~ 472 (532)
+|+|..++... ....++|.+++.++.||++||+|||+++ |+||||||+||||+.++++||+|||+++.........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999988543 3356999999999999999999999998 9999999999999999999999999998776554444
Q ss_pred ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.....||+.|+|||++..+.++.++||||||+++|||++|..|+..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 4556789999999999999999999999999999999997666644
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-44 Score=347.10 Aligned_cols=202 Identities=28% Similarity=0.521 Sum_probs=167.8
Q ss_pred cCCccccccccccCceeEEEEEecCC-----CEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPDG-----REIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
.+.|++.+.||+|+||+||+|+++++ ..||||++.... .....+|.+|++++++++||||++++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688999999999999999997542 369999986543 344567999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||++++++.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999998753 3467999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 466 QEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
...... ......||+.|+|||++.++.++.++|||||||++|||++|..|+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 544322 22345689999999999999999999999999999999997666543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-43 Score=356.12 Aligned_cols=202 Identities=25% Similarity=0.369 Sum_probs=174.4
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHH---HHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANF---YNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+ .+|+.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999975 69999999986432 1222233 34577888889999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999953 456899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~~ 523 (532)
.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...+...
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5433 234579999999999875 468999999999999999999999998765443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-43 Score=344.61 Aligned_cols=204 Identities=25% Similarity=0.432 Sum_probs=171.2
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCc---
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE--- 383 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 383 (532)
+.++|++.+.||+|+||+||+|++ .+|+.||||++... +....+.+.+|+++++.++||||+++++++.....
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357899999999999999999996 47999999999654 23445679999999999999999999999876543
Q ss_pred -ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 384 -SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 384 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
.++||||+++++|.+++.. ...+++.+++.++.||++||.|||+++ |+||||||+|||++.++..+|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 6899999999999998843 457999999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 765433322 3345679999999999999899999999999999999999999998654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=349.00 Aligned_cols=202 Identities=27% Similarity=0.397 Sum_probs=177.7
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC---hhhHHHHHHHHhHhh-cCccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIIS-SVEHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv 387 (532)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 68999999996532 233456677777665 68999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCC
Q 009543 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~ 467 (532)
|||+++|+|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999953 456899999999999999999999998 99999999999999999999999999986654
Q ss_pred CCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
... ..+...||+.|+|||++.++.++.++|||||||++|||++|+.||...+.
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 156 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 332 23456799999999999999999999999999999999999999987553
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.5e-43 Score=338.69 Aligned_cols=201 Identities=24% Similarity=0.429 Sum_probs=177.4
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh---------hhHHHHHHHHhHhhcCc-cceeeeeeeeeecC
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---------HRAANFYNEVNIISSVE-HKNLVRLLGCSCSG 381 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 381 (532)
++|++.+.||+|+||+||+++.. +|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999974 789999999865421 12346889999999997 99999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
+..++||||+++|+|.+++.. ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999953 457999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLA------HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
++....... .....||+.|+|||.+. ...++.++||||+||++|||++|+.||...+.
T Consensus 157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~ 220 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220 (277)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence 987755332 34467999999999885 33578899999999999999999999987653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=341.11 Aligned_cols=205 Identities=23% Similarity=0.377 Sum_probs=165.8
Q ss_pred cCCccccccccccCceeEEEEEecC----CCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.++|++.+.||+|+||+||+|++.. +..||||++... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3579999999999999999998742 346899988644 3444577999999999999999999999985 567899
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998743 3467899999999999999999999998 9999999999999999999999999998776
Q ss_pred CCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 009543 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSE 522 (532)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~ 522 (532)
...........||+.|+|||.+.++.++.++|||||||++|||++ |+.||...+..
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 555444555678999999999999999999999999999999998 89999876543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-43 Score=347.91 Aligned_cols=211 Identities=27% Similarity=0.453 Sum_probs=179.2
Q ss_pred HHHhcCCccccccccccCceeEEEEEec------CCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeec
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCS 380 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 380 (532)
++...++|++.++||+|+||+||+|+++ +++.||||++.... ....+++.+|++++++++||||+++++++.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3334678999999999999999999864 35789999987543 3345679999999999999999999999999
Q ss_pred CCcceEEEEecCCCChhHHhhhcc---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 009543 381 GPESLLVYEFLPNQSLDRFIFDSA---------------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439 (532)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~ 439 (532)
....+++|||+++|+|.+++.... ....+++..++.|+.|++.||+|||+++ |+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 999999999999999999996421 1245899999999999999999999998 9999
Q ss_pred cCCCCCEEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 009543 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR-QNNR 517 (532)
Q Consensus 440 Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~-~p~~ 517 (532)
||||+|||++.++.+||+|||+++........ ..+...|++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 99999999999999999999999866443322 334567899999999999999999999999999999999996 5676
Q ss_pred CCCC
Q 009543 518 SKNS 521 (532)
Q Consensus 518 ~~~~ 521 (532)
..+.
T Consensus 245 ~~~~ 248 (301)
T d1lufa_ 245 GMAH 248 (301)
T ss_dssp TSCH
T ss_pred CCCH
Confidence 6543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=344.08 Aligned_cols=202 Identities=24% Similarity=0.354 Sum_probs=178.6
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.++|++.+.||+|+||+||+|.+. +++.||||++..... ....+.+|+++|+.++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999975 688999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC--CcEEEeecCCccccCCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR--LRAKIADFGLARSFQED 468 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~--~~~kl~Dfgl~~~~~~~ 468 (532)
+++|+|.+++.. ....+++.+++.++.||++||.|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999943 3346999999999999999999999998 9999999999999854 48999999999876543
Q ss_pred CcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus 158 ~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 158 DN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp CE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred Cc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 32 2345689999999999999999999999999999999999999987553
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=346.25 Aligned_cols=204 Identities=26% Similarity=0.480 Sum_probs=171.5
Q ss_pred CCccccccccccCceeEEEEEec-CCC----EEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 386 (532)
.+|+++++||+|+||+||+|++. +|+ +||+|++... +....+++.+|++++++++||||+++++++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46999999999999999999974 444 5899988643 34456789999999999999999999999876 46788
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccC
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~ 466 (532)
++||+.+++|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 9999999999998854 4567999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 009543 467 EDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSE 522 (532)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~ 522 (532)
..... ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||...+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 54433 2334568999999999999999999999999999999998 89999876543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-43 Score=337.21 Aligned_cols=202 Identities=31% Similarity=0.485 Sum_probs=165.8
Q ss_pred CCccccccccccCceeEEEEEec--CC--CEEEEEEeecc---ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcce
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP--DG--REIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 385 (532)
++|++.+.||+|+||+||+|++. ++ .+||||++... +....++|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56999999999999999999864 23 36899988643 33445789999999999999999999999965 5778
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcccc
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~ 465 (532)
+||||+++|++.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998754 3456999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCcc--cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 466 QEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
...... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 555433 2334567889999999999999999999999999999998 899997654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=339.85 Aligned_cols=197 Identities=29% Similarity=0.412 Sum_probs=168.0
Q ss_pred ccccccccCceeEEEEEec-CCCEEEEEEeeccChhh-----HHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 317 EANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHR-----AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 317 ~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
.+++||+|+||+||+|++. +|+.||||++....... .+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999975 69999999986543221 24688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
++++++..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998777665 34567899999999999999999999998 99999999999999999999999999987654432
Q ss_pred ccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. .....||+.|+|||++... .++.++|||||||++|||++|+.||...+
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 205 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence 2 2345799999999998654 57999999999999999999999997643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-43 Score=334.79 Aligned_cols=199 Identities=29% Similarity=0.459 Sum_probs=165.6
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeec-CCcceEEEEec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPESLLVYEFL 391 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 391 (532)
++|++.+.||+|+||.||+|++ .|++||||+++.. ...+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4688899999999999999998 4789999999643 344679999999999999999999998865 45689999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++|+|.+++... ....+++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 999999999542 2345899999999999999999999988 9999999999999999999999999998654332
Q ss_pred cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 009543 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSE 522 (532)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~~ 522 (532)
....+++.|+|||++.++.++.++||||||+++|||+| |+.||...+..
T Consensus 158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence 23457889999999999999999999999999999998 78888765443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=342.27 Aligned_cols=199 Identities=26% Similarity=0.317 Sum_probs=170.8
Q ss_pred cCCccccc-cccccCceeEEEEEe-cCCCEEEEEEeeccChhhHHHHHHHHhHhhc-Cccceeeeeeeeeec----CCcc
Q 009543 312 TGSFDEAN-KLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISS-VEHKNLVRLLGCSCS----GPES 384 (532)
Q Consensus 312 ~~~~~~~~-~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~ 384 (532)
.++|++.+ .||+|+||+||+|++ .+++.||||++... ..+.+|++++.+ .+||||+++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46798876 599999999999997 47899999998532 356789988765 589999999999865 4567
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---CCcEEEeecCC
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGL 461 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~~~~kl~Dfgl 461 (532)
++||||++||+|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999542 2357999999999999999999999998 999999999999986 56799999999
Q ss_pred ccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 987654432 2446799999999999999999999999999999999999999976543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=337.72 Aligned_cols=210 Identities=29% Similarity=0.396 Sum_probs=167.7
Q ss_pred HHHhcCCccccccccccCceeEEEEEec------CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcC-ccceeeeeeeeee
Q 009543 308 LEKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSC 379 (532)
Q Consensus 308 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 379 (532)
++...++|++.++||+|+||.||+|++. +++.||||++... .....+.+.+|..++.++ +|+||+++++++.
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3334568999999999999999999863 3468999998654 334456788888888777 6899999999876
Q ss_pred cC-CcceEEEEecCCCChhHHhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 009543 380 SG-PESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (532)
Q Consensus 380 ~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (532)
+. ...++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+++ |+||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccc
Confidence 64 467899999999999999964321 345899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCC
Q 009543 446 ILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR-QNNRSKN 520 (532)
Q Consensus 446 iLl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~-~p~~~~~ 520 (532)
|||++++++||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||. .||....
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999876544433 334567999999999999999999999999999999999975 5776543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-42 Score=336.22 Aligned_cols=202 Identities=28% Similarity=0.476 Sum_probs=172.1
Q ss_pred CCccccccccccCceeEEEEEe-cCCCEEEEEEeeccCh--hhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|+++++||+|+||+||+|++ .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999997 4799999999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
|+.++.+. ++.. .....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765444 4322 34567999999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 2 234457999999999876655 5889999999999999999999997643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-41 Score=332.27 Aligned_cols=201 Identities=27% Similarity=0.433 Sum_probs=173.9
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 390 (532)
++|+++++||+|+||+||+|++++|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999996553 23357899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCc
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~ 470 (532)
+.++.+..+. .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9888777766 34577999999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 471 HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 2334468999999999865 457899999999999999999999997653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=334.54 Aligned_cols=201 Identities=28% Similarity=0.407 Sum_probs=165.2
Q ss_pred CCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC----cceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----ESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 388 (532)
.+|.+.++||+|+||+||+|++ +|+.||||++..... .......|+..+..++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4577889999999999999997 689999999864432 2223345666777889999999999997654 468999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-----SKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
||+++|+|.+++.+ ..++|.++++++.|++.||.|||+. ...+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 4689999999999999999999974 12359999999999999999999999999998
Q ss_pred ccCCCCcc---cccccccccccccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 464 SFQEDKSH---ISTAIAGTLGYMAPEYLAHG------QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 464 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
........ ......||+.|+|||++.+. .++.++|||||||++|||+||..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 77554332 23456799999999998754 2577999999999999999999888653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=331.43 Aligned_cols=207 Identities=28% Similarity=0.403 Sum_probs=174.5
Q ss_pred cCCccccccccccCceeEEEEEecC--------CCEEEEEEeeccCh-hhHHHHHHHHhHhhcC-ccceeeeeeeeeecC
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLPD--------GREIAVKRLFFNNR-HRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 381 (532)
.++|++.+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999998532 24799999976543 4457788999999888 899999999999999
Q ss_pred CcceEEEEecCCCChhHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEE
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl 448 (532)
+..++||||+++|+|.+++.... ....+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999996432 1356899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 009543 449 DSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (532)
Q Consensus 449 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~~ 521 (532)
+.++.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |+.||...+.
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999877554433 3345678999999999999999999999999999999998 7888876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-41 Score=330.50 Aligned_cols=197 Identities=31% Similarity=0.484 Sum_probs=169.5
Q ss_pred cccccccCceeEEEEEecCC----CEEEEEEeec-cChhhHHHHHHHHhHhhcCccceeeeeeeeeec-CCcceEEEEec
Q 009543 318 ANKLGQGGFGTVYKGVLPDG----REIAVKRLFF-NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPESLLVYEFL 391 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~g----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 391 (532)
.++||+|+||+||+|++.++ ..||||++.. .+....++|.+|++++++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 2589999864 355566889999999999999999999999875 45789999999
Q ss_pred CCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCCcc
Q 009543 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (532)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~~~ 471 (532)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998853 4556889999999999999999999998 999999999999999999999999999876544322
Q ss_pred ---cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 472 ---ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 472 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
......||+.|+|||.+..+.++.++||||||+++|||+||+.||...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 233457899999999999999999999999999999999988887653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-42 Score=331.35 Aligned_cols=199 Identities=28% Similarity=0.398 Sum_probs=170.2
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccCh------hhHHHHHHHHhHhhcCc--cceeeeeeeeeecCC
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR------HRAANFYNEVNIISSVE--HKNLVRLLGCSCSGP 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 382 (532)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999974 789999999864321 11234678999999986 999999999999999
Q ss_pred cceEEEEecCC-CChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCC-CcEEEeecC
Q 009543 383 ESLLVYEFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFG 460 (532)
Q Consensus 383 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~-~~~kl~Dfg 460 (532)
..++||||+.+ +++.+++. +...+++.+++.++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 57777773 3457999999999999999999999998 9999999999999855 799999999
Q ss_pred CccccCCCCcccccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 009543 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSK 519 (532)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvll~el~tG~~p~~~~ 519 (532)
+++...... .+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 998654332 345679999999999987665 67799999999999999999999763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=332.62 Aligned_cols=207 Identities=28% Similarity=0.429 Sum_probs=178.8
Q ss_pred hcCCccccccccccCceeEEEEEe------cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCC
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 382 (532)
..++|++.++||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 346899999999999999999985 246789999997543 34456799999999999 6999999999999999
Q ss_pred cceEEEEecCCCChhHHhhhcc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEE
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSA---------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiL 447 (532)
..++||||+++|+|.+++.... ....+++..++.++.||++||.|||+++ ++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999996432 2336899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009543 448 LDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKN 520 (532)
Q Consensus 448 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~t-G~~p~~~~~ 520 (532)
++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||+| |++||...+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999977654433 3455678999999999999999999999999999999999 555565543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-41 Score=331.04 Aligned_cols=206 Identities=27% Similarity=0.461 Sum_probs=178.5
Q ss_pred cCCccccccccccCceeEEEEEec------CCCEEEEEEeecc-ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcc
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 384 (532)
.++|++.++||+|+||+||+|.++ +++.||||++... .......+.+|++++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 468899999999999999999863 3578999999754 334446789999999999999999999999999999
Q ss_pred eEEEEecCCCChhHHhhhc-------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEe
Q 009543 385 LLVYEFLPNQSLDRFIFDS-------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~ 457 (532)
++||||+++|+|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998542 22345799999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCcc-cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCC
Q 009543 458 DFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR-QNNRSKN 520 (532)
Q Consensus 458 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~-~p~~~~~ 520 (532)
|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||+||. .||...+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 99999876554433 334456899999999999999999999999999999999985 6776544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=333.44 Aligned_cols=203 Identities=31% Similarity=0.452 Sum_probs=171.1
Q ss_pred CCccccccccccCceeEEEEEec-CCC--EEEEEEeecc-ChhhHHHHHHHHhHhhcC-ccceeeeeeeeeecCCcceEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGR--EIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 387 (532)
++|++.++||+|+||+||+|+++ +|. .||||++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57889999999999999999976 444 4788887543 334456799999999998 799999999999999999999
Q ss_pred EEecCCCChhHHhhhc-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcE
Q 009543 388 YEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (532)
Q Consensus 388 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~ 454 (532)
|||+++|+|.++++.. .....+++.++++++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23467999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCC
Q 009543 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ-NNRSKN 520 (532)
Q Consensus 455 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~-p~~~~~ 520 (532)
||+|||+++....... .....||..|+|||.+.++.++.++||||||+++|||++|.. ||...+
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 9999999986543322 233468999999999999999999999999999999999765 676544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-41 Score=330.49 Aligned_cols=202 Identities=27% Similarity=0.442 Sum_probs=169.4
Q ss_pred cCCccccccccccCceeEEEEEec-C-CCEEEEEEeeccC--hhhHHHHHHHHhHhhcC---ccceeeeeeeeeec----
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-D-GREIAVKRLFFNN--RHRAANFYNEVNIISSV---EHKNLVRLLGCSCS---- 380 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 380 (532)
.++|+++++||+|+||+||+|++. + ++.||||++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999973 4 5679999986542 22233566777777665 79999999998853
Q ss_pred -CCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeec
Q 009543 381 -GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (532)
Q Consensus 381 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Df 459 (532)
....+++|||++++++..... .....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 345789999999887765442 34567899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 460 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 9987654332 3345679999999999999999999999999999999999999998654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=330.46 Aligned_cols=203 Identities=24% Similarity=0.408 Sum_probs=170.8
Q ss_pred hcCCccccccccccCceeEEEEEe-cCCCEEEEEEeeccC-hhhHHHHHHHHhHhhcCccceeeeeeeeeecCC----cc
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----ES 384 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 384 (532)
+..+|+++++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999999996 479999999996543 444578899999999999999999999986543 33
Q ss_pred eEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
+++++++.+|+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 566777889999999843 46999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc--ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 465 FQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
....... ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 6443222 2345679999999999854 467899999999999999999999997754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=327.65 Aligned_cols=202 Identities=27% Similarity=0.437 Sum_probs=169.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeec--------C
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--------G 381 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 381 (532)
++|+++++||+|+||+||+|++. +|+.||||++... ......++.+|+.++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999974 7999999998644 23344678999999999999999999998755 3
Q ss_pred CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
...+++|||++++.+..+. .....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4578999999888776554 34567899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcc---cccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSH---ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++........ ......||+.|+|||.+... .++.++|||||||++|||++|+.||...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 9876543322 22345799999999998754 68999999999999999999999997654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-40 Score=327.53 Aligned_cols=198 Identities=27% Similarity=0.489 Sum_probs=166.6
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecCC-----
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----- 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 382 (532)
..++|+++++||+|+||+||+|++. +|+.||||++... +....+.+.+|+.+|+.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999975 6999999999643 3344567899999999999999999999987654
Q ss_pred -cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCC
Q 009543 383 -ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (532)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl 461 (532)
..++||||+ +.+|..+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 468999999 567777663 356999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
++...... +...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 98765432 34678999999999876 456899999999999999999999997753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.7e-40 Score=319.14 Aligned_cols=203 Identities=17% Similarity=0.301 Sum_probs=174.0
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCcc-ceeeeeeeeeecCCcceEEEE
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEH-KNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 389 (532)
.++|++.++||+|+||+||+|++. +|+.||||++..... ...+.+|++.+..++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 689999998854432 2356788888888865 899999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC-----CCcEEEeecCCccc
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-----RLRAKIADFGLARS 464 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~-----~~~~kl~Dfgl~~~ 464 (532)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6899988853 3457999999999999999999999998 999999999999974 57899999999987
Q ss_pred cCCCCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 465 FQEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 465 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
....... ......||+.|||||.+.+..++.++||||||+++|||++|+.||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 6543221 233467999999999999999999999999999999999999999865443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-40 Score=327.77 Aligned_cols=198 Identities=28% Similarity=0.413 Sum_probs=167.1
Q ss_pred CccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeeeeeeeecC------CcceE
Q 009543 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------PESLL 386 (532)
Q Consensus 314 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 386 (532)
+|+..++||+|+||+||+|++. +|+.||||++...... ..+|++++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999975 6999999999755422 34799999999999999999998543 23689
Q ss_pred EEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCcccc
Q 009543 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSF 465 (532)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~~ 465 (532)
||||++++.+..+.........+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755554433345667999999999999999999999998 99999999999999875 8999999999876
Q ss_pred CCCCccccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 466 QEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... ....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 544332 34578999999998764 578999999999999999999999997654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=327.04 Aligned_cols=204 Identities=26% Similarity=0.371 Sum_probs=176.5
Q ss_pred CCccccccccccCceeEEEEEe----cCCCEEEEEEeecc----ChhhHHHHHHHHhHhhcCcc-ceeeeeeeeeecCCc
Q 009543 313 GSFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFN----NRHRAANFYNEVNIISSVEH-KNLVRLLGCSCSGPE 383 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 383 (532)
++|++.++||+|+||+||+++. .+|+.||||++... +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999985 25889999988543 22334668899999999977 899999999999999
Q ss_pred ceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCcc
Q 009543 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (532)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~ 463 (532)
.+++|||+++|+|.+++.. ...+++...+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999843 456788999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcccccccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 009543 464 SFQEDKSHISTAIAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (532)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvll~el~tG~~p~~~~~~~ 522 (532)
..............|++.|++||.+... .++.++|||||||++|||++|+.||...+..
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 7765555445567899999999998754 4688999999999999999999999776443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-39 Score=314.19 Aligned_cols=199 Identities=26% Similarity=0.413 Sum_probs=175.2
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecCCcceEEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 389 (532)
++|+++++||+|+||+||+|++. +++.||||++.... .....++.+|+.+++.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 78999999986543 3446789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 009543 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (532)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~~~~~~ 469 (532)
++.+++|..++. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888773 4567899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Q 009543 470 SHISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRS 518 (532)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvll~el~tG~~p~~~ 518 (532)
.. .....+++.|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred cc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 32 23345788999999987654 68999999999999999999999744
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-39 Score=313.99 Aligned_cols=201 Identities=22% Similarity=0.369 Sum_probs=167.1
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceeeee-eeeeecCCcceEEEEe
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL-LGCSCSGPESLLVYEF 390 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e~ 390 (532)
++|++.++||+|+||+||+|++. +|+.||||++..... ..++.+|+++++.++|+|++.. ..+..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999974 689999998865433 2457889999999987775555 5555677788899999
Q ss_pred cCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcC---CCcEEEeecCCccccCC
Q 009543 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGLARSFQE 467 (532)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~---~~~~kl~Dfgl~~~~~~ 467 (532)
+ +++|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+++.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 8 4566665532 3467999999999999999999999998 999999999999864 45799999999998754
Q ss_pred CCcc------cccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 009543 468 DKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (532)
Q Consensus 468 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~~ 521 (532)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 4321 23456799999999999999999999999999999999999999987543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-38 Score=317.13 Aligned_cols=194 Identities=21% Similarity=0.363 Sum_probs=168.5
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeeec--CCcceEEE
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCS--GPESLLVY 388 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 388 (532)
++|+++++||+|+||+||+|++. +|+.||||++.... .+++.+|+.+|+.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999974 78999999986443 457889999999995 9999999999874 35688999
Q ss_pred EecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCC-cEEEeecCCccccCC
Q 009543 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQE 467 (532)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~-~~kl~Dfgl~~~~~~ 467 (532)
||+++++|..+. +.+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 45899999999999999999999998 99999999999998755 699999999987654
Q ss_pred CCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 468 DKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
... .....+|+.|+|||.+... .++.++||||+|+++|||++|+.||....
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 432 2445789999999998764 57999999999999999999999997654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=318.77 Aligned_cols=199 Identities=27% Similarity=0.448 Sum_probs=168.7
Q ss_pred hcCCccccccccccCceeEEEEEec-CCCEEEEEEeeccC--hhhHHHHHHHHhHhhcCccceeeeeeeeeecC-----C
Q 009543 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-----P 382 (532)
Q Consensus 311 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 382 (532)
++++|+++++||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3578999999999999999999964 79999999997543 34456789999999999999999999998643 3
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..+++++|+.+|+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4577888899999999983 356999999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCcccccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
...... .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 754322 2346789999999987664 56889999999999999999999997654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=316.78 Aligned_cols=198 Identities=29% Similarity=0.402 Sum_probs=161.9
Q ss_pred cCCccccccccccCceeEEEEEec-CCCEEEEEEeecc--ChhhHHHHHHHHhHhhcCccceeeeeeeeeecC------C
Q 009543 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------P 382 (532)
Q Consensus 312 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 382 (532)
.++|+++++||+|+||+||+|++. +|+.||||++... +......+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999975 6999999999754 344456789999999999999999999998643 5
Q ss_pred cceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEEeecCCc
Q 009543 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (532)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~ 462 (532)
..++||||+.++.+.. + ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~-~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV-I-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHH-H-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHh-h-----hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 6799999997765543 3 245899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+...... ..+...+|+.|+|||.+.+..++.++||||+||+++||++|+.||...+
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 8655433 2344578999999999999999999999999999999999999997654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-33 Score=283.61 Aligned_cols=200 Identities=24% Similarity=0.267 Sum_probs=162.6
Q ss_pred CCccccccccccCceeEEEEEec-CCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-----------cceeeeeeeeeec
Q 009543 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-----------HKNLVRLLGCSCS 380 (532)
Q Consensus 313 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 380 (532)
++|+++++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999974 79999999986543 33467788888888775 5789999988765
Q ss_pred C--CcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCEEEcCCCc----
Q 009543 381 G--PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLR---- 453 (532)
Q Consensus 381 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NiLl~~~~~---- 453 (532)
. ...++++++...+..............+++..+..++.||++||.|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4456777777666554444444566789999999999999999999998 66 999999999999987653
Q ss_pred --EEEeecCCccccCCCCcccccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 009543 454 --AKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (532)
Q Consensus 454 --~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvll~el~tG~~p~~~~~ 520 (532)
+||+|||.+....... ....||+.|+|||.+....++.++||||+||+++||++|+.||....
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 9999999987654332 34678999999999999999999999999999999999999997643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.1e-24 Score=196.08 Aligned_cols=164 Identities=16% Similarity=0.171 Sum_probs=121.4
Q ss_pred ccccccccccCceeEEEEEecCCCEEEEEEeeccCh------------------hhHHHHHHHHhHhhcCccceeeeeee
Q 009543 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR------------------HRAANFYNEVNIISSVEHKNLVRLLG 376 (532)
Q Consensus 315 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~ 376 (532)
+.+.++||+|+||+||+|++.+|++||||+++.... .......+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999998999999998753210 11233556888999999999988876
Q ss_pred eeecCCcceEEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCEEEcCCCcEEE
Q 009543 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (532)
Q Consensus 377 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NiLl~~~~~~kl 456 (532)
+. ..+++|||+++..+.+ +++.....++.|++++|.|||+++ |+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 53 3479999998865533 233445678999999999999998 9999999999999965 5899
Q ss_pred eecCCccccCCCCccccccccccccccc------ccccccCCCCchhhHHHHHHHH
Q 009543 457 ADFGLARSFQEDKSHISTAIAGTLGYMA------PEYLAHGQLTEKADVYSFGMLL 506 (532)
Q Consensus 457 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Dv~SlGvll 506 (532)
+|||++......... .|.. .|.+ .+.|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999765433211 1111 1111 35678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.66 E-value=3.4e-08 Score=92.08 Aligned_cols=149 Identities=16% Similarity=0.091 Sum_probs=102.2
Q ss_pred hHHHhcCCccccccccccCceeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCc-cceeeeeeeeeecCCcce
Q 009543 307 TLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESL 385 (532)
Q Consensus 307 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 385 (532)
++...-..|+..+..+-+....||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4455556777777655555678999765 56778888876554444455677888877663 333567777777788889
Q ss_pred EEEEecCCCChhHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 009543 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS--------------------------------- 432 (532)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------- 432 (532)
+||++++|.++.+.... ......++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999888665421 1112234555566666666421
Q ss_pred -----------------------CCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 433 -----------------------KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 433 -----------------------~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877778999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.12 E-value=5.6e-06 Score=76.06 Aligned_cols=131 Identities=16% Similarity=0.131 Sum_probs=85.4
Q ss_pred cccccCc-eeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCcc--ceeeeeeeeeecCCcceEEEEecCCCCh
Q 009543 320 KLGQGGF-GTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH--KNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (532)
Q Consensus 320 ~lG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L 396 (532)
.+..|.. ..||+...+++..+++|....... ..+..|...++.+.. -.+.+++.+..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 678999988888899997654432 235667777766642 2356677777778888999999998766
Q ss_pred hHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 009543 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE---------------------------------------------- 430 (532)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~---------------------------------------------- 430 (532)
.+.. .... .++.++.+.|.-||+
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 1111 112233333333332
Q ss_pred -----C----CCCCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 431 -----Q----SKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 431 -----~----~~~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
. .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 123489999999999999887778999997754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=5.5e-05 Score=74.13 Aligned_cols=77 Identities=14% Similarity=0.160 Sum_probs=48.6
Q ss_pred cccccccCceeEEEEEecC-CCEEEEEEeeccC-------hhhHHHHHHHHhHhhcCc-c--ceeeeeeeeeecCCcceE
Q 009543 318 ANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNN-------RHRAANFYNEVNIISSVE-H--KNLVRLLGCSCSGPESLL 386 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~l 386 (532)
.+.||.|....||+....+ ++.+++|.-...- .....+...|.+.|..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998754 6789999643211 112234456777776552 2 345555544 4556789
Q ss_pred EEEecCCCCh
Q 009543 387 VYEFLPNQSL 396 (532)
Q Consensus 387 v~e~~~~g~L 396 (532)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.18 E-value=0.00065 Score=64.36 Aligned_cols=135 Identities=16% Similarity=0.119 Sum_probs=76.9
Q ss_pred eeEEEEEecCCCEEEEEEeeccChhhHHHHHHHHhHhhcCccceee--eeee-----eeecCCcceEEEEecCCCChhH-
Q 009543 327 GTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV--RLLG-----CSCSGPESLLVYEFLPNQSLDR- 398 (532)
Q Consensus 327 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~~~-----~~~~~~~~~lv~e~~~~g~L~~- 398 (532)
-.||+.+.++|+.+++|+.+.. ....+++..|...+..|...++. ..+. .....+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799999999999999988654 23345677788888777533322 1111 2234556778999998754321
Q ss_pred ---Hh----------hh------ccCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCCe
Q 009543 399 ---FI----------FD------SAKAKTLTWE----------------------KRYEIILGTVEGLVYL-HEQSKIRI 436 (532)
Q Consensus 399 ---~l----------~~------~~~~~~l~~~----------------------~~~~i~~~ia~~l~~L-H~~~~~~i 436 (532)
.+ +. .......++. .....+.++...+.-. .+..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 00 0001111111 1122223333322222 12223458
Q ss_pred EEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 437 IHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 437 iH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45889997764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.69 E-value=0.0018 Score=62.97 Aligned_cols=73 Identities=16% Similarity=0.323 Sum_probs=49.5
Q ss_pred cccccccCceeEEEEEecC--------CCEEEEEEeeccChhhHHHHHHHHhHhhcCcccee-eeeeeeeecCCcceEEE
Q 009543 318 ANKLGQGGFGTVYKGVLPD--------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVY 388 (532)
Q Consensus 318 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 388 (532)
++.|+.|-.-.+|+...++ .+.|.+++.- . ........+|..+++.+.-.++ .++++++. -.+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence 4678889999999998654 3456666654 2 2233456688888888753344 46676653 37899
Q ss_pred EecCCCCh
Q 009543 389 EFLPNQSL 396 (532)
Q Consensus 389 e~~~~g~L 396 (532)
||++|..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.69 E-value=0.057 Score=49.91 Aligned_cols=31 Identities=23% Similarity=0.324 Sum_probs=27.3
Q ss_pred CCeEEccCCCCCEEEcCCCcEEEeecCCccc
Q 009543 434 IRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (532)
Q Consensus 434 ~~iiH~Dlkp~NiLl~~~~~~kl~Dfgl~~~ 464 (532)
..+||+|+.+.||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4599999999999999988788999998754
|